data_2myu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2myu _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.8 ttm . . . . . 0 N--CA 1.503 2.207 0 CA-C-O 119.739 -0.172 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -88.01 83.2 7.06 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.3 1.04 . . . . 0.0 110.207 176.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -73.44 150.16 41.87 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 121.764 -0.585 . . . . 0.0 111.563 -175.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.6 t -109.7 146.86 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.346 1.058 . . . . 0.0 111.124 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.428 ' HE1' ' CD2' ' A' ' 68' ' ' PHE . 46.2 tpp -131.36 118.39 20.22 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.747 0.819 . . . . 0.0 110.643 168.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -88.41 131.32 34.9 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.302 1.041 . . . . 0.0 111.185 169.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.3 t -127.06 126.37 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.981 1.312 . . . . 0.0 110.643 -173.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.1 m -140.66 172.0 13.32 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.46 1.104 . . . . 0.0 111.303 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.95 -46.3 82.16 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.779 -1.201 . . . . 0.0 109.986 169.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -98.66 113.71 25.89 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.126 1.371 . . . . 0.0 109.821 169.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -62.28 -41.84 98.83 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 119.474 1.034 . . . . 0.0 109.43 169.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.2 p -46.35 -32.97 3.49 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.972 2.509 . . . . 0.0 116.894 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.4 p -98.99 -97.39 0.23 Allowed 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 123.832 0.853 . . . . 0.0 110.233 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -64.22 -44.1 92.95 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.859 1.264 . . . . 0.0 113.792 -169.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.9 m -63.11 -45.39 92.25 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.789 1.177 . . . . 0.0 111.889 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -63.81 -39.57 94.56 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 171.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 71.7 mtp -61.44 -44.76 96.55 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 120.769 -1.207 . . . . 0.0 110.994 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.52 -31.53 69.81 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 173.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -66.52 -50.44 63.19 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 119.478 1.036 . . . . 0.0 109.196 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.02 -45.48 95.85 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 118.868 -0.962 . . . . 0.0 112.634 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -64.17 -40.03 95.26 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.521 1.161 . . . . 0.0 112.416 173.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.44 -32.27 66.16 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.492 -1.38 . . . . 0.0 111.006 -176.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -62.42 -56.0 22.41 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 126.273 1.829 . . . . 0.0 110.159 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 67.9 p -70.46 -14.95 62.75 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.5 mt -100.98 -4.58 27.26 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.234 1.013 . . . . 0.0 113.62 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.58 5.37 1.15 Allowed Glycine 0 CA--C 1.534 1.256 0 N-CA-C 117.166 1.626 . . . . 0.0 117.166 -169.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.6 126.74 22.83 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.38 1.59 . . . . 0.0 112.539 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.9 -3.91 63.24 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 124.759 1.171 . . . . 0.0 115.877 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -87.61 -59.71 2.17 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 119.254 1.527 . . . . 0.0 110.613 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 pp -140.4 175.57 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 127.317 2.247 . . . . 0.0 109.538 170.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.78 125.98 42.89 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.998 0.904 . . . . 0.0 111.547 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.4 m -90.13 151.14 3.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 124.268 1.027 . . . . 0.0 112.295 169.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.72 152.81 39.43 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.439 1.095 . . . . 0.0 111.621 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.2 p -130.26 133.1 46.26 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.348 1.459 . . . . 0.0 114.925 174.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.3 p -134.47 173.3 11.8 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 127.618 2.367 . . . . 0.0 110.399 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.8 176.89 47.83 Favored Glycine 0 CA--C 1.525 0.68 0 O-C-N 120.248 -1.533 . . . . 0.0 114.7 169.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 27.9 mt -65.84 -34.09 77.35 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.035 0.534 . . . . 0.0 111.78 -175.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -117.39 116.3 26.91 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.981 2.112 . . . . 0.0 109.63 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.2 p -77.53 48.91 0.69 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.282 2.233 . . . . 0.0 111.917 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.7 t -70.72 165.72 22.41 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.038 -1.437 . . . . 0.0 112.67 -170.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -64.99 159.14 23.71 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 125.024 1.329 . . . . 0.0 112.495 -175.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.7 m -54.39 114.44 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.093 -1.004 . . . . 0.0 109.133 169.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -66.44 129.54 94.15 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -168.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -60.01 -39.64 68.76 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.475 2.784 . . . . 0.0 113.682 -171.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.4 m -79.33 -32.23 43.3 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.86 -0.525 . . . . 0.0 110.986 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.0 -40.91 87.43 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.832 -1.168 . . . . 0.0 112.568 173.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.9 mt -53.02 -39.82 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 120.613 1.551 . . . . 0.0 110.614 172.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.55 -64.31 0.89 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.432 0.693 . . . . 0.0 112.781 172.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.8 mmt -65.11 -23.68 67.22 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -171.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 89.7 mmm -85.59 -34.55 21.42 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.584 0.754 . . . . 0.0 110.732 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -62.06 -31.04 71.42 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.698 -1.251 . . . . 0.0 111.963 171.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -55.27 -30.57 60.37 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.75 0.82 . . . . 0.0 112.891 172.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.4 m -106.45 17.28 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 175.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.0 13.14 69.75 Favored Glycine 0 CA--C 1.536 1.388 0 O-C-N 121.085 -1.009 . . . . 0.0 115.225 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.4 mt -117.13 91.63 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.123 1.369 . . . . 0.0 110.061 -169.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -77.63 114.4 16.43 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.795 -1.19 . . . . 0.0 110.615 171.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.9 pt -91.31 -5.3 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 172.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 t -63.17 -27.65 69.52 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.352 1.433 . . . . 0.0 113.558 -169.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.62 9.82 60.68 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 124.977 1.275 . . . . 0.0 115.353 173.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -89.36 148.8 23.31 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 118.838 1.319 . . . . 0.0 113.2 -169.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.7 t -61.62 146.81 47.79 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.9 t -136.78 49.95 2.04 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 122.082 0.944 . . . . 0.0 112.403 175.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -64.66 145.05 98.81 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 125.241 1.416 . . . . 0.0 113.542 -172.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.28 154.39 32.17 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.804 2.336 . . . . 0.0 112.035 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.1 tt -62.93 -21.96 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -92.6 -10.83 36.08 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -91.4 -35.24 14.49 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.484 0.714 . . . . 0.0 111.962 171.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.428 ' CD2' ' HE1' ' A' ' 5' ' ' MET . 0.0 OUTLIER -71.36 164.48 25.67 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.562 0.745 . . . . 0.0 112.045 174.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -140.8 131.36 25.45 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.89 0.876 . . . . 0.0 110.921 169.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.4 6.13 4.93 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 115.551 1.685 . . . . 0.0 115.551 -174.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -71.58 -30.07 65.42 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.007 -1.058 . . . . 0.0 112.181 -174.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -93.48 -4.92 50.31 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.905 1.282 . . . . 0.0 113.511 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -125.24 79.47 1.8 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.542 1.537 . . . . 0.0 110.431 -171.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -69.06 0.78 4.17 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -171.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.0 t -129.03 94.64 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 125.868 1.667 . . . . 0.0 108.832 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.3 t -112.43 119.03 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 121.315 -0.866 . . . . 0.0 110.457 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 mp -110.2 134.38 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 124.281 1.032 . . . . 0.0 110.112 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.8 t -94.15 145.24 24.84 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.704 1.602 . . . . 0.0 109.854 169.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.5 mt -125.05 44.44 2.79 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.305 1.042 . . . . 0.0 111.39 -173.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.8 p . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 -170.185 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 80.5 mt . . . . . 0 CA--C 1.55 0.949 0 CA-C-O 119.247 -0.406 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.54 132.12 48.57 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.657 2.238 . . . . 0.0 110.755 174.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -60.62 -30.63 90.91 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.542 2.162 . . . . 0.0 113.57 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -60.19 -31.74 70.43 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.949 -1.094 . . . . 0.0 112.867 171.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -87.98 13.2 11.49 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.747 1.219 . . . . 0.0 113.631 175.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.9 t -118.86 -34.75 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 126.565 1.946 . . . . 0.0 112.168 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.0 p -80.85 12.65 3.1 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 -169.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -66.91 161.97 22.86 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.348 1.459 . . . . 0.0 112.149 170.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -60.02 -36.75 77.92 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -169.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.7 mt -115.35 117.05 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.79 0.836 . . . . 0.0 109.307 169.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -134.51 126.56 29.63 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.362 1.065 . . . . 0.0 110.372 169.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -147.24 160.46 42.46 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.802 1.641 . . . . 0.0 110.85 -173.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -126.04 133.03 51.85 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.328 0.651 . . . . 0.0 111.679 169.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -90.04 -0.42 57.58 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 63.88 39.62 8.06 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 169.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.3 mt -93.01 157.6 16.22 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -172.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -102.58 144.48 30.94 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.552 1.941 . . . . 0.0 111.223 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -73.65 121.73 85.87 Favored Pre-proline 0 N--CA 1.475 0.791 0 CA-C-N 119.463 1.029 . . . . 0.0 111.866 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -83.89 -15.32 7.05 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.702 2.268 . . . . 0.0 114.856 -172.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -51.57 109.86 0.4 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.312 1.045 . . . . 0.0 112.442 175.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.85 -0.63 84.61 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 123.804 0.716 . . . . 0.0 114.446 176.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -76.01 171.36 14.59 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 118.437 1.119 . . . . 0.0 109.863 169.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 88.1 p -65.92 156.3 33.9 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.051 -1.031 . . . . 0.0 111.707 169.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.7 mp -64.51 -28.18 69.48 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.112 -0.993 . . . . 0.0 111.725 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -59.48 -41.06 88.95 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.048 -1.032 . . . . 0.0 112.389 170.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 79.4 t -73.79 -36.69 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 O-C-N 121.24 -0.913 . . . . 0.0 110.243 175.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.02 -40.3 97.35 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.277 0.631 . . . . 0.0 111.038 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -70.45 -36.49 73.97 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 120.772 -1.205 . . . . 0.0 112.545 170.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 55.0 m -58.98 -47.63 84.46 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.866 0.867 . . . . 0.0 111.662 175.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.6 m -67.46 -29.08 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 119.784 1.175 . . . . 0.0 111.673 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -45.36 94.11 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 119.968 1.258 . . . . 0.0 110.934 169.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.23 -40.85 97.88 Favored Glycine 0 N--CA 1.474 1.232 0 CA-C-N 118.856 0.753 . . . . 0.0 112.125 174.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -67.28 -43.41 81.85 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.0 m -66.91 -40.37 85.59 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.598 0 CA-C-N 120.071 1.305 . . . . 0.0 110.53 176.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -51.43 -55.0 21.1 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 120.587 1.539 . . . . 0.0 111.464 175.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -50.33 -47.48 55.83 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.301 1.44 . . . . 0.0 112.19 177.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -89.54 -27.75 20.06 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.451 0.701 . . . . 0.0 112.423 -170.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.22 -49.85 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.027 1.331 . . . . 0.0 109.308 169.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -54.09 -54.83 34.02 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.12 0.873 . . . . 0.0 109.551 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -51.58 -37.34 49.39 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.769 1.628 . . . . 0.0 112.676 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -79.22 -61.35 2.04 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.057 0.943 . . . . 0.0 112.92 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.72 -33.76 63.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.25 1.42 . . . . 0.0 112.063 -174.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.69 -17.89 61.08 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -174.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -77.56 -15.98 58.92 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.699 1.199 . . . . 0.0 113.816 171.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.6 pt -120.88 24.72 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 126.934 2.094 . . . . 0.0 111.778 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--O 1.255 1.344 0 C-N-CA 127.824 2.45 . . . . 0.0 111.469 178.099 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 tpp . . . . . 0 N--CA 1.501 2.092 0 CA-C-O 119.362 -0.352 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -83.22 87.92 6.93 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 119.408 1.004 . . . . 0.0 111.21 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -77.94 146.87 35.26 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -171.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.2 t -108.38 143.5 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.672 1.189 . . . . 0.0 110.473 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.1 tpp -129.44 114.4 16.1 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.964 0.906 . . . . 0.0 110.919 169.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -83.31 140.89 32.2 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.642 -0.661 . . . . 0.0 110.382 169.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.5 t -135.89 127.72 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 125.165 1.386 . . . . 0.0 110.507 -175.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.0 p -144.04 -179.2 6.35 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.673 1.189 . . . . 0.0 111.932 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -60.23 -70.98 0.14 Allowed 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 119.472 1.033 . . . . 0.0 109.744 169.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.3 mtt-85 -82.8 121.39 26.85 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 169.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -66.93 -45.26 78.42 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 119.137 0.881 . . . . 0.0 108.883 169.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.4 p -48.77 -31.41 6.95 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.975 2.51 . . . . 0.0 115.829 -175.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.9 p -91.66 -96.1 0.13 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.186 1.394 . . . . 0.0 110.908 169.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -56.27 -56.25 23.35 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -168.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.2 m -69.04 -33.28 73.35 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.709 1.14 . . . . 0.0 113.034 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -66.69 -39.05 87.93 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.358 1.463 . . . . 0.0 113.17 169.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 77.2 mtp -58.85 -45.47 90.01 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.633 0.773 . . . . 0.0 110.977 170.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.56 -28.59 67.09 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 117.7 -1.143 . . . . 0.0 113.609 173.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -72.23 -46.14 57.34 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 121.464 1.938 . . . . 0.0 108.836 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.11 -50.82 62.67 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-O 118.556 -1.136 . . . . 0.0 112.343 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -61.55 -41.24 97.08 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.126 1.463 . . . . 0.0 112.782 175.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.69 -29.72 63.64 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 120.812 -1.18 . . . . 0.0 111.216 -176.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -65.31 -55.89 15.77 Favored 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 125.205 1.402 . . . . 0.0 109.977 170.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.5 p -71.09 -9.54 58.23 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 49.7 mt -101.83 -1.6 31.89 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 170.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -160.57 13.59 0.17 Allowed Glycine 0 CA--C 1.536 1.402 0 N-CA-C 118.262 2.065 . . . . 0.0 118.262 -171.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.82 -30.26 68.82 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 120.673 2.237 . . . . 0.0 114.331 -171.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.97 1.13 87.5 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 124.454 1.026 . . . . 0.0 114.949 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -112.28 -107.75 0.36 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.42 1.888 . . . . 0.0 110.407 -171.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -95.73 174.55 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 126.104 1.762 . . . . 0.0 111.492 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.6 129.13 39.97 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.22 -0.925 . . . . 0.0 112.264 175.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.1 m -99.19 148.25 6.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 124.367 1.067 . . . . 0.0 112.662 170.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.48 153.79 39.97 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.254 1.022 . . . . 0.0 111.115 -174.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.6 p -137.2 136.61 38.32 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.974 1.31 . . . . 0.0 114.163 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.5 t -140.38 -178.84 5.68 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.843 2.057 . . . . 0.0 110.746 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.88 177.97 41.86 Favored Glycine 0 CA--C 1.527 0.815 0 O-C-N 120.684 -1.26 . . . . 0.0 114.834 171.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.9 mt -62.5 -34.26 76.51 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.044 0.938 . . . . 0.0 111.725 -176.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -127.02 112.39 15.18 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.21 2.204 . . . . 0.0 107.754 169.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.5 p -61.51 -36.35 80.28 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.41 -0.806 . . . . 0.0 111.886 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.2 t 52.57 -135.22 1.54 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.943 1.297 . . . . 0.0 110.41 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -127.22 -139.59 0.26 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 126.735 2.014 . . . . 0.0 110.827 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.4 m -105.77 115.08 46.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 168.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -64.62 131.1 95.02 Favored Pre-proline 0 N--CA 1.48 1.045 0 O-C-N 121.176 -0.953 . . . . 0.0 112.378 -168.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -60.06 -37.66 82.95 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.432 2.755 . . . . 0.0 113.944 -169.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.5 m -77.78 -33.37 52.66 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.933 -0.479 . . . . 0.0 110.461 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.38 -38.79 92.27 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.073 -1.017 . . . . 0.0 112.56 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 70.4 mt -53.23 -44.46 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 120.657 1.571 . . . . 0.0 110.134 174.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.0 -58.95 4.77 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.0 mmt -65.15 -21.64 66.81 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -174.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 87.8 mmm -89.9 -38.89 13.39 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.015 0.926 . . . . 0.0 110.762 176.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -58.52 -36.61 74.09 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.577 -1.327 . . . . 0.0 112.205 169.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -54.43 -32.24 57.01 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.333 1.053 . . . . 0.0 113.672 173.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.2 m -101.6 13.98 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.694 1.198 . . . . 0.0 113.973 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.29 16.38 62.64 Favored Glycine 0 CA--C 1.535 1.337 0 O-C-N 121.184 -0.947 . . . . 0.0 114.917 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.4 mt -122.08 75.7 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.727 1.611 . . . . 0.0 109.952 -169.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -68.09 105.33 2.02 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 120.283 -1.511 . . . . 0.0 110.494 173.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.0 pt -84.35 -5.52 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.542 0.737 . . . . 0.0 112.833 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 92.4 p -64.92 -28.93 69.87 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -169.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.43 7.8 77.6 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.803 1.192 . . . . 0.0 114.58 172.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -98.87 149.83 22.52 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.196 1.398 . . . . 0.0 112.522 -169.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.8 t -85.64 145.58 27.25 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -173.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.3 m -124.49 111.65 15.96 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.352 1.061 . . . . 0.0 110.381 170.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.15 158.11 50.04 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 124.001 0.92 . . . . 0.0 113.009 177.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -95.7 150.79 1.46 Allowed 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 124.176 3.251 . . . . 0.0 111.879 169.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.38 -19.15 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 115.424 1.638 . . . . 0.0 115.424 -172.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -99.68 -7.79 25.19 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -87.92 -39.43 14.76 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.379 -0.826 . . . . 0.0 111.491 169.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.98 161.12 31.68 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.559 0.743 . . . . 0.0 111.759 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -136.56 117.21 13.93 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.388 1.075 . . . . 0.0 110.452 173.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.98 -1.76 4.48 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -171.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.91 -30.49 67.92 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.083 -1.011 . . . . 0.0 112.202 -173.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -86.14 -2.57 58.46 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.781 1.232 . . . . 0.0 113.293 177.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -124.35 90.56 3.28 Favored 'General case' 0 C--N 1.343 0.326 0 C-N-CA 125.711 1.604 . . . . 0.0 110.269 -171.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -55.18 -27.84 48.72 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.196 1.398 . . . . 0.0 113.37 -177.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.29 115.74 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 125.156 1.382 . . . . 0.0 110.541 -172.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.0 t -122.91 129.08 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.913 0.885 . . . . 0.0 110.746 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.7 mm -117.58 124.15 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.455 0.702 . . . . 0.0 111.109 -172.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.1 t -88.19 105.6 17.64 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 169.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.419 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 64.0 mt -82.91 31.89 0.43 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.805 1.642 . . . . 0.0 110.966 175.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.3 t . . . . . 0 CA--C 1.538 0.488 0 C-N-CA 127.866 2.466 . . . . 0.0 109.162 -169.678 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.6 mt . . . . . 0 CA--C 1.549 0.923 0 CA-C-O 119.232 -0.413 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -59.22 132.11 44.96 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.708 2.272 . . . . 0.0 110.698 169.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -59.73 -33.23 96.46 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.468 2.112 . . . . 0.0 113.522 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -66.18 -26.64 67.5 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.72 1.145 . . . . 0.0 113.538 175.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.38 -15.96 59.11 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.772 -1.205 . . . . 0.0 112.629 171.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.8 t -90.63 -40.22 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.882 1.673 . . . . 0.0 111.725 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.1 p -81.99 27.9 0.45 Allowed 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -172.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -79.61 169.7 17.63 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.084 1.354 . . . . 0.0 112.14 170.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -55.35 -39.79 70.47 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.121 0.968 . . . . 0.0 113.431 -169.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 58.9 mt -128.31 125.06 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.594 1.157 . . . . 0.0 109.545 170.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -128.52 141.46 51.37 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.436 1.094 . . . . 0.0 110.339 169.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.37 154.54 43.11 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.215 1.006 . . . . 0.0 112.121 -171.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -129.16 113.22 14.81 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.49 1.516 . . . . 0.0 110.226 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.419 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 37.0 m0 -94.0 5.32 52.07 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -173.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 63.45 -89.12 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.497 1.519 . . . . 0.0 112.026 -173.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.7 mt 53.85 -177.96 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 127.789 2.435 . . . . 0.0 115.511 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -142.0 148.26 38.27 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.8 2.04 . . . . 0.0 108.887 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.26 119.48 77.64 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 119.654 1.115 . . . . 0.0 110.575 176.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -83.94 -6.85 10.42 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 121.912 1.742 . . . . 0.0 113.881 -171.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -45.25 112.4 0.44 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.184 1.394 . . . . 0.0 112.783 174.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.42 3.14 82.04 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 123.66 0.647 . . . . 0.0 114.375 173.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -79.88 173.18 12.85 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.103 0.961 . . . . 0.0 109.927 169.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 86.2 p -63.68 153.8 35.01 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.183 -0.948 . . . . 0.0 111.732 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.47 -29.49 70.57 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.53 -0.731 . . . . 0.0 111.497 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -67.15 -34.9 78.55 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.786 -1.196 . . . . 0.0 113.144 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 78.8 t -69.46 -37.48 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 O-C-N 121.163 -0.96 . . . . 0.0 109.611 170.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.52 -39.08 93.11 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.717 0.807 . . . . 0.0 111.109 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -71.69 -38.09 70.63 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.062 1.345 . . . . 0.0 112.376 171.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 51.7 m -57.84 -48.1 80.75 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.608 1.095 . . . . 0.0 111.525 177.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.4 m -69.3 -29.92 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.937 176.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.28 -42.86 99.35 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 120.155 1.343 . . . . 0.0 111.515 169.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.76 -42.13 95.37 Favored Glycine 0 N--CA 1.476 1.331 0 C-N-CA 124.253 0.93 . . . . 0.0 112.661 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -63.32 -48.18 79.09 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.127 -0.631 . . . . 0.0 112.218 171.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.0 t -58.52 -44.9 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.633 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -52.37 -54.55 30.36 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 120.046 1.293 . . . . 0.0 111.51 175.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -61.76 -43.38 98.97 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.13 0.572 . . . . 0.0 112.209 -176.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 49.3 mtp85 -76.16 -31.86 58.76 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 36.8 t -61.87 -49.01 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.532 1.133 . . . . 0.0 110.591 170.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -53.62 -54.75 33.17 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.018 0.827 . . . . 0.0 109.701 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -55.19 -31.59 61.53 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.374 1.47 . . . . 0.0 112.9 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -81.83 -59.97 2.4 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.035 -1.04 . . . . 0.0 112.704 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.24 -32.68 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.789 1.236 . . . . 0.0 111.691 -176.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.58 -0.39 33.39 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -90.88 -15.65 29.55 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.809 1.244 . . . . 0.0 113.51 170.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.5 pt -121.31 8.43 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 126.188 1.795 . . . . 0.0 113.041 -176.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.4 p . . . . . 0 C--O 1.254 1.323 0 C-N-CA 126.446 1.898 . . . . 0.0 113.815 171.92 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.9 ttm . . . . . 0 N--CA 1.501 2.084 0 CA-C-O 119.325 -0.369 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -86.35 107.1 17.84 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 169.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -82.11 144.87 30.47 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 118.077 0.398 . . . . 0.0 110.907 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.0 t -101.66 142.22 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.672 0.789 . . . . 0.0 109.804 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.418 ' HE1' ' CD2' ' A' ' 68' ' ' PHE . 42.3 tpp -127.97 118.27 23.26 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.692 0.797 . . . . 0.0 110.754 169.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -89.67 138.51 31.41 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.88 -0.512 . . . . 0.0 110.834 169.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 t -130.17 129.32 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.546 1.538 . . . . 0.0 109.631 -171.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.7 m -141.14 171.48 14.0 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.002 1.321 . . . . 0.0 110.503 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -66.0 -49.28 68.34 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 119.91 1.232 . . . . 0.0 108.934 169.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -103.67 114.08 28.07 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 167.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.518 ' ND2' ' H ' ' A' ' 63' ' ' ASP . 31.1 t-20 -51.92 -48.51 64.17 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 120.474 1.488 . . . . 0.0 109.673 172.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.0 p -53.17 -32.85 49.91 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.1 p -78.37 -33.58 48.85 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -174.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 -140.34 -55.79 0.53 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.903 0.881 . . . . 0.0 112.488 -170.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 m -55.71 -40.86 73.0 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 120.087 1.312 . . . . 0.0 113.333 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -66.91 -35.43 79.98 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.698 1.599 . . . . 0.0 113.46 173.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.5 mtm -64.92 -50.43 66.52 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.782 -0.574 . . . . 0.0 110.565 172.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.8 -26.19 67.58 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.415 -0.803 . . . . 0.0 113.011 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -71.4 -49.44 42.0 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 119.507 1.048 . . . . 0.0 108.45 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.462 ' CA ' HE22 ' A' ' 60' ' ' GLN . . . -63.32 -41.62 99.43 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 119.245 -0.753 . . . . 0.0 112.953 177.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -62.45 -43.32 99.1 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.287 1.544 . . . . 0.0 112.22 172.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.64 -35.96 67.89 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.683 -1.26 . . . . 0.0 110.863 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -57.73 -49.6 76.0 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.344 1.858 . . . . 0.0 110.833 171.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.4 p -78.67 -24.46 45.11 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.868 1.432 . . . . 0.0 114.868 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.8 mt -89.5 -28.19 19.82 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.157 0.89 . . . . 0.0 113.045 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.74 -68.74 1.15 Allowed Glycine 0 N--CA 1.473 1.118 0 C-N-CA 124.711 1.148 . . . . 0.0 112.065 175.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 54.32 90.83 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.176 2.59 . . . . 0.0 115.462 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.85 -7.25 78.15 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 116.299 1.28 . . . . 0.0 116.299 169.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -68.85 -47.19 66.56 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 118.898 1.349 . . . . 0.0 110.817 174.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.6 pp -140.35 -176.06 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 127.749 2.42 . . . . 0.0 110.479 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.13 128.52 55.08 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.52 0.676 . . . . 0.0 112.551 172.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.5 m -95.16 151.48 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 124.592 1.157 . . . . 0.0 112.907 170.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.14 156.45 42.6 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.672 0.789 . . . . 0.0 111.41 -172.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 97.5 p -126.77 142.37 51.56 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.169 1.388 . . . . 0.0 114.023 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.6 t -145.77 170.78 15.85 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 126.897 2.079 . . . . 0.0 109.874 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.24 171.11 34.6 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 120.883 -1.136 . . . . 0.0 114.358 170.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 38.3 mt -62.17 -35.18 78.01 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 117.4 0.6 . . . . 0.0 111.812 -174.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -125.08 122.05 36.08 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.559 2.744 . . . . 0.0 106.545 169.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 55.4 p -73.07 -41.88 63.64 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.842 -1.162 . . . . 0.0 111.024 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.5 t 55.49 -167.51 0.1 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 126.282 1.833 . . . . 0.0 113.877 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -94.0 168.79 10.73 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 126.936 2.094 . . . . 0.0 112.29 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.6 m -61.15 114.16 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 169.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -71.04 132.19 86.68 Favored Pre-proline 0 N--CA 1.476 0.864 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -168.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -57.77 -39.72 84.99 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.951 3.1 . . . . 0.0 114.305 -173.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.3 m -80.31 -37.59 32.34 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.776 -0.578 . . . . 0.0 110.626 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.28 96.54 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.267 0.939 . . . . 0.0 112.076 175.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.0 mt -48.95 -49.09 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 120.132 1.333 . . . . 0.0 110.376 171.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.03 -58.13 7.6 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.6 mmt -65.71 -22.46 66.61 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -172.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 76.6 mmm -90.28 -40.01 12.41 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.372 1.469 . . . . 0.0 110.998 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -57.78 -35.47 70.84 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.83 -1.169 . . . . 0.0 112.348 170.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -53.41 -32.44 49.64 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.469 1.107 . . . . 0.0 113.064 170.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -94.85 5.98 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.703 1.201 . . . . 0.0 113.521 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.97 15.55 64.91 Favored Glycine 0 CA--C 1.538 1.498 0 O-C-N 120.916 -1.115 . . . . 0.0 114.433 -173.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.4 mt -121.04 61.64 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.95 1.7 . . . . 0.0 109.651 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -62.24 110.46 1.63 Allowed 'General case' 0 CA--C 1.548 0.893 0 O-C-N 120.082 -1.636 . . . . 0.0 110.892 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.6 pt -85.89 -4.5 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 118.496 -0.764 . . . . 0.0 112.941 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.5 t -61.79 -33.86 74.86 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.159 1.345 . . . . 0.0 112.731 -171.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.49 10.08 66.92 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.133 1.349 . . . . 0.0 115.432 172.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.462 HE22 ' CA ' ' A' ' 20' ' ' GLY . 5.8 tt0 -101.74 163.03 12.47 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.911 1.284 . . . . 0.0 112.838 -170.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 p -72.94 158.75 34.87 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.022 1.729 . . . . 0.0 115.408 -170.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.8 t -151.31 148.14 27.8 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.153 2.181 . . . . 0.0 108.466 168.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.518 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 1.0 OUTLIER -149.36 147.91 24.79 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.672 1.189 . . . . 0.0 111.201 178.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -90.3 152.19 4.55 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.679 2.92 . . . . 0.0 111.854 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 tt -65.31 -18.78 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -171.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -98.22 -7.21 29.69 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -88.47 -38.98 14.56 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.585 0.629 . . . . 0.0 111.436 169.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.418 ' CD2' ' HE1' ' A' ' 5' ' ' MET . 0.0 OUTLIER -72.87 161.8 30.27 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.697 0.799 . . . . 0.0 112.241 173.34 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.94 123.51 17.23 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.271 1.028 . . . . 0.0 110.926 169.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.94 2.43 3.5 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -169.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -67.58 -28.6 67.91 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.341 -0.85 . . . . 0.0 112.437 -173.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -93.4 -2.31 54.82 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.157 1.383 . . . . 0.0 113.28 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -123.43 80.12 1.75 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.196 1.798 . . . . 0.0 109.878 -170.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -59.41 -21.29 59.74 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.707 1.203 . . . . 0.0 114.087 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.6 t -117.91 109.6 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.869 1.268 . . . . 0.0 110.015 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.8 t -121.21 129.37 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.819 0.848 . . . . 0.0 111.233 -176.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.1 mm -119.7 118.35 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 O-C-N 121.534 -0.729 . . . . 0.0 111.233 -171.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.3 t -82.85 105.8 14.16 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 168.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.428 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 85.4 mt -79.07 -32.38 44.74 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.622 -0.674 . . . . 0.0 111.135 177.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 31.7 p . . . . . 0 CA--C 1.539 0.55 0 C-N-CA 122.993 0.517 . . . . 0.0 110.41 169.004 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.5 mt . . . . . 0 CA--C 1.547 0.856 0 CA-C-O 119.149 -0.453 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.32 133.43 54.97 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.852 2.368 . . . . 0.0 111.68 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -60.59 -31.03 91.76 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.795 2.33 . . . . 0.0 113.62 -174.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -65.48 -30.01 70.74 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.729 -1.232 . . . . 0.0 113.264 173.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.35 -19.94 49.01 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.855 -1.153 . . . . 0.0 112.688 173.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.6 t -87.73 -34.39 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.047 1.739 . . . . 0.0 112.41 176.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.6 p -88.59 25.83 1.62 Allowed 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -171.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -77.2 168.35 20.21 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.508 1.123 . . . . 0.0 112.263 169.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -55.72 -38.59 69.95 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -169.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 59.7 mt -126.03 123.51 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.717 1.207 . . . . 0.0 108.872 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -128.24 140.87 51.66 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.097 0.959 . . . . 0.0 110.702 169.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.84 154.95 44.67 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.671 1.188 . . . . 0.0 112.093 -171.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -130.13 115.45 17.07 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.9 1.28 . . . . 0.0 110.89 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.428 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 35.7 m0 -98.51 -1.63 40.72 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.457 1.103 . . . . 0.0 113.792 -175.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.32 1.2 pp0? 44.75 41.73 5.29 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 172.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.8 mt -84.42 134.25 34.47 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.984 1.313 . . . . 0.0 112.977 -177.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -64.74 153.87 38.51 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.987 1.315 . . . . 0.0 111.977 172.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -81.72 116.74 64.98 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 121.192 -0.942 . . . . 0.0 112.832 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -84.52 -27.27 1.42 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.794 2.329 . . . . 0.0 115.103 -169.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -70.97 81.7 0.66 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.667 1.987 . . . . 0.0 111.949 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 141.17 -10.66 2.78 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 126.496 1.998 . . . . 0.0 113.785 -174.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -91.39 175.8 6.79 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.845 1.658 . . . . 0.0 111.624 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 96.9 p -70.86 159.77 34.0 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.628 -0.67 . . . . 0.0 111.581 169.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.9 -31.04 72.02 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.463 -0.773 . . . . 0.0 112.194 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.08 -40.89 95.41 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.05 -1.031 . . . . 0.0 112.283 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 94.0 t -72.93 -35.91 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.626 0.77 . . . . 0.0 110.47 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -60.15 -49.76 76.38 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.781 0.832 . . . . 0.0 110.638 173.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 66.4 mtt85 -63.14 -23.54 67.48 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.307 1.443 . . . . 0.0 113.453 173.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 57.4 m -75.63 -55.32 5.78 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.624 1.169 . . . . 0.0 111.412 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 19.2 m -65.54 -32.31 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 119.82 1.191 . . . . 0.0 110.762 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.47 -43.75 89.06 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 126.606 1.962 . . . . 0.0 112.939 169.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.43 -38.4 86.83 Favored Glycine 0 N--CA 1.476 1.323 0 C-N-CA 123.964 0.792 . . . . 0.0 113.392 174.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -61.94 -43.31 99.1 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.512 -0.993 . . . . 0.0 111.814 169.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 32.5 t -58.58 -47.65 87.91 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 CA-C-O 117.861 -1.066 . . . . 0.0 109.772 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -49.81 -55.36 14.43 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.866 1.212 . . . . 0.0 111.571 175.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -61.1 -43.75 98.41 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.5 mtp85 -76.12 -33.55 59.45 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.6 t -63.56 -46.09 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.122 0.969 . . . . 0.0 111.224 172.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -52.49 -54.97 25.46 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.246 0.93 . . . . 0.0 109.943 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -55.17 -37.75 67.42 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.783 1.233 . . . . 0.0 112.676 176.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -74.79 -57.28 4.01 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.18 -0.95 . . . . 0.0 112.752 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.56 -34.53 71.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.692 1.197 . . . . 0.0 112.168 -177.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.57 -15.8 60.83 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -173.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -73.43 -31.03 63.6 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.43 1.092 . . . . 0.0 113.382 170.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.9 pt -107.64 -7.15 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.323 1.449 . . . . 0.0 113.389 -174.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.9 m . . . . . 0 C--O 1.253 1.282 0 C-N-CA 125.779 1.632 . . . . 0.0 112.711 171.007 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 ttm . . . . . 0 N--CA 1.503 2.208 0 CA-C-O 119.77 -0.157 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -85.73 82.33 8.24 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.212 1.005 . . . . 0.0 110.777 173.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -72.18 139.23 48.14 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.208 1.003 . . . . 0.0 111.714 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.9 t -113.2 146.25 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.291 1.036 . . . . 0.0 111.657 -173.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.2 tpp -132.91 122.59 24.56 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.188 0.995 . . . . 0.0 111.573 169.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -95.88 134.86 38.36 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.267 1.027 . . . . 0.0 111.387 169.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.1 t -128.63 130.16 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.968 1.307 . . . . 0.0 111.436 -170.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.0 p -149.28 179.49 7.88 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.471 1.108 . . . . 0.0 111.953 173.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -66.33 -61.92 1.75 Allowed 'General case' 0 N--CA 1.483 1.208 0 O-C-N 120.79 -1.194 . . . . 0.0 111.102 173.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.32 110.98 19.01 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.223 1.009 . . . . 0.0 109.197 169.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -61.68 -34.96 76.67 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.156 0.889 . . . . 0.0 110.331 169.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.3 p -48.47 -37.89 18.53 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.828 2.451 . . . . 0.0 115.836 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.9 p -97.62 -92.39 0.24 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.329 1.052 . . . . 0.0 111.329 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.69 -54.24 49.13 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 120.924 -1.11 . . . . 0.0 113.764 -169.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.5 m -63.6 -42.29 98.27 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.136 0.88 . . . . 0.0 111.868 -176.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -60.74 -39.82 90.11 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.447 1.499 . . . . 0.0 114.564 169.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 78.4 mtp -64.43 -45.97 85.21 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.167 0.894 . . . . 0.0 110.748 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.0 -25.78 64.68 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 172.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -67.27 -53.27 31.4 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.051 1.296 . . . . 0.0 108.168 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.56 -43.55 96.37 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 118.714 -1.048 . . . . 0.0 112.266 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -63.27 -43.41 98.04 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.852 1.826 . . . . 0.0 112.21 172.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.86 -35.56 64.78 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.198 1.363 . . . . 0.0 110.923 -173.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -60.44 -59.22 5.74 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.38 1.472 . . . . 0.0 109.378 169.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.0 p -66.5 -13.58 61.09 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.5 mt -97.87 -5.59 34.23 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 172.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.66 15.69 0.11 Allowed Glycine 0 CA--C 1.536 1.36 0 N-CA-C 118.304 2.081 . . . . 0.0 118.304 -171.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.69 -34.54 59.1 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 119.696 1.748 . . . . 0.0 114.643 -170.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.49 -5.58 86.76 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.38 0.99 . . . . 0.0 115.319 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -99.52 -60.87 1.45 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 118.632 1.216 . . . . 0.0 111.947 -170.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -139.85 170.64 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 126.846 2.059 . . . . 0.0 110.319 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.67 125.13 39.12 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 122.122 0.963 . . . . 0.0 111.275 175.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.2 m -92.79 153.61 3.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.901 169.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.73 149.94 34.39 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.435 0.694 . . . . 0.0 111.71 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.4 p -119.92 139.34 52.57 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.994 2.118 . . . . 0.0 113.347 171.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.9 p -144.88 172.86 12.43 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.015 1.326 . . . . 0.0 110.777 169.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.68 -179.82 44.58 Favored Glycine 0 CA--C 1.52 0.367 0 O-C-N 120.383 -1.448 . . . . 0.0 114.569 171.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 34.7 mt -63.69 -30.07 71.22 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.78 0.432 . . . . 0.0 111.532 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -121.39 123.79 42.95 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.877 2.071 . . . . 0.0 108.948 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.3 p -77.8 43.23 0.41 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.92 1.688 . . . . 0.0 111.898 175.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.9 p -63.14 155.01 29.3 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.564 1.545 . . . . 0.0 113.337 -169.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -65.68 177.66 1.19 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.819 1.647 . . . . 0.0 114.471 -169.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 m -63.45 110.33 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 119.866 -1.771 . . . . 0.0 109.617 169.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -67.9 135.46 92.06 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-O 118.413 -0.803 . . . . 0.0 112.414 -169.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -58.79 -39.92 77.38 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.367 2.711 . . . . 0.0 113.795 -174.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.7 m -77.44 -37.87 50.67 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.869 0.468 . . . . 0.0 110.581 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.04 -41.83 97.26 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 118.143 -0.932 . . . . 0.0 112.448 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 66.8 mt -50.8 -47.01 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 120.482 1.492 . . . . 0.0 110.426 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.99 -59.76 3.8 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 175.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 31.0 mmt -67.29 -20.88 65.69 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -172.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 83.9 mmm -90.15 -37.52 14.14 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.721 0.809 . . . . 0.0 110.619 175.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -58.53 -36.46 73.88 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.58 -1.325 . . . . 0.0 112.129 169.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -54.25 -32.75 56.85 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.162 0.985 . . . . 0.0 113.59 172.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.6 m -100.67 13.18 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 124.818 1.247 . . . . 0.0 114.19 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.14 17.2 59.6 Favored Glycine 0 N--CA 1.476 1.329 0 O-C-N 121.047 -1.033 . . . . 0.0 114.896 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.0 mt -126.6 64.49 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.894 1.678 . . . . 0.0 109.965 -169.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -63.47 109.16 1.54 Allowed 'General case' 0 CA--C 1.545 0.759 0 O-C-N 119.985 -1.697 . . . . 0.0 110.905 173.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.1 pt -83.98 -4.89 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 118.36 -0.828 . . . . 0.0 113.04 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -60.13 -30.1 69.07 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 120.495 1.498 . . . . 0.0 113.502 -169.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.36 5.53 71.02 Favored Glycine 0 CA--C 1.541 1.667 0 C-N-CA 124.82 1.2 . . . . 0.0 115.534 173.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -98.82 140.37 33.11 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.11 1.455 . . . . 0.0 112.324 -171.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.8 t -71.21 155.83 40.27 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -173.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.1 m -128.37 143.2 50.97 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.738 1.615 . . . . 0.0 110.49 169.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -138.15 150.86 68.46 Favored Pre-proline 0 N--CA 1.485 1.295 0 CA-C-N 119.616 1.098 . . . . 0.0 113.36 -172.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -88.92 151.03 5.88 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.533 2.155 . . . . 0.0 112.165 177.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.5 tt -62.57 -17.83 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 125.125 1.37 . . . . 0.0 114.55 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.26 -8.05 27.98 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -87.68 -38.89 15.45 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.077 0.853 . . . . 0.0 111.258 170.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.11 157.52 38.04 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.392 0.677 . . . . 0.0 111.409 172.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.25 121.24 13.66 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.721 0.809 . . . . 0.0 111.156 170.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.16 1.79 1.89 Allowed 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -170.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -67.06 -28.1 67.92 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.147 -0.97 . . . . 0.0 111.979 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -93.8 -1.13 55.39 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.41 1.484 . . . . 0.0 113.418 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -130.24 91.62 3.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.615 1.566 . . . . 0.0 110.586 -171.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -59.62 -21.25 60.17 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.7 t -123.28 108.13 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.956 1.302 . . . . 0.0 110.41 -169.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.6 t -125.58 127.6 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.674 0.79 . . . . 0.0 111.452 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.6 mp -118.86 130.93 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.39 1.076 . . . . 0.0 110.206 -170.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.7 t -90.32 124.88 35.28 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.912 1.285 . . . . 0.0 108.092 168.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.426 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 76.1 mt -104.24 23.44 13.09 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.824 1.649 . . . . 0.0 112.572 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 27.1 p . . . . . 0 CA--C 1.54 0.576 0 C-N-CA 126.705 2.002 . . . . 0.0 108.533 169.661 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.8 mt . . . . . 0 CA--C 1.551 1.01 0 CA-C-O 119.214 -0.422 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.67 132.77 53.82 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.703 2.269 . . . . 0.0 111.076 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -59.71 -33.95 96.29 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.426 2.084 . . . . 0.0 113.502 -171.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -64.62 -28.6 69.73 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.704 -1.247 . . . . 0.0 113.325 174.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.64 -4.52 52.02 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.797 -1.19 . . . . 0.0 112.859 172.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 72.3 t -104.78 -41.54 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.452 1.901 . . . . 0.0 111.391 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.3 p -82.04 49.12 1.33 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.637 1.175 . . . . 0.0 113.517 -173.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -104.64 170.31 7.96 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.282 1.833 . . . . 0.0 111.945 176.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -58.38 -37.25 74.87 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.736 0.815 . . . . 0.0 112.89 -170.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 56.2 mt -128.48 120.61 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.95 1.3 . . . . 0.0 108.512 169.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -130.37 138.11 50.23 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.03 0.932 . . . . 0.0 110.857 169.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -140.08 151.06 45.07 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.88 1.272 . . . . 0.0 112.05 -175.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -123.55 99.97 6.57 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.924 1.29 . . . . 0.0 109.886 175.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.426 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 39.5 m0 -79.37 -4.55 51.51 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -170.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.372 1.1 pp0? 50.4 37.55 15.83 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.034 1.734 . . . . 0.0 115.586 170.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 69.3 mt -75.5 157.82 33.45 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.834 1.254 . . . . 0.0 112.352 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -85.19 161.48 19.59 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.961 1.304 . . . . 0.0 111.438 170.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -89.52 122.03 68.67 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.511 1.124 . . . . 0.0 112.141 175.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -93.82 -18.69 0.5 Allowed 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 121.688 1.592 . . . . 0.0 114.872 -169.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -44.15 108.11 0.11 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.007 2.123 . . . . 0.0 113.355 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.22 8.58 62.27 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.544 1.069 . . . . 0.0 115.606 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -79.24 -65.75 0.96 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.004 1.402 . . . . 0.0 111.279 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.6 t -170.44 151.71 3.78 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.603 1.961 . . . . 0.0 109.247 171.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.2 mp -59.85 -29.09 68.06 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.204 0.602 . . . . 0.0 111.218 172.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.95 -39.88 95.98 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.95 -1.094 . . . . 0.0 112.332 173.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 86.4 t -71.61 -39.45 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.655 0.782 . . . . 0.0 109.254 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.35 -44.49 94.67 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.14 0.976 . . . . 0.0 111.739 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 -68.7 -37.39 79.49 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.201 -0.937 . . . . 0.0 112.092 172.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 64.0 m -58.58 -49.46 77.38 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 119.007 0.821 . . . . 0.0 111.674 175.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.8 m -69.97 -30.17 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 117.847 -1.073 . . . . 0.0 112.186 176.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -42.66 94.94 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 120.595 1.543 . . . . 0.0 111.595 169.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.68 -42.62 95.28 Favored Glycine 0 N--CA 1.474 1.175 0 C-N-CA 124.017 0.817 . . . . 0.0 112.758 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -62.32 -47.48 84.06 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 122.172 -0.605 . . . . 0.0 112.057 171.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 36.2 t -60.25 -45.32 96.37 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.059 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -52.47 -53.96 38.71 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 119.92 1.236 . . . . 0.0 111.843 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.21 -45.89 91.34 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.863 0.465 . . . . 0.0 112.08 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.9 mtt-85 -71.61 -33.29 68.87 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.1 t -65.2 -47.62 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.941 171.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -53.64 -54.32 39.34 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.604 1.093 . . . . 0.0 109.658 174.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -54.42 -37.33 64.97 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.206 1.003 . . . . 0.0 112.704 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -78.0 -57.56 3.73 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.213 0.915 . . . . 0.0 112.278 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.71 -32.69 59.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.666 1.187 . . . . 0.0 112.281 -176.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.77 -18.44 58.44 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -174.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -72.28 -21.89 61.29 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.551 1.141 . . . . 0.0 113.42 170.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.2 pt -114.76 20.48 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 126.504 1.921 . . . . 0.0 112.287 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.255 1.361 0 C-N-CA 127.759 2.424 . . . . 0.0 111.528 176.174 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.7 ttp . . . . . 0 N--CA 1.503 2.181 0 CA-C-O 119.889 -0.1 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -85.61 106.32 16.83 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.227 0.611 . . . . 0.0 109.972 171.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -77.84 149.61 34.33 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.144 0.578 . . . . 0.0 110.973 176.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 56.8 t -107.85 143.5 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.207 1.003 . . . . 0.0 110.226 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 58.4 tpp -130.55 116.22 17.85 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.483 0.713 . . . . 0.0 109.857 169.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -86.75 142.15 28.35 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.705 -0.622 . . . . 0.0 110.541 169.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.8 t -133.06 128.92 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.663 1.185 . . . . 0.0 111.562 -174.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.3 p -145.95 175.64 10.29 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.688 0.795 . . . . 0.0 111.564 169.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -61.21 -36.35 79.67 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 120.901 -1.125 . . . . 0.0 112.212 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -108.21 136.11 48.42 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.234 1.413 . . . . 0.0 111.113 169.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -98.29 -0.15 44.49 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.792 0.724 . . . . 0.0 110.971 168.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.4 p -74.51 -24.94 59.07 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.117 1.367 . . . . 0.0 112.936 169.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 t -133.49 -164.61 1.51 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.481 1.913 . . . . 0.0 109.73 174.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 41.03 -80.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 128.685 2.794 . . . . 0.0 116.159 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.0 p -56.37 -44.26 80.01 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.148 0.979 . . . . 0.0 112.347 173.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -63.64 -35.51 80.75 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 120.068 1.304 . . . . 0.0 113.408 168.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 87.8 mtp -61.45 -47.08 87.36 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.082 0.855 . . . . 0.0 110.177 176.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.76 -29.03 68.14 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 118.043 -0.98 . . . . 0.0 113.129 175.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -65.06 -54.28 32.55 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 120.277 1.398 . . . . 0.0 108.747 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.96 -45.66 96.15 Favored Glycine 0 CA--C 1.521 0.462 0 CA-C-O 118.882 -0.955 . . . . 0.0 112.814 -176.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.48 -33.85 73.19 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.155 0.977 . . . . 0.0 112.464 172.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.73 -37.52 49.13 Favored 'General case' 0 C--O 1.225 -0.189 0 O-C-N 121.256 -0.903 . . . . 0.0 111.607 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -69.17 -40.78 77.93 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.77 1.168 . . . . 0.0 112.358 169.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.1 p -67.52 -6.35 19.37 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 121.489 1.95 . . . . 0.0 114.516 171.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.6 mt -111.62 0.01 16.24 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 171.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.7 16.52 0.22 Allowed Glycine 0 CA--C 1.536 1.37 0 N-CA-C 116.712 1.445 . . . . 0.0 116.712 -169.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.98 129.43 41.91 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.823 1.312 . . . . 0.0 111.634 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.49 -3.65 58.59 Favored Glycine 0 CA--C 1.539 1.531 0 CA-C-O 118.526 -1.152 . . . . 0.0 115.691 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -83.84 -58.47 2.78 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 119.675 1.738 . . . . 0.0 110.892 176.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -141.03 177.4 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.936 2.095 . . . . 0.0 110.898 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.93 109.32 21.7 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.131 -0.98 . . . . 0.0 111.672 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.0 t -85.74 135.75 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 125.757 1.623 . . . . 0.0 111.65 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.85 159.29 43.71 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.173 0.989 . . . . 0.0 112.984 -176.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.8 p -141.71 154.1 45.08 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.658 1.583 . . . . 0.0 114.564 172.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.4 p -151.54 -179.18 7.18 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 126.41 1.884 . . . . 0.0 111.184 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.32 178.97 48.28 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 120.309 -1.494 . . . . 0.0 115.417 176.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 35.0 mt -71.51 -44.31 64.88 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -170.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -116.94 87.59 2.73 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.818 2.447 . . . . 0.0 106.018 169.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.2 p -54.51 -46.46 73.49 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.656 -0.653 . . . . 0.0 111.74 -171.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.7 t 56.57 -166.18 0.13 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.478 1.911 . . . . 0.0 113.476 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -78.24 -153.4 0.06 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.978 2.111 . . . . 0.0 111.863 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.8 m -98.28 125.69 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.12 1.768 . . . . 0.0 106.848 168.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -71.53 131.53 86.28 Favored Pre-proline 0 N--CA 1.478 0.938 0 O-C-N 120.516 -1.365 . . . . 0.0 113.2 -168.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -59.35 -38.82 82.22 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.338 2.692 . . . . 0.0 113.84 -172.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.404 ' HB ' ' CE2' ' A' ' 112' ' ' PHE . 9.1 m -79.64 -36.22 38.17 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.838 -0.539 . . . . 0.0 110.608 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.54 -40.2 95.17 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.956 -1.09 . . . . 0.0 112.383 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 52.1 mt -52.7 -43.68 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 120.847 1.658 . . . . 0.0 110.652 173.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.42 -59.41 4.38 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 174.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.6 mmt -65.98 -21.81 66.43 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -173.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 82.7 mmm -89.79 -37.1 14.74 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.062 0.945 . . . . 0.0 111.238 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -60.8 -35.74 77.24 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.691 1.132 . . . . 0.0 111.572 170.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -55.37 -27.95 50.73 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 171.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.9 m -108.08 20.57 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 125.01 1.324 . . . . 0.0 113.934 175.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.09 11.92 75.06 Favored Glycine 0 CA--C 1.536 1.362 0 O-C-N 121.222 -0.924 . . . . 0.0 115.291 173.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.4 mt -122.84 87.67 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.513 1.525 . . . . 0.0 109.093 -169.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -70.66 111.33 6.06 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 120.315 -1.491 . . . . 0.0 110.419 170.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.7 pt -86.34 -6.28 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 O-C-N 121.496 -0.753 . . . . 0.0 112.608 175.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.3 t -63.78 -30.78 71.84 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 120.007 1.276 . . . . 0.0 112.736 -173.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.95 4.78 75.47 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 125.318 1.437 . . . . 0.0 115.508 171.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -78.06 147.77 34.59 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.108 1.454 . . . . 0.0 111.581 -175.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 10.8 t -62.76 147.47 49.69 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.588 -0.695 . . . . 0.0 112.084 174.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.5 t -127.94 131.98 49.28 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.839 0.856 . . . . 0.0 109.874 169.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -145.33 136.22 12.36 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.899 0.88 . . . . 0.0 113.087 -169.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -84.47 154.23 12.15 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.405 2.737 . . . . 0.0 113.11 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.0 tp -61.56 -18.67 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -103.98 -8.89 19.27 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -86.27 -35.18 20.1 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.297 0.953 . . . . 0.0 110.837 169.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.02 156.0 40.15 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 122.971 0.508 . . . . 0.0 110.702 170.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.1 121.05 15.56 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.557 0.743 . . . . 0.0 110.747 170.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.72 1.68 2.35 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -170.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -69.28 -27.08 65.1 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.343 -0.848 . . . . 0.0 111.918 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -93.33 -2.58 54.71 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.576 1.55 . . . . 0.0 113.225 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -127.1 84.37 2.26 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.998 1.719 . . . . 0.0 109.955 -172.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.69 -18.39 41.92 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.4 t -120.89 111.2 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 125.515 1.526 . . . . 0.0 109.762 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.4 t -126.34 121.39 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 121.611 -0.68 . . . . 0.0 110.476 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 mp -113.15 135.05 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.277 1.031 . . . . 0.0 109.958 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.0 m -95.8 148.4 22.63 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.604 1.162 . . . . 0.0 109.972 169.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.417 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 87.6 mt -129.09 44.21 3.01 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.065 0.946 . . . . 0.0 110.169 -171.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 22.5 p . . . . . 0 CA--C 1.544 0.734 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 -169.062 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 CA--C 1.549 0.911 0 CA-C-O 119.484 -0.293 . . . . 0.0 111.743 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -54.79 138.12 76.07 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.066 2.51 . . . . 0.0 111.827 173.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -59.02 -34.26 99.02 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.359 2.039 . . . . 0.0 113.628 -172.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -65.99 -26.77 67.71 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.817 -1.177 . . . . 0.0 113.692 174.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.38 -15.81 59.18 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.631 -1.293 . . . . 0.0 113.027 170.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.6 t -93.51 -37.75 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 126.548 1.939 . . . . 0.0 112.162 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.8 p -83.97 18.13 2.16 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -172.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -70.22 162.36 28.57 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.496 1.118 . . . . 0.0 112.359 169.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -55.47 -35.19 65.23 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.108 1.363 . . . . 0.0 113.781 -169.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.9 mt -127.9 118.79 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.812 1.245 . . . . 0.0 108.15 169.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -132.57 128.01 36.29 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.121 0.968 . . . . 0.0 111.298 170.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -147.51 161.96 40.04 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.805 1.642 . . . . 0.0 111.075 -174.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -129.94 129.96 44.5 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.557 0.743 . . . . 0.0 111.672 169.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.417 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 46.3 m0 -90.06 1.93 55.79 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -177.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 71.44 -72.35 0.12 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.44 1.896 . . . . 0.0 113.256 175.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 20.5 mt 50.14 -157.97 0.09 Allowed 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 126.143 1.777 . . . . 0.0 114.221 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -144.06 156.66 44.46 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.828 2.451 . . . . 0.0 108.045 172.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -80.13 120.04 78.43 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-N 120.683 1.583 . . . . 0.0 111.887 176.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -91.31 -21.69 0.63 Allowed 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 122.249 1.966 . . . . 0.0 115.746 -169.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -53.44 110.16 0.53 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.507 1.123 . . . . 0.0 112.403 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.73 1.43 87.32 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.068 0.842 . . . . 0.0 114.749 176.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -75.05 170.07 16.75 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.584 1.192 . . . . 0.0 110.822 169.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.2 t -63.31 148.27 48.76 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.531 -0.73 . . . . 0.0 110.361 169.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 mp -61.43 -27.86 68.85 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.604 -0.685 . . . . 0.0 112.485 -173.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.85 -34.76 78.02 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.998 -1.064 . . . . 0.0 113.444 171.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.2 t -71.12 -35.72 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 O-C-N 120.975 -1.078 . . . . 0.0 109.885 172.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.404 ' CE2' ' HB ' ' A' ' 45' ' ' THR . 0.3 OUTLIER -67.7 -38.52 83.77 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.322 0.649 . . . . 0.0 111.125 177.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -70.25 -37.38 74.93 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.994 1.318 . . . . 0.0 111.739 170.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.6 m -57.51 -45.88 84.43 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 119.118 0.872 . . . . 0.0 111.66 175.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.0 m -69.33 -29.91 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 119.723 1.147 . . . . 0.0 112.609 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -62.44 -41.75 98.95 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 120.542 1.519 . . . . 0.0 111.77 170.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.07 -45.41 87.51 Favored Glycine 0 N--CA 1.474 1.195 0 C-N-CA 124.039 0.828 . . . . 0.0 112.745 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -60.56 -40.53 91.96 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 122.197 -0.59 . . . . 0.0 112.375 171.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.2 t -64.99 -46.76 90.58 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.103 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -52.03 -53.15 45.45 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 120.141 1.337 . . . . 0.0 111.593 176.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -49.81 -45.1 49.65 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.301 1.44 . . . . 0.0 112.111 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -92.16 -27.05 17.95 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.058 0.943 . . . . 0.0 112.179 -171.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.9 t -62.19 -49.8 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.042 1.337 . . . . 0.0 109.799 169.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -54.06 -53.73 49.09 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.005 0.82 . . . . 0.0 109.583 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -53.03 -37.93 61.95 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.141 1.776 . . . . 0.0 112.364 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -78.83 -59.87 2.6 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.157 -0.964 . . . . 0.0 112.781 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.18 -33.55 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.887 1.275 . . . . 0.0 112.498 -174.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.97 -18.79 61.96 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -78.42 -25.13 45.93 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.648 1.179 . . . . 0.0 113.52 174.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.1 pt -106.25 -8.18 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.498 1.519 . . . . 0.0 113.678 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 C--O 1.254 1.315 0 C-N-CA 125.493 1.517 . . . . 0.0 113.088 173.653 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.2 ttp . . . . . 0 N--CA 1.503 2.203 0 CA-C-O 119.754 -0.165 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -88.35 97.85 11.27 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.079 0.952 . . . . 0.0 110.69 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -81.24 133.73 35.49 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 121.633 -0.667 . . . . 0.0 110.811 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.5 m -100.15 146.51 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.088 0.955 . . . . 0.0 110.998 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.8 tpp -126.41 112.11 15.26 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.907 0.883 . . . . 0.0 110.876 172.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -81.54 138.07 35.48 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.967 -0.458 . . . . 0.0 110.656 169.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.2 t -137.38 129.79 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.316 1.047 . . . . 0.0 111.234 -171.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 t -145.69 -175.6 4.8 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 119.166 0.894 . . . . 0.0 113.345 169.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -60.03 -37.66 80.45 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 121.752 -0.593 . . . . 0.0 110.323 169.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.95 127.74 56.09 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.985 0.914 . . . . 0.0 110.695 168.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -66.97 -33.65 76.04 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.552 168.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.8 p -67.97 -47.51 68.41 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.136 1.774 . . . . 0.0 115.584 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.3 p -85.42 -24.96 27.26 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -171.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.27 -60.89 1.59 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 176.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.8 m -60.19 -41.06 92.15 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.147 0.885 . . . . 0.0 112.947 -169.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -60.44 -40.05 89.71 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.847 1.659 . . . . 0.0 113.088 169.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.7 mtm -61.94 -46.06 90.95 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.852 -1.155 . . . . 0.0 111.023 174.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.89 -28.52 66.76 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 173.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -71.24 -46.04 61.93 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.227 1.376 . . . . 0.0 108.96 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.61 -44.07 97.03 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 118.602 -1.11 . . . . 0.0 112.408 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -63.15 -41.31 99.25 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.974 1.387 . . . . 0.0 111.971 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.94 -34.58 71.63 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 120.719 -1.238 . . . . 0.0 110.572 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -59.45 -57.92 10.86 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.112 1.765 . . . . 0.0 109.94 170.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.6 p -69.09 -14.64 63.13 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.1 mt -99.87 -6.38 26.88 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.5 10.77 0.52 Allowed Glycine 0 N--CA 1.476 1.357 0 N-CA-C 117.192 1.637 . . . . 0.0 117.192 -169.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.02 131.06 39.88 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.076 1.438 . . . . 0.0 112.142 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.97 -8.68 49.71 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.387 -1.229 . . . . 0.0 115.777 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -84.76 -57.08 3.26 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 120.03 1.915 . . . . 0.0 110.461 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -139.02 179.43 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 126.57 1.948 . . . . 0.0 110.597 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.76 127.39 47.2 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.341 -0.849 . . . . 0.0 112.091 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.5 m -90.99 145.26 7.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 123.989 0.916 . . . . 0.0 113.212 169.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.8 157.4 43.66 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.998 0.919 . . . . 0.0 110.88 -174.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.9 p -141.89 141.85 33.04 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.394 1.478 . . . . 0.0 112.757 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.1 t -143.46 178.15 7.96 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.414 1.486 . . . . 0.0 111.208 169.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.03 170.21 37.11 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 119.905 -1.747 . . . . 0.0 114.494 172.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.5 mt -60.53 -45.0 95.46 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.453 0.701 . . . . 0.0 111.851 -170.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -109.45 111.63 23.27 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 127.239 2.216 . . . . 0.0 106.251 169.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.4 p -66.72 -43.17 84.96 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.446 -1.409 . . . . 0.0 110.975 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 t 52.62 -170.69 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.711 2.004 . . . . 0.0 114.081 -176.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -88.63 174.37 8.09 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.587 1.955 . . . . 0.0 111.787 173.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 m -60.77 113.4 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 169.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -64.45 130.37 94.64 Favored Pre-proline 0 N--CA 1.477 0.902 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -168.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -59.98 -39.2 72.93 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.475 2.783 . . . . 0.0 114.028 -171.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 m -78.3 -37.28 45.13 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.117 0.567 . . . . 0.0 110.507 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.22 93.59 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.084 -0.96 . . . . 0.0 112.355 175.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.9 mt -52.07 -45.75 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 120.687 1.585 . . . . 0.0 110.083 173.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.2 -57.8 7.58 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.2 mmt -64.88 -23.07 67.12 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -174.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 87.7 mmm -89.97 -37.83 14.07 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.224 1.01 . . . . 0.0 110.851 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -58.75 -36.81 74.96 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 120.766 -1.209 . . . . 0.0 112.067 169.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -54.97 -30.57 59.44 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.353 1.061 . . . . 0.0 113.704 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.2 m -104.47 15.69 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 125.059 1.344 . . . . 0.0 114.113 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.86 15.43 63.16 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.131 0.872 . . . . 0.0 115.087 176.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.2 mt -124.56 74.2 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.832 1.653 . . . . 0.0 109.461 -169.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -66.39 108.06 2.24 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 119.938 -1.726 . . . . 0.0 110.498 172.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.8 pt -86.95 -0.47 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.0 p -67.71 -24.87 65.44 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.535 -1.353 . . . . 0.0 114.588 -169.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.61 6.0 64.86 Favored Glycine 0 CA--C 1.541 1.671 0 C-N-CA 125.389 1.471 . . . . 0.0 114.66 170.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -82.06 147.92 28.87 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.704 1.202 . . . . 0.0 112.029 -172.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.6 t -69.06 156.1 39.23 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 121.505 -0.747 . . . . 0.0 112.157 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.5 t -136.6 142.68 43.33 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.743 0.817 . . . . 0.0 111.243 170.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.31 140.6 21.08 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -171.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -89.96 156.48 4.91 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 124.123 3.215 . . . . 0.0 113.024 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.7 tp -61.52 -22.98 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -170.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -102.62 -5.34 23.97 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -87.87 -38.89 15.27 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.651 -0.656 . . . . 0.0 110.852 169.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.06 153.36 43.9 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.23 0.538 . . . . 0.0 111.436 171.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -136.98 120.63 17.26 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.529 1.132 . . . . 0.0 110.444 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.49 8.48 1.78 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -170.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -73.35 -29.87 62.95 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.47 -0.769 . . . . 0.0 112.305 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -93.39 -3.55 53.07 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.091 1.357 . . . . 0.0 113.642 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -125.06 89.36 3.04 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.869 1.668 . . . . 0.0 109.351 -172.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -59.7 -24.66 64.14 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -175.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.0 t -121.35 105.11 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.703 1.201 . . . . 0.0 110.106 -169.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.8 t -116.05 130.49 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.584 1.154 . . . . 0.0 110.66 -174.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.6 mp -119.38 124.97 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.714 0.806 . . . . 0.0 109.98 -174.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 t -85.7 124.68 32.49 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.419 1.088 . . . . 0.0 108.969 168.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.414 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 75.2 mt -111.54 37.68 2.83 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 126.673 1.989 . . . . 0.0 110.506 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 9.6 t . . . . . 0 CA--C 1.536 0.433 0 O-C-N 121.446 -0.783 . . . . 0.0 112.697 -175.924 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.5 mt . . . . . 0 CA--C 1.548 0.881 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.83 134.7 58.7 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.031 2.487 . . . . 0.0 111.798 176.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -61.62 -30.18 85.29 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.483 2.122 . . . . 0.0 113.557 -174.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -66.58 -30.89 71.29 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.544 -1.348 . . . . 0.0 113.183 173.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -78.61 -20.12 51.15 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.926 -1.108 . . . . 0.0 112.632 174.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.3 t -86.77 -38.65 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.801 1.64 . . . . 0.0 112.107 174.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.3 p -85.12 52.43 2.44 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 120.785 -1.197 . . . . 0.0 113.366 -172.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -110.65 171.51 7.42 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.339 1.856 . . . . 0.0 112.306 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -53.29 -42.48 66.66 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.401 1.08 . . . . 0.0 113.003 -169.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.3 mt -130.2 122.42 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.867 1.267 . . . . 0.0 108.756 169.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -122.36 132.45 54.39 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.706 0.802 . . . . 0.0 109.157 169.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.82 155.12 44.6 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.127 1.371 . . . . 0.0 111.156 -176.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -136.21 118.86 16.0 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.493 0.717 . . . . 0.0 111.92 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.414 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 31.8 m0 -97.94 3.06 49.66 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.725 1.21 . . . . 0.0 113.338 -175.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.329 1.2 pp0? 45.59 43.42 9.18 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.9 2.08 . . . . 0.0 115.905 171.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 83.9 mt -84.49 158.16 21.09 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.698 1.199 . . . . 0.0 113.917 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -79.85 164.07 23.88 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.331 1.852 . . . . 0.0 112.188 169.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -95.84 111.71 56.86 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 123.861 0.864 . . . . 0.0 108.975 169.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -85.44 -10.57 7.58 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.049 2.499 . . . . 0.0 116.067 -169.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -49.67 112.7 0.69 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.533 1.133 . . . . 0.0 112.816 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.6 -0.15 89.69 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 123.844 0.735 . . . . 0.0 114.836 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -75.79 170.68 15.75 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 118.295 1.047 . . . . 0.0 110.31 169.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.5 t -58.84 145.27 41.55 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.507 -0.746 . . . . 0.0 111.028 169.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.45 -28.32 68.22 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.15 0.58 . . . . 0.0 111.998 -176.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -65.82 -33.18 75.27 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 120.96 -1.087 . . . . 0.0 113.237 173.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.2 t -70.28 -36.47 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 O-C-N 121.037 -1.039 . . . . 0.0 109.823 171.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.87 -42.68 90.07 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.645 0.778 . . . . 0.0 110.736 176.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -67.12 -36.06 81.09 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.78 1.232 . . . . 0.0 112.367 171.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.5 m -59.53 -48.89 79.89 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 119.306 0.957 . . . . 0.0 111.427 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.3 m -68.21 -32.31 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 117.909 -1.043 . . . . 0.0 111.983 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.08 -43.4 91.8 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 120.825 1.648 . . . . 0.0 111.978 169.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.47 -41.89 89.91 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 124.388 0.994 . . . . 0.0 112.556 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -61.95 -46.14 90.59 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 122.214 -0.58 . . . . 0.0 111.897 169.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.42 -46.73 92.44 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.267 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -51.95 -54.92 23.92 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.654 1.182 . . . . 0.0 111.827 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -60.61 -41.42 94.74 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.351 0.661 . . . . 0.0 112.305 -176.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 50.7 mtp85 -79.2 -33.83 43.5 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.4 t -59.81 -47.58 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.182 0.993 . . . . 0.0 110.653 170.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -53.35 -55.3 26.0 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.11 0.868 . . . . 0.0 109.966 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -54.71 -40.63 69.4 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.881 1.273 . . . . 0.0 112.301 176.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.7 -58.81 3.07 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.183 -0.948 . . . . 0.0 112.52 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.36 -34.95 70.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.599 1.16 . . . . 0.0 111.624 -176.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.42 -15.95 61.33 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -173.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -71.17 -28.16 64.05 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.435 1.094 . . . . 0.0 113.42 170.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.7 pt -113.81 -6.95 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.189 1.796 . . . . 0.0 113.287 -173.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.7 m . . . . . 0 C--O 1.254 1.299 0 C-N-CA 125.735 1.614 . . . . 0.0 113.713 173.561 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.503 2.217 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -79.62 96.51 6.2 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.773 0.829 . . . . 0.0 110.079 171.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -77.12 144.96 38.09 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.759 -0.588 . . . . 0.0 111.191 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 p -122.43 141.72 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.524 1.13 . . . . 0.0 111.047 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.422 ' HE2' ' CD2' ' A' ' 68' ' ' PHE . 50.8 tpp -124.38 120.41 32.03 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.616 1.167 . . . . 0.0 111.774 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -88.89 130.06 35.49 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.313 0.645 . . . . 0.0 111.507 169.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.2 t -129.24 124.31 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.918 1.287 . . . . 0.0 110.188 -172.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.3 m -136.17 169.65 17.28 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.556 1.142 . . . . 0.0 111.467 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -64.92 -48.69 73.25 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 168.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.424 ' HB3' ' H ' ' A' ' 13' ' ' SER . 0.9 OUTLIER -99.87 105.4 17.14 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.314 1.446 . . . . 0.0 108.366 168.549 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -53.58 -33.49 55.04 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 122.952 0.501 . . . . 0.0 110.884 169.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.9 p -65.37 -40.2 93.25 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.164 2.185 . . . . 0.0 115.793 176.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.424 ' H ' ' HB3' ' A' ' 10' ' ' ARG . 14.4 p -97.09 -22.9 16.5 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -170.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.43 -51.14 1.75 Allowed 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 171.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.0 m -59.07 -44.57 91.89 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 121.284 1.857 . . . . 0.0 111.926 -175.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -58.23 -43.56 87.79 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.997 1.319 . . . . 0.0 113.474 169.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 51.2 ttm -58.31 -50.81 72.31 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.325 1.05 . . . . 0.0 111.381 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.67 -27.22 66.66 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.254 1.022 . . . . 0.0 112.524 174.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -76.35 -43.55 40.51 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 120.424 1.466 . . . . 0.0 109.133 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.88 -52.99 47.65 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-O 119.152 -0.804 . . . . 0.0 111.248 174.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -62.2 -41.61 98.53 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.286 1.043 . . . . 0.0 112.919 174.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.01 -40.83 97.23 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.211 1.369 . . . . 0.0 110.837 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -61.21 -50.06 74.65 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.326 1.85 . . . . 0.0 111.32 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.6 p -74.94 -22.73 58.42 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.1 mt -88.84 -23.26 22.85 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.264 0.938 . . . . 0.0 112.711 176.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -126.4 21.72 6.01 Favored Glycine 0 N--CA 1.473 1.124 0 C-N-CA 125.777 1.656 . . . . 0.0 115.431 -170.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.91 126.48 27.27 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.236 1.018 . . . . 0.0 112.531 -173.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.65 -2.6 47.22 Favored Glycine 0 CA--C 1.537 1.431 0 N-CA-C 116.024 1.17 . . . . 0.0 116.024 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -81.7 -54.77 5.11 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.587 1.694 . . . . 0.0 111.146 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -143.04 -179.37 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 127.355 2.262 . . . . 0.0 110.989 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.23 121.49 42.34 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.482 0.658 . . . . 0.0 111.825 171.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.3 m -87.11 150.8 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 123.473 0.709 . . . . 0.0 111.981 169.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.68 159.77 43.05 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.265 1.026 . . . . 0.0 111.288 -174.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.5 t -144.7 127.7 16.49 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.144 1.378 . . . . 0.0 111.885 -169.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.0 p -144.09 -178.76 6.11 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.532 1.533 . . . . 0.0 111.299 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.06 172.11 35.47 Favored Glycine 0 CA--C 1.532 1.142 0 O-C-N 119.834 -1.791 . . . . 0.0 114.47 173.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 47.6 mt -61.68 -39.15 90.42 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 118.354 1.077 . . . . 0.0 112.176 -173.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -115.81 113.66 23.69 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.809 2.044 . . . . 0.0 107.843 169.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.3 p -65.88 -37.14 85.35 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.933 0.893 . . . . 0.0 112.046 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.4 t 44.09 -129.85 0.87 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 126.159 1.784 . . . . 0.0 112.786 -174.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -146.62 -175.77 4.92 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 127.139 2.176 . . . . 0.0 111.823 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.1 m -59.22 115.75 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 121.134 -0.979 . . . . 0.0 110.291 169.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.8 t-80 -73.85 131.7 81.33 Favored Pre-proline 0 N--CA 1.476 0.855 0 CA-C-O 118.501 -0.762 . . . . 0.0 113.035 -169.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -60.58 -39.74 62.2 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.488 2.792 . . . . 0.0 114.293 -171.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.1 m -80.95 -33.07 34.25 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.803 -0.56 . . . . 0.0 110.833 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.45 -42.46 87.55 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 118.087 -0.959 . . . . 0.0 112.166 174.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.0 mt -47.35 -48.22 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 119.997 1.271 . . . . 0.0 110.395 172.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.61 -61.54 2.14 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.8 mmt -66.31 -27.31 67.82 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.525 -0.735 . . . . 0.0 112.379 -171.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 81.7 mtp -84.22 -38.18 20.88 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.595 0.758 . . . . 0.0 111.364 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -57.35 -38.05 73.54 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.715 1.143 . . . . 0.0 112.099 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -59.39 -23.39 62.55 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.0 m -108.28 15.07 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.39 16.54 58.7 Favored Glycine 0 N--CA 1.478 1.444 0 O-C-N 121.087 -1.008 . . . . 0.0 115.325 176.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.9 mt -125.43 53.31 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.892 1.677 . . . . 0.0 110.307 -169.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -60.4 113.2 2.28 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.26 -1.525 . . . . 0.0 111.435 176.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.8 pt -91.46 2.53 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.215 1.006 . . . . 0.0 113.648 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -62.19 -24.41 67.19 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 120.759 1.618 . . . . 0.0 113.262 -173.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.46 6.87 59.47 Favored Glycine 0 CA--C 1.543 1.84 0 C-N-CA 125.475 1.512 . . . . 0.0 115.77 170.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -83.24 152.21 25.29 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.089 1.445 . . . . 0.0 112.088 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.0 t -71.44 163.67 27.26 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 52.0 m -137.07 140.92 42.34 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.01 1.724 . . . . 0.0 109.49 169.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -145.96 141.89 17.17 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-N 119.548 1.067 . . . . 0.0 113.369 -175.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -86.45 148.27 8.78 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 123.221 2.614 . . . . 0.0 111.441 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.0 tt -66.48 -16.63 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 O-C-N 120.549 -1.344 . . . . 0.0 113.976 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -89.54 -10.52 45.86 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.112 -0.992 . . . . 0.0 113.485 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -88.5 -40.7 13.24 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.764 0.825 . . . . 0.0 111.453 170.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.422 ' CD2' ' HE2' ' A' ' 5' ' ' MET . 0.0 OUTLIER -70.71 153.03 43.19 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.816 0.847 . . . . 0.0 111.694 177.415 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.436 ' HA ' ' CH2' ' A' ' 90' ' ' TRP . 11.1 m120 -128.38 124.87 37.45 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.435 0.694 . . . . 0.0 110.329 169.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.29 5.71 1.62 Allowed 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -73.02 -29.02 62.7 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.983 0.913 . . . . 0.0 112.213 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -97.51 -3.79 39.17 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.81 1.244 . . . . 0.0 113.583 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -121.73 92.01 3.64 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.009 1.724 . . . . 0.0 109.353 -172.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -60.51 -28.17 68.18 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -174.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.5 t -113.67 116.74 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.383 1.073 . . . . 0.0 110.098 -177.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.1 t -126.4 132.51 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.909 0.884 . . . . 0.0 110.377 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.7 mm -123.07 127.78 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 121.771 -0.581 . . . . 0.0 111.466 -170.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.5 t -87.51 126.45 34.92 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.282 1.433 . . . . 0.0 109.964 169.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.5 mt -112.6 42.14 1.9 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.645 1.178 . . . . 0.0 113.015 -174.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 30.4 p . . . . . 0 CA--C 1.545 0.777 0 C-N-CA 127.126 2.17 . . . . 0.0 107.744 168.972 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.0 mt . . . . . 0 CA--C 1.546 0.801 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -71.37 151.32 59.71 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.328 2.019 . . . . 0.0 110.863 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -58.62 -34.78 99.11 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.837 2.358 . . . . 0.0 112.613 -175.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -48.83 -46.25 41.73 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.602 1.561 . . . . 0.0 112.919 175.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.436 ' CH2' ' HA ' ' A' ' 69' ' ' ASN . 1.8 m95 -90.57 8.42 34.21 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.052 1.341 . . . . 0.0 113.072 -177.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.5 t -116.0 -39.32 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 126.868 2.067 . . . . 0.0 111.697 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.6 p -79.9 28.11 0.29 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -174.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -85.22 172.19 11.36 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.826 1.65 . . . . 0.0 111.961 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -53.69 -42.37 67.89 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -169.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.6 mt -129.4 125.67 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.463 1.105 . . . . 0.0 109.069 169.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -131.99 136.26 47.15 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.264 1.026 . . . . 0.0 111.533 169.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -143.06 154.94 44.47 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.111 1.364 . . . . 0.0 111.741 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -122.64 118.95 29.37 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.14 1.376 . . . . 0.0 109.976 171.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -84.86 3.98 35.38 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 117.788 2.514 . . . . 0.0 117.788 -169.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 58.44 51.16 8.43 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.252 1.387 . . . . 0.0 113.048 176.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 66.2 mt -107.73 165.93 11.07 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.336 1.855 . . . . 0.0 113.269 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -122.32 153.73 38.56 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.387 1.875 . . . . 0.0 110.32 173.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -74.34 118.32 68.84 Favored Pre-proline 0 CA--C 1.546 0.816 0 O-C-N 121.296 -0.878 . . . . 0.0 111.342 176.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -85.27 -6.6 9.19 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.32 2.013 . . . . 0.0 114.013 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -48.67 116.03 1.46 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.231 1.013 . . . . 0.0 112.77 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.04 3.68 69.71 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.791 0.71 . . . . 0.0 114.338 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -80.94 171.58 14.82 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.463 1.105 . . . . 0.0 110.115 171.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.3 p -63.9 156.49 27.5 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.339 -0.85 . . . . 0.0 112.082 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.05 -29.06 70.03 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.578 -0.701 . . . . 0.0 111.43 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.27 -40.96 92.22 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.175 -0.953 . . . . 0.0 112.641 172.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.3 t -73.1 -39.85 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.753 0.821 . . . . 0.0 109.691 176.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -63.52 -36.87 85.21 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.051 0.54 . . . . 0.0 111.189 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -70.95 -43.21 68.63 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.339 1.456 . . . . 0.0 112.199 172.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.2 m -57.69 -51.05 71.11 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.177 0.991 . . . . 0.0 111.838 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.4 m -68.1 -29.23 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 O-C-N 121.271 -0.893 . . . . 0.0 112.051 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.6 ptt-85 -70.6 -32.9 70.43 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 119.778 1.172 . . . . 0.0 113.051 173.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.11 -45.12 94.64 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 123.88 0.752 . . . . 0.0 112.262 170.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -61.97 -42.18 98.85 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.926 -0.749 . . . . 0.0 112.348 171.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.3 t -60.22 -50.12 81.49 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.724 0 CA-C-O 117.139 -1.41 . . . . 0.0 110.182 174.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -51.19 -48.91 61.84 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.469 1.508 . . . . 0.0 112.158 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -55.27 -43.7 74.94 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.701 1.2 . . . . 0.0 112.492 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.0 mtt180 -91.59 -32.89 15.34 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.975 0.91 . . . . 0.0 112.75 -169.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.4 p -69.6 -36.66 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.574 1.55 . . . . 0.0 112.012 171.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -56.67 -58.76 6.7 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.81 1.186 . . . . 0.0 109.915 169.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -55.34 -27.65 48.58 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.504 1.122 . . . . 0.0 113.299 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -85.07 -59.33 2.37 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.336 0.971 . . . . 0.0 112.904 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.92 -33.34 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.553 1.141 . . . . 0.0 111.727 -178.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.83 -14.13 60.65 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -82.48 -28.38 31.22 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.501 1.121 . . . . 0.0 113.065 172.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.3 pt -98.92 -12.02 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.612 1.165 . . . . 0.0 113.817 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.2 m . . . . . 0 C--O 1.255 1.356 0 C-N-CA 124.766 1.226 . . . . 0.0 113.245 171.672 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 ttm . . . . . 0 N--CA 1.503 2.182 0 CA-C-O 119.712 -0.185 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -91.95 85.82 5.67 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.19 0.996 . . . . 0.0 110.277 177.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -77.45 150.74 34.94 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.535 -0.728 . . . . 0.0 111.351 -175.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.2 t -108.38 143.27 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.583 0.753 . . . . 0.0 111.45 -175.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.421 ' HE3' ' CD2' ' A' ' 68' ' ' PHE . 43.7 tpp -128.08 110.39 12.44 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.912 0.885 . . . . 0.0 110.156 169.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -81.83 138.51 35.09 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.635 169.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.6 t -135.62 128.39 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.083 0.953 . . . . 0.0 111.587 -174.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.7 p -147.17 -178.23 6.1 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.798 1.239 . . . . 0.0 111.813 175.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -62.35 -64.34 0.96 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 119.847 1.203 . . . . 0.0 110.124 172.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.27 107.42 16.56 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 168.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -56.67 -41.73 77.78 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.748 0.704 . . . . 0.0 109.556 169.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.2 p -53.22 -29.57 33.08 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 127.446 2.299 . . . . 0.0 115.849 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.1 p -97.97 -97.47 0.21 Allowed 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 123.571 0.748 . . . . 0.0 109.82 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -53.19 -50.7 64.11 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.391 1.476 . . . . 0.0 113.38 -169.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.408 ' HB3' ' HB2' ' A' ' 34' ' ' SER . 69.9 m -71.36 -40.2 70.78 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -174.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -64.25 -37.2 86.63 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 168.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 77.0 mtp -58.38 -51.36 70.14 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.108 0.867 . . . . 0.0 109.592 172.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.24 -36.18 82.82 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -66.38 -40.22 89.57 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 119.524 1.056 . . . . 0.0 108.882 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.478 ' N ' HE22 ' A' ' 60' ' ' GLN . . . -68.16 -45.05 73.65 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-O 118.961 -0.911 . . . . 0.0 111.989 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -62.28 -38.88 91.04 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.305 1.052 . . . . 0.0 111.458 170.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.24 -33.46 71.68 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 120.587 -1.32 . . . . 0.0 111.368 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -62.8 -55.5 25.87 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.443 1.897 . . . . 0.0 109.369 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.8 p -71.46 -15.51 62.33 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.6 mt -97.4 -11.12 24.3 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 173.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.99 9.2 2.01 Favored Glycine 0 N--CA 1.477 1.376 0 N-CA-C 117.227 1.651 . . . . 0.0 117.227 -169.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.5 128.98 27.58 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.155 1.478 . . . . 0.0 112.342 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.12 -6.89 55.28 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-O 118.319 -1.267 . . . . 0.0 115.888 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -85.68 -57.16 3.16 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.02 1.91 . . . . 0.0 110.286 175.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 pp -139.71 173.4 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 127.433 2.293 . . . . 0.0 109.141 171.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.37 131.2 44.27 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.522 -0.736 . . . . 0.0 111.833 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.7 m -100.11 143.8 13.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 123.709 0.804 . . . . 0.0 112.805 170.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 m -145.98 162.59 37.48 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.615 1.566 . . . . 0.0 109.467 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.408 ' HB2' ' HB3' ' A' ' 15' ' ' SER . 91.0 p -143.91 148.69 35.76 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.061 0.944 . . . . 0.0 113.097 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.5 p -138.39 -170.38 2.8 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.025 1.33 . . . . 0.0 110.914 171.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.93 173.44 37.36 Favored Glycine 0 CA--C 1.528 0.891 0 O-C-N 121.078 -1.013 . . . . 0.0 113.85 175.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.8 mt -64.78 -35.92 82.64 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.409 0.684 . . . . 0.0 112.253 -172.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -123.24 105.69 10.09 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 128.449 2.699 . . . . 0.0 107.09 172.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.2 p -60.9 -46.9 88.82 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.437 -0.79 . . . . 0.0 111.633 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.1 t 49.72 -171.83 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 127.898 2.479 . . . . 0.0 114.415 -174.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -77.98 166.74 22.47 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.65 1.58 . . . . 0.0 110.214 169.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.1 m -56.99 120.13 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 119.949 1.25 . . . . 0.0 108.098 169.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -65.15 127.56 92.96 Favored Pre-proline 0 N--CA 1.479 0.998 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -167.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -61.73 -39.48 52.75 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.256 2.637 . . . . 0.0 113.845 -169.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.1 m -77.85 -35.66 50.81 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.937 -0.477 . . . . 0.0 110.318 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.17 -38.1 87.24 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 117.956 -1.021 . . . . 0.0 112.407 174.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.0 mt -55.31 -41.64 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 121.455 1.934 . . . . 0.0 110.501 173.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.73 -59.77 4.15 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.0 mmt -63.69 -27.29 69.11 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.483 -0.761 . . . . 0.0 112.66 -174.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 88.0 mmm -85.01 -33.12 22.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.773 0.829 . . . . 0.0 110.561 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -61.86 -33.61 74.49 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.888 -1.133 . . . . 0.0 111.817 171.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -55.06 -33.6 62.87 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.088 0.955 . . . . 0.0 112.763 172.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.4 m -105.49 19.11 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.259 1.424 . . . . 0.0 113.859 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.34 17.01 74.89 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 115.528 0.971 . . . . 0.0 115.528 173.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 71.6 mt -115.36 125.93 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.206 1.402 . . . . 0.0 111.417 -169.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -100.43 73.41 1.65 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.558 1.943 . . . . 0.0 112.727 -172.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.33 -10.23 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 120.373 -1.454 . . . . 0.0 111.672 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.1 p -60.95 -32.03 71.56 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.888 2.475 . . . . 0.0 113.833 169.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.45 47.55 1.02 Allowed Glycine 0 N--CA 1.474 1.224 0 C-N-CA 126.418 1.961 . . . . 0.0 112.168 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.478 HE22 ' N ' ' A' ' 20' ' ' GLY . 11.0 mt-30 -135.87 171.94 13.73 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.668 1.587 . . . . 0.0 113.287 -169.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -76.56 137.26 39.44 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 121.37 -0.832 . . . . 0.0 112.944 -169.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.7 m -125.59 45.58 2.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.189 1.396 . . . . 0.0 111.004 -170.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.83 140.22 54.4 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -169.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -83.11 151.1 13.9 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.186 2.591 . . . . 0.0 111.008 169.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.9 tt -63.33 -21.57 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 -171.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -99.24 -4.71 31.32 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -88.51 -41.55 12.66 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.044 0.838 . . . . 0.0 112.117 171.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.421 ' CD2' ' HE3' ' A' ' 5' ' ' MET . 0.1 OUTLIER -70.35 164.33 24.73 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.229 0.538 . . . . 0.0 112.077 178.687 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -136.48 120.18 17.26 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.046 0.938 . . . . 0.0 111.069 171.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.96 2.86 1.79 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 -172.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -70.27 -31.78 69.31 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.406 1.003 . . . . 0.0 112.179 -174.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -90.27 -8.87 49.87 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.56 1.144 . . . . 0.0 113.364 176.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -120.79 72.23 0.96 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.921 1.689 . . . . 0.0 109.378 -173.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -65.37 -6.47 10.23 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -170.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.2 t -120.87 96.64 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 125.938 1.695 . . . . 0.0 109.055 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.4 t -109.63 135.15 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 121.376 -0.828 . . . . 0.0 110.211 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.4 HG23 ' CE2' ' A' ' 99' ' ' TRP . 12.5 mm -128.6 136.13 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 123.27 0.628 . . . . 0.0 110.297 -176.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.4 t -97.26 130.17 44.49 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.545 1.538 . . . . 0.0 110.736 172.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.8 mp -115.51 49.03 1.12 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.148 1.379 . . . . 0.0 110.295 -171.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.1 p . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 117.27 2.322 . . . . 0.0 117.27 -170.447 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.2 mt . . . . . 0 CA--C 1.554 1.115 0 CA-C-O 119.267 -0.397 . . . . 0.0 111.792 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -58.12 145.97 90.09 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.178 2.585 . . . . 0.0 114.394 -177.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -75.41 41.25 0.76 Allowed 'Trans proline' 0 CA--C 1.551 1.357 1 C-N-CA 126.062 4.508 . . . . 0.0 113.924 -175.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -156.7 -35.56 0.08 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.931 2.492 . . . . 0.0 111.023 -176.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.18 -22.66 61.25 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.49 -1.381 . . . . 0.0 111.346 169.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 m -89.69 -10.22 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 175.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.4 p -98.02 4.32 49.31 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -170.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -69.44 164.68 22.51 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.87 0.868 . . . . 0.0 111.86 175.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -57.32 -36.56 71.27 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -169.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.9 mt -116.61 118.19 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.684 0.793 . . . . 0.0 109.073 169.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -134.08 127.33 31.95 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.35 1.06 . . . . 0.0 110.521 169.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -147.03 157.47 43.62 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.054 1.342 . . . . 0.0 111.376 -172.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -122.62 131.27 53.74 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.413 0.685 . . . . 0.0 110.853 168.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.4 ' CE2' HG23 ' A' ' 77' ' ' ILE . 47.8 m0 -87.37 1.16 54.15 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.404 1.482 . . . . 0.0 114.999 -178.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 62.45 27.37 16.27 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.789 1.235 . . . . 0.0 113.98 170.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 75.5 mt -80.15 152.62 29.14 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -170.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -86.1 157.88 19.94 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.822 1.249 . . . . 0.0 111.131 170.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.68 137.21 77.13 Favored Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 120.658 -1.276 . . . . 0.0 113.1 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -99.91 -30.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.156 2.571 . . . . 0.0 113.842 171.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.97 100.25 0.06 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.942 1.697 . . . . 0.0 112.663 -176.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.48 -0.6 53.3 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.033 1.302 . . . . 0.0 114.689 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -87.68 171.76 10.2 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.06 1.344 . . . . 0.0 111.999 172.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.1 t -62.09 149.71 40.47 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.264 0.626 . . . . 0.0 111.753 171.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 mp -60.62 -28.83 68.83 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.943 0.897 . . . . 0.0 112.514 -174.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -67.56 -34.34 76.86 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.847 -1.158 . . . . 0.0 113.17 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.5 t -70.35 -37.04 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 O-C-N 121.209 -0.932 . . . . 0.0 109.524 171.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.35 -42.38 99.35 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.5 1.12 . . . . 0.0 111.384 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -71.73 -38.61 70.43 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.973 1.309 . . . . 0.0 112.291 173.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.0 m -55.38 -48.77 73.8 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.646 0.779 . . . . 0.0 111.263 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.3 m -73.11 -29.01 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 117.671 -1.157 . . . . 0.0 112.547 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . 0.252 0.0 OUTLIER -63.03 -36.8 84.78 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 121.21 1.823 . . . . 0.0 112.227 169.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.76 -45.75 91.79 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 124.556 1.074 . . . . 0.0 112.894 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -60.01 -42.46 94.36 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 117.767 0.783 . . . . 0.0 112.473 171.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.8 t -63.7 -47.44 91.08 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 C-N-CA 124.643 1.177 . . . . 0.0 110.155 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -49.6 -53.37 24.3 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 120.417 1.462 . . . . 0.0 111.648 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -58.48 -40.18 82.02 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.463 1.105 . . . . 0.0 112.602 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.6 mtt85 -82.55 -31.07 29.28 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.16 0.984 . . . . 0.0 112.931 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.78 -48.52 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.104 1.362 . . . . 0.0 109.947 169.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -54.35 -54.99 33.03 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.397 0.999 . . . . 0.0 109.497 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -50.63 -36.92 37.68 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.392 1.477 . . . . 0.0 112.67 176.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -81.06 -60.73 2.18 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.091 0.956 . . . . 0.0 112.976 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.17 -35.03 70.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.94 1.296 . . . . 0.0 111.856 -175.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.97 -20.73 61.69 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.112 -0.993 . . . . 0.0 113.443 -172.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -74.38 -20.46 60.06 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.822 1.249 . . . . 0.0 113.52 173.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.9 pt -118.07 1.48 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.086 1.754 . . . . 0.0 113.162 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 C--O 1.252 1.228 0 C-N-CA 125.932 1.693 . . . . 0.0 113.501 173.197 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.505 2.315 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -79.54 102.4 8.82 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.894 0.77 . . . . 0.0 109.557 169.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -77.25 144.13 38.43 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.677 0.791 . . . . 0.0 111.541 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 91.1 t -113.54 143.5 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.253 1.421 . . . . 0.0 110.107 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 45.1 ttm -130.72 130.76 44.22 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.18 0.592 . . . . 0.0 111.617 168.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -98.07 136.49 38.25 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.175 0.99 . . . . 0.0 110.612 169.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.1 t -129.73 126.03 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.974 1.31 . . . . 0.0 110.898 -169.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.3 m -143.34 176.6 9.03 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.217 1.007 . . . . 0.0 111.547 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -67.38 -65.21 0.71 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 169.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.13 113.15 19.79 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 168.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.37 -22.35 62.78 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 120.271 1.396 . . . . 0.0 110.294 169.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.4 p -57.63 -53.27 60.02 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 127.551 2.34 . . . . 0.0 116.17 173.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.4 p -93.19 -14.67 26.84 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.885 1.274 . . . . 0.0 113.376 -171.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -124.47 -68.88 0.83 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.406 1.082 . . . . 0.0 113.2 -176.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.1 m -57.24 -43.28 82.8 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 120.05 1.296 . . . . 0.0 113.044 -176.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -55.95 -34.77 65.98 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.757 1.623 . . . . 0.0 113.4 173.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 59.2 mtp -64.18 -48.27 76.61 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 119.399 1.0 . . . . 0.0 111.57 174.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.07 -23.48 63.08 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 118.656 -0.688 . . . . 0.0 112.551 173.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -73.23 -49.16 29.39 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 120.024 1.284 . . . . 0.0 108.598 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.06 -52.2 53.78 Favored Glycine 0 C--O 1.222 -0.628 0 CA-C-O 118.429 -1.206 . . . . 0.0 111.049 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -62.36 -43.47 98.74 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.748 1.274 . . . . 0.0 112.948 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.13 -37.0 83.09 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.676 1.58 . . . . 0.0 111.165 -177.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -59.59 -62.48 1.84 Allowed 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 125.125 1.37 . . . . 0.0 109.925 169.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.9 p -67.71 -14.28 62.81 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -175.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.5 mt -92.59 -10.7 36.58 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 172.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.24 19.08 0.1 Allowed Glycine 0 CA--C 1.539 1.573 0 N-CA-C 118.715 2.246 . . . . 0.0 118.715 -172.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.83 -33.76 62.04 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.856 1.828 . . . . 0.0 114.803 -172.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.45 -8.95 87.05 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 124.069 0.842 . . . . 0.0 114.998 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -98.76 -55.33 2.76 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 118.625 1.212 . . . . 0.0 112.312 -171.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.5 pp -141.45 171.11 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 126.619 1.968 . . . . 0.0 111.053 -174.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.22 125.49 44.83 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 175.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.1 m -94.64 155.63 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.535 1.534 . . . . 0.0 112.896 169.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.34 123.0 11.82 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.1 t -89.18 123.5 33.49 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 120.74 -1.225 . . . . 0.0 113.074 173.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.5 t -148.72 169.61 20.02 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.764 0.711 . . . . 0.0 112.39 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.36 179.27 48.89 Favored Glycine 0 CA--C 1.521 0.457 0 O-C-N 120.577 -1.327 . . . . 0.0 114.27 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.2 mt -65.39 -30.42 71.24 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 122.86 0.464 . . . . 0.0 111.413 176.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -117.22 122.61 44.48 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.651 1.981 . . . . 0.0 108.958 169.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.8 p -78.24 44.69 0.51 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.998 1.719 . . . . 0.0 111.987 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 p -64.9 158.56 24.93 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.771 1.628 . . . . 0.0 114.149 -169.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -64.2 174.16 1.7 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -169.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 m -65.98 109.08 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 120.295 -1.503 . . . . 0.0 107.552 168.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.7 t-80 -65.37 132.68 95.23 Favored Pre-proline 0 N--CA 1.476 0.874 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -169.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -59.55 -40.53 65.14 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.158 2.572 . . . . 0.0 113.334 -172.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.4 m -78.17 -30.62 49.18 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.053 -0.404 . . . . 0.0 110.911 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.5 -44.43 78.47 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.79 -1.194 . . . . 0.0 112.552 172.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.5 mt -52.85 -40.37 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 120.177 1.353 . . . . 0.0 110.463 173.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.58 -65.5 0.67 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 174.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.3 mmt -65.92 -24.92 66.93 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -170.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 85.3 mtp -84.91 -30.72 24.15 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 122.938 0.495 . . . . 0.0 111.484 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -61.14 -31.42 71.14 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.556 -1.34 . . . . 0.0 111.629 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -57.07 -31.95 65.74 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 121.085 -1.009 . . . . 0.0 112.819 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.28 7.61 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.413 1.485 . . . . 0.0 113.396 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.94 19.87 52.06 Favored Glycine 0 N--CA 1.479 1.501 0 O-C-N 120.286 -1.509 . . . . 0.0 115.038 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 25.1 mt -123.43 66.0 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.68 1.592 . . . . 0.0 110.313 -169.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -64.12 112.82 3.17 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 120.605 -1.309 . . . . 0.0 110.962 173.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.0 pt -90.34 -1.11 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 175.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.4 p -64.86 124.46 22.04 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 120.564 1.529 . . . . 0.0 110.36 -174.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.85 1.38 87.16 Favored Glycine 0 CA--C 1.546 2.023 0 N-CA-C 116.191 1.236 . . . . 0.0 116.191 -169.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -74.03 145.93 44.13 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.742 1.771 . . . . 0.0 111.916 177.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.9 t -61.21 145.35 51.52 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -175.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.0 m -137.42 117.64 13.55 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.623 1.569 . . . . 0.0 109.941 174.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -114.08 150.91 44.36 Favored Pre-proline 0 CA--C 1.557 1.214 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -169.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -91.84 126.51 0.92 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.618 2.879 . . . . 0.0 111.603 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.5 tt -77.11 -4.98 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -172.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -86.41 -13.1 47.27 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 120.654 -1.279 . . . . 0.0 113.149 170.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -91.86 -37.4 12.94 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.948 0.899 . . . . 0.0 112.569 174.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.08 169.38 15.12 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.37 1.068 . . . . 0.0 112.763 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.01 126.4 28.46 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.309 1.444 . . . . 0.0 109.785 169.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.48 3.34 3.93 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -175.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -66.44 -29.01 69.05 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.894 0.878 . . . . 0.0 112.887 -170.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -94.75 2.04 55.5 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.556 1.542 . . . . 0.0 113.671 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -122.91 93.13 3.87 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.353 1.461 . . . . 0.0 111.089 -169.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -61.58 -23.74 66.19 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.3 t -124.83 120.84 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.449 1.099 . . . . 0.0 110.697 -174.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.6 t -131.74 133.05 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.031 0.932 . . . . 0.0 109.956 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.0 mm -121.67 122.06 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 123.836 0.854 . . . . 0.0 110.716 -171.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.3 t -85.97 113.56 22.17 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 168.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.5 mt -83.77 45.11 1.04 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.238 1.015 . . . . 0.0 110.623 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.9 t . . . . . 0 CA--C 1.539 0.533 0 C-N-CA 128.536 2.734 . . . . 0.0 109.42 -178.912 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 CA--C 1.55 0.965 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -59.18 145.7 96.89 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.326 2.684 . . . . 0.0 113.913 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.11 44.04 1.11 Allowed 'Trans proline' 0 CA--C 1.548 1.213 1 C-N-CA 125.951 4.434 . . . . 0.0 113.324 -178.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -156.81 -36.66 0.08 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.601 2.36 . . . . 0.0 111.252 -174.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -75.93 -24.26 55.51 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.643 -1.285 . . . . 0.0 111.518 170.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.1 m -89.43 -11.29 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.395 1.478 . . . . 0.0 114.781 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.8 p -95.85 5.96 50.03 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -172.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -70.93 166.19 21.75 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.335 1.054 . . . . 0.0 112.285 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -52.08 -37.4 53.81 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -169.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 63.2 mt -125.15 122.3 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.656 1.182 . . . . 0.0 109.337 169.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -131.21 136.2 48.05 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.539 1.135 . . . . 0.0 111.091 169.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -140.25 146.86 39.17 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.175 0.99 . . . . 0.0 113.357 -173.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -103.18 95.72 6.3 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.189 2.196 . . . . 0.0 111.636 170.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 20.6 m0 -85.13 92.79 8.48 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 169.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.18 77.58 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 127.661 2.384 . . . . 0.0 113.688 169.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.5 mt -116.82 159.88 21.68 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.97 2.108 . . . . 0.0 112.067 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -95.53 148.92 21.99 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.256 1.422 . . . . 0.0 111.484 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -80.99 110.73 18.85 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.056 0.942 . . . . 0.0 109.908 169.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -87.03 -5.03 7.84 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.519 2.146 . . . . 0.0 113.739 -169.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -48.26 105.59 0.08 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.66 1.584 . . . . 0.0 113.36 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.43 1.3 90.04 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 123.815 0.722 . . . . 0.0 114.758 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -77.79 168.79 19.38 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.17 0.985 . . . . 0.0 110.562 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 23.2 t -62.37 149.83 41.31 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.638 -0.664 . . . . 0.0 111.45 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 mp -60.04 -28.46 67.78 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.733 0.813 . . . . 0.0 111.787 -172.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -64.89 -35.8 82.3 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 173.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.6 t -66.32 -31.95 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.545 0.738 . . . . 0.0 109.452 170.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.16 -39.54 48.68 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.732 0.813 . . . . 0.0 110.739 -177.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -68.42 -36.73 79.5 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.939 1.296 . . . . 0.0 112.457 170.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 50.6 m -59.86 -49.12 78.95 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.705 1.202 . . . . 0.0 111.259 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.6 m -67.02 -30.28 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 118.055 -0.974 . . . . 0.0 111.952 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.07 -47.83 84.23 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 120.189 1.359 . . . . 0.0 110.849 169.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.07 -41.57 99.78 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.552 1.072 . . . . 0.0 113.181 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -63.97 -48.76 75.19 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 122.148 -0.619 . . . . 0.0 112.223 171.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.7 t -53.98 -51.86 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 116.939 -1.505 . . . . 0.0 111.086 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -46.14 -47.5 17.49 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 120.33 1.423 . . . . 0.0 113.286 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -66.07 -47.99 72.49 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.815 0.846 . . . . 0.0 112.029 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.8 mtp180 -71.09 -40.49 71.5 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.522 0.729 . . . . 0.0 112.642 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.0 p -72.23 -36.26 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.538 1.535 . . . . 0.0 112.021 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -58.51 -55.34 36.28 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.777 1.172 . . . . 0.0 109.406 169.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -55.16 -36.59 66.0 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.217 1.007 . . . . 0.0 112.03 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.42 -59.48 2.74 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.473 -0.767 . . . . 0.0 112.651 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.25 -34.53 67.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.968 0.907 . . . . 0.0 112.139 -175.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.48 -6.67 52.77 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -174.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -82.41 -20.41 37.13 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.664 1.186 . . . . 0.0 113.319 169.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.7 pt -119.18 -7.69 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.293 1.437 . . . . 0.0 113.837 -173.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.3 p . . . . . 0 C--O 1.254 1.298 0 C-N-CA 125.442 1.497 . . . . 0.0 113.249 170.783 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 tpp . . . . . 0 N--CA 1.5 2.059 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -76.72 105.84 8.03 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 119.621 1.1 . . . . 0.0 110.544 169.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -79.91 136.22 36.61 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 173.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.1 t -97.96 147.0 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.273 1.029 . . . . 0.0 109.95 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 42.6 tpp -130.26 112.29 13.2 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.869 0.868 . . . . 0.0 111.296 169.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -83.68 120.88 26.53 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.301 0.64 . . . . 0.0 111.04 169.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.7 t -118.84 135.52 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.492 1.517 . . . . 0.0 109.672 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.7 p -151.9 178.0 9.86 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 121.419 -0.8 . . . . 0.0 112.537 177.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -63.57 -42.96 98.29 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 121.512 -0.743 . . . . 0.0 111.067 169.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.456 ' HB3' ' H ' ' A' ' 13' ' ' SER . 1.1 mpt_? -117.69 103.6 10.18 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.953 1.301 . . . . 0.0 110.835 172.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -55.66 -33.62 64.25 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.287 -0.883 . . . . 0.0 110.223 169.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.4 p -57.01 -53.6 56.28 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.238 2.215 . . . . 0.0 115.303 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.456 ' H ' ' HB3' ' A' ' 10' ' ' ARG . 89.0 p -103.22 -1.67 28.52 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.09 1.356 . . . . 0.0 114.133 -176.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -126.68 -76.25 0.58 Allowed 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.076 -1.64 . . . . 0.0 111.283 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.9 m -59.59 -39.04 82.82 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -172.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -56.13 -30.63 62.4 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.467 1.507 . . . . 0.0 114.499 171.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 93.2 mtp -69.73 -45.12 68.89 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.308 0.958 . . . . 0.0 110.358 174.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.35 -27.79 66.57 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 171.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -68.0 -49.01 64.15 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.99 1.268 . . . . 0.0 108.25 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.63 -52.3 51.86 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-O 118.814 -0.992 . . . . 0.0 111.854 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -61.35 -42.64 99.02 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.507 1.153 . . . . 0.0 112.848 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.59 -37.17 85.88 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 120.082 -1.636 . . . . 0.0 111.104 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -62.51 -48.63 78.7 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.021 1.329 . . . . 0.0 111.489 174.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.5 p -80.27 -14.19 58.6 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 51.0 mt -97.83 -10.79 24.13 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.08 0.952 . . . . 0.0 113.393 174.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.66 25.3 1.34 Allowed Glycine 0 CA--C 1.534 1.22 0 N-CA-C 115.851 1.1 . . . . 0.0 115.851 -169.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.89 122.78 11.56 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.602 1.201 . . . . 0.0 112.792 -175.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.29 -2.47 36.69 Favored Glycine 0 CA--C 1.538 1.497 0 N-CA-C 116.138 1.215 . . . . 0.0 116.138 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -78.64 -46.58 18.88 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.429 1.615 . . . . 0.0 111.314 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -141.98 -177.78 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 128.265 2.626 . . . . 0.0 109.375 169.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.61 120.59 40.27 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.075 -1.016 . . . . 0.0 112.449 171.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.96 144.15 9.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 122.87 0.468 . . . . 0.0 111.796 169.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.47 163.64 35.05 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.943 1.297 . . . . 0.0 110.371 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.2 p -148.68 150.19 32.78 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.467 1.107 . . . . 0.0 113.723 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 82.5 p -143.22 -175.36 4.5 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.39 1.876 . . . . 0.0 110.433 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.23 177.25 40.91 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-N 120.047 1.294 . . . . 0.0 115.23 172.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 35.6 mt -73.65 -43.78 58.59 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 118.515 1.157 . . . . 0.0 113.493 -169.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -130.42 70.65 1.45 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.387 2.275 . . . . 0.0 107.826 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.1 m -72.44 -20.33 61.42 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -169.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.2 m 37.54 -93.44 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 128.17 2.588 . . . . 0.0 117.316 172.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.1 ptp85 -154.73 -177.99 6.89 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 126.387 1.875 . . . . 0.0 112.228 -169.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.6 m -65.8 118.4 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.04 -1.038 . . . . 0.0 110.558 169.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -74.46 133.28 77.51 Favored Pre-proline 0 N--CA 1.478 0.968 0 O-C-N 121.058 -1.026 . . . . 0.0 113.0 -169.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -59.78 -40.9 59.66 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.543 2.829 . . . . 0.0 114.137 -171.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.1 m -78.29 -38.28 42.87 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 122.061 -0.399 . . . . 0.0 110.48 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.27 -40.35 97.14 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 118.123 -0.942 . . . . 0.0 112.467 176.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 66.7 mt -49.88 -47.69 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 120.197 1.362 . . . . 0.0 110.413 172.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.84 -58.79 4.8 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.5 mmt -66.25 -26.56 67.41 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.413 -0.805 . . . . 0.0 112.741 -173.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 72.2 mmm -84.2 -38.9 20.0 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.713 0.805 . . . . 0.0 110.563 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -59.59 -37.46 78.59 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.718 -1.239 . . . . 0.0 112.097 170.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -56.62 -22.32 33.24 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.538 1.135 . . . . 0.0 113.634 173.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.1 m -113.18 17.83 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 125.044 1.338 . . . . 0.0 114.576 175.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.2 13.63 61.62 Favored Glycine 0 N--CA 1.477 1.39 0 N-CA-C 115.597 0.999 . . . . 0.0 115.597 176.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 29.6 mt -126.67 62.78 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.62 1.568 . . . . 0.0 109.85 -169.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -60.67 110.69 1.37 Allowed 'General case' 0 CA--C 1.548 0.899 0 O-C-N 120.031 -1.668 . . . . 0.0 110.45 172.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.8 pt -89.58 4.2 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.7 p -67.36 -18.53 65.18 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.851 1.659 . . . . 0.0 114.648 -172.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -102.22 8.57 55.55 Favored Glycine 0 CA--C 1.542 1.728 0 C-N-CA 125.413 1.483 . . . . 0.0 114.634 169.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -79.57 143.04 35.14 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.379 1.472 . . . . 0.0 111.927 -171.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 10.8 t -66.05 153.68 41.59 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 121.53 -0.731 . . . . 0.0 112.734 172.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.4 p -147.06 133.7 19.9 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.316 1.446 . . . . 0.0 109.926 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -141.34 135.0 14.67 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.282 0.633 . . . . 0.0 112.049 -169.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -71.61 154.88 59.74 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.384 2.723 . . . . 0.0 112.903 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.1 tt -62.78 -18.96 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.022 1.329 . . . . 0.0 114.566 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -95.55 -9.11 33.25 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -80.39 -43.74 20.55 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.055 0.843 . . . . 0.0 109.236 169.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.31 159.71 32.96 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.889 1.276 . . . . 0.0 112.3 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -142.47 134.91 27.86 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.486 1.114 . . . . 0.0 110.36 169.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.2 9.33 4.65 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 -172.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.35 -28.8 63.26 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.11 -0.993 . . . . 0.0 112.318 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -97.49 -3.65 39.51 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.065 1.346 . . . . 0.0 113.662 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -123.71 90.62 3.31 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.456 1.502 . . . . 0.0 110.039 -172.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -66.91 -12.34 59.14 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.5 t -123.99 116.49 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 126.005 1.722 . . . . 0.0 109.731 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.5 t -131.57 134.76 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.762 0.825 . . . . 0.0 111.016 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.406 HG23 ' CE2' ' A' ' 99' ' ' TRP . 10.5 mm -126.59 137.0 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.319 0.648 . . . . 0.0 111.333 -172.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.2 t -95.49 117.93 31.28 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.431 1.493 . . . . 0.0 108.989 169.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 mp -99.93 61.38 1.11 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.768 1.627 . . . . 0.0 107.816 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.8 t . . . . . 0 CA--C 1.542 0.665 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 -169.506 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.9 mt . . . . . 0 CA--C 1.553 1.069 0 CA-C-O 119.267 -0.397 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -55.34 143.71 75.27 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.06 2.507 . . . . 0.0 113.174 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -75.62 41.36 0.79 Allowed 'Trans proline' 0 CA--C 1.549 1.256 1 C-N-CA 125.46 4.106 . . . . 0.0 113.624 -173.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -156.07 -30.84 0.09 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.995 2.518 . . . . 0.0 111.075 -175.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -82.21 14.82 2.68 Favored 'General case' 0 CA--C 1.553 1.073 0 O-C-N 120.918 -1.113 . . . . 0.0 113.415 169.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.5 m -131.48 -3.96 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 126.399 1.88 . . . . 0.0 113.387 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.6 p -95.68 -6.06 40.83 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.602 1.561 . . . . 0.0 113.667 -171.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -65.04 154.12 38.73 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.802 2.041 . . . . 0.0 111.932 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -53.74 -35.73 61.55 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.372 1.469 . . . . 0.0 114.304 -169.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 54.1 mt -119.02 107.38 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 169.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -121.44 131.69 54.3 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.29 1.036 . . . . 0.0 110.074 169.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -133.46 147.42 51.68 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.566 1.146 . . . . 0.0 111.647 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -115.42 95.41 5.15 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.444 1.116 . . . . 0.0 110.814 172.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.406 ' CE2' HG23 ' A' ' 77' ' ' ILE . 30.3 m0 -74.25 93.99 2.43 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 169.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.8 73.83 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.286 2.635 . . . . 0.0 113.403 169.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 71.1 mt -113.83 147.72 37.89 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.574 2.35 . . . . 0.0 111.616 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -84.47 158.88 20.88 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.369 1.068 . . . . 0.0 111.945 175.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -88.12 110.21 34.03 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 126.262 1.825 . . . . 0.0 111.765 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -84.95 -13.7 6.52 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 123.139 2.56 . . . . 0.0 116.21 -169.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -50.92 107.34 0.17 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.807 1.243 . . . . 0.0 112.527 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.18 11.54 85.45 Favored Glycine 0 CA--C 1.538 1.504 0 CA-C-O 118.837 -0.98 . . . . 0.0 115.487 177.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -74.42 -71.68 0.33 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.33 1.565 . . . . 0.0 110.625 176.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.5 t -173.89 150.1 1.61 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.891 2.476 . . . . 0.0 108.285 174.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.7 mp -60.4 -32.5 71.39 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.62 0.645 . . . . 0.0 111.799 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -70.59 -33.64 71.29 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.936 -1.103 . . . . 0.0 112.923 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 83.3 t -68.85 -37.38 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.398 -0.814 . . . . 0.0 109.527 170.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -45.09 92.06 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.58 1.152 . . . . 0.0 110.888 176.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -65.95 -23.88 66.69 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.868 1.667 . . . . 0.0 113.993 172.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.9 m -78.75 -51.74 9.36 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.672 1.589 . . . . 0.0 111.098 177.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.0 m -66.34 -26.52 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 121.104 -0.997 . . . . 0.0 111.628 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.78 -44.18 94.03 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.429 1.892 . . . . 0.0 111.203 169.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.84 -41.57 88.12 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 124.106 0.86 . . . . 0.0 112.771 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -60.87 -48.32 82.36 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 122.185 -0.597 . . . . 0.0 111.757 172.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.2 t -57.65 -47.58 85.23 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-O 117.249 -1.358 . . . . 0.0 110.232 176.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -52.29 -48.61 65.24 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 120.423 1.465 . . . . 0.0 112.327 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -63.51 -48.01 79.36 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.935 0.494 . . . . 0.0 112.19 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -70.74 -36.79 73.31 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.0 p -74.54 -36.37 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.682 1.193 . . . . 0.0 111.831 177.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -56.53 -54.82 41.44 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.649 1.113 . . . . 0.0 108.334 168.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -59.81 -17.02 32.78 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -92.23 -60.46 1.84 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.381 1.446 . . . . 0.0 112.37 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -57.76 -33.79 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.17 0.988 . . . . 0.0 111.283 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.12 -6.97 53.65 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -176.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -74.37 -23.12 58.96 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.319 1.047 . . . . 0.0 112.165 169.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.5 pt -130.42 -0.87 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 125.717 1.607 . . . . 0.0 114.983 -168.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 60.9 p . . . . . 0 C--O 1.255 1.362 0 C-N-CA 125.052 1.341 . . . . 0.0 113.509 170.424 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttm . . . . . 0 N--CA 1.503 2.213 0 CA-C-O 119.429 -0.319 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -95.59 97.27 9.62 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.467 1.107 . . . . 0.0 110.519 174.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -86.61 149.26 25.05 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.594 -0.691 . . . . 0.0 112.693 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.3 t -117.97 143.39 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.652 1.181 . . . . 0.0 111.777 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 42.9 tpp -131.9 125.35 31.49 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.419 1.087 . . . . 0.0 110.865 169.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -94.59 142.35 27.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.221 0.608 . . . . 0.0 109.985 169.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.6 t -135.42 119.79 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.11 1.364 . . . . 0.0 111.093 -174.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 p -135.37 178.06 7.33 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.294 1.438 . . . . 0.0 111.823 175.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -58.53 -57.37 13.27 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 120.751 -1.218 . . . . 0.0 110.581 174.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -101.45 120.07 39.73 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 168.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -54.14 -50.54 66.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 120.41 1.459 . . . . 0.0 110.876 175.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.1 p -64.99 -16.61 63.6 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -174.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.5 p -77.48 -37.81 50.51 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.7 ptt-85 -152.19 -32.47 0.14 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 117.279 2.326 . . . . 0.0 117.279 -174.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.4 m -68.13 -38.11 81.85 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 121.503 1.956 . . . . 0.0 113.388 171.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -67.22 -31.81 72.43 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.187 0.995 . . . . 0.0 111.724 168.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.439 ' HA ' ' CE ' ' A' ' 50' ' ' MET . 45.6 ttm -62.27 -52.44 63.7 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.328 1.051 . . . . 0.0 111.532 173.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.43 -27.6 69.4 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 124.485 1.114 . . . . 0.0 112.327 172.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -73.0 -47.83 41.74 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.928 1.694 . . . . 0.0 109.465 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.89 -54.76 31.51 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-O 118.797 -1.002 . . . . 0.0 111.344 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -57.58 -41.58 81.41 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.955 0.878 . . . . 0.0 112.379 174.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.68 -39.87 91.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.86 1.209 . . . . 0.0 112.187 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -71.31 -44.15 65.69 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.951 1.25 . . . . 0.0 112.325 173.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.6 p -65.93 -5.96 10.95 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 120.735 1.607 . . . . 0.0 114.632 173.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.8 mt -110.01 -5.43 15.43 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.847 1.259 . . . . 0.0 114.083 171.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.68 17.49 0.28 Allowed Glycine 0 N--CA 1.478 1.442 0 N-CA-C 116.841 1.496 . . . . 0.0 116.841 -170.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.11 135.22 56.99 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.923 1.362 . . . . 0.0 112.176 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.6 -6.33 46.72 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-O 118.62 -1.1 . . . . 0.0 115.588 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -85.52 -60.54 2.0 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.608 1.704 . . . . 0.0 110.672 175.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -141.37 172.53 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 127.359 2.264 . . . . 0.0 110.44 177.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.8 130.77 44.72 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.898 0.856 . . . . 0.0 112.831 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.9 m -105.34 151.76 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 124.744 1.218 . . . . 0.0 112.024 169.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.83 144.03 30.0 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.262 0.625 . . . . 0.0 111.369 -171.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.3 p -112.87 136.39 52.56 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.61 1.564 . . . . 0.0 113.46 176.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.0 t -152.61 177.26 10.85 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.866 1.266 . . . . 0.0 111.88 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.92 -175.72 47.05 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 120.671 -1.268 . . . . 0.0 114.294 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.2 mt -72.09 -33.57 67.98 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -175.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -134.44 73.32 1.49 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.535 2.334 . . . . 0.0 108.565 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.5 m -65.74 -22.7 66.62 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -172.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.9 t 43.96 -106.59 0.1 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.665 1.986 . . . . 0.0 114.607 169.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -149.34 171.55 16.35 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 127.002 2.121 . . . . 0.0 111.169 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.7 m -53.74 120.16 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.608 1.163 . . . . 0.0 110.758 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -82.52 136.03 45.98 Favored Pre-proline 0 N--CA 1.478 0.931 0 CA-C-O 118.053 -0.975 . . . . 0.0 112.237 -169.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -57.99 -44.65 38.01 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.455 2.77 . . . . 0.0 113.913 -173.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.9 m -76.98 -28.43 55.12 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.674 -0.641 . . . . 0.0 110.812 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.89 -47.09 66.71 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.223 -0.923 . . . . 0.0 111.973 169.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 57.6 mt -51.68 -48.3 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 120.27 1.396 . . . . 0.0 109.66 171.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.07 -65.13 0.65 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 177.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.44 -27.2 66.85 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -174.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.439 ' CE ' ' HA ' ' A' ' 17' ' ' MET . 87.4 mtp -80.62 -29.59 36.81 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.438 1.017 . . . . 0.0 111.669 178.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -63.93 -28.05 69.56 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.897 -1.127 . . . . 0.0 112.875 169.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -57.65 -34.71 69.64 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 119.307 0.958 . . . . 0.0 112.27 174.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.2 8.24 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.62 1.568 . . . . 0.0 113.232 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.14 23.7 43.7 Favored Glycine 0 N--CA 1.477 1.403 0 O-C-N 120.58 -1.325 . . . . 0.0 115.074 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.6 mt -123.83 60.66 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.678 1.591 . . . . 0.0 110.54 -169.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -62.34 109.82 1.46 Allowed 'General case' 0 CA--C 1.546 0.823 0 O-C-N 120.469 -1.394 . . . . 0.0 111.833 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 pt -85.87 -5.27 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 117.735 -1.126 . . . . 0.0 113.479 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.3 t -60.07 -28.54 67.89 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 120.917 1.69 . . . . 0.0 113.267 -170.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -101.34 8.52 57.08 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 125.405 1.479 . . . . 0.0 115.799 171.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -95.6 150.55 20.22 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.601 1.56 . . . . 0.0 112.034 -171.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.0 t -68.47 159.39 31.8 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -172.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.8 t -150.08 135.08 17.82 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.831 1.653 . . . . 0.0 109.625 169.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -144.02 138.78 15.31 Favored Pre-proline 0 N--CA 1.475 0.784 0 C-N-CA 123.659 0.784 . . . . 0.0 111.046 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -77.85 152.59 28.8 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.459 2.773 . . . . 0.0 113.382 -174.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.4 tt -59.21 -23.89 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -173.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -96.58 -8.2 32.42 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -94.27 -36.1 12.14 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.487 0.715 . . . . 0.0 111.439 170.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.28 161.26 30.7 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.146 0.498 . . . . 0.0 111.165 170.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.86 127.86 25.73 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.522 0.729 . . . . 0.0 111.431 169.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.23 2.61 4.46 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -173.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.8 -30.64 69.26 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.005 -1.059 . . . . 0.0 112.602 -170.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -89.37 -1.45 58.06 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.779 1.231 . . . . 0.0 113.422 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -120.66 97.06 5.38 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.224 1.41 . . . . 0.0 111.361 -169.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -55.35 -31.52 61.8 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.044 1.337 . . . . 0.0 112.85 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.6 120.23 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 124.544 1.138 . . . . 0.0 110.633 -172.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.6 t -124.92 132.83 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.14 0.976 . . . . 0.0 109.813 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.4 mm -123.51 123.51 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 123.581 0.752 . . . . 0.0 110.678 -172.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.4 t -82.55 123.55 29.31 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.968 0.907 . . . . 0.0 109.862 169.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 30.4 mt -114.34 34.55 4.65 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.853 1.661 . . . . 0.0 110.775 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 30.4 p . . . . . 0 CA--C 1.541 0.604 0 C-N-CA 124.536 1.134 . . . . 0.0 113.194 -178.877 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.3 mt . . . . . 0 CA--C 1.552 1.023 0 CA-C-O 119.245 -0.407 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -58.99 145.07 98.83 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.031 2.488 . . . . 0.0 113.848 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.02 41.9 0.79 Allowed 'Trans proline' 0 CA--C 1.55 1.293 1 C-N-CA 125.979 4.453 . . . . 0.0 113.483 -177.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -156.75 -35.74 0.08 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.921 2.489 . . . . 0.0 111.084 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.06 -26.07 61.15 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.247 -1.533 . . . . 0.0 111.698 169.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.2 m -85.8 -11.25 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 79.6 p -98.36 5.57 48.08 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -172.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -69.6 164.79 22.54 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.367 1.067 . . . . 0.0 112.505 177.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -50.2 -39.98 45.8 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.752 1.221 . . . . 0.0 114.25 -169.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.8 mt -124.03 120.01 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.383 1.073 . . . . 0.0 109.011 169.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -129.35 125.39 36.55 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.126 0.97 . . . . 0.0 110.206 169.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -139.56 158.75 43.6 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.957 1.303 . . . . 0.0 111.647 -174.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -128.21 126.18 40.45 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.49 1.116 . . . . 0.0 112.121 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -100.48 7.04 44.4 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -174.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 62.06 22.73 13.31 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 169.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 68.3 mt -78.62 142.37 37.3 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -169.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -78.03 159.03 28.99 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.059 1.744 . . . . 0.0 111.866 173.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -85.31 113.29 49.72 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 124.214 1.006 . . . . 0.0 111.247 173.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -87.06 -17.26 3.11 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.203 2.602 . . . . 0.0 114.88 -170.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -61.6 120.33 10.37 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.888 -1.132 . . . . 0.0 111.366 178.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.57 -4.77 85.13 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 123.994 0.807 . . . . 0.0 113.967 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -80.89 171.19 15.32 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 118.083 0.941 . . . . 0.0 109.577 169.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 39.4 m -62.96 151.03 40.75 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.169 -0.957 . . . . 0.0 111.419 170.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.25 -29.22 68.64 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.241 -0.912 . . . . 0.0 112.439 -175.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -62.31 -33.56 74.9 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.988 0.915 . . . . 0.0 113.317 172.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 50.3 t -72.87 -35.27 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 121.048 -1.032 . . . . 0.0 110.219 172.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -66.43 -38.26 87.02 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.003 0.521 . . . . 0.0 111.093 175.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -68.69 -39.68 80.43 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.554 1.142 . . . . 0.0 112.249 169.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 42.8 m -58.48 -47.76 83.0 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.397 1.079 . . . . 0.0 111.951 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.0 m -66.39 -30.69 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 119.382 0.992 . . . . 0.0 111.816 176.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -41.06 95.26 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 120.111 1.323 . . . . 0.0 112.633 170.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.88 -44.73 97.0 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.174 0.892 . . . . 0.0 112.591 174.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -61.81 -47.3 85.75 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 122.171 -0.605 . . . . 0.0 111.931 172.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.4 t -57.06 -48.01 82.62 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.517 0 CA-C-O 117.495 -1.24 . . . . 0.0 110.442 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -53.55 -50.69 64.98 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 120.115 1.325 . . . . 0.0 112.221 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -59.25 -44.51 92.39 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.044 0.538 . . . . 0.0 112.397 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.8 mtp85 -79.57 -35.99 38.9 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -176.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.4 p -74.01 -33.89 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.212 1.405 . . . . 0.0 112.417 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -55.47 -55.33 33.03 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.162 0.892 . . . . 0.0 108.855 169.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.94 -32.11 52.62 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.586 1.554 . . . . 0.0 112.894 176.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -79.02 -56.57 4.29 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.949 0.795 . . . . 0.0 112.256 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -65.45 -35.35 75.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.553 0.741 . . . . 0.0 112.038 -177.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.18 -8.59 55.56 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -174.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -84.65 -15.46 45.32 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.145 1.378 . . . . 0.0 113.538 171.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 21.2 pt -127.34 -8.38 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.544 1.538 . . . . 0.0 113.923 -173.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.7 p . . . . . 0 C--O 1.255 1.371 0 C-N-CA 125.227 1.411 . . . . 0.0 113.358 169.866 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.8 ttm . . . . . 0 N--CA 1.503 2.198 0 CA-C-O 119.479 -0.296 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -84.93 91.29 8.01 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.064 0.946 . . . . 0.0 111.261 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -77.75 145.85 36.24 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 121.605 -0.684 . . . . 0.0 112.376 -173.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.0 t -110.09 143.48 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.707 1.203 . . . . 0.0 110.397 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.44 ' HE3' ' CD1' ' A' ' 68' ' ' PHE . 48.4 tpp -128.91 118.37 22.55 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.852 0.861 . . . . 0.0 111.024 170.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -89.16 135.55 33.5 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.943 0.497 . . . . 0.0 111.124 169.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.9 129.11 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.755 1.222 . . . . 0.0 110.467 -171.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 t -144.3 -177.09 5.29 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.281 0.632 . . . . 0.0 112.449 172.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -64.44 -47.51 78.81 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 121.468 -0.77 . . . . 0.0 110.152 169.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.66 116.75 32.49 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.903 1.281 . . . . 0.0 109.312 169.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.69 -37.04 85.37 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 168.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.8 p -56.41 -29.47 61.58 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 128.034 2.534 . . . . 0.0 115.067 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.2 p -102.33 -101.92 0.28 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.43 1.092 . . . . 0.0 111.98 176.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.14 -44.4 71.35 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 120.227 1.376 . . . . 0.0 113.947 -168.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 m -63.16 -51.63 65.65 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.169 0.895 . . . . 0.0 112.067 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -64.6 -33.76 76.67 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 96.4 mtp -60.08 -50.35 74.04 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.725 0.693 . . . . 0.0 110.478 171.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.86 -31.16 70.78 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.28 -45.73 72.29 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 120.119 1.327 . . . . 0.0 108.642 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.46 ' CA ' HE22 ' A' ' 60' ' ' GLN . . . -67.35 -39.67 91.73 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 118.631 -1.094 . . . . 0.0 112.7 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -65.02 -39.85 93.99 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.109 1.454 . . . . 0.0 111.783 170.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.72 -33.26 70.67 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.503 -1.373 . . . . 0.0 111.385 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -59.89 -56.95 15.43 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.32 1.848 . . . . 0.0 109.61 170.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.6 p -70.16 -15.69 62.98 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.0 mt -99.24 -1.95 37.86 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 173.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.32 4.34 0.59 Allowed Glycine 0 CA--C 1.536 1.387 0 N-CA-C 117.226 1.651 . . . . 0.0 117.226 -169.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.44 133.92 56.2 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.9 1.85 . . . . 0.0 111.869 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.87 -2.36 74.83 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 124.676 1.131 . . . . 0.0 115.386 -174.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -94.35 -76.48 0.48 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.881 1.341 . . . . 0.0 110.111 175.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -128.39 176.18 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 126.608 1.963 . . . . 0.0 111.349 173.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.1 125.56 40.71 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.3 -0.875 . . . . 0.0 112.129 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.8 m -92.93 147.97 5.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 123.787 0.835 . . . . 0.0 111.664 169.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.49 159.27 43.62 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.747 0.819 . . . . 0.0 110.591 -172.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.63 133.21 34.07 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.111 1.364 . . . . 0.0 113.153 -171.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.3 p -144.7 176.17 9.63 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.305 1.442 . . . . 0.0 111.465 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.85 175.85 43.59 Favored Glycine 0 CA--C 1.526 0.774 0 O-C-N 120.396 -1.44 . . . . 0.0 114.552 169.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.4 mt -63.69 -37.79 88.66 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.112 0.565 . . . . 0.0 111.263 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -121.39 113.35 19.75 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.964 2.105 . . . . 0.0 107.829 169.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.6 p -66.74 -35.3 79.78 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.799 0.84 . . . . 0.0 112.085 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.7 t 46.59 -127.29 1.5 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 126.324 1.849 . . . . 0.0 112.293 -177.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -141.41 -176.58 4.78 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 127.511 2.324 . . . . 0.0 111.26 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.8 m -66.42 113.51 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 120.162 -1.587 . . . . 0.0 108.886 169.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -68.56 133.61 90.8 Favored Pre-proline 0 N--CA 1.477 0.917 0 O-C-N 121.48 -0.762 . . . . 0.0 112.304 -169.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.39 -38.27 85.16 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.26 2.64 . . . . 0.0 113.543 -172.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.407 ' HB ' ' CE2' ' A' ' 112' ' ' PHE . 8.7 m -79.45 -35.39 40.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.996 0.519 . . . . 0.0 110.667 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.13 -42.25 99.46 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.268 0.94 . . . . 0.0 112.133 174.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.7 mt -52.88 -44.79 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 120.287 1.403 . . . . 0.0 110.436 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.72 -60.67 2.65 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 33.5 mmt -68.03 -19.57 64.92 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.767 0.827 . . . . 0.0 113.192 -172.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 84.1 mmm -89.47 -38.04 14.34 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.896 0.878 . . . . 0.0 110.553 173.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -59.39 -35.32 73.71 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.538 -1.351 . . . . 0.0 112.399 170.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -55.19 -31.76 61.67 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.123 0.969 . . . . 0.0 113.492 171.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.9 m -103.15 20.77 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.888 1.275 . . . . 0.0 113.978 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.56 12.13 78.62 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.329 0.966 . . . . 0.0 115.255 174.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.3 mt -120.38 78.25 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.21 1.804 . . . . 0.0 108.934 -170.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -69.06 106.88 2.94 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.044 -1.66 . . . . 0.0 110.276 171.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.7 pt -84.75 -0.89 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 121.578 -0.701 . . . . 0.0 112.832 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.9 t -64.23 -28.76 69.96 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 120.157 1.344 . . . . 0.0 112.827 -172.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.32 4.22 73.43 Favored Glycine 0 CA--C 1.541 1.7 0 C-N-CA 125.102 1.334 . . . . 0.0 115.368 172.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.46 HE22 ' CA ' ' A' ' 20' ' ' GLY . 9.8 mt-30 -92.31 160.07 15.3 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.268 1.427 . . . . 0.0 112.634 -176.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.0 t -95.59 156.91 16.13 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -170.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.8 m -137.15 140.72 42.02 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.925 1.69 . . . . 0.0 108.21 169.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -141.49 134.4 14.22 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.636 1.174 . . . . 0.0 111.393 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.15 145.91 50.4 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.305 2.003 . . . . 0.0 110.297 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.5 tt -56.07 -30.72 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -169.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -94.44 -9.18 36.39 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -82.4 -41.22 20.21 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.003 0.82 . . . . 0.0 109.958 169.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.44 ' CD1' ' HE3' ' A' ' 5' ' ' MET . 0.0 OUTLIER -72.75 159.17 34.23 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.244 0.545 . . . . 0.0 110.777 170.033 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -139.75 135.77 33.44 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.589 -0.694 . . . . 0.0 111.223 169.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.3 -0.73 8.61 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -169.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -68.02 -33.51 74.73 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.759 1.163 . . . . 0.0 113.006 -171.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -84.68 -3.03 58.34 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.224 1.01 . . . . 0.0 113.598 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -120.97 92.62 3.8 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.417 1.487 . . . . 0.0 110.163 -170.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -54.29 -27.47 35.52 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.115 1.366 . . . . 0.0 113.201 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.1 118.44 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 125.209 1.404 . . . . 0.0 110.126 -174.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.2 t -127.01 132.52 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.634 0.774 . . . . 0.0 110.268 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.3 mm -124.94 122.45 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 123.715 0.806 . . . . 0.0 111.61 -169.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.2 t -81.58 130.75 35.17 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.803 0.841 . . . . 0.0 109.962 169.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.0 mt -121.19 32.72 5.82 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.161 1.784 . . . . 0.0 111.282 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.3 p . . . . . 0 CA--C 1.54 0.588 0 C-N-CA 124.575 1.15 . . . . 0.0 112.779 -176.28 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 CA--C 1.553 1.069 0 CA-C-O 118.987 -0.53 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -58.68 162.94 11.78 Favored 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 123.528 2.819 . . . . 0.0 113.728 174.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.05 -51.73 2.05 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.563 2.175 . . . . 0.0 113.663 -172.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -62.12 -35.42 78.69 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 120.653 -1.279 . . . . 0.0 112.28 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -64.89 5.64 0.31 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 127.298 2.239 . . . . 0.0 114.926 169.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.0 t -131.08 -43.01 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 127.26 2.224 . . . . 0.0 111.116 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.4 p -80.57 29.48 0.31 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -170.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -77.15 167.59 21.51 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.057 -1.027 . . . . 0.0 112.002 170.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -56.74 -36.12 69.38 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -169.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.7 mt -125.95 123.86 64.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.741 1.216 . . . . 0.0 108.88 169.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -131.76 138.56 48.65 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.758 0.823 . . . . 0.0 111.089 169.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -138.94 151.87 47.25 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.897 1.279 . . . . 0.0 110.517 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -122.41 114.3 20.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.482 0.713 . . . . 0.0 110.536 169.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 32.8 m0 -89.4 -2.36 58.38 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.205 1.002 . . . . 0.0 113.053 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.305 1.5 pp0? 47.35 37.64 6.26 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 171.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 81.7 mt -74.09 148.99 41.35 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.286 1.034 . . . . 0.0 112.686 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -75.0 153.46 38.5 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.537 1.135 . . . . 0.0 111.666 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -79.65 122.36 83.54 Favored Pre-proline 0 CA--C 1.542 0.673 0 O-C-N 121.126 -0.984 . . . . 0.0 111.858 173.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -93.86 -21.5 0.33 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.091 1.861 . . . . 0.0 113.847 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.6 104.59 0.07 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.891 2.076 . . . . 0.0 112.636 -176.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.5 8.6 87.11 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.517 1.056 . . . . 0.0 114.96 175.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -84.27 -64.78 1.1 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.711 1.256 . . . . 0.0 111.343 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.7 t -169.3 152.37 4.91 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.174 1.789 . . . . 0.0 109.592 171.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.92 -30.89 68.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.322 0.649 . . . . 0.0 111.041 172.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -62.81 -39.94 95.83 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.173 -0.955 . . . . 0.0 112.565 174.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 79.0 t -71.1 -39.6 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.41 -0.806 . . . . 0.0 109.083 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.407 ' CE2' ' HB ' ' A' ' 45' ' ' THR . 0.2 OUTLIER -59.32 -49.88 76.11 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.398 1.079 . . . . 0.0 112.097 176.719 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -69.45 -34.46 74.43 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.667 -0.646 . . . . 0.0 111.979 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 65.2 m -59.06 -52.59 65.11 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.286 0.634 . . . . 0.0 111.199 172.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.1 m -73.5 -27.55 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 117.74 -1.124 . . . . 0.0 112.664 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.7 ptt180 -61.27 -38.71 87.74 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 121.227 1.83 . . . . 0.0 111.88 170.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.94 -43.08 96.48 Favored Glycine 0 N--CA 1.473 1.156 0 C-N-CA 123.847 0.737 . . . . 0.0 112.739 176.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -61.19 -46.75 89.19 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.406 0.682 . . . . 0.0 111.929 170.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 25.5 t -60.45 -45.05 97.42 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.302 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -52.86 -54.5 33.51 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.093 1.315 . . . . 0.0 111.69 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -62.6 -43.47 98.74 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.067 0.547 . . . . 0.0 112.36 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.9 mtt-85 -74.8 -31.85 61.84 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 39.6 t -64.37 -47.98 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.489 169.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -53.92 -55.18 29.31 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.3 0.955 . . . . 0.0 109.239 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -49.34 -38.95 29.79 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.81 1.644 . . . . 0.0 112.242 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -81.19 -62.08 1.76 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.5 -30.32 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.545 1.138 . . . . 0.0 111.588 -175.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -78.11 -2.86 39.49 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -79.2 -20.51 48.18 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.339 1.056 . . . . 0.0 112.568 169.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.3 pt -126.89 13.38 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 126.303 1.841 . . . . 0.0 113.408 -169.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 47.1 p . . . . . 0 C--O 1.256 1.425 0 C-N-CA 125.748 1.619 . . . . 0.0 113.966 172.561 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.6 ttm . . . . . 0 N--CA 1.501 2.111 0 CA-C-O 119.596 -0.24 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -88.19 92.05 9.01 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.887 0.875 . . . . 0.0 109.958 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -79.85 151.2 30.36 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.49 -0.756 . . . . 0.0 111.607 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.6 p -118.84 142.09 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.045 0.938 . . . . 0.0 112.209 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 62.0 tpp -122.33 132.66 54.5 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.372 1.069 . . . . 0.0 110.881 171.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -105.09 138.8 40.73 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.78 0.718 . . . . 0.0 110.894 169.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.8 t -131.31 138.84 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.537 1.135 . . . . 0.0 112.272 -169.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 54.7 p -155.72 -169.81 3.22 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.282 1.033 . . . . 0.0 110.147 169.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -68.0 -40.74 82.98 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 120.354 -1.466 . . . . 0.0 110.102 168.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 51.7 mtp85 -124.0 101.76 7.4 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.925 1.69 . . . . 0.0 111.341 -176.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.488 HD22 ' NE2' ' A' ' 16' ' ' GLN . 19.7 t30 -52.53 -54.25 35.27 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 169.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.4 p -30.83 -57.25 0.22 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.018 2.127 . . . . 0.0 115.551 175.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.1 p -88.98 -41.95 12.07 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.27 1.028 . . . . 0.0 113.085 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -103.0 -73.87 0.65 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.047 1.339 . . . . 0.0 112.998 -174.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.11 -37.22 84.28 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -169.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.488 ' NE2' HD22 ' A' ' 11' ' ' ASN . 1.6 tp60 -50.65 -37.89 43.33 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.734 2.014 . . . . 0.0 113.17 170.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 60.2 ttm -66.3 -46.14 77.96 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.09 -1.006 . . . . 0.0 111.183 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.51 -21.94 65.47 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 118.524 -0.751 . . . . 0.0 111.957 170.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -73.34 -53.1 11.6 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 120.402 1.455 . . . . 0.0 108.461 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.99 -50.23 62.67 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.24 0.924 . . . . 0.0 112.424 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -66.55 -41.39 88.75 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.808 1.304 . . . . 0.0 113.078 176.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.38 -36.19 83.35 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.541 1.519 . . . . 0.0 110.091 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -64.3 -55.98 17.61 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.444 1.498 . . . . 0.0 109.916 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.7 p -70.59 -13.42 62.09 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 120.467 -1.395 . . . . 0.0 114.435 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.6 mt -96.82 -7.0 34.71 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.72 9.35 0.09 OUTLIER Glycine 0 N--CA 1.477 1.416 0 N-CA-C 119.028 2.371 . . . . 0.0 119.028 -172.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.53 -29.09 64.06 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.006 1.903 . . . . 0.0 114.464 -174.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.73 -9.33 86.92 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-O 119.247 -0.752 . . . . 0.0 114.891 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -101.75 -60.17 1.58 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.811 1.245 . . . . 0.0 111.968 -172.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.47 174.38 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 127.048 2.139 . . . . 0.0 110.483 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.26 129.23 42.46 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 121.384 -0.823 . . . . 0.0 110.926 176.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 m -101.68 148.42 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.014 0.926 . . . . 0.0 110.436 170.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 m -146.94 157.35 43.61 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.011 0.924 . . . . 0.0 110.367 173.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -135.45 152.03 50.98 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 170.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 88.8 p -152.32 179.24 8.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.285 1.834 . . . . 0.0 111.886 -170.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.13 -178.78 48.51 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 115.639 1.015 . . . . 0.0 115.639 169.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.9 mt -64.81 -52.08 58.7 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.849 0.86 . . . . 0.0 112.069 -174.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -91.12 -38.14 12.95 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.561 1.544 . . . . 0.0 110.86 170.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.483 ' HA ' ' H ' ' A' ' 11' ' ' ASN . 0.6 OUTLIER 62.69 -46.46 0.19 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 127.727 2.411 . . . . 0.0 115.996 -177.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . 0.256 38.2 t 63.5 -123.86 0.56 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 127.247 2.219 . . . . 0.0 113.391 174.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -143.91 -178.23 5.82 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 126.447 1.899 . . . . 0.0 113.71 -171.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.5 m -64.79 111.18 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 120.853 -1.154 . . . . 0.0 109.793 169.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -77.97 137.69 61.54 Favored Pre-proline 0 N--CA 1.476 0.83 0 O-C-N 121.092 -1.005 . . . . 0.0 112.988 -169.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -57.59 -43.43 50.77 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.538 2.825 . . . . 0.0 113.768 -175.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.9 m -75.75 -31.6 59.62 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.763 -0.586 . . . . 0.0 110.795 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.46 -43.11 81.88 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.172 -0.955 . . . . 0.0 112.408 171.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.9 mt -55.47 -40.58 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 121.268 1.849 . . . . 0.0 109.913 175.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.17 -62.53 1.56 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 173.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.95 -11.96 61.27 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -174.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 96.3 mmm -91.86 -42.49 10.04 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.177 0.899 . . . . 0.0 110.325 171.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -60.73 -37.52 82.03 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.673 -1.267 . . . . 0.0 112.518 174.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -60.66 -25.66 66.51 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.25 7.8 p -105.19 15.67 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 125.525 1.53 . . . . 0.0 113.399 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.13 18.58 49.61 Favored Glycine 0 N--CA 1.477 1.37 0 O-C-N 120.796 -1.19 . . . . 0.0 115.555 173.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.7 mt -125.78 90.65 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.974 1.31 . . . . 0.0 110.853 -169.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -70.58 114.61 8.85 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.863 -1.148 . . . . 0.0 110.657 171.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.3 pt -101.37 0.29 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 123.73 0.812 . . . . 0.0 112.756 172.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.1 p -69.51 -17.63 63.61 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -169.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -101.89 8.98 56.48 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 125.344 1.45 . . . . 0.0 114.548 169.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -87.49 156.15 19.67 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.348 1.459 . . . . 0.0 112.295 -169.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.8 t -86.89 165.4 15.95 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -175.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.5 m -135.31 93.66 3.01 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.495 1.518 . . . . 0.0 109.103 169.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -88.97 133.37 35.61 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-O 118.469 -0.777 . . . . 0.0 111.806 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.09 153.94 22.14 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.655 2.237 . . . . 0.0 112.922 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.9 tp -55.96 -32.46 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -169.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -89.22 -13.83 37.33 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 120.786 -1.196 . . . . 0.0 113.267 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -90.1 -26.28 20.31 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.102 0.961 . . . . 0.0 112.832 175.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -52.81 46.72 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -169.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.401 ' HA ' ' CH2' ' A' ' 90' ' ' TRP . 3.1 m120 59.47 106.0 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.547 2.739 . . . . 0.0 114.561 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.05 13.85 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.97 1.708 . . . . 0.0 115.474 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -73.87 -29.28 62.01 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.069 0.948 . . . . 0.0 111.138 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -100.15 -5.67 27.42 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -124.89 94.46 4.19 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.27 1.428 . . . . 0.0 110.152 -172.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -73.12 -5.08 36.75 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -174.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.3 t -128.39 121.85 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 125.601 1.561 . . . . 0.0 109.451 173.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.2 t -132.31 119.35 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.052 0.541 . . . . 0.0 110.852 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 mp -110.24 134.35 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.001 0.92 . . . . 0.0 110.564 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.0 m -89.79 147.73 23.63 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.301 1.041 . . . . 0.0 108.253 168.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.9 mt -127.13 43.59 3.09 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.395 1.078 . . . . 0.0 110.728 -173.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 24.3 p . . . . . 0 N--CA 1.473 0.724 0 N-CA-C 117.59 2.441 . . . . 0.0 117.59 -169.172 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.7 mt . . . . . 0 CA--C 1.55 0.96 0 CA-C-O 119.447 -0.311 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.91 141.01 93.43 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.641 2.227 . . . . 0.0 111.522 172.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -63.07 -29.73 75.18 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.477 2.118 . . . . 0.0 112.666 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -62.79 -25.71 68.37 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 173.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.401 ' CH2' ' HA ' ' A' ' 69' ' ' ASN . 0.4 OUTLIER -87.14 4.08 43.74 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 170.201 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.8 t -112.51 -36.63 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.949 1.7 . . . . 0.0 112.544 -175.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.9 p -79.28 10.09 4.01 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 -169.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -66.16 166.54 11.65 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.342 1.457 . . . . 0.0 112.056 169.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -56.78 -37.94 71.8 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -169.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 74.3 mt -127.07 119.8 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.52 1.128 . . . . 0.0 109.674 174.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -133.2 128.23 35.51 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.825 1.25 . . . . 0.0 110.57 169.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -146.81 161.19 41.18 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.809 1.644 . . . . 0.0 110.759 -174.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -127.47 117.02 21.32 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.384 -0.822 . . . . 0.0 112.93 173.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -88.36 94.17 9.76 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 169.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -51.79 59.82 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 128.823 2.849 . . . . 0.0 116.167 169.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 93.2 mt -84.24 153.35 23.65 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.735 2.414 . . . . 0.0 111.842 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -70.91 162.53 29.14 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.853 0.861 . . . . 0.0 111.408 169.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -88.28 107.79 18.44 Favored Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 120.76 -1.212 . . . . 0.0 108.136 169.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -79.05 -11.96 14.7 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 121.346 1.364 . . . . 0.0 114.643 -169.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -46.2 105.34 0.06 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.745 2.018 . . . . 0.0 113.792 -173.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.04 10.85 53.25 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.331 0.967 . . . . 0.0 115.507 174.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -74.87 -59.21 2.84 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.024 1.412 . . . . 0.0 111.141 -175.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.1 t -172.08 152.44 2.89 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.061 2.145 . . . . 0.0 108.542 170.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.4 mp -60.05 -30.95 69.53 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.75 -0.594 . . . . 0.0 111.117 172.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.0 -38.05 89.66 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.324 -0.86 . . . . 0.0 112.397 173.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.5 t -72.84 -39.85 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.568 0.747 . . . . 0.0 109.194 177.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -45.81 92.1 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.745 0.818 . . . . 0.0 111.406 176.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -69.09 -36.01 77.12 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.367 1.067 . . . . 0.0 112.273 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 62.3 m -59.6 -51.28 70.48 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 118.8 0.727 . . . . 0.0 111.286 174.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.0 m -70.39 -28.92 36.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 CA-C-O 117.206 -1.378 . . . . 0.0 112.553 177.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . 0.255 0.0 OUTLIER -67.06 -37.25 83.71 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 121.21 1.823 . . . . 0.0 112.46 172.249 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.55 -44.15 95.54 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.039 0.828 . . . . 0.0 112.446 173.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -61.65 -46.93 87.64 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 117.61 0.705 . . . . 0.0 112.129 171.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.7 t -58.63 -47.45 88.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 CA-C-O 117.042 -1.456 . . . . 0.0 110.593 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -51.53 -47.06 63.49 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 120.695 1.589 . . . . 0.0 112.79 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.21 -48.06 77.35 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.407 0.683 . . . . 0.0 112.265 177.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 63.8 mtt-85 -76.15 -32.24 59.0 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -176.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.0 p -73.93 -34.44 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.697 1.199 . . . . 0.0 111.427 175.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -60.97 -56.09 25.2 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.34 0.973 . . . . 0.0 108.621 168.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -50.25 -38.72 42.22 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.052 1.741 . . . . 0.0 112.487 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -78.16 -60.52 2.34 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.29 -0.882 . . . . 0.0 113.134 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.61 -34.54 51.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 123.981 0.913 . . . . 0.0 111.63 -175.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.91 -0.17 17.69 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.774 1.229 . . . . 0.0 114.239 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -98.27 -10.97 23.11 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.215 1.406 . . . . 0.0 113.312 169.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.7 pt -118.47 -0.25 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.66 1.584 . . . . 0.0 113.359 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 51.2 p . . . . . 0 C--O 1.256 1.429 0 C-N-CA 125.225 1.41 . . . . 0.0 113.69 169.824 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.3 ttm . . . . . 0 N--CA 1.503 2.214 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.795 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -83.96 92.53 7.85 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 119.273 0.942 . . . . 0.0 111.29 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -78.33 145.29 35.38 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.55 -0.719 . . . . 0.0 112.704 -173.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.2 t -113.63 142.65 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 125.117 1.367 . . . . 0.0 111.252 178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.403 ' HE3' ' CD1' ' A' ' 68' ' ' PHE . 62.8 tpp -131.02 122.35 26.65 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.015 0.926 . . . . 0.0 111.279 169.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -92.85 143.35 26.35 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.158 0.583 . . . . 0.0 109.611 168.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.0 t -135.42 130.69 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.905 1.282 . . . . 0.0 109.578 -173.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 p -144.33 174.2 11.12 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.19 0.996 . . . . 0.0 111.606 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -61.26 -56.62 18.49 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.904 -1.122 . . . . 0.0 109.663 173.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -94.5 123.69 38.08 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 106.503 -1.665 . . . . 0.0 106.503 168.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -63.29 -48.77 76.7 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 120.363 1.438 . . . . 0.0 108.89 169.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 94.1 p -47.53 -35.08 8.36 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.822 2.449 . . . . 0.0 115.273 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.6 p -91.03 -27.87 18.34 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.69 1.196 . . . . 0.0 114.139 -173.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 -136.97 -63.09 0.62 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -169.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 95.2 p -62.87 -30.34 71.44 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 120.757 1.617 . . . . 0.0 112.135 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -63.1 -41.84 99.45 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.86 1.264 . . . . 0.0 112.507 169.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.8 mtm -62.14 -45.54 92.98 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.827 -0.546 . . . . 0.0 111.08 174.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.39 -24.01 65.64 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.827 -1.083 . . . . 0.0 113.522 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -74.1 -48.66 28.15 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 121.656 2.025 . . . . 0.0 108.35 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.66 -43.15 99.41 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-O 119.024 -0.875 . . . . 0.0 112.829 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -64.47 -42.86 95.65 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.636 1.718 . . . . 0.0 112.267 173.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.31 -31.05 63.79 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.622 1.101 . . . . 0.0 111.135 -176.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -65.24 -53.9 37.4 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 125.354 1.462 . . . . 0.0 109.919 171.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.1 p -69.62 -11.07 60.55 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.6 mt -103.89 -1.68 27.35 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.551 1.141 . . . . 0.0 113.88 171.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.6 9.06 0.47 Allowed Glycine 0 N--CA 1.477 1.399 0 N-CA-C 117.288 1.675 . . . . 0.0 117.288 -169.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.98 133.8 55.82 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 119.249 1.525 . . . . 0.0 111.886 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.87 -6.83 54.02 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.473 1.035 . . . . 0.0 115.332 -175.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -87.59 -63.55 1.29 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.349 1.575 . . . . 0.0 110.6 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -142.98 173.94 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 127.222 2.209 . . . . 0.0 110.946 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.0 130.34 41.71 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.369 -0.832 . . . . 0.0 112.61 176.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -105.48 154.03 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.73 1.212 . . . . 0.0 112.974 171.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.5 147.0 25.7 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -172.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.7 p -108.75 139.76 43.11 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 127.107 2.163 . . . . 0.0 114.031 170.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.5 t -143.05 177.37 8.42 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.498 1.519 . . . . 0.0 110.463 169.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.69 173.26 39.76 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 120.122 -1.611 . . . . 0.0 115.06 173.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.1 mt -61.76 -35.52 78.35 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.457 0.703 . . . . 0.0 111.752 -174.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -125.19 111.56 15.42 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.836 2.455 . . . . 0.0 107.565 169.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.4 p -65.51 -33.79 76.75 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.179 -0.95 . . . . 0.0 112.064 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.5 t 48.72 -120.63 1.36 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.386 1.474 . . . . 0.0 111.814 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -144.28 -151.54 0.37 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.594 1.957 . . . . 0.0 111.008 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.2 m -91.18 116.26 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 168.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -68.66 133.77 90.58 Favored Pre-proline 0 N--CA 1.481 1.11 0 O-C-N 120.963 -1.086 . . . . 0.0 111.686 -169.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -59.82 -37.61 85.3 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.446 2.764 . . . . 0.0 113.736 -171.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.9 m -79.02 -35.68 42.35 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.912 -0.492 . . . . 0.0 110.364 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.13 93.8 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.903 -1.123 . . . . 0.0 112.422 174.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.3 mt -53.32 -44.84 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 120.944 1.702 . . . . 0.0 110.71 172.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.67 -56.23 17.31 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.972 0.731 . . . . 0.0 112.972 175.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 30.1 mmt -68.66 -19.21 64.4 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -174.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 87.0 mmm -91.86 -40.23 11.3 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.888 0.875 . . . . 0.0 110.659 176.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -60.49 -39.83 89.12 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.741 -1.224 . . . . 0.0 112.404 174.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -60.31 -26.86 66.87 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.173 -0.954 . . . . 0.0 113.533 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.7 p -100.34 12.83 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 124.894 1.277 . . . . 0.0 113.103 174.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.39 18.59 48.63 Favored Glycine 0 N--CA 1.475 1.286 0 C-N-CA 124.795 1.188 . . . . 0.0 115.263 172.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.4 mt -127.22 85.5 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.426 1.49 . . . . 0.0 110.048 -169.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -71.27 109.81 5.52 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.133 -1.604 . . . . 0.0 110.831 173.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.5 pt -87.5 -9.31 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 118.251 -0.88 . . . . 0.0 112.512 173.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.3 t -62.36 -34.55 76.9 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 120.552 1.524 . . . . 0.0 113.149 -169.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.86 3.99 85.81 Favored Glycine 0 CA--C 1.541 1.683 0 C-N-CA 124.782 1.182 . . . . 0.0 115.282 173.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -97.26 150.68 20.66 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.41 1.484 . . . . 0.0 111.895 -173.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.3 t -84.87 149.62 25.55 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.268 -0.895 . . . . 0.0 112.886 -175.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 71.1 m -121.8 111.45 17.15 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.04 0.936 . . . . 0.0 109.914 169.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -89.17 152.58 48.18 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.039 0.936 . . . . 0.0 112.825 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -91.83 150.84 3.35 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.268 3.312 . . . . 0.0 112.0 171.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 tt -63.18 -27.87 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -170.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -82.1 -11.41 58.78 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.0 -1.063 . . . . 0.0 113.246 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -96.81 -27.97 14.47 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.436 1.094 . . . . 0.0 113.323 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.403 ' CD1' ' HE3' ' A' ' 5' ' ' MET . 0.0 OUTLIER -62.54 -41.72 99.07 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -168.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.4 ' HA ' ' CH2' ' A' ' 90' ' ' TRP 0.341 0.0 OUTLIER 53.97 99.44 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.662 2.785 . . . . 0.0 115.043 -176.834 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.66 5.31 0.85 Allowed 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -175.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -72.2 -27.13 62.36 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.023 1.329 . . . . 0.0 112.27 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -90.07 -2.47 58.11 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -119.79 140.2 51.12 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.982 1.313 . . . . 0.0 112.604 -169.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -88.74 -28.83 20.26 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.894 0.877 . . . . 0.0 111.83 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.6 t -130.08 120.42 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.516 1.127 . . . . 0.0 110.003 -170.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.6 t -126.42 129.34 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.573 0.749 . . . . 0.0 110.193 177.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.8 mm -121.73 126.94 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.086 0.954 . . . . 0.0 110.632 -171.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.6 t -89.45 121.7 31.94 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.863 0.465 . . . . 0.0 109.835 169.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.416 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 75.9 mt -98.6 13.42 32.07 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.496 1.518 . . . . 0.0 112.024 175.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.5 p . . . . . 0 CA--C 1.535 0.401 0 C-N-CA 126.799 2.039 . . . . 0.0 109.032 169.39 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.6 mt . . . . . 0 CA--C 1.549 0.94 0 CA-C-O 119.251 -0.404 . . . . 0.0 111.814 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -58.82 133.29 52.86 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.673 2.249 . . . . 0.0 111.081 173.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -61.18 -31.6 90.18 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.393 2.062 . . . . 0.0 113.184 -176.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -59.17 -32.86 70.28 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.059 -1.026 . . . . 0.0 112.959 171.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.4 ' CH2' ' HA ' ' A' ' 69' ' ' ASN . 0.4 OUTLIER -86.0 12.03 10.31 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.35 1.06 . . . . 0.0 113.821 174.633 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.9 t -116.48 -36.5 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.856 1.662 . . . . 0.0 111.74 178.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.8 p -79.59 25.31 0.34 Allowed 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 -169.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -76.17 167.02 22.62 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.858 1.663 . . . . 0.0 111.975 171.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -57.94 -37.09 73.48 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.932 0.893 . . . . 0.0 112.837 -171.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 67.4 mt -126.81 123.74 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.636 1.175 . . . . 0.0 109.215 169.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -131.52 134.25 45.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.208 1.003 . . . . 0.0 110.597 169.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -141.43 153.97 45.32 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.542 1.137 . . . . 0.0 112.155 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -120.92 117.67 27.92 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.74 1.216 . . . . 0.0 110.157 173.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.416 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 37.0 m0 -95.32 -0.79 52.43 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.669 1.188 . . . . 0.0 113.612 -177.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.308 1.3 pp0? 46.44 39.21 6.26 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 171.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.8 mt -79.4 159.64 26.99 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.8 0.84 . . . . 0.0 112.765 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -87.04 150.81 23.77 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.624 1.569 . . . . 0.0 111.958 173.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.44 116.26 59.32 Favored Pre-proline 0 CA--C 1.546 0.815 0 O-C-N 121.298 -0.877 . . . . 0.0 110.574 172.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -83.23 -14.82 8.13 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.496 2.131 . . . . 0.0 115.457 -169.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -46.59 108.08 0.13 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.759 1.624 . . . . 0.0 112.98 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.69 9.34 78.61 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-O 118.878 -0.957 . . . . 0.0 115.407 175.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -73.81 -68.17 0.54 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.04 1.42 . . . . 0.0 110.431 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.6 t -177.23 152.26 0.86 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 128.505 2.722 . . . . 0.0 108.106 173.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.8 mp -60.36 -29.94 69.23 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.822 0.737 . . . . 0.0 111.549 174.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -64.23 -38.65 91.81 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.091 -1.006 . . . . 0.0 112.423 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.2 t -73.61 -37.63 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.016 0.926 . . . . 0.0 109.476 176.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.8 -45.22 95.23 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.23 1.012 . . . . 0.0 111.177 175.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -67.79 -38.05 82.84 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.638 1.175 . . . . 0.0 112.491 173.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.4 m -58.86 -50.36 74.29 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 118.778 0.717 . . . . 0.0 110.886 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.6 m -71.25 -30.97 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 117.643 -1.17 . . . . 0.0 112.266 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -40.33 97.08 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 121.21 1.823 . . . . 0.0 111.966 171.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.49 -42.83 95.56 Favored Glycine 0 N--CA 1.474 1.183 0 C-N-CA 124.391 0.996 . . . . 0.0 112.579 176.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -60.75 -45.64 93.53 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.915 -0.756 . . . . 0.0 111.947 170.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 29.3 t -58.67 -48.73 84.94 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.807 177.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -51.56 -55.13 20.84 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.856 1.207 . . . . 0.0 111.487 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -59.69 -42.05 92.1 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.619 0.768 . . . . 0.0 112.572 -176.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -78.06 -35.01 50.08 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 39.1 t -61.19 -48.25 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.185 1.394 . . . . 0.0 111.19 172.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -51.88 -55.22 21.41 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.06 0.845 . . . . 0.0 109.606 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -56.93 -37.46 71.52 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.191 1.397 . . . . 0.0 112.276 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -74.25 -56.28 5.07 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.33 -0.856 . . . . 0.0 112.556 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.63 -34.44 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.775 1.23 . . . . 0.0 112.363 -175.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.14 -22.78 62.02 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 121.118 -0.989 . . . . 0.0 113.486 -174.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -70.2 -19.73 63.15 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.593 1.157 . . . . 0.0 113.849 173.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 28.7 pt -118.89 17.15 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 126.259 1.824 . . . . 0.0 112.652 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--O 1.256 1.401 0 C-N-CA 126.459 1.904 . . . . 0.0 111.313 172.158 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.6 tpp . . . . . 0 N--CA 1.502 2.139 0 CA-C-O 118.989 -0.529 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -82.7 85.42 7.04 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 119.873 1.215 . . . . 0.0 111.338 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -77.42 147.55 35.93 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -171.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.64 139.5 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.938 1.295 . . . . 0.0 111.074 176.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 49.4 tpp -127.36 115.36 18.85 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.499 0.72 . . . . 0.0 111.093 169.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -81.53 142.58 32.73 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.624 -0.673 . . . . 0.0 110.331 169.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.92 128.17 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 119.187 0.903 . . . . 0.0 111.66 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.5 p -144.76 178.02 8.3 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.462 1.105 . . . . 0.0 111.757 175.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -59.8 -61.46 2.6 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 120.083 1.31 . . . . 0.0 109.617 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -83.72 125.18 31.63 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 167.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -59.68 -43.25 94.08 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 120.029 1.286 . . . . 0.0 108.476 169.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.0 p -65.49 -48.58 72.13 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 115.848 1.795 . . . . 0.0 115.848 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.3 m -71.8 -15.51 62.15 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -169.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.82 -55.05 0.82 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 120.325 1.421 . . . . 0.0 113.258 168.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.8 m -61.97 -38.2 87.64 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -171.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -62.71 -36.14 82.0 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.377 0.99 . . . . 0.0 113.214 169.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 82.5 mtp -59.83 -45.58 91.96 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.161 -0.962 . . . . 0.0 110.3 173.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.62 -31.38 69.47 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 117.954 -1.022 . . . . 0.0 113.555 174.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -68.61 -46.17 69.99 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 121.553 1.979 . . . . 0.0 109.033 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.49 -42.99 97.29 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 118.527 -1.152 . . . . 0.0 112.668 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -66.13 -42.3 89.33 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.202 1.501 . . . . 0.0 112.144 171.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.93 -35.75 81.68 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.61 -1.306 . . . . 0.0 111.114 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -63.53 -55.78 21.18 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.135 1.774 . . . . 0.0 109.976 174.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.7 p -68.41 -14.47 63.02 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 178.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 50.8 mt -99.14 -6.68 27.83 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.384 1.074 . . . . 0.0 113.864 174.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -152.13 9.56 0.62 Allowed Glycine 0 N--CA 1.476 1.311 0 N-CA-C 117.185 1.634 . . . . 0.0 117.185 -169.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.36 132.21 50.37 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 119.514 1.657 . . . . 0.0 111.609 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.37 -6.22 57.92 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.803 1.192 . . . . 0.0 115.475 -176.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -86.46 -59.16 2.36 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 119.459 1.629 . . . . 0.0 110.813 175.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.6 pp -144.7 175.71 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 128.226 2.61 . . . . 0.0 110.118 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.35 132.5 41.79 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.22 -0.925 . . . . 0.0 112.788 174.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.7 m -104.02 145.93 12.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 124.667 1.187 . . . . 0.0 112.704 171.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.8 m -146.94 156.35 43.0 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.217 1.007 . . . . 0.0 111.707 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.9 p -126.02 139.83 53.1 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.885 2.074 . . . . 0.0 113.9 175.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.7 t -133.66 172.1 13.21 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 129.567 3.147 . . . . 0.0 109.322 -176.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.64 173.56 44.84 Favored Glycine 0 CA--C 1.523 0.587 0 O-C-N 120.551 -1.343 . . . . 0.0 115.094 169.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.1 mt -66.46 -28.43 68.58 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.291 0.636 . . . . 0.0 111.723 -178.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -121.26 127.91 51.86 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.48 1.912 . . . . 0.0 108.383 170.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.5 p -78.02 55.99 1.54 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.675 1.59 . . . . 0.0 110.381 171.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.5 p -68.13 149.2 49.89 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.29 1.436 . . . . 0.0 112.037 -169.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -58.24 155.3 11.7 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.395 0.678 . . . . 0.0 111.673 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.1 m -50.91 109.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 169.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -65.95 130.63 94.44 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 118.478 -0.772 . . . . 0.0 112.319 -168.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.03 -38.79 85.65 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.489 2.793 . . . . 0.0 113.391 -172.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.9 m -77.55 -34.02 53.95 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 119.224 -0.417 . . . . 0.0 110.684 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.82 -43.48 96.09 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.844 -1.16 . . . . 0.0 111.986 172.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.7 mt -54.72 -40.3 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 120.795 1.634 . . . . 0.0 110.328 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.62 -62.87 1.27 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 173.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 30.4 mmt -67.11 -21.69 65.84 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.951 0.9 . . . . 0.0 113.415 -172.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 86.4 mmm -85.36 -37.78 19.5 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.616 0.767 . . . . 0.0 110.524 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -63.75 -33.44 75.67 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.665 -1.272 . . . . 0.0 111.983 173.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -55.26 -28.49 53.75 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 170.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.1 m -107.11 19.48 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 125.328 1.451 . . . . 0.0 113.525 174.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.64 13.73 74.98 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.65 1.119 . . . . 0.0 115.37 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.3 mt -117.67 97.19 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.448 1.499 . . . . 0.0 109.855 -170.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -78.35 112.09 15.0 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.958 -1.089 . . . . 0.0 110.438 171.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.0 pt -93.09 -4.22 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 172.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.4 p -65.98 -26.33 67.51 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -169.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -100.58 9.29 58.77 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.362 1.458 . . . . 0.0 114.445 172.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -86.72 149.11 25.11 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.983 1.313 . . . . 0.0 112.266 -170.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.9 t -63.59 148.16 49.58 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.459 -0.776 . . . . 0.0 112.109 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.5 t -138.96 54.95 1.72 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.046 0.927 . . . . 0.0 111.689 174.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -68.88 147.45 97.84 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 125.192 1.397 . . . . 0.0 113.185 -170.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -82.75 151.81 14.77 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.635 2.224 . . . . 0.0 112.442 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.8 tt -60.48 -21.83 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -91.99 -9.42 43.02 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 177.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -97.58 -35.2 10.69 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.781 0.832 . . . . 0.0 111.913 171.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -68.43 160.41 29.73 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.18 0.592 . . . . 0.0 111.571 175.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.404 ' HA ' ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -136.63 119.38 16.16 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.666 0.786 . . . . 0.0 111.985 170.479 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.54 0.8 2.01 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -175.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -70.59 -29.26 65.63 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.906 0.882 . . . . 0.0 112.209 -175.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -88.78 -2.36 58.55 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.116 1.366 . . . . 0.0 113.322 177.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -124.67 95.15 4.41 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.706 1.602 . . . . 0.0 110.498 -171.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -55.13 -29.48 57.81 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.768 1.227 . . . . 0.0 112.83 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 t -121.55 118.3 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 125.111 1.364 . . . . 0.0 110.19 -172.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.8 t -130.17 134.38 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.818 0.847 . . . . 0.0 110.644 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.0 mm -128.71 132.64 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 121.434 -0.791 . . . . 0.0 111.399 -170.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.4 t -87.87 117.59 26.82 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.521 0.728 . . . . 0.0 111.116 169.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 mp -97.68 37.07 1.42 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.734 1.614 . . . . 0.0 109.177 173.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.2 t . . . . . 0 CA--C 1.54 0.562 0 C-N-CA 126.192 1.797 . . . . 0.0 111.647 -178.219 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.6 mt . . . . . 0 CA--C 1.545 0.787 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.96 153.73 47.46 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.47 2.114 . . . . 0.0 110.675 174.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -59.82 -34.0 95.87 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.859 2.372 . . . . 0.0 112.222 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -48.89 -46.25 42.38 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.499 1.52 . . . . 0.0 112.938 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.404 ' CH2' ' HA ' ' A' ' 69' ' ' ASN . 1.8 m95 -90.75 8.2 35.77 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.747 1.219 . . . . 0.0 112.961 -177.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.7 t -114.94 -38.53 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 127.03 2.132 . . . . 0.0 111.704 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.9 p -81.39 26.71 0.45 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -174.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -80.89 169.34 17.67 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.31 1.444 . . . . 0.0 111.896 174.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -53.58 -41.79 66.92 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 -169.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 59.9 mt -125.71 123.46 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.591 1.157 . . . . 0.0 109.373 170.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -133.49 135.06 44.23 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.007 0.923 . . . . 0.0 111.44 169.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -142.84 153.12 42.87 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.69 1.196 . . . . 0.0 112.42 -175.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -113.36 125.88 54.75 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.279 1.432 . . . . 0.0 111.133 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 44.3 m0 -100.91 -5.69 25.67 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 177.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.355 1.2 pp0? 50.3 31.89 5.71 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.3 mt -75.52 151.87 37.89 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -87.28 160.6 18.36 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.704 2.002 . . . . 0.0 112.511 178.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.61 115.02 60.75 Favored Pre-proline 0 CA--C 1.547 0.83 0 O-C-N 121.282 -0.886 . . . . 0.0 111.4 169.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.87 -13.74 9.14 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.471 2.114 . . . . 0.0 114.822 -170.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -44.05 113.7 0.56 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.506 1.922 . . . . 0.0 113.556 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.81 6.46 55.88 Favored Glycine 0 CA--C 1.534 1.234 0 N-CA-C 115.86 1.104 . . . . 0.0 115.86 173.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -78.04 -63.63 1.35 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.921 1.361 . . . . 0.0 110.881 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.6 t -174.24 152.47 1.82 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.391 2.277 . . . . 0.0 108.889 169.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.1 mp -59.96 -29.92 68.75 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.624 -0.672 . . . . 0.0 111.299 171.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -63.09 -39.75 95.63 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.056 -1.028 . . . . 0.0 112.483 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.3 t -71.43 -37.1 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.843 0.857 . . . . 0.0 109.733 175.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -41.9 92.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.914 0.885 . . . . 0.0 111.699 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -70.09 -36.8 75.17 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 121.22 -0.925 . . . . 0.0 111.987 171.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.3 m -58.06 -48.94 78.58 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.087 0.858 . . . . 0.0 111.639 174.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 23.8 m -68.25 -31.25 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 117.802 -1.094 . . . . 0.0 112.09 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.26 -42.22 98.27 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 120.867 1.667 . . . . 0.0 111.786 170.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.74 -43.82 93.44 Favored Glycine 0 N--CA 1.473 1.158 0 C-N-CA 124.256 0.932 . . . . 0.0 112.785 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -60.51 -45.21 94.65 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 122.166 -0.608 . . . . 0.0 112.032 170.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.9 t -59.67 -50.35 80.33 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 CA-C-O 117.518 -1.23 . . . . 0.0 109.434 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -50.81 -49.89 57.59 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.045 1.293 . . . . 0.0 112.068 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -60.48 -44.37 95.99 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.528 0.731 . . . . 0.0 112.948 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 46.4 mtp85 -81.92 -35.93 28.6 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.0 p -72.51 -34.07 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.17 1.388 . . . . 0.0 111.747 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -56.44 -56.98 14.48 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.249 0.931 . . . . 0.0 109.535 169.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -55.64 -35.68 66.18 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.885 1.274 . . . . 0.0 111.877 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -73.45 -57.16 4.19 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.631 -0.668 . . . . 0.0 112.385 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.96 -33.07 61.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.848 0.859 . . . . 0.0 112.211 -176.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.32 -23.25 60.23 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -173.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -68.57 -21.35 64.53 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.693 1.197 . . . . 0.0 113.811 173.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 29.0 pt -117.77 15.28 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 126.452 1.901 . . . . 0.0 112.634 -177.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--O 1.255 1.358 0 C-N-CA 126.501 1.92 . . . . 0.0 111.753 173.522 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.505 2.295 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -81.23 98.01 7.9 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.0 0.92 . . . . 0.0 110.147 175.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -80.47 146.46 31.37 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.647 -0.658 . . . . 0.0 112.324 -174.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.0 t -111.95 146.59 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.673 1.189 . . . . 0.0 110.743 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 45.3 tpp -130.83 112.81 13.36 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.226 1.011 . . . . 0.0 111.448 169.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -82.2 129.57 34.87 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.31 1.044 . . . . 0.0 110.362 169.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.3 t -127.22 136.23 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.069 1.348 . . . . 0.0 110.925 -176.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 t -149.78 -176.81 5.57 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 121.443 -0.786 . . . . 0.0 111.919 169.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -61.15 -45.0 96.43 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.412 -0.805 . . . . 0.0 110.617 170.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.56 129.59 56.68 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.435 1.494 . . . . 0.0 110.787 169.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -72.78 -55.79 6.21 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 169.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.0 p -27.35 -52.22 0.07 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 128.882 2.873 . . . . 0.0 116.758 173.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.4 p -100.96 -24.47 14.33 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.857 1.263 . . . . 0.0 113.898 -174.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -118.04 -71.46 0.74 Allowed 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 119.643 1.111 . . . . 0.0 111.98 -173.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.96 -30.38 70.88 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 121.256 -0.903 . . . . 0.0 112.924 -175.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -66.42 -34.25 77.52 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 126.405 1.882 . . . . 0.0 113.801 172.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 27.3 mmm -65.73 -36.4 83.5 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.656 -0.652 . . . . 0.0 110.27 172.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.41 -26.69 61.07 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.263 -0.898 . . . . 0.0 113.394 169.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -68.96 -53.25 21.8 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.395 1.452 . . . . 0.0 108.439 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.67 -49.07 77.0 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-O 118.935 -0.925 . . . . 0.0 112.488 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -66.71 -38.34 86.51 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.586 1.193 . . . . 0.0 112.49 175.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.65 -38.07 80.16 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 120.024 1.283 . . . . 0.0 110.215 -178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -57.74 -57.48 12.58 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 125.796 1.639 . . . . 0.0 110.889 171.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.9 p -71.35 -15.4 62.39 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -177.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.1 mt -95.14 -13.24 25.23 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -142.84 8.88 2.27 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 117.783 1.873 . . . . 0.0 117.783 -169.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.14 129.52 38.48 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.771 1.786 . . . . 0.0 111.784 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.33 -6.55 56.89 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 124.677 1.132 . . . . 0.0 115.571 -177.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -86.78 -57.37 3.01 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 119.471 1.636 . . . . 0.0 110.603 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.6 pp -142.17 177.13 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 127.504 2.322 . . . . 0.0 110.161 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.28 122.17 43.21 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.725 0.774 . . . . 0.0 111.591 173.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.9 m -87.74 149.92 3.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 123.781 0.833 . . . . 0.0 111.746 169.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.42 152.04 38.42 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.728 0.811 . . . . 0.0 110.93 176.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.0 p -133.44 145.65 50.45 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.941 1.696 . . . . 0.0 112.541 175.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.4 t -150.01 178.46 8.91 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.884 1.674 . . . . 0.0 110.573 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.26 -179.57 46.42 Favored Glycine 0 CA--C 1.527 0.794 0 O-C-N 120.92 -1.112 . . . . 0.0 114.185 170.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.1 mt -71.95 -44.39 63.65 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -169.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -90.73 -25.57 19.95 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.747 1.619 . . . . 0.0 112.473 173.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 60.3 p 58.84 -65.1 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 127.814 2.445 . . . . 0.0 113.128 -169.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 t 56.59 -174.58 0.06 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 130.22 3.408 . . . . 0.0 114.095 -177.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 54.6 ttt85 -79.83 147.51 31.75 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.873 1.669 . . . . 0.0 111.034 174.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.0 m -47.35 112.92 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.794 1.238 . . . . 0.0 109.739 169.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -63.12 137.56 97.1 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -167.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.4 -40.01 61.62 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.716 2.944 . . . . 0.0 113.518 -175.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.1 m -77.23 -33.04 56.19 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.978 -0.451 . . . . 0.0 110.513 176.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.3 -47.88 83.91 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.403 1.001 . . . . 0.0 111.706 171.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 68.7 mt -49.25 -44.56 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 120.388 1.449 . . . . 0.0 110.823 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.84 -59.44 5.14 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 174.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.2 mmt -67.11 -22.17 65.82 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -175.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.2 mtp -80.88 -45.16 17.24 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.993 1.317 . . . . 0.0 110.665 173.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -61.69 -33.45 74.02 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.804 -1.185 . . . . 0.0 112.532 176.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -55.53 -30.23 60.35 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.264 1.026 . . . . 0.0 113.455 172.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.0 m -105.87 14.98 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 125.146 1.379 . . . . 0.0 113.792 177.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.93 17.79 64.65 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.166 0.889 . . . . 0.0 115.124 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.6 mt -112.68 114.86 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.91 1.284 . . . . 0.0 110.944 -169.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -90.81 110.83 22.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.7 1.2 . . . . 0.0 111.783 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.3 pt -110.62 -5.89 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 169.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.8 p -67.32 -25.6 66.09 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 120.548 -1.345 . . . . 0.0 114.44 -169.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -106.99 14.12 40.84 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 125.683 1.611 . . . . 0.0 114.378 170.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -95.51 151.23 19.5 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.307 1.443 . . . . 0.0 112.128 -170.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.7 t -77.32 146.8 36.54 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 121.247 -0.908 . . . . 0.0 112.856 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.6 m -126.21 98.58 5.53 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.787 1.235 . . . . 0.0 109.069 169.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.79 155.99 75.3 Favored Pre-proline 0 CA--C 1.553 1.088 0 O-C-N 121.223 -0.923 . . . . 0.0 113.388 -174.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -97.63 152.45 0.92 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.866 3.711 . . . . 0.0 113.708 171.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.6 tp -60.81 -21.1 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 -169.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -103.15 -6.88 21.75 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -84.28 -37.91 21.11 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.97 0.804 . . . . 0.0 111.674 171.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.45 159.32 34.16 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.803 0.841 . . . . 0.0 111.574 173.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.432 ' HA ' ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -138.29 112.9 8.9 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.528 0.731 . . . . 0.0 111.728 171.428 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.7 -3.67 2.48 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -169.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.86 -27.62 67.67 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.004 -1.06 . . . . 0.0 112.214 -174.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -91.86 -0.87 57.53 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.087 1.355 . . . . 0.0 113.655 176.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -122.54 95.12 4.51 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.359 1.464 . . . . 0.0 110.597 -170.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -56.2 -31.3 63.33 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.878 1.271 . . . . 0.0 112.968 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.3 t -121.43 121.43 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 124.527 1.131 . . . . 0.0 110.494 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.7 t -127.1 133.59 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.079 0.952 . . . . 0.0 110.169 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.8 mm -122.84 136.7 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.909 0.883 . . . . 0.0 110.375 -175.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.7 t -96.96 127.23 42.73 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.042 0.937 . . . . 0.0 110.464 169.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -108.95 25.86 11.3 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.542 1.537 . . . . 0.0 110.173 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 31.3 p . . . . . 0 CA--C 1.541 0.613 0 C-N-CA 128.138 2.575 . . . . 0.0 111.837 177.081 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.2 mt . . . . . 0 CA--C 1.549 0.941 0 CA-C-O 119.37 -0.348 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -64.28 149.27 90.51 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.751 2.301 . . . . 0.0 113.954 -175.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -72.89 56.82 3.06 Favored 'Trans proline' 0 CA--C 1.549 1.261 1 C-N-CA 125.879 4.386 . . . . 0.0 111.183 171.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -157.03 -51.0 0.07 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.671 2.388 . . . . 0.0 109.431 -169.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.432 ' CH2' ' HA ' ' A' ' 69' ' ' ASN . 1.0 OUTLIER -85.39 -28.1 25.36 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.112 0.965 . . . . 0.0 111.899 177.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.4 m -84.16 -12.95 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 175.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.9 p -94.37 8.71 41.02 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.042 1.337 . . . . 0.0 114.202 -172.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -74.61 169.15 18.37 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.797 1.239 . . . . 0.0 112.98 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -52.07 -39.98 60.49 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -169.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.2 mt -126.3 122.98 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.553 1.141 . . . . 0.0 109.429 169.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -129.38 124.56 34.52 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.391 1.076 . . . . 0.0 110.143 169.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -141.79 167.61 21.74 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.334 1.454 . . . . 0.0 111.017 -174.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -135.27 146.84 48.94 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 172.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 36.7 m0 -109.38 7.68 25.13 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 64.46 -78.76 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.097 1.759 . . . . 0.0 112.983 -177.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 27.0 mt 49.94 -163.89 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 127.585 2.354 . . . . 0.0 113.852 -175.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -141.58 160.49 40.04 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.953 2.101 . . . . 0.0 108.105 171.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -81.1 110.53 18.3 Favored Pre-proline 0 N--CA 1.471 0.625 0 CA-C-N 119.764 1.166 . . . . 0.0 109.689 169.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -81.63 -10.77 11.83 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 121.249 1.3 . . . . 0.0 114.273 -169.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -45.47 109.26 0.16 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.666 1.586 . . . . 0.0 113.568 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.52 9.77 62.2 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 118.767 -1.018 . . . . 0.0 115.478 172.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -78.46 -64.8 1.09 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.877 1.338 . . . . 0.0 111.079 -176.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 21.4 t -173.74 151.62 1.88 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.372 2.269 . . . . 0.0 108.429 170.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.8 mp -60.81 -28.2 68.61 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.577 -0.702 . . . . 0.0 111.119 172.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.18 -39.6 95.1 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.027 -1.046 . . . . 0.0 112.334 173.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.5 t -71.68 -38.9 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.084 0.954 . . . . 0.0 109.654 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.34 -40.0 95.01 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.259 1.024 . . . . 0.0 111.608 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.8 mtt85 -73.23 -36.46 66.44 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 121.062 -1.024 . . . . 0.0 112.185 170.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 55.2 m -58.02 -47.73 82.17 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 119.147 0.885 . . . . 0.0 111.646 175.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.6 m -68.39 -30.24 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 119.589 1.086 . . . . 0.0 111.778 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.66 -43.52 98.59 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 120.236 1.38 . . . . 0.0 111.76 169.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.74 -44.33 94.99 Favored Glycine 0 N--CA 1.473 1.11 0 C-N-CA 124.47 1.033 . . . . 0.0 112.68 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -59.87 -46.41 89.4 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.242 0.617 . . . . 0.0 112.069 170.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.9 t -59.42 -52.06 65.39 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.506 0 CA-C-O 117.136 -1.411 . . . . 0.0 110.3 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -49.52 -44.23 46.15 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.122 1.369 . . . . 0.0 113.215 -175.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -65.91 -45.59 81.4 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.416 0.686 . . . . 0.0 112.556 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 53.8 mtp85 -82.05 -34.46 29.46 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.752 0.821 . . . . 0.0 112.823 -173.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.4 p -68.64 -38.61 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.327 1.451 . . . . 0.0 111.785 173.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -57.54 -56.16 25.53 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.607 1.094 . . . . 0.0 109.631 169.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -55.23 -32.65 62.45 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.723 1.209 . . . . 0.0 112.342 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -77.04 -58.71 3.13 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.228 -0.92 . . . . 0.0 112.68 176.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.75 -32.64 58.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.88 1.272 . . . . 0.0 112.36 -174.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.93 -15.06 59.78 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -172.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -74.51 -26.54 60.06 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.529 1.131 . . . . 0.0 113.446 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 23.8 pt -110.23 -7.41 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.544 1.538 . . . . 0.0 113.589 -177.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.0 m . . . . . 0 C--O 1.252 1.207 0 C-N-CA 125.103 1.361 . . . . 0.0 113.117 173.83 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.9 ttm . . . . . 0 N--CA 1.502 2.138 0 CA-C-O 119.519 -0.277 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -93.92 91.11 6.75 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.658 1.183 . . . . 0.0 110.756 173.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.34 144.47 42.35 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 121.444 -0.785 . . . . 0.0 111.276 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 p -125.3 145.2 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.249 1.02 . . . . 0.0 112.199 -176.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 40.3 tpp -133.45 117.19 16.91 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.939 1.296 . . . . 0.0 112.071 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -84.19 141.08 31.3 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 119.198 -0.429 . . . . 0.0 111.138 169.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.7 t -134.23 124.73 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.297 1.439 . . . . 0.0 111.622 -176.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.9 p -145.8 -179.4 6.66 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.009 1.324 . . . . 0.0 111.608 175.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.79 -59.96 4.15 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 119.947 -1.721 . . . . 0.0 110.803 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -87.31 136.07 33.08 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 168.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -72.57 -55.92 6.17 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 169.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.486 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 24.9 p -50.8 -49.29 58.77 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.681 1.364 . . . . 0.0 114.681 -176.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 m -74.96 -10.88 59.9 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 -143.12 -68.25 0.35 Allowed 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 119.841 1.2 . . . . 0.0 113.571 177.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 44.5 m -65.43 -35.72 81.77 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.456 -1.402 . . . . 0.0 114.472 -172.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -68.97 -29.72 67.99 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 120.922 -1.111 . . . . 0.0 112.887 169.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.2 mtm -61.96 -46.97 86.94 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 169.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.31 -31.2 71.86 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -69.58 -45.9 67.59 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 120.431 1.469 . . . . 0.0 109.531 176.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.44 ' CA ' HE22 ' A' ' 60' ' ' GLN . . . -63.05 -43.84 98.2 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 118.939 -0.923 . . . . 0.0 111.767 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -63.69 -42.97 97.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.47 1.135 . . . . 0.0 112.409 170.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.43 -31.7 72.07 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 120.515 -1.365 . . . . 0.0 111.056 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -67.86 -55.1 14.18 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 126.502 1.921 . . . . 0.0 109.296 174.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.8 p -68.69 -14.54 63.09 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 177.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 39.8 mt -101.05 1.51 39.55 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.66 1.184 . . . . 0.0 113.83 172.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.97 9.97 0.22 Allowed Glycine 0 CA--C 1.535 1.322 0 N-CA-C 117.402 1.721 . . . . 0.0 117.402 -169.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.96 131.35 50.79 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.763 1.782 . . . . 0.0 111.71 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.54 -3.39 59.66 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.491 1.043 . . . . 0.0 115.469 -175.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -87.11 -63.38 1.32 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 119.102 1.451 . . . . 0.0 110.329 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -142.09 173.9 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 127.44 2.296 . . . . 0.0 110.203 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.18 120.81 33.11 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 121.232 -0.917 . . . . 0.0 111.302 176.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 m -94.31 148.13 5.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.791 169.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.55 157.78 43.69 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.758 0.823 . . . . 0.0 110.741 -172.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.7 p -145.06 146.42 31.86 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 79.7 p -150.56 -179.04 6.91 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.676 1.591 . . . . 0.0 110.691 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.37 -174.3 43.63 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 116.46 1.344 . . . . 0.0 116.46 170.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.7 mt -71.49 -47.63 54.2 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.261 0.624 . . . . 0.0 111.822 -172.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -92.81 -32.8 14.52 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.26 1.824 . . . . 0.0 111.412 170.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . 0.282 26.0 p 61.22 -53.53 0.11 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 128.177 2.591 . . . . 0.0 114.813 -171.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.0 t 60.36 -178.82 0.1 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 127.579 2.352 . . . . 0.0 115.07 173.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -71.6 166.18 22.4 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 126.531 1.933 . . . . 0.0 112.375 172.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.1 m -62.54 117.83 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 169.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.486 ' H ' ' HB2' ' A' ' 12' ' ' SER . 56.0 t-80 -76.14 132.46 73.61 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 124.033 0.933 . . . . 0.0 113.141 -168.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -57.73 -41.93 65.07 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.484 2.789 . . . . 0.0 114.059 -170.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.6 m -77.68 -35.46 52.24 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.797 -0.564 . . . . 0.0 110.864 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.74 -43.14 94.33 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.327 -0.844 . . . . 0.0 111.942 173.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.7 mt -54.06 -46.54 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 120.34 1.427 . . . . 0.0 109.717 174.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.38 -60.01 4.38 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.4 mmt -66.71 -29.7 69.75 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.414 -0.804 . . . . 0.0 112.13 -172.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 75.4 mmm -80.43 -40.0 27.17 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.668 0.787 . . . . 0.0 110.364 178.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -58.33 -37.31 74.87 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.588 -1.32 . . . . 0.0 112.315 171.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -59.71 -23.8 63.46 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.3 m -105.19 16.0 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 124.715 1.206 . . . . 0.0 114.021 172.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.01 13.65 66.04 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.398 0.999 . . . . 0.0 115.029 177.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.9 mt -120.72 68.81 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.032 1.733 . . . . 0.0 109.601 -169.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -65.17 105.14 1.02 Allowed 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.231 -1.543 . . . . 0.0 110.668 174.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.1 pt -81.2 -0.42 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 O-C-N 121.528 -0.733 . . . . 0.0 112.815 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 85.1 p -71.67 -28.35 63.67 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.399 -1.438 . . . . 0.0 114.043 -172.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.28 2.93 71.88 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 125.332 1.444 . . . . 0.0 114.432 171.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.44 HE22 ' CA ' ' A' ' 20' ' ' GLY . 12.9 mt-30 -86.4 159.16 19.44 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.463 1.505 . . . . 0.0 112.202 -177.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.8 t -87.73 152.63 21.99 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -170.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.3 m -139.36 134.8 32.99 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.362 1.465 . . . . 0.0 110.398 169.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -142.26 142.69 24.81 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 123.979 0.912 . . . . 0.0 111.066 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -81.0 150.52 18.07 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.186 2.591 . . . . 0.0 112.714 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.3 tt -64.5 -18.25 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -172.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -95.86 -9.1 32.32 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -95.68 -36.32 11.25 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.095 0.958 . . . . 0.0 111.2 169.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -67.9 161.49 26.3 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.315 0.579 . . . . 0.0 111.609 174.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -135.78 122.23 20.66 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.338 1.055 . . . . 0.0 110.505 174.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.44 -0.35 10.16 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -171.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -70.49 -32.88 70.57 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.265 0.939 . . . . 0.0 113.421 -169.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -77.34 -21.01 54.02 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -105.27 90.9 3.57 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.003 1.321 . . . . 0.0 110.448 -169.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -58.08 -30.13 65.99 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.21 108.26 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.385 1.074 . . . . 0.0 109.874 -177.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.8 t -112.13 132.65 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.16 0.984 . . . . 0.0 109.81 177.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.6 mm -128.59 118.22 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 123.556 0.742 . . . . 0.0 110.374 -170.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 t -78.88 136.16 37.22 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.536 0.684 . . . . 0.0 109.346 168.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.6 mt -108.58 23.8 13.99 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.342 1.057 . . . . 0.0 109.848 169.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.8 p . . . . . 0 CA--C 1.544 0.727 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 -174.904 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 CA--C 1.547 0.851 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -59.57 137.34 76.98 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.902 2.401 . . . . 0.0 110.074 169.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -59.0 -33.86 98.94 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.241 1.961 . . . . 0.0 113.33 -174.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -65.41 -25.69 67.65 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.774 1.17 . . . . 0.0 113.974 176.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.72 -19.8 54.6 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.761 -1.212 . . . . 0.0 112.573 171.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.7 t -89.63 -37.28 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.834 1.654 . . . . 0.0 112.087 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.7 p -83.46 18.14 1.93 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -173.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -69.0 166.49 17.9 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.147 0.979 . . . . 0.0 111.519 169.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -53.16 -40.84 64.61 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -169.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 63.4 mt -129.4 126.65 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.664 1.186 . . . . 0.0 109.791 169.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -131.03 125.21 32.67 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.671 1.188 . . . . 0.0 109.929 169.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -140.96 166.16 25.56 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.906 1.282 . . . . 0.0 112.115 -175.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -129.81 134.38 47.52 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.087 1.355 . . . . 0.0 112.306 173.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 46.8 m0 -96.29 0.71 51.23 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 64.63 33.45 10.63 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.829 1.251 . . . . 0.0 114.275 170.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 26.7 mt -90.66 166.43 13.17 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -119.65 148.9 42.81 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.684 1.994 . . . . 0.0 111.178 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.74 119.13 76.12 Favored Pre-proline 0 CA--C 1.55 0.971 0 O-C-N 121.402 -0.812 . . . . 0.0 110.984 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -85.85 -10.19 7.29 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.234 1.956 . . . . 0.0 115.338 -173.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -47.74 113.81 0.78 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.927 1.291 . . . . 0.0 112.938 177.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.04 -3.65 84.57 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 123.978 0.799 . . . . 0.0 114.289 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -78.45 169.52 18.11 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.143 0.972 . . . . 0.0 110.044 169.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 97.2 p -64.13 156.82 27.22 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.383 -0.823 . . . . 0.0 111.903 173.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.9 -30.96 70.49 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.413 -0.804 . . . . 0.0 111.695 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -64.48 -36.34 83.87 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 120.957 -1.089 . . . . 0.0 113.388 173.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.5 t -73.7 -36.65 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 O-C-N 121.061 -1.024 . . . . 0.0 110.272 173.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.54 -40.03 95.95 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.805 0.842 . . . . 0.0 110.675 175.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -67.03 -42.49 84.77 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.046 1.738 . . . . 0.0 111.961 172.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.9 m -58.5 -50.72 72.74 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.402 1.081 . . . . 0.0 111.938 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 19.7 m -67.7 -31.81 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 119.389 0.995 . . . . 0.0 111.699 179.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.2 ptt-85 -70.44 -30.72 67.63 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 120.255 1.389 . . . . 0.0 112.954 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.58 -43.64 96.22 Favored Glycine 0 N--CA 1.477 1.429 0 C-N-CA 123.797 0.713 . . . . 0.0 111.998 169.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -62.61 -38.25 89.47 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.63 -0.923 . . . . 0.0 112.456 170.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.7 t -60.23 -50.41 80.34 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.595 173.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -53.13 -52.73 57.77 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 120.177 1.353 . . . . 0.0 111.79 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -48.31 -44.81 34.36 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.468 1.507 . . . . 0.0 112.352 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -90.91 -28.87 17.82 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.125 0.97 . . . . 0.0 112.022 -171.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.8 t -63.91 -50.07 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.916 1.286 . . . . 0.0 109.569 169.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -53.4 -55.27 26.44 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.663 0.665 . . . . 0.0 109.292 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -50.89 -36.69 39.45 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.107 1.763 . . . . 0.0 113.376 174.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -84.78 -61.53 1.76 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.609 1.095 . . . . 0.0 113.513 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -57.49 -33.33 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.751 1.62 . . . . 0.0 111.599 -177.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.5 -10.48 59.84 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 44.7 mttm -80.15 -20.12 45.66 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.596 1.158 . . . . 0.0 112.425 169.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.1 pt -122.23 28.27 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 127.309 2.243 . . . . 0.0 111.569 -176.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 24.3 t . . . . . 0 C--O 1.252 1.228 0 C-N-CA 127.633 2.373 . . . . 0.0 111.114 179.141 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.502 2.166 0 CA-C-O 119.378 -0.344 . . . . 0.0 111.87 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -84.51 99.66 10.86 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 118.995 0.816 . . . . 0.0 110.115 174.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -75.41 147.85 39.63 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.741 0.417 . . . . 0.0 111.855 -174.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.6 t -104.92 140.08 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.464 1.106 . . . . 0.0 110.635 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 49.3 tpp -127.15 113.97 17.08 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.586 0.755 . . . . 0.0 110.331 169.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -81.49 143.35 32.13 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.39 0.676 . . . . 0.0 110.315 169.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.4 t -134.86 123.95 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.443 1.497 . . . . 0.0 110.558 -178.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 p -136.32 170.9 15.28 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.472 1.109 . . . . 0.0 111.162 171.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -58.46 -53.94 52.66 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 120.342 1.428 . . . . 0.0 110.16 175.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -93.87 121.76 35.66 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 168.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.577 ' ND2' ' H ' ' A' ' 63' ' ' ASP . 23.0 t-20 -47.12 -41.36 17.29 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 121.406 1.912 . . . . 0.0 110.713 169.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.6 p -66.59 -35.89 81.31 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.888 1.675 . . . . 0.0 114.868 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 95.1 p -65.69 -37.07 85.45 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -169.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.27 -43.92 0.41 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.8 m -63.11 -42.68 99.62 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 119.731 1.15 . . . . 0.0 113.009 -169.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -57.63 -40.96 80.37 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.292 1.837 . . . . 0.0 112.456 169.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 94.7 mtp -64.87 -43.03 94.31 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.283 0.633 . . . . 0.0 110.488 175.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.14 -29.69 67.78 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 117.701 -1.142 . . . . 0.0 113.409 173.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -70.43 -48.3 56.67 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 121.45 1.932 . . . . 0.0 108.48 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.73 -46.24 94.37 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.607 -1.107 . . . . 0.0 113.676 176.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -66.96 -34.12 77.06 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.542 1.671 . . . . 0.0 112.378 175.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.05 -33.6 61.74 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.88 -1.137 . . . . 0.0 110.639 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -60.41 -56.21 24.24 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 125.621 1.569 . . . . 0.0 109.444 170.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.0 p -70.3 -11.01 60.61 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.6 mt -98.1 -5.47 33.66 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 171.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.59 17.4 0.08 OUTLIER Glycine 0 CA--C 1.536 1.368 0 N-CA-C 118.661 2.224 . . . . 0.0 118.661 -172.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.73 -33.25 64.08 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.848 1.824 . . . . 0.0 114.511 -173.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.36 -6.15 88.95 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 124.161 0.886 . . . . 0.0 115.043 177.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -101.1 -59.17 1.74 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.958 1.303 . . . . 0.0 112.003 -170.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.5 pp -143.84 171.91 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 127.345 2.258 . . . . 0.0 110.536 -174.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.53 131.99 42.58 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.409 -0.807 . . . . 0.0 112.9 175.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.9 m -104.28 149.37 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 C-N-CA 125.09 1.356 . . . . 0.0 113.259 171.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.53 144.87 27.6 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.413 0.685 . . . . 0.0 112.382 -173.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.0 t -114.24 129.44 56.63 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.976 2.111 . . . . 0.0 113.799 175.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 t -132.33 177.02 7.91 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.505 1.922 . . . . 0.0 110.764 171.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.55 175.08 46.11 Favored Glycine 0 CA--C 1.523 0.557 0 O-C-N 120.572 -1.33 . . . . 0.0 114.286 171.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.0 mt -67.39 -27.39 67.05 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 122.275 -0.544 . . . . 0.0 111.829 -176.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -123.48 115.56 21.76 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.157 2.183 . . . . 0.0 105.765 169.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 77.3 p -62.31 -20.37 64.25 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.314 -0.866 . . . . 0.0 113.076 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.6 t 54.83 -149.91 0.43 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.773 1.629 . . . . 0.0 113.905 168.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.68 165.11 28.39 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 128.244 2.618 . . . . 0.0 110.052 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 m -67.34 102.12 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 169.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -70.26 135.59 86.79 Favored Pre-proline 0 N--CA 1.476 0.841 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.936 -169.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -60.31 -36.79 86.2 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.911 2.407 . . . . 0.0 113.618 -171.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.2 m -77.56 -33.44 54.04 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.543 -0.723 . . . . 0.0 111.193 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.75 -44.32 81.79 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.053 0.842 . . . . 0.0 111.761 170.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 74.7 mt -50.97 -47.07 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 120.343 1.429 . . . . 0.0 110.337 173.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.54 -63.74 1.13 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 31.9 mmt -68.81 -24.43 64.39 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.45 -0.781 . . . . 0.0 112.942 -170.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 80.7 mmm -79.54 -35.74 39.43 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.732 0.696 . . . . 0.0 110.803 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -61.09 -30.88 70.62 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.631 -1.293 . . . . 0.0 112.693 171.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -54.35 -37.31 64.77 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.207 0.912 . . . . 0.0 112.755 172.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.2 m -98.16 15.2 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.58 1.152 . . . . 0.0 113.914 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.03 13.01 67.16 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.115 0.864 . . . . 0.0 115.029 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.6 mt -119.49 70.34 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.63 1.572 . . . . 0.0 109.709 -169.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -66.13 108.96 2.43 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 119.995 -1.691 . . . . 0.0 110.56 171.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.7 pt -84.52 -4.74 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.0 t -61.86 -32.68 73.05 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 120.382 1.446 . . . . 0.0 112.912 -170.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.32 4.51 80.49 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.03 1.3 . . . . 0.0 115.383 173.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -87.77 149.0 24.45 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.017 1.408 . . . . 0.0 112.36 -172.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.8 t -76.08 157.08 33.3 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.0 p -139.21 154.7 48.06 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.185 1.394 . . . . 0.0 109.847 169.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.577 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -146.88 149.98 37.7 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.387 1.075 . . . . 0.0 111.62 -175.099 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -88.79 152.61 6.07 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.637 2.891 . . . . 0.0 111.335 174.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.6 tp -60.23 -21.53 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.31 1.444 . . . . 0.0 114.863 -177.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -97.6 -9.1 27.53 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -92.08 -38.77 12.0 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 118.891 0.769 . . . . 0.0 111.609 172.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.0 158.24 36.0 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.388 0.613 . . . . 0.0 111.192 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -138.13 115.82 11.4 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.778 1.231 . . . . 0.0 109.476 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.5 0.18 5.65 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 -169.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -70.04 -29.12 66.08 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.715 1.143 . . . . 0.0 112.328 -172.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -87.43 -2.8 58.87 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.008 1.323 . . . . 0.0 113.062 175.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -124.88 83.29 2.14 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.106 1.762 . . . . 0.0 109.5 -171.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -57.76 -19.13 25.78 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.18 0.992 . . . . 0.0 113.404 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.3 t -121.03 113.9 41.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.46 1.504 . . . . 0.0 109.931 -177.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.6 t -127.42 133.79 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 121.501 -0.749 . . . . 0.0 110.199 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.2 mm -129.09 133.21 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 121.567 -0.708 . . . . 0.0 111.21 -169.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.7 t -92.7 119.4 32.06 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.798 1.639 . . . . 0.0 110.835 173.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 mp -103.33 27.96 6.82 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.21 1.804 . . . . 0.0 111.327 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.4 p . . . . . 0 CA--C 1.543 0.706 0 C-N-CA 126.465 1.906 . . . . 0.0 109.827 169.823 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.6 mt . . . . . 0 CA--C 1.549 0.905 0 CA-C-O 119.217 -0.42 . . . . 0.0 111.394 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.65 138.57 86.73 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.747 2.298 . . . . 0.0 111.51 172.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.1 -38.48 45.42 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.466 2.111 . . . . 0.0 112.595 -169.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.93 -23.96 65.13 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.121 -0.987 . . . . 0.0 113.586 176.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -78.69 -9.6 59.46 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.699 -1.251 . . . . 0.0 112.949 169.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.5 t -100.78 -41.66 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 126.513 1.925 . . . . 0.0 111.481 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.1 p -80.52 28.98 0.31 Allowed 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -172.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -79.29 170.47 16.58 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.955 1.302 . . . . 0.0 111.99 170.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -57.79 -36.6 72.4 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.125 0.97 . . . . 0.0 113.496 -170.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 61.9 mt -128.01 125.65 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.909 1.284 . . . . 0.0 109.59 170.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -135.71 138.96 43.28 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.041 0.937 . . . . 0.0 111.479 169.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -143.26 146.71 33.86 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.128 1.371 . . . . 0.0 112.03 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -109.35 116.84 32.6 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.175 1.39 . . . . 0.0 109.586 169.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -94.08 -6.95 43.92 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.331 1.2 pp0? 50.12 30.28 4.12 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 176.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.5 mt -73.04 150.05 42.69 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -86.07 158.9 19.71 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.872 1.669 . . . . 0.0 113.016 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -81.89 128.42 68.67 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.848 1.259 . . . . 0.0 112.866 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -88.24 -38.58 0.06 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.61 2.207 . . . . 0.0 113.595 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 19.43 51.35 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 131.622 3.969 . . . . 0.0 117.786 169.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.36 11.56 79.79 Favored Glycine 0 CA--C 1.539 1.588 0 O-C-N 120.797 -1.189 . . . . 0.0 115.046 176.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -63.37 -52.89 59.82 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.807 1.243 . . . . 0.0 111.076 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 34.1 t -168.48 153.56 6.38 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.742 2.017 . . . . 0.0 109.627 169.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.5 mp -56.85 -31.84 65.2 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.982 0.913 . . . . 0.0 110.999 172.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.56 -39.83 74.12 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.978 1.311 . . . . 0.0 112.568 173.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.6 t -73.16 -38.11 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 121.503 -0.748 . . . . 0.0 109.668 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -63.86 -44.58 92.67 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.265 0.484 . . . . 0.0 111.463 175.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -64.35 -39.12 93.27 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.514 1.126 . . . . 0.0 111.74 176.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.1 m -62.51 -52.84 61.88 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.012 0.925 . . . . 0.0 111.469 173.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.5 m -72.69 -29.71 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 117.047 -1.454 . . . . 0.0 112.78 -177.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.9 ptt85 -64.16 -37.12 86.33 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 121.805 2.093 . . . . 0.0 112.181 171.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.55 -48.99 77.65 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.886 0.755 . . . . 0.0 112.316 173.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -59.81 -45.58 91.89 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 117.586 0.693 . . . . 0.0 112.407 173.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.9 t -58.67 -46.88 90.2 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.495 0 CA-C-O 117.843 -1.075 . . . . 0.0 110.169 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -52.12 -53.57 41.08 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.044 1.293 . . . . 0.0 111.853 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -58.3 -45.66 87.59 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.098 0.475 . . . . 0.0 111.854 -178.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -75.11 -33.5 61.61 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 36.4 t -63.13 -47.91 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.97 1.308 . . . . 0.0 111.03 169.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -53.77 -55.71 23.95 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.523 1.056 . . . . 0.0 109.481 174.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -53.33 -26.2 17.99 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.059 1.344 . . . . 0.0 113.545 177.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -91.68 -62.27 1.46 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.277 1.431 . . . . 0.0 112.945 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.84 -31.03 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.581 1.552 . . . . 0.0 111.551 -176.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.52 -7.22 54.7 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -74.06 -27.79 61.09 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.6 1.16 . . . . 0.0 112.693 169.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.4 pt -117.26 -7.91 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.616 1.966 . . . . 0.0 113.555 -171.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 C--O 1.255 1.391 0 C-N-CA 125.261 1.424 . . . . 0.0 112.458 172.426 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 ttm . . . . . 0 N--CA 1.502 2.159 0 CA-C-O 119.653 -0.213 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -90.32 90.25 7.98 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.257 1.023 . . . . 0.0 110.487 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -80.94 149.24 29.47 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 121.573 -0.704 . . . . 0.0 112.232 -174.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.2 t -115.09 143.41 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.663 1.185 . . . . 0.0 111.124 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.405 ' HE1' ' CD2' ' A' ' 68' ' ' PHE . 46.1 tpp -130.62 122.68 27.88 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.248 1.019 . . . . 0.0 111.019 169.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -93.22 138.67 31.39 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.509 -0.744 . . . . 0.0 110.597 169.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.8 t -134.41 130.5 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.984 1.314 . . . . 0.0 110.384 -171.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 t -151.8 -165.67 2.29 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.439 0.696 . . . . 0.0 112.542 169.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -63.0 -70.54 0.2 Allowed 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 119.406 1.003 . . . . 0.0 111.045 170.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 56.6 mtt-85 -79.07 127.76 32.41 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 118.569 0.622 . . . . 0.0 109.955 169.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.594 ' ND2' ' H ' ' A' ' 63' ' ' ASP . 19.2 t-20 -61.06 -43.37 98.98 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 168.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 99.3 p -73.97 -48.26 31.69 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -169.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.0 p -83.29 -11.23 57.95 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.763 -1.211 . . . . 0.0 113.695 -173.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 -126.63 -67.42 0.86 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.788 1.235 . . . . 0.0 111.734 -176.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.3 m -64.21 -44.51 91.68 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.16 1.171 . . . . 0.0 114.16 -175.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -57.5 -30.68 65.31 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.832 1.253 . . . . 0.0 113.792 170.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.1 mtm -68.17 -49.36 61.44 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.072 0.851 . . . . 0.0 110.92 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.72 -29.93 70.04 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.622 -0.674 . . . . 0.0 112.686 172.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -71.23 -44.22 65.78 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 119.691 1.132 . . . . 0.0 109.269 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.96 -41.31 98.7 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 119.299 -0.723 . . . . 0.0 112.073 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -62.73 -44.24 96.73 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.885 1.342 . . . . 0.0 111.719 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.82 -32.79 69.97 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 120.574 -1.329 . . . . 0.0 111.224 -174.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -64.91 -56.3 14.14 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 126.432 1.893 . . . . 0.0 109.449 171.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.3 p -68.08 -14.93 63.35 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 52.7 mt -100.74 -8.16 23.04 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.454 1.102 . . . . 0.0 113.816 174.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.58 10.55 1.27 Allowed Glycine 0 CA--C 1.534 1.273 0 N-CA-C 117.181 1.632 . . . . 0.0 117.181 -169.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.98 131.01 46.19 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.16 1.48 . . . . 0.0 112.067 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.47 -6.44 57.66 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.528 1.061 . . . . 0.0 115.531 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -86.25 -61.32 1.77 Allowed 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 119.296 1.548 . . . . 0.0 110.339 175.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -142.75 173.01 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 127.667 2.387 . . . . 0.0 110.316 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.75 130.02 41.45 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.366 -0.834 . . . . 0.0 112.314 175.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.7 m -104.15 153.04 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.716 1.206 . . . . 0.0 112.478 170.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.19 145.7 27.27 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -171.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.1 t -110.33 133.49 53.2 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.835 2.054 . . . . 0.0 113.615 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.8 t -141.84 171.33 14.2 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.521 1.928 . . . . 0.0 110.949 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.59 -179.82 45.66 Favored Glycine 0 CA--C 1.526 0.778 0 O-C-N 120.883 -1.136 . . . . 0.0 114.567 169.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 38.0 mt -63.19 -26.7 68.93 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.23 1.012 . . . . 0.0 112.074 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -128.34 127.43 42.67 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.19 1.396 . . . . 0.0 109.09 170.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.6 p -77.48 58.04 1.65 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.262 1.425 . . . . 0.0 110.492 171.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.4 p -65.9 156.62 32.87 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 114.146 -1.388 . . . . 0.0 112.818 -169.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -64.74 144.64 57.1 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.251 1.02 . . . . 0.0 109.981 177.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.7 m -41.23 109.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.852 1.661 . . . . 0.0 109.082 170.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -68.03 132.31 92.06 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-O 118.383 -0.817 . . . . 0.0 112.82 -167.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.31 -39.15 80.17 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.372 2.715 . . . . 0.0 113.566 -170.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.0 m -78.05 -37.06 47.66 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 119.151 -0.452 . . . . 0.0 110.496 177.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.67 -40.78 96.02 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.626 1.103 . . . . 0.0 112.475 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.4 mt -52.38 -47.17 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 120.98 1.718 . . . . 0.0 109.927 172.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.82 -58.38 8.68 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 175.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.6 mmt -66.18 -22.0 66.34 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 88.5 mmm -90.93 -37.36 13.58 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.941 0.896 . . . . 0.0 110.592 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -60.89 -33.89 73.81 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.407 -1.433 . . . . 0.0 112.319 169.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -56.0 -30.06 61.26 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.036 0.934 . . . . 0.0 113.313 173.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.4 m -103.41 13.64 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.857 1.263 . . . . 0.0 114.155 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.13 17.2 63.32 Favored Glycine 0 CA--C 1.537 1.467 0 O-C-N 121.209 -0.932 . . . . 0.0 115.106 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.1 mt -122.54 79.68 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.977 1.711 . . . . 0.0 109.631 -169.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -70.28 106.59 3.4 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.053 -1.655 . . . . 0.0 111.185 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.1 pt -82.3 -10.14 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 118.166 -0.921 . . . . 0.0 112.576 175.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.5 t -61.85 -33.15 73.66 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 120.3 1.409 . . . . 0.0 113.029 -169.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -95.94 6.52 66.91 Favored Glycine 0 CA--C 1.541 1.674 0 C-N-CA 125.098 1.333 . . . . 0.0 115.294 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -93.32 151.27 19.89 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.028 1.414 . . . . 0.0 111.477 -171.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.6 t -68.25 149.98 48.83 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -170.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.8 t -135.81 133.24 37.67 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.36 1.464 . . . . 0.0 109.183 169.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.594 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 4.1 t70 -148.21 146.22 22.65 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.696 1.598 . . . . 0.0 110.836 -172.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -91.15 154.46 3.82 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.574 2.183 . . . . 0.0 112.65 -173.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.3 tt -60.66 -21.42 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -94.06 -9.58 36.24 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -94.51 -37.44 11.39 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.785 0.834 . . . . 0.0 111.816 170.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.405 ' CD2' ' HE1' ' A' ' 5' ' ' MET . 0.0 OUTLIER -70.58 163.18 27.5 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.26 0.552 . . . . 0.0 111.644 174.56 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -139.38 134.1 31.99 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.015 0.926 . . . . 0.0 110.633 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.62 6.87 6.41 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -174.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -74.31 -30.86 62.25 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.068 -1.02 . . . . 0.0 112.594 -173.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -88.86 -3.74 58.67 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.657 1.183 . . . . 0.0 113.6 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -123.72 94.01 4.11 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.739 1.616 . . . . 0.0 110.151 -171.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -62.75 -18.9 63.37 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.0 t -120.09 114.74 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.812 1.245 . . . . 0.0 110.472 -176.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.3 t -127.9 129.88 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.995 0.918 . . . . 0.0 110.814 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.5 mm -116.35 125.29 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.301 0.641 . . . . 0.0 111.56 -172.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.0 t -86.11 92.12 8.63 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.379 1.472 . . . . 0.0 109.155 169.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.9 mt -76.94 -11.04 59.75 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.884 0.873 . . . . 0.0 112.158 171.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 27.5 p . . . . . 0 CA--C 1.547 0.833 0 C-N-CA 123.586 0.755 . . . . 0.0 111.673 169.16 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.0 mt . . . . . 0 CA--C 1.547 0.845 0 CA-C-O 119.081 -0.485 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.86 136.68 75.26 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.326 2.018 . . . . 0.0 110.645 169.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -64.22 -29.55 64.43 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.485 2.123 . . . . 0.0 112.63 -176.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -61.37 -28.68 69.41 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 171.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.35 13.28 13.95 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.829 1.252 . . . . 0.0 114.163 171.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.6 t -114.1 -37.19 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.666 1.587 . . . . 0.0 111.416 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -81.04 27.09 0.41 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 115.297 1.592 . . . . 0.0 115.297 -169.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -77.11 165.7 24.25 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.822 1.649 . . . . 0.0 112.64 173.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -56.23 -38.23 70.8 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.776 1.23 . . . . 0.0 113.008 -172.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.0 mt -127.48 116.99 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.14 1.376 . . . . 0.0 108.704 169.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -128.14 128.44 44.82 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.191 0.997 . . . . 0.0 109.881 169.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -137.29 140.0 41.28 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.613 0.765 . . . . 0.0 113.007 -170.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -97.9 104.59 16.63 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.265 1.826 . . . . 0.0 112.173 176.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 16.2 m0 -95.2 92.14 6.63 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 169.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -60.92 54.43 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 128.277 2.631 . . . . 0.0 115.718 176.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 77.3 mt -76.43 167.71 21.37 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.036 2.134 . . . . 0.0 111.841 175.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -96.73 153.89 17.61 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.748 1.219 . . . . 0.0 110.628 169.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -77.31 120.24 80.75 Favored Pre-proline 0 CA--C 1.546 0.809 0 O-C-N 120.88 -1.138 . . . . 0.0 111.114 172.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -87.13 -19.29 2.54 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.466 1.444 . . . . 0.0 114.957 -170.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -53.42 107.41 0.24 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.635 1.174 . . . . 0.0 112.092 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.04 -0.94 69.78 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.288 0.947 . . . . 0.0 114.62 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -77.95 172.15 13.91 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 118.316 1.058 . . . . 0.0 110.18 169.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 90.4 p -66.35 156.68 33.8 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.045 -1.034 . . . . 0.0 111.557 169.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.92 -27.58 68.95 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.306 -0.871 . . . . 0.0 111.862 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.2 -40.73 86.69 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.128 -0.983 . . . . 0.0 112.354 170.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 78.7 t -74.04 -37.73 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.371 -0.831 . . . . 0.0 110.416 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.59 -41.56 99.03 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.515 0.726 . . . . 0.0 111.075 176.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -69.55 -37.54 77.1 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.715 1.206 . . . . 0.0 112.29 171.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 55.3 m -58.3 -49.09 78.38 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 119.157 0.89 . . . . 0.0 111.589 176.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 31.2 m -67.22 -30.68 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 119.934 1.243 . . . . 0.0 111.719 177.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.37 -46.54 89.58 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 119.811 1.187 . . . . 0.0 111.318 169.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.53 -35.66 92.33 Favored Glycine 0 N--CA 1.472 1.054 0 C-N-CA 123.823 0.725 . . . . 0.0 112.153 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -68.46 -51.43 43.57 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 171.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.6 m -61.26 -39.68 83.43 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 CA-C-O 117.372 -1.299 . . . . 0.0 111.179 178.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -47.92 -57.5 5.63 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.331 1.423 . . . . 0.0 111.898 174.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -63.67 -41.78 98.15 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.274 0.629 . . . . 0.0 112.387 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 59.1 mtp85 -73.77 -34.74 64.82 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.87 -47.97 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.271 1.428 . . . . 0.0 111.465 171.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -52.63 -54.41 33.66 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.454 1.025 . . . . 0.0 109.563 177.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -55.56 -38.83 69.83 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.063 1.345 . . . . 0.0 112.668 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -73.1 -56.93 4.44 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.169 -0.957 . . . . 0.0 112.454 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -67.77 -34.22 66.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.014 1.326 . . . . 0.0 112.115 -176.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.21 -17.02 60.95 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -173.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -72.94 -22.07 60.78 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.39 1.076 . . . . 0.0 113.649 171.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.0 pt -118.37 11.29 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.3 1.84 . . . . 0.0 112.925 -175.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.19 1.796 . . . . 0.0 112.332 177.572 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.5 ttm . . . . . 0 N--CA 1.504 2.249 0 CA-C-O 119.246 -0.407 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -77.64 100.89 6.34 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 119.117 0.871 . . . . 0.0 110.74 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -86.6 136.06 33.19 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.111 1.764 . . . . 0.0 111.763 -172.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.4 t -114.64 143.06 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 124.176 0.991 . . . . 0.0 111.793 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.2 tpp -131.05 125.06 32.23 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.277 1.031 . . . . 0.0 111.602 169.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -93.05 136.84 32.94 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.533 0.733 . . . . 0.0 110.48 169.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 t -130.61 130.15 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.38 1.472 . . . . 0.0 110.2 -174.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.8 p -149.14 176.42 10.5 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.989 0.916 . . . . 0.0 112.628 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -63.93 -46.79 83.21 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.904 -1.122 . . . . 0.0 111.251 171.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.418 ' HB3' ' H ' ' A' ' 13' ' ' SER . 1.0 OUTLIER -109.26 111.66 23.38 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.358 1.463 . . . . 0.0 109.791 169.326 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.505 ' ND2' ' H ' ' A' ' 63' ' ' ASP . 58.8 t-20 -57.56 -46.95 83.32 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 169.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.6 p -43.48 -46.59 6.91 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 174.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.418 ' H ' ' HB3' ' A' ' 10' ' ' ARG . 27.3 p -97.44 -16.12 20.32 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.05 1.129 . . . . 0.0 114.05 -172.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -130.94 -62.63 0.89 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 119.738 1.153 . . . . 0.0 113.979 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.8 m -61.34 -35.08 76.42 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 120.118 1.326 . . . . 0.0 112.953 -177.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -62.98 -38.19 90.15 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.722 1.209 . . . . 0.0 113.446 169.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 84.9 mtp -64.29 -48.79 74.35 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.445 1.021 . . . . 0.0 110.714 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.07 -28.45 68.85 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 175.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -75.27 -41.52 57.03 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 119.72 1.145 . . . . 0.0 109.067 -178.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.66 -45.0 96.7 Favored Glycine 0 CA--C 1.52 0.37 0 CA-C-O 119.345 -0.697 . . . . 0.0 112.425 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -64.55 -43.81 92.79 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.851 1.326 . . . . 0.0 112.065 172.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.56 -32.49 69.92 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.454 -1.404 . . . . 0.0 111.767 -175.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -64.89 -55.63 18.17 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 125.332 1.453 . . . . 0.0 109.425 170.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.1 p -73.12 -8.92 57.9 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.587 -1.32 . . . . 0.0 114.523 -176.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 51.7 mt -100.28 -5.75 27.0 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.48 1.112 . . . . 0.0 113.701 170.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.29 15.2 0.1 OUTLIER Glycine 0 CA--C 1.537 1.417 0 N-CA-C 118.609 2.204 . . . . 0.0 118.609 -171.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.22 -33.67 67.77 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.162 1.981 . . . . 0.0 114.308 -172.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.43 -5.5 89.93 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.257 0.932 . . . . 0.0 115.029 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -100.77 -63.01 1.17 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.862 1.265 . . . . 0.0 111.409 -172.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -141.87 173.34 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 126.128 1.771 . . . . 0.0 112.122 -175.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.93 123.22 36.04 Favored 'General case' 0 C--N 1.343 0.291 0 O-C-N 121.368 -0.832 . . . . 0.0 112.502 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.0 m -101.47 151.97 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.05 0.94 . . . . 0.0 111.67 169.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.65 152.38 37.76 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.15 0.58 . . . . 0.0 111.544 -173.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.5 p -120.69 141.47 50.38 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.661 1.585 . . . . 0.0 114.731 175.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.3 t -145.99 167.54 23.07 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 127.308 2.243 . . . . 0.0 110.005 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.87 171.46 38.32 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 120.73 -1.231 . . . . 0.0 114.803 169.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 35.0 mt -62.12 -40.28 95.38 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.738 0.815 . . . . 0.0 111.477 -173.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -120.55 116.6 25.7 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 127.879 2.472 . . . . 0.0 105.874 169.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.7 p -67.21 -49.19 65.5 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.128 -0.982 . . . . 0.0 110.41 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.4 t 53.64 -173.26 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 127.031 2.132 . . . . 0.0 113.838 -174.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -80.86 177.8 8.81 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 127.051 2.14 . . . . 0.0 113.005 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.4 m -66.44 116.69 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 120.596 -1.315 . . . . 0.0 107.639 168.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -66.36 128.09 93.65 Favored Pre-proline 0 N--CA 1.478 0.934 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -168.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.64 -39.23 55.53 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.265 2.644 . . . . 0.0 113.994 -169.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.4 m -80.48 -32.65 37.01 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 122.023 -0.423 . . . . 0.0 110.629 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.67 -38.07 86.06 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.011 -1.056 . . . . 0.0 112.375 174.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 65.1 mt -53.02 -42.18 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 120.634 1.561 . . . . 0.0 110.559 172.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.86 -61.23 2.3 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.355 0.662 . . . . 0.0 112.702 173.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.4 mmt -66.08 -24.18 66.66 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -172.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 79.3 mmm -87.78 -33.9 18.5 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.976 0.91 . . . . 0.0 110.95 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -60.84 -32.74 72.13 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.704 -1.247 . . . . 0.0 111.901 169.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -54.41 -31.58 55.41 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.326 -0.859 . . . . 0.0 113.232 173.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.1 m -104.0 14.27 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 175.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.52 13.35 65.51 Favored Glycine 0 CA--C 1.536 1.365 0 O-C-N 120.984 -1.072 . . . . 0.0 115.224 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.5 mt -118.36 71.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.803 1.641 . . . . 0.0 109.411 -169.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -64.07 110.69 2.24 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 120.34 -1.475 . . . . 0.0 110.218 172.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 pt -92.73 4.33 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.326 0.65 . . . . 0.0 112.627 178.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.3 p -68.4 -22.62 64.62 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.492 1.496 . . . . 0.0 113.855 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.5 8.24 62.03 Favored Glycine 0 CA--C 1.541 1.712 0 C-N-CA 125.548 1.547 . . . . 0.0 114.353 169.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -76.0 139.71 41.63 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.556 1.178 . . . . 0.0 111.274 -174.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.1 t -64.78 156.35 30.87 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.262 0.553 . . . . 0.0 111.588 169.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.0 t -143.57 127.99 17.89 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 169.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.505 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -124.64 142.23 40.07 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.593 1.157 . . . . 0.0 111.305 -174.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -87.58 152.87 7.63 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.611 2.874 . . . . 0.0 111.368 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.0 tt -60.91 -29.86 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -169.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -94.85 -6.92 41.67 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -80.91 -38.51 27.81 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.477 -0.764 . . . . 0.0 110.592 169.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.22 160.09 29.18 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.375 1.07 . . . . 0.0 111.716 172.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.63 116.5 14.12 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.899 1.28 . . . . 0.0 109.612 174.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.97 -3.85 6.01 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 -169.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -67.44 -30.56 70.33 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.3 0.954 . . . . 0.0 113.431 -169.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -84.3 -8.78 58.91 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 176.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -104.72 100.4 10.05 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 120.898 -1.127 . . . . 0.0 110.12 -169.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -52.19 -33.74 42.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.279 1.431 . . . . 0.0 112.736 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.0 t -125.41 122.75 63.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 125.385 1.474 . . . . 0.0 110.003 -174.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.0 t -124.05 130.43 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.671 0.788 . . . . 0.0 109.86 175.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 50.1 mm -125.45 123.12 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 123.927 0.891 . . . . 0.0 110.687 -169.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.8 t -82.2 137.4 34.92 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 168.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.401 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 76.5 mt -110.03 28.25 8.79 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.871 1.268 . . . . 0.0 109.857 170.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.1 t . . . . . 0 CA--C 1.542 0.641 0 C-N-CA 125.322 1.449 . . . . 0.0 113.307 -169.73 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 CA--C 1.55 0.975 0 CA-C-O 119.233 -0.413 . . . . 0.0 111.721 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -58.77 163.69 10.8 Favored 'Trans proline' 0 CA--C 1.551 1.34 0 C-N-CA 123.716 2.944 . . . . 0.0 113.608 171.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.81 -52.74 1.16 Allowed 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.521 2.147 . . . . 0.0 113.784 -171.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -60.18 -36.61 78.01 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 120.664 -1.272 . . . . 0.0 111.897 177.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -63.89 7.01 0.13 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 127.928 2.491 . . . . 0.0 115.046 170.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.1 t -134.86 -42.7 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 127.109 2.164 . . . . 0.0 111.525 175.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.7 p -79.9 32.64 0.26 Allowed 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -169.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -85.47 168.8 14.22 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.374 1.069 . . . . 0.0 112.187 172.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -57.06 -36.1 70.13 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -169.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.4 mt -125.87 125.58 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.772 1.229 . . . . 0.0 108.813 169.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -133.33 131.14 39.78 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.172 0.989 . . . . 0.0 111.536 169.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -145.96 162.0 38.79 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.196 1.398 . . . . 0.0 111.757 -175.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -125.52 122.53 36.85 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.679 1.192 . . . . 0.0 111.422 170.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.401 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 44.1 m0 -82.54 -4.55 57.75 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 61.43 47.57 6.63 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.328 1.451 . . . . 0.0 113.62 169.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.0 mt -99.89 149.02 23.84 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -171.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -82.69 152.89 25.61 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.327 1.451 . . . . 0.0 111.336 170.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -80.85 120.67 79.56 Favored Pre-proline 0 CA--C 1.545 0.786 0 O-C-N 121.27 -0.894 . . . . 0.0 111.232 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -82.17 -10.6 11.25 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.231 1.954 . . . . 0.0 114.564 -176.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -53.23 107.63 0.25 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.754 1.161 . . . . 0.0 112.583 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.37 3.36 90.02 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 119.306 -0.719 . . . . 0.0 114.803 177.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -73.66 165.21 25.52 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.501 1.151 . . . . 0.0 110.437 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.2 m -60.66 147.84 40.59 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.42 -0.8 . . . . 0.0 111.171 170.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.83 -27.85 69.61 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.413 -0.805 . . . . 0.0 112.916 -172.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -59.04 -39.4 81.89 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.053 -1.029 . . . . 0.0 112.648 170.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.7 t -72.19 -37.03 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.907 0.883 . . . . 0.0 110.032 175.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.07 -40.93 97.35 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.435 0.694 . . . . 0.0 111.172 177.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -69.64 -37.2 76.67 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 120.778 -1.201 . . . . 0.0 112.521 171.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 55.1 m -59.15 -48.7 80.64 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.135 0.974 . . . . 0.0 111.558 175.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 19.7 m -66.51 -29.96 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 119.743 1.156 . . . . 0.0 111.947 175.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -45.94 89.61 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 120.086 1.312 . . . . 0.0 110.875 169.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.91 -41.33 97.73 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 118.955 0.798 . . . . 0.0 112.393 174.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -67.24 -43.04 82.93 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 175.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.3 m -67.15 -41.2 86.65 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.695 0 CA-C-N 119.807 1.185 . . . . 0.0 110.547 176.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -51.55 -54.13 30.7 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.689 1.586 . . . . 0.0 111.581 175.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -50.6 -49.64 55.99 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.779 1.631 . . . . 0.0 112.347 176.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -87.41 -27.95 22.44 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.661 0.784 . . . . 0.0 112.248 -170.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.4 t -63.53 -51.79 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.201 1.4 . . . . 0.0 109.187 169.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -54.01 -53.77 48.41 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.312 0.96 . . . . 0.0 109.613 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -52.01 -37.78 54.53 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.803 1.641 . . . . 0.0 112.49 176.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -79.07 -59.09 2.92 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.007 -1.058 . . . . 0.0 113.357 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.54 -33.89 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.789 1.636 . . . . 0.0 112.14 -174.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.53 -17.01 60.81 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.085 -1.009 . . . . 0.0 113.57 -174.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -74.03 -21.25 60.03 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.537 1.135 . . . . 0.0 113.786 171.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.5 pt -118.19 10.42 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.144 1.778 . . . . 0.0 113.006 -175.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.6 m . . . . . 0 C--O 1.253 1.283 0 C-N-CA 126.473 1.909 . . . . 0.0 112.024 177.721 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.8 ttm . . . . . 0 N--CA 1.503 2.207 0 CA-C-O 119.739 -0.172 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -88.01 83.2 7.06 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.3 1.04 . . . . 0.0 110.207 176.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -73.44 150.16 41.87 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 121.764 -0.585 . . . . 0.0 111.563 -175.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.6 t -109.7 146.86 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.346 1.058 . . . . 0.0 111.124 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.428 ' HE1' ' CD2' ' A' ' 68' ' ' PHE . 46.2 tpp -131.36 118.39 20.22 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.747 0.819 . . . . 0.0 110.643 168.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -88.41 131.32 34.9 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.302 1.041 . . . . 0.0 111.185 169.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.3 t -127.06 126.37 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.981 1.312 . . . . 0.0 110.643 -173.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.1 m -140.66 172.0 13.32 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.46 1.104 . . . . 0.0 111.303 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.95 -46.3 82.16 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.779 -1.201 . . . . 0.0 109.986 169.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -98.66 113.71 25.89 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.126 1.371 . . . . 0.0 109.821 169.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -62.28 -41.84 98.83 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 119.474 1.034 . . . . 0.0 109.43 169.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.2 p -46.35 -32.97 3.49 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.972 2.509 . . . . 0.0 116.894 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.4 p -98.99 -97.39 0.23 Allowed 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 123.832 0.853 . . . . 0.0 110.233 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -64.22 -44.1 92.95 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.859 1.264 . . . . 0.0 113.792 -169.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.9 m -63.11 -45.39 92.25 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.789 1.177 . . . . 0.0 111.889 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -63.81 -39.57 94.56 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 171.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 71.7 mtp -61.44 -44.76 96.55 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 120.769 -1.207 . . . . 0.0 110.994 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.52 -31.53 69.81 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 173.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -66.52 -50.44 63.19 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 119.478 1.036 . . . . 0.0 109.196 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.02 -45.48 95.85 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 118.868 -0.962 . . . . 0.0 112.634 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -64.17 -40.03 95.26 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.521 1.161 . . . . 0.0 112.416 173.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.44 -32.27 66.16 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.492 -1.38 . . . . 0.0 111.006 -176.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -62.42 -56.0 22.41 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 126.273 1.829 . . . . 0.0 110.159 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 67.9 p -70.46 -14.95 62.75 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.5 mt -100.98 -4.58 27.26 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.234 1.013 . . . . 0.0 113.62 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.58 5.37 1.15 Allowed Glycine 0 CA--C 1.534 1.256 0 N-CA-C 117.166 1.626 . . . . 0.0 117.166 -169.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.6 126.74 22.83 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.38 1.59 . . . . 0.0 112.539 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.9 -3.91 63.24 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 124.759 1.171 . . . . 0.0 115.877 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -87.61 -59.71 2.17 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 119.254 1.527 . . . . 0.0 110.613 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 pp -140.4 175.57 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 127.317 2.247 . . . . 0.0 109.538 170.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.78 125.98 42.89 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.998 0.904 . . . . 0.0 111.547 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.4 m -90.13 151.14 3.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 124.268 1.027 . . . . 0.0 112.295 169.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.72 152.81 39.43 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.439 1.095 . . . . 0.0 111.621 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.2 p -130.26 133.1 46.26 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.348 1.459 . . . . 0.0 114.925 174.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.3 p -134.47 173.3 11.8 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 127.618 2.367 . . . . 0.0 110.399 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.8 176.89 47.83 Favored Glycine 0 CA--C 1.525 0.68 0 O-C-N 120.248 -1.533 . . . . 0.0 114.7 169.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 27.9 mt -65.84 -34.09 77.35 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.035 0.534 . . . . 0.0 111.78 -175.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -117.39 116.3 26.91 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.981 2.112 . . . . 0.0 109.63 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.2 p -77.53 48.91 0.69 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.282 2.233 . . . . 0.0 111.917 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.7 t -70.72 165.72 22.41 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.038 -1.437 . . . . 0.0 112.67 -170.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -64.99 159.14 23.71 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 125.024 1.329 . . . . 0.0 112.495 -175.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.7 m -54.39 114.44 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.093 -1.004 . . . . 0.0 109.133 169.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -66.44 129.54 94.15 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -168.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -60.01 -39.64 68.76 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.475 2.784 . . . . 0.0 113.682 -171.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.4 m -79.33 -32.23 43.3 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.86 -0.525 . . . . 0.0 110.986 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.0 -40.91 87.43 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.832 -1.168 . . . . 0.0 112.568 173.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.9 mt -53.02 -39.82 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 120.613 1.551 . . . . 0.0 110.614 172.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.55 -64.31 0.89 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.432 0.693 . . . . 0.0 112.781 172.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.8 mmt -65.11 -23.68 67.22 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -171.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 89.7 mmm -85.59 -34.55 21.42 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.584 0.754 . . . . 0.0 110.732 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -62.06 -31.04 71.42 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.698 -1.251 . . . . 0.0 111.963 171.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -55.27 -30.57 60.37 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.75 0.82 . . . . 0.0 112.891 172.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.4 m -106.45 17.28 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 175.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.0 13.14 69.75 Favored Glycine 0 CA--C 1.536 1.388 0 O-C-N 121.085 -1.009 . . . . 0.0 115.225 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.4 mt -117.13 91.63 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.123 1.369 . . . . 0.0 110.061 -169.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -77.63 114.4 16.43 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.795 -1.19 . . . . 0.0 110.615 171.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.9 pt -91.31 -5.3 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 172.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 t -63.17 -27.65 69.52 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.352 1.433 . . . . 0.0 113.558 -169.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.62 9.82 60.68 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 124.977 1.275 . . . . 0.0 115.353 173.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -89.36 148.8 23.31 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 118.838 1.319 . . . . 0.0 113.2 -169.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.7 t -61.62 146.81 47.79 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.9 t -136.78 49.95 2.04 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 122.082 0.944 . . . . 0.0 112.403 175.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -64.66 145.05 98.81 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 125.241 1.416 . . . . 0.0 113.542 -172.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.28 154.39 32.17 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.804 2.336 . . . . 0.0 112.035 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.1 tt -62.93 -21.96 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -92.6 -10.83 36.08 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -91.4 -35.24 14.49 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.484 0.714 . . . . 0.0 111.962 171.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.428 ' CD2' ' HE1' ' A' ' 5' ' ' MET . 0.0 OUTLIER -71.36 164.48 25.67 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.562 0.745 . . . . 0.0 112.045 174.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -140.8 131.36 25.45 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.89 0.876 . . . . 0.0 110.921 169.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.4 6.13 4.93 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 115.551 1.685 . . . . 0.0 115.551 -174.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -71.58 -30.07 65.42 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.007 -1.058 . . . . 0.0 112.181 -174.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -93.48 -4.92 50.31 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.905 1.282 . . . . 0.0 113.511 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -125.24 79.47 1.8 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.542 1.537 . . . . 0.0 110.431 -171.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -69.06 0.78 4.17 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -171.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.0 t -129.03 94.64 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 125.868 1.667 . . . . 0.0 108.832 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.3 t -112.43 119.03 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 121.315 -0.866 . . . . 0.0 110.457 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 mp -110.2 134.38 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 124.281 1.032 . . . . 0.0 110.112 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.8 t -94.15 145.24 24.84 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.704 1.602 . . . . 0.0 109.854 169.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.5 mt -125.05 44.44 2.79 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.305 1.042 . . . . 0.0 111.39 -173.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.8 p -148.84 -9.13 0.35 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 -170.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.55 29.54 74.95 Favored Glycine 0 CA--C 1.537 1.431 0 O-C-N 121.137 -0.977 . . . . 0.0 111.027 -168.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.8 p -142.28 9.5 1.86 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.613 1.565 . . . . 0.0 114.188 -169.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -51.81 -26.87 18.82 Favored Glycine 0 CA--C 1.536 1.359 0 N-CA-C 116.994 1.558 . . . . 0.0 116.994 -169.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.7 m -64.76 -15.93 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 118.989 1.395 . . . . 0.0 114.108 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -81.96 -10.7 59.18 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.217 1.407 . . . . 0.0 113.433 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 80.5 mt -72.26 158.99 86.59 Favored Pre-proline 0 CA--C 1.55 0.949 0 O-C-N 121.292 -0.88 . . . . 0.0 111.277 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.54 132.12 48.57 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.657 2.238 . . . . 0.0 110.755 174.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -60.62 -30.63 90.91 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.542 2.162 . . . . 0.0 113.57 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -60.19 -31.74 70.43 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.949 -1.094 . . . . 0.0 112.867 171.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -87.98 13.2 11.49 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.747 1.219 . . . . 0.0 113.631 175.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.9 t -118.86 -34.75 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 126.565 1.946 . . . . 0.0 112.168 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.0 p -80.85 12.65 3.1 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 -169.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -66.91 161.97 22.86 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.348 1.459 . . . . 0.0 112.149 170.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -60.02 -36.75 77.92 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -169.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.7 mt -115.35 117.05 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.79 0.836 . . . . 0.0 109.307 169.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -134.51 126.56 29.63 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.362 1.065 . . . . 0.0 110.372 169.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -147.24 160.46 42.46 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.802 1.641 . . . . 0.0 110.85 -173.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -126.04 133.03 51.85 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.328 0.651 . . . . 0.0 111.679 169.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -90.04 -0.42 57.58 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 63.88 39.62 8.06 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 169.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.3 mt -93.01 157.6 16.22 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -172.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -102.58 144.48 30.94 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.552 1.941 . . . . 0.0 111.223 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -73.65 121.73 85.87 Favored Pre-proline 0 N--CA 1.475 0.791 0 CA-C-N 119.463 1.029 . . . . 0.0 111.866 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -83.89 -15.32 7.05 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.702 2.268 . . . . 0.0 114.856 -172.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -51.57 109.86 0.4 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.312 1.045 . . . . 0.0 112.442 175.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.85 -0.63 84.61 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 123.804 0.716 . . . . 0.0 114.446 176.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -76.01 171.36 14.59 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 118.437 1.119 . . . . 0.0 109.863 169.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 88.1 p -65.92 156.3 33.9 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.051 -1.031 . . . . 0.0 111.707 169.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.7 mp -64.51 -28.18 69.48 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.112 -0.993 . . . . 0.0 111.725 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -59.48 -41.06 88.95 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.048 -1.032 . . . . 0.0 112.389 170.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 79.4 t -73.79 -36.69 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 O-C-N 121.24 -0.913 . . . . 0.0 110.243 175.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.02 -40.3 97.35 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.277 0.631 . . . . 0.0 111.038 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -70.45 -36.49 73.97 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 120.772 -1.205 . . . . 0.0 112.545 170.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 55.0 m -58.98 -47.63 84.46 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.866 0.867 . . . . 0.0 111.662 175.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.6 m -67.46 -29.08 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 119.784 1.175 . . . . 0.0 111.673 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -45.36 94.11 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 119.968 1.258 . . . . 0.0 110.934 169.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.23 -40.85 97.88 Favored Glycine 0 N--CA 1.474 1.232 0 CA-C-N 118.856 0.753 . . . . 0.0 112.125 174.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -67.28 -43.41 81.85 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.0 m -66.91 -40.37 85.59 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.598 0 CA-C-N 120.071 1.305 . . . . 0.0 110.53 176.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -51.43 -55.0 21.1 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 120.587 1.539 . . . . 0.0 111.464 175.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -50.33 -47.48 55.83 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.301 1.44 . . . . 0.0 112.19 177.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -89.54 -27.75 20.06 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.451 0.701 . . . . 0.0 112.423 -170.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.22 -49.85 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.027 1.331 . . . . 0.0 109.308 169.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -54.09 -54.83 34.02 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.12 0.873 . . . . 0.0 109.551 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -51.58 -37.34 49.39 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.769 1.628 . . . . 0.0 112.676 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -79.22 -61.35 2.04 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.057 0.943 . . . . 0.0 112.92 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.72 -33.76 63.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.25 1.42 . . . . 0.0 112.063 -174.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.69 -17.89 61.08 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -174.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -77.56 -15.98 58.92 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.699 1.199 . . . . 0.0 113.816 171.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.6 pt -120.88 24.72 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 126.934 2.094 . . . . 0.0 111.778 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--O 1.255 1.344 0 C-N-CA 127.824 2.45 . . . . 0.0 111.469 178.099 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 tpp . . . . . 0 N--CA 1.501 2.092 0 CA-C-O 119.362 -0.352 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -83.22 87.92 6.93 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 119.408 1.004 . . . . 0.0 111.21 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -77.94 146.87 35.26 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -171.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.2 t -108.38 143.5 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.672 1.189 . . . . 0.0 110.473 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.1 tpp -129.44 114.4 16.1 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.964 0.906 . . . . 0.0 110.919 169.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -83.31 140.89 32.2 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.642 -0.661 . . . . 0.0 110.382 169.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.5 t -135.89 127.72 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 125.165 1.386 . . . . 0.0 110.507 -175.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.0 p -144.04 -179.2 6.35 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.673 1.189 . . . . 0.0 111.932 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -60.23 -70.98 0.14 Allowed 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 119.472 1.033 . . . . 0.0 109.744 169.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.3 mtt-85 -82.8 121.39 26.85 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 169.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -66.93 -45.26 78.42 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 119.137 0.881 . . . . 0.0 108.883 169.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.4 p -48.77 -31.41 6.95 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.975 2.51 . . . . 0.0 115.829 -175.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.9 p -91.66 -96.1 0.13 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.186 1.394 . . . . 0.0 110.908 169.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -56.27 -56.25 23.35 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -168.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.2 m -69.04 -33.28 73.35 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.709 1.14 . . . . 0.0 113.034 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -66.69 -39.05 87.93 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.358 1.463 . . . . 0.0 113.17 169.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 77.2 mtp -58.85 -45.47 90.01 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.633 0.773 . . . . 0.0 110.977 170.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.56 -28.59 67.09 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 117.7 -1.143 . . . . 0.0 113.609 173.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -72.23 -46.14 57.34 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 121.464 1.938 . . . . 0.0 108.836 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.11 -50.82 62.67 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-O 118.556 -1.136 . . . . 0.0 112.343 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -61.55 -41.24 97.08 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.126 1.463 . . . . 0.0 112.782 175.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.69 -29.72 63.64 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 120.812 -1.18 . . . . 0.0 111.216 -176.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -65.31 -55.89 15.77 Favored 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 125.205 1.402 . . . . 0.0 109.977 170.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.5 p -71.09 -9.54 58.23 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 49.7 mt -101.83 -1.6 31.89 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 170.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -160.57 13.59 0.17 Allowed Glycine 0 CA--C 1.536 1.402 0 N-CA-C 118.262 2.065 . . . . 0.0 118.262 -171.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.82 -30.26 68.82 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 120.673 2.237 . . . . 0.0 114.331 -171.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.97 1.13 87.5 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 124.454 1.026 . . . . 0.0 114.949 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -112.28 -107.75 0.36 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.42 1.888 . . . . 0.0 110.407 -171.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -95.73 174.55 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 126.104 1.762 . . . . 0.0 111.492 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.6 129.13 39.97 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.22 -0.925 . . . . 0.0 112.264 175.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.1 m -99.19 148.25 6.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 124.367 1.067 . . . . 0.0 112.662 170.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.48 153.79 39.97 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.254 1.022 . . . . 0.0 111.115 -174.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.6 p -137.2 136.61 38.32 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.974 1.31 . . . . 0.0 114.163 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.5 t -140.38 -178.84 5.68 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.843 2.057 . . . . 0.0 110.746 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.88 177.97 41.86 Favored Glycine 0 CA--C 1.527 0.815 0 O-C-N 120.684 -1.26 . . . . 0.0 114.834 171.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.9 mt -62.5 -34.26 76.51 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.044 0.938 . . . . 0.0 111.725 -176.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -127.02 112.39 15.18 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.21 2.204 . . . . 0.0 107.754 169.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.5 p -61.51 -36.35 80.28 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.41 -0.806 . . . . 0.0 111.886 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.2 t 52.57 -135.22 1.54 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.943 1.297 . . . . 0.0 110.41 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -127.22 -139.59 0.26 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 126.735 2.014 . . . . 0.0 110.827 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.4 m -105.77 115.08 46.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 168.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -64.62 131.1 95.02 Favored Pre-proline 0 N--CA 1.48 1.045 0 O-C-N 121.176 -0.953 . . . . 0.0 112.378 -168.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -60.06 -37.66 82.95 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.432 2.755 . . . . 0.0 113.944 -169.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.5 m -77.78 -33.37 52.66 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.933 -0.479 . . . . 0.0 110.461 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.38 -38.79 92.27 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.073 -1.017 . . . . 0.0 112.56 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 70.4 mt -53.23 -44.46 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 120.657 1.571 . . . . 0.0 110.134 174.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.0 -58.95 4.77 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.0 mmt -65.15 -21.64 66.81 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -174.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 87.8 mmm -89.9 -38.89 13.39 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.015 0.926 . . . . 0.0 110.762 176.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -58.52 -36.61 74.09 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.577 -1.327 . . . . 0.0 112.205 169.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -54.43 -32.24 57.01 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.333 1.053 . . . . 0.0 113.672 173.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.2 m -101.6 13.98 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.694 1.198 . . . . 0.0 113.973 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.29 16.38 62.64 Favored Glycine 0 CA--C 1.535 1.337 0 O-C-N 121.184 -0.947 . . . . 0.0 114.917 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.4 mt -122.08 75.7 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.727 1.611 . . . . 0.0 109.952 -169.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -68.09 105.33 2.02 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 120.283 -1.511 . . . . 0.0 110.494 173.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.0 pt -84.35 -5.52 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.542 0.737 . . . . 0.0 112.833 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 92.4 p -64.92 -28.93 69.87 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -169.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.43 7.8 77.6 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.803 1.192 . . . . 0.0 114.58 172.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -98.87 149.83 22.52 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.196 1.398 . . . . 0.0 112.522 -169.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.8 t -85.64 145.58 27.25 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -173.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.3 m -124.49 111.65 15.96 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.352 1.061 . . . . 0.0 110.381 170.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.15 158.11 50.04 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 124.001 0.92 . . . . 0.0 113.009 177.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -95.7 150.79 1.46 Allowed 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 124.176 3.251 . . . . 0.0 111.879 169.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.38 -19.15 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 115.424 1.638 . . . . 0.0 115.424 -172.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -99.68 -7.79 25.19 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -87.92 -39.43 14.76 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.379 -0.826 . . . . 0.0 111.491 169.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.98 161.12 31.68 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.559 0.743 . . . . 0.0 111.759 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -136.56 117.21 13.93 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.388 1.075 . . . . 0.0 110.452 173.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.98 -1.76 4.48 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -171.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.91 -30.49 67.92 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.083 -1.011 . . . . 0.0 112.202 -173.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -86.14 -2.57 58.46 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.781 1.232 . . . . 0.0 113.293 177.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -124.35 90.56 3.28 Favored 'General case' 0 C--N 1.343 0.326 0 C-N-CA 125.711 1.604 . . . . 0.0 110.269 -171.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -55.18 -27.84 48.72 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.196 1.398 . . . . 0.0 113.37 -177.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.29 115.74 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 125.156 1.382 . . . . 0.0 110.541 -172.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.0 t -122.91 129.08 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.913 0.885 . . . . 0.0 110.746 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.7 mm -117.58 124.15 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.455 0.702 . . . . 0.0 111.109 -172.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.1 t -88.19 105.6 17.64 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 169.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.419 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 64.0 mt -82.91 31.89 0.43 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.805 1.642 . . . . 0.0 110.966 175.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.3 t -164.7 157.2 16.44 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.866 2.466 . . . . 0.0 109.162 -169.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -73.66 34.88 0.85 Allowed Glycine 0 CA--C 1.546 1.97 0 C-N-CA 124.185 0.898 . . . . 0.0 112.385 168.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 67.3 m -90.77 -1.81 57.83 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.764 2.425 . . . . 0.0 113.225 -169.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -49.95 -35.14 24.57 Favored Glycine 0 N--CA 1.477 1.422 0 N-CA-C 116.633 1.413 . . . . 0.0 116.633 -169.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.1 m -82.34 -16.78 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 176.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -92.84 -22.22 19.42 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.501 1.52 . . . . 0.0 112.637 175.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.6 mt -62.83 150.06 88.31 Favored Pre-proline 0 CA--C 1.549 0.923 0 O-C-N 121.384 -0.822 . . . . 0.0 111.507 171.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -59.22 132.11 44.96 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.708 2.272 . . . . 0.0 110.698 169.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -59.73 -33.23 96.46 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.468 2.112 . . . . 0.0 113.522 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -66.18 -26.64 67.5 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.72 1.145 . . . . 0.0 113.538 175.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.38 -15.96 59.11 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.772 -1.205 . . . . 0.0 112.629 171.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.8 t -90.63 -40.22 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.882 1.673 . . . . 0.0 111.725 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.1 p -81.99 27.9 0.45 Allowed 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -172.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -79.61 169.7 17.63 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.084 1.354 . . . . 0.0 112.14 170.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -55.35 -39.79 70.47 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.121 0.968 . . . . 0.0 113.431 -169.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 58.9 mt -128.31 125.06 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.594 1.157 . . . . 0.0 109.545 170.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -128.52 141.46 51.37 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.436 1.094 . . . . 0.0 110.339 169.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.37 154.54 43.11 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.215 1.006 . . . . 0.0 112.121 -171.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -129.16 113.22 14.81 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.49 1.516 . . . . 0.0 110.226 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.419 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 37.0 m0 -94.0 5.32 52.07 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -173.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 63.45 -89.12 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.497 1.519 . . . . 0.0 112.026 -173.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.7 mt 53.85 -177.96 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 127.789 2.435 . . . . 0.0 115.511 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -142.0 148.26 38.27 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.8 2.04 . . . . 0.0 108.887 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.26 119.48 77.64 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 119.654 1.115 . . . . 0.0 110.575 176.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -83.94 -6.85 10.42 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 121.912 1.742 . . . . 0.0 113.881 -171.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -45.25 112.4 0.44 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.184 1.394 . . . . 0.0 112.783 174.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.42 3.14 82.04 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 123.66 0.647 . . . . 0.0 114.375 173.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -79.88 173.18 12.85 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.103 0.961 . . . . 0.0 109.927 169.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 86.2 p -63.68 153.8 35.01 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.183 -0.948 . . . . 0.0 111.732 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.47 -29.49 70.57 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.53 -0.731 . . . . 0.0 111.497 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -67.15 -34.9 78.55 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.786 -1.196 . . . . 0.0 113.144 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 78.8 t -69.46 -37.48 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 O-C-N 121.163 -0.96 . . . . 0.0 109.611 170.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.52 -39.08 93.11 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.717 0.807 . . . . 0.0 111.109 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -71.69 -38.09 70.63 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.062 1.345 . . . . 0.0 112.376 171.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 51.7 m -57.84 -48.1 80.75 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.608 1.095 . . . . 0.0 111.525 177.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.4 m -69.3 -29.92 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.937 176.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.28 -42.86 99.35 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 120.155 1.343 . . . . 0.0 111.515 169.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.76 -42.13 95.37 Favored Glycine 0 N--CA 1.476 1.331 0 C-N-CA 124.253 0.93 . . . . 0.0 112.661 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -63.32 -48.18 79.09 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.127 -0.631 . . . . 0.0 112.218 171.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.0 t -58.52 -44.9 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.633 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -52.37 -54.55 30.36 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 120.046 1.293 . . . . 0.0 111.51 175.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -61.76 -43.38 98.97 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.13 0.572 . . . . 0.0 112.209 -176.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 49.3 mtp85 -76.16 -31.86 58.76 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 36.8 t -61.87 -49.01 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.532 1.133 . . . . 0.0 110.591 170.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -53.62 -54.75 33.17 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.018 0.827 . . . . 0.0 109.701 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -55.19 -31.59 61.53 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.374 1.47 . . . . 0.0 112.9 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -81.83 -59.97 2.4 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.035 -1.04 . . . . 0.0 112.704 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.24 -32.68 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.789 1.236 . . . . 0.0 111.691 -176.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.58 -0.39 33.39 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -90.88 -15.65 29.55 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.809 1.244 . . . . 0.0 113.51 170.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.5 pt -121.31 8.43 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 126.188 1.795 . . . . 0.0 113.041 -176.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.4 p . . . . . 0 C--O 1.254 1.323 0 C-N-CA 126.446 1.898 . . . . 0.0 113.815 171.92 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.9 ttm . . . . . 0 N--CA 1.501 2.084 0 CA-C-O 119.325 -0.369 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -86.35 107.1 17.84 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 169.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -82.11 144.87 30.47 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 118.077 0.398 . . . . 0.0 110.907 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.0 t -101.66 142.22 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.672 0.789 . . . . 0.0 109.804 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.418 ' HE1' ' CD2' ' A' ' 68' ' ' PHE . 42.3 tpp -127.97 118.27 23.26 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.692 0.797 . . . . 0.0 110.754 169.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -89.67 138.51 31.41 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.88 -0.512 . . . . 0.0 110.834 169.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 t -130.17 129.32 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.546 1.538 . . . . 0.0 109.631 -171.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.7 m -141.14 171.48 14.0 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.002 1.321 . . . . 0.0 110.503 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -66.0 -49.28 68.34 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 119.91 1.232 . . . . 0.0 108.934 169.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -103.67 114.08 28.07 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 167.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.518 ' ND2' ' H ' ' A' ' 63' ' ' ASP . 31.1 t-20 -51.92 -48.51 64.17 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 120.474 1.488 . . . . 0.0 109.673 172.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.0 p -53.17 -32.85 49.91 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.1 p -78.37 -33.58 48.85 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -174.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 -140.34 -55.79 0.53 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.903 0.881 . . . . 0.0 112.488 -170.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 m -55.71 -40.86 73.0 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 120.087 1.312 . . . . 0.0 113.333 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -66.91 -35.43 79.98 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.698 1.599 . . . . 0.0 113.46 173.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.5 mtm -64.92 -50.43 66.52 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.782 -0.574 . . . . 0.0 110.565 172.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.8 -26.19 67.58 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.415 -0.803 . . . . 0.0 113.011 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -71.4 -49.44 42.0 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 119.507 1.048 . . . . 0.0 108.45 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.462 ' CA ' HE22 ' A' ' 60' ' ' GLN . . . -63.32 -41.62 99.43 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 119.245 -0.753 . . . . 0.0 112.953 177.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -62.45 -43.32 99.1 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.287 1.544 . . . . 0.0 112.22 172.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.64 -35.96 67.89 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.683 -1.26 . . . . 0.0 110.863 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -57.73 -49.6 76.0 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.344 1.858 . . . . 0.0 110.833 171.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.4 p -78.67 -24.46 45.11 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.868 1.432 . . . . 0.0 114.868 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.8 mt -89.5 -28.19 19.82 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.157 0.89 . . . . 0.0 113.045 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.74 -68.74 1.15 Allowed Glycine 0 N--CA 1.473 1.118 0 C-N-CA 124.711 1.148 . . . . 0.0 112.065 175.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 54.32 90.83 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.176 2.59 . . . . 0.0 115.462 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.85 -7.25 78.15 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 116.299 1.28 . . . . 0.0 116.299 169.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -68.85 -47.19 66.56 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 118.898 1.349 . . . . 0.0 110.817 174.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.6 pp -140.35 -176.06 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 127.749 2.42 . . . . 0.0 110.479 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.13 128.52 55.08 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.52 0.676 . . . . 0.0 112.551 172.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.5 m -95.16 151.48 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 124.592 1.157 . . . . 0.0 112.907 170.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.14 156.45 42.6 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.672 0.789 . . . . 0.0 111.41 -172.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 97.5 p -126.77 142.37 51.56 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.169 1.388 . . . . 0.0 114.023 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.6 t -145.77 170.78 15.85 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 126.897 2.079 . . . . 0.0 109.874 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.24 171.11 34.6 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 120.883 -1.136 . . . . 0.0 114.358 170.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 38.3 mt -62.17 -35.18 78.01 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 117.4 0.6 . . . . 0.0 111.812 -174.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -125.08 122.05 36.08 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.559 2.744 . . . . 0.0 106.545 169.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 55.4 p -73.07 -41.88 63.64 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.842 -1.162 . . . . 0.0 111.024 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.5 t 55.49 -167.51 0.1 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 126.282 1.833 . . . . 0.0 113.877 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -94.0 168.79 10.73 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 126.936 2.094 . . . . 0.0 112.29 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.6 m -61.15 114.16 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 169.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -71.04 132.19 86.68 Favored Pre-proline 0 N--CA 1.476 0.864 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -168.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -57.77 -39.72 84.99 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.951 3.1 . . . . 0.0 114.305 -173.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.3 m -80.31 -37.59 32.34 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.776 -0.578 . . . . 0.0 110.626 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.28 96.54 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.267 0.939 . . . . 0.0 112.076 175.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.0 mt -48.95 -49.09 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 120.132 1.333 . . . . 0.0 110.376 171.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.03 -58.13 7.6 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.6 mmt -65.71 -22.46 66.61 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -172.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 76.6 mmm -90.28 -40.01 12.41 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.372 1.469 . . . . 0.0 110.998 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -57.78 -35.47 70.84 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.83 -1.169 . . . . 0.0 112.348 170.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -53.41 -32.44 49.64 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.469 1.107 . . . . 0.0 113.064 170.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -94.85 5.98 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.703 1.201 . . . . 0.0 113.521 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.97 15.55 64.91 Favored Glycine 0 CA--C 1.538 1.498 0 O-C-N 120.916 -1.115 . . . . 0.0 114.433 -173.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.4 mt -121.04 61.64 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.95 1.7 . . . . 0.0 109.651 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -62.24 110.46 1.63 Allowed 'General case' 0 CA--C 1.548 0.893 0 O-C-N 120.082 -1.636 . . . . 0.0 110.892 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.6 pt -85.89 -4.5 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 118.496 -0.764 . . . . 0.0 112.941 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.5 t -61.79 -33.86 74.86 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.159 1.345 . . . . 0.0 112.731 -171.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.49 10.08 66.92 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.133 1.349 . . . . 0.0 115.432 172.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.462 HE22 ' CA ' ' A' ' 20' ' ' GLY . 5.8 tt0 -101.74 163.03 12.47 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.911 1.284 . . . . 0.0 112.838 -170.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 p -72.94 158.75 34.87 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.022 1.729 . . . . 0.0 115.408 -170.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.8 t -151.31 148.14 27.8 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.153 2.181 . . . . 0.0 108.466 168.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.518 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 1.0 OUTLIER -149.36 147.91 24.79 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.672 1.189 . . . . 0.0 111.201 178.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -90.3 152.19 4.55 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.679 2.92 . . . . 0.0 111.854 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 tt -65.31 -18.78 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -171.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -98.22 -7.21 29.69 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -88.47 -38.98 14.56 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.585 0.629 . . . . 0.0 111.436 169.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.418 ' CD2' ' HE1' ' A' ' 5' ' ' MET . 0.0 OUTLIER -72.87 161.8 30.27 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.697 0.799 . . . . 0.0 112.241 173.34 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.94 123.51 17.23 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.271 1.028 . . . . 0.0 110.926 169.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.94 2.43 3.5 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -169.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -67.58 -28.6 67.91 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.341 -0.85 . . . . 0.0 112.437 -173.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -93.4 -2.31 54.82 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.157 1.383 . . . . 0.0 113.28 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -123.43 80.12 1.75 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.196 1.798 . . . . 0.0 109.878 -170.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -59.41 -21.29 59.74 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.707 1.203 . . . . 0.0 114.087 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.6 t -117.91 109.6 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.869 1.268 . . . . 0.0 110.015 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.8 t -121.21 129.37 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.819 0.848 . . . . 0.0 111.233 -176.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.1 mm -119.7 118.35 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 O-C-N 121.534 -0.729 . . . . 0.0 111.233 -171.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.3 t -82.85 105.8 14.16 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 168.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.428 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 85.4 mt -79.07 -32.38 44.74 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.622 -0.674 . . . . 0.0 111.135 177.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 31.7 p -71.58 158.29 36.46 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 122.993 0.517 . . . . 0.0 110.41 169.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.69 37.71 1.88 Allowed Glycine 0 CA--C 1.54 1.648 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 168.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 5.5 p -127.38 20.82 6.71 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.486 1.914 . . . . 0.0 114.124 -169.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -55.6 -36.3 64.31 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.699 1.143 . . . . 0.0 114.651 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.1 m -69.55 -13.51 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.03 -2.64 49.86 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.485 1.514 . . . . 0.0 112.568 176.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.5 mt -78.68 158.28 75.94 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.991 0.917 . . . . 0.0 111.371 173.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.32 133.43 54.97 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.852 2.368 . . . . 0.0 111.68 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -60.59 -31.03 91.76 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.795 2.33 . . . . 0.0 113.62 -174.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -65.48 -30.01 70.74 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.729 -1.232 . . . . 0.0 113.264 173.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.35 -19.94 49.01 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.855 -1.153 . . . . 0.0 112.688 173.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.6 t -87.73 -34.39 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.047 1.739 . . . . 0.0 112.41 176.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.6 p -88.59 25.83 1.62 Allowed 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -171.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -77.2 168.35 20.21 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.508 1.123 . . . . 0.0 112.263 169.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -55.72 -38.59 69.95 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -169.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 59.7 mt -126.03 123.51 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.717 1.207 . . . . 0.0 108.872 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -128.24 140.87 51.66 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.097 0.959 . . . . 0.0 110.702 169.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.84 154.95 44.67 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.671 1.188 . . . . 0.0 112.093 -171.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -130.13 115.45 17.07 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.9 1.28 . . . . 0.0 110.89 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.428 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 35.7 m0 -98.51 -1.63 40.72 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.457 1.103 . . . . 0.0 113.792 -175.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.32 1.2 pp0? 44.75 41.73 5.29 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 172.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.8 mt -84.42 134.25 34.47 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.984 1.313 . . . . 0.0 112.977 -177.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -64.74 153.87 38.51 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.987 1.315 . . . . 0.0 111.977 172.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -81.72 116.74 64.98 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 121.192 -0.942 . . . . 0.0 112.832 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -84.52 -27.27 1.42 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.794 2.329 . . . . 0.0 115.103 -169.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -70.97 81.7 0.66 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.667 1.987 . . . . 0.0 111.949 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 141.17 -10.66 2.78 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 126.496 1.998 . . . . 0.0 113.785 -174.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -91.39 175.8 6.79 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.845 1.658 . . . . 0.0 111.624 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 96.9 p -70.86 159.77 34.0 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.628 -0.67 . . . . 0.0 111.581 169.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.9 -31.04 72.02 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.463 -0.773 . . . . 0.0 112.194 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.08 -40.89 95.41 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.05 -1.031 . . . . 0.0 112.283 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 94.0 t -72.93 -35.91 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.626 0.77 . . . . 0.0 110.47 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -60.15 -49.76 76.38 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.781 0.832 . . . . 0.0 110.638 173.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 66.4 mtt85 -63.14 -23.54 67.48 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.307 1.443 . . . . 0.0 113.453 173.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 57.4 m -75.63 -55.32 5.78 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.624 1.169 . . . . 0.0 111.412 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 19.2 m -65.54 -32.31 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 119.82 1.191 . . . . 0.0 110.762 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.47 -43.75 89.06 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 126.606 1.962 . . . . 0.0 112.939 169.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.43 -38.4 86.83 Favored Glycine 0 N--CA 1.476 1.323 0 C-N-CA 123.964 0.792 . . . . 0.0 113.392 174.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -61.94 -43.31 99.1 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.512 -0.993 . . . . 0.0 111.814 169.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 32.5 t -58.58 -47.65 87.91 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 CA-C-O 117.861 -1.066 . . . . 0.0 109.772 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -49.81 -55.36 14.43 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.866 1.212 . . . . 0.0 111.571 175.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -61.1 -43.75 98.41 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.5 mtp85 -76.12 -33.55 59.45 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.6 t -63.56 -46.09 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.122 0.969 . . . . 0.0 111.224 172.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -52.49 -54.97 25.46 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.246 0.93 . . . . 0.0 109.943 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -55.17 -37.75 67.42 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.783 1.233 . . . . 0.0 112.676 176.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -74.79 -57.28 4.01 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.18 -0.95 . . . . 0.0 112.752 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.56 -34.53 71.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.692 1.197 . . . . 0.0 112.168 -177.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.57 -15.8 60.83 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -173.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -73.43 -31.03 63.6 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.43 1.092 . . . . 0.0 113.382 170.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.9 pt -107.64 -7.15 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.323 1.449 . . . . 0.0 113.389 -174.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.9 m . . . . . 0 C--O 1.253 1.282 0 C-N-CA 125.779 1.632 . . . . 0.0 112.711 171.007 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 ttm . . . . . 0 N--CA 1.503 2.208 0 CA-C-O 119.77 -0.157 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -85.73 82.33 8.24 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.212 1.005 . . . . 0.0 110.777 173.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -72.18 139.23 48.14 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.208 1.003 . . . . 0.0 111.714 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.9 t -113.2 146.25 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.291 1.036 . . . . 0.0 111.657 -173.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.2 tpp -132.91 122.59 24.56 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.188 0.995 . . . . 0.0 111.573 169.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -95.88 134.86 38.36 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.267 1.027 . . . . 0.0 111.387 169.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.1 t -128.63 130.16 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.968 1.307 . . . . 0.0 111.436 -170.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.0 p -149.28 179.49 7.88 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.471 1.108 . . . . 0.0 111.953 173.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -66.33 -61.92 1.75 Allowed 'General case' 0 N--CA 1.483 1.208 0 O-C-N 120.79 -1.194 . . . . 0.0 111.102 173.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.32 110.98 19.01 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.223 1.009 . . . . 0.0 109.197 169.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -61.68 -34.96 76.67 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.156 0.889 . . . . 0.0 110.331 169.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.3 p -48.47 -37.89 18.53 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.828 2.451 . . . . 0.0 115.836 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.9 p -97.62 -92.39 0.24 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.329 1.052 . . . . 0.0 111.329 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.69 -54.24 49.13 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 120.924 -1.11 . . . . 0.0 113.764 -169.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.5 m -63.6 -42.29 98.27 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.136 0.88 . . . . 0.0 111.868 -176.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -60.74 -39.82 90.11 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.447 1.499 . . . . 0.0 114.564 169.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 78.4 mtp -64.43 -45.97 85.21 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.167 0.894 . . . . 0.0 110.748 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.0 -25.78 64.68 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 172.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -67.27 -53.27 31.4 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.051 1.296 . . . . 0.0 108.168 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.56 -43.55 96.37 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 118.714 -1.048 . . . . 0.0 112.266 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -63.27 -43.41 98.04 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.852 1.826 . . . . 0.0 112.21 172.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.86 -35.56 64.78 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.198 1.363 . . . . 0.0 110.923 -173.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -60.44 -59.22 5.74 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.38 1.472 . . . . 0.0 109.378 169.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.0 p -66.5 -13.58 61.09 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.5 mt -97.87 -5.59 34.23 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 172.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.66 15.69 0.11 Allowed Glycine 0 CA--C 1.536 1.36 0 N-CA-C 118.304 2.081 . . . . 0.0 118.304 -171.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.69 -34.54 59.1 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 119.696 1.748 . . . . 0.0 114.643 -170.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.49 -5.58 86.76 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.38 0.99 . . . . 0.0 115.319 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -99.52 -60.87 1.45 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 118.632 1.216 . . . . 0.0 111.947 -170.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -139.85 170.64 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 126.846 2.059 . . . . 0.0 110.319 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.67 125.13 39.12 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 122.122 0.963 . . . . 0.0 111.275 175.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.2 m -92.79 153.61 3.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.901 169.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.73 149.94 34.39 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.435 0.694 . . . . 0.0 111.71 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.4 p -119.92 139.34 52.57 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.994 2.118 . . . . 0.0 113.347 171.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.9 p -144.88 172.86 12.43 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.015 1.326 . . . . 0.0 110.777 169.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.68 -179.82 44.58 Favored Glycine 0 CA--C 1.52 0.367 0 O-C-N 120.383 -1.448 . . . . 0.0 114.569 171.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 34.7 mt -63.69 -30.07 71.22 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.78 0.432 . . . . 0.0 111.532 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -121.39 123.79 42.95 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.877 2.071 . . . . 0.0 108.948 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.3 p -77.8 43.23 0.41 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.92 1.688 . . . . 0.0 111.898 175.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.9 p -63.14 155.01 29.3 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.564 1.545 . . . . 0.0 113.337 -169.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -65.68 177.66 1.19 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.819 1.647 . . . . 0.0 114.471 -169.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 m -63.45 110.33 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 119.866 -1.771 . . . . 0.0 109.617 169.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -67.9 135.46 92.06 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-O 118.413 -0.803 . . . . 0.0 112.414 -169.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -58.79 -39.92 77.38 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.367 2.711 . . . . 0.0 113.795 -174.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.7 m -77.44 -37.87 50.67 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.869 0.468 . . . . 0.0 110.581 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.04 -41.83 97.26 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 118.143 -0.932 . . . . 0.0 112.448 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 66.8 mt -50.8 -47.01 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 120.482 1.492 . . . . 0.0 110.426 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.99 -59.76 3.8 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 175.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 31.0 mmt -67.29 -20.88 65.69 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -172.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 83.9 mmm -90.15 -37.52 14.14 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.721 0.809 . . . . 0.0 110.619 175.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -58.53 -36.46 73.88 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.58 -1.325 . . . . 0.0 112.129 169.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -54.25 -32.75 56.85 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.162 0.985 . . . . 0.0 113.59 172.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.6 m -100.67 13.18 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 124.818 1.247 . . . . 0.0 114.19 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.14 17.2 59.6 Favored Glycine 0 N--CA 1.476 1.329 0 O-C-N 121.047 -1.033 . . . . 0.0 114.896 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.0 mt -126.6 64.49 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.894 1.678 . . . . 0.0 109.965 -169.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -63.47 109.16 1.54 Allowed 'General case' 0 CA--C 1.545 0.759 0 O-C-N 119.985 -1.697 . . . . 0.0 110.905 173.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.1 pt -83.98 -4.89 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 118.36 -0.828 . . . . 0.0 113.04 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -60.13 -30.1 69.07 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 120.495 1.498 . . . . 0.0 113.502 -169.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.36 5.53 71.02 Favored Glycine 0 CA--C 1.541 1.667 0 C-N-CA 124.82 1.2 . . . . 0.0 115.534 173.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -98.82 140.37 33.11 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.11 1.455 . . . . 0.0 112.324 -171.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.8 t -71.21 155.83 40.27 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -173.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.1 m -128.37 143.2 50.97 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.738 1.615 . . . . 0.0 110.49 169.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -138.15 150.86 68.46 Favored Pre-proline 0 N--CA 1.485 1.295 0 CA-C-N 119.616 1.098 . . . . 0.0 113.36 -172.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -88.92 151.03 5.88 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.533 2.155 . . . . 0.0 112.165 177.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.5 tt -62.57 -17.83 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 125.125 1.37 . . . . 0.0 114.55 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.26 -8.05 27.98 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -87.68 -38.89 15.45 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.077 0.853 . . . . 0.0 111.258 170.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.11 157.52 38.04 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.392 0.677 . . . . 0.0 111.409 172.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.25 121.24 13.66 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.721 0.809 . . . . 0.0 111.156 170.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.16 1.79 1.89 Allowed 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -170.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -67.06 -28.1 67.92 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.147 -0.97 . . . . 0.0 111.979 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -93.8 -1.13 55.39 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.41 1.484 . . . . 0.0 113.418 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -130.24 91.62 3.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.615 1.566 . . . . 0.0 110.586 -171.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -59.62 -21.25 60.17 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.7 t -123.28 108.13 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.956 1.302 . . . . 0.0 110.41 -169.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.6 t -125.58 127.6 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.674 0.79 . . . . 0.0 111.452 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.6 mp -118.86 130.93 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.39 1.076 . . . . 0.0 110.206 -170.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.7 t -90.32 124.88 35.28 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.912 1.285 . . . . 0.0 108.092 168.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.426 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 76.1 mt -104.24 23.44 13.09 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.824 1.649 . . . . 0.0 112.572 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 27.1 p -124.26 -176.92 3.63 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.705 2.002 . . . . 0.0 108.533 169.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.47 38.87 2.94 Favored Glycine 0 CA--C 1.538 1.531 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 168.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.0 p -136.55 16.72 3.13 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -168.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -54.14 -30.34 46.87 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 119.933 1.242 . . . . 0.0 115.872 -171.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.2 m -68.87 -15.52 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 175.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -83.19 -14.19 53.9 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.87 1.268 . . . . 0.0 112.99 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.8 mt -68.81 158.29 86.38 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 123.584 0.754 . . . . 0.0 111.432 174.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.67 132.77 53.82 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.703 2.269 . . . . 0.0 111.076 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -59.71 -33.95 96.29 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.426 2.084 . . . . 0.0 113.502 -171.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -64.62 -28.6 69.73 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.704 -1.247 . . . . 0.0 113.325 174.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.64 -4.52 52.02 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.797 -1.19 . . . . 0.0 112.859 172.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 72.3 t -104.78 -41.54 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.452 1.901 . . . . 0.0 111.391 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.3 p -82.04 49.12 1.33 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.637 1.175 . . . . 0.0 113.517 -173.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -104.64 170.31 7.96 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.282 1.833 . . . . 0.0 111.945 176.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -58.38 -37.25 74.87 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.736 0.815 . . . . 0.0 112.89 -170.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 56.2 mt -128.48 120.61 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.95 1.3 . . . . 0.0 108.512 169.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -130.37 138.11 50.23 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.03 0.932 . . . . 0.0 110.857 169.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -140.08 151.06 45.07 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.88 1.272 . . . . 0.0 112.05 -175.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -123.55 99.97 6.57 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.924 1.29 . . . . 0.0 109.886 175.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.426 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 39.5 m0 -79.37 -4.55 51.51 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -170.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.372 1.1 pp0? 50.4 37.55 15.83 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.034 1.734 . . . . 0.0 115.586 170.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 69.3 mt -75.5 157.82 33.45 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.834 1.254 . . . . 0.0 112.352 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -85.19 161.48 19.59 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.961 1.304 . . . . 0.0 111.438 170.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -89.52 122.03 68.67 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.511 1.124 . . . . 0.0 112.141 175.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -93.82 -18.69 0.5 Allowed 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 121.688 1.592 . . . . 0.0 114.872 -169.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -44.15 108.11 0.11 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.007 2.123 . . . . 0.0 113.355 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.22 8.58 62.27 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.544 1.069 . . . . 0.0 115.606 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -79.24 -65.75 0.96 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.004 1.402 . . . . 0.0 111.279 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.6 t -170.44 151.71 3.78 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.603 1.961 . . . . 0.0 109.247 171.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.2 mp -59.85 -29.09 68.06 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.204 0.602 . . . . 0.0 111.218 172.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.95 -39.88 95.98 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.95 -1.094 . . . . 0.0 112.332 173.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 86.4 t -71.61 -39.45 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.655 0.782 . . . . 0.0 109.254 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.35 -44.49 94.67 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.14 0.976 . . . . 0.0 111.739 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 -68.7 -37.39 79.49 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.201 -0.937 . . . . 0.0 112.092 172.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 64.0 m -58.58 -49.46 77.38 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 119.007 0.821 . . . . 0.0 111.674 175.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.8 m -69.97 -30.17 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 117.847 -1.073 . . . . 0.0 112.186 176.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -42.66 94.94 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 120.595 1.543 . . . . 0.0 111.595 169.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.68 -42.62 95.28 Favored Glycine 0 N--CA 1.474 1.175 0 C-N-CA 124.017 0.817 . . . . 0.0 112.758 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -62.32 -47.48 84.06 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 122.172 -0.605 . . . . 0.0 112.057 171.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 36.2 t -60.25 -45.32 96.37 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.059 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -52.47 -53.96 38.71 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 119.92 1.236 . . . . 0.0 111.843 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.21 -45.89 91.34 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.863 0.465 . . . . 0.0 112.08 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.9 mtt-85 -71.61 -33.29 68.87 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.1 t -65.2 -47.62 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.941 171.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -53.64 -54.32 39.34 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.604 1.093 . . . . 0.0 109.658 174.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -54.42 -37.33 64.97 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.206 1.003 . . . . 0.0 112.704 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -78.0 -57.56 3.73 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.213 0.915 . . . . 0.0 112.278 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.71 -32.69 59.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.666 1.187 . . . . 0.0 112.281 -176.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.77 -18.44 58.44 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -174.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -72.28 -21.89 61.29 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.551 1.141 . . . . 0.0 113.42 170.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.2 pt -114.76 20.48 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 126.504 1.921 . . . . 0.0 112.287 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.255 1.361 0 C-N-CA 127.759 2.424 . . . . 0.0 111.528 176.174 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.7 ttp . . . . . 0 N--CA 1.503 2.181 0 CA-C-O 119.889 -0.1 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -85.61 106.32 16.83 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.227 0.611 . . . . 0.0 109.972 171.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -77.84 149.61 34.33 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.144 0.578 . . . . 0.0 110.973 176.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 56.8 t -107.85 143.5 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.207 1.003 . . . . 0.0 110.226 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 58.4 tpp -130.55 116.22 17.85 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.483 0.713 . . . . 0.0 109.857 169.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -86.75 142.15 28.35 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.705 -0.622 . . . . 0.0 110.541 169.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.8 t -133.06 128.92 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.663 1.185 . . . . 0.0 111.562 -174.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.3 p -145.95 175.64 10.29 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.688 0.795 . . . . 0.0 111.564 169.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -61.21 -36.35 79.67 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 120.901 -1.125 . . . . 0.0 112.212 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -108.21 136.11 48.42 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.234 1.413 . . . . 0.0 111.113 169.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -98.29 -0.15 44.49 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.792 0.724 . . . . 0.0 110.971 168.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.4 p -74.51 -24.94 59.07 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.117 1.367 . . . . 0.0 112.936 169.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 t -133.49 -164.61 1.51 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.481 1.913 . . . . 0.0 109.73 174.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 41.03 -80.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 128.685 2.794 . . . . 0.0 116.159 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.0 p -56.37 -44.26 80.01 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.148 0.979 . . . . 0.0 112.347 173.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -63.64 -35.51 80.75 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 120.068 1.304 . . . . 0.0 113.408 168.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 87.8 mtp -61.45 -47.08 87.36 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.082 0.855 . . . . 0.0 110.177 176.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.76 -29.03 68.14 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 118.043 -0.98 . . . . 0.0 113.129 175.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -65.06 -54.28 32.55 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 120.277 1.398 . . . . 0.0 108.747 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.96 -45.66 96.15 Favored Glycine 0 CA--C 1.521 0.462 0 CA-C-O 118.882 -0.955 . . . . 0.0 112.814 -176.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.48 -33.85 73.19 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.155 0.977 . . . . 0.0 112.464 172.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.73 -37.52 49.13 Favored 'General case' 0 C--O 1.225 -0.189 0 O-C-N 121.256 -0.903 . . . . 0.0 111.607 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -69.17 -40.78 77.93 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.77 1.168 . . . . 0.0 112.358 169.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.1 p -67.52 -6.35 19.37 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 121.489 1.95 . . . . 0.0 114.516 171.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.6 mt -111.62 0.01 16.24 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 171.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.7 16.52 0.22 Allowed Glycine 0 CA--C 1.536 1.37 0 N-CA-C 116.712 1.445 . . . . 0.0 116.712 -169.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.98 129.43 41.91 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.823 1.312 . . . . 0.0 111.634 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.49 -3.65 58.59 Favored Glycine 0 CA--C 1.539 1.531 0 CA-C-O 118.526 -1.152 . . . . 0.0 115.691 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -83.84 -58.47 2.78 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 119.675 1.738 . . . . 0.0 110.892 176.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -141.03 177.4 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.936 2.095 . . . . 0.0 110.898 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.93 109.32 21.7 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.131 -0.98 . . . . 0.0 111.672 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.0 t -85.74 135.75 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 125.757 1.623 . . . . 0.0 111.65 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.85 159.29 43.71 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.173 0.989 . . . . 0.0 112.984 -176.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.8 p -141.71 154.1 45.08 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.658 1.583 . . . . 0.0 114.564 172.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.4 p -151.54 -179.18 7.18 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 126.41 1.884 . . . . 0.0 111.184 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.32 178.97 48.28 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 120.309 -1.494 . . . . 0.0 115.417 176.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 35.0 mt -71.51 -44.31 64.88 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -170.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -116.94 87.59 2.73 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.818 2.447 . . . . 0.0 106.018 169.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.2 p -54.51 -46.46 73.49 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.656 -0.653 . . . . 0.0 111.74 -171.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.7 t 56.57 -166.18 0.13 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.478 1.911 . . . . 0.0 113.476 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -78.24 -153.4 0.06 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.978 2.111 . . . . 0.0 111.863 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.8 m -98.28 125.69 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.12 1.768 . . . . 0.0 106.848 168.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -71.53 131.53 86.28 Favored Pre-proline 0 N--CA 1.478 0.938 0 O-C-N 120.516 -1.365 . . . . 0.0 113.2 -168.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -59.35 -38.82 82.22 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.338 2.692 . . . . 0.0 113.84 -172.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.404 ' HB ' ' CE2' ' A' ' 112' ' ' PHE . 9.1 m -79.64 -36.22 38.17 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.838 -0.539 . . . . 0.0 110.608 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.54 -40.2 95.17 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.956 -1.09 . . . . 0.0 112.383 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 52.1 mt -52.7 -43.68 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 120.847 1.658 . . . . 0.0 110.652 173.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.42 -59.41 4.38 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 174.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.6 mmt -65.98 -21.81 66.43 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -173.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 82.7 mmm -89.79 -37.1 14.74 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.062 0.945 . . . . 0.0 111.238 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -60.8 -35.74 77.24 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.691 1.132 . . . . 0.0 111.572 170.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -55.37 -27.95 50.73 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 171.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.9 m -108.08 20.57 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 125.01 1.324 . . . . 0.0 113.934 175.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.09 11.92 75.06 Favored Glycine 0 CA--C 1.536 1.362 0 O-C-N 121.222 -0.924 . . . . 0.0 115.291 173.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.4 mt -122.84 87.67 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.513 1.525 . . . . 0.0 109.093 -169.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -70.66 111.33 6.06 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 120.315 -1.491 . . . . 0.0 110.419 170.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.7 pt -86.34 -6.28 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 O-C-N 121.496 -0.753 . . . . 0.0 112.608 175.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.3 t -63.78 -30.78 71.84 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 120.007 1.276 . . . . 0.0 112.736 -173.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.95 4.78 75.47 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 125.318 1.437 . . . . 0.0 115.508 171.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -78.06 147.77 34.59 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.108 1.454 . . . . 0.0 111.581 -175.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 10.8 t -62.76 147.47 49.69 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.588 -0.695 . . . . 0.0 112.084 174.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.5 t -127.94 131.98 49.28 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.839 0.856 . . . . 0.0 109.874 169.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -145.33 136.22 12.36 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.899 0.88 . . . . 0.0 113.087 -169.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -84.47 154.23 12.15 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.405 2.737 . . . . 0.0 113.11 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.0 tp -61.56 -18.67 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -103.98 -8.89 19.27 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -86.27 -35.18 20.1 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.297 0.953 . . . . 0.0 110.837 169.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.02 156.0 40.15 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 122.971 0.508 . . . . 0.0 110.702 170.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.1 121.05 15.56 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.557 0.743 . . . . 0.0 110.747 170.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.72 1.68 2.35 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -170.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -69.28 -27.08 65.1 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.343 -0.848 . . . . 0.0 111.918 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -93.33 -2.58 54.71 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.576 1.55 . . . . 0.0 113.225 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -127.1 84.37 2.26 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.998 1.719 . . . . 0.0 109.955 -172.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.69 -18.39 41.92 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.4 t -120.89 111.2 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 125.515 1.526 . . . . 0.0 109.762 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.4 t -126.34 121.39 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 121.611 -0.68 . . . . 0.0 110.476 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 mp -113.15 135.05 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.277 1.031 . . . . 0.0 109.958 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.0 m -95.8 148.4 22.63 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.604 1.162 . . . . 0.0 109.972 169.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.417 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 87.6 mt -129.09 44.21 3.01 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.065 0.946 . . . . 0.0 110.169 -171.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 22.5 p -151.85 -10.03 0.2 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 -169.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.9 31.06 77.07 Favored Glycine 0 CA--C 1.539 1.558 0 CA-C-N 119.553 1.069 . . . . 0.0 111.057 -168.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 2.4 p -139.74 2.09 1.95 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.234 1.814 . . . . 0.0 114.48 -169.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -54.08 -27.27 37.68 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 116.416 1.326 . . . . 0.0 116.416 -170.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.3 m -63.97 -15.34 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 118.673 1.236 . . . . 0.0 113.954 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -80.15 -11.01 59.79 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.042 1.337 . . . . 0.0 113.417 175.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.3 mt -73.58 160.41 82.31 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.91 0.884 . . . . 0.0 111.743 177.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -54.79 138.12 76.07 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.066 2.51 . . . . 0.0 111.827 173.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -59.02 -34.26 99.02 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.359 2.039 . . . . 0.0 113.628 -172.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -65.99 -26.77 67.71 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.817 -1.177 . . . . 0.0 113.692 174.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.38 -15.81 59.18 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.631 -1.293 . . . . 0.0 113.027 170.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.6 t -93.51 -37.75 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 126.548 1.939 . . . . 0.0 112.162 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.8 p -83.97 18.13 2.16 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -172.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -70.22 162.36 28.57 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.496 1.118 . . . . 0.0 112.359 169.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -55.47 -35.19 65.23 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.108 1.363 . . . . 0.0 113.781 -169.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.9 mt -127.9 118.79 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.812 1.245 . . . . 0.0 108.15 169.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -132.57 128.01 36.29 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.121 0.968 . . . . 0.0 111.298 170.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -147.51 161.96 40.04 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.805 1.642 . . . . 0.0 111.075 -174.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -129.94 129.96 44.5 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.557 0.743 . . . . 0.0 111.672 169.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.417 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 46.3 m0 -90.06 1.93 55.79 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -177.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 71.44 -72.35 0.12 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.44 1.896 . . . . 0.0 113.256 175.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 20.5 mt 50.14 -157.97 0.09 Allowed 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 126.143 1.777 . . . . 0.0 114.221 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -144.06 156.66 44.46 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.828 2.451 . . . . 0.0 108.045 172.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -80.13 120.04 78.43 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-N 120.683 1.583 . . . . 0.0 111.887 176.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -91.31 -21.69 0.63 Allowed 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 122.249 1.966 . . . . 0.0 115.746 -169.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -53.44 110.16 0.53 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.507 1.123 . . . . 0.0 112.403 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.73 1.43 87.32 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.068 0.842 . . . . 0.0 114.749 176.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -75.05 170.07 16.75 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.584 1.192 . . . . 0.0 110.822 169.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.2 t -63.31 148.27 48.76 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.531 -0.73 . . . . 0.0 110.361 169.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 mp -61.43 -27.86 68.85 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.604 -0.685 . . . . 0.0 112.485 -173.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.85 -34.76 78.02 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.998 -1.064 . . . . 0.0 113.444 171.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.2 t -71.12 -35.72 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 O-C-N 120.975 -1.078 . . . . 0.0 109.885 172.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.404 ' CE2' ' HB ' ' A' ' 45' ' ' THR . 0.3 OUTLIER -67.7 -38.52 83.77 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.322 0.649 . . . . 0.0 111.125 177.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -70.25 -37.38 74.93 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.994 1.318 . . . . 0.0 111.739 170.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.6 m -57.51 -45.88 84.43 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 119.118 0.872 . . . . 0.0 111.66 175.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.0 m -69.33 -29.91 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 119.723 1.147 . . . . 0.0 112.609 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -62.44 -41.75 98.95 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 120.542 1.519 . . . . 0.0 111.77 170.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.07 -45.41 87.51 Favored Glycine 0 N--CA 1.474 1.195 0 C-N-CA 124.039 0.828 . . . . 0.0 112.745 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -60.56 -40.53 91.96 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 122.197 -0.59 . . . . 0.0 112.375 171.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.2 t -64.99 -46.76 90.58 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.103 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -52.03 -53.15 45.45 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 120.141 1.337 . . . . 0.0 111.593 176.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -49.81 -45.1 49.65 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.301 1.44 . . . . 0.0 112.111 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -92.16 -27.05 17.95 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.058 0.943 . . . . 0.0 112.179 -171.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.9 t -62.19 -49.8 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.042 1.337 . . . . 0.0 109.799 169.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -54.06 -53.73 49.09 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.005 0.82 . . . . 0.0 109.583 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -53.03 -37.93 61.95 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.141 1.776 . . . . 0.0 112.364 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -78.83 -59.87 2.6 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.157 -0.964 . . . . 0.0 112.781 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.18 -33.55 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.887 1.275 . . . . 0.0 112.498 -174.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.97 -18.79 61.96 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -78.42 -25.13 45.93 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.648 1.179 . . . . 0.0 113.52 174.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.1 pt -106.25 -8.18 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.498 1.519 . . . . 0.0 113.678 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 C--O 1.254 1.315 0 C-N-CA 125.493 1.517 . . . . 0.0 113.088 173.653 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.2 ttp . . . . . 0 N--CA 1.503 2.203 0 CA-C-O 119.754 -0.165 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -88.35 97.85 11.27 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.079 0.952 . . . . 0.0 110.69 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -81.24 133.73 35.49 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 121.633 -0.667 . . . . 0.0 110.811 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.5 m -100.15 146.51 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.088 0.955 . . . . 0.0 110.998 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.8 tpp -126.41 112.11 15.26 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.907 0.883 . . . . 0.0 110.876 172.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -81.54 138.07 35.48 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.967 -0.458 . . . . 0.0 110.656 169.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.2 t -137.38 129.79 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.316 1.047 . . . . 0.0 111.234 -171.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 t -145.69 -175.6 4.8 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 119.166 0.894 . . . . 0.0 113.345 169.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -60.03 -37.66 80.45 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 121.752 -0.593 . . . . 0.0 110.323 169.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.95 127.74 56.09 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.985 0.914 . . . . 0.0 110.695 168.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -66.97 -33.65 76.04 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.552 168.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.8 p -67.97 -47.51 68.41 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.136 1.774 . . . . 0.0 115.584 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.3 p -85.42 -24.96 27.26 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -171.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.27 -60.89 1.59 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 176.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.8 m -60.19 -41.06 92.15 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.147 0.885 . . . . 0.0 112.947 -169.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -60.44 -40.05 89.71 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.847 1.659 . . . . 0.0 113.088 169.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.7 mtm -61.94 -46.06 90.95 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.852 -1.155 . . . . 0.0 111.023 174.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.89 -28.52 66.76 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 173.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -71.24 -46.04 61.93 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.227 1.376 . . . . 0.0 108.96 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.61 -44.07 97.03 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 118.602 -1.11 . . . . 0.0 112.408 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -63.15 -41.31 99.25 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.974 1.387 . . . . 0.0 111.971 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.94 -34.58 71.63 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 120.719 -1.238 . . . . 0.0 110.572 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -59.45 -57.92 10.86 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.112 1.765 . . . . 0.0 109.94 170.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.6 p -69.09 -14.64 63.13 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.1 mt -99.87 -6.38 26.88 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.5 10.77 0.52 Allowed Glycine 0 N--CA 1.476 1.357 0 N-CA-C 117.192 1.637 . . . . 0.0 117.192 -169.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.02 131.06 39.88 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.076 1.438 . . . . 0.0 112.142 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.97 -8.68 49.71 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.387 -1.229 . . . . 0.0 115.777 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -84.76 -57.08 3.26 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 120.03 1.915 . . . . 0.0 110.461 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -139.02 179.43 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 126.57 1.948 . . . . 0.0 110.597 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.76 127.39 47.2 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.341 -0.849 . . . . 0.0 112.091 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.5 m -90.99 145.26 7.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 123.989 0.916 . . . . 0.0 113.212 169.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.8 157.4 43.66 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.998 0.919 . . . . 0.0 110.88 -174.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.9 p -141.89 141.85 33.04 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.394 1.478 . . . . 0.0 112.757 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.1 t -143.46 178.15 7.96 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.414 1.486 . . . . 0.0 111.208 169.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.03 170.21 37.11 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 119.905 -1.747 . . . . 0.0 114.494 172.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.5 mt -60.53 -45.0 95.46 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.453 0.701 . . . . 0.0 111.851 -170.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -109.45 111.63 23.27 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 127.239 2.216 . . . . 0.0 106.251 169.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.4 p -66.72 -43.17 84.96 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.446 -1.409 . . . . 0.0 110.975 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 t 52.62 -170.69 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.711 2.004 . . . . 0.0 114.081 -176.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -88.63 174.37 8.09 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.587 1.955 . . . . 0.0 111.787 173.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 m -60.77 113.4 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 169.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -64.45 130.37 94.64 Favored Pre-proline 0 N--CA 1.477 0.902 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -168.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -59.98 -39.2 72.93 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.475 2.783 . . . . 0.0 114.028 -171.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 m -78.3 -37.28 45.13 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.117 0.567 . . . . 0.0 110.507 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.22 93.59 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.084 -0.96 . . . . 0.0 112.355 175.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.9 mt -52.07 -45.75 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 120.687 1.585 . . . . 0.0 110.083 173.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.2 -57.8 7.58 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.2 mmt -64.88 -23.07 67.12 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -174.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 87.7 mmm -89.97 -37.83 14.07 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.224 1.01 . . . . 0.0 110.851 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -58.75 -36.81 74.96 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 120.766 -1.209 . . . . 0.0 112.067 169.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -54.97 -30.57 59.44 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.353 1.061 . . . . 0.0 113.704 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.2 m -104.47 15.69 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 125.059 1.344 . . . . 0.0 114.113 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.86 15.43 63.16 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.131 0.872 . . . . 0.0 115.087 176.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.2 mt -124.56 74.2 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.832 1.653 . . . . 0.0 109.461 -169.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -66.39 108.06 2.24 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 119.938 -1.726 . . . . 0.0 110.498 172.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.8 pt -86.95 -0.47 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.0 p -67.71 -24.87 65.44 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.535 -1.353 . . . . 0.0 114.588 -169.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.61 6.0 64.86 Favored Glycine 0 CA--C 1.541 1.671 0 C-N-CA 125.389 1.471 . . . . 0.0 114.66 170.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -82.06 147.92 28.87 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.704 1.202 . . . . 0.0 112.029 -172.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.6 t -69.06 156.1 39.23 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 121.505 -0.747 . . . . 0.0 112.157 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.5 t -136.6 142.68 43.33 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.743 0.817 . . . . 0.0 111.243 170.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.31 140.6 21.08 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -171.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -89.96 156.48 4.91 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 124.123 3.215 . . . . 0.0 113.024 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.7 tp -61.52 -22.98 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -170.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -102.62 -5.34 23.97 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -87.87 -38.89 15.27 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.651 -0.656 . . . . 0.0 110.852 169.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.06 153.36 43.9 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.23 0.538 . . . . 0.0 111.436 171.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -136.98 120.63 17.26 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.529 1.132 . . . . 0.0 110.444 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.49 8.48 1.78 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -170.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -73.35 -29.87 62.95 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.47 -0.769 . . . . 0.0 112.305 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -93.39 -3.55 53.07 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.091 1.357 . . . . 0.0 113.642 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -125.06 89.36 3.04 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.869 1.668 . . . . 0.0 109.351 -172.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -59.7 -24.66 64.14 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -175.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.0 t -121.35 105.11 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.703 1.201 . . . . 0.0 110.106 -169.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.8 t -116.05 130.49 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.584 1.154 . . . . 0.0 110.66 -174.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.6 mp -119.38 124.97 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.714 0.806 . . . . 0.0 109.98 -174.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 t -85.7 124.68 32.49 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.419 1.088 . . . . 0.0 108.969 168.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.414 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 75.2 mt -111.54 37.68 2.83 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 126.673 1.989 . . . . 0.0 110.506 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 9.6 t -148.92 142.74 25.66 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.446 -0.783 . . . . 0.0 112.697 -175.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -62.92 -23.45 65.72 Favored Glycine 0 CA--C 1.547 2.069 0 O-C-N 121.617 -0.677 . . . . 0.0 111.469 168.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 16.9 p -73.44 3.99 5.34 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.267 2.227 . . . . 0.0 115.602 170.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -55.29 -26.22 43.03 Favored Glycine 0 CA--C 1.536 1.367 0 N-CA-C 116.727 1.451 . . . . 0.0 116.727 -169.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.9 m -62.84 -16.35 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 173.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -88.43 -0.29 57.04 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.025 1.33 . . . . 0.0 113.871 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.5 mt -67.94 152.8 96.11 Favored Pre-proline 0 CA--C 1.548 0.881 0 O-C-N 120.863 -1.148 . . . . 0.0 112.291 176.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.83 134.7 58.7 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.031 2.487 . . . . 0.0 111.798 176.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -61.62 -30.18 85.29 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.483 2.122 . . . . 0.0 113.557 -174.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -66.58 -30.89 71.29 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.544 -1.348 . . . . 0.0 113.183 173.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -78.61 -20.12 51.15 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.926 -1.108 . . . . 0.0 112.632 174.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.3 t -86.77 -38.65 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.801 1.64 . . . . 0.0 112.107 174.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.3 p -85.12 52.43 2.44 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 120.785 -1.197 . . . . 0.0 113.366 -172.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -110.65 171.51 7.42 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.339 1.856 . . . . 0.0 112.306 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -53.29 -42.48 66.66 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.401 1.08 . . . . 0.0 113.003 -169.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.3 mt -130.2 122.42 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.867 1.267 . . . . 0.0 108.756 169.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -122.36 132.45 54.39 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.706 0.802 . . . . 0.0 109.157 169.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.82 155.12 44.6 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.127 1.371 . . . . 0.0 111.156 -176.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -136.21 118.86 16.0 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.493 0.717 . . . . 0.0 111.92 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.414 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 31.8 m0 -97.94 3.06 49.66 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.725 1.21 . . . . 0.0 113.338 -175.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.329 1.2 pp0? 45.59 43.42 9.18 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.9 2.08 . . . . 0.0 115.905 171.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 83.9 mt -84.49 158.16 21.09 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.698 1.199 . . . . 0.0 113.917 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -79.85 164.07 23.88 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.331 1.852 . . . . 0.0 112.188 169.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -95.84 111.71 56.86 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 123.861 0.864 . . . . 0.0 108.975 169.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -85.44 -10.57 7.58 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.049 2.499 . . . . 0.0 116.067 -169.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -49.67 112.7 0.69 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.533 1.133 . . . . 0.0 112.816 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.6 -0.15 89.69 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 123.844 0.735 . . . . 0.0 114.836 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -75.79 170.68 15.75 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 118.295 1.047 . . . . 0.0 110.31 169.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.5 t -58.84 145.27 41.55 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.507 -0.746 . . . . 0.0 111.028 169.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.45 -28.32 68.22 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.15 0.58 . . . . 0.0 111.998 -176.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -65.82 -33.18 75.27 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 120.96 -1.087 . . . . 0.0 113.237 173.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.2 t -70.28 -36.47 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 O-C-N 121.037 -1.039 . . . . 0.0 109.823 171.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.87 -42.68 90.07 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.645 0.778 . . . . 0.0 110.736 176.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -67.12 -36.06 81.09 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.78 1.232 . . . . 0.0 112.367 171.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.5 m -59.53 -48.89 79.89 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 119.306 0.957 . . . . 0.0 111.427 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.3 m -68.21 -32.31 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 117.909 -1.043 . . . . 0.0 111.983 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.08 -43.4 91.8 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 120.825 1.648 . . . . 0.0 111.978 169.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.47 -41.89 89.91 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 124.388 0.994 . . . . 0.0 112.556 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -61.95 -46.14 90.59 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 122.214 -0.58 . . . . 0.0 111.897 169.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.42 -46.73 92.44 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.267 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -51.95 -54.92 23.92 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.654 1.182 . . . . 0.0 111.827 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -60.61 -41.42 94.74 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.351 0.661 . . . . 0.0 112.305 -176.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 50.7 mtp85 -79.2 -33.83 43.5 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.4 t -59.81 -47.58 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.182 0.993 . . . . 0.0 110.653 170.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -53.35 -55.3 26.0 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.11 0.868 . . . . 0.0 109.966 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -54.71 -40.63 69.4 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.881 1.273 . . . . 0.0 112.301 176.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.7 -58.81 3.07 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.183 -0.948 . . . . 0.0 112.52 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.36 -34.95 70.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.599 1.16 . . . . 0.0 111.624 -176.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.42 -15.95 61.33 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -173.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -71.17 -28.16 64.05 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.435 1.094 . . . . 0.0 113.42 170.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.7 pt -113.81 -6.95 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.189 1.796 . . . . 0.0 113.287 -173.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.7 m . . . . . 0 C--O 1.254 1.299 0 C-N-CA 125.735 1.614 . . . . 0.0 113.713 173.561 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.503 2.217 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -79.62 96.51 6.2 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.773 0.829 . . . . 0.0 110.079 171.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -77.12 144.96 38.09 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.759 -0.588 . . . . 0.0 111.191 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 p -122.43 141.72 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.524 1.13 . . . . 0.0 111.047 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.422 ' HE2' ' CD2' ' A' ' 68' ' ' PHE . 50.8 tpp -124.38 120.41 32.03 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.616 1.167 . . . . 0.0 111.774 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -88.89 130.06 35.49 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.313 0.645 . . . . 0.0 111.507 169.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.2 t -129.24 124.31 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.918 1.287 . . . . 0.0 110.188 -172.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.3 m -136.17 169.65 17.28 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.556 1.142 . . . . 0.0 111.467 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -64.92 -48.69 73.25 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 168.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.424 ' HB3' ' H ' ' A' ' 13' ' ' SER . 0.9 OUTLIER -99.87 105.4 17.14 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.314 1.446 . . . . 0.0 108.366 168.549 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -53.58 -33.49 55.04 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 122.952 0.501 . . . . 0.0 110.884 169.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.9 p -65.37 -40.2 93.25 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.164 2.185 . . . . 0.0 115.793 176.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.424 ' H ' ' HB3' ' A' ' 10' ' ' ARG . 14.4 p -97.09 -22.9 16.5 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -170.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.43 -51.14 1.75 Allowed 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 171.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.0 m -59.07 -44.57 91.89 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 121.284 1.857 . . . . 0.0 111.926 -175.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -58.23 -43.56 87.79 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.997 1.319 . . . . 0.0 113.474 169.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 51.2 ttm -58.31 -50.81 72.31 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.325 1.05 . . . . 0.0 111.381 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.67 -27.22 66.66 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.254 1.022 . . . . 0.0 112.524 174.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -76.35 -43.55 40.51 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 120.424 1.466 . . . . 0.0 109.133 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.88 -52.99 47.65 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-O 119.152 -0.804 . . . . 0.0 111.248 174.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -62.2 -41.61 98.53 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.286 1.043 . . . . 0.0 112.919 174.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.01 -40.83 97.23 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.211 1.369 . . . . 0.0 110.837 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -61.21 -50.06 74.65 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.326 1.85 . . . . 0.0 111.32 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.6 p -74.94 -22.73 58.42 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.1 mt -88.84 -23.26 22.85 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.264 0.938 . . . . 0.0 112.711 176.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -126.4 21.72 6.01 Favored Glycine 0 N--CA 1.473 1.124 0 C-N-CA 125.777 1.656 . . . . 0.0 115.431 -170.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.91 126.48 27.27 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.236 1.018 . . . . 0.0 112.531 -173.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.65 -2.6 47.22 Favored Glycine 0 CA--C 1.537 1.431 0 N-CA-C 116.024 1.17 . . . . 0.0 116.024 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -81.7 -54.77 5.11 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.587 1.694 . . . . 0.0 111.146 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -143.04 -179.37 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 127.355 2.262 . . . . 0.0 110.989 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.23 121.49 42.34 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.482 0.658 . . . . 0.0 111.825 171.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.3 m -87.11 150.8 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 123.473 0.709 . . . . 0.0 111.981 169.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.68 159.77 43.05 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.265 1.026 . . . . 0.0 111.288 -174.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.5 t -144.7 127.7 16.49 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.144 1.378 . . . . 0.0 111.885 -169.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.0 p -144.09 -178.76 6.11 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.532 1.533 . . . . 0.0 111.299 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.06 172.11 35.47 Favored Glycine 0 CA--C 1.532 1.142 0 O-C-N 119.834 -1.791 . . . . 0.0 114.47 173.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 47.6 mt -61.68 -39.15 90.42 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 118.354 1.077 . . . . 0.0 112.176 -173.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -115.81 113.66 23.69 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.809 2.044 . . . . 0.0 107.843 169.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.3 p -65.88 -37.14 85.35 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.933 0.893 . . . . 0.0 112.046 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.4 t 44.09 -129.85 0.87 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 126.159 1.784 . . . . 0.0 112.786 -174.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -146.62 -175.77 4.92 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 127.139 2.176 . . . . 0.0 111.823 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.1 m -59.22 115.75 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 121.134 -0.979 . . . . 0.0 110.291 169.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.8 t-80 -73.85 131.7 81.33 Favored Pre-proline 0 N--CA 1.476 0.855 0 CA-C-O 118.501 -0.762 . . . . 0.0 113.035 -169.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -60.58 -39.74 62.2 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.488 2.792 . . . . 0.0 114.293 -171.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.1 m -80.95 -33.07 34.25 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.803 -0.56 . . . . 0.0 110.833 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.45 -42.46 87.55 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 118.087 -0.959 . . . . 0.0 112.166 174.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.0 mt -47.35 -48.22 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 119.997 1.271 . . . . 0.0 110.395 172.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.61 -61.54 2.14 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.8 mmt -66.31 -27.31 67.82 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.525 -0.735 . . . . 0.0 112.379 -171.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 81.7 mtp -84.22 -38.18 20.88 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.595 0.758 . . . . 0.0 111.364 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -57.35 -38.05 73.54 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.715 1.143 . . . . 0.0 112.099 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -59.39 -23.39 62.55 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.0 m -108.28 15.07 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.39 16.54 58.7 Favored Glycine 0 N--CA 1.478 1.444 0 O-C-N 121.087 -1.008 . . . . 0.0 115.325 176.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.9 mt -125.43 53.31 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.892 1.677 . . . . 0.0 110.307 -169.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -60.4 113.2 2.28 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.26 -1.525 . . . . 0.0 111.435 176.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.8 pt -91.46 2.53 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.215 1.006 . . . . 0.0 113.648 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -62.19 -24.41 67.19 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 120.759 1.618 . . . . 0.0 113.262 -173.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.46 6.87 59.47 Favored Glycine 0 CA--C 1.543 1.84 0 C-N-CA 125.475 1.512 . . . . 0.0 115.77 170.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -83.24 152.21 25.29 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.089 1.445 . . . . 0.0 112.088 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.0 t -71.44 163.67 27.26 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 52.0 m -137.07 140.92 42.34 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.01 1.724 . . . . 0.0 109.49 169.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -145.96 141.89 17.17 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-N 119.548 1.067 . . . . 0.0 113.369 -175.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -86.45 148.27 8.78 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 123.221 2.614 . . . . 0.0 111.441 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.0 tt -66.48 -16.63 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 O-C-N 120.549 -1.344 . . . . 0.0 113.976 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -89.54 -10.52 45.86 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.112 -0.992 . . . . 0.0 113.485 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -88.5 -40.7 13.24 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.764 0.825 . . . . 0.0 111.453 170.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.422 ' CD2' ' HE2' ' A' ' 5' ' ' MET . 0.0 OUTLIER -70.71 153.03 43.19 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.816 0.847 . . . . 0.0 111.694 177.415 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.436 ' HA ' ' CH2' ' A' ' 90' ' ' TRP . 11.1 m120 -128.38 124.87 37.45 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.435 0.694 . . . . 0.0 110.329 169.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.29 5.71 1.62 Allowed 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -73.02 -29.02 62.7 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.983 0.913 . . . . 0.0 112.213 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -97.51 -3.79 39.17 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.81 1.244 . . . . 0.0 113.583 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -121.73 92.01 3.64 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.009 1.724 . . . . 0.0 109.353 -172.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -60.51 -28.17 68.18 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -174.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.5 t -113.67 116.74 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.383 1.073 . . . . 0.0 110.098 -177.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.1 t -126.4 132.51 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.909 0.884 . . . . 0.0 110.377 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.7 mm -123.07 127.78 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 121.771 -0.581 . . . . 0.0 111.466 -170.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.5 t -87.51 126.45 34.92 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.282 1.433 . . . . 0.0 109.964 169.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.5 mt -112.6 42.14 1.9 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.645 1.178 . . . . 0.0 113.015 -174.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 30.4 p -123.66 -162.28 1.04 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.126 2.17 . . . . 0.0 107.744 168.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -120.21 47.16 1.05 Allowed Glycine 0 CA--C 1.53 0.976 0 N-CA-C 107.729 -2.148 . . . . 0.0 107.729 168.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 16.2 p -138.42 -54.13 0.62 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -168.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.89 -43.37 0.2 Allowed Glycine 0 CA--C 1.543 1.837 0 C-N-CA 126.98 2.229 . . . . 0.0 116.04 -175.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 p -65.77 -20.69 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 126.933 2.093 . . . . 0.0 115.161 -169.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -79.24 -4.29 49.96 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.0 mt -91.65 146.98 34.18 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 125.355 1.462 . . . . 0.0 110.769 172.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -71.37 151.32 59.71 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.328 2.019 . . . . 0.0 110.863 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -58.62 -34.78 99.11 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.837 2.358 . . . . 0.0 112.613 -175.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -48.83 -46.25 41.73 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.602 1.561 . . . . 0.0 112.919 175.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.436 ' CH2' ' HA ' ' A' ' 69' ' ' ASN . 1.8 m95 -90.57 8.42 34.21 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.052 1.341 . . . . 0.0 113.072 -177.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.5 t -116.0 -39.32 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 126.868 2.067 . . . . 0.0 111.697 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.6 p -79.9 28.11 0.29 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -174.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -85.22 172.19 11.36 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.826 1.65 . . . . 0.0 111.961 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -53.69 -42.37 67.89 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -169.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.6 mt -129.4 125.67 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.463 1.105 . . . . 0.0 109.069 169.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -131.99 136.26 47.15 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.264 1.026 . . . . 0.0 111.533 169.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -143.06 154.94 44.47 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.111 1.364 . . . . 0.0 111.741 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -122.64 118.95 29.37 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.14 1.376 . . . . 0.0 109.976 171.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -84.86 3.98 35.38 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 117.788 2.514 . . . . 0.0 117.788 -169.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 58.44 51.16 8.43 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.252 1.387 . . . . 0.0 113.048 176.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 66.2 mt -107.73 165.93 11.07 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.336 1.855 . . . . 0.0 113.269 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -122.32 153.73 38.56 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.387 1.875 . . . . 0.0 110.32 173.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -74.34 118.32 68.84 Favored Pre-proline 0 CA--C 1.546 0.816 0 O-C-N 121.296 -0.878 . . . . 0.0 111.342 176.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -85.27 -6.6 9.19 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.32 2.013 . . . . 0.0 114.013 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -48.67 116.03 1.46 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.231 1.013 . . . . 0.0 112.77 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.04 3.68 69.71 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.791 0.71 . . . . 0.0 114.338 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -80.94 171.58 14.82 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.463 1.105 . . . . 0.0 110.115 171.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.3 p -63.9 156.49 27.5 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.339 -0.85 . . . . 0.0 112.082 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.05 -29.06 70.03 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.578 -0.701 . . . . 0.0 111.43 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.27 -40.96 92.22 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.175 -0.953 . . . . 0.0 112.641 172.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.3 t -73.1 -39.85 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.753 0.821 . . . . 0.0 109.691 176.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -63.52 -36.87 85.21 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.051 0.54 . . . . 0.0 111.189 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -70.95 -43.21 68.63 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.339 1.456 . . . . 0.0 112.199 172.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.2 m -57.69 -51.05 71.11 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.177 0.991 . . . . 0.0 111.838 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.4 m -68.1 -29.23 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 O-C-N 121.271 -0.893 . . . . 0.0 112.051 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.6 ptt-85 -70.6 -32.9 70.43 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 119.778 1.172 . . . . 0.0 113.051 173.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.11 -45.12 94.64 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 123.88 0.752 . . . . 0.0 112.262 170.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -61.97 -42.18 98.85 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.926 -0.749 . . . . 0.0 112.348 171.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.3 t -60.22 -50.12 81.49 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.724 0 CA-C-O 117.139 -1.41 . . . . 0.0 110.182 174.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -51.19 -48.91 61.84 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.469 1.508 . . . . 0.0 112.158 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -55.27 -43.7 74.94 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.701 1.2 . . . . 0.0 112.492 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.0 mtt180 -91.59 -32.89 15.34 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.975 0.91 . . . . 0.0 112.75 -169.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.4 p -69.6 -36.66 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.574 1.55 . . . . 0.0 112.012 171.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -56.67 -58.76 6.7 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.81 1.186 . . . . 0.0 109.915 169.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -55.34 -27.65 48.58 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.504 1.122 . . . . 0.0 113.299 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -85.07 -59.33 2.37 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.336 0.971 . . . . 0.0 112.904 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.92 -33.34 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.553 1.141 . . . . 0.0 111.727 -178.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.83 -14.13 60.65 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -82.48 -28.38 31.22 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.501 1.121 . . . . 0.0 113.065 172.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.3 pt -98.92 -12.02 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.612 1.165 . . . . 0.0 113.817 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.2 m . . . . . 0 C--O 1.255 1.356 0 C-N-CA 124.766 1.226 . . . . 0.0 113.245 171.672 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 ttm . . . . . 0 N--CA 1.503 2.182 0 CA-C-O 119.712 -0.185 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -91.95 85.82 5.67 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.19 0.996 . . . . 0.0 110.277 177.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -77.45 150.74 34.94 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.535 -0.728 . . . . 0.0 111.351 -175.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.2 t -108.38 143.27 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.583 0.753 . . . . 0.0 111.45 -175.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.421 ' HE3' ' CD2' ' A' ' 68' ' ' PHE . 43.7 tpp -128.08 110.39 12.44 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.912 0.885 . . . . 0.0 110.156 169.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -81.83 138.51 35.09 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.635 169.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.6 t -135.62 128.39 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.083 0.953 . . . . 0.0 111.587 -174.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.7 p -147.17 -178.23 6.1 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.798 1.239 . . . . 0.0 111.813 175.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -62.35 -64.34 0.96 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 119.847 1.203 . . . . 0.0 110.124 172.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.27 107.42 16.56 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 168.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -56.67 -41.73 77.78 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.748 0.704 . . . . 0.0 109.556 169.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.2 p -53.22 -29.57 33.08 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 127.446 2.299 . . . . 0.0 115.849 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.1 p -97.97 -97.47 0.21 Allowed 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 123.571 0.748 . . . . 0.0 109.82 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -53.19 -50.7 64.11 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.391 1.476 . . . . 0.0 113.38 -169.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.408 ' HB3' ' HB2' ' A' ' 34' ' ' SER . 69.9 m -71.36 -40.2 70.78 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -174.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -64.25 -37.2 86.63 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 168.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 77.0 mtp -58.38 -51.36 70.14 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.108 0.867 . . . . 0.0 109.592 172.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.24 -36.18 82.82 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -66.38 -40.22 89.57 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 119.524 1.056 . . . . 0.0 108.882 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.478 ' N ' HE22 ' A' ' 60' ' ' GLN . . . -68.16 -45.05 73.65 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-O 118.961 -0.911 . . . . 0.0 111.989 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -62.28 -38.88 91.04 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.305 1.052 . . . . 0.0 111.458 170.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.24 -33.46 71.68 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 120.587 -1.32 . . . . 0.0 111.368 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -62.8 -55.5 25.87 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.443 1.897 . . . . 0.0 109.369 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.8 p -71.46 -15.51 62.33 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.6 mt -97.4 -11.12 24.3 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 173.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.99 9.2 2.01 Favored Glycine 0 N--CA 1.477 1.376 0 N-CA-C 117.227 1.651 . . . . 0.0 117.227 -169.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.5 128.98 27.58 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.155 1.478 . . . . 0.0 112.342 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.12 -6.89 55.28 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-O 118.319 -1.267 . . . . 0.0 115.888 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -85.68 -57.16 3.16 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.02 1.91 . . . . 0.0 110.286 175.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 pp -139.71 173.4 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 127.433 2.293 . . . . 0.0 109.141 171.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.37 131.2 44.27 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.522 -0.736 . . . . 0.0 111.833 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.7 m -100.11 143.8 13.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 123.709 0.804 . . . . 0.0 112.805 170.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 m -145.98 162.59 37.48 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.615 1.566 . . . . 0.0 109.467 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.408 ' HB2' ' HB3' ' A' ' 15' ' ' SER . 91.0 p -143.91 148.69 35.76 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.061 0.944 . . . . 0.0 113.097 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.5 p -138.39 -170.38 2.8 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.025 1.33 . . . . 0.0 110.914 171.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.93 173.44 37.36 Favored Glycine 0 CA--C 1.528 0.891 0 O-C-N 121.078 -1.013 . . . . 0.0 113.85 175.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.8 mt -64.78 -35.92 82.64 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.409 0.684 . . . . 0.0 112.253 -172.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -123.24 105.69 10.09 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 128.449 2.699 . . . . 0.0 107.09 172.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.2 p -60.9 -46.9 88.82 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.437 -0.79 . . . . 0.0 111.633 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.1 t 49.72 -171.83 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 127.898 2.479 . . . . 0.0 114.415 -174.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -77.98 166.74 22.47 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.65 1.58 . . . . 0.0 110.214 169.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.1 m -56.99 120.13 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 119.949 1.25 . . . . 0.0 108.098 169.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -65.15 127.56 92.96 Favored Pre-proline 0 N--CA 1.479 0.998 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -167.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -61.73 -39.48 52.75 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.256 2.637 . . . . 0.0 113.845 -169.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.1 m -77.85 -35.66 50.81 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.937 -0.477 . . . . 0.0 110.318 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.17 -38.1 87.24 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 117.956 -1.021 . . . . 0.0 112.407 174.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.0 mt -55.31 -41.64 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 121.455 1.934 . . . . 0.0 110.501 173.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.73 -59.77 4.15 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.0 mmt -63.69 -27.29 69.11 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.483 -0.761 . . . . 0.0 112.66 -174.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 88.0 mmm -85.01 -33.12 22.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.773 0.829 . . . . 0.0 110.561 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -61.86 -33.61 74.49 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.888 -1.133 . . . . 0.0 111.817 171.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -55.06 -33.6 62.87 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.088 0.955 . . . . 0.0 112.763 172.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.4 m -105.49 19.11 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.259 1.424 . . . . 0.0 113.859 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.34 17.01 74.89 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 115.528 0.971 . . . . 0.0 115.528 173.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 71.6 mt -115.36 125.93 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.206 1.402 . . . . 0.0 111.417 -169.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -100.43 73.41 1.65 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.558 1.943 . . . . 0.0 112.727 -172.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.33 -10.23 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 120.373 -1.454 . . . . 0.0 111.672 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.1 p -60.95 -32.03 71.56 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.888 2.475 . . . . 0.0 113.833 169.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.45 47.55 1.02 Allowed Glycine 0 N--CA 1.474 1.224 0 C-N-CA 126.418 1.961 . . . . 0.0 112.168 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.478 HE22 ' N ' ' A' ' 20' ' ' GLY . 11.0 mt-30 -135.87 171.94 13.73 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.668 1.587 . . . . 0.0 113.287 -169.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -76.56 137.26 39.44 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 121.37 -0.832 . . . . 0.0 112.944 -169.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.7 m -125.59 45.58 2.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.189 1.396 . . . . 0.0 111.004 -170.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.83 140.22 54.4 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -169.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -83.11 151.1 13.9 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.186 2.591 . . . . 0.0 111.008 169.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.9 tt -63.33 -21.57 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 -171.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -99.24 -4.71 31.32 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -88.51 -41.55 12.66 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.044 0.838 . . . . 0.0 112.117 171.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.421 ' CD2' ' HE3' ' A' ' 5' ' ' MET . 0.1 OUTLIER -70.35 164.33 24.73 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.229 0.538 . . . . 0.0 112.077 178.687 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -136.48 120.18 17.26 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.046 0.938 . . . . 0.0 111.069 171.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.96 2.86 1.79 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 -172.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -70.27 -31.78 69.31 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.406 1.003 . . . . 0.0 112.179 -174.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -90.27 -8.87 49.87 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.56 1.144 . . . . 0.0 113.364 176.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -120.79 72.23 0.96 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.921 1.689 . . . . 0.0 109.378 -173.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -65.37 -6.47 10.23 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -170.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.2 t -120.87 96.64 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 125.938 1.695 . . . . 0.0 109.055 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.4 t -109.63 135.15 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 121.376 -0.828 . . . . 0.0 110.211 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.4 HG23 ' CE2' ' A' ' 99' ' ' TRP . 12.5 mm -128.6 136.13 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 123.27 0.628 . . . . 0.0 110.297 -176.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.4 t -97.26 130.17 44.49 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.545 1.538 . . . . 0.0 110.736 172.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.8 mp -115.51 49.03 1.12 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.148 1.379 . . . . 0.0 110.295 -171.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.1 p -154.53 -9.17 0.14 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 117.27 2.322 . . . . 0.0 117.27 -170.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.01 30.9 76.61 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-N 119.685 1.13 . . . . 0.0 111.482 -169.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 3.9 p -139.68 10.24 2.44 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.879 1.671 . . . . 0.0 114.39 -169.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -55.1 -27.1 44.65 Favored Glycine 0 CA--C 1.533 1.157 0 N-CA-C 116.287 1.275 . . . . 0.0 116.287 -169.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 p -61.13 -21.73 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-N 118.505 1.152 . . . . 0.0 113.267 174.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -84.15 -6.77 59.45 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.038 1.335 . . . . 0.0 113.768 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.2 mt -76.66 160.94 75.9 Favored Pre-proline 0 CA--C 1.554 1.115 0 O-C-N 121.06 -1.025 . . . . 0.0 111.792 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -58.12 145.97 90.09 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.178 2.585 . . . . 0.0 114.394 -177.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -75.41 41.25 0.76 Allowed 'Trans proline' 0 CA--C 1.551 1.357 1 C-N-CA 126.062 4.508 . . . . 0.0 113.924 -175.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -156.7 -35.56 0.08 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.931 2.492 . . . . 0.0 111.023 -176.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.18 -22.66 61.25 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.49 -1.381 . . . . 0.0 111.346 169.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 m -89.69 -10.22 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 175.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.4 p -98.02 4.32 49.31 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -170.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -69.44 164.68 22.51 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.87 0.868 . . . . 0.0 111.86 175.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -57.32 -36.56 71.27 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -169.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.9 mt -116.61 118.19 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.684 0.793 . . . . 0.0 109.073 169.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -134.08 127.33 31.95 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.35 1.06 . . . . 0.0 110.521 169.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -147.03 157.47 43.62 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.054 1.342 . . . . 0.0 111.376 -172.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -122.62 131.27 53.74 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.413 0.685 . . . . 0.0 110.853 168.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.4 ' CE2' HG23 ' A' ' 77' ' ' ILE . 47.8 m0 -87.37 1.16 54.15 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.404 1.482 . . . . 0.0 114.999 -178.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 62.45 27.37 16.27 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.789 1.235 . . . . 0.0 113.98 170.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 75.5 mt -80.15 152.62 29.14 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -170.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -86.1 157.88 19.94 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.822 1.249 . . . . 0.0 111.131 170.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.68 137.21 77.13 Favored Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 120.658 -1.276 . . . . 0.0 113.1 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -99.91 -30.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.156 2.571 . . . . 0.0 113.842 171.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.97 100.25 0.06 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.942 1.697 . . . . 0.0 112.663 -176.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.48 -0.6 53.3 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.033 1.302 . . . . 0.0 114.689 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -87.68 171.76 10.2 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.06 1.344 . . . . 0.0 111.999 172.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.1 t -62.09 149.71 40.47 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.264 0.626 . . . . 0.0 111.753 171.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 mp -60.62 -28.83 68.83 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.943 0.897 . . . . 0.0 112.514 -174.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -67.56 -34.34 76.86 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.847 -1.158 . . . . 0.0 113.17 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.5 t -70.35 -37.04 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 O-C-N 121.209 -0.932 . . . . 0.0 109.524 171.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.35 -42.38 99.35 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.5 1.12 . . . . 0.0 111.384 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -71.73 -38.61 70.43 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.973 1.309 . . . . 0.0 112.291 173.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.0 m -55.38 -48.77 73.8 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.646 0.779 . . . . 0.0 111.263 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.3 m -73.11 -29.01 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 117.671 -1.157 . . . . 0.0 112.547 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . 0.252 0.0 OUTLIER -63.03 -36.8 84.78 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 121.21 1.823 . . . . 0.0 112.227 169.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.76 -45.75 91.79 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 124.556 1.074 . . . . 0.0 112.894 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -60.01 -42.46 94.36 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 117.767 0.783 . . . . 0.0 112.473 171.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.8 t -63.7 -47.44 91.08 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 C-N-CA 124.643 1.177 . . . . 0.0 110.155 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -49.6 -53.37 24.3 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 120.417 1.462 . . . . 0.0 111.648 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -58.48 -40.18 82.02 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.463 1.105 . . . . 0.0 112.602 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.6 mtt85 -82.55 -31.07 29.28 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.16 0.984 . . . . 0.0 112.931 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.78 -48.52 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.104 1.362 . . . . 0.0 109.947 169.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -54.35 -54.99 33.03 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.397 0.999 . . . . 0.0 109.497 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -50.63 -36.92 37.68 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.392 1.477 . . . . 0.0 112.67 176.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -81.06 -60.73 2.18 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.091 0.956 . . . . 0.0 112.976 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.17 -35.03 70.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.94 1.296 . . . . 0.0 111.856 -175.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.97 -20.73 61.69 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.112 -0.993 . . . . 0.0 113.443 -172.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -74.38 -20.46 60.06 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.822 1.249 . . . . 0.0 113.52 173.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.9 pt -118.07 1.48 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.086 1.754 . . . . 0.0 113.162 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 C--O 1.252 1.228 0 C-N-CA 125.932 1.693 . . . . 0.0 113.501 173.197 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.505 2.315 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -79.54 102.4 8.82 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.894 0.77 . . . . 0.0 109.557 169.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -77.25 144.13 38.43 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.677 0.791 . . . . 0.0 111.541 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 91.1 t -113.54 143.5 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.253 1.421 . . . . 0.0 110.107 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 45.1 ttm -130.72 130.76 44.22 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.18 0.592 . . . . 0.0 111.617 168.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -98.07 136.49 38.25 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.175 0.99 . . . . 0.0 110.612 169.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.1 t -129.73 126.03 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.974 1.31 . . . . 0.0 110.898 -169.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.3 m -143.34 176.6 9.03 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.217 1.007 . . . . 0.0 111.547 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -67.38 -65.21 0.71 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 169.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.13 113.15 19.79 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 168.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.37 -22.35 62.78 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 120.271 1.396 . . . . 0.0 110.294 169.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.4 p -57.63 -53.27 60.02 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 127.551 2.34 . . . . 0.0 116.17 173.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.4 p -93.19 -14.67 26.84 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.885 1.274 . . . . 0.0 113.376 -171.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -124.47 -68.88 0.83 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.406 1.082 . . . . 0.0 113.2 -176.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.1 m -57.24 -43.28 82.8 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 120.05 1.296 . . . . 0.0 113.044 -176.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -55.95 -34.77 65.98 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.757 1.623 . . . . 0.0 113.4 173.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 59.2 mtp -64.18 -48.27 76.61 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 119.399 1.0 . . . . 0.0 111.57 174.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.07 -23.48 63.08 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 118.656 -0.688 . . . . 0.0 112.551 173.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -73.23 -49.16 29.39 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 120.024 1.284 . . . . 0.0 108.598 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.06 -52.2 53.78 Favored Glycine 0 C--O 1.222 -0.628 0 CA-C-O 118.429 -1.206 . . . . 0.0 111.049 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -62.36 -43.47 98.74 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.748 1.274 . . . . 0.0 112.948 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.13 -37.0 83.09 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.676 1.58 . . . . 0.0 111.165 -177.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -59.59 -62.48 1.84 Allowed 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 125.125 1.37 . . . . 0.0 109.925 169.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.9 p -67.71 -14.28 62.81 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -175.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.5 mt -92.59 -10.7 36.58 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 172.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.24 19.08 0.1 Allowed Glycine 0 CA--C 1.539 1.573 0 N-CA-C 118.715 2.246 . . . . 0.0 118.715 -172.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.83 -33.76 62.04 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.856 1.828 . . . . 0.0 114.803 -172.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.45 -8.95 87.05 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 124.069 0.842 . . . . 0.0 114.998 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -98.76 -55.33 2.76 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 118.625 1.212 . . . . 0.0 112.312 -171.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.5 pp -141.45 171.11 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 126.619 1.968 . . . . 0.0 111.053 -174.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.22 125.49 44.83 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 175.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.1 m -94.64 155.63 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.535 1.534 . . . . 0.0 112.896 169.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.34 123.0 11.82 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.1 t -89.18 123.5 33.49 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 120.74 -1.225 . . . . 0.0 113.074 173.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.5 t -148.72 169.61 20.02 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.764 0.711 . . . . 0.0 112.39 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.36 179.27 48.89 Favored Glycine 0 CA--C 1.521 0.457 0 O-C-N 120.577 -1.327 . . . . 0.0 114.27 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.2 mt -65.39 -30.42 71.24 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 122.86 0.464 . . . . 0.0 111.413 176.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -117.22 122.61 44.48 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.651 1.981 . . . . 0.0 108.958 169.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.8 p -78.24 44.69 0.51 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.998 1.719 . . . . 0.0 111.987 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 p -64.9 158.56 24.93 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.771 1.628 . . . . 0.0 114.149 -169.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -64.2 174.16 1.7 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -169.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 m -65.98 109.08 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 120.295 -1.503 . . . . 0.0 107.552 168.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.7 t-80 -65.37 132.68 95.23 Favored Pre-proline 0 N--CA 1.476 0.874 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -169.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -59.55 -40.53 65.14 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.158 2.572 . . . . 0.0 113.334 -172.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.4 m -78.17 -30.62 49.18 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.053 -0.404 . . . . 0.0 110.911 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.5 -44.43 78.47 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.79 -1.194 . . . . 0.0 112.552 172.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.5 mt -52.85 -40.37 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 120.177 1.353 . . . . 0.0 110.463 173.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.58 -65.5 0.67 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 174.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.3 mmt -65.92 -24.92 66.93 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -170.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 85.3 mtp -84.91 -30.72 24.15 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 122.938 0.495 . . . . 0.0 111.484 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -61.14 -31.42 71.14 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.556 -1.34 . . . . 0.0 111.629 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -57.07 -31.95 65.74 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 121.085 -1.009 . . . . 0.0 112.819 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.28 7.61 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.413 1.485 . . . . 0.0 113.396 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.94 19.87 52.06 Favored Glycine 0 N--CA 1.479 1.501 0 O-C-N 120.286 -1.509 . . . . 0.0 115.038 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 25.1 mt -123.43 66.0 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.68 1.592 . . . . 0.0 110.313 -169.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -64.12 112.82 3.17 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 120.605 -1.309 . . . . 0.0 110.962 173.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.0 pt -90.34 -1.11 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 175.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.4 p -64.86 124.46 22.04 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 120.564 1.529 . . . . 0.0 110.36 -174.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.85 1.38 87.16 Favored Glycine 0 CA--C 1.546 2.023 0 N-CA-C 116.191 1.236 . . . . 0.0 116.191 -169.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -74.03 145.93 44.13 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.742 1.771 . . . . 0.0 111.916 177.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.9 t -61.21 145.35 51.52 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -175.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.0 m -137.42 117.64 13.55 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.623 1.569 . . . . 0.0 109.941 174.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -114.08 150.91 44.36 Favored Pre-proline 0 CA--C 1.557 1.214 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -169.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -91.84 126.51 0.92 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.618 2.879 . . . . 0.0 111.603 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.5 tt -77.11 -4.98 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -172.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -86.41 -13.1 47.27 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 120.654 -1.279 . . . . 0.0 113.149 170.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -91.86 -37.4 12.94 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.948 0.899 . . . . 0.0 112.569 174.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.08 169.38 15.12 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.37 1.068 . . . . 0.0 112.763 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.01 126.4 28.46 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.309 1.444 . . . . 0.0 109.785 169.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.48 3.34 3.93 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -175.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -66.44 -29.01 69.05 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.894 0.878 . . . . 0.0 112.887 -170.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -94.75 2.04 55.5 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.556 1.542 . . . . 0.0 113.671 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -122.91 93.13 3.87 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.353 1.461 . . . . 0.0 111.089 -169.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -61.58 -23.74 66.19 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.3 t -124.83 120.84 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.449 1.099 . . . . 0.0 110.697 -174.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.6 t -131.74 133.05 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.031 0.932 . . . . 0.0 109.956 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.0 mm -121.67 122.06 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 123.836 0.854 . . . . 0.0 110.716 -171.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.3 t -85.97 113.56 22.17 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 168.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.5 mt -83.77 45.11 1.04 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.238 1.015 . . . . 0.0 110.623 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.9 t -141.26 153.89 45.46 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.536 2.734 . . . . 0.0 109.42 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -73.67 -9.5 78.74 Favored Glycine 0 CA--C 1.541 1.701 0 O-C-N 121.477 -0.765 . . . . 0.0 112.885 169.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 24.5 p -80.79 -62.14 1.76 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.073 1.749 . . . . 0.0 113.985 -174.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.43 -56.03 0.66 Allowed Glycine 0 CA--C 1.54 1.61 0 C-N-CA 126.002 1.763 . . . . 0.0 115.031 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.3 p -59.53 -19.85 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 127.347 2.259 . . . . 0.0 114.928 -173.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -69.1 -19.83 64.06 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.233 1.013 . . . . 0.0 113.49 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.9 mt -79.51 159.95 71.01 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 124.363 1.065 . . . . 0.0 112.96 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -59.18 145.7 96.89 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.326 2.684 . . . . 0.0 113.913 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.11 44.04 1.11 Allowed 'Trans proline' 0 CA--C 1.548 1.213 1 C-N-CA 125.951 4.434 . . . . 0.0 113.324 -178.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -156.81 -36.66 0.08 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.601 2.36 . . . . 0.0 111.252 -174.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -75.93 -24.26 55.51 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.643 -1.285 . . . . 0.0 111.518 170.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.1 m -89.43 -11.29 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.395 1.478 . . . . 0.0 114.781 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.8 p -95.85 5.96 50.03 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -172.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -70.93 166.19 21.75 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.335 1.054 . . . . 0.0 112.285 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -52.08 -37.4 53.81 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -169.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 63.2 mt -125.15 122.3 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.656 1.182 . . . . 0.0 109.337 169.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -131.21 136.2 48.05 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.539 1.135 . . . . 0.0 111.091 169.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -140.25 146.86 39.17 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.175 0.99 . . . . 0.0 113.357 -173.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -103.18 95.72 6.3 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.189 2.196 . . . . 0.0 111.636 170.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 20.6 m0 -85.13 92.79 8.48 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 169.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.18 77.58 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 127.661 2.384 . . . . 0.0 113.688 169.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.5 mt -116.82 159.88 21.68 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.97 2.108 . . . . 0.0 112.067 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -95.53 148.92 21.99 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.256 1.422 . . . . 0.0 111.484 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -80.99 110.73 18.85 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.056 0.942 . . . . 0.0 109.908 169.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -87.03 -5.03 7.84 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.519 2.146 . . . . 0.0 113.739 -169.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -48.26 105.59 0.08 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.66 1.584 . . . . 0.0 113.36 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.43 1.3 90.04 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 123.815 0.722 . . . . 0.0 114.758 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -77.79 168.79 19.38 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.17 0.985 . . . . 0.0 110.562 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 23.2 t -62.37 149.83 41.31 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.638 -0.664 . . . . 0.0 111.45 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 mp -60.04 -28.46 67.78 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.733 0.813 . . . . 0.0 111.787 -172.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -64.89 -35.8 82.3 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 173.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.6 t -66.32 -31.95 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.545 0.738 . . . . 0.0 109.452 170.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.16 -39.54 48.68 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.732 0.813 . . . . 0.0 110.739 -177.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -68.42 -36.73 79.5 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.939 1.296 . . . . 0.0 112.457 170.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 50.6 m -59.86 -49.12 78.95 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.705 1.202 . . . . 0.0 111.259 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.6 m -67.02 -30.28 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 118.055 -0.974 . . . . 0.0 111.952 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.07 -47.83 84.23 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 120.189 1.359 . . . . 0.0 110.849 169.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.07 -41.57 99.78 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.552 1.072 . . . . 0.0 113.181 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -63.97 -48.76 75.19 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 122.148 -0.619 . . . . 0.0 112.223 171.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.7 t -53.98 -51.86 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 116.939 -1.505 . . . . 0.0 111.086 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -46.14 -47.5 17.49 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 120.33 1.423 . . . . 0.0 113.286 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -66.07 -47.99 72.49 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.815 0.846 . . . . 0.0 112.029 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.8 mtp180 -71.09 -40.49 71.5 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.522 0.729 . . . . 0.0 112.642 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.0 p -72.23 -36.26 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.538 1.535 . . . . 0.0 112.021 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -58.51 -55.34 36.28 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.777 1.172 . . . . 0.0 109.406 169.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -55.16 -36.59 66.0 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.217 1.007 . . . . 0.0 112.03 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.42 -59.48 2.74 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.473 -0.767 . . . . 0.0 112.651 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.25 -34.53 67.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.968 0.907 . . . . 0.0 112.139 -175.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.48 -6.67 52.77 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -174.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -82.41 -20.41 37.13 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.664 1.186 . . . . 0.0 113.319 169.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.7 pt -119.18 -7.69 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.293 1.437 . . . . 0.0 113.837 -173.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.3 p . . . . . 0 C--O 1.254 1.298 0 C-N-CA 125.442 1.497 . . . . 0.0 113.249 170.783 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 tpp . . . . . 0 N--CA 1.5 2.059 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -76.72 105.84 8.03 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 119.621 1.1 . . . . 0.0 110.544 169.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -79.91 136.22 36.61 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 173.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.1 t -97.96 147.0 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.273 1.029 . . . . 0.0 109.95 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 42.6 tpp -130.26 112.29 13.2 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.869 0.868 . . . . 0.0 111.296 169.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -83.68 120.88 26.53 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.301 0.64 . . . . 0.0 111.04 169.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.7 t -118.84 135.52 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.492 1.517 . . . . 0.0 109.672 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.7 p -151.9 178.0 9.86 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 121.419 -0.8 . . . . 0.0 112.537 177.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -63.57 -42.96 98.29 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 121.512 -0.743 . . . . 0.0 111.067 169.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.456 ' HB3' ' H ' ' A' ' 13' ' ' SER . 1.1 mpt_? -117.69 103.6 10.18 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.953 1.301 . . . . 0.0 110.835 172.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -55.66 -33.62 64.25 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.287 -0.883 . . . . 0.0 110.223 169.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.4 p -57.01 -53.6 56.28 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.238 2.215 . . . . 0.0 115.303 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.456 ' H ' ' HB3' ' A' ' 10' ' ' ARG . 89.0 p -103.22 -1.67 28.52 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.09 1.356 . . . . 0.0 114.133 -176.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -126.68 -76.25 0.58 Allowed 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.076 -1.64 . . . . 0.0 111.283 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.9 m -59.59 -39.04 82.82 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -172.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -56.13 -30.63 62.4 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.467 1.507 . . . . 0.0 114.499 171.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 93.2 mtp -69.73 -45.12 68.89 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.308 0.958 . . . . 0.0 110.358 174.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.35 -27.79 66.57 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 171.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -68.0 -49.01 64.15 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.99 1.268 . . . . 0.0 108.25 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.63 -52.3 51.86 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-O 118.814 -0.992 . . . . 0.0 111.854 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -61.35 -42.64 99.02 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.507 1.153 . . . . 0.0 112.848 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.59 -37.17 85.88 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 120.082 -1.636 . . . . 0.0 111.104 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -62.51 -48.63 78.7 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.021 1.329 . . . . 0.0 111.489 174.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.5 p -80.27 -14.19 58.6 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 51.0 mt -97.83 -10.79 24.13 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.08 0.952 . . . . 0.0 113.393 174.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.66 25.3 1.34 Allowed Glycine 0 CA--C 1.534 1.22 0 N-CA-C 115.851 1.1 . . . . 0.0 115.851 -169.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.89 122.78 11.56 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.602 1.201 . . . . 0.0 112.792 -175.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.29 -2.47 36.69 Favored Glycine 0 CA--C 1.538 1.497 0 N-CA-C 116.138 1.215 . . . . 0.0 116.138 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -78.64 -46.58 18.88 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.429 1.615 . . . . 0.0 111.314 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -141.98 -177.78 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 128.265 2.626 . . . . 0.0 109.375 169.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.61 120.59 40.27 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.075 -1.016 . . . . 0.0 112.449 171.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.96 144.15 9.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 122.87 0.468 . . . . 0.0 111.796 169.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.47 163.64 35.05 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.943 1.297 . . . . 0.0 110.371 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.2 p -148.68 150.19 32.78 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.467 1.107 . . . . 0.0 113.723 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 82.5 p -143.22 -175.36 4.5 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.39 1.876 . . . . 0.0 110.433 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.23 177.25 40.91 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-N 120.047 1.294 . . . . 0.0 115.23 172.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 35.6 mt -73.65 -43.78 58.59 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 118.515 1.157 . . . . 0.0 113.493 -169.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -130.42 70.65 1.45 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.387 2.275 . . . . 0.0 107.826 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.1 m -72.44 -20.33 61.42 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -169.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.2 m 37.54 -93.44 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 128.17 2.588 . . . . 0.0 117.316 172.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.1 ptp85 -154.73 -177.99 6.89 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 126.387 1.875 . . . . 0.0 112.228 -169.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.6 m -65.8 118.4 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.04 -1.038 . . . . 0.0 110.558 169.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -74.46 133.28 77.51 Favored Pre-proline 0 N--CA 1.478 0.968 0 O-C-N 121.058 -1.026 . . . . 0.0 113.0 -169.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -59.78 -40.9 59.66 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.543 2.829 . . . . 0.0 114.137 -171.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.1 m -78.29 -38.28 42.87 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 122.061 -0.399 . . . . 0.0 110.48 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.27 -40.35 97.14 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 118.123 -0.942 . . . . 0.0 112.467 176.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 66.7 mt -49.88 -47.69 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 120.197 1.362 . . . . 0.0 110.413 172.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.84 -58.79 4.8 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.5 mmt -66.25 -26.56 67.41 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.413 -0.805 . . . . 0.0 112.741 -173.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 72.2 mmm -84.2 -38.9 20.0 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.713 0.805 . . . . 0.0 110.563 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -59.59 -37.46 78.59 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.718 -1.239 . . . . 0.0 112.097 170.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -56.62 -22.32 33.24 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.538 1.135 . . . . 0.0 113.634 173.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.1 m -113.18 17.83 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 125.044 1.338 . . . . 0.0 114.576 175.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.2 13.63 61.62 Favored Glycine 0 N--CA 1.477 1.39 0 N-CA-C 115.597 0.999 . . . . 0.0 115.597 176.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 29.6 mt -126.67 62.78 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.62 1.568 . . . . 0.0 109.85 -169.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -60.67 110.69 1.37 Allowed 'General case' 0 CA--C 1.548 0.899 0 O-C-N 120.031 -1.668 . . . . 0.0 110.45 172.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.8 pt -89.58 4.2 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.7 p -67.36 -18.53 65.18 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.851 1.659 . . . . 0.0 114.648 -172.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -102.22 8.57 55.55 Favored Glycine 0 CA--C 1.542 1.728 0 C-N-CA 125.413 1.483 . . . . 0.0 114.634 169.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -79.57 143.04 35.14 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.379 1.472 . . . . 0.0 111.927 -171.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 10.8 t -66.05 153.68 41.59 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 121.53 -0.731 . . . . 0.0 112.734 172.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.4 p -147.06 133.7 19.9 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.316 1.446 . . . . 0.0 109.926 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -141.34 135.0 14.67 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.282 0.633 . . . . 0.0 112.049 -169.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -71.61 154.88 59.74 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.384 2.723 . . . . 0.0 112.903 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.1 tt -62.78 -18.96 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.022 1.329 . . . . 0.0 114.566 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -95.55 -9.11 33.25 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -80.39 -43.74 20.55 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.055 0.843 . . . . 0.0 109.236 169.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.31 159.71 32.96 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.889 1.276 . . . . 0.0 112.3 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -142.47 134.91 27.86 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.486 1.114 . . . . 0.0 110.36 169.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.2 9.33 4.65 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 -172.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.35 -28.8 63.26 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.11 -0.993 . . . . 0.0 112.318 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -97.49 -3.65 39.51 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.065 1.346 . . . . 0.0 113.662 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -123.71 90.62 3.31 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.456 1.502 . . . . 0.0 110.039 -172.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -66.91 -12.34 59.14 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.5 t -123.99 116.49 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 126.005 1.722 . . . . 0.0 109.731 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.5 t -131.57 134.76 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.762 0.825 . . . . 0.0 111.016 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.406 HG23 ' CE2' ' A' ' 99' ' ' TRP . 10.5 mm -126.59 137.0 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.319 0.648 . . . . 0.0 111.333 -172.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.2 t -95.49 117.93 31.28 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.431 1.493 . . . . 0.0 108.989 169.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 mp -99.93 61.38 1.11 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.768 1.627 . . . . 0.0 107.816 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.8 t -155.39 -30.94 0.1 Allowed 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 -169.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.91 22.34 78.16 Favored Glycine 0 CA--C 1.54 1.628 0 O-C-N 120.798 -1.189 . . . . 0.0 111.223 -168.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 14.8 p -135.34 28.58 3.37 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.621 1.968 . . . . 0.0 112.411 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -55.74 -31.29 57.8 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 120.877 -1.139 . . . . 0.0 115.224 -169.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.6 m -67.98 -14.3 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -84.97 -11.02 56.42 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.858 1.263 . . . . 0.0 112.87 174.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.9 mt -72.03 157.47 89.39 Favored Pre-proline 0 CA--C 1.553 1.069 0 O-C-N 121.452 -0.78 . . . . 0.0 110.762 170.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -55.34 143.71 75.27 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.06 2.507 . . . . 0.0 113.174 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -75.62 41.36 0.79 Allowed 'Trans proline' 0 CA--C 1.549 1.256 1 C-N-CA 125.46 4.106 . . . . 0.0 113.624 -173.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -156.07 -30.84 0.09 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.995 2.518 . . . . 0.0 111.075 -175.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -82.21 14.82 2.68 Favored 'General case' 0 CA--C 1.553 1.073 0 O-C-N 120.918 -1.113 . . . . 0.0 113.415 169.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.5 m -131.48 -3.96 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 126.399 1.88 . . . . 0.0 113.387 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.6 p -95.68 -6.06 40.83 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.602 1.561 . . . . 0.0 113.667 -171.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -65.04 154.12 38.73 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.802 2.041 . . . . 0.0 111.932 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -53.74 -35.73 61.55 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.372 1.469 . . . . 0.0 114.304 -169.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 54.1 mt -119.02 107.38 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 169.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -121.44 131.69 54.3 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.29 1.036 . . . . 0.0 110.074 169.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -133.46 147.42 51.68 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.566 1.146 . . . . 0.0 111.647 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -115.42 95.41 5.15 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.444 1.116 . . . . 0.0 110.814 172.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.406 ' CE2' HG23 ' A' ' 77' ' ' ILE . 30.3 m0 -74.25 93.99 2.43 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 169.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.8 73.83 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.286 2.635 . . . . 0.0 113.403 169.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 71.1 mt -113.83 147.72 37.89 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.574 2.35 . . . . 0.0 111.616 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -84.47 158.88 20.88 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.369 1.068 . . . . 0.0 111.945 175.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -88.12 110.21 34.03 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 126.262 1.825 . . . . 0.0 111.765 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -84.95 -13.7 6.52 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 123.139 2.56 . . . . 0.0 116.21 -169.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -50.92 107.34 0.17 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.807 1.243 . . . . 0.0 112.527 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.18 11.54 85.45 Favored Glycine 0 CA--C 1.538 1.504 0 CA-C-O 118.837 -0.98 . . . . 0.0 115.487 177.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -74.42 -71.68 0.33 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.33 1.565 . . . . 0.0 110.625 176.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.5 t -173.89 150.1 1.61 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.891 2.476 . . . . 0.0 108.285 174.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.7 mp -60.4 -32.5 71.39 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.62 0.645 . . . . 0.0 111.799 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -70.59 -33.64 71.29 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.936 -1.103 . . . . 0.0 112.923 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 83.3 t -68.85 -37.38 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.398 -0.814 . . . . 0.0 109.527 170.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -45.09 92.06 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.58 1.152 . . . . 0.0 110.888 176.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -65.95 -23.88 66.69 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.868 1.667 . . . . 0.0 113.993 172.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.9 m -78.75 -51.74 9.36 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.672 1.589 . . . . 0.0 111.098 177.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.0 m -66.34 -26.52 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 121.104 -0.997 . . . . 0.0 111.628 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.78 -44.18 94.03 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.429 1.892 . . . . 0.0 111.203 169.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.84 -41.57 88.12 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 124.106 0.86 . . . . 0.0 112.771 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -60.87 -48.32 82.36 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 122.185 -0.597 . . . . 0.0 111.757 172.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.2 t -57.65 -47.58 85.23 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-O 117.249 -1.358 . . . . 0.0 110.232 176.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -52.29 -48.61 65.24 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 120.423 1.465 . . . . 0.0 112.327 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -63.51 -48.01 79.36 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.935 0.494 . . . . 0.0 112.19 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -70.74 -36.79 73.31 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.0 p -74.54 -36.37 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.682 1.193 . . . . 0.0 111.831 177.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -56.53 -54.82 41.44 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.649 1.113 . . . . 0.0 108.334 168.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -59.81 -17.02 32.78 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -92.23 -60.46 1.84 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.381 1.446 . . . . 0.0 112.37 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -57.76 -33.79 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.17 0.988 . . . . 0.0 111.283 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.12 -6.97 53.65 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -176.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -74.37 -23.12 58.96 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.319 1.047 . . . . 0.0 112.165 169.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.5 pt -130.42 -0.87 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 125.717 1.607 . . . . 0.0 114.983 -168.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 60.9 p . . . . . 0 C--O 1.255 1.362 0 C-N-CA 125.052 1.341 . . . . 0.0 113.509 170.424 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttm . . . . . 0 N--CA 1.503 2.213 0 CA-C-O 119.429 -0.319 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -95.59 97.27 9.62 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.467 1.107 . . . . 0.0 110.519 174.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -86.61 149.26 25.05 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.594 -0.691 . . . . 0.0 112.693 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.3 t -117.97 143.39 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.652 1.181 . . . . 0.0 111.777 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 42.9 tpp -131.9 125.35 31.49 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.419 1.087 . . . . 0.0 110.865 169.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -94.59 142.35 27.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.221 0.608 . . . . 0.0 109.985 169.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.6 t -135.42 119.79 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.11 1.364 . . . . 0.0 111.093 -174.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 p -135.37 178.06 7.33 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.294 1.438 . . . . 0.0 111.823 175.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -58.53 -57.37 13.27 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 120.751 -1.218 . . . . 0.0 110.581 174.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -101.45 120.07 39.73 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 168.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -54.14 -50.54 66.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 120.41 1.459 . . . . 0.0 110.876 175.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.1 p -64.99 -16.61 63.6 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -174.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.5 p -77.48 -37.81 50.51 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.7 ptt-85 -152.19 -32.47 0.14 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 117.279 2.326 . . . . 0.0 117.279 -174.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.4 m -68.13 -38.11 81.85 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 121.503 1.956 . . . . 0.0 113.388 171.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -67.22 -31.81 72.43 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.187 0.995 . . . . 0.0 111.724 168.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.439 ' HA ' ' CE ' ' A' ' 50' ' ' MET . 45.6 ttm -62.27 -52.44 63.7 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.328 1.051 . . . . 0.0 111.532 173.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.43 -27.6 69.4 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 124.485 1.114 . . . . 0.0 112.327 172.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -73.0 -47.83 41.74 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.928 1.694 . . . . 0.0 109.465 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.89 -54.76 31.51 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-O 118.797 -1.002 . . . . 0.0 111.344 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -57.58 -41.58 81.41 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.955 0.878 . . . . 0.0 112.379 174.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.68 -39.87 91.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.86 1.209 . . . . 0.0 112.187 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -71.31 -44.15 65.69 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.951 1.25 . . . . 0.0 112.325 173.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.6 p -65.93 -5.96 10.95 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 120.735 1.607 . . . . 0.0 114.632 173.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.8 mt -110.01 -5.43 15.43 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.847 1.259 . . . . 0.0 114.083 171.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.68 17.49 0.28 Allowed Glycine 0 N--CA 1.478 1.442 0 N-CA-C 116.841 1.496 . . . . 0.0 116.841 -170.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.11 135.22 56.99 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.923 1.362 . . . . 0.0 112.176 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.6 -6.33 46.72 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-O 118.62 -1.1 . . . . 0.0 115.588 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -85.52 -60.54 2.0 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.608 1.704 . . . . 0.0 110.672 175.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -141.37 172.53 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 127.359 2.264 . . . . 0.0 110.44 177.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.8 130.77 44.72 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.898 0.856 . . . . 0.0 112.831 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.9 m -105.34 151.76 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 124.744 1.218 . . . . 0.0 112.024 169.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.83 144.03 30.0 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.262 0.625 . . . . 0.0 111.369 -171.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.3 p -112.87 136.39 52.56 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.61 1.564 . . . . 0.0 113.46 176.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.0 t -152.61 177.26 10.85 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.866 1.266 . . . . 0.0 111.88 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.92 -175.72 47.05 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 120.671 -1.268 . . . . 0.0 114.294 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.2 mt -72.09 -33.57 67.98 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -175.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -134.44 73.32 1.49 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.535 2.334 . . . . 0.0 108.565 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.5 m -65.74 -22.7 66.62 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -172.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.9 t 43.96 -106.59 0.1 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.665 1.986 . . . . 0.0 114.607 169.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -149.34 171.55 16.35 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 127.002 2.121 . . . . 0.0 111.169 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.7 m -53.74 120.16 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.608 1.163 . . . . 0.0 110.758 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -82.52 136.03 45.98 Favored Pre-proline 0 N--CA 1.478 0.931 0 CA-C-O 118.053 -0.975 . . . . 0.0 112.237 -169.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -57.99 -44.65 38.01 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.455 2.77 . . . . 0.0 113.913 -173.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.9 m -76.98 -28.43 55.12 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.674 -0.641 . . . . 0.0 110.812 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.89 -47.09 66.71 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.223 -0.923 . . . . 0.0 111.973 169.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 57.6 mt -51.68 -48.3 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 120.27 1.396 . . . . 0.0 109.66 171.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.07 -65.13 0.65 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 177.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.44 -27.2 66.85 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -174.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.439 ' CE ' ' HA ' ' A' ' 17' ' ' MET . 87.4 mtp -80.62 -29.59 36.81 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.438 1.017 . . . . 0.0 111.669 178.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -63.93 -28.05 69.56 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.897 -1.127 . . . . 0.0 112.875 169.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -57.65 -34.71 69.64 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 119.307 0.958 . . . . 0.0 112.27 174.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.2 8.24 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.62 1.568 . . . . 0.0 113.232 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.14 23.7 43.7 Favored Glycine 0 N--CA 1.477 1.403 0 O-C-N 120.58 -1.325 . . . . 0.0 115.074 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.6 mt -123.83 60.66 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.678 1.591 . . . . 0.0 110.54 -169.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -62.34 109.82 1.46 Allowed 'General case' 0 CA--C 1.546 0.823 0 O-C-N 120.469 -1.394 . . . . 0.0 111.833 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 pt -85.87 -5.27 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 117.735 -1.126 . . . . 0.0 113.479 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.3 t -60.07 -28.54 67.89 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 120.917 1.69 . . . . 0.0 113.267 -170.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -101.34 8.52 57.08 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 125.405 1.479 . . . . 0.0 115.799 171.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -95.6 150.55 20.22 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.601 1.56 . . . . 0.0 112.034 -171.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.0 t -68.47 159.39 31.8 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -172.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.8 t -150.08 135.08 17.82 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.831 1.653 . . . . 0.0 109.625 169.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -144.02 138.78 15.31 Favored Pre-proline 0 N--CA 1.475 0.784 0 C-N-CA 123.659 0.784 . . . . 0.0 111.046 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -77.85 152.59 28.8 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.459 2.773 . . . . 0.0 113.382 -174.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.4 tt -59.21 -23.89 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -173.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -96.58 -8.2 32.42 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -94.27 -36.1 12.14 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.487 0.715 . . . . 0.0 111.439 170.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.28 161.26 30.7 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.146 0.498 . . . . 0.0 111.165 170.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.86 127.86 25.73 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.522 0.729 . . . . 0.0 111.431 169.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.23 2.61 4.46 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -173.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.8 -30.64 69.26 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.005 -1.059 . . . . 0.0 112.602 -170.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -89.37 -1.45 58.06 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.779 1.231 . . . . 0.0 113.422 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -120.66 97.06 5.38 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.224 1.41 . . . . 0.0 111.361 -169.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -55.35 -31.52 61.8 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.044 1.337 . . . . 0.0 112.85 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.6 120.23 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 124.544 1.138 . . . . 0.0 110.633 -172.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.6 t -124.92 132.83 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.14 0.976 . . . . 0.0 109.813 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.4 mm -123.51 123.51 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 123.581 0.752 . . . . 0.0 110.678 -172.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.4 t -82.55 123.55 29.31 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.968 0.907 . . . . 0.0 109.862 169.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 30.4 mt -114.34 34.55 4.65 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.853 1.661 . . . . 0.0 110.775 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 30.4 p -158.16 162.57 37.95 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.536 1.134 . . . . 0.0 113.194 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.39 -19.94 67.07 Favored Glycine 0 CA--C 1.544 1.854 0 O-C-N 121.388 -0.82 . . . . 0.0 111.532 168.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 11.6 p -64.49 0.07 1.18 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.977 2.111 . . . . 0.0 115.698 170.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -54.38 -33.68 53.52 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.671 1.129 . . . . 0.0 114.855 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.0 m -73.25 -13.8 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -101.75 -0.73 33.88 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.54 1.536 . . . . 0.0 113.124 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.3 mt -68.59 155.38 93.02 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 123.691 0.797 . . . . 0.0 111.703 176.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -58.99 145.07 98.83 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.031 2.488 . . . . 0.0 113.848 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.02 41.9 0.79 Allowed 'Trans proline' 0 CA--C 1.55 1.293 1 C-N-CA 125.979 4.453 . . . . 0.0 113.483 -177.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -156.75 -35.74 0.08 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.921 2.489 . . . . 0.0 111.084 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.06 -26.07 61.15 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.247 -1.533 . . . . 0.0 111.698 169.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.2 m -85.8 -11.25 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 79.6 p -98.36 5.57 48.08 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -172.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -69.6 164.79 22.54 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.367 1.067 . . . . 0.0 112.505 177.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -50.2 -39.98 45.8 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.752 1.221 . . . . 0.0 114.25 -169.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.8 mt -124.03 120.01 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.383 1.073 . . . . 0.0 109.011 169.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -129.35 125.39 36.55 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.126 0.97 . . . . 0.0 110.206 169.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -139.56 158.75 43.6 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.957 1.303 . . . . 0.0 111.647 -174.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -128.21 126.18 40.45 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.49 1.116 . . . . 0.0 112.121 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -100.48 7.04 44.4 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -174.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 62.06 22.73 13.31 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 169.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 68.3 mt -78.62 142.37 37.3 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -169.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -78.03 159.03 28.99 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.059 1.744 . . . . 0.0 111.866 173.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -85.31 113.29 49.72 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 124.214 1.006 . . . . 0.0 111.247 173.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -87.06 -17.26 3.11 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.203 2.602 . . . . 0.0 114.88 -170.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -61.6 120.33 10.37 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.888 -1.132 . . . . 0.0 111.366 178.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.57 -4.77 85.13 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 123.994 0.807 . . . . 0.0 113.967 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -80.89 171.19 15.32 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 118.083 0.941 . . . . 0.0 109.577 169.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 39.4 m -62.96 151.03 40.75 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.169 -0.957 . . . . 0.0 111.419 170.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.25 -29.22 68.64 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.241 -0.912 . . . . 0.0 112.439 -175.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -62.31 -33.56 74.9 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.988 0.915 . . . . 0.0 113.317 172.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 50.3 t -72.87 -35.27 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 121.048 -1.032 . . . . 0.0 110.219 172.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -66.43 -38.26 87.02 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.003 0.521 . . . . 0.0 111.093 175.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -68.69 -39.68 80.43 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.554 1.142 . . . . 0.0 112.249 169.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 42.8 m -58.48 -47.76 83.0 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.397 1.079 . . . . 0.0 111.951 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.0 m -66.39 -30.69 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 119.382 0.992 . . . . 0.0 111.816 176.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -41.06 95.26 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 120.111 1.323 . . . . 0.0 112.633 170.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.88 -44.73 97.0 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.174 0.892 . . . . 0.0 112.591 174.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -61.81 -47.3 85.75 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 122.171 -0.605 . . . . 0.0 111.931 172.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.4 t -57.06 -48.01 82.62 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.517 0 CA-C-O 117.495 -1.24 . . . . 0.0 110.442 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -53.55 -50.69 64.98 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 120.115 1.325 . . . . 0.0 112.221 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -59.25 -44.51 92.39 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.044 0.538 . . . . 0.0 112.397 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.8 mtp85 -79.57 -35.99 38.9 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -176.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.4 p -74.01 -33.89 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.212 1.405 . . . . 0.0 112.417 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -55.47 -55.33 33.03 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.162 0.892 . . . . 0.0 108.855 169.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.94 -32.11 52.62 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.586 1.554 . . . . 0.0 112.894 176.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -79.02 -56.57 4.29 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.949 0.795 . . . . 0.0 112.256 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -65.45 -35.35 75.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.553 0.741 . . . . 0.0 112.038 -177.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.18 -8.59 55.56 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -174.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -84.65 -15.46 45.32 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.145 1.378 . . . . 0.0 113.538 171.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 21.2 pt -127.34 -8.38 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.544 1.538 . . . . 0.0 113.923 -173.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.7 p . . . . . 0 C--O 1.255 1.371 0 C-N-CA 125.227 1.411 . . . . 0.0 113.358 169.866 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.8 ttm . . . . . 0 N--CA 1.503 2.198 0 CA-C-O 119.479 -0.296 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -84.93 91.29 8.01 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.064 0.946 . . . . 0.0 111.261 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -77.75 145.85 36.24 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 121.605 -0.684 . . . . 0.0 112.376 -173.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.0 t -110.09 143.48 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.707 1.203 . . . . 0.0 110.397 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.44 ' HE3' ' CD1' ' A' ' 68' ' ' PHE . 48.4 tpp -128.91 118.37 22.55 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.852 0.861 . . . . 0.0 111.024 170.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -89.16 135.55 33.5 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.943 0.497 . . . . 0.0 111.124 169.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.9 129.11 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.755 1.222 . . . . 0.0 110.467 -171.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 t -144.3 -177.09 5.29 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.281 0.632 . . . . 0.0 112.449 172.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -64.44 -47.51 78.81 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 121.468 -0.77 . . . . 0.0 110.152 169.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.66 116.75 32.49 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.903 1.281 . . . . 0.0 109.312 169.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.69 -37.04 85.37 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 168.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.8 p -56.41 -29.47 61.58 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 128.034 2.534 . . . . 0.0 115.067 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.2 p -102.33 -101.92 0.28 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.43 1.092 . . . . 0.0 111.98 176.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.14 -44.4 71.35 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 120.227 1.376 . . . . 0.0 113.947 -168.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 m -63.16 -51.63 65.65 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.169 0.895 . . . . 0.0 112.067 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -64.6 -33.76 76.67 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 96.4 mtp -60.08 -50.35 74.04 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.725 0.693 . . . . 0.0 110.478 171.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.86 -31.16 70.78 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.28 -45.73 72.29 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 120.119 1.327 . . . . 0.0 108.642 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.46 ' CA ' HE22 ' A' ' 60' ' ' GLN . . . -67.35 -39.67 91.73 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 118.631 -1.094 . . . . 0.0 112.7 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -65.02 -39.85 93.99 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.109 1.454 . . . . 0.0 111.783 170.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.72 -33.26 70.67 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.503 -1.373 . . . . 0.0 111.385 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -59.89 -56.95 15.43 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.32 1.848 . . . . 0.0 109.61 170.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.6 p -70.16 -15.69 62.98 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.0 mt -99.24 -1.95 37.86 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 173.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.32 4.34 0.59 Allowed Glycine 0 CA--C 1.536 1.387 0 N-CA-C 117.226 1.651 . . . . 0.0 117.226 -169.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.44 133.92 56.2 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.9 1.85 . . . . 0.0 111.869 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.87 -2.36 74.83 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 124.676 1.131 . . . . 0.0 115.386 -174.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -94.35 -76.48 0.48 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.881 1.341 . . . . 0.0 110.111 175.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -128.39 176.18 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 126.608 1.963 . . . . 0.0 111.349 173.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.1 125.56 40.71 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.3 -0.875 . . . . 0.0 112.129 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.8 m -92.93 147.97 5.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 123.787 0.835 . . . . 0.0 111.664 169.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.49 159.27 43.62 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.747 0.819 . . . . 0.0 110.591 -172.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.63 133.21 34.07 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.111 1.364 . . . . 0.0 113.153 -171.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.3 p -144.7 176.17 9.63 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.305 1.442 . . . . 0.0 111.465 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.85 175.85 43.59 Favored Glycine 0 CA--C 1.526 0.774 0 O-C-N 120.396 -1.44 . . . . 0.0 114.552 169.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.4 mt -63.69 -37.79 88.66 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.112 0.565 . . . . 0.0 111.263 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -121.39 113.35 19.75 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.964 2.105 . . . . 0.0 107.829 169.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.6 p -66.74 -35.3 79.78 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.799 0.84 . . . . 0.0 112.085 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.7 t 46.59 -127.29 1.5 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 126.324 1.849 . . . . 0.0 112.293 -177.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -141.41 -176.58 4.78 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 127.511 2.324 . . . . 0.0 111.26 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.8 m -66.42 113.51 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 120.162 -1.587 . . . . 0.0 108.886 169.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -68.56 133.61 90.8 Favored Pre-proline 0 N--CA 1.477 0.917 0 O-C-N 121.48 -0.762 . . . . 0.0 112.304 -169.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.39 -38.27 85.16 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.26 2.64 . . . . 0.0 113.543 -172.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.407 ' HB ' ' CE2' ' A' ' 112' ' ' PHE . 8.7 m -79.45 -35.39 40.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.996 0.519 . . . . 0.0 110.667 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.13 -42.25 99.46 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.268 0.94 . . . . 0.0 112.133 174.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.7 mt -52.88 -44.79 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 120.287 1.403 . . . . 0.0 110.436 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.72 -60.67 2.65 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 33.5 mmt -68.03 -19.57 64.92 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.767 0.827 . . . . 0.0 113.192 -172.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 84.1 mmm -89.47 -38.04 14.34 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.896 0.878 . . . . 0.0 110.553 173.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -59.39 -35.32 73.71 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.538 -1.351 . . . . 0.0 112.399 170.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -55.19 -31.76 61.67 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.123 0.969 . . . . 0.0 113.492 171.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.9 m -103.15 20.77 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.888 1.275 . . . . 0.0 113.978 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.56 12.13 78.62 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.329 0.966 . . . . 0.0 115.255 174.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.3 mt -120.38 78.25 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.21 1.804 . . . . 0.0 108.934 -170.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -69.06 106.88 2.94 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.044 -1.66 . . . . 0.0 110.276 171.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.7 pt -84.75 -0.89 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 121.578 -0.701 . . . . 0.0 112.832 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.9 t -64.23 -28.76 69.96 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 120.157 1.344 . . . . 0.0 112.827 -172.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.32 4.22 73.43 Favored Glycine 0 CA--C 1.541 1.7 0 C-N-CA 125.102 1.334 . . . . 0.0 115.368 172.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.46 HE22 ' CA ' ' A' ' 20' ' ' GLY . 9.8 mt-30 -92.31 160.07 15.3 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.268 1.427 . . . . 0.0 112.634 -176.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.0 t -95.59 156.91 16.13 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -170.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.8 m -137.15 140.72 42.02 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.925 1.69 . . . . 0.0 108.21 169.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -141.49 134.4 14.22 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.636 1.174 . . . . 0.0 111.393 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.15 145.91 50.4 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.305 2.003 . . . . 0.0 110.297 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.5 tt -56.07 -30.72 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -169.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -94.44 -9.18 36.39 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -82.4 -41.22 20.21 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.003 0.82 . . . . 0.0 109.958 169.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.44 ' CD1' ' HE3' ' A' ' 5' ' ' MET . 0.0 OUTLIER -72.75 159.17 34.23 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.244 0.545 . . . . 0.0 110.777 170.033 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -139.75 135.77 33.44 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.589 -0.694 . . . . 0.0 111.223 169.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.3 -0.73 8.61 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -169.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -68.02 -33.51 74.73 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.759 1.163 . . . . 0.0 113.006 -171.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -84.68 -3.03 58.34 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.224 1.01 . . . . 0.0 113.598 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -120.97 92.62 3.8 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.417 1.487 . . . . 0.0 110.163 -170.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -54.29 -27.47 35.52 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.115 1.366 . . . . 0.0 113.201 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.1 118.44 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 125.209 1.404 . . . . 0.0 110.126 -174.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.2 t -127.01 132.52 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.634 0.774 . . . . 0.0 110.268 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.3 mm -124.94 122.45 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 123.715 0.806 . . . . 0.0 111.61 -169.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.2 t -81.58 130.75 35.17 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.803 0.841 . . . . 0.0 109.962 169.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.0 mt -121.19 32.72 5.82 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.161 1.784 . . . . 0.0 111.282 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.3 p -158.54 162.24 37.4 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.575 1.15 . . . . 0.0 112.779 -176.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -64.96 -19.96 66.24 Favored Glycine 0 CA--C 1.545 1.931 0 O-C-N 121.215 -0.928 . . . . 0.0 111.307 168.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.6 p -63.92 -0.61 1.14 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.915 2.086 . . . . 0.0 115.547 170.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -54.22 -31.9 50.21 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 119.842 1.201 . . . . 0.0 114.748 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.7 m -75.18 -14.53 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 175.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -93.95 -9.08 38.21 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.434 1.494 . . . . 0.0 112.98 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.0 mt -61.02 139.9 94.11 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.091 0.956 . . . . 0.0 111.107 174.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -58.68 162.94 11.78 Favored 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 123.528 2.819 . . . . 0.0 113.728 174.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.05 -51.73 2.05 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.563 2.175 . . . . 0.0 113.663 -172.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -62.12 -35.42 78.69 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 120.653 -1.279 . . . . 0.0 112.28 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -64.89 5.64 0.31 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 127.298 2.239 . . . . 0.0 114.926 169.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.0 t -131.08 -43.01 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 127.26 2.224 . . . . 0.0 111.116 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.4 p -80.57 29.48 0.31 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -170.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -77.15 167.59 21.51 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.057 -1.027 . . . . 0.0 112.002 170.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -56.74 -36.12 69.38 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -169.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.7 mt -125.95 123.86 64.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.741 1.216 . . . . 0.0 108.88 169.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -131.76 138.56 48.65 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.758 0.823 . . . . 0.0 111.089 169.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -138.94 151.87 47.25 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.897 1.279 . . . . 0.0 110.517 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -122.41 114.3 20.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.482 0.713 . . . . 0.0 110.536 169.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 32.8 m0 -89.4 -2.36 58.38 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.205 1.002 . . . . 0.0 113.053 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.305 1.5 pp0? 47.35 37.64 6.26 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 171.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 81.7 mt -74.09 148.99 41.35 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.286 1.034 . . . . 0.0 112.686 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -75.0 153.46 38.5 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.537 1.135 . . . . 0.0 111.666 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -79.65 122.36 83.54 Favored Pre-proline 0 CA--C 1.542 0.673 0 O-C-N 121.126 -0.984 . . . . 0.0 111.858 173.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -93.86 -21.5 0.33 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.091 1.861 . . . . 0.0 113.847 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.6 104.59 0.07 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.891 2.076 . . . . 0.0 112.636 -176.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.5 8.6 87.11 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.517 1.056 . . . . 0.0 114.96 175.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -84.27 -64.78 1.1 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.711 1.256 . . . . 0.0 111.343 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.7 t -169.3 152.37 4.91 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.174 1.789 . . . . 0.0 109.592 171.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.92 -30.89 68.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.322 0.649 . . . . 0.0 111.041 172.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -62.81 -39.94 95.83 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.173 -0.955 . . . . 0.0 112.565 174.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 79.0 t -71.1 -39.6 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.41 -0.806 . . . . 0.0 109.083 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.407 ' CE2' ' HB ' ' A' ' 45' ' ' THR . 0.2 OUTLIER -59.32 -49.88 76.11 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.398 1.079 . . . . 0.0 112.097 176.719 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -69.45 -34.46 74.43 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.667 -0.646 . . . . 0.0 111.979 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 65.2 m -59.06 -52.59 65.11 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.286 0.634 . . . . 0.0 111.199 172.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.1 m -73.5 -27.55 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 117.74 -1.124 . . . . 0.0 112.664 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.7 ptt180 -61.27 -38.71 87.74 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 121.227 1.83 . . . . 0.0 111.88 170.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.94 -43.08 96.48 Favored Glycine 0 N--CA 1.473 1.156 0 C-N-CA 123.847 0.737 . . . . 0.0 112.739 176.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -61.19 -46.75 89.19 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.406 0.682 . . . . 0.0 111.929 170.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 25.5 t -60.45 -45.05 97.42 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.302 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -52.86 -54.5 33.51 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.093 1.315 . . . . 0.0 111.69 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -62.6 -43.47 98.74 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.067 0.547 . . . . 0.0 112.36 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.9 mtt-85 -74.8 -31.85 61.84 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 39.6 t -64.37 -47.98 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.489 169.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -53.92 -55.18 29.31 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.3 0.955 . . . . 0.0 109.239 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -49.34 -38.95 29.79 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.81 1.644 . . . . 0.0 112.242 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -81.19 -62.08 1.76 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.5 -30.32 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.545 1.138 . . . . 0.0 111.588 -175.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -78.11 -2.86 39.49 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -79.2 -20.51 48.18 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.339 1.056 . . . . 0.0 112.568 169.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.3 pt -126.89 13.38 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 126.303 1.841 . . . . 0.0 113.408 -169.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 47.1 p . . . . . 0 C--O 1.256 1.425 0 C-N-CA 125.748 1.619 . . . . 0.0 113.966 172.561 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.6 ttm . . . . . 0 N--CA 1.501 2.111 0 CA-C-O 119.596 -0.24 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -88.19 92.05 9.01 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.887 0.875 . . . . 0.0 109.958 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -79.85 151.2 30.36 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.49 -0.756 . . . . 0.0 111.607 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.6 p -118.84 142.09 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.045 0.938 . . . . 0.0 112.209 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 62.0 tpp -122.33 132.66 54.5 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.372 1.069 . . . . 0.0 110.881 171.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -105.09 138.8 40.73 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.78 0.718 . . . . 0.0 110.894 169.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.8 t -131.31 138.84 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.537 1.135 . . . . 0.0 112.272 -169.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 54.7 p -155.72 -169.81 3.22 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.282 1.033 . . . . 0.0 110.147 169.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -68.0 -40.74 82.98 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 120.354 -1.466 . . . . 0.0 110.102 168.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 51.7 mtp85 -124.0 101.76 7.4 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.925 1.69 . . . . 0.0 111.341 -176.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.488 HD22 ' NE2' ' A' ' 16' ' ' GLN . 19.7 t30 -52.53 -54.25 35.27 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 169.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.4 p -30.83 -57.25 0.22 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.018 2.127 . . . . 0.0 115.551 175.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.1 p -88.98 -41.95 12.07 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.27 1.028 . . . . 0.0 113.085 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -103.0 -73.87 0.65 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.047 1.339 . . . . 0.0 112.998 -174.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.11 -37.22 84.28 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -169.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.488 ' NE2' HD22 ' A' ' 11' ' ' ASN . 1.6 tp60 -50.65 -37.89 43.33 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.734 2.014 . . . . 0.0 113.17 170.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 60.2 ttm -66.3 -46.14 77.96 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.09 -1.006 . . . . 0.0 111.183 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.51 -21.94 65.47 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 118.524 -0.751 . . . . 0.0 111.957 170.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -73.34 -53.1 11.6 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 120.402 1.455 . . . . 0.0 108.461 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.99 -50.23 62.67 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.24 0.924 . . . . 0.0 112.424 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -66.55 -41.39 88.75 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.808 1.304 . . . . 0.0 113.078 176.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.38 -36.19 83.35 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.541 1.519 . . . . 0.0 110.091 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -64.3 -55.98 17.61 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.444 1.498 . . . . 0.0 109.916 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.7 p -70.59 -13.42 62.09 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 120.467 -1.395 . . . . 0.0 114.435 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.6 mt -96.82 -7.0 34.71 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.72 9.35 0.09 OUTLIER Glycine 0 N--CA 1.477 1.416 0 N-CA-C 119.028 2.371 . . . . 0.0 119.028 -172.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.53 -29.09 64.06 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.006 1.903 . . . . 0.0 114.464 -174.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.73 -9.33 86.92 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-O 119.247 -0.752 . . . . 0.0 114.891 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -101.75 -60.17 1.58 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.811 1.245 . . . . 0.0 111.968 -172.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.47 174.38 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 127.048 2.139 . . . . 0.0 110.483 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.26 129.23 42.46 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 121.384 -0.823 . . . . 0.0 110.926 176.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 m -101.68 148.42 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.014 0.926 . . . . 0.0 110.436 170.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 m -146.94 157.35 43.61 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.011 0.924 . . . . 0.0 110.367 173.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -135.45 152.03 50.98 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 170.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 88.8 p -152.32 179.24 8.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.285 1.834 . . . . 0.0 111.886 -170.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.13 -178.78 48.51 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 115.639 1.015 . . . . 0.0 115.639 169.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.9 mt -64.81 -52.08 58.7 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.849 0.86 . . . . 0.0 112.069 -174.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -91.12 -38.14 12.95 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.561 1.544 . . . . 0.0 110.86 170.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.483 ' HA ' ' H ' ' A' ' 11' ' ' ASN . 0.6 OUTLIER 62.69 -46.46 0.19 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 127.727 2.411 . . . . 0.0 115.996 -177.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . 0.256 38.2 t 63.5 -123.86 0.56 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 127.247 2.219 . . . . 0.0 113.391 174.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -143.91 -178.23 5.82 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 126.447 1.899 . . . . 0.0 113.71 -171.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.5 m -64.79 111.18 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 120.853 -1.154 . . . . 0.0 109.793 169.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -77.97 137.69 61.54 Favored Pre-proline 0 N--CA 1.476 0.83 0 O-C-N 121.092 -1.005 . . . . 0.0 112.988 -169.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -57.59 -43.43 50.77 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.538 2.825 . . . . 0.0 113.768 -175.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.9 m -75.75 -31.6 59.62 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.763 -0.586 . . . . 0.0 110.795 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.46 -43.11 81.88 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.172 -0.955 . . . . 0.0 112.408 171.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.9 mt -55.47 -40.58 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 121.268 1.849 . . . . 0.0 109.913 175.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.17 -62.53 1.56 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 173.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.95 -11.96 61.27 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -174.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 96.3 mmm -91.86 -42.49 10.04 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.177 0.899 . . . . 0.0 110.325 171.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -60.73 -37.52 82.03 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.673 -1.267 . . . . 0.0 112.518 174.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -60.66 -25.66 66.51 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.25 7.8 p -105.19 15.67 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 125.525 1.53 . . . . 0.0 113.399 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.13 18.58 49.61 Favored Glycine 0 N--CA 1.477 1.37 0 O-C-N 120.796 -1.19 . . . . 0.0 115.555 173.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.7 mt -125.78 90.65 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.974 1.31 . . . . 0.0 110.853 -169.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -70.58 114.61 8.85 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.863 -1.148 . . . . 0.0 110.657 171.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.3 pt -101.37 0.29 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 123.73 0.812 . . . . 0.0 112.756 172.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.1 p -69.51 -17.63 63.61 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -169.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -101.89 8.98 56.48 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 125.344 1.45 . . . . 0.0 114.548 169.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -87.49 156.15 19.67 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.348 1.459 . . . . 0.0 112.295 -169.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.8 t -86.89 165.4 15.95 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -175.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.5 m -135.31 93.66 3.01 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.495 1.518 . . . . 0.0 109.103 169.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -88.97 133.37 35.61 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-O 118.469 -0.777 . . . . 0.0 111.806 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.09 153.94 22.14 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.655 2.237 . . . . 0.0 112.922 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.9 tp -55.96 -32.46 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -169.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -89.22 -13.83 37.33 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 120.786 -1.196 . . . . 0.0 113.267 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -90.1 -26.28 20.31 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.102 0.961 . . . . 0.0 112.832 175.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -52.81 46.72 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -169.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.401 ' HA ' ' CH2' ' A' ' 90' ' ' TRP . 3.1 m120 59.47 106.0 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.547 2.739 . . . . 0.0 114.561 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.05 13.85 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.97 1.708 . . . . 0.0 115.474 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -73.87 -29.28 62.01 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.069 0.948 . . . . 0.0 111.138 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -100.15 -5.67 27.42 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -124.89 94.46 4.19 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.27 1.428 . . . . 0.0 110.152 -172.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -73.12 -5.08 36.75 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -174.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.3 t -128.39 121.85 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 125.601 1.561 . . . . 0.0 109.451 173.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.2 t -132.31 119.35 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.052 0.541 . . . . 0.0 110.852 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 mp -110.24 134.35 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.001 0.92 . . . . 0.0 110.564 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.0 m -89.79 147.73 23.63 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.301 1.041 . . . . 0.0 108.253 168.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.9 mt -127.13 43.59 3.09 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.395 1.078 . . . . 0.0 110.728 -173.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 24.3 p -151.57 -16.56 0.2 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 117.59 2.441 . . . . 0.0 117.59 -169.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.08 34.42 70.31 Favored Glycine 0 CA--C 1.539 1.547 0 CA-C-N 119.898 1.226 . . . . 0.0 111.118 -168.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 4.0 p -141.97 -1.03 1.27 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.578 1.951 . . . . 0.0 114.756 -169.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -55.88 -21.47 30.42 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.064 1.792 . . . . 0.0 116.709 -169.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.09 -22.33 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 CA-C-N 118.692 1.246 . . . . 0.0 112.022 173.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -78.5 -10.19 59.62 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 176.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.7 mt -74.26 157.86 86.11 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-N 119.054 0.843 . . . . 0.0 111.707 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.91 141.01 93.43 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.641 2.227 . . . . 0.0 111.522 172.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -63.07 -29.73 75.18 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.477 2.118 . . . . 0.0 112.666 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -62.79 -25.71 68.37 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 173.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.401 ' CH2' ' HA ' ' A' ' 69' ' ' ASN . 0.4 OUTLIER -87.14 4.08 43.74 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 170.201 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.8 t -112.51 -36.63 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.949 1.7 . . . . 0.0 112.544 -175.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.9 p -79.28 10.09 4.01 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 -169.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -66.16 166.54 11.65 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.342 1.457 . . . . 0.0 112.056 169.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -56.78 -37.94 71.8 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -169.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 74.3 mt -127.07 119.8 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.52 1.128 . . . . 0.0 109.674 174.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -133.2 128.23 35.51 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.825 1.25 . . . . 0.0 110.57 169.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -146.81 161.19 41.18 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.809 1.644 . . . . 0.0 110.759 -174.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -127.47 117.02 21.32 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.384 -0.822 . . . . 0.0 112.93 173.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -88.36 94.17 9.76 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 169.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -51.79 59.82 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 128.823 2.849 . . . . 0.0 116.167 169.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 93.2 mt -84.24 153.35 23.65 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.735 2.414 . . . . 0.0 111.842 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -70.91 162.53 29.14 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.853 0.861 . . . . 0.0 111.408 169.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -88.28 107.79 18.44 Favored Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 120.76 -1.212 . . . . 0.0 108.136 169.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -79.05 -11.96 14.7 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 121.346 1.364 . . . . 0.0 114.643 -169.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -46.2 105.34 0.06 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.745 2.018 . . . . 0.0 113.792 -173.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.04 10.85 53.25 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.331 0.967 . . . . 0.0 115.507 174.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -74.87 -59.21 2.84 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.024 1.412 . . . . 0.0 111.141 -175.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.1 t -172.08 152.44 2.89 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.061 2.145 . . . . 0.0 108.542 170.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.4 mp -60.05 -30.95 69.53 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.75 -0.594 . . . . 0.0 111.117 172.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.0 -38.05 89.66 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.324 -0.86 . . . . 0.0 112.397 173.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.5 t -72.84 -39.85 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.568 0.747 . . . . 0.0 109.194 177.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -45.81 92.1 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.745 0.818 . . . . 0.0 111.406 176.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -69.09 -36.01 77.12 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.367 1.067 . . . . 0.0 112.273 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 62.3 m -59.6 -51.28 70.48 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 118.8 0.727 . . . . 0.0 111.286 174.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.0 m -70.39 -28.92 36.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 CA-C-O 117.206 -1.378 . . . . 0.0 112.553 177.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . 0.255 0.0 OUTLIER -67.06 -37.25 83.71 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 121.21 1.823 . . . . 0.0 112.46 172.249 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.55 -44.15 95.54 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.039 0.828 . . . . 0.0 112.446 173.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -61.65 -46.93 87.64 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 117.61 0.705 . . . . 0.0 112.129 171.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.7 t -58.63 -47.45 88.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 CA-C-O 117.042 -1.456 . . . . 0.0 110.593 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -51.53 -47.06 63.49 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 120.695 1.589 . . . . 0.0 112.79 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.21 -48.06 77.35 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.407 0.683 . . . . 0.0 112.265 177.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 63.8 mtt-85 -76.15 -32.24 59.0 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -176.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.0 p -73.93 -34.44 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.697 1.199 . . . . 0.0 111.427 175.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -60.97 -56.09 25.2 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.34 0.973 . . . . 0.0 108.621 168.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -50.25 -38.72 42.22 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.052 1.741 . . . . 0.0 112.487 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -78.16 -60.52 2.34 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.29 -0.882 . . . . 0.0 113.134 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.61 -34.54 51.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 123.981 0.913 . . . . 0.0 111.63 -175.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.91 -0.17 17.69 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.774 1.229 . . . . 0.0 114.239 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -98.27 -10.97 23.11 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.215 1.406 . . . . 0.0 113.312 169.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.7 pt -118.47 -0.25 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.66 1.584 . . . . 0.0 113.359 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 51.2 p . . . . . 0 C--O 1.256 1.429 0 C-N-CA 125.225 1.41 . . . . 0.0 113.69 169.824 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.3 ttm . . . . . 0 N--CA 1.503 2.214 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.795 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -83.96 92.53 7.85 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 119.273 0.942 . . . . 0.0 111.29 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -78.33 145.29 35.38 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.55 -0.719 . . . . 0.0 112.704 -173.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.2 t -113.63 142.65 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 125.117 1.367 . . . . 0.0 111.252 178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.403 ' HE3' ' CD1' ' A' ' 68' ' ' PHE . 62.8 tpp -131.02 122.35 26.65 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.015 0.926 . . . . 0.0 111.279 169.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -92.85 143.35 26.35 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.158 0.583 . . . . 0.0 109.611 168.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.0 t -135.42 130.69 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.905 1.282 . . . . 0.0 109.578 -173.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 p -144.33 174.2 11.12 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.19 0.996 . . . . 0.0 111.606 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -61.26 -56.62 18.49 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.904 -1.122 . . . . 0.0 109.663 173.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -94.5 123.69 38.08 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 106.503 -1.665 . . . . 0.0 106.503 168.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -63.29 -48.77 76.7 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 120.363 1.438 . . . . 0.0 108.89 169.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 94.1 p -47.53 -35.08 8.36 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.822 2.449 . . . . 0.0 115.273 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.6 p -91.03 -27.87 18.34 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.69 1.196 . . . . 0.0 114.139 -173.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 -136.97 -63.09 0.62 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -169.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 95.2 p -62.87 -30.34 71.44 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 120.757 1.617 . . . . 0.0 112.135 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -63.1 -41.84 99.45 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.86 1.264 . . . . 0.0 112.507 169.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.8 mtm -62.14 -45.54 92.98 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.827 -0.546 . . . . 0.0 111.08 174.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.39 -24.01 65.64 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.827 -1.083 . . . . 0.0 113.522 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -74.1 -48.66 28.15 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 121.656 2.025 . . . . 0.0 108.35 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.66 -43.15 99.41 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-O 119.024 -0.875 . . . . 0.0 112.829 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -64.47 -42.86 95.65 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.636 1.718 . . . . 0.0 112.267 173.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.31 -31.05 63.79 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.622 1.101 . . . . 0.0 111.135 -176.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -65.24 -53.9 37.4 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 125.354 1.462 . . . . 0.0 109.919 171.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.1 p -69.62 -11.07 60.55 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.6 mt -103.89 -1.68 27.35 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.551 1.141 . . . . 0.0 113.88 171.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.6 9.06 0.47 Allowed Glycine 0 N--CA 1.477 1.399 0 N-CA-C 117.288 1.675 . . . . 0.0 117.288 -169.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.98 133.8 55.82 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 119.249 1.525 . . . . 0.0 111.886 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.87 -6.83 54.02 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.473 1.035 . . . . 0.0 115.332 -175.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -87.59 -63.55 1.29 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.349 1.575 . . . . 0.0 110.6 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -142.98 173.94 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 127.222 2.209 . . . . 0.0 110.946 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.0 130.34 41.71 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.369 -0.832 . . . . 0.0 112.61 176.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -105.48 154.03 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.73 1.212 . . . . 0.0 112.974 171.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.5 147.0 25.7 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -172.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.7 p -108.75 139.76 43.11 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 127.107 2.163 . . . . 0.0 114.031 170.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.5 t -143.05 177.37 8.42 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.498 1.519 . . . . 0.0 110.463 169.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.69 173.26 39.76 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 120.122 -1.611 . . . . 0.0 115.06 173.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.1 mt -61.76 -35.52 78.35 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.457 0.703 . . . . 0.0 111.752 -174.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -125.19 111.56 15.42 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.836 2.455 . . . . 0.0 107.565 169.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.4 p -65.51 -33.79 76.75 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.179 -0.95 . . . . 0.0 112.064 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.5 t 48.72 -120.63 1.36 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.386 1.474 . . . . 0.0 111.814 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -144.28 -151.54 0.37 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.594 1.957 . . . . 0.0 111.008 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.2 m -91.18 116.26 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 168.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -68.66 133.77 90.58 Favored Pre-proline 0 N--CA 1.481 1.11 0 O-C-N 120.963 -1.086 . . . . 0.0 111.686 -169.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -59.82 -37.61 85.3 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.446 2.764 . . . . 0.0 113.736 -171.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.9 m -79.02 -35.68 42.35 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.912 -0.492 . . . . 0.0 110.364 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.13 93.8 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.903 -1.123 . . . . 0.0 112.422 174.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.3 mt -53.32 -44.84 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 120.944 1.702 . . . . 0.0 110.71 172.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.67 -56.23 17.31 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.972 0.731 . . . . 0.0 112.972 175.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 30.1 mmt -68.66 -19.21 64.4 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -174.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 87.0 mmm -91.86 -40.23 11.3 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.888 0.875 . . . . 0.0 110.659 176.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -60.49 -39.83 89.12 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.741 -1.224 . . . . 0.0 112.404 174.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -60.31 -26.86 66.87 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.173 -0.954 . . . . 0.0 113.533 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.7 p -100.34 12.83 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 124.894 1.277 . . . . 0.0 113.103 174.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.39 18.59 48.63 Favored Glycine 0 N--CA 1.475 1.286 0 C-N-CA 124.795 1.188 . . . . 0.0 115.263 172.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.4 mt -127.22 85.5 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.426 1.49 . . . . 0.0 110.048 -169.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -71.27 109.81 5.52 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.133 -1.604 . . . . 0.0 110.831 173.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.5 pt -87.5 -9.31 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 118.251 -0.88 . . . . 0.0 112.512 173.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.3 t -62.36 -34.55 76.9 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 120.552 1.524 . . . . 0.0 113.149 -169.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.86 3.99 85.81 Favored Glycine 0 CA--C 1.541 1.683 0 C-N-CA 124.782 1.182 . . . . 0.0 115.282 173.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -97.26 150.68 20.66 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.41 1.484 . . . . 0.0 111.895 -173.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.3 t -84.87 149.62 25.55 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.268 -0.895 . . . . 0.0 112.886 -175.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 71.1 m -121.8 111.45 17.15 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.04 0.936 . . . . 0.0 109.914 169.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -89.17 152.58 48.18 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.039 0.936 . . . . 0.0 112.825 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -91.83 150.84 3.35 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.268 3.312 . . . . 0.0 112.0 171.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 tt -63.18 -27.87 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -170.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -82.1 -11.41 58.78 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.0 -1.063 . . . . 0.0 113.246 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -96.81 -27.97 14.47 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.436 1.094 . . . . 0.0 113.323 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.403 ' CD1' ' HE3' ' A' ' 5' ' ' MET . 0.0 OUTLIER -62.54 -41.72 99.07 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -168.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.4 ' HA ' ' CH2' ' A' ' 90' ' ' TRP 0.341 0.0 OUTLIER 53.97 99.44 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.662 2.785 . . . . 0.0 115.043 -176.834 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.66 5.31 0.85 Allowed 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -175.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -72.2 -27.13 62.36 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.023 1.329 . . . . 0.0 112.27 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -90.07 -2.47 58.11 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -119.79 140.2 51.12 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.982 1.313 . . . . 0.0 112.604 -169.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -88.74 -28.83 20.26 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.894 0.877 . . . . 0.0 111.83 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.6 t -130.08 120.42 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.516 1.127 . . . . 0.0 110.003 -170.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.6 t -126.42 129.34 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.573 0.749 . . . . 0.0 110.193 177.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.8 mm -121.73 126.94 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.086 0.954 . . . . 0.0 110.632 -171.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.6 t -89.45 121.7 31.94 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.863 0.465 . . . . 0.0 109.835 169.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.416 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 75.9 mt -98.6 13.42 32.07 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.496 1.518 . . . . 0.0 112.024 175.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.5 p -133.22 157.99 44.0 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.799 2.039 . . . . 0.0 109.032 169.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.71 72.84 0.36 Allowed Glycine 0 N--CA 1.476 1.364 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 171.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 82.3 m -129.93 5.27 4.97 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.403 1.881 . . . . 0.0 114.872 -168.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -54.84 -28.09 46.23 Favored Glycine 0 CA--C 1.538 1.507 0 CA-C-N 120.321 1.419 . . . . 0.0 116.098 -173.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.2 m -99.05 -8.71 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 174.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -95.36 -28.56 14.89 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.093 1.357 . . . . 0.0 112.452 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.6 mt -63.22 150.07 89.84 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.585 1.154 . . . . 0.0 111.814 174.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -58.82 133.29 52.86 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.673 2.249 . . . . 0.0 111.081 173.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -61.18 -31.6 90.18 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.393 2.062 . . . . 0.0 113.184 -176.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -59.17 -32.86 70.28 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.059 -1.026 . . . . 0.0 112.959 171.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.4 ' CH2' ' HA ' ' A' ' 69' ' ' ASN . 0.4 OUTLIER -86.0 12.03 10.31 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.35 1.06 . . . . 0.0 113.821 174.633 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.9 t -116.48 -36.5 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.856 1.662 . . . . 0.0 111.74 178.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.8 p -79.59 25.31 0.34 Allowed 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 -169.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -76.17 167.02 22.62 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.858 1.663 . . . . 0.0 111.975 171.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -57.94 -37.09 73.48 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.932 0.893 . . . . 0.0 112.837 -171.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 67.4 mt -126.81 123.74 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.636 1.175 . . . . 0.0 109.215 169.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -131.52 134.25 45.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.208 1.003 . . . . 0.0 110.597 169.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -141.43 153.97 45.32 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.542 1.137 . . . . 0.0 112.155 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -120.92 117.67 27.92 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.74 1.216 . . . . 0.0 110.157 173.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.416 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 37.0 m0 -95.32 -0.79 52.43 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.669 1.188 . . . . 0.0 113.612 -177.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.308 1.3 pp0? 46.44 39.21 6.26 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 171.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.8 mt -79.4 159.64 26.99 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.8 0.84 . . . . 0.0 112.765 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -87.04 150.81 23.77 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.624 1.569 . . . . 0.0 111.958 173.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.44 116.26 59.32 Favored Pre-proline 0 CA--C 1.546 0.815 0 O-C-N 121.298 -0.877 . . . . 0.0 110.574 172.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -83.23 -14.82 8.13 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.496 2.131 . . . . 0.0 115.457 -169.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -46.59 108.08 0.13 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.759 1.624 . . . . 0.0 112.98 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.69 9.34 78.61 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-O 118.878 -0.957 . . . . 0.0 115.407 175.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -73.81 -68.17 0.54 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.04 1.42 . . . . 0.0 110.431 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.6 t -177.23 152.26 0.86 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 128.505 2.722 . . . . 0.0 108.106 173.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.8 mp -60.36 -29.94 69.23 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.822 0.737 . . . . 0.0 111.549 174.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -64.23 -38.65 91.81 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.091 -1.006 . . . . 0.0 112.423 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.2 t -73.61 -37.63 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.016 0.926 . . . . 0.0 109.476 176.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.8 -45.22 95.23 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.23 1.012 . . . . 0.0 111.177 175.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -67.79 -38.05 82.84 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.638 1.175 . . . . 0.0 112.491 173.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.4 m -58.86 -50.36 74.29 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 118.778 0.717 . . . . 0.0 110.886 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.6 m -71.25 -30.97 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 117.643 -1.17 . . . . 0.0 112.266 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -40.33 97.08 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 121.21 1.823 . . . . 0.0 111.966 171.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.49 -42.83 95.56 Favored Glycine 0 N--CA 1.474 1.183 0 C-N-CA 124.391 0.996 . . . . 0.0 112.579 176.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -60.75 -45.64 93.53 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.915 -0.756 . . . . 0.0 111.947 170.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 29.3 t -58.67 -48.73 84.94 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.807 177.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -51.56 -55.13 20.84 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.856 1.207 . . . . 0.0 111.487 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -59.69 -42.05 92.1 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.619 0.768 . . . . 0.0 112.572 -176.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -78.06 -35.01 50.08 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 39.1 t -61.19 -48.25 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.185 1.394 . . . . 0.0 111.19 172.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -51.88 -55.22 21.41 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.06 0.845 . . . . 0.0 109.606 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -56.93 -37.46 71.52 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.191 1.397 . . . . 0.0 112.276 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -74.25 -56.28 5.07 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.33 -0.856 . . . . 0.0 112.556 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.63 -34.44 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.775 1.23 . . . . 0.0 112.363 -175.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.14 -22.78 62.02 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 121.118 -0.989 . . . . 0.0 113.486 -174.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -70.2 -19.73 63.15 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.593 1.157 . . . . 0.0 113.849 173.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 28.7 pt -118.89 17.15 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 126.259 1.824 . . . . 0.0 112.652 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--O 1.256 1.401 0 C-N-CA 126.459 1.904 . . . . 0.0 111.313 172.158 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.6 tpp . . . . . 0 N--CA 1.502 2.139 0 CA-C-O 118.989 -0.529 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -82.7 85.42 7.04 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 119.873 1.215 . . . . 0.0 111.338 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -77.42 147.55 35.93 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -171.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.64 139.5 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.938 1.295 . . . . 0.0 111.074 176.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 49.4 tpp -127.36 115.36 18.85 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.499 0.72 . . . . 0.0 111.093 169.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -81.53 142.58 32.73 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.624 -0.673 . . . . 0.0 110.331 169.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.92 128.17 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 119.187 0.903 . . . . 0.0 111.66 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.5 p -144.76 178.02 8.3 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.462 1.105 . . . . 0.0 111.757 175.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -59.8 -61.46 2.6 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 120.083 1.31 . . . . 0.0 109.617 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -83.72 125.18 31.63 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 167.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -59.68 -43.25 94.08 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 120.029 1.286 . . . . 0.0 108.476 169.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.0 p -65.49 -48.58 72.13 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 115.848 1.795 . . . . 0.0 115.848 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.3 m -71.8 -15.51 62.15 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -169.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.82 -55.05 0.82 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 120.325 1.421 . . . . 0.0 113.258 168.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.8 m -61.97 -38.2 87.64 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -171.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -62.71 -36.14 82.0 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.377 0.99 . . . . 0.0 113.214 169.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 82.5 mtp -59.83 -45.58 91.96 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.161 -0.962 . . . . 0.0 110.3 173.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.62 -31.38 69.47 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 117.954 -1.022 . . . . 0.0 113.555 174.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -68.61 -46.17 69.99 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 121.553 1.979 . . . . 0.0 109.033 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.49 -42.99 97.29 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 118.527 -1.152 . . . . 0.0 112.668 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -66.13 -42.3 89.33 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.202 1.501 . . . . 0.0 112.144 171.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.93 -35.75 81.68 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.61 -1.306 . . . . 0.0 111.114 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -63.53 -55.78 21.18 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.135 1.774 . . . . 0.0 109.976 174.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.7 p -68.41 -14.47 63.02 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 178.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 50.8 mt -99.14 -6.68 27.83 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.384 1.074 . . . . 0.0 113.864 174.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -152.13 9.56 0.62 Allowed Glycine 0 N--CA 1.476 1.311 0 N-CA-C 117.185 1.634 . . . . 0.0 117.185 -169.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.36 132.21 50.37 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 119.514 1.657 . . . . 0.0 111.609 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.37 -6.22 57.92 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.803 1.192 . . . . 0.0 115.475 -176.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -86.46 -59.16 2.36 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 119.459 1.629 . . . . 0.0 110.813 175.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.6 pp -144.7 175.71 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 128.226 2.61 . . . . 0.0 110.118 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.35 132.5 41.79 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.22 -0.925 . . . . 0.0 112.788 174.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.7 m -104.02 145.93 12.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 124.667 1.187 . . . . 0.0 112.704 171.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.8 m -146.94 156.35 43.0 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.217 1.007 . . . . 0.0 111.707 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.9 p -126.02 139.83 53.1 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.885 2.074 . . . . 0.0 113.9 175.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.7 t -133.66 172.1 13.21 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 129.567 3.147 . . . . 0.0 109.322 -176.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.64 173.56 44.84 Favored Glycine 0 CA--C 1.523 0.587 0 O-C-N 120.551 -1.343 . . . . 0.0 115.094 169.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.1 mt -66.46 -28.43 68.58 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.291 0.636 . . . . 0.0 111.723 -178.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -121.26 127.91 51.86 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.48 1.912 . . . . 0.0 108.383 170.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.5 p -78.02 55.99 1.54 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.675 1.59 . . . . 0.0 110.381 171.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.5 p -68.13 149.2 49.89 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.29 1.436 . . . . 0.0 112.037 -169.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -58.24 155.3 11.7 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.395 0.678 . . . . 0.0 111.673 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.1 m -50.91 109.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 169.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -65.95 130.63 94.44 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 118.478 -0.772 . . . . 0.0 112.319 -168.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.03 -38.79 85.65 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.489 2.793 . . . . 0.0 113.391 -172.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.9 m -77.55 -34.02 53.95 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 119.224 -0.417 . . . . 0.0 110.684 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.82 -43.48 96.09 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.844 -1.16 . . . . 0.0 111.986 172.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.7 mt -54.72 -40.3 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 120.795 1.634 . . . . 0.0 110.328 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.62 -62.87 1.27 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 173.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 30.4 mmt -67.11 -21.69 65.84 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.951 0.9 . . . . 0.0 113.415 -172.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 86.4 mmm -85.36 -37.78 19.5 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.616 0.767 . . . . 0.0 110.524 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -63.75 -33.44 75.67 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.665 -1.272 . . . . 0.0 111.983 173.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -55.26 -28.49 53.75 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 170.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.1 m -107.11 19.48 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 125.328 1.451 . . . . 0.0 113.525 174.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.64 13.73 74.98 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.65 1.119 . . . . 0.0 115.37 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.3 mt -117.67 97.19 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.448 1.499 . . . . 0.0 109.855 -170.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -78.35 112.09 15.0 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.958 -1.089 . . . . 0.0 110.438 171.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.0 pt -93.09 -4.22 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 172.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.4 p -65.98 -26.33 67.51 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -169.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -100.58 9.29 58.77 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.362 1.458 . . . . 0.0 114.445 172.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -86.72 149.11 25.11 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.983 1.313 . . . . 0.0 112.266 -170.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.9 t -63.59 148.16 49.58 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.459 -0.776 . . . . 0.0 112.109 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.5 t -138.96 54.95 1.72 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.046 0.927 . . . . 0.0 111.689 174.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -68.88 147.45 97.84 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 125.192 1.397 . . . . 0.0 113.185 -170.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -82.75 151.81 14.77 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.635 2.224 . . . . 0.0 112.442 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.8 tt -60.48 -21.83 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -91.99 -9.42 43.02 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 177.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -97.58 -35.2 10.69 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.781 0.832 . . . . 0.0 111.913 171.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -68.43 160.41 29.73 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.18 0.592 . . . . 0.0 111.571 175.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.404 ' HA ' ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -136.63 119.38 16.16 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.666 0.786 . . . . 0.0 111.985 170.479 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.54 0.8 2.01 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -175.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -70.59 -29.26 65.63 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.906 0.882 . . . . 0.0 112.209 -175.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -88.78 -2.36 58.55 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.116 1.366 . . . . 0.0 113.322 177.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -124.67 95.15 4.41 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.706 1.602 . . . . 0.0 110.498 -171.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -55.13 -29.48 57.81 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.768 1.227 . . . . 0.0 112.83 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 t -121.55 118.3 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 125.111 1.364 . . . . 0.0 110.19 -172.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.8 t -130.17 134.38 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.818 0.847 . . . . 0.0 110.644 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.0 mm -128.71 132.64 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 121.434 -0.791 . . . . 0.0 111.399 -170.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.4 t -87.87 117.59 26.82 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.521 0.728 . . . . 0.0 111.116 169.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 mp -97.68 37.07 1.42 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.734 1.614 . . . . 0.0 109.177 173.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.2 t -135.63 146.2 47.63 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.192 1.797 . . . . 0.0 111.647 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.16 -16.58 80.59 Favored Glycine 0 CA--C 1.542 1.723 0 O-C-N 121.946 -0.471 . . . . 0.0 112.798 169.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 24.5 p -63.35 -56.46 16.16 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.652 1.581 . . . . 0.0 114.173 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.27 -60.7 0.82 Allowed Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.69 1.614 . . . . 0.0 114.908 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.9 m -59.74 -21.62 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 126.23 1.812 . . . . 0.0 115.468 -170.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -76.79 -11.11 59.78 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.6 mt -80.82 135.97 51.61 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.615 0.766 . . . . 0.0 110.685 170.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.96 153.73 47.46 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.47 2.114 . . . . 0.0 110.675 174.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -59.82 -34.0 95.87 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.859 2.372 . . . . 0.0 112.222 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -48.89 -46.25 42.38 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.499 1.52 . . . . 0.0 112.938 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.404 ' CH2' ' HA ' ' A' ' 69' ' ' ASN . 1.8 m95 -90.75 8.2 35.77 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.747 1.219 . . . . 0.0 112.961 -177.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.7 t -114.94 -38.53 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 127.03 2.132 . . . . 0.0 111.704 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.9 p -81.39 26.71 0.45 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -174.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -80.89 169.34 17.67 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.31 1.444 . . . . 0.0 111.896 174.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -53.58 -41.79 66.92 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 -169.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 59.9 mt -125.71 123.46 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.591 1.157 . . . . 0.0 109.373 170.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -133.49 135.06 44.23 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.007 0.923 . . . . 0.0 111.44 169.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -142.84 153.12 42.87 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.69 1.196 . . . . 0.0 112.42 -175.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -113.36 125.88 54.75 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.279 1.432 . . . . 0.0 111.133 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 44.3 m0 -100.91 -5.69 25.67 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 177.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.355 1.2 pp0? 50.3 31.89 5.71 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.3 mt -75.52 151.87 37.89 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -87.28 160.6 18.36 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.704 2.002 . . . . 0.0 112.511 178.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.61 115.02 60.75 Favored Pre-proline 0 CA--C 1.547 0.83 0 O-C-N 121.282 -0.886 . . . . 0.0 111.4 169.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.87 -13.74 9.14 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.471 2.114 . . . . 0.0 114.822 -170.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -44.05 113.7 0.56 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.506 1.922 . . . . 0.0 113.556 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.81 6.46 55.88 Favored Glycine 0 CA--C 1.534 1.234 0 N-CA-C 115.86 1.104 . . . . 0.0 115.86 173.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -78.04 -63.63 1.35 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.921 1.361 . . . . 0.0 110.881 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.6 t -174.24 152.47 1.82 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.391 2.277 . . . . 0.0 108.889 169.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.1 mp -59.96 -29.92 68.75 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.624 -0.672 . . . . 0.0 111.299 171.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -63.09 -39.75 95.63 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.056 -1.028 . . . . 0.0 112.483 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.3 t -71.43 -37.1 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.843 0.857 . . . . 0.0 109.733 175.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -41.9 92.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.914 0.885 . . . . 0.0 111.699 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -70.09 -36.8 75.17 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 121.22 -0.925 . . . . 0.0 111.987 171.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.3 m -58.06 -48.94 78.58 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.087 0.858 . . . . 0.0 111.639 174.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 23.8 m -68.25 -31.25 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 117.802 -1.094 . . . . 0.0 112.09 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.26 -42.22 98.27 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 120.867 1.667 . . . . 0.0 111.786 170.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.74 -43.82 93.44 Favored Glycine 0 N--CA 1.473 1.158 0 C-N-CA 124.256 0.932 . . . . 0.0 112.785 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -60.51 -45.21 94.65 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 122.166 -0.608 . . . . 0.0 112.032 170.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.9 t -59.67 -50.35 80.33 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 CA-C-O 117.518 -1.23 . . . . 0.0 109.434 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -50.81 -49.89 57.59 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.045 1.293 . . . . 0.0 112.068 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -60.48 -44.37 95.99 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.528 0.731 . . . . 0.0 112.948 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 46.4 mtp85 -81.92 -35.93 28.6 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.0 p -72.51 -34.07 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.17 1.388 . . . . 0.0 111.747 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -56.44 -56.98 14.48 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.249 0.931 . . . . 0.0 109.535 169.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -55.64 -35.68 66.18 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.885 1.274 . . . . 0.0 111.877 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -73.45 -57.16 4.19 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.631 -0.668 . . . . 0.0 112.385 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.96 -33.07 61.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.848 0.859 . . . . 0.0 112.211 -176.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.32 -23.25 60.23 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -173.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -68.57 -21.35 64.53 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.693 1.197 . . . . 0.0 113.811 173.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 29.0 pt -117.77 15.28 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 126.452 1.901 . . . . 0.0 112.634 -177.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--O 1.255 1.358 0 C-N-CA 126.501 1.92 . . . . 0.0 111.753 173.522 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.505 2.295 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -81.23 98.01 7.9 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.0 0.92 . . . . 0.0 110.147 175.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -80.47 146.46 31.37 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.647 -0.658 . . . . 0.0 112.324 -174.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.0 t -111.95 146.59 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.673 1.189 . . . . 0.0 110.743 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 45.3 tpp -130.83 112.81 13.36 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.226 1.011 . . . . 0.0 111.448 169.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -82.2 129.57 34.87 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.31 1.044 . . . . 0.0 110.362 169.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.3 t -127.22 136.23 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.069 1.348 . . . . 0.0 110.925 -176.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 t -149.78 -176.81 5.57 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 121.443 -0.786 . . . . 0.0 111.919 169.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -61.15 -45.0 96.43 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.412 -0.805 . . . . 0.0 110.617 170.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.56 129.59 56.68 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.435 1.494 . . . . 0.0 110.787 169.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -72.78 -55.79 6.21 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 169.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.0 p -27.35 -52.22 0.07 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 128.882 2.873 . . . . 0.0 116.758 173.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.4 p -100.96 -24.47 14.33 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.857 1.263 . . . . 0.0 113.898 -174.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -118.04 -71.46 0.74 Allowed 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 119.643 1.111 . . . . 0.0 111.98 -173.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.96 -30.38 70.88 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 121.256 -0.903 . . . . 0.0 112.924 -175.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -66.42 -34.25 77.52 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 126.405 1.882 . . . . 0.0 113.801 172.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 27.3 mmm -65.73 -36.4 83.5 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.656 -0.652 . . . . 0.0 110.27 172.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.41 -26.69 61.07 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.263 -0.898 . . . . 0.0 113.394 169.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -68.96 -53.25 21.8 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.395 1.452 . . . . 0.0 108.439 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.67 -49.07 77.0 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-O 118.935 -0.925 . . . . 0.0 112.488 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -66.71 -38.34 86.51 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.586 1.193 . . . . 0.0 112.49 175.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.65 -38.07 80.16 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 120.024 1.283 . . . . 0.0 110.215 -178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -57.74 -57.48 12.58 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 125.796 1.639 . . . . 0.0 110.889 171.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.9 p -71.35 -15.4 62.39 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -177.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.1 mt -95.14 -13.24 25.23 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -142.84 8.88 2.27 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 117.783 1.873 . . . . 0.0 117.783 -169.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.14 129.52 38.48 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.771 1.786 . . . . 0.0 111.784 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.33 -6.55 56.89 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 124.677 1.132 . . . . 0.0 115.571 -177.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -86.78 -57.37 3.01 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 119.471 1.636 . . . . 0.0 110.603 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.6 pp -142.17 177.13 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 127.504 2.322 . . . . 0.0 110.161 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.28 122.17 43.21 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.725 0.774 . . . . 0.0 111.591 173.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.9 m -87.74 149.92 3.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 123.781 0.833 . . . . 0.0 111.746 169.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.42 152.04 38.42 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.728 0.811 . . . . 0.0 110.93 176.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.0 p -133.44 145.65 50.45 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.941 1.696 . . . . 0.0 112.541 175.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.4 t -150.01 178.46 8.91 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.884 1.674 . . . . 0.0 110.573 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.26 -179.57 46.42 Favored Glycine 0 CA--C 1.527 0.794 0 O-C-N 120.92 -1.112 . . . . 0.0 114.185 170.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.1 mt -71.95 -44.39 63.65 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -169.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -90.73 -25.57 19.95 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.747 1.619 . . . . 0.0 112.473 173.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 60.3 p 58.84 -65.1 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 127.814 2.445 . . . . 0.0 113.128 -169.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 t 56.59 -174.58 0.06 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 130.22 3.408 . . . . 0.0 114.095 -177.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 54.6 ttt85 -79.83 147.51 31.75 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.873 1.669 . . . . 0.0 111.034 174.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.0 m -47.35 112.92 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.794 1.238 . . . . 0.0 109.739 169.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -63.12 137.56 97.1 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -167.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.4 -40.01 61.62 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.716 2.944 . . . . 0.0 113.518 -175.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.1 m -77.23 -33.04 56.19 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.978 -0.451 . . . . 0.0 110.513 176.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.3 -47.88 83.91 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.403 1.001 . . . . 0.0 111.706 171.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 68.7 mt -49.25 -44.56 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 120.388 1.449 . . . . 0.0 110.823 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.84 -59.44 5.14 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 174.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.2 mmt -67.11 -22.17 65.82 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -175.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.2 mtp -80.88 -45.16 17.24 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.993 1.317 . . . . 0.0 110.665 173.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -61.69 -33.45 74.02 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.804 -1.185 . . . . 0.0 112.532 176.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -55.53 -30.23 60.35 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.264 1.026 . . . . 0.0 113.455 172.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.0 m -105.87 14.98 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 125.146 1.379 . . . . 0.0 113.792 177.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.93 17.79 64.65 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.166 0.889 . . . . 0.0 115.124 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.6 mt -112.68 114.86 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.91 1.284 . . . . 0.0 110.944 -169.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -90.81 110.83 22.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.7 1.2 . . . . 0.0 111.783 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.3 pt -110.62 -5.89 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 169.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.8 p -67.32 -25.6 66.09 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 120.548 -1.345 . . . . 0.0 114.44 -169.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -106.99 14.12 40.84 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 125.683 1.611 . . . . 0.0 114.378 170.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -95.51 151.23 19.5 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.307 1.443 . . . . 0.0 112.128 -170.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.7 t -77.32 146.8 36.54 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 121.247 -0.908 . . . . 0.0 112.856 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.6 m -126.21 98.58 5.53 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.787 1.235 . . . . 0.0 109.069 169.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.79 155.99 75.3 Favored Pre-proline 0 CA--C 1.553 1.088 0 O-C-N 121.223 -0.923 . . . . 0.0 113.388 -174.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -97.63 152.45 0.92 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.866 3.711 . . . . 0.0 113.708 171.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.6 tp -60.81 -21.1 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 -169.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -103.15 -6.88 21.75 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -84.28 -37.91 21.11 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.97 0.804 . . . . 0.0 111.674 171.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.45 159.32 34.16 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.803 0.841 . . . . 0.0 111.574 173.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.432 ' HA ' ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -138.29 112.9 8.9 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.528 0.731 . . . . 0.0 111.728 171.428 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.7 -3.67 2.48 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -169.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.86 -27.62 67.67 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.004 -1.06 . . . . 0.0 112.214 -174.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -91.86 -0.87 57.53 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.087 1.355 . . . . 0.0 113.655 176.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -122.54 95.12 4.51 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.359 1.464 . . . . 0.0 110.597 -170.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -56.2 -31.3 63.33 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.878 1.271 . . . . 0.0 112.968 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.3 t -121.43 121.43 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 124.527 1.131 . . . . 0.0 110.494 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.7 t -127.1 133.59 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.079 0.952 . . . . 0.0 110.169 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.8 mm -122.84 136.7 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.909 0.883 . . . . 0.0 110.375 -175.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.7 t -96.96 127.23 42.73 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.042 0.937 . . . . 0.0 110.464 169.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -108.95 25.86 11.3 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.542 1.537 . . . . 0.0 110.173 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 31.3 p -150.56 165.28 33.76 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.138 2.575 . . . . 0.0 111.837 177.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.31 -19.25 75.8 Favored Glycine 0 CA--C 1.541 1.672 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 168.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 11.0 p -61.99 -6.39 2.84 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 127.235 2.214 . . . . 0.0 115.431 174.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.1 -31.96 59.4 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.613 1.102 . . . . 0.0 114.633 177.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.2 m -67.81 -16.09 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 176.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -97.61 2.25 49.69 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.256 1.422 . . . . 0.0 113.195 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.2 mt -71.92 155.3 92.15 Favored Pre-proline 0 CA--C 1.549 0.941 0 O-C-N 121.148 -0.97 . . . . 0.0 111.538 173.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -64.28 149.27 90.51 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.751 2.301 . . . . 0.0 113.954 -175.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -72.89 56.82 3.06 Favored 'Trans proline' 0 CA--C 1.549 1.261 1 C-N-CA 125.879 4.386 . . . . 0.0 111.183 171.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -157.03 -51.0 0.07 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.671 2.388 . . . . 0.0 109.431 -169.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.432 ' CH2' ' HA ' ' A' ' 69' ' ' ASN . 1.0 OUTLIER -85.39 -28.1 25.36 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.112 0.965 . . . . 0.0 111.899 177.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.4 m -84.16 -12.95 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 175.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.9 p -94.37 8.71 41.02 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.042 1.337 . . . . 0.0 114.202 -172.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -74.61 169.15 18.37 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.797 1.239 . . . . 0.0 112.98 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -52.07 -39.98 60.49 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -169.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.2 mt -126.3 122.98 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.553 1.141 . . . . 0.0 109.429 169.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -129.38 124.56 34.52 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.391 1.076 . . . . 0.0 110.143 169.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -141.79 167.61 21.74 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.334 1.454 . . . . 0.0 111.017 -174.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -135.27 146.84 48.94 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 172.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 36.7 m0 -109.38 7.68 25.13 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 64.46 -78.76 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.097 1.759 . . . . 0.0 112.983 -177.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 27.0 mt 49.94 -163.89 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 127.585 2.354 . . . . 0.0 113.852 -175.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -141.58 160.49 40.04 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.953 2.101 . . . . 0.0 108.105 171.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -81.1 110.53 18.3 Favored Pre-proline 0 N--CA 1.471 0.625 0 CA-C-N 119.764 1.166 . . . . 0.0 109.689 169.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -81.63 -10.77 11.83 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 121.249 1.3 . . . . 0.0 114.273 -169.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -45.47 109.26 0.16 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.666 1.586 . . . . 0.0 113.568 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.52 9.77 62.2 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 118.767 -1.018 . . . . 0.0 115.478 172.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -78.46 -64.8 1.09 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.877 1.338 . . . . 0.0 111.079 -176.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 21.4 t -173.74 151.62 1.88 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.372 2.269 . . . . 0.0 108.429 170.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.8 mp -60.81 -28.2 68.61 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.577 -0.702 . . . . 0.0 111.119 172.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.18 -39.6 95.1 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.027 -1.046 . . . . 0.0 112.334 173.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.5 t -71.68 -38.9 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.084 0.954 . . . . 0.0 109.654 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.34 -40.0 95.01 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.259 1.024 . . . . 0.0 111.608 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.8 mtt85 -73.23 -36.46 66.44 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 121.062 -1.024 . . . . 0.0 112.185 170.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 55.2 m -58.02 -47.73 82.17 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 119.147 0.885 . . . . 0.0 111.646 175.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.6 m -68.39 -30.24 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 119.589 1.086 . . . . 0.0 111.778 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.66 -43.52 98.59 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 120.236 1.38 . . . . 0.0 111.76 169.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.74 -44.33 94.99 Favored Glycine 0 N--CA 1.473 1.11 0 C-N-CA 124.47 1.033 . . . . 0.0 112.68 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -59.87 -46.41 89.4 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.242 0.617 . . . . 0.0 112.069 170.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.9 t -59.42 -52.06 65.39 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.506 0 CA-C-O 117.136 -1.411 . . . . 0.0 110.3 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -49.52 -44.23 46.15 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.122 1.369 . . . . 0.0 113.215 -175.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -65.91 -45.59 81.4 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.416 0.686 . . . . 0.0 112.556 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 53.8 mtp85 -82.05 -34.46 29.46 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.752 0.821 . . . . 0.0 112.823 -173.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.4 p -68.64 -38.61 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.327 1.451 . . . . 0.0 111.785 173.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -57.54 -56.16 25.53 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.607 1.094 . . . . 0.0 109.631 169.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -55.23 -32.65 62.45 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.723 1.209 . . . . 0.0 112.342 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -77.04 -58.71 3.13 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.228 -0.92 . . . . 0.0 112.68 176.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.75 -32.64 58.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.88 1.272 . . . . 0.0 112.36 -174.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.93 -15.06 59.78 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -172.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -74.51 -26.54 60.06 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.529 1.131 . . . . 0.0 113.446 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 23.8 pt -110.23 -7.41 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.544 1.538 . . . . 0.0 113.589 -177.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.0 m . . . . . 0 C--O 1.252 1.207 0 C-N-CA 125.103 1.361 . . . . 0.0 113.117 173.83 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.9 ttm . . . . . 0 N--CA 1.502 2.138 0 CA-C-O 119.519 -0.277 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -93.92 91.11 6.75 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.658 1.183 . . . . 0.0 110.756 173.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.34 144.47 42.35 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 121.444 -0.785 . . . . 0.0 111.276 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 p -125.3 145.2 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.249 1.02 . . . . 0.0 112.199 -176.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 40.3 tpp -133.45 117.19 16.91 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.939 1.296 . . . . 0.0 112.071 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -84.19 141.08 31.3 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 119.198 -0.429 . . . . 0.0 111.138 169.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.7 t -134.23 124.73 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.297 1.439 . . . . 0.0 111.622 -176.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.9 p -145.8 -179.4 6.66 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.009 1.324 . . . . 0.0 111.608 175.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.79 -59.96 4.15 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 119.947 -1.721 . . . . 0.0 110.803 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -87.31 136.07 33.08 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 168.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -72.57 -55.92 6.17 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 169.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.486 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 24.9 p -50.8 -49.29 58.77 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.681 1.364 . . . . 0.0 114.681 -176.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 m -74.96 -10.88 59.9 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 -143.12 -68.25 0.35 Allowed 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 119.841 1.2 . . . . 0.0 113.571 177.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 44.5 m -65.43 -35.72 81.77 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.456 -1.402 . . . . 0.0 114.472 -172.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -68.97 -29.72 67.99 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 120.922 -1.111 . . . . 0.0 112.887 169.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.2 mtm -61.96 -46.97 86.94 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 169.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.31 -31.2 71.86 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -69.58 -45.9 67.59 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 120.431 1.469 . . . . 0.0 109.531 176.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.44 ' CA ' HE22 ' A' ' 60' ' ' GLN . . . -63.05 -43.84 98.2 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 118.939 -0.923 . . . . 0.0 111.767 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -63.69 -42.97 97.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.47 1.135 . . . . 0.0 112.409 170.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.43 -31.7 72.07 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 120.515 -1.365 . . . . 0.0 111.056 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -67.86 -55.1 14.18 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 126.502 1.921 . . . . 0.0 109.296 174.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.8 p -68.69 -14.54 63.09 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 177.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 39.8 mt -101.05 1.51 39.55 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.66 1.184 . . . . 0.0 113.83 172.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.97 9.97 0.22 Allowed Glycine 0 CA--C 1.535 1.322 0 N-CA-C 117.402 1.721 . . . . 0.0 117.402 -169.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.96 131.35 50.79 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.763 1.782 . . . . 0.0 111.71 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.54 -3.39 59.66 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.491 1.043 . . . . 0.0 115.469 -175.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -87.11 -63.38 1.32 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 119.102 1.451 . . . . 0.0 110.329 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -142.09 173.9 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 127.44 2.296 . . . . 0.0 110.203 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.18 120.81 33.11 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 121.232 -0.917 . . . . 0.0 111.302 176.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 m -94.31 148.13 5.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.791 169.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.55 157.78 43.69 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.758 0.823 . . . . 0.0 110.741 -172.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.7 p -145.06 146.42 31.86 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 79.7 p -150.56 -179.04 6.91 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.676 1.591 . . . . 0.0 110.691 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.37 -174.3 43.63 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 116.46 1.344 . . . . 0.0 116.46 170.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.7 mt -71.49 -47.63 54.2 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.261 0.624 . . . . 0.0 111.822 -172.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -92.81 -32.8 14.52 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.26 1.824 . . . . 0.0 111.412 170.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . 0.282 26.0 p 61.22 -53.53 0.11 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 128.177 2.591 . . . . 0.0 114.813 -171.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.0 t 60.36 -178.82 0.1 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 127.579 2.352 . . . . 0.0 115.07 173.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -71.6 166.18 22.4 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 126.531 1.933 . . . . 0.0 112.375 172.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.1 m -62.54 117.83 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 169.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.486 ' H ' ' HB2' ' A' ' 12' ' ' SER . 56.0 t-80 -76.14 132.46 73.61 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 124.033 0.933 . . . . 0.0 113.141 -168.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -57.73 -41.93 65.07 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.484 2.789 . . . . 0.0 114.059 -170.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.6 m -77.68 -35.46 52.24 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.797 -0.564 . . . . 0.0 110.864 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.74 -43.14 94.33 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.327 -0.844 . . . . 0.0 111.942 173.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.7 mt -54.06 -46.54 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 120.34 1.427 . . . . 0.0 109.717 174.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.38 -60.01 4.38 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.4 mmt -66.71 -29.7 69.75 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.414 -0.804 . . . . 0.0 112.13 -172.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 75.4 mmm -80.43 -40.0 27.17 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.668 0.787 . . . . 0.0 110.364 178.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -58.33 -37.31 74.87 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.588 -1.32 . . . . 0.0 112.315 171.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -59.71 -23.8 63.46 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.3 m -105.19 16.0 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 124.715 1.206 . . . . 0.0 114.021 172.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.01 13.65 66.04 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.398 0.999 . . . . 0.0 115.029 177.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.9 mt -120.72 68.81 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.032 1.733 . . . . 0.0 109.601 -169.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -65.17 105.14 1.02 Allowed 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.231 -1.543 . . . . 0.0 110.668 174.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.1 pt -81.2 -0.42 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 O-C-N 121.528 -0.733 . . . . 0.0 112.815 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 85.1 p -71.67 -28.35 63.67 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.399 -1.438 . . . . 0.0 114.043 -172.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.28 2.93 71.88 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 125.332 1.444 . . . . 0.0 114.432 171.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.44 HE22 ' CA ' ' A' ' 20' ' ' GLY . 12.9 mt-30 -86.4 159.16 19.44 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.463 1.505 . . . . 0.0 112.202 -177.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.8 t -87.73 152.63 21.99 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -170.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.3 m -139.36 134.8 32.99 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.362 1.465 . . . . 0.0 110.398 169.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -142.26 142.69 24.81 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 123.979 0.912 . . . . 0.0 111.066 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -81.0 150.52 18.07 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.186 2.591 . . . . 0.0 112.714 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.3 tt -64.5 -18.25 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -172.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -95.86 -9.1 32.32 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -95.68 -36.32 11.25 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.095 0.958 . . . . 0.0 111.2 169.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -67.9 161.49 26.3 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.315 0.579 . . . . 0.0 111.609 174.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -135.78 122.23 20.66 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.338 1.055 . . . . 0.0 110.505 174.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.44 -0.35 10.16 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -171.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -70.49 -32.88 70.57 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.265 0.939 . . . . 0.0 113.421 -169.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -77.34 -21.01 54.02 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -105.27 90.9 3.57 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.003 1.321 . . . . 0.0 110.448 -169.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -58.08 -30.13 65.99 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.21 108.26 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.385 1.074 . . . . 0.0 109.874 -177.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.8 t -112.13 132.65 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.16 0.984 . . . . 0.0 109.81 177.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.6 mm -128.59 118.22 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 123.556 0.742 . . . . 0.0 110.374 -170.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 t -78.88 136.16 37.22 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.536 0.684 . . . . 0.0 109.346 168.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.6 mt -108.58 23.8 13.99 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.342 1.057 . . . . 0.0 109.848 169.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.8 p -151.05 2.36 0.43 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 -174.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.81 26.93 69.29 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-N 119.642 1.11 . . . . 0.0 113.57 -171.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 74.0 m -80.48 -2.04 44.24 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -169.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.88 -22.15 46.96 Favored Glycine 0 CA--C 1.538 1.489 0 O-C-N 120.291 -1.506 . . . . 0.0 115.162 -171.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.8 m -72.71 -13.8 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 172.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -113.57 -17.15 12.24 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.44 1.496 . . . . 0.0 112.135 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.8 mp -67.03 153.72 93.98 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 124.403 1.081 . . . . 0.0 113.039 176.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -59.57 137.34 76.98 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.902 2.401 . . . . 0.0 110.074 169.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -59.0 -33.86 98.94 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.241 1.961 . . . . 0.0 113.33 -174.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -65.41 -25.69 67.65 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.774 1.17 . . . . 0.0 113.974 176.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.72 -19.8 54.6 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.761 -1.212 . . . . 0.0 112.573 171.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.7 t -89.63 -37.28 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.834 1.654 . . . . 0.0 112.087 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.7 p -83.46 18.14 1.93 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -173.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -69.0 166.49 17.9 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.147 0.979 . . . . 0.0 111.519 169.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -53.16 -40.84 64.61 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -169.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 63.4 mt -129.4 126.65 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.664 1.186 . . . . 0.0 109.791 169.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -131.03 125.21 32.67 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.671 1.188 . . . . 0.0 109.929 169.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -140.96 166.16 25.56 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.906 1.282 . . . . 0.0 112.115 -175.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -129.81 134.38 47.52 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.087 1.355 . . . . 0.0 112.306 173.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 46.8 m0 -96.29 0.71 51.23 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 64.63 33.45 10.63 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.829 1.251 . . . . 0.0 114.275 170.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 26.7 mt -90.66 166.43 13.17 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -119.65 148.9 42.81 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.684 1.994 . . . . 0.0 111.178 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.74 119.13 76.12 Favored Pre-proline 0 CA--C 1.55 0.971 0 O-C-N 121.402 -0.812 . . . . 0.0 110.984 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -85.85 -10.19 7.29 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.234 1.956 . . . . 0.0 115.338 -173.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -47.74 113.81 0.78 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.927 1.291 . . . . 0.0 112.938 177.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.04 -3.65 84.57 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 123.978 0.799 . . . . 0.0 114.289 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -78.45 169.52 18.11 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.143 0.972 . . . . 0.0 110.044 169.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 97.2 p -64.13 156.82 27.22 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.383 -0.823 . . . . 0.0 111.903 173.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.9 -30.96 70.49 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.413 -0.804 . . . . 0.0 111.695 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -64.48 -36.34 83.87 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 120.957 -1.089 . . . . 0.0 113.388 173.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.5 t -73.7 -36.65 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 O-C-N 121.061 -1.024 . . . . 0.0 110.272 173.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.54 -40.03 95.95 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.805 0.842 . . . . 0.0 110.675 175.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -67.03 -42.49 84.77 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.046 1.738 . . . . 0.0 111.961 172.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.9 m -58.5 -50.72 72.74 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.402 1.081 . . . . 0.0 111.938 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 19.7 m -67.7 -31.81 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 119.389 0.995 . . . . 0.0 111.699 179.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.2 ptt-85 -70.44 -30.72 67.63 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 120.255 1.389 . . . . 0.0 112.954 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.58 -43.64 96.22 Favored Glycine 0 N--CA 1.477 1.429 0 C-N-CA 123.797 0.713 . . . . 0.0 111.998 169.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -62.61 -38.25 89.47 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.63 -0.923 . . . . 0.0 112.456 170.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.7 t -60.23 -50.41 80.34 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.595 173.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -53.13 -52.73 57.77 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 120.177 1.353 . . . . 0.0 111.79 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -48.31 -44.81 34.36 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.468 1.507 . . . . 0.0 112.352 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -90.91 -28.87 17.82 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.125 0.97 . . . . 0.0 112.022 -171.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.8 t -63.91 -50.07 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.916 1.286 . . . . 0.0 109.569 169.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -53.4 -55.27 26.44 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.663 0.665 . . . . 0.0 109.292 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -50.89 -36.69 39.45 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.107 1.763 . . . . 0.0 113.376 174.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -84.78 -61.53 1.76 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.609 1.095 . . . . 0.0 113.513 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -57.49 -33.33 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.751 1.62 . . . . 0.0 111.599 -177.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.5 -10.48 59.84 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 44.7 mttm -80.15 -20.12 45.66 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.596 1.158 . . . . 0.0 112.425 169.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.1 pt -122.23 28.27 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 127.309 2.243 . . . . 0.0 111.569 -176.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 24.3 t . . . . . 0 C--O 1.252 1.228 0 C-N-CA 127.633 2.373 . . . . 0.0 111.114 179.141 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.502 2.166 0 CA-C-O 119.378 -0.344 . . . . 0.0 111.87 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -84.51 99.66 10.86 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 118.995 0.816 . . . . 0.0 110.115 174.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -75.41 147.85 39.63 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.741 0.417 . . . . 0.0 111.855 -174.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.6 t -104.92 140.08 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.464 1.106 . . . . 0.0 110.635 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 49.3 tpp -127.15 113.97 17.08 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.586 0.755 . . . . 0.0 110.331 169.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -81.49 143.35 32.13 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.39 0.676 . . . . 0.0 110.315 169.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.4 t -134.86 123.95 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.443 1.497 . . . . 0.0 110.558 -178.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 p -136.32 170.9 15.28 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.472 1.109 . . . . 0.0 111.162 171.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -58.46 -53.94 52.66 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 120.342 1.428 . . . . 0.0 110.16 175.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -93.87 121.76 35.66 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 168.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.577 ' ND2' ' H ' ' A' ' 63' ' ' ASP . 23.0 t-20 -47.12 -41.36 17.29 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 121.406 1.912 . . . . 0.0 110.713 169.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.6 p -66.59 -35.89 81.31 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.888 1.675 . . . . 0.0 114.868 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 95.1 p -65.69 -37.07 85.45 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -169.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.27 -43.92 0.41 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.8 m -63.11 -42.68 99.62 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 119.731 1.15 . . . . 0.0 113.009 -169.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -57.63 -40.96 80.37 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.292 1.837 . . . . 0.0 112.456 169.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 94.7 mtp -64.87 -43.03 94.31 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.283 0.633 . . . . 0.0 110.488 175.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.14 -29.69 67.78 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 117.701 -1.142 . . . . 0.0 113.409 173.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -70.43 -48.3 56.67 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 121.45 1.932 . . . . 0.0 108.48 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.73 -46.24 94.37 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.607 -1.107 . . . . 0.0 113.676 176.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -66.96 -34.12 77.06 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.542 1.671 . . . . 0.0 112.378 175.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.05 -33.6 61.74 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.88 -1.137 . . . . 0.0 110.639 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -60.41 -56.21 24.24 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 125.621 1.569 . . . . 0.0 109.444 170.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.0 p -70.3 -11.01 60.61 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.6 mt -98.1 -5.47 33.66 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 171.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.59 17.4 0.08 OUTLIER Glycine 0 CA--C 1.536 1.368 0 N-CA-C 118.661 2.224 . . . . 0.0 118.661 -172.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.73 -33.25 64.08 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.848 1.824 . . . . 0.0 114.511 -173.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.36 -6.15 88.95 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 124.161 0.886 . . . . 0.0 115.043 177.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -101.1 -59.17 1.74 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.958 1.303 . . . . 0.0 112.003 -170.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.5 pp -143.84 171.91 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 127.345 2.258 . . . . 0.0 110.536 -174.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.53 131.99 42.58 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.409 -0.807 . . . . 0.0 112.9 175.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.9 m -104.28 149.37 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 C-N-CA 125.09 1.356 . . . . 0.0 113.259 171.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.53 144.87 27.6 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.413 0.685 . . . . 0.0 112.382 -173.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.0 t -114.24 129.44 56.63 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.976 2.111 . . . . 0.0 113.799 175.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 t -132.33 177.02 7.91 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.505 1.922 . . . . 0.0 110.764 171.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.55 175.08 46.11 Favored Glycine 0 CA--C 1.523 0.557 0 O-C-N 120.572 -1.33 . . . . 0.0 114.286 171.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.0 mt -67.39 -27.39 67.05 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 122.275 -0.544 . . . . 0.0 111.829 -176.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -123.48 115.56 21.76 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.157 2.183 . . . . 0.0 105.765 169.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 77.3 p -62.31 -20.37 64.25 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.314 -0.866 . . . . 0.0 113.076 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.6 t 54.83 -149.91 0.43 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.773 1.629 . . . . 0.0 113.905 168.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.68 165.11 28.39 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 128.244 2.618 . . . . 0.0 110.052 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 m -67.34 102.12 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 169.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -70.26 135.59 86.79 Favored Pre-proline 0 N--CA 1.476 0.841 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.936 -169.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -60.31 -36.79 86.2 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.911 2.407 . . . . 0.0 113.618 -171.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.2 m -77.56 -33.44 54.04 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.543 -0.723 . . . . 0.0 111.193 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.75 -44.32 81.79 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.053 0.842 . . . . 0.0 111.761 170.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 74.7 mt -50.97 -47.07 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 120.343 1.429 . . . . 0.0 110.337 173.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.54 -63.74 1.13 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 31.9 mmt -68.81 -24.43 64.39 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.45 -0.781 . . . . 0.0 112.942 -170.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 80.7 mmm -79.54 -35.74 39.43 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.732 0.696 . . . . 0.0 110.803 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -61.09 -30.88 70.62 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.631 -1.293 . . . . 0.0 112.693 171.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -54.35 -37.31 64.77 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.207 0.912 . . . . 0.0 112.755 172.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.2 m -98.16 15.2 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.58 1.152 . . . . 0.0 113.914 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.03 13.01 67.16 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.115 0.864 . . . . 0.0 115.029 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.6 mt -119.49 70.34 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.63 1.572 . . . . 0.0 109.709 -169.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -66.13 108.96 2.43 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 119.995 -1.691 . . . . 0.0 110.56 171.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.7 pt -84.52 -4.74 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.0 t -61.86 -32.68 73.05 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 120.382 1.446 . . . . 0.0 112.912 -170.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.32 4.51 80.49 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.03 1.3 . . . . 0.0 115.383 173.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -87.77 149.0 24.45 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.017 1.408 . . . . 0.0 112.36 -172.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.8 t -76.08 157.08 33.3 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.0 p -139.21 154.7 48.06 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.185 1.394 . . . . 0.0 109.847 169.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.577 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -146.88 149.98 37.7 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.387 1.075 . . . . 0.0 111.62 -175.099 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -88.79 152.61 6.07 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.637 2.891 . . . . 0.0 111.335 174.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.6 tp -60.23 -21.53 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.31 1.444 . . . . 0.0 114.863 -177.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -97.6 -9.1 27.53 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -92.08 -38.77 12.0 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 118.891 0.769 . . . . 0.0 111.609 172.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.0 158.24 36.0 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.388 0.613 . . . . 0.0 111.192 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -138.13 115.82 11.4 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.778 1.231 . . . . 0.0 109.476 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.5 0.18 5.65 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 -169.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -70.04 -29.12 66.08 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.715 1.143 . . . . 0.0 112.328 -172.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -87.43 -2.8 58.87 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.008 1.323 . . . . 0.0 113.062 175.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -124.88 83.29 2.14 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.106 1.762 . . . . 0.0 109.5 -171.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -57.76 -19.13 25.78 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.18 0.992 . . . . 0.0 113.404 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.3 t -121.03 113.9 41.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.46 1.504 . . . . 0.0 109.931 -177.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.6 t -127.42 133.79 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 121.501 -0.749 . . . . 0.0 110.199 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.2 mm -129.09 133.21 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 121.567 -0.708 . . . . 0.0 111.21 -169.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.7 t -92.7 119.4 32.06 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.798 1.639 . . . . 0.0 110.835 173.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 mp -103.33 27.96 6.82 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.21 1.804 . . . . 0.0 111.327 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.4 p -146.23 173.37 12.29 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.465 1.906 . . . . 0.0 109.827 169.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.82 58.47 4.24 Favored Glycine 0 N--CA 1.478 1.493 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 168.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 27.4 p -133.32 -3.93 3.04 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -167.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.14 -36.86 76.84 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 120.463 1.483 . . . . 0.0 114.997 -170.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.9 m -68.69 -14.59 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 176.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -99.11 -4.23 32.77 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.2 1.4 . . . . 0.0 113.177 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.6 mt -74.67 158.92 84.34 Favored Pre-proline 0 CA--C 1.549 0.905 0 O-C-N 121.239 -0.913 . . . . 0.0 111.394 173.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.65 138.57 86.73 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.747 2.298 . . . . 0.0 111.51 172.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.1 -38.48 45.42 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.466 2.111 . . . . 0.0 112.595 -169.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.93 -23.96 65.13 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.121 -0.987 . . . . 0.0 113.586 176.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -78.69 -9.6 59.46 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.699 -1.251 . . . . 0.0 112.949 169.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.5 t -100.78 -41.66 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 126.513 1.925 . . . . 0.0 111.481 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.1 p -80.52 28.98 0.31 Allowed 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -172.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -79.29 170.47 16.58 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.955 1.302 . . . . 0.0 111.99 170.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -57.79 -36.6 72.4 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.125 0.97 . . . . 0.0 113.496 -170.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 61.9 mt -128.01 125.65 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.909 1.284 . . . . 0.0 109.59 170.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -135.71 138.96 43.28 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.041 0.937 . . . . 0.0 111.479 169.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -143.26 146.71 33.86 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.128 1.371 . . . . 0.0 112.03 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -109.35 116.84 32.6 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.175 1.39 . . . . 0.0 109.586 169.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -94.08 -6.95 43.92 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.331 1.2 pp0? 50.12 30.28 4.12 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 176.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.5 mt -73.04 150.05 42.69 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -86.07 158.9 19.71 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.872 1.669 . . . . 0.0 113.016 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -81.89 128.42 68.67 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.848 1.259 . . . . 0.0 112.866 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -88.24 -38.58 0.06 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.61 2.207 . . . . 0.0 113.595 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 19.43 51.35 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 131.622 3.969 . . . . 0.0 117.786 169.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.36 11.56 79.79 Favored Glycine 0 CA--C 1.539 1.588 0 O-C-N 120.797 -1.189 . . . . 0.0 115.046 176.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -63.37 -52.89 59.82 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.807 1.243 . . . . 0.0 111.076 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 34.1 t -168.48 153.56 6.38 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.742 2.017 . . . . 0.0 109.627 169.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.5 mp -56.85 -31.84 65.2 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.982 0.913 . . . . 0.0 110.999 172.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.56 -39.83 74.12 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.978 1.311 . . . . 0.0 112.568 173.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.6 t -73.16 -38.11 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 121.503 -0.748 . . . . 0.0 109.668 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -63.86 -44.58 92.67 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.265 0.484 . . . . 0.0 111.463 175.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -64.35 -39.12 93.27 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.514 1.126 . . . . 0.0 111.74 176.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.1 m -62.51 -52.84 61.88 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.012 0.925 . . . . 0.0 111.469 173.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.5 m -72.69 -29.71 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 117.047 -1.454 . . . . 0.0 112.78 -177.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.9 ptt85 -64.16 -37.12 86.33 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 121.805 2.093 . . . . 0.0 112.181 171.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.55 -48.99 77.65 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.886 0.755 . . . . 0.0 112.316 173.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -59.81 -45.58 91.89 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 117.586 0.693 . . . . 0.0 112.407 173.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.9 t -58.67 -46.88 90.2 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.495 0 CA-C-O 117.843 -1.075 . . . . 0.0 110.169 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -52.12 -53.57 41.08 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.044 1.293 . . . . 0.0 111.853 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -58.3 -45.66 87.59 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.098 0.475 . . . . 0.0 111.854 -178.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -75.11 -33.5 61.61 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 36.4 t -63.13 -47.91 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.97 1.308 . . . . 0.0 111.03 169.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -53.77 -55.71 23.95 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.523 1.056 . . . . 0.0 109.481 174.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -53.33 -26.2 17.99 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.059 1.344 . . . . 0.0 113.545 177.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -91.68 -62.27 1.46 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.277 1.431 . . . . 0.0 112.945 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.84 -31.03 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.581 1.552 . . . . 0.0 111.551 -176.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.52 -7.22 54.7 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -74.06 -27.79 61.09 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.6 1.16 . . . . 0.0 112.693 169.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.4 pt -117.26 -7.91 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.616 1.966 . . . . 0.0 113.555 -171.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 C--O 1.255 1.391 0 C-N-CA 125.261 1.424 . . . . 0.0 112.458 172.426 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 ttm . . . . . 0 N--CA 1.502 2.159 0 CA-C-O 119.653 -0.213 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -90.32 90.25 7.98 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.257 1.023 . . . . 0.0 110.487 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -80.94 149.24 29.47 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 121.573 -0.704 . . . . 0.0 112.232 -174.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.2 t -115.09 143.41 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.663 1.185 . . . . 0.0 111.124 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.405 ' HE1' ' CD2' ' A' ' 68' ' ' PHE . 46.1 tpp -130.62 122.68 27.88 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.248 1.019 . . . . 0.0 111.019 169.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -93.22 138.67 31.39 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.509 -0.744 . . . . 0.0 110.597 169.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.8 t -134.41 130.5 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.984 1.314 . . . . 0.0 110.384 -171.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 t -151.8 -165.67 2.29 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.439 0.696 . . . . 0.0 112.542 169.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -63.0 -70.54 0.2 Allowed 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 119.406 1.003 . . . . 0.0 111.045 170.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 56.6 mtt-85 -79.07 127.76 32.41 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 118.569 0.622 . . . . 0.0 109.955 169.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.594 ' ND2' ' H ' ' A' ' 63' ' ' ASP . 19.2 t-20 -61.06 -43.37 98.98 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 168.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 99.3 p -73.97 -48.26 31.69 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -169.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.0 p -83.29 -11.23 57.95 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.763 -1.211 . . . . 0.0 113.695 -173.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 -126.63 -67.42 0.86 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.788 1.235 . . . . 0.0 111.734 -176.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.3 m -64.21 -44.51 91.68 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.16 1.171 . . . . 0.0 114.16 -175.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -57.5 -30.68 65.31 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.832 1.253 . . . . 0.0 113.792 170.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.1 mtm -68.17 -49.36 61.44 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.072 0.851 . . . . 0.0 110.92 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.72 -29.93 70.04 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.622 -0.674 . . . . 0.0 112.686 172.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -71.23 -44.22 65.78 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 119.691 1.132 . . . . 0.0 109.269 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.96 -41.31 98.7 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 119.299 -0.723 . . . . 0.0 112.073 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -62.73 -44.24 96.73 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.885 1.342 . . . . 0.0 111.719 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.82 -32.79 69.97 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 120.574 -1.329 . . . . 0.0 111.224 -174.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -64.91 -56.3 14.14 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 126.432 1.893 . . . . 0.0 109.449 171.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.3 p -68.08 -14.93 63.35 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 52.7 mt -100.74 -8.16 23.04 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.454 1.102 . . . . 0.0 113.816 174.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.58 10.55 1.27 Allowed Glycine 0 CA--C 1.534 1.273 0 N-CA-C 117.181 1.632 . . . . 0.0 117.181 -169.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.98 131.01 46.19 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.16 1.48 . . . . 0.0 112.067 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.47 -6.44 57.66 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.528 1.061 . . . . 0.0 115.531 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -86.25 -61.32 1.77 Allowed 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 119.296 1.548 . . . . 0.0 110.339 175.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -142.75 173.01 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 127.667 2.387 . . . . 0.0 110.316 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.75 130.02 41.45 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.366 -0.834 . . . . 0.0 112.314 175.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.7 m -104.15 153.04 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.716 1.206 . . . . 0.0 112.478 170.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.19 145.7 27.27 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -171.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.1 t -110.33 133.49 53.2 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.835 2.054 . . . . 0.0 113.615 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.8 t -141.84 171.33 14.2 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.521 1.928 . . . . 0.0 110.949 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.59 -179.82 45.66 Favored Glycine 0 CA--C 1.526 0.778 0 O-C-N 120.883 -1.136 . . . . 0.0 114.567 169.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 38.0 mt -63.19 -26.7 68.93 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.23 1.012 . . . . 0.0 112.074 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -128.34 127.43 42.67 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.19 1.396 . . . . 0.0 109.09 170.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.6 p -77.48 58.04 1.65 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.262 1.425 . . . . 0.0 110.492 171.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.4 p -65.9 156.62 32.87 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 114.146 -1.388 . . . . 0.0 112.818 -169.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -64.74 144.64 57.1 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.251 1.02 . . . . 0.0 109.981 177.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.7 m -41.23 109.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.852 1.661 . . . . 0.0 109.082 170.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -68.03 132.31 92.06 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-O 118.383 -0.817 . . . . 0.0 112.82 -167.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.31 -39.15 80.17 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.372 2.715 . . . . 0.0 113.566 -170.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.0 m -78.05 -37.06 47.66 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 119.151 -0.452 . . . . 0.0 110.496 177.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.67 -40.78 96.02 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.626 1.103 . . . . 0.0 112.475 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.4 mt -52.38 -47.17 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 120.98 1.718 . . . . 0.0 109.927 172.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.82 -58.38 8.68 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 175.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.6 mmt -66.18 -22.0 66.34 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 88.5 mmm -90.93 -37.36 13.58 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.941 0.896 . . . . 0.0 110.592 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -60.89 -33.89 73.81 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.407 -1.433 . . . . 0.0 112.319 169.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -56.0 -30.06 61.26 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.036 0.934 . . . . 0.0 113.313 173.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.4 m -103.41 13.64 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.857 1.263 . . . . 0.0 114.155 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.13 17.2 63.32 Favored Glycine 0 CA--C 1.537 1.467 0 O-C-N 121.209 -0.932 . . . . 0.0 115.106 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.1 mt -122.54 79.68 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.977 1.711 . . . . 0.0 109.631 -169.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -70.28 106.59 3.4 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.053 -1.655 . . . . 0.0 111.185 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.1 pt -82.3 -10.14 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 118.166 -0.921 . . . . 0.0 112.576 175.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.5 t -61.85 -33.15 73.66 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 120.3 1.409 . . . . 0.0 113.029 -169.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -95.94 6.52 66.91 Favored Glycine 0 CA--C 1.541 1.674 0 C-N-CA 125.098 1.333 . . . . 0.0 115.294 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -93.32 151.27 19.89 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.028 1.414 . . . . 0.0 111.477 -171.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.6 t -68.25 149.98 48.83 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -170.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.8 t -135.81 133.24 37.67 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.36 1.464 . . . . 0.0 109.183 169.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.594 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 4.1 t70 -148.21 146.22 22.65 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.696 1.598 . . . . 0.0 110.836 -172.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -91.15 154.46 3.82 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.574 2.183 . . . . 0.0 112.65 -173.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.3 tt -60.66 -21.42 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -94.06 -9.58 36.24 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -94.51 -37.44 11.39 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.785 0.834 . . . . 0.0 111.816 170.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.405 ' CD2' ' HE1' ' A' ' 5' ' ' MET . 0.0 OUTLIER -70.58 163.18 27.5 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.26 0.552 . . . . 0.0 111.644 174.56 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -139.38 134.1 31.99 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.015 0.926 . . . . 0.0 110.633 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.62 6.87 6.41 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -174.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -74.31 -30.86 62.25 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.068 -1.02 . . . . 0.0 112.594 -173.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -88.86 -3.74 58.67 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.657 1.183 . . . . 0.0 113.6 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -123.72 94.01 4.11 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.739 1.616 . . . . 0.0 110.151 -171.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -62.75 -18.9 63.37 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.0 t -120.09 114.74 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.812 1.245 . . . . 0.0 110.472 -176.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.3 t -127.9 129.88 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.995 0.918 . . . . 0.0 110.814 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.5 mm -116.35 125.29 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.301 0.641 . . . . 0.0 111.56 -172.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.0 t -86.11 92.12 8.63 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.379 1.472 . . . . 0.0 109.155 169.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.9 mt -76.94 -11.04 59.75 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.884 0.873 . . . . 0.0 112.158 171.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 27.5 p -75.71 -22.88 56.19 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.586 0.755 . . . . 0.0 111.673 169.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.88 21.86 65.91 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 123.587 0.613 . . . . 0.0 112.503 -169.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 31.3 p -98.06 -54.28 3.13 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.163 1.385 . . . . 0.0 113.028 -169.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.29 -65.02 1.0 Allowed Glycine 0 N--CA 1.476 1.344 0 C-N-CA 124.791 1.186 . . . . 0.0 114.002 177.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.5 m -64.24 -22.09 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.444 1.498 . . . . 0.0 114.175 -176.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -87.98 -0.96 57.67 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.177 0.991 . . . . 0.0 112.998 175.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.0 mt -94.43 151.31 39.26 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 124.958 1.303 . . . . 0.0 109.867 170.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.86 136.68 75.26 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.326 2.018 . . . . 0.0 110.645 169.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -64.22 -29.55 64.43 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.485 2.123 . . . . 0.0 112.63 -176.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -61.37 -28.68 69.41 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 171.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.35 13.28 13.95 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.829 1.252 . . . . 0.0 114.163 171.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.6 t -114.1 -37.19 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.666 1.587 . . . . 0.0 111.416 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -81.04 27.09 0.41 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 115.297 1.592 . . . . 0.0 115.297 -169.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -77.11 165.7 24.25 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.822 1.649 . . . . 0.0 112.64 173.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -56.23 -38.23 70.8 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.776 1.23 . . . . 0.0 113.008 -172.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.0 mt -127.48 116.99 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.14 1.376 . . . . 0.0 108.704 169.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -128.14 128.44 44.82 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.191 0.997 . . . . 0.0 109.881 169.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -137.29 140.0 41.28 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.613 0.765 . . . . 0.0 113.007 -170.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -97.9 104.59 16.63 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.265 1.826 . . . . 0.0 112.173 176.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 16.2 m0 -95.2 92.14 6.63 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 169.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -60.92 54.43 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 128.277 2.631 . . . . 0.0 115.718 176.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 77.3 mt -76.43 167.71 21.37 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.036 2.134 . . . . 0.0 111.841 175.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -96.73 153.89 17.61 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.748 1.219 . . . . 0.0 110.628 169.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -77.31 120.24 80.75 Favored Pre-proline 0 CA--C 1.546 0.809 0 O-C-N 120.88 -1.138 . . . . 0.0 111.114 172.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -87.13 -19.29 2.54 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.466 1.444 . . . . 0.0 114.957 -170.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -53.42 107.41 0.24 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.635 1.174 . . . . 0.0 112.092 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.04 -0.94 69.78 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.288 0.947 . . . . 0.0 114.62 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -77.95 172.15 13.91 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 118.316 1.058 . . . . 0.0 110.18 169.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 90.4 p -66.35 156.68 33.8 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.045 -1.034 . . . . 0.0 111.557 169.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.92 -27.58 68.95 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.306 -0.871 . . . . 0.0 111.862 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.2 -40.73 86.69 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.128 -0.983 . . . . 0.0 112.354 170.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 78.7 t -74.04 -37.73 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.371 -0.831 . . . . 0.0 110.416 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.59 -41.56 99.03 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.515 0.726 . . . . 0.0 111.075 176.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -69.55 -37.54 77.1 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.715 1.206 . . . . 0.0 112.29 171.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 55.3 m -58.3 -49.09 78.38 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 119.157 0.89 . . . . 0.0 111.589 176.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 31.2 m -67.22 -30.68 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 119.934 1.243 . . . . 0.0 111.719 177.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.37 -46.54 89.58 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 119.811 1.187 . . . . 0.0 111.318 169.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.53 -35.66 92.33 Favored Glycine 0 N--CA 1.472 1.054 0 C-N-CA 123.823 0.725 . . . . 0.0 112.153 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -68.46 -51.43 43.57 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 171.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.6 m -61.26 -39.68 83.43 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 CA-C-O 117.372 -1.299 . . . . 0.0 111.179 178.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -47.92 -57.5 5.63 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.331 1.423 . . . . 0.0 111.898 174.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -63.67 -41.78 98.15 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.274 0.629 . . . . 0.0 112.387 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 59.1 mtp85 -73.77 -34.74 64.82 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.87 -47.97 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.271 1.428 . . . . 0.0 111.465 171.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -52.63 -54.41 33.66 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.454 1.025 . . . . 0.0 109.563 177.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -55.56 -38.83 69.83 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.063 1.345 . . . . 0.0 112.668 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -73.1 -56.93 4.44 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.169 -0.957 . . . . 0.0 112.454 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -67.77 -34.22 66.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.014 1.326 . . . . 0.0 112.115 -176.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.21 -17.02 60.95 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -173.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -72.94 -22.07 60.78 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.39 1.076 . . . . 0.0 113.649 171.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.0 pt -118.37 11.29 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.3 1.84 . . . . 0.0 112.925 -175.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.19 1.796 . . . . 0.0 112.332 177.572 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.5 ttm . . . . . 0 N--CA 1.504 2.249 0 CA-C-O 119.246 -0.407 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -77.64 100.89 6.34 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 119.117 0.871 . . . . 0.0 110.74 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -86.6 136.06 33.19 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.111 1.764 . . . . 0.0 111.763 -172.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.4 t -114.64 143.06 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 124.176 0.991 . . . . 0.0 111.793 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.2 tpp -131.05 125.06 32.23 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.277 1.031 . . . . 0.0 111.602 169.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -93.05 136.84 32.94 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.533 0.733 . . . . 0.0 110.48 169.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 t -130.61 130.15 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.38 1.472 . . . . 0.0 110.2 -174.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.8 p -149.14 176.42 10.5 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.989 0.916 . . . . 0.0 112.628 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -63.93 -46.79 83.21 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.904 -1.122 . . . . 0.0 111.251 171.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.418 ' HB3' ' H ' ' A' ' 13' ' ' SER . 1.0 OUTLIER -109.26 111.66 23.38 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.358 1.463 . . . . 0.0 109.791 169.326 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.505 ' ND2' ' H ' ' A' ' 63' ' ' ASP . 58.8 t-20 -57.56 -46.95 83.32 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 169.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.6 p -43.48 -46.59 6.91 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 174.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.418 ' H ' ' HB3' ' A' ' 10' ' ' ARG . 27.3 p -97.44 -16.12 20.32 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.05 1.129 . . . . 0.0 114.05 -172.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -130.94 -62.63 0.89 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 119.738 1.153 . . . . 0.0 113.979 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.8 m -61.34 -35.08 76.42 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 120.118 1.326 . . . . 0.0 112.953 -177.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -62.98 -38.19 90.15 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.722 1.209 . . . . 0.0 113.446 169.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 84.9 mtp -64.29 -48.79 74.35 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.445 1.021 . . . . 0.0 110.714 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.07 -28.45 68.85 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 175.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -75.27 -41.52 57.03 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 119.72 1.145 . . . . 0.0 109.067 -178.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.66 -45.0 96.7 Favored Glycine 0 CA--C 1.52 0.37 0 CA-C-O 119.345 -0.697 . . . . 0.0 112.425 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -64.55 -43.81 92.79 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.851 1.326 . . . . 0.0 112.065 172.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.56 -32.49 69.92 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.454 -1.404 . . . . 0.0 111.767 -175.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -64.89 -55.63 18.17 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 125.332 1.453 . . . . 0.0 109.425 170.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.1 p -73.12 -8.92 57.9 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.587 -1.32 . . . . 0.0 114.523 -176.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 51.7 mt -100.28 -5.75 27.0 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.48 1.112 . . . . 0.0 113.701 170.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.29 15.2 0.1 OUTLIER Glycine 0 CA--C 1.537 1.417 0 N-CA-C 118.609 2.204 . . . . 0.0 118.609 -171.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.22 -33.67 67.77 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.162 1.981 . . . . 0.0 114.308 -172.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.43 -5.5 89.93 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.257 0.932 . . . . 0.0 115.029 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -100.77 -63.01 1.17 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.862 1.265 . . . . 0.0 111.409 -172.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -141.87 173.34 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 126.128 1.771 . . . . 0.0 112.122 -175.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.93 123.22 36.04 Favored 'General case' 0 C--N 1.343 0.291 0 O-C-N 121.368 -0.832 . . . . 0.0 112.502 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.0 m -101.47 151.97 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.05 0.94 . . . . 0.0 111.67 169.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.65 152.38 37.76 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.15 0.58 . . . . 0.0 111.544 -173.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.5 p -120.69 141.47 50.38 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.661 1.585 . . . . 0.0 114.731 175.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.3 t -145.99 167.54 23.07 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 127.308 2.243 . . . . 0.0 110.005 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.87 171.46 38.32 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 120.73 -1.231 . . . . 0.0 114.803 169.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 35.0 mt -62.12 -40.28 95.38 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.738 0.815 . . . . 0.0 111.477 -173.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -120.55 116.6 25.7 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 127.879 2.472 . . . . 0.0 105.874 169.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.7 p -67.21 -49.19 65.5 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.128 -0.982 . . . . 0.0 110.41 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.4 t 53.64 -173.26 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 127.031 2.132 . . . . 0.0 113.838 -174.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -80.86 177.8 8.81 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 127.051 2.14 . . . . 0.0 113.005 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.4 m -66.44 116.69 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 120.596 -1.315 . . . . 0.0 107.639 168.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -66.36 128.09 93.65 Favored Pre-proline 0 N--CA 1.478 0.934 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -168.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.64 -39.23 55.53 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.265 2.644 . . . . 0.0 113.994 -169.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.4 m -80.48 -32.65 37.01 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 122.023 -0.423 . . . . 0.0 110.629 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.67 -38.07 86.06 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.011 -1.056 . . . . 0.0 112.375 174.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 65.1 mt -53.02 -42.18 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 120.634 1.561 . . . . 0.0 110.559 172.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.86 -61.23 2.3 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.355 0.662 . . . . 0.0 112.702 173.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.4 mmt -66.08 -24.18 66.66 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -172.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 79.3 mmm -87.78 -33.9 18.5 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.976 0.91 . . . . 0.0 110.95 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -60.84 -32.74 72.13 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.704 -1.247 . . . . 0.0 111.901 169.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -54.41 -31.58 55.41 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.326 -0.859 . . . . 0.0 113.232 173.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.1 m -104.0 14.27 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 175.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.52 13.35 65.51 Favored Glycine 0 CA--C 1.536 1.365 0 O-C-N 120.984 -1.072 . . . . 0.0 115.224 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.5 mt -118.36 71.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.803 1.641 . . . . 0.0 109.411 -169.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -64.07 110.69 2.24 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 120.34 -1.475 . . . . 0.0 110.218 172.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 pt -92.73 4.33 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.326 0.65 . . . . 0.0 112.627 178.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.3 p -68.4 -22.62 64.62 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.492 1.496 . . . . 0.0 113.855 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.5 8.24 62.03 Favored Glycine 0 CA--C 1.541 1.712 0 C-N-CA 125.548 1.547 . . . . 0.0 114.353 169.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -76.0 139.71 41.63 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.556 1.178 . . . . 0.0 111.274 -174.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.1 t -64.78 156.35 30.87 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.262 0.553 . . . . 0.0 111.588 169.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.0 t -143.57 127.99 17.89 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 169.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.505 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -124.64 142.23 40.07 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.593 1.157 . . . . 0.0 111.305 -174.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -87.58 152.87 7.63 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.611 2.874 . . . . 0.0 111.368 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.0 tt -60.91 -29.86 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -169.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -94.85 -6.92 41.67 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -80.91 -38.51 27.81 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.477 -0.764 . . . . 0.0 110.592 169.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.22 160.09 29.18 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.375 1.07 . . . . 0.0 111.716 172.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.63 116.5 14.12 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.899 1.28 . . . . 0.0 109.612 174.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.97 -3.85 6.01 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 -169.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -67.44 -30.56 70.33 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.3 0.954 . . . . 0.0 113.431 -169.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -84.3 -8.78 58.91 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 176.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -104.72 100.4 10.05 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 120.898 -1.127 . . . . 0.0 110.12 -169.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -52.19 -33.74 42.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.279 1.431 . . . . 0.0 112.736 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.0 t -125.41 122.75 63.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 125.385 1.474 . . . . 0.0 110.003 -174.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.0 t -124.05 130.43 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.671 0.788 . . . . 0.0 109.86 175.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 50.1 mm -125.45 123.12 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 123.927 0.891 . . . . 0.0 110.687 -169.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.8 t -82.2 137.4 34.92 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 168.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.401 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 76.5 mt -110.03 28.25 8.79 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.871 1.268 . . . . 0.0 109.857 170.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.1 t -155.11 140.02 17.27 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.322 1.449 . . . . 0.0 113.307 -169.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.05 -21.57 59.37 Favored Glycine 0 CA--C 1.541 1.667 0 O-C-N 121.418 -0.801 . . . . 0.0 112.921 169.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.1 p -66.41 -0.19 2.54 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.154 1.782 . . . . 0.0 114.915 169.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.0 -23.93 40.76 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.843 1.211 . . . . 0.0 114.878 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.3 m -64.05 -17.09 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 O-C-N 121.272 -1.134 . . . . 0.0 113.969 172.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.16 5.09 51.85 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.215 1.406 . . . . 0.0 113.073 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.3 mt -70.0 145.64 94.29 Favored Pre-proline 0 CA--C 1.55 0.975 0 O-C-N 120.828 -1.17 . . . . 0.0 111.721 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -58.77 163.69 10.8 Favored 'Trans proline' 0 CA--C 1.551 1.34 0 C-N-CA 123.716 2.944 . . . . 0.0 113.608 171.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.81 -52.74 1.16 Allowed 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.521 2.147 . . . . 0.0 113.784 -171.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -60.18 -36.61 78.01 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 120.664 -1.272 . . . . 0.0 111.897 177.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -63.89 7.01 0.13 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 127.928 2.491 . . . . 0.0 115.046 170.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.1 t -134.86 -42.7 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 127.109 2.164 . . . . 0.0 111.525 175.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.7 p -79.9 32.64 0.26 Allowed 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -169.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -85.47 168.8 14.22 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.374 1.069 . . . . 0.0 112.187 172.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -57.06 -36.1 70.13 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -169.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.4 mt -125.87 125.58 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.772 1.229 . . . . 0.0 108.813 169.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -133.33 131.14 39.78 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.172 0.989 . . . . 0.0 111.536 169.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -145.96 162.0 38.79 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.196 1.398 . . . . 0.0 111.757 -175.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -125.52 122.53 36.85 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.679 1.192 . . . . 0.0 111.422 170.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.401 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 44.1 m0 -82.54 -4.55 57.75 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 61.43 47.57 6.63 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.328 1.451 . . . . 0.0 113.62 169.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.0 mt -99.89 149.02 23.84 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -171.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -82.69 152.89 25.61 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.327 1.451 . . . . 0.0 111.336 170.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -80.85 120.67 79.56 Favored Pre-proline 0 CA--C 1.545 0.786 0 O-C-N 121.27 -0.894 . . . . 0.0 111.232 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -82.17 -10.6 11.25 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.231 1.954 . . . . 0.0 114.564 -176.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -53.23 107.63 0.25 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.754 1.161 . . . . 0.0 112.583 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.37 3.36 90.02 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 119.306 -0.719 . . . . 0.0 114.803 177.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -73.66 165.21 25.52 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.501 1.151 . . . . 0.0 110.437 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.2 m -60.66 147.84 40.59 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.42 -0.8 . . . . 0.0 111.171 170.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.83 -27.85 69.61 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.413 -0.805 . . . . 0.0 112.916 -172.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -59.04 -39.4 81.89 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.053 -1.029 . . . . 0.0 112.648 170.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.7 t -72.19 -37.03 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.907 0.883 . . . . 0.0 110.032 175.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.07 -40.93 97.35 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.435 0.694 . . . . 0.0 111.172 177.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -69.64 -37.2 76.67 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 120.778 -1.201 . . . . 0.0 112.521 171.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 55.1 m -59.15 -48.7 80.64 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.135 0.974 . . . . 0.0 111.558 175.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 19.7 m -66.51 -29.96 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 119.743 1.156 . . . . 0.0 111.947 175.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -45.94 89.61 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 120.086 1.312 . . . . 0.0 110.875 169.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.91 -41.33 97.73 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 118.955 0.798 . . . . 0.0 112.393 174.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -67.24 -43.04 82.93 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 175.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.3 m -67.15 -41.2 86.65 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.695 0 CA-C-N 119.807 1.185 . . . . 0.0 110.547 176.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -51.55 -54.13 30.7 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.689 1.586 . . . . 0.0 111.581 175.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -50.6 -49.64 55.99 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.779 1.631 . . . . 0.0 112.347 176.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -87.41 -27.95 22.44 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.661 0.784 . . . . 0.0 112.248 -170.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.4 t -63.53 -51.79 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.201 1.4 . . . . 0.0 109.187 169.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -54.01 -53.77 48.41 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.312 0.96 . . . . 0.0 109.613 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -52.01 -37.78 54.53 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.803 1.641 . . . . 0.0 112.49 176.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -79.07 -59.09 2.92 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.007 -1.058 . . . . 0.0 113.357 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.54 -33.89 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.789 1.636 . . . . 0.0 112.14 -174.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.53 -17.01 60.81 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.085 -1.009 . . . . 0.0 113.57 -174.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -74.03 -21.25 60.03 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.537 1.135 . . . . 0.0 113.786 171.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.5 pt -118.19 10.42 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.144 1.778 . . . . 0.0 113.006 -175.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.6 m . . . . . 0 C--O 1.253 1.283 0 C-N-CA 126.473 1.909 . . . . 0.0 112.024 177.721 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.8 ttm . . . . . 0 N--CA 1.503 2.207 0 CA-C-O 119.739 -0.172 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -88.01 83.2 7.06 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.3 1.04 . . . . 0.0 110.207 176.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -73.44 150.16 41.87 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 121.764 -0.585 . . . . 0.0 111.563 -175.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.6 t -109.7 146.86 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.346 1.058 . . . . 0.0 111.124 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.2 tpp -131.36 118.39 20.22 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.747 0.819 . . . . 0.0 110.643 168.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -88.41 131.32 34.9 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.302 1.041 . . . . 0.0 111.185 169.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.3 t -127.06 126.37 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.981 1.312 . . . . 0.0 110.643 -173.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.1 m -140.66 172.0 13.32 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.46 1.104 . . . . 0.0 111.303 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.95 -46.3 82.16 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.779 -1.201 . . . . 0.0 109.986 169.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -98.66 113.71 25.89 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.126 1.371 . . . . 0.0 109.821 169.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -62.28 -41.84 98.83 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 119.474 1.034 . . . . 0.0 109.43 169.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.2 p -46.35 -32.97 3.49 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.972 2.509 . . . . 0.0 116.894 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.4 p -98.99 -97.39 0.23 Allowed 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 123.832 0.853 . . . . 0.0 110.233 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -64.22 -44.1 92.95 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.859 1.264 . . . . 0.0 113.792 -169.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.9 m -63.11 -45.39 92.25 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.789 1.177 . . . . 0.0 111.889 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -63.81 -39.57 94.56 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 171.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 71.7 mtp -61.44 -44.76 96.55 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 120.769 -1.207 . . . . 0.0 110.994 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.52 -31.53 69.81 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 173.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -66.52 -50.44 63.19 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 119.478 1.036 . . . . 0.0 109.196 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.02 -45.48 95.85 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 118.868 -0.962 . . . . 0.0 112.634 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -64.17 -40.03 95.26 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.521 1.161 . . . . 0.0 112.416 173.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.44 -32.27 66.16 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.492 -1.38 . . . . 0.0 111.006 -176.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -62.42 -56.0 22.41 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 126.273 1.829 . . . . 0.0 110.159 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 67.9 p -70.46 -14.95 62.75 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.5 mt -100.98 -4.58 27.26 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.234 1.013 . . . . 0.0 113.62 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.58 5.37 1.15 Allowed Glycine 0 CA--C 1.534 1.256 0 N-CA-C 117.166 1.626 . . . . 0.0 117.166 -169.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.6 126.74 22.83 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.38 1.59 . . . . 0.0 112.539 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.9 -3.91 63.24 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 124.759 1.171 . . . . 0.0 115.877 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -87.61 -59.71 2.17 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 119.254 1.527 . . . . 0.0 110.613 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 pp -140.4 175.57 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 127.317 2.247 . . . . 0.0 109.538 170.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.78 125.98 42.89 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.998 0.904 . . . . 0.0 111.547 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.4 m -90.13 151.14 3.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 124.268 1.027 . . . . 0.0 112.295 169.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.72 152.81 39.43 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.439 1.095 . . . . 0.0 111.621 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.2 p -130.26 133.1 46.26 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.348 1.459 . . . . 0.0 114.925 174.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.3 p -134.47 173.3 11.8 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 127.618 2.367 . . . . 0.0 110.399 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.8 176.89 47.83 Favored Glycine 0 CA--C 1.525 0.68 0 O-C-N 120.248 -1.533 . . . . 0.0 114.7 169.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 27.9 mt -65.84 -34.09 77.35 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.035 0.534 . . . . 0.0 111.78 -175.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -117.39 116.3 26.91 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.981 2.112 . . . . 0.0 109.63 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.2 p -77.53 48.91 0.69 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.282 2.233 . . . . 0.0 111.917 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.7 t -70.72 165.72 22.41 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.038 -1.437 . . . . 0.0 112.67 -170.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -64.99 159.14 23.71 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 125.024 1.329 . . . . 0.0 112.495 -175.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.7 m -54.39 114.44 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.093 -1.004 . . . . 0.0 109.133 169.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -66.44 129.54 94.15 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -168.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -60.01 -39.64 68.76 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.475 2.784 . . . . 0.0 113.682 -171.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.4 m -79.33 -32.23 43.3 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.86 -0.525 . . . . 0.0 110.986 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.0 -40.91 87.43 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.832 -1.168 . . . . 0.0 112.568 173.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.9 mt -53.02 -39.82 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 120.613 1.551 . . . . 0.0 110.614 172.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.55 -64.31 0.89 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.432 0.693 . . . . 0.0 112.781 172.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.8 mmt -65.11 -23.68 67.22 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -171.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 89.7 mmm -85.59 -34.55 21.42 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.584 0.754 . . . . 0.0 110.732 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -62.06 -31.04 71.42 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.698 -1.251 . . . . 0.0 111.963 171.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -55.27 -30.57 60.37 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.75 0.82 . . . . 0.0 112.891 172.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.4 m -106.45 17.28 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 175.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.0 13.14 69.75 Favored Glycine 0 CA--C 1.536 1.388 0 O-C-N 121.085 -1.009 . . . . 0.0 115.225 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.4 mt -117.13 91.63 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.123 1.369 . . . . 0.0 110.061 -169.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -77.63 114.4 16.43 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.795 -1.19 . . . . 0.0 110.615 171.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.9 pt -91.31 -5.3 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 172.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 t -63.17 -27.65 69.52 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.352 1.433 . . . . 0.0 113.558 -169.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.62 9.82 60.68 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 124.977 1.275 . . . . 0.0 115.353 173.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -89.36 148.8 23.31 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 118.838 1.319 . . . . 0.0 113.2 -169.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.7 t -61.62 146.81 47.79 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.9 t -136.78 49.95 2.04 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 122.082 0.944 . . . . 0.0 112.403 175.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -64.66 145.05 98.81 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 125.241 1.416 . . . . 0.0 113.542 -172.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.28 154.39 32.17 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.804 2.336 . . . . 0.0 112.035 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.1 tt -62.93 -21.96 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -92.6 -10.83 36.08 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -91.4 -35.24 14.49 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.484 0.714 . . . . 0.0 111.962 171.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.36 164.48 25.67 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.562 0.745 . . . . 0.0 112.045 174.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -140.8 131.36 25.45 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.89 0.876 . . . . 0.0 110.921 169.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.4 6.13 4.93 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 115.551 1.685 . . . . 0.0 115.551 -174.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -71.58 -30.07 65.42 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.007 -1.058 . . . . 0.0 112.181 -174.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -93.48 -4.92 50.31 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.905 1.282 . . . . 0.0 113.511 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -125.24 79.47 1.8 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.542 1.537 . . . . 0.0 110.431 -171.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -69.06 0.78 4.17 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -171.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.0 t -129.03 94.64 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 125.868 1.667 . . . . 0.0 108.832 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.3 t -112.43 119.03 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 121.315 -0.866 . . . . 0.0 110.457 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 mp -110.2 134.38 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 124.281 1.032 . . . . 0.0 110.112 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.8 t -94.15 145.24 24.84 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.704 1.602 . . . . 0.0 109.854 169.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.5 mt -125.05 44.44 2.79 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.305 1.042 . . . . 0.0 111.39 -173.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.8 p . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 -170.185 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 80.5 mt . . . . . 0 CA--C 1.55 0.949 0 CA-C-O 119.247 -0.406 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.54 132.12 48.57 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.657 2.238 . . . . 0.0 110.755 174.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -60.62 -30.63 90.91 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.542 2.162 . . . . 0.0 113.57 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -60.19 -31.74 70.43 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.949 -1.094 . . . . 0.0 112.867 171.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -87.98 13.2 11.49 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.747 1.219 . . . . 0.0 113.631 175.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.9 t -118.86 -34.75 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 126.565 1.946 . . . . 0.0 112.168 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.0 p -80.85 12.65 3.1 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 -169.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -66.91 161.97 22.86 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.348 1.459 . . . . 0.0 112.149 170.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -60.02 -36.75 77.92 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -169.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.7 mt -115.35 117.05 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.79 0.836 . . . . 0.0 109.307 169.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -134.51 126.56 29.63 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.362 1.065 . . . . 0.0 110.372 169.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -147.24 160.46 42.46 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.802 1.641 . . . . 0.0 110.85 -173.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -126.04 133.03 51.85 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.328 0.651 . . . . 0.0 111.679 169.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -90.04 -0.42 57.58 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 63.88 39.62 8.06 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 169.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.3 mt -93.01 157.6 16.22 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -172.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -102.58 144.48 30.94 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.552 1.941 . . . . 0.0 111.223 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -73.65 121.73 85.87 Favored Pre-proline 0 N--CA 1.475 0.791 0 CA-C-N 119.463 1.029 . . . . 0.0 111.866 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -83.89 -15.32 7.05 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.702 2.268 . . . . 0.0 114.856 -172.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -51.57 109.86 0.4 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.312 1.045 . . . . 0.0 112.442 175.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.85 -0.63 84.61 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 123.804 0.716 . . . . 0.0 114.446 176.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -76.01 171.36 14.59 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 118.437 1.119 . . . . 0.0 109.863 169.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 88.1 p -65.92 156.3 33.9 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.051 -1.031 . . . . 0.0 111.707 169.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.7 mp -64.51 -28.18 69.48 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.112 -0.993 . . . . 0.0 111.725 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -59.48 -41.06 88.95 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.048 -1.032 . . . . 0.0 112.389 170.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 79.4 t -73.79 -36.69 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 O-C-N 121.24 -0.913 . . . . 0.0 110.243 175.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.02 -40.3 97.35 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.277 0.631 . . . . 0.0 111.038 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -70.45 -36.49 73.97 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 120.772 -1.205 . . . . 0.0 112.545 170.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 55.0 m -58.98 -47.63 84.46 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.866 0.867 . . . . 0.0 111.662 175.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.6 m -67.46 -29.08 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 119.784 1.175 . . . . 0.0 111.673 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -45.36 94.11 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 119.968 1.258 . . . . 0.0 110.934 169.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.23 -40.85 97.88 Favored Glycine 0 N--CA 1.474 1.232 0 CA-C-N 118.856 0.753 . . . . 0.0 112.125 174.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -67.28 -43.41 81.85 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.0 m -66.91 -40.37 85.59 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.598 0 CA-C-N 120.071 1.305 . . . . 0.0 110.53 176.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -51.43 -55.0 21.1 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 120.587 1.539 . . . . 0.0 111.464 175.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -50.33 -47.48 55.83 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.301 1.44 . . . . 0.0 112.19 177.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -89.54 -27.75 20.06 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.451 0.701 . . . . 0.0 112.423 -170.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.22 -49.85 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.027 1.331 . . . . 0.0 109.308 169.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -54.09 -54.83 34.02 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.12 0.873 . . . . 0.0 109.551 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -51.58 -37.34 49.39 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.769 1.628 . . . . 0.0 112.676 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -79.22 -61.35 2.04 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.057 0.943 . . . . 0.0 112.92 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.72 -33.76 63.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.25 1.42 . . . . 0.0 112.063 -174.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.69 -17.89 61.08 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -174.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -77.56 -15.98 58.92 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.699 1.199 . . . . 0.0 113.816 171.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.6 pt -120.88 24.72 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 126.934 2.094 . . . . 0.0 111.778 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--O 1.255 1.344 0 C-N-CA 127.824 2.45 . . . . 0.0 111.469 178.099 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 tpp . . . . . 0 N--CA 1.501 2.092 0 CA-C-O 119.362 -0.352 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -83.22 87.92 6.93 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 119.408 1.004 . . . . 0.0 111.21 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -77.94 146.87 35.26 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -171.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.2 t -108.38 143.5 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.672 1.189 . . . . 0.0 110.473 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.1 tpp -129.44 114.4 16.1 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.964 0.906 . . . . 0.0 110.919 169.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -83.31 140.89 32.2 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.642 -0.661 . . . . 0.0 110.382 169.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.5 t -135.89 127.72 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 125.165 1.386 . . . . 0.0 110.507 -175.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.0 p -144.04 -179.2 6.35 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.673 1.189 . . . . 0.0 111.932 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -60.23 -70.98 0.14 Allowed 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 119.472 1.033 . . . . 0.0 109.744 169.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.3 mtt-85 -82.8 121.39 26.85 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 169.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -66.93 -45.26 78.42 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 119.137 0.881 . . . . 0.0 108.883 169.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.4 p -48.77 -31.41 6.95 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.975 2.51 . . . . 0.0 115.829 -175.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.9 p -91.66 -96.1 0.13 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.186 1.394 . . . . 0.0 110.908 169.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -56.27 -56.25 23.35 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -168.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.2 m -69.04 -33.28 73.35 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.709 1.14 . . . . 0.0 113.034 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -66.69 -39.05 87.93 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.358 1.463 . . . . 0.0 113.17 169.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 77.2 mtp -58.85 -45.47 90.01 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.633 0.773 . . . . 0.0 110.977 170.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.56 -28.59 67.09 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 117.7 -1.143 . . . . 0.0 113.609 173.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -72.23 -46.14 57.34 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 121.464 1.938 . . . . 0.0 108.836 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.11 -50.82 62.67 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-O 118.556 -1.136 . . . . 0.0 112.343 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -61.55 -41.24 97.08 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.126 1.463 . . . . 0.0 112.782 175.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.467 ' HB1' HG11 ' A' ' 32' ' ' VAL . . . -72.69 -29.72 63.64 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 120.812 -1.18 . . . . 0.0 111.216 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -65.31 -55.89 15.77 Favored 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 125.205 1.402 . . . . 0.0 109.977 170.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.5 p -71.09 -9.54 58.23 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 49.7 mt -101.83 -1.6 31.89 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 170.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -160.57 13.59 0.17 Allowed Glycine 0 CA--C 1.536 1.402 0 N-CA-C 118.262 2.065 . . . . 0.0 118.262 -171.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.82 -30.26 68.82 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 120.673 2.237 . . . . 0.0 114.331 -171.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.97 1.13 87.5 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 124.454 1.026 . . . . 0.0 114.949 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -112.28 -107.75 0.36 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.42 1.888 . . . . 0.0 110.407 -171.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -95.73 174.55 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 126.104 1.762 . . . . 0.0 111.492 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.6 129.13 39.97 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.22 -0.925 . . . . 0.0 112.264 175.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.467 HG11 ' HB1' ' A' ' 22' ' ' ALA . 30.1 m -99.19 148.25 6.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 124.367 1.067 . . . . 0.0 112.662 170.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.48 153.79 39.97 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.254 1.022 . . . . 0.0 111.115 -174.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.6 p -137.2 136.61 38.32 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.974 1.31 . . . . 0.0 114.163 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.5 t -140.38 -178.84 5.68 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.843 2.057 . . . . 0.0 110.746 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.88 177.97 41.86 Favored Glycine 0 CA--C 1.527 0.815 0 O-C-N 120.684 -1.26 . . . . 0.0 114.834 171.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.9 mt -62.5 -34.26 76.51 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.044 0.938 . . . . 0.0 111.725 -176.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -127.02 112.39 15.18 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.21 2.204 . . . . 0.0 107.754 169.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.5 p -61.51 -36.35 80.28 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.41 -0.806 . . . . 0.0 111.886 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.2 t 52.57 -135.22 1.54 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.943 1.297 . . . . 0.0 110.41 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -127.22 -139.59 0.26 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 126.735 2.014 . . . . 0.0 110.827 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.4 m -105.77 115.08 46.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 168.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -64.62 131.1 95.02 Favored Pre-proline 0 N--CA 1.48 1.045 0 O-C-N 121.176 -0.953 . . . . 0.0 112.378 -168.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -60.06 -37.66 82.95 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.432 2.755 . . . . 0.0 113.944 -169.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.5 m -77.78 -33.37 52.66 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.933 -0.479 . . . . 0.0 110.461 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.38 -38.79 92.27 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.073 -1.017 . . . . 0.0 112.56 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 70.4 mt -53.23 -44.46 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 120.657 1.571 . . . . 0.0 110.134 174.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.0 -58.95 4.77 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.0 mmt -65.15 -21.64 66.81 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -174.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 87.8 mmm -89.9 -38.89 13.39 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.015 0.926 . . . . 0.0 110.762 176.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -58.52 -36.61 74.09 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.577 -1.327 . . . . 0.0 112.205 169.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -54.43 -32.24 57.01 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.333 1.053 . . . . 0.0 113.672 173.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.2 m -101.6 13.98 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.694 1.198 . . . . 0.0 113.973 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.29 16.38 62.64 Favored Glycine 0 CA--C 1.535 1.337 0 O-C-N 121.184 -0.947 . . . . 0.0 114.917 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.4 mt -122.08 75.7 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.727 1.611 . . . . 0.0 109.952 -169.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -68.09 105.33 2.02 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 120.283 -1.511 . . . . 0.0 110.494 173.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.0 pt -84.35 -5.52 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.542 0.737 . . . . 0.0 112.833 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 92.4 p -64.92 -28.93 69.87 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -169.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.43 7.8 77.6 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.803 1.192 . . . . 0.0 114.58 172.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -98.87 149.83 22.52 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.196 1.398 . . . . 0.0 112.522 -169.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.8 t -85.64 145.58 27.25 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -173.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.3 m -124.49 111.65 15.96 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.352 1.061 . . . . 0.0 110.381 170.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.15 158.11 50.04 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 124.001 0.92 . . . . 0.0 113.009 177.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -95.7 150.79 1.46 Allowed 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 124.176 3.251 . . . . 0.0 111.879 169.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.38 -19.15 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 115.424 1.638 . . . . 0.0 115.424 -172.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -99.68 -7.79 25.19 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -87.92 -39.43 14.76 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.379 -0.826 . . . . 0.0 111.491 169.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.98 161.12 31.68 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.559 0.743 . . . . 0.0 111.759 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -136.56 117.21 13.93 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.388 1.075 . . . . 0.0 110.452 173.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.98 -1.76 4.48 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -171.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.91 -30.49 67.92 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.083 -1.011 . . . . 0.0 112.202 -173.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -86.14 -2.57 58.46 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.781 1.232 . . . . 0.0 113.293 177.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -124.35 90.56 3.28 Favored 'General case' 0 C--N 1.343 0.326 0 C-N-CA 125.711 1.604 . . . . 0.0 110.269 -171.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -55.18 -27.84 48.72 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.196 1.398 . . . . 0.0 113.37 -177.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.29 115.74 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 125.156 1.382 . . . . 0.0 110.541 -172.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.0 t -122.91 129.08 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.913 0.885 . . . . 0.0 110.746 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.7 mm -117.58 124.15 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.455 0.702 . . . . 0.0 111.109 -172.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.1 t -88.19 105.6 17.64 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 169.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.419 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 64.0 mt -82.91 31.89 0.43 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.805 1.642 . . . . 0.0 110.966 175.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.3 t . . . . . 0 CA--C 1.538 0.488 0 C-N-CA 127.866 2.466 . . . . 0.0 109.162 -169.678 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.6 mt . . . . . 0 CA--C 1.549 0.923 0 CA-C-O 119.232 -0.413 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -59.22 132.11 44.96 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.708 2.272 . . . . 0.0 110.698 169.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -59.73 -33.23 96.46 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.468 2.112 . . . . 0.0 113.522 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -66.18 -26.64 67.5 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.72 1.145 . . . . 0.0 113.538 175.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.38 -15.96 59.11 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.772 -1.205 . . . . 0.0 112.629 171.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.8 t -90.63 -40.22 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.882 1.673 . . . . 0.0 111.725 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.1 p -81.99 27.9 0.45 Allowed 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -172.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -79.61 169.7 17.63 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.084 1.354 . . . . 0.0 112.14 170.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -55.35 -39.79 70.47 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.121 0.968 . . . . 0.0 113.431 -169.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 58.9 mt -128.31 125.06 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.594 1.157 . . . . 0.0 109.545 170.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -128.52 141.46 51.37 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.436 1.094 . . . . 0.0 110.339 169.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.37 154.54 43.11 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.215 1.006 . . . . 0.0 112.121 -171.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -129.16 113.22 14.81 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.49 1.516 . . . . 0.0 110.226 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.419 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 37.0 m0 -94.0 5.32 52.07 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -173.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 63.45 -89.12 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.497 1.519 . . . . 0.0 112.026 -173.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.7 mt 53.85 -177.96 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 127.789 2.435 . . . . 0.0 115.511 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -142.0 148.26 38.27 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.8 2.04 . . . . 0.0 108.887 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.26 119.48 77.64 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 119.654 1.115 . . . . 0.0 110.575 176.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -83.94 -6.85 10.42 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 121.912 1.742 . . . . 0.0 113.881 -171.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -45.25 112.4 0.44 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.184 1.394 . . . . 0.0 112.783 174.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.42 3.14 82.04 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 123.66 0.647 . . . . 0.0 114.375 173.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -79.88 173.18 12.85 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.103 0.961 . . . . 0.0 109.927 169.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 86.2 p -63.68 153.8 35.01 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.183 -0.948 . . . . 0.0 111.732 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.47 -29.49 70.57 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.53 -0.731 . . . . 0.0 111.497 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -67.15 -34.9 78.55 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.786 -1.196 . . . . 0.0 113.144 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 78.8 t -69.46 -37.48 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 O-C-N 121.163 -0.96 . . . . 0.0 109.611 170.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.52 -39.08 93.11 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.717 0.807 . . . . 0.0 111.109 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -71.69 -38.09 70.63 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.062 1.345 . . . . 0.0 112.376 171.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 51.7 m -57.84 -48.1 80.75 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.608 1.095 . . . . 0.0 111.525 177.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.4 m -69.3 -29.92 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.937 176.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.28 -42.86 99.35 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 120.155 1.343 . . . . 0.0 111.515 169.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.76 -42.13 95.37 Favored Glycine 0 N--CA 1.476 1.331 0 C-N-CA 124.253 0.93 . . . . 0.0 112.661 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -63.32 -48.18 79.09 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.127 -0.631 . . . . 0.0 112.218 171.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.0 t -58.52 -44.9 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.633 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -52.37 -54.55 30.36 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 120.046 1.293 . . . . 0.0 111.51 175.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -61.76 -43.38 98.97 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.13 0.572 . . . . 0.0 112.209 -176.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 49.3 mtp85 -76.16 -31.86 58.76 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 36.8 t -61.87 -49.01 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.532 1.133 . . . . 0.0 110.591 170.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -53.62 -54.75 33.17 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.018 0.827 . . . . 0.0 109.701 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -55.19 -31.59 61.53 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.374 1.47 . . . . 0.0 112.9 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -81.83 -59.97 2.4 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.035 -1.04 . . . . 0.0 112.704 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.24 -32.68 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.789 1.236 . . . . 0.0 111.691 -176.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.58 -0.39 33.39 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -90.88 -15.65 29.55 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.809 1.244 . . . . 0.0 113.51 170.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.5 pt -121.31 8.43 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 126.188 1.795 . . . . 0.0 113.041 -176.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.4 p . . . . . 0 C--O 1.254 1.323 0 C-N-CA 126.446 1.898 . . . . 0.0 113.815 171.92 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.9 ttm . . . . . 0 N--CA 1.501 2.084 0 CA-C-O 119.325 -0.369 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -86.35 107.1 17.84 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 169.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -82.11 144.87 30.47 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 118.077 0.398 . . . . 0.0 110.907 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.0 t -101.66 142.22 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.672 0.789 . . . . 0.0 109.804 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 42.3 tpp -127.97 118.27 23.26 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.692 0.797 . . . . 0.0 110.754 169.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -89.67 138.51 31.41 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.88 -0.512 . . . . 0.0 110.834 169.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 t -130.17 129.32 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.546 1.538 . . . . 0.0 109.631 -171.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.7 m -141.14 171.48 14.0 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.002 1.321 . . . . 0.0 110.503 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -66.0 -49.28 68.34 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 119.91 1.232 . . . . 0.0 108.934 169.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -103.67 114.08 28.07 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 167.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.535 ' ND2' ' H ' ' A' ' 63' ' ' ASP . 31.1 t-20 -51.92 -48.51 64.17 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 120.474 1.488 . . . . 0.0 109.673 172.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.0 p -53.17 -32.85 49.91 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.1 p -78.37 -33.58 48.85 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -174.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 -140.34 -55.79 0.53 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.903 0.881 . . . . 0.0 112.488 -170.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 m -55.71 -40.86 73.0 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 120.087 1.312 . . . . 0.0 113.333 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -66.91 -35.43 79.98 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.698 1.599 . . . . 0.0 113.46 173.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.5 mtm -64.92 -50.43 66.52 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.782 -0.574 . . . . 0.0 110.565 172.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.8 -26.19 67.58 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.415 -0.803 . . . . 0.0 113.011 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -71.4 -49.44 42.0 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 119.507 1.048 . . . . 0.0 108.45 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.32 -41.62 99.43 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 119.245 -0.753 . . . . 0.0 112.953 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -62.45 -43.32 99.1 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.287 1.544 . . . . 0.0 112.22 172.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.64 -35.96 67.89 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.683 -1.26 . . . . 0.0 110.863 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -57.73 -49.6 76.0 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.344 1.858 . . . . 0.0 110.833 171.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.4 p -78.67 -24.46 45.11 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.868 1.432 . . . . 0.0 114.868 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.8 mt -89.5 -28.19 19.82 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.157 0.89 . . . . 0.0 113.045 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.74 -68.74 1.15 Allowed Glycine 0 N--CA 1.473 1.118 0 C-N-CA 124.711 1.148 . . . . 0.0 112.065 175.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 54.32 90.83 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.176 2.59 . . . . 0.0 115.462 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.85 -7.25 78.15 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 116.299 1.28 . . . . 0.0 116.299 169.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -68.85 -47.19 66.56 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 118.898 1.349 . . . . 0.0 110.817 174.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.6 pp -140.35 -176.06 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 127.749 2.42 . . . . 0.0 110.479 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.13 128.52 55.08 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.52 0.676 . . . . 0.0 112.551 172.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.5 m -95.16 151.48 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 124.592 1.157 . . . . 0.0 112.907 170.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.14 156.45 42.6 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.672 0.789 . . . . 0.0 111.41 -172.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 97.5 p -126.77 142.37 51.56 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.169 1.388 . . . . 0.0 114.023 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.6 t -145.77 170.78 15.85 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 126.897 2.079 . . . . 0.0 109.874 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.24 171.11 34.6 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 120.883 -1.136 . . . . 0.0 114.358 170.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 38.3 mt -62.17 -35.18 78.01 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 117.4 0.6 . . . . 0.0 111.812 -174.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -125.08 122.05 36.08 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.559 2.744 . . . . 0.0 106.545 169.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 55.4 p -73.07 -41.88 63.64 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.842 -1.162 . . . . 0.0 111.024 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.5 t 55.49 -167.51 0.1 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 126.282 1.833 . . . . 0.0 113.877 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -94.0 168.79 10.73 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 126.936 2.094 . . . . 0.0 112.29 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.6 m -61.15 114.16 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 169.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -71.04 132.19 86.68 Favored Pre-proline 0 N--CA 1.476 0.864 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -168.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -57.77 -39.72 84.99 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.951 3.1 . . . . 0.0 114.305 -173.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.3 m -80.31 -37.59 32.34 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.776 -0.578 . . . . 0.0 110.626 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.28 96.54 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.267 0.939 . . . . 0.0 112.076 175.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.0 mt -48.95 -49.09 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 120.132 1.333 . . . . 0.0 110.376 171.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.03 -58.13 7.6 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.6 mmt -65.71 -22.46 66.61 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -172.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 76.6 mmm -90.28 -40.01 12.41 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.372 1.469 . . . . 0.0 110.998 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -57.78 -35.47 70.84 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.83 -1.169 . . . . 0.0 112.348 170.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -53.41 -32.44 49.64 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.469 1.107 . . . . 0.0 113.064 170.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -94.85 5.98 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.703 1.201 . . . . 0.0 113.521 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.97 15.55 64.91 Favored Glycine 0 CA--C 1.538 1.498 0 O-C-N 120.916 -1.115 . . . . 0.0 114.433 -173.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.4 mt -121.04 61.64 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.95 1.7 . . . . 0.0 109.651 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -62.24 110.46 1.63 Allowed 'General case' 0 CA--C 1.548 0.893 0 O-C-N 120.082 -1.636 . . . . 0.0 110.892 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.6 pt -85.89 -4.5 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 118.496 -0.764 . . . . 0.0 112.941 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.5 t -61.79 -33.86 74.86 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.159 1.345 . . . . 0.0 112.731 -171.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.49 10.08 66.92 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.133 1.349 . . . . 0.0 115.432 172.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -101.74 163.03 12.47 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.911 1.284 . . . . 0.0 112.838 -170.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 p -72.94 158.75 34.87 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.022 1.729 . . . . 0.0 115.408 -170.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.8 t -151.31 148.14 27.8 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.153 2.181 . . . . 0.0 108.466 168.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.535 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 1.0 OUTLIER -149.36 147.91 24.79 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.672 1.189 . . . . 0.0 111.201 178.915 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -90.3 152.19 4.55 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.679 2.92 . . . . 0.0 111.854 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 tt -65.31 -18.78 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -171.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -98.22 -7.21 29.69 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -88.47 -38.98 14.56 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.585 0.629 . . . . 0.0 111.436 169.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.87 161.8 30.27 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.697 0.799 . . . . 0.0 112.241 173.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.94 123.51 17.23 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.271 1.028 . . . . 0.0 110.926 169.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.94 2.43 3.5 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -169.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -67.58 -28.6 67.91 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.341 -0.85 . . . . 0.0 112.437 -173.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -93.4 -2.31 54.82 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.157 1.383 . . . . 0.0 113.28 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -123.43 80.12 1.75 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.196 1.798 . . . . 0.0 109.878 -170.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -59.41 -21.29 59.74 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.707 1.203 . . . . 0.0 114.087 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.6 t -117.91 109.6 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.869 1.268 . . . . 0.0 110.015 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.8 t -121.21 129.37 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.819 0.848 . . . . 0.0 111.233 -176.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.1 mm -119.7 118.35 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 O-C-N 121.534 -0.729 . . . . 0.0 111.233 -171.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.3 t -82.85 105.8 14.16 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 168.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.428 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 85.4 mt -79.07 -32.38 44.74 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.622 -0.674 . . . . 0.0 111.135 177.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 31.7 p . . . . . 0 CA--C 1.539 0.55 0 C-N-CA 122.993 0.517 . . . . 0.0 110.41 169.004 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.5 mt . . . . . 0 CA--C 1.547 0.856 0 CA-C-O 119.149 -0.453 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.32 133.43 54.97 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.852 2.368 . . . . 0.0 111.68 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -60.59 -31.03 91.76 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.795 2.33 . . . . 0.0 113.62 -174.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -65.48 -30.01 70.74 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.729 -1.232 . . . . 0.0 113.264 173.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.35 -19.94 49.01 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.855 -1.153 . . . . 0.0 112.688 173.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.6 t -87.73 -34.39 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.047 1.739 . . . . 0.0 112.41 176.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.6 p -88.59 25.83 1.62 Allowed 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -171.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -77.2 168.35 20.21 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.508 1.123 . . . . 0.0 112.263 169.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -55.72 -38.59 69.95 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -169.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 59.7 mt -126.03 123.51 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.717 1.207 . . . . 0.0 108.872 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -128.24 140.87 51.66 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.097 0.959 . . . . 0.0 110.702 169.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.84 154.95 44.67 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.671 1.188 . . . . 0.0 112.093 -171.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -130.13 115.45 17.07 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.9 1.28 . . . . 0.0 110.89 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.428 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 35.7 m0 -98.51 -1.63 40.72 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.457 1.103 . . . . 0.0 113.792 -175.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.32 1.2 pp0? 44.75 41.73 5.29 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 172.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.8 mt -84.42 134.25 34.47 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.984 1.313 . . . . 0.0 112.977 -177.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -64.74 153.87 38.51 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.987 1.315 . . . . 0.0 111.977 172.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -81.72 116.74 64.98 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 121.192 -0.942 . . . . 0.0 112.832 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -84.52 -27.27 1.42 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.794 2.329 . . . . 0.0 115.103 -169.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -70.97 81.7 0.66 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.667 1.987 . . . . 0.0 111.949 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 141.17 -10.66 2.78 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 126.496 1.998 . . . . 0.0 113.785 -174.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -91.39 175.8 6.79 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.845 1.658 . . . . 0.0 111.624 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 96.9 p -70.86 159.77 34.0 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.628 -0.67 . . . . 0.0 111.581 169.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.9 -31.04 72.02 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.463 -0.773 . . . . 0.0 112.194 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.08 -40.89 95.41 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.05 -1.031 . . . . 0.0 112.283 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 94.0 t -72.93 -35.91 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.626 0.77 . . . . 0.0 110.47 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -60.15 -49.76 76.38 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.781 0.832 . . . . 0.0 110.638 173.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 66.4 mtt85 -63.14 -23.54 67.48 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.307 1.443 . . . . 0.0 113.453 173.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 57.4 m -75.63 -55.32 5.78 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.624 1.169 . . . . 0.0 111.412 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 19.2 m -65.54 -32.31 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 119.82 1.191 . . . . 0.0 110.762 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.47 -43.75 89.06 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 126.606 1.962 . . . . 0.0 112.939 169.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.43 -38.4 86.83 Favored Glycine 0 N--CA 1.476 1.323 0 C-N-CA 123.964 0.792 . . . . 0.0 113.392 174.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -61.94 -43.31 99.1 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.512 -0.993 . . . . 0.0 111.814 169.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 32.5 t -58.58 -47.65 87.91 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 CA-C-O 117.861 -1.066 . . . . 0.0 109.772 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -49.81 -55.36 14.43 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.866 1.212 . . . . 0.0 111.571 175.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -61.1 -43.75 98.41 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.5 mtp85 -76.12 -33.55 59.45 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.6 t -63.56 -46.09 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.122 0.969 . . . . 0.0 111.224 172.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -52.49 -54.97 25.46 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.246 0.93 . . . . 0.0 109.943 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -55.17 -37.75 67.42 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.783 1.233 . . . . 0.0 112.676 176.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -74.79 -57.28 4.01 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.18 -0.95 . . . . 0.0 112.752 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.56 -34.53 71.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.692 1.197 . . . . 0.0 112.168 -177.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.57 -15.8 60.83 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -173.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -73.43 -31.03 63.6 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.43 1.092 . . . . 0.0 113.382 170.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.9 pt -107.64 -7.15 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.323 1.449 . . . . 0.0 113.389 -174.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.9 m . . . . . 0 C--O 1.253 1.282 0 C-N-CA 125.779 1.632 . . . . 0.0 112.711 171.007 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 ttm . . . . . 0 N--CA 1.503 2.208 0 CA-C-O 119.77 -0.157 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -85.73 82.33 8.24 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.212 1.005 . . . . 0.0 110.777 173.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -72.18 139.23 48.14 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.208 1.003 . . . . 0.0 111.714 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.9 t -113.2 146.25 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.291 1.036 . . . . 0.0 111.657 -173.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.2 tpp -132.91 122.59 24.56 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.188 0.995 . . . . 0.0 111.573 169.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -95.88 134.86 38.36 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.267 1.027 . . . . 0.0 111.387 169.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.1 t -128.63 130.16 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.968 1.307 . . . . 0.0 111.436 -170.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.0 p -149.28 179.49 7.88 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.471 1.108 . . . . 0.0 111.953 173.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -66.33 -61.92 1.75 Allowed 'General case' 0 N--CA 1.483 1.208 0 O-C-N 120.79 -1.194 . . . . 0.0 111.102 173.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.32 110.98 19.01 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.223 1.009 . . . . 0.0 109.197 169.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -61.68 -34.96 76.67 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.156 0.889 . . . . 0.0 110.331 169.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.3 p -48.47 -37.89 18.53 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.828 2.451 . . . . 0.0 115.836 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.9 p -97.62 -92.39 0.24 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.329 1.052 . . . . 0.0 111.329 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.69 -54.24 49.13 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 120.924 -1.11 . . . . 0.0 113.764 -169.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.402 ' HB3' ' HB2' ' A' ' 34' ' ' SER . 18.5 m -63.6 -42.29 98.27 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.136 0.88 . . . . 0.0 111.868 -176.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -60.74 -39.82 90.11 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.447 1.499 . . . . 0.0 114.564 169.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 78.4 mtp -64.43 -45.97 85.21 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.167 0.894 . . . . 0.0 110.748 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.0 -25.78 64.68 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 172.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -67.27 -53.27 31.4 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.051 1.296 . . . . 0.0 108.168 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.56 -43.55 96.37 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 118.714 -1.048 . . . . 0.0 112.266 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -63.27 -43.41 98.04 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.852 1.826 . . . . 0.0 112.21 172.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.86 -35.56 64.78 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.198 1.363 . . . . 0.0 110.923 -173.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -60.44 -59.22 5.74 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.38 1.472 . . . . 0.0 109.378 169.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.0 p -66.5 -13.58 61.09 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.5 mt -97.87 -5.59 34.23 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 172.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.66 15.69 0.11 Allowed Glycine 0 CA--C 1.536 1.36 0 N-CA-C 118.304 2.081 . . . . 0.0 118.304 -171.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.69 -34.54 59.1 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 119.696 1.748 . . . . 0.0 114.643 -170.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.49 -5.58 86.76 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.38 0.99 . . . . 0.0 115.319 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -99.52 -60.87 1.45 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 118.632 1.216 . . . . 0.0 111.947 -170.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -139.85 170.64 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 126.846 2.059 . . . . 0.0 110.319 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.67 125.13 39.12 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 122.122 0.963 . . . . 0.0 111.275 175.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.2 m -92.79 153.61 3.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.901 169.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.73 149.94 34.39 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.435 0.694 . . . . 0.0 111.71 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' A' ' 15' ' ' SER . 34.4 p -119.92 139.34 52.57 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.994 2.118 . . . . 0.0 113.347 171.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.9 p -144.88 172.86 12.43 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.015 1.326 . . . . 0.0 110.777 169.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.68 -179.82 44.58 Favored Glycine 0 CA--C 1.52 0.367 0 O-C-N 120.383 -1.448 . . . . 0.0 114.569 171.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 34.7 mt -63.69 -30.07 71.22 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.78 0.432 . . . . 0.0 111.532 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -121.39 123.79 42.95 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.877 2.071 . . . . 0.0 108.948 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.3 p -77.8 43.23 0.41 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.92 1.688 . . . . 0.0 111.898 175.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.9 p -63.14 155.01 29.3 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.564 1.545 . . . . 0.0 113.337 -169.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -65.68 177.66 1.19 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.819 1.647 . . . . 0.0 114.471 -169.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 m -63.45 110.33 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 119.866 -1.771 . . . . 0.0 109.617 169.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -67.9 135.46 92.06 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-O 118.413 -0.803 . . . . 0.0 112.414 -169.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -58.79 -39.92 77.38 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.367 2.711 . . . . 0.0 113.795 -174.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.7 m -77.44 -37.87 50.67 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.869 0.468 . . . . 0.0 110.581 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.04 -41.83 97.26 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 118.143 -0.932 . . . . 0.0 112.448 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 66.8 mt -50.8 -47.01 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 120.482 1.492 . . . . 0.0 110.426 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.99 -59.76 3.8 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 175.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 31.0 mmt -67.29 -20.88 65.69 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -172.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 83.9 mmm -90.15 -37.52 14.14 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.721 0.809 . . . . 0.0 110.619 175.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -58.53 -36.46 73.88 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.58 -1.325 . . . . 0.0 112.129 169.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -54.25 -32.75 56.85 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.162 0.985 . . . . 0.0 113.59 172.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.6 m -100.67 13.18 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 124.818 1.247 . . . . 0.0 114.19 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.14 17.2 59.6 Favored Glycine 0 N--CA 1.476 1.329 0 O-C-N 121.047 -1.033 . . . . 0.0 114.896 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.0 mt -126.6 64.49 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.894 1.678 . . . . 0.0 109.965 -169.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -63.47 109.16 1.54 Allowed 'General case' 0 CA--C 1.545 0.759 0 O-C-N 119.985 -1.697 . . . . 0.0 110.905 173.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.1 pt -83.98 -4.89 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 118.36 -0.828 . . . . 0.0 113.04 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -60.13 -30.1 69.07 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 120.495 1.498 . . . . 0.0 113.502 -169.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.36 5.53 71.02 Favored Glycine 0 CA--C 1.541 1.667 0 C-N-CA 124.82 1.2 . . . . 0.0 115.534 173.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -98.82 140.37 33.11 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.11 1.455 . . . . 0.0 112.324 -171.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.8 t -71.21 155.83 40.27 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -173.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.1 m -128.37 143.2 50.97 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.738 1.615 . . . . 0.0 110.49 169.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -138.15 150.86 68.46 Favored Pre-proline 0 N--CA 1.485 1.295 0 CA-C-N 119.616 1.098 . . . . 0.0 113.36 -172.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -88.92 151.03 5.88 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.533 2.155 . . . . 0.0 112.165 177.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.5 tt -62.57 -17.83 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 125.125 1.37 . . . . 0.0 114.55 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.26 -8.05 27.98 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -87.68 -38.89 15.45 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.077 0.853 . . . . 0.0 111.258 170.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.11 157.52 38.04 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.392 0.677 . . . . 0.0 111.409 172.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.25 121.24 13.66 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.721 0.809 . . . . 0.0 111.156 170.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.16 1.79 1.89 Allowed 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -170.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -67.06 -28.1 67.92 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.147 -0.97 . . . . 0.0 111.979 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -93.8 -1.13 55.39 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.41 1.484 . . . . 0.0 113.418 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -130.24 91.62 3.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.615 1.566 . . . . 0.0 110.586 -171.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -59.62 -21.25 60.17 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.7 t -123.28 108.13 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.956 1.302 . . . . 0.0 110.41 -169.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.416 ' C ' HD12 ' A' ' 77' ' ' ILE . 22.6 t -125.58 127.6 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.674 0.79 . . . . 0.0 111.452 -176.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.416 HD12 ' C ' ' A' ' 76' ' ' VAL . 1.6 mp -118.86 130.93 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.39 1.076 . . . . 0.0 110.206 -170.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.7 t -90.32 124.88 35.28 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.912 1.285 . . . . 0.0 108.092 168.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.426 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 76.1 mt -104.24 23.44 13.09 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.824 1.649 . . . . 0.0 112.572 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 27.1 p . . . . . 0 CA--C 1.54 0.576 0 C-N-CA 126.705 2.002 . . . . 0.0 108.533 169.661 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.8 mt . . . . . 0 CA--C 1.551 1.01 0 CA-C-O 119.214 -0.422 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.67 132.77 53.82 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.703 2.269 . . . . 0.0 111.076 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -59.71 -33.95 96.29 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.426 2.084 . . . . 0.0 113.502 -171.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -64.62 -28.6 69.73 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.704 -1.247 . . . . 0.0 113.325 174.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.64 -4.52 52.02 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.797 -1.19 . . . . 0.0 112.859 172.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 72.3 t -104.78 -41.54 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.452 1.901 . . . . 0.0 111.391 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.3 p -82.04 49.12 1.33 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.637 1.175 . . . . 0.0 113.517 -173.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -104.64 170.31 7.96 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.282 1.833 . . . . 0.0 111.945 176.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -58.38 -37.25 74.87 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.736 0.815 . . . . 0.0 112.89 -170.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 56.2 mt -128.48 120.61 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.95 1.3 . . . . 0.0 108.512 169.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -130.37 138.11 50.23 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.03 0.932 . . . . 0.0 110.857 169.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -140.08 151.06 45.07 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.88 1.272 . . . . 0.0 112.05 -175.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -123.55 99.97 6.57 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.924 1.29 . . . . 0.0 109.886 175.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.426 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 39.5 m0 -79.37 -4.55 51.51 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -170.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.372 1.1 pp0? 50.4 37.55 15.83 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.034 1.734 . . . . 0.0 115.586 170.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 69.3 mt -75.5 157.82 33.45 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.834 1.254 . . . . 0.0 112.352 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -85.19 161.48 19.59 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.961 1.304 . . . . 0.0 111.438 170.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -89.52 122.03 68.67 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.511 1.124 . . . . 0.0 112.141 175.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -93.82 -18.69 0.5 Allowed 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 121.688 1.592 . . . . 0.0 114.872 -169.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -44.15 108.11 0.11 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.007 2.123 . . . . 0.0 113.355 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.22 8.58 62.27 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.544 1.069 . . . . 0.0 115.606 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -79.24 -65.75 0.96 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.004 1.402 . . . . 0.0 111.279 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.6 t -170.44 151.71 3.78 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.603 1.961 . . . . 0.0 109.247 171.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.2 mp -59.85 -29.09 68.06 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.204 0.602 . . . . 0.0 111.218 172.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.95 -39.88 95.98 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.95 -1.094 . . . . 0.0 112.332 173.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 86.4 t -71.61 -39.45 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.655 0.782 . . . . 0.0 109.254 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.35 -44.49 94.67 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.14 0.976 . . . . 0.0 111.739 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 -68.7 -37.39 79.49 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.201 -0.937 . . . . 0.0 112.092 172.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 64.0 m -58.58 -49.46 77.38 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 119.007 0.821 . . . . 0.0 111.674 175.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.8 m -69.97 -30.17 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 117.847 -1.073 . . . . 0.0 112.186 176.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -42.66 94.94 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 120.595 1.543 . . . . 0.0 111.595 169.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.68 -42.62 95.28 Favored Glycine 0 N--CA 1.474 1.175 0 C-N-CA 124.017 0.817 . . . . 0.0 112.758 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -62.32 -47.48 84.06 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 122.172 -0.605 . . . . 0.0 112.057 171.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 36.2 t -60.25 -45.32 96.37 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.059 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -52.47 -53.96 38.71 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 119.92 1.236 . . . . 0.0 111.843 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.21 -45.89 91.34 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.863 0.465 . . . . 0.0 112.08 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.9 mtt-85 -71.61 -33.29 68.87 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.1 t -65.2 -47.62 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.941 171.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -53.64 -54.32 39.34 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.604 1.093 . . . . 0.0 109.658 174.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -54.42 -37.33 64.97 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.206 1.003 . . . . 0.0 112.704 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -78.0 -57.56 3.73 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.213 0.915 . . . . 0.0 112.278 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.71 -32.69 59.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.666 1.187 . . . . 0.0 112.281 -176.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.77 -18.44 58.44 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -174.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -72.28 -21.89 61.29 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.551 1.141 . . . . 0.0 113.42 170.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.2 pt -114.76 20.48 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 126.504 1.921 . . . . 0.0 112.287 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.255 1.361 0 C-N-CA 127.759 2.424 . . . . 0.0 111.528 176.174 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.7 ttp . . . . . 0 N--CA 1.503 2.181 0 CA-C-O 119.889 -0.1 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -85.61 106.32 16.83 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.227 0.611 . . . . 0.0 109.972 171.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -77.84 149.61 34.33 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.144 0.578 . . . . 0.0 110.973 176.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 56.8 t -107.85 143.5 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.207 1.003 . . . . 0.0 110.226 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 58.4 tpp -130.55 116.22 17.85 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.483 0.713 . . . . 0.0 109.857 169.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -86.75 142.15 28.35 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.705 -0.622 . . . . 0.0 110.541 169.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.8 t -133.06 128.92 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.663 1.185 . . . . 0.0 111.562 -174.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.3 p -145.95 175.64 10.29 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.688 0.795 . . . . 0.0 111.564 169.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -61.21 -36.35 79.67 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 120.901 -1.125 . . . . 0.0 112.212 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -108.21 136.11 48.42 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.234 1.413 . . . . 0.0 111.113 169.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -98.29 -0.15 44.49 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.792 0.724 . . . . 0.0 110.971 168.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.4 p -74.51 -24.94 59.07 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.117 1.367 . . . . 0.0 112.936 169.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 t -133.49 -164.61 1.51 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.481 1.913 . . . . 0.0 109.73 174.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 41.03 -80.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 128.685 2.794 . . . . 0.0 116.159 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.0 p -56.37 -44.26 80.01 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.148 0.979 . . . . 0.0 112.347 173.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -63.64 -35.51 80.75 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 120.068 1.304 . . . . 0.0 113.408 168.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 87.8 mtp -61.45 -47.08 87.36 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.082 0.855 . . . . 0.0 110.177 176.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.76 -29.03 68.14 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 118.043 -0.98 . . . . 0.0 113.129 175.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -65.06 -54.28 32.55 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 120.277 1.398 . . . . 0.0 108.747 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.96 -45.66 96.15 Favored Glycine 0 CA--C 1.521 0.462 0 CA-C-O 118.882 -0.955 . . . . 0.0 112.814 -176.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.48 -33.85 73.19 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.155 0.977 . . . . 0.0 112.464 172.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.506 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -77.73 -37.52 49.13 Favored 'General case' 0 C--O 1.225 -0.189 0 O-C-N 121.256 -0.903 . . . . 0.0 111.607 -175.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -69.17 -40.78 77.93 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.77 1.168 . . . . 0.0 112.358 169.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.1 p -67.52 -6.35 19.37 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 121.489 1.95 . . . . 0.0 114.516 171.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.6 mt -111.62 0.01 16.24 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 171.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.7 16.52 0.22 Allowed Glycine 0 CA--C 1.536 1.37 0 N-CA-C 116.712 1.445 . . . . 0.0 116.712 -169.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.98 129.43 41.91 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.823 1.312 . . . . 0.0 111.634 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.49 -3.65 58.59 Favored Glycine 0 CA--C 1.539 1.531 0 CA-C-O 118.526 -1.152 . . . . 0.0 115.691 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -83.84 -58.47 2.78 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 119.675 1.738 . . . . 0.0 110.892 176.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -141.03 177.4 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.936 2.095 . . . . 0.0 110.898 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.93 109.32 21.7 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.131 -0.98 . . . . 0.0 111.672 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.506 HG11 ' HB3' ' A' ' 22' ' ' ALA . 40.0 t -85.74 135.75 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 125.757 1.623 . . . . 0.0 111.65 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.85 159.29 43.71 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.173 0.989 . . . . 0.0 112.984 -176.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.8 p -141.71 154.1 45.08 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.658 1.583 . . . . 0.0 114.564 172.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.4 p -151.54 -179.18 7.18 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 126.41 1.884 . . . . 0.0 111.184 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.32 178.97 48.28 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 120.309 -1.494 . . . . 0.0 115.417 176.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 35.0 mt -71.51 -44.31 64.88 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -170.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -116.94 87.59 2.73 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.818 2.447 . . . . 0.0 106.018 169.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.2 p -54.51 -46.46 73.49 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.656 -0.653 . . . . 0.0 111.74 -171.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.7 t 56.57 -166.18 0.13 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.478 1.911 . . . . 0.0 113.476 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -78.24 -153.4 0.06 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.978 2.111 . . . . 0.0 111.863 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.8 m -98.28 125.69 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.12 1.768 . . . . 0.0 106.848 168.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -71.53 131.53 86.28 Favored Pre-proline 0 N--CA 1.478 0.938 0 O-C-N 120.516 -1.365 . . . . 0.0 113.2 -168.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -59.35 -38.82 82.22 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.338 2.692 . . . . 0.0 113.84 -172.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.402 ' HB ' ' CE2' ' A' ' 112' ' ' PHE . 9.1 m -79.64 -36.22 38.17 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.838 -0.539 . . . . 0.0 110.608 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.54 -40.2 95.17 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.956 -1.09 . . . . 0.0 112.383 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 52.1 mt -52.7 -43.68 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 120.847 1.658 . . . . 0.0 110.652 173.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.42 -59.41 4.38 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 174.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.6 mmt -65.98 -21.81 66.43 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -173.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 82.7 mmm -89.79 -37.1 14.74 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.062 0.945 . . . . 0.0 111.238 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -60.8 -35.74 77.24 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.691 1.132 . . . . 0.0 111.572 170.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -55.37 -27.95 50.73 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 171.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.9 m -108.08 20.57 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 125.01 1.324 . . . . 0.0 113.934 175.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.09 11.92 75.06 Favored Glycine 0 CA--C 1.536 1.362 0 O-C-N 121.222 -0.924 . . . . 0.0 115.291 173.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.4 mt -122.84 87.67 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.513 1.525 . . . . 0.0 109.093 -169.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -70.66 111.33 6.06 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 120.315 -1.491 . . . . 0.0 110.419 170.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.7 pt -86.34 -6.28 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 O-C-N 121.496 -0.753 . . . . 0.0 112.608 175.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.3 t -63.78 -30.78 71.84 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 120.007 1.276 . . . . 0.0 112.736 -173.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.95 4.78 75.47 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 125.318 1.437 . . . . 0.0 115.508 171.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -78.06 147.77 34.59 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.108 1.454 . . . . 0.0 111.581 -175.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 10.8 t -62.76 147.47 49.69 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.588 -0.695 . . . . 0.0 112.084 174.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.5 t -127.94 131.98 49.28 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.839 0.856 . . . . 0.0 109.874 169.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -145.33 136.22 12.36 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.899 0.88 . . . . 0.0 113.087 -169.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -84.47 154.23 12.15 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.405 2.737 . . . . 0.0 113.11 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.0 tp -61.56 -18.67 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -103.98 -8.89 19.27 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -86.27 -35.18 20.1 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.297 0.953 . . . . 0.0 110.837 169.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.02 156.0 40.15 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 122.971 0.508 . . . . 0.0 110.702 170.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.1 121.05 15.56 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.557 0.743 . . . . 0.0 110.747 170.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.72 1.68 2.35 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -170.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -69.28 -27.08 65.1 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.343 -0.848 . . . . 0.0 111.918 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -93.33 -2.58 54.71 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.576 1.55 . . . . 0.0 113.225 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -127.1 84.37 2.26 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.998 1.719 . . . . 0.0 109.955 -172.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.69 -18.39 41.92 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.4 t -120.89 111.2 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 125.515 1.526 . . . . 0.0 109.762 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.4 t -126.34 121.39 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 121.611 -0.68 . . . . 0.0 110.476 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 mp -113.15 135.05 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.277 1.031 . . . . 0.0 109.958 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.0 m -95.8 148.4 22.63 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.604 1.162 . . . . 0.0 109.972 169.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.417 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 87.6 mt -129.09 44.21 3.01 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.065 0.946 . . . . 0.0 110.169 -171.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 22.5 p . . . . . 0 CA--C 1.544 0.734 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 -169.062 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 CA--C 1.549 0.911 0 CA-C-O 119.484 -0.293 . . . . 0.0 111.743 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -54.79 138.12 76.07 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.066 2.51 . . . . 0.0 111.827 173.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -59.02 -34.26 99.02 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.359 2.039 . . . . 0.0 113.628 -172.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -65.99 -26.77 67.71 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.817 -1.177 . . . . 0.0 113.692 174.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.38 -15.81 59.18 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.631 -1.293 . . . . 0.0 113.027 170.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.6 t -93.51 -37.75 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 126.548 1.939 . . . . 0.0 112.162 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.8 p -83.97 18.13 2.16 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -172.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -70.22 162.36 28.57 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.496 1.118 . . . . 0.0 112.359 169.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -55.47 -35.19 65.23 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.108 1.363 . . . . 0.0 113.781 -169.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.9 mt -127.9 118.79 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.812 1.245 . . . . 0.0 108.15 169.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -132.57 128.01 36.29 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.121 0.968 . . . . 0.0 111.298 170.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -147.51 161.96 40.04 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.805 1.642 . . . . 0.0 111.075 -174.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -129.94 129.96 44.5 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.557 0.743 . . . . 0.0 111.672 169.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.417 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 46.3 m0 -90.06 1.93 55.79 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -177.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 71.44 -72.35 0.12 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.44 1.896 . . . . 0.0 113.256 175.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 20.5 mt 50.14 -157.97 0.09 Allowed 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 126.143 1.777 . . . . 0.0 114.221 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -144.06 156.66 44.46 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.828 2.451 . . . . 0.0 108.045 172.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -80.13 120.04 78.43 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-N 120.683 1.583 . . . . 0.0 111.887 176.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -91.31 -21.69 0.63 Allowed 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 122.249 1.966 . . . . 0.0 115.746 -169.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -53.44 110.16 0.53 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.507 1.123 . . . . 0.0 112.403 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.73 1.43 87.32 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.068 0.842 . . . . 0.0 114.749 176.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -75.05 170.07 16.75 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.584 1.192 . . . . 0.0 110.822 169.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.2 t -63.31 148.27 48.76 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.531 -0.73 . . . . 0.0 110.361 169.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 mp -61.43 -27.86 68.85 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.604 -0.685 . . . . 0.0 112.485 -173.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.85 -34.76 78.02 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.998 -1.064 . . . . 0.0 113.444 171.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.2 t -71.12 -35.72 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 O-C-N 120.975 -1.078 . . . . 0.0 109.885 172.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.402 ' CE2' ' HB ' ' A' ' 45' ' ' THR . 0.3 OUTLIER -67.7 -38.52 83.77 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.322 0.649 . . . . 0.0 111.125 177.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -70.25 -37.38 74.93 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.994 1.318 . . . . 0.0 111.739 170.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.6 m -57.51 -45.88 84.43 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 119.118 0.872 . . . . 0.0 111.66 175.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.0 m -69.33 -29.91 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 119.723 1.147 . . . . 0.0 112.609 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -62.44 -41.75 98.95 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 120.542 1.519 . . . . 0.0 111.77 170.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.07 -45.41 87.51 Favored Glycine 0 N--CA 1.474 1.195 0 C-N-CA 124.039 0.828 . . . . 0.0 112.745 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -60.56 -40.53 91.96 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 122.197 -0.59 . . . . 0.0 112.375 171.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.2 t -64.99 -46.76 90.58 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.103 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -52.03 -53.15 45.45 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 120.141 1.337 . . . . 0.0 111.593 176.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -49.81 -45.1 49.65 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.301 1.44 . . . . 0.0 112.111 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -92.16 -27.05 17.95 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.058 0.943 . . . . 0.0 112.179 -171.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.9 t -62.19 -49.8 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.042 1.337 . . . . 0.0 109.799 169.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -54.06 -53.73 49.09 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.005 0.82 . . . . 0.0 109.583 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -53.03 -37.93 61.95 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.141 1.776 . . . . 0.0 112.364 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -78.83 -59.87 2.6 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.157 -0.964 . . . . 0.0 112.781 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.18 -33.55 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.887 1.275 . . . . 0.0 112.498 -174.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.97 -18.79 61.96 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -78.42 -25.13 45.93 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.648 1.179 . . . . 0.0 113.52 174.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.1 pt -106.25 -8.18 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.498 1.519 . . . . 0.0 113.678 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 C--O 1.254 1.315 0 C-N-CA 125.493 1.517 . . . . 0.0 113.088 173.653 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.2 ttp . . . . . 0 N--CA 1.503 2.203 0 CA-C-O 119.754 -0.165 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -88.35 97.85 11.27 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.079 0.952 . . . . 0.0 110.69 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -81.24 133.73 35.49 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 121.633 -0.667 . . . . 0.0 110.811 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.5 m -100.15 146.51 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.088 0.955 . . . . 0.0 110.998 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.8 tpp -126.41 112.11 15.26 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.907 0.883 . . . . 0.0 110.876 172.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -81.54 138.07 35.48 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.967 -0.458 . . . . 0.0 110.656 169.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.2 t -137.38 129.79 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.316 1.047 . . . . 0.0 111.234 -171.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 t -145.69 -175.6 4.8 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 119.166 0.894 . . . . 0.0 113.345 169.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -60.03 -37.66 80.45 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 121.752 -0.593 . . . . 0.0 110.323 169.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.434 ' HB3' ' H ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -113.95 127.74 56.09 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.985 0.914 . . . . 0.0 110.695 168.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -66.97 -33.65 76.04 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.552 168.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.8 p -67.97 -47.51 68.41 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.136 1.774 . . . . 0.0 115.584 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.434 ' H ' ' HB3' ' A' ' 10' ' ' ARG . 56.3 p -85.42 -24.96 27.26 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -171.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.27 -60.89 1.59 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 176.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.8 m -60.19 -41.06 92.15 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.147 0.885 . . . . 0.0 112.947 -169.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -60.44 -40.05 89.71 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.847 1.659 . . . . 0.0 113.088 169.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.7 mtm -61.94 -46.06 90.95 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.852 -1.155 . . . . 0.0 111.023 174.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.89 -28.52 66.76 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 173.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -71.24 -46.04 61.93 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.227 1.376 . . . . 0.0 108.96 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.61 -44.07 97.03 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 118.602 -1.11 . . . . 0.0 112.408 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -63.15 -41.31 99.25 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.974 1.387 . . . . 0.0 111.971 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.94 -34.58 71.63 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 120.719 -1.238 . . . . 0.0 110.572 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -59.45 -57.92 10.86 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.112 1.765 . . . . 0.0 109.94 170.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.6 p -69.09 -14.64 63.13 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.1 mt -99.87 -6.38 26.88 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.5 10.77 0.52 Allowed Glycine 0 N--CA 1.476 1.357 0 N-CA-C 117.192 1.637 . . . . 0.0 117.192 -169.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.02 131.06 39.88 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.076 1.438 . . . . 0.0 112.142 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.97 -8.68 49.71 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.387 -1.229 . . . . 0.0 115.777 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -84.76 -57.08 3.26 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 120.03 1.915 . . . . 0.0 110.461 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -139.02 179.43 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 126.57 1.948 . . . . 0.0 110.597 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.76 127.39 47.2 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.341 -0.849 . . . . 0.0 112.091 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.5 m -90.99 145.26 7.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 123.989 0.916 . . . . 0.0 113.212 169.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.8 157.4 43.66 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.998 0.919 . . . . 0.0 110.88 -174.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.9 p -141.89 141.85 33.04 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.394 1.478 . . . . 0.0 112.757 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.1 t -143.46 178.15 7.96 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.414 1.486 . . . . 0.0 111.208 169.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.03 170.21 37.11 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 119.905 -1.747 . . . . 0.0 114.494 172.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.5 mt -60.53 -45.0 95.46 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.453 0.701 . . . . 0.0 111.851 -170.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -109.45 111.63 23.27 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 127.239 2.216 . . . . 0.0 106.251 169.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.4 p -66.72 -43.17 84.96 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.446 -1.409 . . . . 0.0 110.975 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 t 52.62 -170.69 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.711 2.004 . . . . 0.0 114.081 -176.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -88.63 174.37 8.09 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.587 1.955 . . . . 0.0 111.787 173.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 m -60.77 113.4 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 169.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -64.45 130.37 94.64 Favored Pre-proline 0 N--CA 1.477 0.902 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -168.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -59.98 -39.2 72.93 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.475 2.783 . . . . 0.0 114.028 -171.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 m -78.3 -37.28 45.13 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.117 0.567 . . . . 0.0 110.507 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.22 93.59 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.084 -0.96 . . . . 0.0 112.355 175.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.9 mt -52.07 -45.75 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 120.687 1.585 . . . . 0.0 110.083 173.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.2 -57.8 7.58 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.2 mmt -64.88 -23.07 67.12 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -174.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 87.7 mmm -89.97 -37.83 14.07 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.224 1.01 . . . . 0.0 110.851 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -58.75 -36.81 74.96 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 120.766 -1.209 . . . . 0.0 112.067 169.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -54.97 -30.57 59.44 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.353 1.061 . . . . 0.0 113.704 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.2 m -104.47 15.69 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 125.059 1.344 . . . . 0.0 114.113 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.86 15.43 63.16 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.131 0.872 . . . . 0.0 115.087 176.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.2 mt -124.56 74.2 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.832 1.653 . . . . 0.0 109.461 -169.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -66.39 108.06 2.24 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 119.938 -1.726 . . . . 0.0 110.498 172.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.8 pt -86.95 -0.47 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.0 p -67.71 -24.87 65.44 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.535 -1.353 . . . . 0.0 114.588 -169.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.61 6.0 64.86 Favored Glycine 0 CA--C 1.541 1.671 0 C-N-CA 125.389 1.471 . . . . 0.0 114.66 170.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -82.06 147.92 28.87 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.704 1.202 . . . . 0.0 112.029 -172.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.6 t -69.06 156.1 39.23 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 121.505 -0.747 . . . . 0.0 112.157 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.5 t -136.6 142.68 43.33 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.743 0.817 . . . . 0.0 111.243 170.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.31 140.6 21.08 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -171.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -89.96 156.48 4.91 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 124.123 3.215 . . . . 0.0 113.024 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.7 tp -61.52 -22.98 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -170.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -102.62 -5.34 23.97 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -87.87 -38.89 15.27 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.651 -0.656 . . . . 0.0 110.852 169.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.06 153.36 43.9 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.23 0.538 . . . . 0.0 111.436 171.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -136.98 120.63 17.26 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.529 1.132 . . . . 0.0 110.444 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.49 8.48 1.78 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -170.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -73.35 -29.87 62.95 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.47 -0.769 . . . . 0.0 112.305 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -93.39 -3.55 53.07 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.091 1.357 . . . . 0.0 113.642 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -125.06 89.36 3.04 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.869 1.668 . . . . 0.0 109.351 -172.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -59.7 -24.66 64.14 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -175.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.0 t -121.35 105.11 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.703 1.201 . . . . 0.0 110.106 -169.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.433 ' C ' HD12 ' A' ' 77' ' ' ILE . 37.8 t -116.05 130.49 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.584 1.154 . . . . 0.0 110.66 -174.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.433 HD12 ' C ' ' A' ' 76' ' ' VAL . 1.6 mp -119.38 124.97 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.714 0.806 . . . . 0.0 109.98 -174.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 t -85.7 124.68 32.49 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.419 1.088 . . . . 0.0 108.969 168.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.414 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 75.2 mt -111.54 37.68 2.83 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 126.673 1.989 . . . . 0.0 110.506 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 9.6 t . . . . . 0 CA--C 1.536 0.433 0 O-C-N 121.446 -0.783 . . . . 0.0 112.697 -175.924 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.5 mt . . . . . 0 CA--C 1.548 0.881 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.83 134.7 58.7 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.031 2.487 . . . . 0.0 111.798 176.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -61.62 -30.18 85.29 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.483 2.122 . . . . 0.0 113.557 -174.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -66.58 -30.89 71.29 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.544 -1.348 . . . . 0.0 113.183 173.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -78.61 -20.12 51.15 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.926 -1.108 . . . . 0.0 112.632 174.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.3 t -86.77 -38.65 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.801 1.64 . . . . 0.0 112.107 174.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.3 p -85.12 52.43 2.44 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 120.785 -1.197 . . . . 0.0 113.366 -172.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -110.65 171.51 7.42 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.339 1.856 . . . . 0.0 112.306 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -53.29 -42.48 66.66 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.401 1.08 . . . . 0.0 113.003 -169.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.3 mt -130.2 122.42 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.867 1.267 . . . . 0.0 108.756 169.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -122.36 132.45 54.39 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.706 0.802 . . . . 0.0 109.157 169.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.82 155.12 44.6 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.127 1.371 . . . . 0.0 111.156 -176.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -136.21 118.86 16.0 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.493 0.717 . . . . 0.0 111.92 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.414 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 31.8 m0 -97.94 3.06 49.66 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.725 1.21 . . . . 0.0 113.338 -175.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.329 1.2 pp0? 45.59 43.42 9.18 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.9 2.08 . . . . 0.0 115.905 171.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 83.9 mt -84.49 158.16 21.09 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.698 1.199 . . . . 0.0 113.917 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -79.85 164.07 23.88 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.331 1.852 . . . . 0.0 112.188 169.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -95.84 111.71 56.86 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 123.861 0.864 . . . . 0.0 108.975 169.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -85.44 -10.57 7.58 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.049 2.499 . . . . 0.0 116.067 -169.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -49.67 112.7 0.69 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.533 1.133 . . . . 0.0 112.816 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.6 -0.15 89.69 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 123.844 0.735 . . . . 0.0 114.836 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -75.79 170.68 15.75 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 118.295 1.047 . . . . 0.0 110.31 169.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.5 t -58.84 145.27 41.55 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.507 -0.746 . . . . 0.0 111.028 169.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.45 -28.32 68.22 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.15 0.58 . . . . 0.0 111.998 -176.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -65.82 -33.18 75.27 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 120.96 -1.087 . . . . 0.0 113.237 173.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.2 t -70.28 -36.47 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 O-C-N 121.037 -1.039 . . . . 0.0 109.823 171.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.87 -42.68 90.07 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.645 0.778 . . . . 0.0 110.736 176.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -67.12 -36.06 81.09 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.78 1.232 . . . . 0.0 112.367 171.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.5 m -59.53 -48.89 79.89 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 119.306 0.957 . . . . 0.0 111.427 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.3 m -68.21 -32.31 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 117.909 -1.043 . . . . 0.0 111.983 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.08 -43.4 91.8 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 120.825 1.648 . . . . 0.0 111.978 169.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.47 -41.89 89.91 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 124.388 0.994 . . . . 0.0 112.556 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -61.95 -46.14 90.59 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 122.214 -0.58 . . . . 0.0 111.897 169.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.42 -46.73 92.44 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.267 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -51.95 -54.92 23.92 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.654 1.182 . . . . 0.0 111.827 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -60.61 -41.42 94.74 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.351 0.661 . . . . 0.0 112.305 -176.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 50.7 mtp85 -79.2 -33.83 43.5 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.4 t -59.81 -47.58 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.182 0.993 . . . . 0.0 110.653 170.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -53.35 -55.3 26.0 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.11 0.868 . . . . 0.0 109.966 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -54.71 -40.63 69.4 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.881 1.273 . . . . 0.0 112.301 176.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.7 -58.81 3.07 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.183 -0.948 . . . . 0.0 112.52 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.36 -34.95 70.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.599 1.16 . . . . 0.0 111.624 -176.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.42 -15.95 61.33 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -173.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -71.17 -28.16 64.05 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.435 1.094 . . . . 0.0 113.42 170.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.7 pt -113.81 -6.95 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.189 1.796 . . . . 0.0 113.287 -173.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.7 m . . . . . 0 C--O 1.254 1.299 0 C-N-CA 125.735 1.614 . . . . 0.0 113.713 173.561 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.503 2.217 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -79.62 96.51 6.2 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.773 0.829 . . . . 0.0 110.079 171.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -77.12 144.96 38.09 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.759 -0.588 . . . . 0.0 111.191 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 p -122.43 141.72 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.524 1.13 . . . . 0.0 111.047 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 50.8 tpp -124.38 120.41 32.03 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.616 1.167 . . . . 0.0 111.774 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -88.89 130.06 35.49 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.313 0.645 . . . . 0.0 111.507 169.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.2 t -129.24 124.31 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.918 1.287 . . . . 0.0 110.188 -172.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.3 m -136.17 169.65 17.28 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.556 1.142 . . . . 0.0 111.467 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -64.92 -48.69 73.25 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 168.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -99.87 105.4 17.14 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.314 1.446 . . . . 0.0 108.366 168.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -53.58 -33.49 55.04 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 122.952 0.501 . . . . 0.0 110.884 169.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.9 p -65.37 -40.2 93.25 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.164 2.185 . . . . 0.0 115.793 176.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.4 p -97.09 -22.9 16.5 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.43 -51.14 1.75 Allowed 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 171.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.0 m -59.07 -44.57 91.89 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 121.284 1.857 . . . . 0.0 111.926 -175.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -58.23 -43.56 87.79 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.997 1.319 . . . . 0.0 113.474 169.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.415 ' HA ' ' CE ' ' A' ' 50' ' ' MET . 51.2 ttm -58.31 -50.81 72.31 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.325 1.05 . . . . 0.0 111.381 175.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.67 -27.22 66.66 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.254 1.022 . . . . 0.0 112.524 174.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -76.35 -43.55 40.51 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 120.424 1.466 . . . . 0.0 109.133 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.88 -52.99 47.65 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-O 119.152 -0.804 . . . . 0.0 111.248 174.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.513 ' HB3' HG11 ' A' ' 123' ' ' VAL . 17.3 m-85 -62.2 -41.61 98.53 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.286 1.043 . . . . 0.0 112.919 174.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.01 -40.83 97.23 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.211 1.369 . . . . 0.0 110.837 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -61.21 -50.06 74.65 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.326 1.85 . . . . 0.0 111.32 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.6 p -74.94 -22.73 58.42 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.1 mt -88.84 -23.26 22.85 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.264 0.938 . . . . 0.0 112.711 176.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -126.4 21.72 6.01 Favored Glycine 0 N--CA 1.473 1.124 0 C-N-CA 125.777 1.656 . . . . 0.0 115.431 -170.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.91 126.48 27.27 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.236 1.018 . . . . 0.0 112.531 -173.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.65 -2.6 47.22 Favored Glycine 0 CA--C 1.537 1.431 0 N-CA-C 116.024 1.17 . . . . 0.0 116.024 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -81.7 -54.77 5.11 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.587 1.694 . . . . 0.0 111.146 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.415 HD11 HD11 ' A' ' 127' ' ' ILE . 2.3 pp -143.04 -179.37 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 127.355 2.262 . . . . 0.0 110.989 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.23 121.49 42.34 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.482 0.658 . . . . 0.0 111.825 171.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.3 m -87.11 150.8 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 123.473 0.709 . . . . 0.0 111.981 169.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.68 159.77 43.05 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.265 1.026 . . . . 0.0 111.288 -174.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.5 t -144.7 127.7 16.49 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.144 1.378 . . . . 0.0 111.885 -169.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.0 p -144.09 -178.76 6.11 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.532 1.533 . . . . 0.0 111.299 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.06 172.11 35.47 Favored Glycine 0 CA--C 1.532 1.142 0 O-C-N 119.834 -1.791 . . . . 0.0 114.47 173.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 47.6 mt -61.68 -39.15 90.42 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 118.354 1.077 . . . . 0.0 112.176 -173.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -115.81 113.66 23.69 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.809 2.044 . . . . 0.0 107.843 169.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.3 p -65.88 -37.14 85.35 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.933 0.893 . . . . 0.0 112.046 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.4 t 44.09 -129.85 0.87 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 126.159 1.784 . . . . 0.0 112.786 -174.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -146.62 -175.77 4.92 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 127.139 2.176 . . . . 0.0 111.823 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.1 m -59.22 115.75 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 121.134 -0.979 . . . . 0.0 110.291 169.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.8 t-80 -73.85 131.7 81.33 Favored Pre-proline 0 N--CA 1.476 0.855 0 CA-C-O 118.501 -0.762 . . . . 0.0 113.035 -169.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -60.58 -39.74 62.2 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.488 2.792 . . . . 0.0 114.293 -171.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.1 m -80.95 -33.07 34.25 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.803 -0.56 . . . . 0.0 110.833 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.45 -42.46 87.55 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 118.087 -0.959 . . . . 0.0 112.166 174.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.0 mt -47.35 -48.22 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 119.997 1.271 . . . . 0.0 110.395 172.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.61 -61.54 2.14 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.8 mmt -66.31 -27.31 67.82 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.525 -0.735 . . . . 0.0 112.379 -171.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.415 ' CE ' ' HA ' ' A' ' 17' ' ' MET . 81.7 mtp -84.22 -38.18 20.88 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.595 0.758 . . . . 0.0 111.364 177.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -57.35 -38.05 73.54 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.715 1.143 . . . . 0.0 112.099 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -59.39 -23.39 62.55 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.0 m -108.28 15.07 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.39 16.54 58.7 Favored Glycine 0 N--CA 1.478 1.444 0 O-C-N 121.087 -1.008 . . . . 0.0 115.325 176.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.9 mt -125.43 53.31 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.892 1.677 . . . . 0.0 110.307 -169.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -60.4 113.2 2.28 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.26 -1.525 . . . . 0.0 111.435 176.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.8 pt -91.46 2.53 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.215 1.006 . . . . 0.0 113.648 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -62.19 -24.41 67.19 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 120.759 1.618 . . . . 0.0 113.262 -173.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.46 6.87 59.47 Favored Glycine 0 CA--C 1.543 1.84 0 C-N-CA 125.475 1.512 . . . . 0.0 115.77 170.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -83.24 152.21 25.29 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.089 1.445 . . . . 0.0 112.088 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.0 t -71.44 163.67 27.26 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 52.0 m -137.07 140.92 42.34 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.01 1.724 . . . . 0.0 109.49 169.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -145.96 141.89 17.17 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-N 119.548 1.067 . . . . 0.0 113.369 -175.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -86.45 148.27 8.78 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 123.221 2.614 . . . . 0.0 111.441 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.0 tt -66.48 -16.63 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 O-C-N 120.549 -1.344 . . . . 0.0 113.976 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -89.54 -10.52 45.86 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.112 -0.992 . . . . 0.0 113.485 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -88.5 -40.7 13.24 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.764 0.825 . . . . 0.0 111.453 170.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.71 153.03 43.19 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.816 0.847 . . . . 0.0 111.694 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.443 ' HA ' ' CH2' ' A' ' 90' ' ' TRP . 11.1 m120 -128.38 124.87 37.45 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.435 0.694 . . . . 0.0 110.329 169.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.405 ' HB3' ' CE3' ' A' ' 90' ' ' TRP . . . -70.29 5.71 1.62 Allowed 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -175.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -73.02 -29.02 62.7 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.983 0.913 . . . . 0.0 112.213 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -97.51 -3.79 39.17 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.81 1.244 . . . . 0.0 113.583 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -121.73 92.01 3.64 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.009 1.724 . . . . 0.0 109.353 -172.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -60.51 -28.17 68.18 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -174.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.5 t -113.67 116.74 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.383 1.073 . . . . 0.0 110.098 -177.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.1 t -126.4 132.51 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.909 0.884 . . . . 0.0 110.377 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.7 mm -123.07 127.78 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 121.771 -0.581 . . . . 0.0 111.466 -170.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.5 t -87.51 126.45 34.92 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.282 1.433 . . . . 0.0 109.964 169.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.5 mt -112.6 42.14 1.9 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.645 1.178 . . . . 0.0 113.015 -174.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 30.4 p . . . . . 0 CA--C 1.545 0.777 0 C-N-CA 127.126 2.17 . . . . 0.0 107.744 168.972 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.0 mt . . . . . 0 CA--C 1.546 0.801 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -71.37 151.32 59.71 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.328 2.019 . . . . 0.0 110.863 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -58.62 -34.78 99.11 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.837 2.358 . . . . 0.0 112.613 -175.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -48.83 -46.25 41.73 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.602 1.561 . . . . 0.0 112.919 175.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.443 ' CH2' ' HA ' ' A' ' 69' ' ' ASN . 1.8 m95 -90.57 8.42 34.21 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.052 1.341 . . . . 0.0 113.072 -177.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.5 t -116.0 -39.32 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 126.868 2.067 . . . . 0.0 111.697 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.6 p -79.9 28.11 0.29 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -174.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -85.22 172.19 11.36 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.826 1.65 . . . . 0.0 111.961 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -53.69 -42.37 67.89 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -169.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.6 mt -129.4 125.67 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.463 1.105 . . . . 0.0 109.069 169.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -131.99 136.26 47.15 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.264 1.026 . . . . 0.0 111.533 169.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -143.06 154.94 44.47 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.111 1.364 . . . . 0.0 111.741 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -122.64 118.95 29.37 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.14 1.376 . . . . 0.0 109.976 171.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -84.86 3.98 35.38 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 117.788 2.514 . . . . 0.0 117.788 -169.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 58.44 51.16 8.43 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.252 1.387 . . . . 0.0 113.048 176.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 66.2 mt -107.73 165.93 11.07 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.336 1.855 . . . . 0.0 113.269 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -122.32 153.73 38.56 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.387 1.875 . . . . 0.0 110.32 173.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -74.34 118.32 68.84 Favored Pre-proline 0 CA--C 1.546 0.816 0 O-C-N 121.296 -0.878 . . . . 0.0 111.342 176.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.413 ' HB2' ' CD2' ' A' ' 112' ' ' PHE . 27.6 Cg_endo -85.27 -6.6 9.19 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.32 2.013 . . . . 0.0 114.013 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -48.67 116.03 1.46 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.231 1.013 . . . . 0.0 112.77 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.04 3.68 69.71 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.791 0.71 . . . . 0.0 114.338 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -80.94 171.58 14.82 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.463 1.105 . . . . 0.0 110.115 171.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.3 p -63.9 156.49 27.5 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.339 -0.85 . . . . 0.0 112.082 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.05 -29.06 70.03 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.578 -0.701 . . . . 0.0 111.43 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.27 -40.96 92.22 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.175 -0.953 . . . . 0.0 112.641 172.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.3 t -73.1 -39.85 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.753 0.821 . . . . 0.0 109.691 176.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.413 ' CD2' ' HB2' ' A' ' 104' ' ' PRO . 0.6 OUTLIER -63.52 -36.87 85.21 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.051 0.54 . . . . 0.0 111.189 177.553 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -70.95 -43.21 68.63 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.339 1.456 . . . . 0.0 112.199 172.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.2 m -57.69 -51.05 71.11 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.177 0.991 . . . . 0.0 111.838 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.4 m -68.1 -29.23 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 O-C-N 121.271 -0.893 . . . . 0.0 112.051 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.6 ptt-85 -70.6 -32.9 70.43 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 119.778 1.172 . . . . 0.0 113.051 173.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.11 -45.12 94.64 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 123.88 0.752 . . . . 0.0 112.262 170.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -61.97 -42.18 98.85 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.926 -0.749 . . . . 0.0 112.348 171.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.422 ' O ' HG12 ' A' ' 123' ' ' VAL . 8.3 t -60.22 -50.12 81.49 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.724 0 CA-C-O 117.139 -1.41 . . . . 0.0 110.182 174.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -51.19 -48.91 61.84 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.469 1.508 . . . . 0.0 112.158 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -55.27 -43.7 74.94 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.701 1.2 . . . . 0.0 112.492 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.0 mtt180 -91.59 -32.89 15.34 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.975 0.91 . . . . 0.0 112.75 -169.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.513 HG11 ' HB3' ' A' ' 21' ' ' PHE . 9.4 p -69.6 -36.66 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.574 1.55 . . . . 0.0 112.012 171.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -56.67 -58.76 6.7 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.81 1.186 . . . . 0.0 109.915 169.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -55.34 -27.65 48.58 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.504 1.122 . . . . 0.0 113.299 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -85.07 -59.33 2.37 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.336 0.971 . . . . 0.0 112.904 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.415 HD11 HD11 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -58.92 -33.34 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.553 1.141 . . . . 0.0 111.727 -178.063 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.83 -14.13 60.65 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -82.48 -28.38 31.22 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.501 1.121 . . . . 0.0 113.065 172.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.3 pt -98.92 -12.02 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.612 1.165 . . . . 0.0 113.817 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.2 m . . . . . 0 C--O 1.255 1.356 0 C-N-CA 124.766 1.226 . . . . 0.0 113.245 171.672 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 ttm . . . . . 0 N--CA 1.503 2.182 0 CA-C-O 119.712 -0.185 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -91.95 85.82 5.67 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.19 0.996 . . . . 0.0 110.277 177.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -77.45 150.74 34.94 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.535 -0.728 . . . . 0.0 111.351 -175.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.2 t -108.38 143.27 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.583 0.753 . . . . 0.0 111.45 -175.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 43.7 tpp -128.08 110.39 12.44 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.912 0.885 . . . . 0.0 110.156 169.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -81.83 138.51 35.09 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.635 169.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.6 t -135.62 128.39 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.083 0.953 . . . . 0.0 111.587 -174.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.7 p -147.17 -178.23 6.1 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.798 1.239 . . . . 0.0 111.813 175.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -62.35 -64.34 0.96 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 119.847 1.203 . . . . 0.0 110.124 172.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.27 107.42 16.56 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 168.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 39' ' ' SER . 13.7 t-20 -56.67 -41.73 77.78 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.748 0.704 . . . . 0.0 109.556 169.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.2 p -53.22 -29.57 33.08 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 127.446 2.299 . . . . 0.0 115.849 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.1 p -97.97 -97.47 0.21 Allowed 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 123.571 0.748 . . . . 0.0 109.82 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -53.19 -50.7 64.11 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.391 1.476 . . . . 0.0 113.38 -169.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.533 ' HB3' ' HB2' ' A' ' 34' ' ' SER . 69.9 m -71.36 -40.2 70.78 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -174.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -64.25 -37.2 86.63 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 168.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 77.0 mtp -58.38 -51.36 70.14 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.108 0.867 . . . . 0.0 109.592 172.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.24 -36.18 82.82 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -66.38 -40.22 89.57 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 119.524 1.056 . . . . 0.0 108.882 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.404 ' HA3' ' CG2' ' A' ' 55' ' ' ILE . . . -68.16 -45.05 73.65 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-O 118.961 -0.911 . . . . 0.0 111.989 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -62.28 -38.88 91.04 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.305 1.052 . . . . 0.0 111.458 170.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.401 ' HB1' HG11 ' A' ' 32' ' ' VAL . . . -70.24 -33.46 71.68 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 120.587 -1.32 . . . . 0.0 111.368 -178.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -62.8 -55.5 25.87 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.443 1.897 . . . . 0.0 109.369 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.8 p -71.46 -15.51 62.33 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.6 mt -97.4 -11.12 24.3 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 173.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.99 9.2 2.01 Favored Glycine 0 N--CA 1.477 1.376 0 N-CA-C 117.227 1.651 . . . . 0.0 117.227 -169.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.5 128.98 27.58 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.155 1.478 . . . . 0.0 112.342 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.12 -6.89 55.28 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-O 118.319 -1.267 . . . . 0.0 115.888 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -85.68 -57.16 3.16 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.02 1.91 . . . . 0.0 110.286 175.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 pp -139.71 173.4 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 127.433 2.293 . . . . 0.0 109.141 171.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.37 131.2 44.27 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.522 -0.736 . . . . 0.0 111.833 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.401 HG11 ' HB1' ' A' ' 22' ' ' ALA . 32.7 m -100.11 143.8 13.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 123.709 0.804 . . . . 0.0 112.805 170.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 m -145.98 162.59 37.48 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.615 1.566 . . . . 0.0 109.467 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.533 ' HB2' ' HB3' ' A' ' 15' ' ' SER . 91.0 p -143.91 148.69 35.76 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.061 0.944 . . . . 0.0 113.097 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.5 p -138.39 -170.38 2.8 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.025 1.33 . . . . 0.0 110.914 171.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.93 173.44 37.36 Favored Glycine 0 CA--C 1.528 0.891 0 O-C-N 121.078 -1.013 . . . . 0.0 113.85 175.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.8 mt -64.78 -35.92 82.64 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.409 0.684 . . . . 0.0 112.253 -172.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -123.24 105.69 10.09 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 128.449 2.699 . . . . 0.0 107.09 172.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.408 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 11.2 p -60.9 -46.9 88.82 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.437 -0.79 . . . . 0.0 111.633 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.1 t 49.72 -171.83 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 127.898 2.479 . . . . 0.0 114.415 -174.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -77.98 166.74 22.47 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.65 1.58 . . . . 0.0 110.214 169.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.1 m -56.99 120.13 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 119.949 1.25 . . . . 0.0 108.098 169.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -65.15 127.56 92.96 Favored Pre-proline 0 N--CA 1.479 0.998 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -167.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -61.73 -39.48 52.75 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.256 2.637 . . . . 0.0 113.845 -169.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.1 m -77.85 -35.66 50.81 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.937 -0.477 . . . . 0.0 110.318 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.17 -38.1 87.24 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 117.956 -1.021 . . . . 0.0 112.407 174.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.0 mt -55.31 -41.64 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 121.455 1.934 . . . . 0.0 110.501 173.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.73 -59.77 4.15 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.0 mmt -63.69 -27.29 69.11 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.483 -0.761 . . . . 0.0 112.66 -174.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 88.0 mmm -85.01 -33.12 22.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.773 0.829 . . . . 0.0 110.561 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -61.86 -33.61 74.49 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.888 -1.133 . . . . 0.0 111.817 171.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -55.06 -33.6 62.87 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.088 0.955 . . . . 0.0 112.763 172.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.4 m -105.49 19.11 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.259 1.424 . . . . 0.0 113.859 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.34 17.01 74.89 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 115.528 0.971 . . . . 0.0 115.528 173.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.404 ' CG2' ' HA3' ' A' ' 20' ' ' GLY . 71.6 mt -115.36 125.93 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.206 1.402 . . . . 0.0 111.417 -169.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -100.43 73.41 1.65 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.558 1.943 . . . . 0.0 112.727 -172.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.33 -10.23 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 120.373 -1.454 . . . . 0.0 111.672 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.1 p -60.95 -32.03 71.56 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.888 2.475 . . . . 0.0 113.833 169.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.45 47.55 1.02 Allowed Glycine 0 N--CA 1.474 1.224 0 C-N-CA 126.418 1.961 . . . . 0.0 112.168 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -135.87 171.94 13.73 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.668 1.587 . . . . 0.0 113.287 -169.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -76.56 137.26 39.44 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 121.37 -0.832 . . . . 0.0 112.944 -169.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.7 m -125.59 45.58 2.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.189 1.396 . . . . 0.0 111.004 -170.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.83 140.22 54.4 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -169.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -83.11 151.1 13.9 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.186 2.591 . . . . 0.0 111.008 169.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.9 tt -63.33 -21.57 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 -171.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -99.24 -4.71 31.32 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -88.51 -41.55 12.66 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.044 0.838 . . . . 0.0 112.117 171.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.35 164.33 24.73 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.229 0.538 . . . . 0.0 112.077 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -136.48 120.18 17.26 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.046 0.938 . . . . 0.0 111.069 171.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.96 2.86 1.79 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 -172.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -70.27 -31.78 69.31 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.406 1.003 . . . . 0.0 112.179 -174.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -90.27 -8.87 49.87 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.56 1.144 . . . . 0.0 113.364 176.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -120.79 72.23 0.96 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.921 1.689 . . . . 0.0 109.378 -173.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -65.37 -6.47 10.23 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -170.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.2 t -120.87 96.64 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 125.938 1.695 . . . . 0.0 109.055 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.4 t -109.63 135.15 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 121.376 -0.828 . . . . 0.0 110.211 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.462 HG21 ' CE2' ' A' ' 99' ' ' TRP . 12.5 mm -128.6 136.13 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 123.27 0.628 . . . . 0.0 110.297 -176.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.4 t -97.26 130.17 44.49 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.545 1.538 . . . . 0.0 110.736 172.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.8 mp -115.51 49.03 1.12 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.148 1.379 . . . . 0.0 110.295 -171.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.1 p . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 117.27 2.322 . . . . 0.0 117.27 -170.447 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.2 mt . . . . . 0 CA--C 1.554 1.115 0 CA-C-O 119.267 -0.397 . . . . 0.0 111.792 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -58.12 145.97 90.09 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.178 2.585 . . . . 0.0 114.394 -177.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -75.41 41.25 0.76 Allowed 'Trans proline' 0 CA--C 1.551 1.357 1 C-N-CA 126.062 4.508 . . . . 0.0 113.924 -175.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -156.7 -35.56 0.08 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.931 2.492 . . . . 0.0 111.023 -176.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.18 -22.66 61.25 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.49 -1.381 . . . . 0.0 111.346 169.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 m -89.69 -10.22 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 175.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.4 p -98.02 4.32 49.31 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -170.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -69.44 164.68 22.51 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.87 0.868 . . . . 0.0 111.86 175.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -57.32 -36.56 71.27 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -169.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.9 mt -116.61 118.19 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.684 0.793 . . . . 0.0 109.073 169.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -134.08 127.33 31.95 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.35 1.06 . . . . 0.0 110.521 169.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -147.03 157.47 43.62 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.054 1.342 . . . . 0.0 111.376 -172.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -122.62 131.27 53.74 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.413 0.685 . . . . 0.0 110.853 168.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.462 ' CE2' HG21 ' A' ' 77' ' ' ILE . 47.8 m0 -87.37 1.16 54.15 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.404 1.482 . . . . 0.0 114.999 -178.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 62.45 27.37 16.27 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.789 1.235 . . . . 0.0 113.98 170.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 75.5 mt -80.15 152.62 29.14 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -170.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -86.1 157.88 19.94 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.822 1.249 . . . . 0.0 111.131 170.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.68 137.21 77.13 Favored Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 120.658 -1.276 . . . . 0.0 113.1 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -99.91 -30.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.156 2.571 . . . . 0.0 113.842 171.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.97 100.25 0.06 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.942 1.697 . . . . 0.0 112.663 -176.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.48 -0.6 53.3 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.033 1.302 . . . . 0.0 114.689 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -87.68 171.76 10.2 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.06 1.344 . . . . 0.0 111.999 172.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.1 t -62.09 149.71 40.47 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.264 0.626 . . . . 0.0 111.753 171.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 mp -60.62 -28.83 68.83 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.943 0.897 . . . . 0.0 112.514 -174.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -67.56 -34.34 76.86 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.847 -1.158 . . . . 0.0 113.17 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.5 t -70.35 -37.04 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 O-C-N 121.209 -0.932 . . . . 0.0 109.524 171.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.35 -42.38 99.35 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.5 1.12 . . . . 0.0 111.384 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -71.73 -38.61 70.43 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.973 1.309 . . . . 0.0 112.291 173.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.0 m -55.38 -48.77 73.8 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.646 0.779 . . . . 0.0 111.263 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.3 m -73.11 -29.01 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 117.671 -1.157 . . . . 0.0 112.547 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . 0.252 0.0 OUTLIER -63.03 -36.8 84.78 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 121.21 1.823 . . . . 0.0 112.227 169.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.76 -45.75 91.79 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 124.556 1.074 . . . . 0.0 112.894 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -60.01 -42.46 94.36 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 117.767 0.783 . . . . 0.0 112.473 171.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.8 t -63.7 -47.44 91.08 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 C-N-CA 124.643 1.177 . . . . 0.0 110.155 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -49.6 -53.37 24.3 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 120.417 1.462 . . . . 0.0 111.648 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -58.48 -40.18 82.02 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.463 1.105 . . . . 0.0 112.602 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.6 mtt85 -82.55 -31.07 29.28 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.16 0.984 . . . . 0.0 112.931 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.78 -48.52 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.104 1.362 . . . . 0.0 109.947 169.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -54.35 -54.99 33.03 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.397 0.999 . . . . 0.0 109.497 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -50.63 -36.92 37.68 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.392 1.477 . . . . 0.0 112.67 176.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -81.06 -60.73 2.18 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.091 0.956 . . . . 0.0 112.976 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.17 -35.03 70.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.94 1.296 . . . . 0.0 111.856 -175.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.97 -20.73 61.69 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.112 -0.993 . . . . 0.0 113.443 -172.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -74.38 -20.46 60.06 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.822 1.249 . . . . 0.0 113.52 173.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.9 pt -118.07 1.48 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.086 1.754 . . . . 0.0 113.162 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 C--O 1.252 1.228 0 C-N-CA 125.932 1.693 . . . . 0.0 113.501 173.197 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.505 2.315 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -79.54 102.4 8.82 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.894 0.77 . . . . 0.0 109.557 169.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -77.25 144.13 38.43 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.677 0.791 . . . . 0.0 111.541 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 91.1 t -113.54 143.5 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.253 1.421 . . . . 0.0 110.107 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 45.1 ttm -130.72 130.76 44.22 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.18 0.592 . . . . 0.0 111.617 168.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -98.07 136.49 38.25 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.175 0.99 . . . . 0.0 110.612 169.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.1 t -129.73 126.03 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.974 1.31 . . . . 0.0 110.898 -169.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.3 m -143.34 176.6 9.03 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.217 1.007 . . . . 0.0 111.547 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -67.38 -65.21 0.71 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 169.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.13 113.15 19.79 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 168.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.461 HD21 ' HA ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -70.37 -22.35 62.78 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 120.271 1.396 . . . . 0.0 110.294 169.464 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.4 p -57.63 -53.27 60.02 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 127.551 2.34 . . . . 0.0 116.17 173.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.4 p -93.19 -14.67 26.84 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.885 1.274 . . . . 0.0 113.376 -171.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -124.47 -68.88 0.83 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.406 1.082 . . . . 0.0 113.2 -176.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.1 m -57.24 -43.28 82.8 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 120.05 1.296 . . . . 0.0 113.044 -176.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -55.95 -34.77 65.98 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.757 1.623 . . . . 0.0 113.4 173.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 59.2 mtp -64.18 -48.27 76.61 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 119.399 1.0 . . . . 0.0 111.57 174.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.07 -23.48 63.08 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 118.656 -0.688 . . . . 0.0 112.551 173.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -73.23 -49.16 29.39 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 120.024 1.284 . . . . 0.0 108.598 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.06 -52.2 53.78 Favored Glycine 0 C--O 1.222 -0.628 0 CA-C-O 118.429 -1.206 . . . . 0.0 111.049 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.544 ' HB3' HG11 ' A' ' 123' ' ' VAL . 13.4 m-85 -62.36 -43.47 98.74 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.748 1.274 . . . . 0.0 112.948 176.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.13 -37.0 83.09 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.676 1.58 . . . . 0.0 111.165 -177.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -59.59 -62.48 1.84 Allowed 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 125.125 1.37 . . . . 0.0 109.925 169.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.9 p -67.71 -14.28 62.81 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -175.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.5 mt -92.59 -10.7 36.58 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 172.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.24 19.08 0.1 Allowed Glycine 0 CA--C 1.539 1.573 0 N-CA-C 118.715 2.246 . . . . 0.0 118.715 -172.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.83 -33.76 62.04 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.856 1.828 . . . . 0.0 114.803 -172.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.45 -8.95 87.05 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 124.069 0.842 . . . . 0.0 114.998 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -98.76 -55.33 2.76 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 118.625 1.212 . . . . 0.0 112.312 -171.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.5 pp -141.45 171.11 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 126.619 1.968 . . . . 0.0 111.053 -174.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.22 125.49 44.83 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 175.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.1 m -94.64 155.63 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.535 1.534 . . . . 0.0 112.896 169.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.34 123.0 11.82 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.1 t -89.18 123.5 33.49 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 120.74 -1.225 . . . . 0.0 113.074 173.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.5 t -148.72 169.61 20.02 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.764 0.711 . . . . 0.0 112.39 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.36 179.27 48.89 Favored Glycine 0 CA--C 1.521 0.457 0 O-C-N 120.577 -1.327 . . . . 0.0 114.27 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.2 mt -65.39 -30.42 71.24 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 122.86 0.464 . . . . 0.0 111.413 176.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -117.22 122.61 44.48 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.651 1.981 . . . . 0.0 108.958 169.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.8 p -78.24 44.69 0.51 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.998 1.719 . . . . 0.0 111.987 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 p -64.9 158.56 24.93 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.771 1.628 . . . . 0.0 114.149 -169.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -64.2 174.16 1.7 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -169.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 m -65.98 109.08 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 120.295 -1.503 . . . . 0.0 107.552 168.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.7 t-80 -65.37 132.68 95.23 Favored Pre-proline 0 N--CA 1.476 0.874 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -169.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -59.55 -40.53 65.14 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.158 2.572 . . . . 0.0 113.334 -172.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.4 m -78.17 -30.62 49.18 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.053 -0.404 . . . . 0.0 110.911 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.5 -44.43 78.47 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.79 -1.194 . . . . 0.0 112.552 172.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.5 mt -52.85 -40.37 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 120.177 1.353 . . . . 0.0 110.463 173.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.58 -65.5 0.67 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 174.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.3 mmt -65.92 -24.92 66.93 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -170.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 85.3 mtp -84.91 -30.72 24.15 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 122.938 0.495 . . . . 0.0 111.484 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -61.14 -31.42 71.14 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.556 -1.34 . . . . 0.0 111.629 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -57.07 -31.95 65.74 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 121.085 -1.009 . . . . 0.0 112.819 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.28 7.61 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.413 1.485 . . . . 0.0 113.396 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.94 19.87 52.06 Favored Glycine 0 N--CA 1.479 1.501 0 O-C-N 120.286 -1.509 . . . . 0.0 115.038 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 25.1 mt -123.43 66.0 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.68 1.592 . . . . 0.0 110.313 -169.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -64.12 112.82 3.17 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 120.605 -1.309 . . . . 0.0 110.962 173.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.0 pt -90.34 -1.11 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 175.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.4 p -64.86 124.46 22.04 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 120.564 1.529 . . . . 0.0 110.36 -174.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.85 1.38 87.16 Favored Glycine 0 CA--C 1.546 2.023 0 N-CA-C 116.191 1.236 . . . . 0.0 116.191 -169.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -74.03 145.93 44.13 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.742 1.771 . . . . 0.0 111.916 177.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.9 t -61.21 145.35 51.52 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -175.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.461 ' HA ' HD21 ' A' ' 11' ' ' ASN . 2.0 m -137.42 117.64 13.55 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.623 1.569 . . . . 0.0 109.941 174.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -114.08 150.91 44.36 Favored Pre-proline 0 CA--C 1.557 1.214 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -169.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -91.84 126.51 0.92 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.618 2.879 . . . . 0.0 111.603 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.5 tt -77.11 -4.98 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -172.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -86.41 -13.1 47.27 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 120.654 -1.279 . . . . 0.0 113.149 170.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -91.86 -37.4 12.94 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.948 0.899 . . . . 0.0 112.569 174.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.08 169.38 15.12 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.37 1.068 . . . . 0.0 112.763 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.01 126.4 28.46 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.309 1.444 . . . . 0.0 109.785 169.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.48 3.34 3.93 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -175.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -66.44 -29.01 69.05 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.894 0.878 . . . . 0.0 112.887 -170.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -94.75 2.04 55.5 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.556 1.542 . . . . 0.0 113.671 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -122.91 93.13 3.87 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.353 1.461 . . . . 0.0 111.089 -169.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -61.58 -23.74 66.19 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.3 t -124.83 120.84 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.449 1.099 . . . . 0.0 110.697 -174.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.6 t -131.74 133.05 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.031 0.932 . . . . 0.0 109.956 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.0 mm -121.67 122.06 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 123.836 0.854 . . . . 0.0 110.716 -171.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.3 t -85.97 113.56 22.17 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 168.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.5 mt -83.77 45.11 1.04 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.238 1.015 . . . . 0.0 110.623 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.9 t . . . . . 0 CA--C 1.539 0.533 0 C-N-CA 128.536 2.734 . . . . 0.0 109.42 -178.912 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 CA--C 1.55 0.965 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -59.18 145.7 96.89 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.326 2.684 . . . . 0.0 113.913 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.11 44.04 1.11 Allowed 'Trans proline' 0 CA--C 1.548 1.213 1 C-N-CA 125.951 4.434 . . . . 0.0 113.324 -178.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -156.81 -36.66 0.08 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.601 2.36 . . . . 0.0 111.252 -174.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -75.93 -24.26 55.51 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.643 -1.285 . . . . 0.0 111.518 170.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.1 m -89.43 -11.29 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.395 1.478 . . . . 0.0 114.781 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.8 p -95.85 5.96 50.03 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -172.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -70.93 166.19 21.75 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.335 1.054 . . . . 0.0 112.285 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -52.08 -37.4 53.81 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -169.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 63.2 mt -125.15 122.3 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.656 1.182 . . . . 0.0 109.337 169.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -131.21 136.2 48.05 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.539 1.135 . . . . 0.0 111.091 169.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -140.25 146.86 39.17 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.175 0.99 . . . . 0.0 113.357 -173.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -103.18 95.72 6.3 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.189 2.196 . . . . 0.0 111.636 170.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 20.6 m0 -85.13 92.79 8.48 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 169.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.18 77.58 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 127.661 2.384 . . . . 0.0 113.688 169.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.5 mt -116.82 159.88 21.68 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.97 2.108 . . . . 0.0 112.067 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -95.53 148.92 21.99 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.256 1.422 . . . . 0.0 111.484 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -80.99 110.73 18.85 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.056 0.942 . . . . 0.0 109.908 169.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.415 ' HB2' ' CD2' ' A' ' 112' ' ' PHE . 15.1 Cg_endo -87.03 -5.03 7.84 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.519 2.146 . . . . 0.0 113.739 -169.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -48.26 105.59 0.08 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.66 1.584 . . . . 0.0 113.36 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.43 1.3 90.04 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 123.815 0.722 . . . . 0.0 114.758 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -77.79 168.79 19.38 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.17 0.985 . . . . 0.0 110.562 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 23.2 t -62.37 149.83 41.31 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.638 -0.664 . . . . 0.0 111.45 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 mp -60.04 -28.46 67.78 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.733 0.813 . . . . 0.0 111.787 -172.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -64.89 -35.8 82.3 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 173.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.6 t -66.32 -31.95 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.545 0.738 . . . . 0.0 109.452 170.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.415 ' CD2' ' HB2' ' A' ' 104' ' ' PRO . 0.4 OUTLIER -77.16 -39.54 48.68 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.732 0.813 . . . . 0.0 110.739 -177.16 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -68.42 -36.73 79.5 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.939 1.296 . . . . 0.0 112.457 170.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 50.6 m -59.86 -49.12 78.95 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.705 1.202 . . . . 0.0 111.259 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.6 m -67.02 -30.28 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 118.055 -0.974 . . . . 0.0 111.952 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.07 -47.83 84.23 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 120.189 1.359 . . . . 0.0 110.849 169.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.07 -41.57 99.78 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.552 1.072 . . . . 0.0 113.181 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -63.97 -48.76 75.19 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 122.148 -0.619 . . . . 0.0 112.223 171.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.422 ' O ' HG12 ' A' ' 123' ' ' VAL . 21.7 t -53.98 -51.86 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 116.939 -1.505 . . . . 0.0 111.086 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -46.14 -47.5 17.49 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 120.33 1.423 . . . . 0.0 113.286 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -66.07 -47.99 72.49 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.815 0.846 . . . . 0.0 112.029 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.8 mtp180 -71.09 -40.49 71.5 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.522 0.729 . . . . 0.0 112.642 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.544 HG11 ' HB3' ' A' ' 21' ' ' PHE . 8.0 p -72.23 -36.26 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.538 1.535 . . . . 0.0 112.021 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -58.51 -55.34 36.28 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.777 1.172 . . . . 0.0 109.406 169.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -55.16 -36.59 66.0 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.217 1.007 . . . . 0.0 112.03 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.42 -59.48 2.74 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.473 -0.767 . . . . 0.0 112.651 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.25 -34.53 67.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.968 0.907 . . . . 0.0 112.139 -175.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.48 -6.67 52.77 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -174.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -82.41 -20.41 37.13 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.664 1.186 . . . . 0.0 113.319 169.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.7 pt -119.18 -7.69 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.293 1.437 . . . . 0.0 113.837 -173.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.3 p . . . . . 0 C--O 1.254 1.298 0 C-N-CA 125.442 1.497 . . . . 0.0 113.249 170.783 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 tpp . . . . . 0 N--CA 1.5 2.059 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -76.72 105.84 8.03 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 119.621 1.1 . . . . 0.0 110.544 169.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -79.91 136.22 36.61 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 173.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.1 t -97.96 147.0 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.273 1.029 . . . . 0.0 109.95 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 42.6 tpp -130.26 112.29 13.2 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.869 0.868 . . . . 0.0 111.296 169.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -83.68 120.88 26.53 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.301 0.64 . . . . 0.0 111.04 169.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.7 t -118.84 135.52 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.492 1.517 . . . . 0.0 109.672 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.7 p -151.9 178.0 9.86 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 121.419 -0.8 . . . . 0.0 112.537 177.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -63.57 -42.96 98.29 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 121.512 -0.743 . . . . 0.0 111.067 169.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.484 ' HB3' ' H ' ' A' ' 13' ' ' SER . 1.1 mpt_? -117.69 103.6 10.18 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.953 1.301 . . . . 0.0 110.835 172.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -55.66 -33.62 64.25 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.287 -0.883 . . . . 0.0 110.223 169.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.4 p -57.01 -53.6 56.28 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.238 2.215 . . . . 0.0 115.303 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.484 ' H ' ' HB3' ' A' ' 10' ' ' ARG . 89.0 p -103.22 -1.67 28.52 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.09 1.356 . . . . 0.0 114.133 -176.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -126.68 -76.25 0.58 Allowed 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.076 -1.64 . . . . 0.0 111.283 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.424 ' HB3' ' HB2' ' A' ' 34' ' ' SER . 4.9 m -59.59 -39.04 82.82 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -172.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -56.13 -30.63 62.4 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.467 1.507 . . . . 0.0 114.499 171.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 93.2 mtp -69.73 -45.12 68.89 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.308 0.958 . . . . 0.0 110.358 174.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.35 -27.79 66.57 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 171.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -68.0 -49.01 64.15 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.99 1.268 . . . . 0.0 108.25 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.63 -52.3 51.86 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-O 118.814 -0.992 . . . . 0.0 111.854 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.491 ' HB3' HG11 ' A' ' 123' ' ' VAL . 12.7 m-85 -61.35 -42.64 99.02 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.507 1.153 . . . . 0.0 112.848 175.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.59 -37.17 85.88 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 120.082 -1.636 . . . . 0.0 111.104 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -62.51 -48.63 78.7 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.021 1.329 . . . . 0.0 111.489 174.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.5 p -80.27 -14.19 58.6 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 51.0 mt -97.83 -10.79 24.13 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.08 0.952 . . . . 0.0 113.393 174.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.66 25.3 1.34 Allowed Glycine 0 CA--C 1.534 1.22 0 N-CA-C 115.851 1.1 . . . . 0.0 115.851 -169.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.89 122.78 11.56 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.602 1.201 . . . . 0.0 112.792 -175.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.29 -2.47 36.69 Favored Glycine 0 CA--C 1.538 1.497 0 N-CA-C 116.138 1.215 . . . . 0.0 116.138 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -78.64 -46.58 18.88 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.429 1.615 . . . . 0.0 111.314 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -141.98 -177.78 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 128.265 2.626 . . . . 0.0 109.375 169.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.61 120.59 40.27 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.075 -1.016 . . . . 0.0 112.449 171.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.96 144.15 9.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 122.87 0.468 . . . . 0.0 111.796 169.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.47 163.64 35.05 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.943 1.297 . . . . 0.0 110.371 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.424 ' HB2' ' HB3' ' A' ' 15' ' ' SER . 88.2 p -148.68 150.19 32.78 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.467 1.107 . . . . 0.0 113.723 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 82.5 p -143.22 -175.36 4.5 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.39 1.876 . . . . 0.0 110.433 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.23 177.25 40.91 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-N 120.047 1.294 . . . . 0.0 115.23 172.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 35.6 mt -73.65 -43.78 58.59 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 118.515 1.157 . . . . 0.0 113.493 -169.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -130.42 70.65 1.45 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.387 2.275 . . . . 0.0 107.826 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.1 m -72.44 -20.33 61.42 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -169.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.2 m 37.54 -93.44 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 128.17 2.588 . . . . 0.0 117.316 172.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.1 ptp85 -154.73 -177.99 6.89 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 126.387 1.875 . . . . 0.0 112.228 -169.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.6 m -65.8 118.4 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.04 -1.038 . . . . 0.0 110.558 169.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -74.46 133.28 77.51 Favored Pre-proline 0 N--CA 1.478 0.968 0 O-C-N 121.058 -1.026 . . . . 0.0 113.0 -169.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -59.78 -40.9 59.66 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.543 2.829 . . . . 0.0 114.137 -171.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.1 m -78.29 -38.28 42.87 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 122.061 -0.399 . . . . 0.0 110.48 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.27 -40.35 97.14 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 118.123 -0.942 . . . . 0.0 112.467 176.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 66.7 mt -49.88 -47.69 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 120.197 1.362 . . . . 0.0 110.413 172.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.84 -58.79 4.8 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.5 mmt -66.25 -26.56 67.41 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.413 -0.805 . . . . 0.0 112.741 -173.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 72.2 mmm -84.2 -38.9 20.0 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.713 0.805 . . . . 0.0 110.563 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -59.59 -37.46 78.59 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.718 -1.239 . . . . 0.0 112.097 170.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -56.62 -22.32 33.24 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.538 1.135 . . . . 0.0 113.634 173.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.1 m -113.18 17.83 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 125.044 1.338 . . . . 0.0 114.576 175.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.2 13.63 61.62 Favored Glycine 0 N--CA 1.477 1.39 0 N-CA-C 115.597 0.999 . . . . 0.0 115.597 176.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 29.6 mt -126.67 62.78 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.62 1.568 . . . . 0.0 109.85 -169.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -60.67 110.69 1.37 Allowed 'General case' 0 CA--C 1.548 0.899 0 O-C-N 120.031 -1.668 . . . . 0.0 110.45 172.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.8 pt -89.58 4.2 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.7 p -67.36 -18.53 65.18 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.851 1.659 . . . . 0.0 114.648 -172.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -102.22 8.57 55.55 Favored Glycine 0 CA--C 1.542 1.728 0 C-N-CA 125.413 1.483 . . . . 0.0 114.634 169.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -79.57 143.04 35.14 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.379 1.472 . . . . 0.0 111.927 -171.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 10.8 t -66.05 153.68 41.59 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 121.53 -0.731 . . . . 0.0 112.734 172.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.4 p -147.06 133.7 19.9 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.316 1.446 . . . . 0.0 109.926 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -141.34 135.0 14.67 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.282 0.633 . . . . 0.0 112.049 -169.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -71.61 154.88 59.74 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.384 2.723 . . . . 0.0 112.903 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.1 tt -62.78 -18.96 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.022 1.329 . . . . 0.0 114.566 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -95.55 -9.11 33.25 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -80.39 -43.74 20.55 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.055 0.843 . . . . 0.0 109.236 169.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.31 159.71 32.96 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.889 1.276 . . . . 0.0 112.3 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -142.47 134.91 27.86 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.486 1.114 . . . . 0.0 110.36 169.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.2 9.33 4.65 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 -172.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.35 -28.8 63.26 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.11 -0.993 . . . . 0.0 112.318 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -97.49 -3.65 39.51 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.065 1.346 . . . . 0.0 113.662 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -123.71 90.62 3.31 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.456 1.502 . . . . 0.0 110.039 -172.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -66.91 -12.34 59.14 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.5 t -123.99 116.49 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 126.005 1.722 . . . . 0.0 109.731 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.5 t -131.57 134.76 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.762 0.825 . . . . 0.0 111.016 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.509 HG21 ' CE2' ' A' ' 99' ' ' TRP . 10.5 mm -126.59 137.0 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.319 0.648 . . . . 0.0 111.333 -172.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.2 t -95.49 117.93 31.28 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.431 1.493 . . . . 0.0 108.989 169.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 mp -99.93 61.38 1.11 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.768 1.627 . . . . 0.0 107.816 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.8 t . . . . . 0 CA--C 1.542 0.665 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 -169.506 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.9 mt . . . . . 0 CA--C 1.553 1.069 0 CA-C-O 119.267 -0.397 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -55.34 143.71 75.27 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.06 2.507 . . . . 0.0 113.174 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -75.62 41.36 0.79 Allowed 'Trans proline' 0 CA--C 1.549 1.256 1 C-N-CA 125.46 4.106 . . . . 0.0 113.624 -173.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -156.07 -30.84 0.09 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.995 2.518 . . . . 0.0 111.075 -175.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -82.21 14.82 2.68 Favored 'General case' 0 CA--C 1.553 1.073 0 O-C-N 120.918 -1.113 . . . . 0.0 113.415 169.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.5 m -131.48 -3.96 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 126.399 1.88 . . . . 0.0 113.387 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.6 p -95.68 -6.06 40.83 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.602 1.561 . . . . 0.0 113.667 -171.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -65.04 154.12 38.73 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.802 2.041 . . . . 0.0 111.932 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -53.74 -35.73 61.55 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.372 1.469 . . . . 0.0 114.304 -169.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 54.1 mt -119.02 107.38 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 169.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -121.44 131.69 54.3 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.29 1.036 . . . . 0.0 110.074 169.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -133.46 147.42 51.68 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.566 1.146 . . . . 0.0 111.647 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -115.42 95.41 5.15 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.444 1.116 . . . . 0.0 110.814 172.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.509 ' CE2' HG21 ' A' ' 77' ' ' ILE . 30.3 m0 -74.25 93.99 2.43 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 169.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.8 73.83 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.286 2.635 . . . . 0.0 113.403 169.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 71.1 mt -113.83 147.72 37.89 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.574 2.35 . . . . 0.0 111.616 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -84.47 158.88 20.88 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.369 1.068 . . . . 0.0 111.945 175.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -88.12 110.21 34.03 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 126.262 1.825 . . . . 0.0 111.765 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -84.95 -13.7 6.52 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 123.139 2.56 . . . . 0.0 116.21 -169.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -50.92 107.34 0.17 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.807 1.243 . . . . 0.0 112.527 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.18 11.54 85.45 Favored Glycine 0 CA--C 1.538 1.504 0 CA-C-O 118.837 -0.98 . . . . 0.0 115.487 177.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -74.42 -71.68 0.33 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.33 1.565 . . . . 0.0 110.625 176.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.5 t -173.89 150.1 1.61 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.891 2.476 . . . . 0.0 108.285 174.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.7 mp -60.4 -32.5 71.39 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.62 0.645 . . . . 0.0 111.799 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -70.59 -33.64 71.29 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.936 -1.103 . . . . 0.0 112.923 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 83.3 t -68.85 -37.38 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.398 -0.814 . . . . 0.0 109.527 170.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -45.09 92.06 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.58 1.152 . . . . 0.0 110.888 176.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -65.95 -23.88 66.69 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.868 1.667 . . . . 0.0 113.993 172.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.9 m -78.75 -51.74 9.36 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.672 1.589 . . . . 0.0 111.098 177.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.0 m -66.34 -26.52 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 121.104 -0.997 . . . . 0.0 111.628 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.78 -44.18 94.03 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.429 1.892 . . . . 0.0 111.203 169.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.84 -41.57 88.12 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 124.106 0.86 . . . . 0.0 112.771 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -60.87 -48.32 82.36 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 122.185 -0.597 . . . . 0.0 111.757 172.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.424 ' O ' HG12 ' A' ' 123' ' ' VAL . 38.2 t -57.65 -47.58 85.23 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-O 117.249 -1.358 . . . . 0.0 110.232 176.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -52.29 -48.61 65.24 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 120.423 1.465 . . . . 0.0 112.327 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -63.51 -48.01 79.36 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.935 0.494 . . . . 0.0 112.19 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -70.74 -36.79 73.31 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.491 HG11 ' HB3' ' A' ' 21' ' ' PHE . 6.0 p -74.54 -36.37 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.682 1.193 . . . . 0.0 111.831 177.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -56.53 -54.82 41.44 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.649 1.113 . . . . 0.0 108.334 168.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -59.81 -17.02 32.78 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -92.23 -60.46 1.84 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.381 1.446 . . . . 0.0 112.37 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -57.76 -33.79 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.17 0.988 . . . . 0.0 111.283 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.12 -6.97 53.65 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -176.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -74.37 -23.12 58.96 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.319 1.047 . . . . 0.0 112.165 169.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.5 pt -130.42 -0.87 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 125.717 1.607 . . . . 0.0 114.983 -168.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 60.9 p . . . . . 0 C--O 1.255 1.362 0 C-N-CA 125.052 1.341 . . . . 0.0 113.509 170.424 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttm . . . . . 0 N--CA 1.503 2.213 0 CA-C-O 119.429 -0.319 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -95.59 97.27 9.62 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.467 1.107 . . . . 0.0 110.519 174.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -86.61 149.26 25.05 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.594 -0.691 . . . . 0.0 112.693 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.3 t -117.97 143.39 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.652 1.181 . . . . 0.0 111.777 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 42.9 tpp -131.9 125.35 31.49 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.419 1.087 . . . . 0.0 110.865 169.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -94.59 142.35 27.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.221 0.608 . . . . 0.0 109.985 169.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.6 t -135.42 119.79 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.11 1.364 . . . . 0.0 111.093 -174.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 p -135.37 178.06 7.33 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.294 1.438 . . . . 0.0 111.823 175.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -58.53 -57.37 13.27 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 120.751 -1.218 . . . . 0.0 110.581 174.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -101.45 120.07 39.73 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 168.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -54.14 -50.54 66.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 120.41 1.459 . . . . 0.0 110.876 175.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.1 p -64.99 -16.61 63.6 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -174.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.5 p -77.48 -37.81 50.51 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.7 ptt-85 -152.19 -32.47 0.14 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 117.279 2.326 . . . . 0.0 117.279 -174.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.407 ' HA ' HD12 ' A' ' 79' ' ' LEU . 58.4 m -68.13 -38.11 81.85 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 121.503 1.956 . . . . 0.0 113.388 171.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -67.22 -31.81 72.43 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.187 0.995 . . . . 0.0 111.724 168.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.464 ' HA ' ' CE ' ' A' ' 50' ' ' MET . 45.6 ttm -62.27 -52.44 63.7 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.328 1.051 . . . . 0.0 111.532 173.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.43 -27.6 69.4 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 124.485 1.114 . . . . 0.0 112.327 172.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -73.0 -47.83 41.74 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.928 1.694 . . . . 0.0 109.465 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.89 -54.76 31.51 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-O 118.797 -1.002 . . . . 0.0 111.344 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.486 ' HB3' HG11 ' A' ' 123' ' ' VAL . 9.6 m-85 -57.58 -41.58 81.41 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.955 0.878 . . . . 0.0 112.379 174.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.73 ' HB1' HG11 ' A' ' 32' ' ' VAL . . . -65.68 -39.87 91.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.86 1.209 . . . . 0.0 112.187 -179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -71.31 -44.15 65.69 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.951 1.25 . . . . 0.0 112.325 173.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.6 p -65.93 -5.96 10.95 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 120.735 1.607 . . . . 0.0 114.632 173.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.8 mt -110.01 -5.43 15.43 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.847 1.259 . . . . 0.0 114.083 171.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.68 17.49 0.28 Allowed Glycine 0 N--CA 1.478 1.442 0 N-CA-C 116.841 1.496 . . . . 0.0 116.841 -170.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.11 135.22 56.99 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.923 1.362 . . . . 0.0 112.176 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.6 -6.33 46.72 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-O 118.62 -1.1 . . . . 0.0 115.588 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -85.52 -60.54 2.0 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.608 1.704 . . . . 0.0 110.672 175.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -141.37 172.53 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 127.359 2.264 . . . . 0.0 110.44 177.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.8 130.77 44.72 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.898 0.856 . . . . 0.0 112.831 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.73 HG11 ' HB1' ' A' ' 22' ' ' ALA . 15.9 m -105.34 151.76 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 124.744 1.218 . . . . 0.0 112.024 169.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.83 144.03 30.0 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.262 0.625 . . . . 0.0 111.369 -171.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.3 p -112.87 136.39 52.56 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.61 1.564 . . . . 0.0 113.46 176.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.0 t -152.61 177.26 10.85 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.866 1.266 . . . . 0.0 111.88 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.92 -175.72 47.05 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 120.671 -1.268 . . . . 0.0 114.294 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.2 mt -72.09 -33.57 67.98 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -175.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -134.44 73.32 1.49 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.535 2.334 . . . . 0.0 108.565 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.5 m -65.74 -22.7 66.62 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -172.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.9 t 43.96 -106.59 0.1 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.665 1.986 . . . . 0.0 114.607 169.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -149.34 171.55 16.35 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 127.002 2.121 . . . . 0.0 111.169 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.7 m -53.74 120.16 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.608 1.163 . . . . 0.0 110.758 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -82.52 136.03 45.98 Favored Pre-proline 0 N--CA 1.478 0.931 0 CA-C-O 118.053 -0.975 . . . . 0.0 112.237 -169.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -57.99 -44.65 38.01 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.455 2.77 . . . . 0.0 113.913 -173.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.9 m -76.98 -28.43 55.12 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.674 -0.641 . . . . 0.0 110.812 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.89 -47.09 66.71 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.223 -0.923 . . . . 0.0 111.973 169.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 57.6 mt -51.68 -48.3 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 120.27 1.396 . . . . 0.0 109.66 171.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.07 -65.13 0.65 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 177.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.44 -27.2 66.85 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -174.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.464 ' CE ' ' HA ' ' A' ' 17' ' ' MET . 87.4 mtp -80.62 -29.59 36.81 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.438 1.017 . . . . 0.0 111.669 178.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -63.93 -28.05 69.56 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.897 -1.127 . . . . 0.0 112.875 169.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -57.65 -34.71 69.64 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 119.307 0.958 . . . . 0.0 112.27 174.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.2 8.24 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.62 1.568 . . . . 0.0 113.232 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.14 23.7 43.7 Favored Glycine 0 N--CA 1.477 1.403 0 O-C-N 120.58 -1.325 . . . . 0.0 115.074 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.6 mt -123.83 60.66 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.678 1.591 . . . . 0.0 110.54 -169.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -62.34 109.82 1.46 Allowed 'General case' 0 CA--C 1.546 0.823 0 O-C-N 120.469 -1.394 . . . . 0.0 111.833 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 pt -85.87 -5.27 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 117.735 -1.126 . . . . 0.0 113.479 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.3 t -60.07 -28.54 67.89 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 120.917 1.69 . . . . 0.0 113.267 -170.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -101.34 8.52 57.08 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 125.405 1.479 . . . . 0.0 115.799 171.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -95.6 150.55 20.22 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.601 1.56 . . . . 0.0 112.034 -171.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.0 t -68.47 159.39 31.8 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -172.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.8 t -150.08 135.08 17.82 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.831 1.653 . . . . 0.0 109.625 169.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -144.02 138.78 15.31 Favored Pre-proline 0 N--CA 1.475 0.784 0 C-N-CA 123.659 0.784 . . . . 0.0 111.046 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -77.85 152.59 28.8 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.459 2.773 . . . . 0.0 113.382 -174.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.4 tt -59.21 -23.89 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -173.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -96.58 -8.2 32.42 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -94.27 -36.1 12.14 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.487 0.715 . . . . 0.0 111.439 170.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.28 161.26 30.7 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.146 0.498 . . . . 0.0 111.165 170.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.86 127.86 25.73 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.522 0.729 . . . . 0.0 111.431 169.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.23 2.61 4.46 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -173.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.8 -30.64 69.26 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.005 -1.059 . . . . 0.0 112.602 -170.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -89.37 -1.45 58.06 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.779 1.231 . . . . 0.0 113.422 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -120.66 97.06 5.38 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.224 1.41 . . . . 0.0 111.361 -169.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -55.35 -31.52 61.8 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.044 1.337 . . . . 0.0 112.85 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.6 120.23 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 124.544 1.138 . . . . 0.0 110.633 -172.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.6 t -124.92 132.83 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.14 0.976 . . . . 0.0 109.813 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.4 mm -123.51 123.51 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 123.581 0.752 . . . . 0.0 110.678 -172.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.4 t -82.55 123.55 29.31 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.968 0.907 . . . . 0.0 109.862 169.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 15' ' ' SER . 30.4 mt -114.34 34.55 4.65 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.853 1.661 . . . . 0.0 110.775 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 30.4 p . . . . . 0 CA--C 1.541 0.604 0 C-N-CA 124.536 1.134 . . . . 0.0 113.194 -178.877 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.3 mt . . . . . 0 CA--C 1.552 1.023 0 CA-C-O 119.245 -0.407 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -58.99 145.07 98.83 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.031 2.488 . . . . 0.0 113.848 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.02 41.9 0.79 Allowed 'Trans proline' 0 CA--C 1.55 1.293 1 C-N-CA 125.979 4.453 . . . . 0.0 113.483 -177.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -156.75 -35.74 0.08 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.921 2.489 . . . . 0.0 111.084 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.06 -26.07 61.15 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.247 -1.533 . . . . 0.0 111.698 169.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.2 m -85.8 -11.25 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 79.6 p -98.36 5.57 48.08 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -172.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -69.6 164.79 22.54 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.367 1.067 . . . . 0.0 112.505 177.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -50.2 -39.98 45.8 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.752 1.221 . . . . 0.0 114.25 -169.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.8 mt -124.03 120.01 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.383 1.073 . . . . 0.0 109.011 169.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -129.35 125.39 36.55 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.126 0.97 . . . . 0.0 110.206 169.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -139.56 158.75 43.6 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.957 1.303 . . . . 0.0 111.647 -174.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -128.21 126.18 40.45 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.49 1.116 . . . . 0.0 112.121 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -100.48 7.04 44.4 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -174.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 62.06 22.73 13.31 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 169.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 68.3 mt -78.62 142.37 37.3 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -169.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -78.03 159.03 28.99 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.059 1.744 . . . . 0.0 111.866 173.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -85.31 113.29 49.72 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 124.214 1.006 . . . . 0.0 111.247 173.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -87.06 -17.26 3.11 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.203 2.602 . . . . 0.0 114.88 -170.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -61.6 120.33 10.37 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.888 -1.132 . . . . 0.0 111.366 178.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.57 -4.77 85.13 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 123.994 0.807 . . . . 0.0 113.967 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -80.89 171.19 15.32 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 118.083 0.941 . . . . 0.0 109.577 169.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 39.4 m -62.96 151.03 40.75 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.169 -0.957 . . . . 0.0 111.419 170.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.25 -29.22 68.64 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.241 -0.912 . . . . 0.0 112.439 -175.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -62.31 -33.56 74.9 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.988 0.915 . . . . 0.0 113.317 172.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 50.3 t -72.87 -35.27 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 121.048 -1.032 . . . . 0.0 110.219 172.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -66.43 -38.26 87.02 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.003 0.521 . . . . 0.0 111.093 175.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -68.69 -39.68 80.43 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.554 1.142 . . . . 0.0 112.249 169.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 42.8 m -58.48 -47.76 83.0 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.397 1.079 . . . . 0.0 111.951 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.0 m -66.39 -30.69 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 119.382 0.992 . . . . 0.0 111.816 176.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -41.06 95.26 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 120.111 1.323 . . . . 0.0 112.633 170.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.88 -44.73 97.0 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.174 0.892 . . . . 0.0 112.591 174.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -61.81 -47.3 85.75 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 122.171 -0.605 . . . . 0.0 111.931 172.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.4 t -57.06 -48.01 82.62 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.517 0 CA-C-O 117.495 -1.24 . . . . 0.0 110.442 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -53.55 -50.69 64.98 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 120.115 1.325 . . . . 0.0 112.221 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -59.25 -44.51 92.39 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.044 0.538 . . . . 0.0 112.397 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.8 mtp85 -79.57 -35.99 38.9 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -176.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.486 HG11 ' HB3' ' A' ' 21' ' ' PHE . 4.4 p -74.01 -33.89 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.212 1.405 . . . . 0.0 112.417 178.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -55.47 -55.33 33.03 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.162 0.892 . . . . 0.0 108.855 169.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.94 -32.11 52.62 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.586 1.554 . . . . 0.0 112.894 176.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -79.02 -56.57 4.29 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.949 0.795 . . . . 0.0 112.256 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -65.45 -35.35 75.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.553 0.741 . . . . 0.0 112.038 -177.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.18 -8.59 55.56 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -174.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -84.65 -15.46 45.32 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.145 1.378 . . . . 0.0 113.538 171.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 21.2 pt -127.34 -8.38 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.544 1.538 . . . . 0.0 113.923 -173.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.7 p . . . . . 0 C--O 1.255 1.371 0 C-N-CA 125.227 1.411 . . . . 0.0 113.358 169.866 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.8 ttm . . . . . 0 N--CA 1.503 2.198 0 CA-C-O 119.479 -0.296 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -84.93 91.29 8.01 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.064 0.946 . . . . 0.0 111.261 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -77.75 145.85 36.24 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 121.605 -0.684 . . . . 0.0 112.376 -173.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.0 t -110.09 143.48 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.707 1.203 . . . . 0.0 110.397 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.4 tpp -128.91 118.37 22.55 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.852 0.861 . . . . 0.0 111.024 170.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -89.16 135.55 33.5 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.943 0.497 . . . . 0.0 111.124 169.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.9 129.11 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.755 1.222 . . . . 0.0 110.467 -171.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 t -144.3 -177.09 5.29 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.281 0.632 . . . . 0.0 112.449 172.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -64.44 -47.51 78.81 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 121.468 -0.77 . . . . 0.0 110.152 169.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.66 116.75 32.49 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.903 1.281 . . . . 0.0 109.312 169.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.69 -37.04 85.37 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 168.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.8 p -56.41 -29.47 61.58 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 128.034 2.534 . . . . 0.0 115.067 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.2 p -102.33 -101.92 0.28 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.43 1.092 . . . . 0.0 111.98 176.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.14 -44.4 71.35 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 120.227 1.376 . . . . 0.0 113.947 -168.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 m -63.16 -51.63 65.65 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.169 0.895 . . . . 0.0 112.067 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -64.6 -33.76 76.67 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 96.4 mtp -60.08 -50.35 74.04 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.725 0.693 . . . . 0.0 110.478 171.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.86 -31.16 70.78 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.28 -45.73 72.29 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 120.119 1.327 . . . . 0.0 108.642 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.35 -39.67 91.73 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 118.631 -1.094 . . . . 0.0 112.7 -178.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -65.02 -39.85 93.99 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.109 1.454 . . . . 0.0 111.783 170.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.72 -33.26 70.67 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.503 -1.373 . . . . 0.0 111.385 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -59.89 -56.95 15.43 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.32 1.848 . . . . 0.0 109.61 170.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.6 p -70.16 -15.69 62.98 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.0 mt -99.24 -1.95 37.86 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 173.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.32 4.34 0.59 Allowed Glycine 0 CA--C 1.536 1.387 0 N-CA-C 117.226 1.651 . . . . 0.0 117.226 -169.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.44 133.92 56.2 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.9 1.85 . . . . 0.0 111.869 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.87 -2.36 74.83 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 124.676 1.131 . . . . 0.0 115.386 -174.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -94.35 -76.48 0.48 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.881 1.341 . . . . 0.0 110.111 175.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -128.39 176.18 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 126.608 1.963 . . . . 0.0 111.349 173.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.1 125.56 40.71 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.3 -0.875 . . . . 0.0 112.129 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.8 m -92.93 147.97 5.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 123.787 0.835 . . . . 0.0 111.664 169.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.49 159.27 43.62 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.747 0.819 . . . . 0.0 110.591 -172.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.63 133.21 34.07 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.111 1.364 . . . . 0.0 113.153 -171.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.3 p -144.7 176.17 9.63 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.305 1.442 . . . . 0.0 111.465 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.85 175.85 43.59 Favored Glycine 0 CA--C 1.526 0.774 0 O-C-N 120.396 -1.44 . . . . 0.0 114.552 169.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.4 mt -63.69 -37.79 88.66 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.112 0.565 . . . . 0.0 111.263 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -121.39 113.35 19.75 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.964 2.105 . . . . 0.0 107.829 169.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.6 p -66.74 -35.3 79.78 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.799 0.84 . . . . 0.0 112.085 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.7 t 46.59 -127.29 1.5 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 126.324 1.849 . . . . 0.0 112.293 -177.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -141.41 -176.58 4.78 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 127.511 2.324 . . . . 0.0 111.26 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.8 m -66.42 113.51 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 120.162 -1.587 . . . . 0.0 108.886 169.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -68.56 133.61 90.8 Favored Pre-proline 0 N--CA 1.477 0.917 0 O-C-N 121.48 -0.762 . . . . 0.0 112.304 -169.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.39 -38.27 85.16 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.26 2.64 . . . . 0.0 113.543 -172.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.407 ' HB ' ' CE2' ' A' ' 112' ' ' PHE . 8.7 m -79.45 -35.39 40.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.996 0.519 . . . . 0.0 110.667 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.13 -42.25 99.46 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.268 0.94 . . . . 0.0 112.133 174.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.7 mt -52.88 -44.79 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 120.287 1.403 . . . . 0.0 110.436 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.72 -60.67 2.65 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 33.5 mmt -68.03 -19.57 64.92 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.767 0.827 . . . . 0.0 113.192 -172.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 84.1 mmm -89.47 -38.04 14.34 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.896 0.878 . . . . 0.0 110.553 173.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -59.39 -35.32 73.71 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.538 -1.351 . . . . 0.0 112.399 170.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -55.19 -31.76 61.67 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.123 0.969 . . . . 0.0 113.492 171.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.9 m -103.15 20.77 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.888 1.275 . . . . 0.0 113.978 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.56 12.13 78.62 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.329 0.966 . . . . 0.0 115.255 174.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.3 mt -120.38 78.25 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.21 1.804 . . . . 0.0 108.934 -170.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -69.06 106.88 2.94 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.044 -1.66 . . . . 0.0 110.276 171.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.7 pt -84.75 -0.89 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 121.578 -0.701 . . . . 0.0 112.832 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.9 t -64.23 -28.76 69.96 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 120.157 1.344 . . . . 0.0 112.827 -172.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.32 4.22 73.43 Favored Glycine 0 CA--C 1.541 1.7 0 C-N-CA 125.102 1.334 . . . . 0.0 115.368 172.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -92.31 160.07 15.3 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.268 1.427 . . . . 0.0 112.634 -176.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.0 t -95.59 156.91 16.13 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -170.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.8 m -137.15 140.72 42.02 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.925 1.69 . . . . 0.0 108.21 169.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -141.49 134.4 14.22 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.636 1.174 . . . . 0.0 111.393 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.15 145.91 50.4 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.305 2.003 . . . . 0.0 110.297 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.5 tt -56.07 -30.72 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -169.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -94.44 -9.18 36.39 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -82.4 -41.22 20.21 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.003 0.82 . . . . 0.0 109.958 169.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.75 159.17 34.23 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.244 0.545 . . . . 0.0 110.777 170.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -139.75 135.77 33.44 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.589 -0.694 . . . . 0.0 111.223 169.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.3 -0.73 8.61 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -169.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -68.02 -33.51 74.73 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.759 1.163 . . . . 0.0 113.006 -171.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -84.68 -3.03 58.34 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.224 1.01 . . . . 0.0 113.598 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -120.97 92.62 3.8 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.417 1.487 . . . . 0.0 110.163 -170.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -54.29 -27.47 35.52 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.115 1.366 . . . . 0.0 113.201 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.1 118.44 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 125.209 1.404 . . . . 0.0 110.126 -174.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.2 t -127.01 132.52 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.634 0.774 . . . . 0.0 110.268 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.3 mm -124.94 122.45 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 123.715 0.806 . . . . 0.0 111.61 -169.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.2 t -81.58 130.75 35.17 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.803 0.841 . . . . 0.0 109.962 169.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.0 mt -121.19 32.72 5.82 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.161 1.784 . . . . 0.0 111.282 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.3 p . . . . . 0 CA--C 1.54 0.588 0 C-N-CA 124.575 1.15 . . . . 0.0 112.779 -176.28 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 CA--C 1.553 1.069 0 CA-C-O 118.987 -0.53 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -58.68 162.94 11.78 Favored 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 123.528 2.819 . . . . 0.0 113.728 174.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.05 -51.73 2.05 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.563 2.175 . . . . 0.0 113.663 -172.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -62.12 -35.42 78.69 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 120.653 -1.279 . . . . 0.0 112.28 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -64.89 5.64 0.31 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 127.298 2.239 . . . . 0.0 114.926 169.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.0 t -131.08 -43.01 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 127.26 2.224 . . . . 0.0 111.116 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.4 p -80.57 29.48 0.31 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -170.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -77.15 167.59 21.51 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.057 -1.027 . . . . 0.0 112.002 170.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -56.74 -36.12 69.38 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -169.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.7 mt -125.95 123.86 64.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.741 1.216 . . . . 0.0 108.88 169.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -131.76 138.56 48.65 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.758 0.823 . . . . 0.0 111.089 169.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -138.94 151.87 47.25 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.897 1.279 . . . . 0.0 110.517 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -122.41 114.3 20.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.482 0.713 . . . . 0.0 110.536 169.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 32.8 m0 -89.4 -2.36 58.38 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.205 1.002 . . . . 0.0 113.053 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.305 1.5 pp0? 47.35 37.64 6.26 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 171.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 81.7 mt -74.09 148.99 41.35 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.286 1.034 . . . . 0.0 112.686 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -75.0 153.46 38.5 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.537 1.135 . . . . 0.0 111.666 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -79.65 122.36 83.54 Favored Pre-proline 0 CA--C 1.542 0.673 0 O-C-N 121.126 -0.984 . . . . 0.0 111.858 173.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -93.86 -21.5 0.33 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.091 1.861 . . . . 0.0 113.847 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.6 104.59 0.07 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.891 2.076 . . . . 0.0 112.636 -176.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.5 8.6 87.11 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.517 1.056 . . . . 0.0 114.96 175.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -84.27 -64.78 1.1 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.711 1.256 . . . . 0.0 111.343 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.7 t -169.3 152.37 4.91 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.174 1.789 . . . . 0.0 109.592 171.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.92 -30.89 68.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.322 0.649 . . . . 0.0 111.041 172.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -62.81 -39.94 95.83 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.173 -0.955 . . . . 0.0 112.565 174.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 79.0 t -71.1 -39.6 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.41 -0.806 . . . . 0.0 109.083 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.407 ' CE2' ' HB ' ' A' ' 45' ' ' THR . 0.2 OUTLIER -59.32 -49.88 76.11 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.398 1.079 . . . . 0.0 112.097 176.719 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -69.45 -34.46 74.43 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.667 -0.646 . . . . 0.0 111.979 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 65.2 m -59.06 -52.59 65.11 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.286 0.634 . . . . 0.0 111.199 172.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.1 m -73.5 -27.55 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 117.74 -1.124 . . . . 0.0 112.664 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.7 ptt180 -61.27 -38.71 87.74 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 121.227 1.83 . . . . 0.0 111.88 170.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.94 -43.08 96.48 Favored Glycine 0 N--CA 1.473 1.156 0 C-N-CA 123.847 0.737 . . . . 0.0 112.739 176.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -61.19 -46.75 89.19 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.406 0.682 . . . . 0.0 111.929 170.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 25.5 t -60.45 -45.05 97.42 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.302 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -52.86 -54.5 33.51 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.093 1.315 . . . . 0.0 111.69 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -62.6 -43.47 98.74 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.067 0.547 . . . . 0.0 112.36 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.9 mtt-85 -74.8 -31.85 61.84 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 39.6 t -64.37 -47.98 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.489 169.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -53.92 -55.18 29.31 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.3 0.955 . . . . 0.0 109.239 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -49.34 -38.95 29.79 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.81 1.644 . . . . 0.0 112.242 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -81.19 -62.08 1.76 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.5 -30.32 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.545 1.138 . . . . 0.0 111.588 -175.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -78.11 -2.86 39.49 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -79.2 -20.51 48.18 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.339 1.056 . . . . 0.0 112.568 169.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.3 pt -126.89 13.38 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 126.303 1.841 . . . . 0.0 113.408 -169.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 47.1 p . . . . . 0 C--O 1.256 1.425 0 C-N-CA 125.748 1.619 . . . . 0.0 113.966 172.561 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.6 ttm . . . . . 0 N--CA 1.501 2.111 0 CA-C-O 119.596 -0.24 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -88.19 92.05 9.01 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.887 0.875 . . . . 0.0 109.958 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -79.85 151.2 30.36 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.49 -0.756 . . . . 0.0 111.607 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.6 p -118.84 142.09 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.045 0.938 . . . . 0.0 112.209 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.459 ' HE1' ' HB ' ' A' ' 33' ' ' THR . 62.0 tpp -122.33 132.66 54.5 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.372 1.069 . . . . 0.0 110.881 171.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -105.09 138.8 40.73 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.78 0.718 . . . . 0.0 110.894 169.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.8 t -131.31 138.84 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.537 1.135 . . . . 0.0 112.272 -169.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 54.7 p -155.72 -169.81 3.22 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.282 1.033 . . . . 0.0 110.147 169.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -68.0 -40.74 82.98 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 120.354 -1.466 . . . . 0.0 110.102 168.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 51.7 mtp85 -124.0 101.76 7.4 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.925 1.69 . . . . 0.0 111.341 -176.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.549 ' H ' ' HA ' ' A' ' 39' ' ' SER . 19.7 t30 -52.53 -54.25 35.27 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 169.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.4 p -30.83 -57.25 0.22 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.018 2.127 . . . . 0.0 115.551 175.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.1 p -88.98 -41.95 12.07 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.27 1.028 . . . . 0.0 113.085 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -103.0 -73.87 0.65 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.047 1.339 . . . . 0.0 112.998 -174.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.11 -37.22 84.28 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -169.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -50.65 -37.89 43.33 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.734 2.014 . . . . 0.0 113.17 170.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 60.2 ttm -66.3 -46.14 77.96 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.09 -1.006 . . . . 0.0 111.183 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.51 -21.94 65.47 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 118.524 -0.751 . . . . 0.0 111.957 170.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -73.34 -53.1 11.6 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 120.402 1.455 . . . . 0.0 108.461 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.99 -50.23 62.67 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.24 0.924 . . . . 0.0 112.424 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.594 ' HB3' HG11 ' A' ' 123' ' ' VAL . 5.8 m-85 -66.55 -41.39 88.75 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.808 1.304 . . . . 0.0 113.078 176.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.38 -36.19 83.35 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.541 1.519 . . . . 0.0 110.091 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -64.3 -55.98 17.61 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.444 1.498 . . . . 0.0 109.916 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.7 p -70.59 -13.42 62.09 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 120.467 -1.395 . . . . 0.0 114.435 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.6 mt -96.82 -7.0 34.71 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.72 9.35 0.09 OUTLIER Glycine 0 N--CA 1.477 1.416 0 N-CA-C 119.028 2.371 . . . . 0.0 119.028 -172.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.53 -29.09 64.06 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.006 1.903 . . . . 0.0 114.464 -174.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.73 -9.33 86.92 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-O 119.247 -0.752 . . . . 0.0 114.891 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -101.75 -60.17 1.58 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.811 1.245 . . . . 0.0 111.968 -172.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.47 174.38 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 127.048 2.139 . . . . 0.0 110.483 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.26 129.23 42.46 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 121.384 -0.823 . . . . 0.0 110.926 176.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 m -101.68 148.42 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.014 0.926 . . . . 0.0 110.436 170.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.459 ' HB ' ' HE1' ' A' ' 5' ' ' MET . 3.3 m -146.94 157.35 43.61 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.011 0.924 . . . . 0.0 110.367 173.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -135.45 152.03 50.98 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 170.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 88.8 p -152.32 179.24 8.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.285 1.834 . . . . 0.0 111.886 -170.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.13 -178.78 48.51 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 115.639 1.015 . . . . 0.0 115.639 169.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.9 mt -64.81 -52.08 58.7 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.849 0.86 . . . . 0.0 112.069 -174.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -91.12 -38.14 12.95 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.561 1.544 . . . . 0.0 110.86 170.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.549 ' HA ' ' H ' ' A' ' 11' ' ' ASN . 0.6 OUTLIER 62.69 -46.46 0.19 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 127.727 2.411 . . . . 0.0 115.996 -177.964 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . 0.256 38.2 t 63.5 -123.86 0.56 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 127.247 2.219 . . . . 0.0 113.391 174.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -143.91 -178.23 5.82 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 126.447 1.899 . . . . 0.0 113.71 -171.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.5 m -64.79 111.18 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 120.853 -1.154 . . . . 0.0 109.793 169.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -77.97 137.69 61.54 Favored Pre-proline 0 N--CA 1.476 0.83 0 O-C-N 121.092 -1.005 . . . . 0.0 112.988 -169.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -57.59 -43.43 50.77 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.538 2.825 . . . . 0.0 113.768 -175.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.9 m -75.75 -31.6 59.62 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.763 -0.586 . . . . 0.0 110.795 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.46 -43.11 81.88 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.172 -0.955 . . . . 0.0 112.408 171.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.9 mt -55.47 -40.58 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 121.268 1.849 . . . . 0.0 109.913 175.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.17 -62.53 1.56 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 173.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.95 -11.96 61.27 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -174.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 96.3 mmm -91.86 -42.49 10.04 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.177 0.899 . . . . 0.0 110.325 171.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -60.73 -37.52 82.03 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.673 -1.267 . . . . 0.0 112.518 174.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -60.66 -25.66 66.51 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.25 7.8 p -105.19 15.67 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 125.525 1.53 . . . . 0.0 113.399 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.13 18.58 49.61 Favored Glycine 0 N--CA 1.477 1.37 0 O-C-N 120.796 -1.19 . . . . 0.0 115.555 173.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.7 mt -125.78 90.65 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.974 1.31 . . . . 0.0 110.853 -169.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -70.58 114.61 8.85 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.863 -1.148 . . . . 0.0 110.657 171.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.3 pt -101.37 0.29 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 123.73 0.812 . . . . 0.0 112.756 172.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.1 p -69.51 -17.63 63.61 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -169.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -101.89 8.98 56.48 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 125.344 1.45 . . . . 0.0 114.548 169.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -87.49 156.15 19.67 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.348 1.459 . . . . 0.0 112.295 -169.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.8 t -86.89 165.4 15.95 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -175.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.5 m -135.31 93.66 3.01 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.495 1.518 . . . . 0.0 109.103 169.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -88.97 133.37 35.61 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-O 118.469 -0.777 . . . . 0.0 111.806 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.09 153.94 22.14 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.655 2.237 . . . . 0.0 112.922 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.9 tp -55.96 -32.46 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -169.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -89.22 -13.83 37.33 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 120.786 -1.196 . . . . 0.0 113.267 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -90.1 -26.28 20.31 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.102 0.961 . . . . 0.0 112.832 175.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -52.81 46.72 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -169.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.1 m120 59.47 106.0 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.547 2.739 . . . . 0.0 114.561 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.05 13.85 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.97 1.708 . . . . 0.0 115.474 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -73.87 -29.28 62.01 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.069 0.948 . . . . 0.0 111.138 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -100.15 -5.67 27.42 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -124.89 94.46 4.19 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.27 1.428 . . . . 0.0 110.152 -172.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -73.12 -5.08 36.75 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -174.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.3 t -128.39 121.85 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 125.601 1.561 . . . . 0.0 109.451 173.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.2 t -132.31 119.35 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.052 0.541 . . . . 0.0 110.852 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 mp -110.24 134.35 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.001 0.92 . . . . 0.0 110.564 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.0 m -89.79 147.73 23.63 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.301 1.041 . . . . 0.0 108.253 168.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.9 mt -127.13 43.59 3.09 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.395 1.078 . . . . 0.0 110.728 -173.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 24.3 p . . . . . 0 N--CA 1.473 0.724 0 N-CA-C 117.59 2.441 . . . . 0.0 117.59 -169.172 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.7 mt . . . . . 0 CA--C 1.55 0.96 0 CA-C-O 119.447 -0.311 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.91 141.01 93.43 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.641 2.227 . . . . 0.0 111.522 172.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -63.07 -29.73 75.18 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.477 2.118 . . . . 0.0 112.666 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -62.79 -25.71 68.37 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 173.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -87.14 4.08 43.74 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 170.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.8 t -112.51 -36.63 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.949 1.7 . . . . 0.0 112.544 -175.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.9 p -79.28 10.09 4.01 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 -169.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -66.16 166.54 11.65 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.342 1.457 . . . . 0.0 112.056 169.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -56.78 -37.94 71.8 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -169.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 74.3 mt -127.07 119.8 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.52 1.128 . . . . 0.0 109.674 174.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -133.2 128.23 35.51 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.825 1.25 . . . . 0.0 110.57 169.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -146.81 161.19 41.18 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.809 1.644 . . . . 0.0 110.759 -174.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -127.47 117.02 21.32 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.384 -0.822 . . . . 0.0 112.93 173.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -88.36 94.17 9.76 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 169.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.405 ' H ' ' HG3' ' A' ' 100' ' ' GLN . 2.0 pp0? -51.79 59.82 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 128.823 2.849 . . . . 0.0 116.167 169.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 93.2 mt -84.24 153.35 23.65 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.735 2.414 . . . . 0.0 111.842 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -70.91 162.53 29.14 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.853 0.861 . . . . 0.0 111.408 169.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -88.28 107.79 18.44 Favored Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 120.76 -1.212 . . . . 0.0 108.136 169.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -79.05 -11.96 14.7 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 121.346 1.364 . . . . 0.0 114.643 -169.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -46.2 105.34 0.06 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.745 2.018 . . . . 0.0 113.792 -173.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.04 10.85 53.25 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.331 0.967 . . . . 0.0 115.507 174.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -74.87 -59.21 2.84 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.024 1.412 . . . . 0.0 111.141 -175.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.1 t -172.08 152.44 2.89 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.061 2.145 . . . . 0.0 108.542 170.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.4 mp -60.05 -30.95 69.53 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.75 -0.594 . . . . 0.0 111.117 172.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.0 -38.05 89.66 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.324 -0.86 . . . . 0.0 112.397 173.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.5 t -72.84 -39.85 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.568 0.747 . . . . 0.0 109.194 177.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -45.81 92.1 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.745 0.818 . . . . 0.0 111.406 176.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -69.09 -36.01 77.12 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.367 1.067 . . . . 0.0 112.273 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 62.3 m -59.6 -51.28 70.48 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 118.8 0.727 . . . . 0.0 111.286 174.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.0 m -70.39 -28.92 36.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 CA-C-O 117.206 -1.378 . . . . 0.0 112.553 177.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . 0.255 0.0 OUTLIER -67.06 -37.25 83.71 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 121.21 1.823 . . . . 0.0 112.46 172.249 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.55 -44.15 95.54 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.039 0.828 . . . . 0.0 112.446 173.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -61.65 -46.93 87.64 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 117.61 0.705 . . . . 0.0 112.129 171.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.7 t -58.63 -47.45 88.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 CA-C-O 117.042 -1.456 . . . . 0.0 110.593 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -51.53 -47.06 63.49 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 120.695 1.589 . . . . 0.0 112.79 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.21 -48.06 77.35 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.407 0.683 . . . . 0.0 112.265 177.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 63.8 mtt-85 -76.15 -32.24 59.0 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -176.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.594 HG11 ' HB3' ' A' ' 21' ' ' PHE . 4.0 p -73.93 -34.44 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.697 1.199 . . . . 0.0 111.427 175.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -60.97 -56.09 25.2 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.34 0.973 . . . . 0.0 108.621 168.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -50.25 -38.72 42.22 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.052 1.741 . . . . 0.0 112.487 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -78.16 -60.52 2.34 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.29 -0.882 . . . . 0.0 113.134 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.61 -34.54 51.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 123.981 0.913 . . . . 0.0 111.63 -175.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.91 -0.17 17.69 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.774 1.229 . . . . 0.0 114.239 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -98.27 -10.97 23.11 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.215 1.406 . . . . 0.0 113.312 169.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.7 pt -118.47 -0.25 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.66 1.584 . . . . 0.0 113.359 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 51.2 p . . . . . 0 C--O 1.256 1.429 0 C-N-CA 125.225 1.41 . . . . 0.0 113.69 169.824 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.3 ttm . . . . . 0 N--CA 1.503 2.214 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.795 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -83.96 92.53 7.85 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 119.273 0.942 . . . . 0.0 111.29 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -78.33 145.29 35.38 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.55 -0.719 . . . . 0.0 112.704 -173.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.2 t -113.63 142.65 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 125.117 1.367 . . . . 0.0 111.252 178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.444 ' HE3' ' CD1' ' A' ' 68' ' ' PHE . 62.8 tpp -131.02 122.35 26.65 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.015 0.926 . . . . 0.0 111.279 169.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -92.85 143.35 26.35 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.158 0.583 . . . . 0.0 109.611 168.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.0 t -135.42 130.69 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.905 1.282 . . . . 0.0 109.578 -173.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 p -144.33 174.2 11.12 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.19 0.996 . . . . 0.0 111.606 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -61.26 -56.62 18.49 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.904 -1.122 . . . . 0.0 109.663 173.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -94.5 123.69 38.08 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 106.503 -1.665 . . . . 0.0 106.503 168.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -63.29 -48.77 76.7 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 120.363 1.438 . . . . 0.0 108.89 169.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 94.1 p -47.53 -35.08 8.36 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.822 2.449 . . . . 0.0 115.273 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.6 p -91.03 -27.87 18.34 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.69 1.196 . . . . 0.0 114.139 -173.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 -136.97 -63.09 0.62 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -169.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 95.2 p -62.87 -30.34 71.44 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 120.757 1.617 . . . . 0.0 112.135 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -63.1 -41.84 99.45 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.86 1.264 . . . . 0.0 112.507 169.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.8 mtm -62.14 -45.54 92.98 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.827 -0.546 . . . . 0.0 111.08 174.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.39 -24.01 65.64 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.827 -1.083 . . . . 0.0 113.522 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -74.1 -48.66 28.15 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 121.656 2.025 . . . . 0.0 108.35 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.66 -43.15 99.41 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-O 119.024 -0.875 . . . . 0.0 112.829 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -64.47 -42.86 95.65 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.636 1.718 . . . . 0.0 112.267 173.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.31 -31.05 63.79 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.622 1.101 . . . . 0.0 111.135 -176.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -65.24 -53.9 37.4 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 125.354 1.462 . . . . 0.0 109.919 171.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.1 p -69.62 -11.07 60.55 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.6 mt -103.89 -1.68 27.35 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.551 1.141 . . . . 0.0 113.88 171.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.6 9.06 0.47 Allowed Glycine 0 N--CA 1.477 1.399 0 N-CA-C 117.288 1.675 . . . . 0.0 117.288 -169.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.98 133.8 55.82 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 119.249 1.525 . . . . 0.0 111.886 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.87 -6.83 54.02 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.473 1.035 . . . . 0.0 115.332 -175.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -87.59 -63.55 1.29 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.349 1.575 . . . . 0.0 110.6 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -142.98 173.94 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 127.222 2.209 . . . . 0.0 110.946 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.0 130.34 41.71 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.369 -0.832 . . . . 0.0 112.61 176.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -105.48 154.03 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.73 1.212 . . . . 0.0 112.974 171.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.5 147.0 25.7 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -172.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.7 p -108.75 139.76 43.11 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 127.107 2.163 . . . . 0.0 114.031 170.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.5 t -143.05 177.37 8.42 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.498 1.519 . . . . 0.0 110.463 169.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.69 173.26 39.76 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 120.122 -1.611 . . . . 0.0 115.06 173.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.1 mt -61.76 -35.52 78.35 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.457 0.703 . . . . 0.0 111.752 -174.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -125.19 111.56 15.42 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.836 2.455 . . . . 0.0 107.565 169.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.4 p -65.51 -33.79 76.75 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.179 -0.95 . . . . 0.0 112.064 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.5 t 48.72 -120.63 1.36 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.386 1.474 . . . . 0.0 111.814 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -144.28 -151.54 0.37 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.594 1.957 . . . . 0.0 111.008 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.2 m -91.18 116.26 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 168.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -68.66 133.77 90.58 Favored Pre-proline 0 N--CA 1.481 1.11 0 O-C-N 120.963 -1.086 . . . . 0.0 111.686 -169.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -59.82 -37.61 85.3 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.446 2.764 . . . . 0.0 113.736 -171.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.9 m -79.02 -35.68 42.35 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.912 -0.492 . . . . 0.0 110.364 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.13 93.8 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.903 -1.123 . . . . 0.0 112.422 174.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.3 mt -53.32 -44.84 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 120.944 1.702 . . . . 0.0 110.71 172.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.67 -56.23 17.31 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.972 0.731 . . . . 0.0 112.972 175.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 30.1 mmt -68.66 -19.21 64.4 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -174.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 87.0 mmm -91.86 -40.23 11.3 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.888 0.875 . . . . 0.0 110.659 176.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -60.49 -39.83 89.12 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.741 -1.224 . . . . 0.0 112.404 174.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -60.31 -26.86 66.87 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.173 -0.954 . . . . 0.0 113.533 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.7 p -100.34 12.83 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 124.894 1.277 . . . . 0.0 113.103 174.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.39 18.59 48.63 Favored Glycine 0 N--CA 1.475 1.286 0 C-N-CA 124.795 1.188 . . . . 0.0 115.263 172.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.4 mt -127.22 85.5 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.426 1.49 . . . . 0.0 110.048 -169.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -71.27 109.81 5.52 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.133 -1.604 . . . . 0.0 110.831 173.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.5 pt -87.5 -9.31 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 118.251 -0.88 . . . . 0.0 112.512 173.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.3 t -62.36 -34.55 76.9 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 120.552 1.524 . . . . 0.0 113.149 -169.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.86 3.99 85.81 Favored Glycine 0 CA--C 1.541 1.683 0 C-N-CA 124.782 1.182 . . . . 0.0 115.282 173.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -97.26 150.68 20.66 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.41 1.484 . . . . 0.0 111.895 -173.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.3 t -84.87 149.62 25.55 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.268 -0.895 . . . . 0.0 112.886 -175.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 71.1 m -121.8 111.45 17.15 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.04 0.936 . . . . 0.0 109.914 169.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -89.17 152.58 48.18 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.039 0.936 . . . . 0.0 112.825 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -91.83 150.84 3.35 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.268 3.312 . . . . 0.0 112.0 171.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 tt -63.18 -27.87 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -170.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -82.1 -11.41 58.78 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.0 -1.063 . . . . 0.0 113.246 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -96.81 -27.97 14.47 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.436 1.094 . . . . 0.0 113.323 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.444 ' CD1' ' HE3' ' A' ' 5' ' ' MET . 0.0 OUTLIER -62.54 -41.72 99.07 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -168.916 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.4 ' HA ' ' CH2' ' A' ' 90' ' ' TRP 0.341 0.0 OUTLIER 53.97 99.44 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.662 2.785 . . . . 0.0 115.043 -176.834 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 68' ' ' PHE . . . -67.66 5.31 0.85 Allowed 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -175.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -72.2 -27.13 62.36 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.023 1.329 . . . . 0.0 112.27 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -90.07 -2.47 58.11 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -119.79 140.2 51.12 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.982 1.313 . . . . 0.0 112.604 -169.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -88.74 -28.83 20.26 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.894 0.877 . . . . 0.0 111.83 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.6 t -130.08 120.42 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.516 1.127 . . . . 0.0 110.003 -170.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.6 t -126.42 129.34 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.573 0.749 . . . . 0.0 110.193 177.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.8 mm -121.73 126.94 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.086 0.954 . . . . 0.0 110.632 -171.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.6 t -89.45 121.7 31.94 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.863 0.465 . . . . 0.0 109.835 169.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.416 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 75.9 mt -98.6 13.42 32.07 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.496 1.518 . . . . 0.0 112.024 175.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.5 p . . . . . 0 CA--C 1.535 0.401 0 C-N-CA 126.799 2.039 . . . . 0.0 109.032 169.39 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.6 mt . . . . . 0 CA--C 1.549 0.94 0 CA-C-O 119.251 -0.404 . . . . 0.0 111.814 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -58.82 133.29 52.86 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.673 2.249 . . . . 0.0 111.081 173.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -61.18 -31.6 90.18 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.393 2.062 . . . . 0.0 113.184 -176.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -59.17 -32.86 70.28 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.059 -1.026 . . . . 0.0 112.959 171.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.4 ' CH2' ' HA ' ' A' ' 69' ' ' ASN . 0.4 OUTLIER -86.0 12.03 10.31 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.35 1.06 . . . . 0.0 113.821 174.633 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.9 t -116.48 -36.5 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.856 1.662 . . . . 0.0 111.74 178.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.8 p -79.59 25.31 0.34 Allowed 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 -169.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -76.17 167.02 22.62 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.858 1.663 . . . . 0.0 111.975 171.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -57.94 -37.09 73.48 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.932 0.893 . . . . 0.0 112.837 -171.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 67.4 mt -126.81 123.74 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.636 1.175 . . . . 0.0 109.215 169.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -131.52 134.25 45.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.208 1.003 . . . . 0.0 110.597 169.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -141.43 153.97 45.32 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.542 1.137 . . . . 0.0 112.155 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -120.92 117.67 27.92 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.74 1.216 . . . . 0.0 110.157 173.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.416 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 37.0 m0 -95.32 -0.79 52.43 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.669 1.188 . . . . 0.0 113.612 -177.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.308 1.3 pp0? 46.44 39.21 6.26 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 171.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.8 mt -79.4 159.64 26.99 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.8 0.84 . . . . 0.0 112.765 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -87.04 150.81 23.77 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.624 1.569 . . . . 0.0 111.958 173.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.44 116.26 59.32 Favored Pre-proline 0 CA--C 1.546 0.815 0 O-C-N 121.298 -0.877 . . . . 0.0 110.574 172.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -83.23 -14.82 8.13 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.496 2.131 . . . . 0.0 115.457 -169.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -46.59 108.08 0.13 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.759 1.624 . . . . 0.0 112.98 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.69 9.34 78.61 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-O 118.878 -0.957 . . . . 0.0 115.407 175.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -73.81 -68.17 0.54 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.04 1.42 . . . . 0.0 110.431 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.6 t -177.23 152.26 0.86 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 128.505 2.722 . . . . 0.0 108.106 173.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.8 mp -60.36 -29.94 69.23 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.822 0.737 . . . . 0.0 111.549 174.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -64.23 -38.65 91.81 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.091 -1.006 . . . . 0.0 112.423 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.2 t -73.61 -37.63 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.016 0.926 . . . . 0.0 109.476 176.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.8 -45.22 95.23 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.23 1.012 . . . . 0.0 111.177 175.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -67.79 -38.05 82.84 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.638 1.175 . . . . 0.0 112.491 173.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.4 m -58.86 -50.36 74.29 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 118.778 0.717 . . . . 0.0 110.886 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.6 m -71.25 -30.97 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 117.643 -1.17 . . . . 0.0 112.266 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -40.33 97.08 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 121.21 1.823 . . . . 0.0 111.966 171.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.49 -42.83 95.56 Favored Glycine 0 N--CA 1.474 1.183 0 C-N-CA 124.391 0.996 . . . . 0.0 112.579 176.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -60.75 -45.64 93.53 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.915 -0.756 . . . . 0.0 111.947 170.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 29.3 t -58.67 -48.73 84.94 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.807 177.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -51.56 -55.13 20.84 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.856 1.207 . . . . 0.0 111.487 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -59.69 -42.05 92.1 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.619 0.768 . . . . 0.0 112.572 -176.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -78.06 -35.01 50.08 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 39.1 t -61.19 -48.25 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.185 1.394 . . . . 0.0 111.19 172.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -51.88 -55.22 21.41 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.06 0.845 . . . . 0.0 109.606 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -56.93 -37.46 71.52 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.191 1.397 . . . . 0.0 112.276 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -74.25 -56.28 5.07 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.33 -0.856 . . . . 0.0 112.556 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.63 -34.44 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.775 1.23 . . . . 0.0 112.363 -175.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.14 -22.78 62.02 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 121.118 -0.989 . . . . 0.0 113.486 -174.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -70.2 -19.73 63.15 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.593 1.157 . . . . 0.0 113.849 173.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 28.7 pt -118.89 17.15 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 126.259 1.824 . . . . 0.0 112.652 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--O 1.256 1.401 0 C-N-CA 126.459 1.904 . . . . 0.0 111.313 172.158 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.6 tpp . . . . . 0 N--CA 1.502 2.139 0 CA-C-O 118.989 -0.529 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -82.7 85.42 7.04 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 119.873 1.215 . . . . 0.0 111.338 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -77.42 147.55 35.93 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -171.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.64 139.5 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.938 1.295 . . . . 0.0 111.074 176.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 49.4 tpp -127.36 115.36 18.85 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.499 0.72 . . . . 0.0 111.093 169.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -81.53 142.58 32.73 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.624 -0.673 . . . . 0.0 110.331 169.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.92 128.17 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 119.187 0.903 . . . . 0.0 111.66 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.5 p -144.76 178.02 8.3 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.462 1.105 . . . . 0.0 111.757 175.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -59.8 -61.46 2.6 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 120.083 1.31 . . . . 0.0 109.617 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.463 ' HB3' ' H ' ' A' ' 13' ' ' SER . 2.4 mpt_? -83.72 125.18 31.63 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 167.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -59.68 -43.25 94.08 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 120.029 1.286 . . . . 0.0 108.476 169.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.0 p -65.49 -48.58 72.13 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 115.848 1.795 . . . . 0.0 115.848 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.463 ' H ' ' HB3' ' A' ' 10' ' ' ARG . 4.3 m -71.8 -15.51 62.15 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -169.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.82 -55.05 0.82 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 120.325 1.421 . . . . 0.0 113.258 168.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.8 m -61.97 -38.2 87.64 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -171.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -62.71 -36.14 82.0 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.377 0.99 . . . . 0.0 113.214 169.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 82.5 mtp -59.83 -45.58 91.96 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.161 -0.962 . . . . 0.0 110.3 173.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.62 -31.38 69.47 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 117.954 -1.022 . . . . 0.0 113.555 174.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -68.61 -46.17 69.99 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 121.553 1.979 . . . . 0.0 109.033 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.49 -42.99 97.29 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 118.527 -1.152 . . . . 0.0 112.668 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.529 ' HB3' HG11 ' A' ' 123' ' ' VAL . 3.5 m-85 -66.13 -42.3 89.33 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.202 1.501 . . . . 0.0 112.144 171.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.501 ' HB1' HG11 ' A' ' 32' ' ' VAL . . . -63.93 -35.75 81.68 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.61 -1.306 . . . . 0.0 111.114 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -63.53 -55.78 21.18 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.135 1.774 . . . . 0.0 109.976 174.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.7 p -68.41 -14.47 63.02 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 178.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 50.8 mt -99.14 -6.68 27.83 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.384 1.074 . . . . 0.0 113.864 174.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -152.13 9.56 0.62 Allowed Glycine 0 N--CA 1.476 1.311 0 N-CA-C 117.185 1.634 . . . . 0.0 117.185 -169.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.36 132.21 50.37 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 119.514 1.657 . . . . 0.0 111.609 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.37 -6.22 57.92 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.803 1.192 . . . . 0.0 115.475 -176.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -86.46 -59.16 2.36 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 119.459 1.629 . . . . 0.0 110.813 175.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.6 pp -144.7 175.71 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 128.226 2.61 . . . . 0.0 110.118 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.35 132.5 41.79 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.22 -0.925 . . . . 0.0 112.788 174.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.501 HG11 ' HB1' ' A' ' 22' ' ' ALA . 30.7 m -104.02 145.93 12.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 124.667 1.187 . . . . 0.0 112.704 171.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.8 m -146.94 156.35 43.0 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.217 1.007 . . . . 0.0 111.707 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.9 p -126.02 139.83 53.1 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.885 2.074 . . . . 0.0 113.9 175.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.7 t -133.66 172.1 13.21 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 129.567 3.147 . . . . 0.0 109.322 -176.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.64 173.56 44.84 Favored Glycine 0 CA--C 1.523 0.587 0 O-C-N 120.551 -1.343 . . . . 0.0 115.094 169.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.1 mt -66.46 -28.43 68.58 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.291 0.636 . . . . 0.0 111.723 -178.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -121.26 127.91 51.86 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.48 1.912 . . . . 0.0 108.383 170.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.5 p -78.02 55.99 1.54 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.675 1.59 . . . . 0.0 110.381 171.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.5 p -68.13 149.2 49.89 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.29 1.436 . . . . 0.0 112.037 -169.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -58.24 155.3 11.7 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.395 0.678 . . . . 0.0 111.673 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.1 m -50.91 109.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 169.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -65.95 130.63 94.44 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 118.478 -0.772 . . . . 0.0 112.319 -168.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.03 -38.79 85.65 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.489 2.793 . . . . 0.0 113.391 -172.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.9 m -77.55 -34.02 53.95 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 119.224 -0.417 . . . . 0.0 110.684 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.82 -43.48 96.09 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.844 -1.16 . . . . 0.0 111.986 172.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.7 mt -54.72 -40.3 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 120.795 1.634 . . . . 0.0 110.328 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.62 -62.87 1.27 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 173.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 30.4 mmt -67.11 -21.69 65.84 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.951 0.9 . . . . 0.0 113.415 -172.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 86.4 mmm -85.36 -37.78 19.5 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.616 0.767 . . . . 0.0 110.524 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -63.75 -33.44 75.67 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.665 -1.272 . . . . 0.0 111.983 173.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -55.26 -28.49 53.75 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 170.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.1 m -107.11 19.48 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 125.328 1.451 . . . . 0.0 113.525 174.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.64 13.73 74.98 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.65 1.119 . . . . 0.0 115.37 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.3 mt -117.67 97.19 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.448 1.499 . . . . 0.0 109.855 -170.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -78.35 112.09 15.0 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.958 -1.089 . . . . 0.0 110.438 171.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.0 pt -93.09 -4.22 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 172.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.4 p -65.98 -26.33 67.51 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -169.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -100.58 9.29 58.77 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.362 1.458 . . . . 0.0 114.445 172.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -86.72 149.11 25.11 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.983 1.313 . . . . 0.0 112.266 -170.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.9 t -63.59 148.16 49.58 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.459 -0.776 . . . . 0.0 112.109 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.5 t -138.96 54.95 1.72 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.046 0.927 . . . . 0.0 111.689 174.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -68.88 147.45 97.84 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 125.192 1.397 . . . . 0.0 113.185 -170.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -82.75 151.81 14.77 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.635 2.224 . . . . 0.0 112.442 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.8 tt -60.48 -21.83 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -91.99 -9.42 43.02 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 177.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -97.58 -35.2 10.69 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.781 0.832 . . . . 0.0 111.913 171.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -68.43 160.41 29.73 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.18 0.592 . . . . 0.0 111.571 175.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.416 ' HA ' ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -136.63 119.38 16.16 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.666 0.786 . . . . 0.0 111.985 170.479 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.423 ' HB3' ' CE3' ' A' ' 90' ' ' TRP . . . -66.54 0.8 2.01 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -175.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -70.59 -29.26 65.63 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.906 0.882 . . . . 0.0 112.209 -175.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -88.78 -2.36 58.55 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.116 1.366 . . . . 0.0 113.322 177.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -124.67 95.15 4.41 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.706 1.602 . . . . 0.0 110.498 -171.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -55.13 -29.48 57.81 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.768 1.227 . . . . 0.0 112.83 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 t -121.55 118.3 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 125.111 1.364 . . . . 0.0 110.19 -172.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.8 t -130.17 134.38 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.818 0.847 . . . . 0.0 110.644 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.406 HG21 ' CE2' ' A' ' 99' ' ' TRP . 19.0 mm -128.71 132.64 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 121.434 -0.791 . . . . 0.0 111.399 -170.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.4 t -87.87 117.59 26.82 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.521 0.728 . . . . 0.0 111.116 169.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 mp -97.68 37.07 1.42 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.734 1.614 . . . . 0.0 109.177 173.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.2 t . . . . . 0 CA--C 1.54 0.562 0 C-N-CA 126.192 1.797 . . . . 0.0 111.647 -178.219 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.6 mt . . . . . 0 CA--C 1.545 0.787 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.96 153.73 47.46 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.47 2.114 . . . . 0.0 110.675 174.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -59.82 -34.0 95.87 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.859 2.372 . . . . 0.0 112.222 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -48.89 -46.25 42.38 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.499 1.52 . . . . 0.0 112.938 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.423 ' CE3' ' HB3' ' A' ' 70' ' ' ALA . 1.8 m95 -90.75 8.2 35.77 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.747 1.219 . . . . 0.0 112.961 -177.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.7 t -114.94 -38.53 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 127.03 2.132 . . . . 0.0 111.704 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.9 p -81.39 26.71 0.45 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -174.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -80.89 169.34 17.67 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.31 1.444 . . . . 0.0 111.896 174.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -53.58 -41.79 66.92 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 -169.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 59.9 mt -125.71 123.46 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.591 1.157 . . . . 0.0 109.373 170.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -133.49 135.06 44.23 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.007 0.923 . . . . 0.0 111.44 169.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -142.84 153.12 42.87 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.69 1.196 . . . . 0.0 112.42 -175.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -113.36 125.88 54.75 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.279 1.432 . . . . 0.0 111.133 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.406 ' CE2' HG21 ' A' ' 77' ' ' ILE . 44.3 m0 -100.91 -5.69 25.67 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 177.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.355 1.2 pp0? 50.3 31.89 5.71 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.3 mt -75.52 151.87 37.89 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -87.28 160.6 18.36 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.704 2.002 . . . . 0.0 112.511 178.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.61 115.02 60.75 Favored Pre-proline 0 CA--C 1.547 0.83 0 O-C-N 121.282 -0.886 . . . . 0.0 111.4 169.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.87 -13.74 9.14 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.471 2.114 . . . . 0.0 114.822 -170.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -44.05 113.7 0.56 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.506 1.922 . . . . 0.0 113.556 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.81 6.46 55.88 Favored Glycine 0 CA--C 1.534 1.234 0 N-CA-C 115.86 1.104 . . . . 0.0 115.86 173.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -78.04 -63.63 1.35 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.921 1.361 . . . . 0.0 110.881 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.6 t -174.24 152.47 1.82 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.391 2.277 . . . . 0.0 108.889 169.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.1 mp -59.96 -29.92 68.75 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.624 -0.672 . . . . 0.0 111.299 171.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -63.09 -39.75 95.63 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.056 -1.028 . . . . 0.0 112.483 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.3 t -71.43 -37.1 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.843 0.857 . . . . 0.0 109.733 175.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -41.9 92.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.914 0.885 . . . . 0.0 111.699 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -70.09 -36.8 75.17 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 121.22 -0.925 . . . . 0.0 111.987 171.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.3 m -58.06 -48.94 78.58 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.087 0.858 . . . . 0.0 111.639 174.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 23.8 m -68.25 -31.25 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 117.802 -1.094 . . . . 0.0 112.09 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.26 -42.22 98.27 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 120.867 1.667 . . . . 0.0 111.786 170.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.74 -43.82 93.44 Favored Glycine 0 N--CA 1.473 1.158 0 C-N-CA 124.256 0.932 . . . . 0.0 112.785 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -60.51 -45.21 94.65 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 122.166 -0.608 . . . . 0.0 112.032 170.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.9 t -59.67 -50.35 80.33 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 CA-C-O 117.518 -1.23 . . . . 0.0 109.434 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -50.81 -49.89 57.59 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.045 1.293 . . . . 0.0 112.068 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -60.48 -44.37 95.99 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.528 0.731 . . . . 0.0 112.948 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 46.4 mtp85 -81.92 -35.93 28.6 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.529 HG11 ' HB3' ' A' ' 21' ' ' PHE . 4.0 p -72.51 -34.07 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.17 1.388 . . . . 0.0 111.747 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -56.44 -56.98 14.48 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.249 0.931 . . . . 0.0 109.535 169.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -55.64 -35.68 66.18 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.885 1.274 . . . . 0.0 111.877 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -73.45 -57.16 4.19 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.631 -0.668 . . . . 0.0 112.385 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.96 -33.07 61.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.848 0.859 . . . . 0.0 112.211 -176.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.32 -23.25 60.23 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -173.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -68.57 -21.35 64.53 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.693 1.197 . . . . 0.0 113.811 173.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 29.0 pt -117.77 15.28 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 126.452 1.901 . . . . 0.0 112.634 -177.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--O 1.255 1.358 0 C-N-CA 126.501 1.92 . . . . 0.0 111.753 173.522 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.505 2.295 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -81.23 98.01 7.9 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.0 0.92 . . . . 0.0 110.147 175.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -80.47 146.46 31.37 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.647 -0.658 . . . . 0.0 112.324 -174.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.0 t -111.95 146.59 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.673 1.189 . . . . 0.0 110.743 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 45.3 tpp -130.83 112.81 13.36 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.226 1.011 . . . . 0.0 111.448 169.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -82.2 129.57 34.87 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.31 1.044 . . . . 0.0 110.362 169.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.3 t -127.22 136.23 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.069 1.348 . . . . 0.0 110.925 -176.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 t -149.78 -176.81 5.57 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 121.443 -0.786 . . . . 0.0 111.919 169.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -61.15 -45.0 96.43 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.412 -0.805 . . . . 0.0 110.617 170.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.56 129.59 56.68 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.435 1.494 . . . . 0.0 110.787 169.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -72.78 -55.79 6.21 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 169.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.0 p -27.35 -52.22 0.07 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 128.882 2.873 . . . . 0.0 116.758 173.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.4 p -100.96 -24.47 14.33 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.857 1.263 . . . . 0.0 113.898 -174.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -118.04 -71.46 0.74 Allowed 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 119.643 1.111 . . . . 0.0 111.98 -173.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.96 -30.38 70.88 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 121.256 -0.903 . . . . 0.0 112.924 -175.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -66.42 -34.25 77.52 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 126.405 1.882 . . . . 0.0 113.801 172.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 27.3 mmm -65.73 -36.4 83.5 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.656 -0.652 . . . . 0.0 110.27 172.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.41 -26.69 61.07 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.263 -0.898 . . . . 0.0 113.394 169.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -68.96 -53.25 21.8 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.395 1.452 . . . . 0.0 108.439 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.67 -49.07 77.0 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-O 118.935 -0.925 . . . . 0.0 112.488 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.575 ' HB3' HG11 ' A' ' 123' ' ' VAL . 8.4 m-85 -66.71 -38.34 86.51 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.586 1.193 . . . . 0.0 112.49 175.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.65 -38.07 80.16 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 120.024 1.283 . . . . 0.0 110.215 -178.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -57.74 -57.48 12.58 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 125.796 1.639 . . . . 0.0 110.889 171.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.9 p -71.35 -15.4 62.39 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -177.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.1 mt -95.14 -13.24 25.23 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -142.84 8.88 2.27 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 117.783 1.873 . . . . 0.0 117.783 -169.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.14 129.52 38.48 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.771 1.786 . . . . 0.0 111.784 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.33 -6.55 56.89 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 124.677 1.132 . . . . 0.0 115.571 -177.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -86.78 -57.37 3.01 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 119.471 1.636 . . . . 0.0 110.603 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.6 pp -142.17 177.13 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 127.504 2.322 . . . . 0.0 110.161 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.28 122.17 43.21 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.725 0.774 . . . . 0.0 111.591 173.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.9 m -87.74 149.92 3.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 123.781 0.833 . . . . 0.0 111.746 169.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.42 152.04 38.42 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.728 0.811 . . . . 0.0 110.93 176.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.0 p -133.44 145.65 50.45 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.941 1.696 . . . . 0.0 112.541 175.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.4 t -150.01 178.46 8.91 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.884 1.674 . . . . 0.0 110.573 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.26 -179.57 46.42 Favored Glycine 0 CA--C 1.527 0.794 0 O-C-N 120.92 -1.112 . . . . 0.0 114.185 170.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.1 mt -71.95 -44.39 63.65 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -169.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -90.73 -25.57 19.95 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.747 1.619 . . . . 0.0 112.473 173.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 60.3 p 58.84 -65.1 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 127.814 2.445 . . . . 0.0 113.128 -169.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 t 56.59 -174.58 0.06 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 130.22 3.408 . . . . 0.0 114.095 -177.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 54.6 ttt85 -79.83 147.51 31.75 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.873 1.669 . . . . 0.0 111.034 174.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.0 m -47.35 112.92 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.794 1.238 . . . . 0.0 109.739 169.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -63.12 137.56 97.1 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -167.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.4 -40.01 61.62 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.716 2.944 . . . . 0.0 113.518 -175.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.1 m -77.23 -33.04 56.19 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.978 -0.451 . . . . 0.0 110.513 176.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.3 -47.88 83.91 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.403 1.001 . . . . 0.0 111.706 171.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 68.7 mt -49.25 -44.56 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 120.388 1.449 . . . . 0.0 110.823 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.84 -59.44 5.14 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 174.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.2 mmt -67.11 -22.17 65.82 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -175.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.2 mtp -80.88 -45.16 17.24 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.993 1.317 . . . . 0.0 110.665 173.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -61.69 -33.45 74.02 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.804 -1.185 . . . . 0.0 112.532 176.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -55.53 -30.23 60.35 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.264 1.026 . . . . 0.0 113.455 172.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.0 m -105.87 14.98 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 125.146 1.379 . . . . 0.0 113.792 177.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.93 17.79 64.65 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.166 0.889 . . . . 0.0 115.124 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.6 mt -112.68 114.86 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.91 1.284 . . . . 0.0 110.944 -169.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -90.81 110.83 22.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.7 1.2 . . . . 0.0 111.783 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.3 pt -110.62 -5.89 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 169.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.8 p -67.32 -25.6 66.09 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 120.548 -1.345 . . . . 0.0 114.44 -169.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -106.99 14.12 40.84 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 125.683 1.611 . . . . 0.0 114.378 170.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -95.51 151.23 19.5 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.307 1.443 . . . . 0.0 112.128 -170.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.7 t -77.32 146.8 36.54 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 121.247 -0.908 . . . . 0.0 112.856 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.6 m -126.21 98.58 5.53 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.787 1.235 . . . . 0.0 109.069 169.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.79 155.99 75.3 Favored Pre-proline 0 CA--C 1.553 1.088 0 O-C-N 121.223 -0.923 . . . . 0.0 113.388 -174.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -97.63 152.45 0.92 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.866 3.711 . . . . 0.0 113.708 171.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.6 tp -60.81 -21.1 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 -169.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -103.15 -6.88 21.75 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -84.28 -37.91 21.11 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.97 0.804 . . . . 0.0 111.674 171.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.45 159.32 34.16 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.803 0.841 . . . . 0.0 111.574 173.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.449 ' HA ' ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -138.29 112.9 8.9 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.528 0.731 . . . . 0.0 111.728 171.428 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.7 -3.67 2.48 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -169.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.86 -27.62 67.67 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.004 -1.06 . . . . 0.0 112.214 -174.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -91.86 -0.87 57.53 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.087 1.355 . . . . 0.0 113.655 176.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -122.54 95.12 4.51 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.359 1.464 . . . . 0.0 110.597 -170.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -56.2 -31.3 63.33 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.878 1.271 . . . . 0.0 112.968 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.3 t -121.43 121.43 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 124.527 1.131 . . . . 0.0 110.494 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.7 t -127.1 133.59 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.079 0.952 . . . . 0.0 110.169 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.8 mm -122.84 136.7 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.909 0.883 . . . . 0.0 110.375 -175.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.7 t -96.96 127.23 42.73 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.042 0.937 . . . . 0.0 110.464 169.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -108.95 25.86 11.3 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.542 1.537 . . . . 0.0 110.173 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 31.3 p . . . . . 0 CA--C 1.541 0.613 0 C-N-CA 128.138 2.575 . . . . 0.0 111.837 177.081 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.2 mt . . . . . 0 CA--C 1.549 0.941 0 CA-C-O 119.37 -0.348 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -64.28 149.27 90.51 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.751 2.301 . . . . 0.0 113.954 -175.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -72.89 56.82 3.06 Favored 'Trans proline' 0 CA--C 1.549 1.261 1 C-N-CA 125.879 4.386 . . . . 0.0 111.183 171.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -157.03 -51.0 0.07 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.671 2.388 . . . . 0.0 109.431 -169.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.449 ' CH2' ' HA ' ' A' ' 69' ' ' ASN . 1.0 OUTLIER -85.39 -28.1 25.36 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.112 0.965 . . . . 0.0 111.899 177.907 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.4 m -84.16 -12.95 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 175.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.9 p -94.37 8.71 41.02 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.042 1.337 . . . . 0.0 114.202 -172.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -74.61 169.15 18.37 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.797 1.239 . . . . 0.0 112.98 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -52.07 -39.98 60.49 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -169.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.2 mt -126.3 122.98 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.553 1.141 . . . . 0.0 109.429 169.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -129.38 124.56 34.52 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.391 1.076 . . . . 0.0 110.143 169.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -141.79 167.61 21.74 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.334 1.454 . . . . 0.0 111.017 -174.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -135.27 146.84 48.94 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 172.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 36.7 m0 -109.38 7.68 25.13 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 64.46 -78.76 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.097 1.759 . . . . 0.0 112.983 -177.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 27.0 mt 49.94 -163.89 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 127.585 2.354 . . . . 0.0 113.852 -175.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -141.58 160.49 40.04 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.953 2.101 . . . . 0.0 108.105 171.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -81.1 110.53 18.3 Favored Pre-proline 0 N--CA 1.471 0.625 0 CA-C-N 119.764 1.166 . . . . 0.0 109.689 169.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -81.63 -10.77 11.83 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 121.249 1.3 . . . . 0.0 114.273 -169.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -45.47 109.26 0.16 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.666 1.586 . . . . 0.0 113.568 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.52 9.77 62.2 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 118.767 -1.018 . . . . 0.0 115.478 172.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -78.46 -64.8 1.09 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.877 1.338 . . . . 0.0 111.079 -176.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 21.4 t -173.74 151.62 1.88 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.372 2.269 . . . . 0.0 108.429 170.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.8 mp -60.81 -28.2 68.61 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.577 -0.702 . . . . 0.0 111.119 172.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.18 -39.6 95.1 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.027 -1.046 . . . . 0.0 112.334 173.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.5 t -71.68 -38.9 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.084 0.954 . . . . 0.0 109.654 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.34 -40.0 95.01 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.259 1.024 . . . . 0.0 111.608 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.8 mtt85 -73.23 -36.46 66.44 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 121.062 -1.024 . . . . 0.0 112.185 170.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 55.2 m -58.02 -47.73 82.17 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 119.147 0.885 . . . . 0.0 111.646 175.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.6 m -68.39 -30.24 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 119.589 1.086 . . . . 0.0 111.778 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.66 -43.52 98.59 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 120.236 1.38 . . . . 0.0 111.76 169.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.74 -44.33 94.99 Favored Glycine 0 N--CA 1.473 1.11 0 C-N-CA 124.47 1.033 . . . . 0.0 112.68 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -59.87 -46.41 89.4 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.242 0.617 . . . . 0.0 112.069 170.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.459 ' O ' HG12 ' A' ' 123' ' ' VAL . 3.9 t -59.42 -52.06 65.39 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.506 0 CA-C-O 117.136 -1.411 . . . . 0.0 110.3 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -49.52 -44.23 46.15 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.122 1.369 . . . . 0.0 113.215 -175.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -65.91 -45.59 81.4 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.416 0.686 . . . . 0.0 112.556 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 53.8 mtp85 -82.05 -34.46 29.46 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.752 0.821 . . . . 0.0 112.823 -173.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.575 HG11 ' HB3' ' A' ' 21' ' ' PHE . 9.4 p -68.64 -38.61 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.327 1.451 . . . . 0.0 111.785 173.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -57.54 -56.16 25.53 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.607 1.094 . . . . 0.0 109.631 169.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -55.23 -32.65 62.45 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.723 1.209 . . . . 0.0 112.342 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -77.04 -58.71 3.13 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.228 -0.92 . . . . 0.0 112.68 176.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.75 -32.64 58.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.88 1.272 . . . . 0.0 112.36 -174.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.93 -15.06 59.78 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -172.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -74.51 -26.54 60.06 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.529 1.131 . . . . 0.0 113.446 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 23.8 pt -110.23 -7.41 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.544 1.538 . . . . 0.0 113.589 -177.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.0 m . . . . . 0 C--O 1.252 1.207 0 C-N-CA 125.103 1.361 . . . . 0.0 113.117 173.83 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.9 ttm . . . . . 0 N--CA 1.502 2.138 0 CA-C-O 119.519 -0.277 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -93.92 91.11 6.75 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.658 1.183 . . . . 0.0 110.756 173.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.34 144.47 42.35 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 121.444 -0.785 . . . . 0.0 111.276 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 p -125.3 145.2 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.249 1.02 . . . . 0.0 112.199 -176.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 40.3 tpp -133.45 117.19 16.91 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.939 1.296 . . . . 0.0 112.071 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -84.19 141.08 31.3 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 119.198 -0.429 . . . . 0.0 111.138 169.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.7 t -134.23 124.73 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.297 1.439 . . . . 0.0 111.622 -176.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.9 p -145.8 -179.4 6.66 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.009 1.324 . . . . 0.0 111.608 175.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.79 -59.96 4.15 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 119.947 -1.721 . . . . 0.0 110.803 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -87.31 136.07 33.08 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 168.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -72.57 -55.92 6.17 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 169.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.479 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 24.9 p -50.8 -49.29 58.77 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.681 1.364 . . . . 0.0 114.681 -176.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 m -74.96 -10.88 59.9 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 -143.12 -68.25 0.35 Allowed 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 119.841 1.2 . . . . 0.0 113.571 177.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 44.5 m -65.43 -35.72 81.77 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.456 -1.402 . . . . 0.0 114.472 -172.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -68.97 -29.72 67.99 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 120.922 -1.111 . . . . 0.0 112.887 169.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.2 mtm -61.96 -46.97 86.94 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 169.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.31 -31.2 71.86 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 34' ' ' SER . 27.4 tt0 -69.58 -45.9 67.59 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 120.431 1.469 . . . . 0.0 109.531 176.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.05 -43.84 98.2 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 118.939 -0.923 . . . . 0.0 111.767 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -63.69 -42.97 97.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.47 1.135 . . . . 0.0 112.409 170.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.43 -31.7 72.07 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 120.515 -1.365 . . . . 0.0 111.056 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -67.86 -55.1 14.18 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 126.502 1.921 . . . . 0.0 109.296 174.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.8 p -68.69 -14.54 63.09 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 177.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 39.8 mt -101.05 1.51 39.55 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.66 1.184 . . . . 0.0 113.83 172.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.97 9.97 0.22 Allowed Glycine 0 CA--C 1.535 1.322 0 N-CA-C 117.402 1.721 . . . . 0.0 117.402 -169.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.96 131.35 50.79 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.763 1.782 . . . . 0.0 111.71 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.54 -3.39 59.66 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.491 1.043 . . . . 0.0 115.469 -175.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -87.11 -63.38 1.32 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 119.102 1.451 . . . . 0.0 110.329 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -142.09 173.9 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 127.44 2.296 . . . . 0.0 110.203 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.18 120.81 33.11 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 121.232 -0.917 . . . . 0.0 111.302 176.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 m -94.31 148.13 5.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.791 169.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.55 157.78 43.69 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.758 0.823 . . . . 0.0 110.741 -172.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.423 ' HB3' ' HB2' ' A' ' 19' ' ' GLU . 93.7 p -145.06 146.42 31.86 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 175.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 79.7 p -150.56 -179.04 6.91 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.676 1.591 . . . . 0.0 110.691 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.37 -174.3 43.63 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 116.46 1.344 . . . . 0.0 116.46 170.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.7 mt -71.49 -47.63 54.2 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.261 0.624 . . . . 0.0 111.822 -172.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -92.81 -32.8 14.52 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.26 1.824 . . . . 0.0 111.412 170.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . 0.282 26.0 p 61.22 -53.53 0.11 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 128.177 2.591 . . . . 0.0 114.813 -171.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.0 t 60.36 -178.82 0.1 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 127.579 2.352 . . . . 0.0 115.07 173.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -71.6 166.18 22.4 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 126.531 1.933 . . . . 0.0 112.375 172.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.1 m -62.54 117.83 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 169.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.479 ' H ' ' HB2' ' A' ' 12' ' ' SER . 56.0 t-80 -76.14 132.46 73.61 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 124.033 0.933 . . . . 0.0 113.141 -168.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -57.73 -41.93 65.07 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.484 2.789 . . . . 0.0 114.059 -170.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.6 m -77.68 -35.46 52.24 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.797 -0.564 . . . . 0.0 110.864 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.74 -43.14 94.33 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.327 -0.844 . . . . 0.0 111.942 173.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.7 mt -54.06 -46.54 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 120.34 1.427 . . . . 0.0 109.717 174.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.38 -60.01 4.38 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.4 mmt -66.71 -29.7 69.75 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.414 -0.804 . . . . 0.0 112.13 -172.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 75.4 mmm -80.43 -40.0 27.17 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.668 0.787 . . . . 0.0 110.364 178.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -58.33 -37.31 74.87 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.588 -1.32 . . . . 0.0 112.315 171.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -59.71 -23.8 63.46 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.3 m -105.19 16.0 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 124.715 1.206 . . . . 0.0 114.021 172.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.01 13.65 66.04 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.398 0.999 . . . . 0.0 115.029 177.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.9 mt -120.72 68.81 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.032 1.733 . . . . 0.0 109.601 -169.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -65.17 105.14 1.02 Allowed 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.231 -1.543 . . . . 0.0 110.668 174.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.1 pt -81.2 -0.42 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 O-C-N 121.528 -0.733 . . . . 0.0 112.815 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 85.1 p -71.67 -28.35 63.67 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.399 -1.438 . . . . 0.0 114.043 -172.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.28 2.93 71.88 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 125.332 1.444 . . . . 0.0 114.432 171.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -86.4 159.16 19.44 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.463 1.505 . . . . 0.0 112.202 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.8 t -87.73 152.63 21.99 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -170.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.3 m -139.36 134.8 32.99 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.362 1.465 . . . . 0.0 110.398 169.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -142.26 142.69 24.81 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 123.979 0.912 . . . . 0.0 111.066 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -81.0 150.52 18.07 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.186 2.591 . . . . 0.0 112.714 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.3 tt -64.5 -18.25 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -172.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -95.86 -9.1 32.32 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -95.68 -36.32 11.25 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.095 0.958 . . . . 0.0 111.2 169.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -67.9 161.49 26.3 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.315 0.579 . . . . 0.0 111.609 174.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -135.78 122.23 20.66 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.338 1.055 . . . . 0.0 110.505 174.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.44 -0.35 10.16 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -171.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -70.49 -32.88 70.57 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.265 0.939 . . . . 0.0 113.421 -169.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -77.34 -21.01 54.02 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -105.27 90.9 3.57 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.003 1.321 . . . . 0.0 110.448 -169.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -58.08 -30.13 65.99 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.21 108.26 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.385 1.074 . . . . 0.0 109.874 -177.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.8 t -112.13 132.65 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.16 0.984 . . . . 0.0 109.81 177.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.6 mm -128.59 118.22 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 123.556 0.742 . . . . 0.0 110.374 -170.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 t -78.88 136.16 37.22 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.536 0.684 . . . . 0.0 109.346 168.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.6 mt -108.58 23.8 13.99 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.342 1.057 . . . . 0.0 109.848 169.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.8 p . . . . . 0 CA--C 1.544 0.727 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 -174.904 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 CA--C 1.547 0.851 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -59.57 137.34 76.98 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.902 2.401 . . . . 0.0 110.074 169.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -59.0 -33.86 98.94 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.241 1.961 . . . . 0.0 113.33 -174.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -65.41 -25.69 67.65 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.774 1.17 . . . . 0.0 113.974 176.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.72 -19.8 54.6 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.761 -1.212 . . . . 0.0 112.573 171.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.7 t -89.63 -37.28 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.834 1.654 . . . . 0.0 112.087 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.7 p -83.46 18.14 1.93 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -173.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -69.0 166.49 17.9 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.147 0.979 . . . . 0.0 111.519 169.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -53.16 -40.84 64.61 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -169.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 63.4 mt -129.4 126.65 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.664 1.186 . . . . 0.0 109.791 169.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -131.03 125.21 32.67 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.671 1.188 . . . . 0.0 109.929 169.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -140.96 166.16 25.56 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.906 1.282 . . . . 0.0 112.115 -175.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -129.81 134.38 47.52 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.087 1.355 . . . . 0.0 112.306 173.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 46.8 m0 -96.29 0.71 51.23 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 64.63 33.45 10.63 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.829 1.251 . . . . 0.0 114.275 170.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 26.7 mt -90.66 166.43 13.17 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -119.65 148.9 42.81 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.684 1.994 . . . . 0.0 111.178 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.74 119.13 76.12 Favored Pre-proline 0 CA--C 1.55 0.971 0 O-C-N 121.402 -0.812 . . . . 0.0 110.984 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -85.85 -10.19 7.29 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.234 1.956 . . . . 0.0 115.338 -173.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -47.74 113.81 0.78 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.927 1.291 . . . . 0.0 112.938 177.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.04 -3.65 84.57 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 123.978 0.799 . . . . 0.0 114.289 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -78.45 169.52 18.11 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.143 0.972 . . . . 0.0 110.044 169.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 97.2 p -64.13 156.82 27.22 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.383 -0.823 . . . . 0.0 111.903 173.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.9 -30.96 70.49 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.413 -0.804 . . . . 0.0 111.695 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -64.48 -36.34 83.87 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 120.957 -1.089 . . . . 0.0 113.388 173.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.5 t -73.7 -36.65 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 O-C-N 121.061 -1.024 . . . . 0.0 110.272 173.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.54 -40.03 95.95 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.805 0.842 . . . . 0.0 110.675 175.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -67.03 -42.49 84.77 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.046 1.738 . . . . 0.0 111.961 172.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.9 m -58.5 -50.72 72.74 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.402 1.081 . . . . 0.0 111.938 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 19.7 m -67.7 -31.81 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 119.389 0.995 . . . . 0.0 111.699 179.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.2 ptt-85 -70.44 -30.72 67.63 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 120.255 1.389 . . . . 0.0 112.954 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.58 -43.64 96.22 Favored Glycine 0 N--CA 1.477 1.429 0 C-N-CA 123.797 0.713 . . . . 0.0 111.998 169.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -62.61 -38.25 89.47 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.63 -0.923 . . . . 0.0 112.456 170.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.7 t -60.23 -50.41 80.34 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.595 173.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -53.13 -52.73 57.77 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 120.177 1.353 . . . . 0.0 111.79 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -48.31 -44.81 34.36 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.468 1.507 . . . . 0.0 112.352 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -90.91 -28.87 17.82 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.125 0.97 . . . . 0.0 112.022 -171.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.8 t -63.91 -50.07 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.916 1.286 . . . . 0.0 109.569 169.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -53.4 -55.27 26.44 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.663 0.665 . . . . 0.0 109.292 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -50.89 -36.69 39.45 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.107 1.763 . . . . 0.0 113.376 174.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -84.78 -61.53 1.76 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.609 1.095 . . . . 0.0 113.513 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -57.49 -33.33 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.751 1.62 . . . . 0.0 111.599 -177.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.5 -10.48 59.84 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 44.7 mttm -80.15 -20.12 45.66 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.596 1.158 . . . . 0.0 112.425 169.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.1 pt -122.23 28.27 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 127.309 2.243 . . . . 0.0 111.569 -176.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 24.3 t . . . . . 0 C--O 1.252 1.228 0 C-N-CA 127.633 2.373 . . . . 0.0 111.114 179.141 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.502 2.166 0 CA-C-O 119.378 -0.344 . . . . 0.0 111.87 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -84.51 99.66 10.86 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 118.995 0.816 . . . . 0.0 110.115 174.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -75.41 147.85 39.63 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.741 0.417 . . . . 0.0 111.855 -174.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.6 t -104.92 140.08 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.464 1.106 . . . . 0.0 110.635 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 49.3 tpp -127.15 113.97 17.08 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.586 0.755 . . . . 0.0 110.331 169.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -81.49 143.35 32.13 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.39 0.676 . . . . 0.0 110.315 169.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.4 t -134.86 123.95 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.443 1.497 . . . . 0.0 110.558 -178.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 p -136.32 170.9 15.28 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.472 1.109 . . . . 0.0 111.162 171.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -58.46 -53.94 52.66 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 120.342 1.428 . . . . 0.0 110.16 175.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -93.87 121.76 35.66 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 168.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.589 ' ND2' ' H ' ' A' ' 63' ' ' ASP . 23.0 t-20 -47.12 -41.36 17.29 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 121.406 1.912 . . . . 0.0 110.713 169.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.6 p -66.59 -35.89 81.31 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.888 1.675 . . . . 0.0 114.868 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 95.1 p -65.69 -37.07 85.45 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -169.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.27 -43.92 0.41 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.8 m -63.11 -42.68 99.62 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 119.731 1.15 . . . . 0.0 113.009 -169.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -57.63 -40.96 80.37 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.292 1.837 . . . . 0.0 112.456 169.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 94.7 mtp -64.87 -43.03 94.31 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.283 0.633 . . . . 0.0 110.488 175.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.14 -29.69 67.78 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 117.701 -1.142 . . . . 0.0 113.409 173.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -70.43 -48.3 56.67 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 121.45 1.932 . . . . 0.0 108.48 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.73 -46.24 94.37 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.607 -1.107 . . . . 0.0 113.676 176.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -66.96 -34.12 77.06 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.542 1.671 . . . . 0.0 112.378 175.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.447 ' HB1' HG11 ' A' ' 32' ' ' VAL . . . -75.05 -33.6 61.74 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.88 -1.137 . . . . 0.0 110.639 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -60.41 -56.21 24.24 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 125.621 1.569 . . . . 0.0 109.444 170.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.0 p -70.3 -11.01 60.61 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.6 mt -98.1 -5.47 33.66 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 171.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.59 17.4 0.08 OUTLIER Glycine 0 CA--C 1.536 1.368 0 N-CA-C 118.661 2.224 . . . . 0.0 118.661 -172.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.73 -33.25 64.08 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.848 1.824 . . . . 0.0 114.511 -173.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.36 -6.15 88.95 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 124.161 0.886 . . . . 0.0 115.043 177.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -101.1 -59.17 1.74 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.958 1.303 . . . . 0.0 112.003 -170.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.5 pp -143.84 171.91 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 127.345 2.258 . . . . 0.0 110.536 -174.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.53 131.99 42.58 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.409 -0.807 . . . . 0.0 112.9 175.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.447 HG11 ' HB1' ' A' ' 22' ' ' ALA . 28.9 m -104.28 149.37 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 C-N-CA 125.09 1.356 . . . . 0.0 113.259 171.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.53 144.87 27.6 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.413 0.685 . . . . 0.0 112.382 -173.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.0 t -114.24 129.44 56.63 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.976 2.111 . . . . 0.0 113.799 175.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 t -132.33 177.02 7.91 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.505 1.922 . . . . 0.0 110.764 171.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.55 175.08 46.11 Favored Glycine 0 CA--C 1.523 0.557 0 O-C-N 120.572 -1.33 . . . . 0.0 114.286 171.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.0 mt -67.39 -27.39 67.05 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 122.275 -0.544 . . . . 0.0 111.829 -176.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -123.48 115.56 21.76 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.157 2.183 . . . . 0.0 105.765 169.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 77.3 p -62.31 -20.37 64.25 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.314 -0.866 . . . . 0.0 113.076 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.6 t 54.83 -149.91 0.43 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.773 1.629 . . . . 0.0 113.905 168.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.68 165.11 28.39 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 128.244 2.618 . . . . 0.0 110.052 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 m -67.34 102.12 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 169.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -70.26 135.59 86.79 Favored Pre-proline 0 N--CA 1.476 0.841 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.936 -169.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -60.31 -36.79 86.2 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.911 2.407 . . . . 0.0 113.618 -171.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.2 m -77.56 -33.44 54.04 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.543 -0.723 . . . . 0.0 111.193 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.75 -44.32 81.79 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.053 0.842 . . . . 0.0 111.761 170.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 74.7 mt -50.97 -47.07 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 120.343 1.429 . . . . 0.0 110.337 173.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.54 -63.74 1.13 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 31.9 mmt -68.81 -24.43 64.39 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.45 -0.781 . . . . 0.0 112.942 -170.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 80.7 mmm -79.54 -35.74 39.43 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.732 0.696 . . . . 0.0 110.803 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -61.09 -30.88 70.62 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.631 -1.293 . . . . 0.0 112.693 171.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -54.35 -37.31 64.77 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.207 0.912 . . . . 0.0 112.755 172.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.2 m -98.16 15.2 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.58 1.152 . . . . 0.0 113.914 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.03 13.01 67.16 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.115 0.864 . . . . 0.0 115.029 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.6 mt -119.49 70.34 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.63 1.572 . . . . 0.0 109.709 -169.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -66.13 108.96 2.43 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 119.995 -1.691 . . . . 0.0 110.56 171.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.7 pt -84.52 -4.74 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.0 t -61.86 -32.68 73.05 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 120.382 1.446 . . . . 0.0 112.912 -170.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.32 4.51 80.49 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.03 1.3 . . . . 0.0 115.383 173.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -87.77 149.0 24.45 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.017 1.408 . . . . 0.0 112.36 -172.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.8 t -76.08 157.08 33.3 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.0 p -139.21 154.7 48.06 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.185 1.394 . . . . 0.0 109.847 169.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.589 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -146.88 149.98 37.7 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.387 1.075 . . . . 0.0 111.62 -175.099 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -88.79 152.61 6.07 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.637 2.891 . . . . 0.0 111.335 174.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.6 tp -60.23 -21.53 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.31 1.444 . . . . 0.0 114.863 -177.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -97.6 -9.1 27.53 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -92.08 -38.77 12.0 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 118.891 0.769 . . . . 0.0 111.609 172.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.0 158.24 36.0 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.388 0.613 . . . . 0.0 111.192 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -138.13 115.82 11.4 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.778 1.231 . . . . 0.0 109.476 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.5 0.18 5.65 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 -169.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -70.04 -29.12 66.08 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.715 1.143 . . . . 0.0 112.328 -172.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -87.43 -2.8 58.87 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.008 1.323 . . . . 0.0 113.062 175.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -124.88 83.29 2.14 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.106 1.762 . . . . 0.0 109.5 -171.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -57.76 -19.13 25.78 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.18 0.992 . . . . 0.0 113.404 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.3 t -121.03 113.9 41.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.46 1.504 . . . . 0.0 109.931 -177.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.6 t -127.42 133.79 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 121.501 -0.749 . . . . 0.0 110.199 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.454 HG21 ' CE2' ' A' ' 99' ' ' TRP . 24.2 mm -129.09 133.21 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 121.567 -0.708 . . . . 0.0 111.21 -169.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.7 t -92.7 119.4 32.06 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.798 1.639 . . . . 0.0 110.835 173.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.435 ' CD1' HG22 ' A' ' 77' ' ' ILE . 1.3 mp -103.33 27.96 6.82 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.21 1.804 . . . . 0.0 111.327 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.4 p . . . . . 0 CA--C 1.543 0.706 0 C-N-CA 126.465 1.906 . . . . 0.0 109.827 169.823 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.6 mt . . . . . 0 CA--C 1.549 0.905 0 CA-C-O 119.217 -0.42 . . . . 0.0 111.394 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.65 138.57 86.73 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.747 2.298 . . . . 0.0 111.51 172.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.1 -38.48 45.42 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.466 2.111 . . . . 0.0 112.595 -169.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.93 -23.96 65.13 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.121 -0.987 . . . . 0.0 113.586 176.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -78.69 -9.6 59.46 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.699 -1.251 . . . . 0.0 112.949 169.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.5 t -100.78 -41.66 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 126.513 1.925 . . . . 0.0 111.481 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.1 p -80.52 28.98 0.31 Allowed 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -172.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -79.29 170.47 16.58 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.955 1.302 . . . . 0.0 111.99 170.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -57.79 -36.6 72.4 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.125 0.97 . . . . 0.0 113.496 -170.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 61.9 mt -128.01 125.65 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.909 1.284 . . . . 0.0 109.59 170.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -135.71 138.96 43.28 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.041 0.937 . . . . 0.0 111.479 169.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -143.26 146.71 33.86 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.128 1.371 . . . . 0.0 112.03 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -109.35 116.84 32.6 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.175 1.39 . . . . 0.0 109.586 169.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.454 ' CE2' HG21 ' A' ' 77' ' ' ILE . 45.8 m0 -94.08 -6.95 43.92 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.331 1.2 pp0? 50.12 30.28 4.12 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 176.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.5 mt -73.04 150.05 42.69 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -86.07 158.9 19.71 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.872 1.669 . . . . 0.0 113.016 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -81.89 128.42 68.67 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.848 1.259 . . . . 0.0 112.866 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -88.24 -38.58 0.06 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.61 2.207 . . . . 0.0 113.595 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 19.43 51.35 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 131.622 3.969 . . . . 0.0 117.786 169.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.36 11.56 79.79 Favored Glycine 0 CA--C 1.539 1.588 0 O-C-N 120.797 -1.189 . . . . 0.0 115.046 176.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -63.37 -52.89 59.82 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.807 1.243 . . . . 0.0 111.076 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 34.1 t -168.48 153.56 6.38 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.742 2.017 . . . . 0.0 109.627 169.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.5 mp -56.85 -31.84 65.2 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.982 0.913 . . . . 0.0 110.999 172.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.56 -39.83 74.12 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.978 1.311 . . . . 0.0 112.568 173.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.6 t -73.16 -38.11 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 121.503 -0.748 . . . . 0.0 109.668 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -63.86 -44.58 92.67 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.265 0.484 . . . . 0.0 111.463 175.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -64.35 -39.12 93.27 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.514 1.126 . . . . 0.0 111.74 176.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.1 m -62.51 -52.84 61.88 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.012 0.925 . . . . 0.0 111.469 173.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.5 m -72.69 -29.71 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 117.047 -1.454 . . . . 0.0 112.78 -177.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.9 ptt85 -64.16 -37.12 86.33 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 121.805 2.093 . . . . 0.0 112.181 171.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.55 -48.99 77.65 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.886 0.755 . . . . 0.0 112.316 173.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -59.81 -45.58 91.89 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 117.586 0.693 . . . . 0.0 112.407 173.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.9 t -58.67 -46.88 90.2 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.495 0 CA-C-O 117.843 -1.075 . . . . 0.0 110.169 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -52.12 -53.57 41.08 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.044 1.293 . . . . 0.0 111.853 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -58.3 -45.66 87.59 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.098 0.475 . . . . 0.0 111.854 -178.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -75.11 -33.5 61.61 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 36.4 t -63.13 -47.91 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.97 1.308 . . . . 0.0 111.03 169.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -53.77 -55.71 23.95 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.523 1.056 . . . . 0.0 109.481 174.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -53.33 -26.2 17.99 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.059 1.344 . . . . 0.0 113.545 177.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -91.68 -62.27 1.46 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.277 1.431 . . . . 0.0 112.945 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.84 -31.03 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.581 1.552 . . . . 0.0 111.551 -176.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.52 -7.22 54.7 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -74.06 -27.79 61.09 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.6 1.16 . . . . 0.0 112.693 169.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.4 pt -117.26 -7.91 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.616 1.966 . . . . 0.0 113.555 -171.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 C--O 1.255 1.391 0 C-N-CA 125.261 1.424 . . . . 0.0 112.458 172.426 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 ttm . . . . . 0 N--CA 1.502 2.159 0 CA-C-O 119.653 -0.213 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -90.32 90.25 7.98 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.257 1.023 . . . . 0.0 110.487 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -80.94 149.24 29.47 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 121.573 -0.704 . . . . 0.0 112.232 -174.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.2 t -115.09 143.41 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.663 1.185 . . . . 0.0 111.124 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.1 tpp -130.62 122.68 27.88 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.248 1.019 . . . . 0.0 111.019 169.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -93.22 138.67 31.39 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.509 -0.744 . . . . 0.0 110.597 169.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.8 t -134.41 130.5 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.984 1.314 . . . . 0.0 110.384 -171.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 t -151.8 -165.67 2.29 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.439 0.696 . . . . 0.0 112.542 169.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -63.0 -70.54 0.2 Allowed 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 119.406 1.003 . . . . 0.0 111.045 170.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 56.6 mtt-85 -79.07 127.76 32.41 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 118.569 0.622 . . . . 0.0 109.955 169.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.598 ' ND2' ' H ' ' A' ' 63' ' ' ASP . 19.2 t-20 -61.06 -43.37 98.98 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 168.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 99.3 p -73.97 -48.26 31.69 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -169.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.0 p -83.29 -11.23 57.95 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.763 -1.211 . . . . 0.0 113.695 -173.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 -126.63 -67.42 0.86 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.788 1.235 . . . . 0.0 111.734 -176.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.3 m -64.21 -44.51 91.68 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.16 1.171 . . . . 0.0 114.16 -175.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -57.5 -30.68 65.31 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.832 1.253 . . . . 0.0 113.792 170.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.1 mtm -68.17 -49.36 61.44 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.072 0.851 . . . . 0.0 110.92 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.72 -29.93 70.04 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.622 -0.674 . . . . 0.0 112.686 172.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -71.23 -44.22 65.78 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 119.691 1.132 . . . . 0.0 109.269 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.96 -41.31 98.7 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 119.299 -0.723 . . . . 0.0 112.073 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -62.73 -44.24 96.73 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.885 1.342 . . . . 0.0 111.719 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.82 -32.79 69.97 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 120.574 -1.329 . . . . 0.0 111.224 -174.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -64.91 -56.3 14.14 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 126.432 1.893 . . . . 0.0 109.449 171.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.3 p -68.08 -14.93 63.35 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 52.7 mt -100.74 -8.16 23.04 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.454 1.102 . . . . 0.0 113.816 174.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.58 10.55 1.27 Allowed Glycine 0 CA--C 1.534 1.273 0 N-CA-C 117.181 1.632 . . . . 0.0 117.181 -169.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.98 131.01 46.19 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.16 1.48 . . . . 0.0 112.067 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.47 -6.44 57.66 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.528 1.061 . . . . 0.0 115.531 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -86.25 -61.32 1.77 Allowed 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 119.296 1.548 . . . . 0.0 110.339 175.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -142.75 173.01 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 127.667 2.387 . . . . 0.0 110.316 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.75 130.02 41.45 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.366 -0.834 . . . . 0.0 112.314 175.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.7 m -104.15 153.04 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.716 1.206 . . . . 0.0 112.478 170.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.19 145.7 27.27 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -171.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.1 t -110.33 133.49 53.2 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.835 2.054 . . . . 0.0 113.615 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.8 t -141.84 171.33 14.2 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.521 1.928 . . . . 0.0 110.949 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.59 -179.82 45.66 Favored Glycine 0 CA--C 1.526 0.778 0 O-C-N 120.883 -1.136 . . . . 0.0 114.567 169.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 38.0 mt -63.19 -26.7 68.93 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.23 1.012 . . . . 0.0 112.074 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -128.34 127.43 42.67 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.19 1.396 . . . . 0.0 109.09 170.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.6 p -77.48 58.04 1.65 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.262 1.425 . . . . 0.0 110.492 171.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.4 p -65.9 156.62 32.87 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 114.146 -1.388 . . . . 0.0 112.818 -169.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -64.74 144.64 57.1 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.251 1.02 . . . . 0.0 109.981 177.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.7 m -41.23 109.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.852 1.661 . . . . 0.0 109.082 170.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -68.03 132.31 92.06 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-O 118.383 -0.817 . . . . 0.0 112.82 -167.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.31 -39.15 80.17 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.372 2.715 . . . . 0.0 113.566 -170.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.0 m -78.05 -37.06 47.66 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 119.151 -0.452 . . . . 0.0 110.496 177.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.67 -40.78 96.02 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.626 1.103 . . . . 0.0 112.475 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.4 mt -52.38 -47.17 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 120.98 1.718 . . . . 0.0 109.927 172.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.82 -58.38 8.68 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 175.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.6 mmt -66.18 -22.0 66.34 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 88.5 mmm -90.93 -37.36 13.58 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.941 0.896 . . . . 0.0 110.592 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -60.89 -33.89 73.81 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.407 -1.433 . . . . 0.0 112.319 169.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -56.0 -30.06 61.26 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.036 0.934 . . . . 0.0 113.313 173.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.4 m -103.41 13.64 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.857 1.263 . . . . 0.0 114.155 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.13 17.2 63.32 Favored Glycine 0 CA--C 1.537 1.467 0 O-C-N 121.209 -0.932 . . . . 0.0 115.106 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.1 mt -122.54 79.68 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.977 1.711 . . . . 0.0 109.631 -169.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -70.28 106.59 3.4 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.053 -1.655 . . . . 0.0 111.185 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.1 pt -82.3 -10.14 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 118.166 -0.921 . . . . 0.0 112.576 175.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.5 t -61.85 -33.15 73.66 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 120.3 1.409 . . . . 0.0 113.029 -169.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -95.94 6.52 66.91 Favored Glycine 0 CA--C 1.541 1.674 0 C-N-CA 125.098 1.333 . . . . 0.0 115.294 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -93.32 151.27 19.89 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.028 1.414 . . . . 0.0 111.477 -171.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.6 t -68.25 149.98 48.83 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -170.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.8 t -135.81 133.24 37.67 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.36 1.464 . . . . 0.0 109.183 169.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.598 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 4.1 t70 -148.21 146.22 22.65 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.696 1.598 . . . . 0.0 110.836 -172.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -91.15 154.46 3.82 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.574 2.183 . . . . 0.0 112.65 -173.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.3 tt -60.66 -21.42 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -94.06 -9.58 36.24 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -94.51 -37.44 11.39 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.785 0.834 . . . . 0.0 111.816 170.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.58 163.18 27.5 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.26 0.552 . . . . 0.0 111.644 174.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -139.38 134.1 31.99 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.015 0.926 . . . . 0.0 110.633 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.62 6.87 6.41 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -174.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -74.31 -30.86 62.25 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.068 -1.02 . . . . 0.0 112.594 -173.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -88.86 -3.74 58.67 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.657 1.183 . . . . 0.0 113.6 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -123.72 94.01 4.11 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.739 1.616 . . . . 0.0 110.151 -171.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -62.75 -18.9 63.37 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.0 t -120.09 114.74 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.812 1.245 . . . . 0.0 110.472 -176.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.3 t -127.9 129.88 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.995 0.918 . . . . 0.0 110.814 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.5 mm -116.35 125.29 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.301 0.641 . . . . 0.0 111.56 -172.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.0 t -86.11 92.12 8.63 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.379 1.472 . . . . 0.0 109.155 169.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.9 mt -76.94 -11.04 59.75 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.884 0.873 . . . . 0.0 112.158 171.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 27.5 p . . . . . 0 CA--C 1.547 0.833 0 C-N-CA 123.586 0.755 . . . . 0.0 111.673 169.16 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.0 mt . . . . . 0 CA--C 1.547 0.845 0 CA-C-O 119.081 -0.485 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.86 136.68 75.26 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.326 2.018 . . . . 0.0 110.645 169.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -64.22 -29.55 64.43 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.485 2.123 . . . . 0.0 112.63 -176.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -61.37 -28.68 69.41 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 171.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.35 13.28 13.95 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.829 1.252 . . . . 0.0 114.163 171.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.6 t -114.1 -37.19 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.666 1.587 . . . . 0.0 111.416 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -81.04 27.09 0.41 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 115.297 1.592 . . . . 0.0 115.297 -169.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -77.11 165.7 24.25 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.822 1.649 . . . . 0.0 112.64 173.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -56.23 -38.23 70.8 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.776 1.23 . . . . 0.0 113.008 -172.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.0 mt -127.48 116.99 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.14 1.376 . . . . 0.0 108.704 169.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -128.14 128.44 44.82 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.191 0.997 . . . . 0.0 109.881 169.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -137.29 140.0 41.28 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.613 0.765 . . . . 0.0 113.007 -170.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -97.9 104.59 16.63 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.265 1.826 . . . . 0.0 112.173 176.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 16.2 m0 -95.2 92.14 6.63 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 169.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -60.92 54.43 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 128.277 2.631 . . . . 0.0 115.718 176.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 77.3 mt -76.43 167.71 21.37 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.036 2.134 . . . . 0.0 111.841 175.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -96.73 153.89 17.61 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.748 1.219 . . . . 0.0 110.628 169.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -77.31 120.24 80.75 Favored Pre-proline 0 CA--C 1.546 0.809 0 O-C-N 120.88 -1.138 . . . . 0.0 111.114 172.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -87.13 -19.29 2.54 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.466 1.444 . . . . 0.0 114.957 -170.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -53.42 107.41 0.24 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.635 1.174 . . . . 0.0 112.092 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.04 -0.94 69.78 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.288 0.947 . . . . 0.0 114.62 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -77.95 172.15 13.91 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 118.316 1.058 . . . . 0.0 110.18 169.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 90.4 p -66.35 156.68 33.8 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.045 -1.034 . . . . 0.0 111.557 169.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.92 -27.58 68.95 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.306 -0.871 . . . . 0.0 111.862 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.2 -40.73 86.69 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.128 -0.983 . . . . 0.0 112.354 170.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 78.7 t -74.04 -37.73 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.371 -0.831 . . . . 0.0 110.416 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.59 -41.56 99.03 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.515 0.726 . . . . 0.0 111.075 176.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -69.55 -37.54 77.1 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.715 1.206 . . . . 0.0 112.29 171.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 55.3 m -58.3 -49.09 78.38 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 119.157 0.89 . . . . 0.0 111.589 176.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 31.2 m -67.22 -30.68 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 119.934 1.243 . . . . 0.0 111.719 177.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.416 ' HA ' HG22 ' A' ' 119' ' ' VAL . 0.1 OUTLIER -60.37 -46.54 89.58 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 119.811 1.187 . . . . 0.0 111.318 169.592 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.53 -35.66 92.33 Favored Glycine 0 N--CA 1.472 1.054 0 C-N-CA 123.823 0.725 . . . . 0.0 112.153 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -68.46 -51.43 43.57 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 171.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.416 HG22 ' HA ' ' A' ' 116' ' ' ARG . 3.6 m -61.26 -39.68 83.43 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 CA-C-O 117.372 -1.299 . . . . 0.0 111.179 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -47.92 -57.5 5.63 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.331 1.423 . . . . 0.0 111.898 174.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -63.67 -41.78 98.15 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.274 0.629 . . . . 0.0 112.387 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 59.1 mtp85 -73.77 -34.74 64.82 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.87 -47.97 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.271 1.428 . . . . 0.0 111.465 171.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -52.63 -54.41 33.66 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.454 1.025 . . . . 0.0 109.563 177.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -55.56 -38.83 69.83 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.063 1.345 . . . . 0.0 112.668 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -73.1 -56.93 4.44 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.169 -0.957 . . . . 0.0 112.454 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -67.77 -34.22 66.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.014 1.326 . . . . 0.0 112.115 -176.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.21 -17.02 60.95 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -173.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -72.94 -22.07 60.78 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.39 1.076 . . . . 0.0 113.649 171.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.0 pt -118.37 11.29 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.3 1.84 . . . . 0.0 112.925 -175.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.19 1.796 . . . . 0.0 112.332 177.572 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.5 ttm . . . . . 0 N--CA 1.504 2.249 0 CA-C-O 119.246 -0.407 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -77.64 100.89 6.34 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 119.117 0.871 . . . . 0.0 110.74 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -86.6 136.06 33.19 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.111 1.764 . . . . 0.0 111.763 -172.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.4 t -114.64 143.06 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 124.176 0.991 . . . . 0.0 111.793 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.4 ' HG2' ' CZ ' ' A' ' 68' ' ' PHE . 48.2 tpp -131.05 125.06 32.23 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.277 1.031 . . . . 0.0 111.602 169.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -93.05 136.84 32.94 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.533 0.733 . . . . 0.0 110.48 169.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 t -130.61 130.15 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.38 1.472 . . . . 0.0 110.2 -174.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.8 p -149.14 176.42 10.5 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.989 0.916 . . . . 0.0 112.628 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -63.93 -46.79 83.21 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.904 -1.122 . . . . 0.0 111.251 171.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.406 ' HB3' ' H ' ' A' ' 13' ' ' SER . 1.0 OUTLIER -109.26 111.66 23.38 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.358 1.463 . . . . 0.0 109.791 169.326 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.515 ' ND2' ' H ' ' A' ' 63' ' ' ASP . 58.8 t-20 -57.56 -46.95 83.32 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 169.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.6 p -43.48 -46.59 6.91 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 174.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.406 ' H ' ' HB3' ' A' ' 10' ' ' ARG . 27.3 p -97.44 -16.12 20.32 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.05 1.129 . . . . 0.0 114.05 -172.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -130.94 -62.63 0.89 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 119.738 1.153 . . . . 0.0 113.979 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.8 m -61.34 -35.08 76.42 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 120.118 1.326 . . . . 0.0 112.953 -177.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -62.98 -38.19 90.15 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.722 1.209 . . . . 0.0 113.446 169.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 84.9 mtp -64.29 -48.79 74.35 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.445 1.021 . . . . 0.0 110.714 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.07 -28.45 68.85 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 175.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -75.27 -41.52 57.03 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 119.72 1.145 . . . . 0.0 109.067 -178.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.66 -45.0 96.7 Favored Glycine 0 CA--C 1.52 0.37 0 CA-C-O 119.345 -0.697 . . . . 0.0 112.425 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -64.55 -43.81 92.79 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.851 1.326 . . . . 0.0 112.065 172.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.56 -32.49 69.92 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.454 -1.404 . . . . 0.0 111.767 -175.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -64.89 -55.63 18.17 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 125.332 1.453 . . . . 0.0 109.425 170.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.1 p -73.12 -8.92 57.9 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.587 -1.32 . . . . 0.0 114.523 -176.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 51.7 mt -100.28 -5.75 27.0 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.48 1.112 . . . . 0.0 113.701 170.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.29 15.2 0.1 OUTLIER Glycine 0 CA--C 1.537 1.417 0 N-CA-C 118.609 2.204 . . . . 0.0 118.609 -171.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.22 -33.67 67.77 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.162 1.981 . . . . 0.0 114.308 -172.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.43 -5.5 89.93 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.257 0.932 . . . . 0.0 115.029 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -100.77 -63.01 1.17 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.862 1.265 . . . . 0.0 111.409 -172.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -141.87 173.34 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 126.128 1.771 . . . . 0.0 112.122 -175.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.93 123.22 36.04 Favored 'General case' 0 C--N 1.343 0.291 0 O-C-N 121.368 -0.832 . . . . 0.0 112.502 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.0 m -101.47 151.97 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.05 0.94 . . . . 0.0 111.67 169.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.65 152.38 37.76 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.15 0.58 . . . . 0.0 111.544 -173.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.5 p -120.69 141.47 50.38 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.661 1.585 . . . . 0.0 114.731 175.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.3 t -145.99 167.54 23.07 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 127.308 2.243 . . . . 0.0 110.005 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.87 171.46 38.32 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 120.73 -1.231 . . . . 0.0 114.803 169.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 35.0 mt -62.12 -40.28 95.38 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.738 0.815 . . . . 0.0 111.477 -173.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -120.55 116.6 25.7 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 127.879 2.472 . . . . 0.0 105.874 169.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.7 p -67.21 -49.19 65.5 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.128 -0.982 . . . . 0.0 110.41 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.4 t 53.64 -173.26 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 127.031 2.132 . . . . 0.0 113.838 -174.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -80.86 177.8 8.81 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 127.051 2.14 . . . . 0.0 113.005 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.4 m -66.44 116.69 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 120.596 -1.315 . . . . 0.0 107.639 168.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -66.36 128.09 93.65 Favored Pre-proline 0 N--CA 1.478 0.934 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -168.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.64 -39.23 55.53 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.265 2.644 . . . . 0.0 113.994 -169.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.4 ' HB ' ' CE2' ' A' ' 112' ' ' PHE . 28.4 m -80.48 -32.65 37.01 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 122.023 -0.423 . . . . 0.0 110.629 178.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.67 -38.07 86.06 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.011 -1.056 . . . . 0.0 112.375 174.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 65.1 mt -53.02 -42.18 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 120.634 1.561 . . . . 0.0 110.559 172.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.86 -61.23 2.3 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.355 0.662 . . . . 0.0 112.702 173.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.4 mmt -66.08 -24.18 66.66 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -172.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 79.3 mmm -87.78 -33.9 18.5 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.976 0.91 . . . . 0.0 110.95 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -60.84 -32.74 72.13 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.704 -1.247 . . . . 0.0 111.901 169.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -54.41 -31.58 55.41 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.326 -0.859 . . . . 0.0 113.232 173.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.1 m -104.0 14.27 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 175.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.52 13.35 65.51 Favored Glycine 0 CA--C 1.536 1.365 0 O-C-N 120.984 -1.072 . . . . 0.0 115.224 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.5 mt -118.36 71.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.803 1.641 . . . . 0.0 109.411 -169.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -64.07 110.69 2.24 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 120.34 -1.475 . . . . 0.0 110.218 172.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 pt -92.73 4.33 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.326 0.65 . . . . 0.0 112.627 178.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.3 p -68.4 -22.62 64.62 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.492 1.496 . . . . 0.0 113.855 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.5 8.24 62.03 Favored Glycine 0 CA--C 1.541 1.712 0 C-N-CA 125.548 1.547 . . . . 0.0 114.353 169.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -76.0 139.71 41.63 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.556 1.178 . . . . 0.0 111.274 -174.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.1 t -64.78 156.35 30.87 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.262 0.553 . . . . 0.0 111.588 169.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.0 t -143.57 127.99 17.89 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 169.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.515 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -124.64 142.23 40.07 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.593 1.157 . . . . 0.0 111.305 -174.978 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -87.58 152.87 7.63 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.611 2.874 . . . . 0.0 111.368 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.0 tt -60.91 -29.86 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -169.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -94.85 -6.92 41.67 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -80.91 -38.51 27.81 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.477 -0.764 . . . . 0.0 110.592 169.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.4 ' CZ ' ' HG2' ' A' ' 5' ' ' MET . 0.0 OUTLIER -77.22 160.09 29.18 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.375 1.07 . . . . 0.0 111.716 172.45 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.63 116.5 14.12 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.899 1.28 . . . . 0.0 109.612 174.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.97 -3.85 6.01 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 -169.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -67.44 -30.56 70.33 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.3 0.954 . . . . 0.0 113.431 -169.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -84.3 -8.78 58.91 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 176.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -104.72 100.4 10.05 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 120.898 -1.127 . . . . 0.0 110.12 -169.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -52.19 -33.74 42.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.279 1.431 . . . . 0.0 112.736 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.0 t -125.41 122.75 63.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 125.385 1.474 . . . . 0.0 110.003 -174.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.0 t -124.05 130.43 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.671 0.788 . . . . 0.0 109.86 175.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 50.1 mm -125.45 123.12 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 123.927 0.891 . . . . 0.0 110.687 -169.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.8 t -82.2 137.4 34.92 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 168.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.401 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 76.5 mt -110.03 28.25 8.79 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.871 1.268 . . . . 0.0 109.857 170.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.1 t . . . . . 0 CA--C 1.542 0.641 0 C-N-CA 125.322 1.449 . . . . 0.0 113.307 -169.73 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 CA--C 1.55 0.975 0 CA-C-O 119.233 -0.413 . . . . 0.0 111.721 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -58.77 163.69 10.8 Favored 'Trans proline' 0 CA--C 1.551 1.34 0 C-N-CA 123.716 2.944 . . . . 0.0 113.608 171.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.81 -52.74 1.16 Allowed 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.521 2.147 . . . . 0.0 113.784 -171.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -60.18 -36.61 78.01 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 120.664 -1.272 . . . . 0.0 111.897 177.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -63.89 7.01 0.13 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 127.928 2.491 . . . . 0.0 115.046 170.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.1 t -134.86 -42.7 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 127.109 2.164 . . . . 0.0 111.525 175.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.7 p -79.9 32.64 0.26 Allowed 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -169.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -85.47 168.8 14.22 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.374 1.069 . . . . 0.0 112.187 172.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -57.06 -36.1 70.13 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -169.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.4 mt -125.87 125.58 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.772 1.229 . . . . 0.0 108.813 169.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -133.33 131.14 39.78 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.172 0.989 . . . . 0.0 111.536 169.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -145.96 162.0 38.79 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.196 1.398 . . . . 0.0 111.757 -175.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -125.52 122.53 36.85 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.679 1.192 . . . . 0.0 111.422 170.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.401 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 44.1 m0 -82.54 -4.55 57.75 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 61.43 47.57 6.63 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.328 1.451 . . . . 0.0 113.62 169.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.0 mt -99.89 149.02 23.84 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -171.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -82.69 152.89 25.61 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.327 1.451 . . . . 0.0 111.336 170.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -80.85 120.67 79.56 Favored Pre-proline 0 CA--C 1.545 0.786 0 O-C-N 121.27 -0.894 . . . . 0.0 111.232 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -82.17 -10.6 11.25 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.231 1.954 . . . . 0.0 114.564 -176.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -53.23 107.63 0.25 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.754 1.161 . . . . 0.0 112.583 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.37 3.36 90.02 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 119.306 -0.719 . . . . 0.0 114.803 177.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -73.66 165.21 25.52 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.501 1.151 . . . . 0.0 110.437 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.2 m -60.66 147.84 40.59 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.42 -0.8 . . . . 0.0 111.171 170.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.83 -27.85 69.61 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.413 -0.805 . . . . 0.0 112.916 -172.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -59.04 -39.4 81.89 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.053 -1.029 . . . . 0.0 112.648 170.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.7 t -72.19 -37.03 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.907 0.883 . . . . 0.0 110.032 175.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.4 ' CE2' ' HB ' ' A' ' 45' ' ' THR . 0.3 OUTLIER -64.07 -40.93 97.35 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.435 0.694 . . . . 0.0 111.172 177.003 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -69.64 -37.2 76.67 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 120.778 -1.201 . . . . 0.0 112.521 171.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 55.1 m -59.15 -48.7 80.64 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.135 0.974 . . . . 0.0 111.558 175.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 19.7 m -66.51 -29.96 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 119.743 1.156 . . . . 0.0 111.947 175.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -45.94 89.61 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 120.086 1.312 . . . . 0.0 110.875 169.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.91 -41.33 97.73 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 118.955 0.798 . . . . 0.0 112.393 174.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -67.24 -43.04 82.93 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 175.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.3 m -67.15 -41.2 86.65 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.695 0 CA-C-N 119.807 1.185 . . . . 0.0 110.547 176.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -51.55 -54.13 30.7 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.689 1.586 . . . . 0.0 111.581 175.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -50.6 -49.64 55.99 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.779 1.631 . . . . 0.0 112.347 176.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -87.41 -27.95 22.44 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.661 0.784 . . . . 0.0 112.248 -170.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.4 t -63.53 -51.79 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.201 1.4 . . . . 0.0 109.187 169.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -54.01 -53.77 48.41 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.312 0.96 . . . . 0.0 109.613 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -52.01 -37.78 54.53 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.803 1.641 . . . . 0.0 112.49 176.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -79.07 -59.09 2.92 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.007 -1.058 . . . . 0.0 113.357 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.54 -33.89 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.789 1.636 . . . . 0.0 112.14 -174.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.53 -17.01 60.81 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.085 -1.009 . . . . 0.0 113.57 -174.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -74.03 -21.25 60.03 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.537 1.135 . . . . 0.0 113.786 171.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.5 pt -118.19 10.42 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.144 1.778 . . . . 0.0 113.006 -175.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.6 m . . . . . 0 C--O 1.253 1.283 0 C-N-CA 126.473 1.909 . . . . 0.0 112.024 177.721 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.8 ttm . . . . . 0 N--CA 1.503 2.207 0 CA-C-O 119.739 -0.172 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -88.01 83.2 7.06 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.3 1.04 . . . . 0.0 110.207 176.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -73.44 150.16 41.87 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 121.764 -0.585 . . . . 0.0 111.563 -175.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.6 t -109.7 146.86 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.346 1.058 . . . . 0.0 111.124 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.2 tpp -131.36 118.39 20.22 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.747 0.819 . . . . 0.0 110.643 168.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -88.41 131.32 34.9 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.302 1.041 . . . . 0.0 111.185 169.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.3 t -127.06 126.37 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.981 1.312 . . . . 0.0 110.643 -173.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.1 m -140.66 172.0 13.32 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.46 1.104 . . . . 0.0 111.303 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.95 -46.3 82.16 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.779 -1.201 . . . . 0.0 109.986 169.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -98.66 113.71 25.89 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.126 1.371 . . . . 0.0 109.821 169.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -62.28 -41.84 98.83 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 119.474 1.034 . . . . 0.0 109.43 169.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.2 p -46.35 -32.97 3.49 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.972 2.509 . . . . 0.0 116.894 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.4 p -98.99 -97.39 0.23 Allowed 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 123.832 0.853 . . . . 0.0 110.233 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -64.22 -44.1 92.95 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.859 1.264 . . . . 0.0 113.792 -169.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.9 m -63.11 -45.39 92.25 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.789 1.177 . . . . 0.0 111.889 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -63.81 -39.57 94.56 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 171.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 71.7 mtp -61.44 -44.76 96.55 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 120.769 -1.207 . . . . 0.0 110.994 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.52 -31.53 69.81 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 173.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -66.52 -50.44 63.19 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 119.478 1.036 . . . . 0.0 109.196 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.02 -45.48 95.85 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 118.868 -0.962 . . . . 0.0 112.634 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -64.17 -40.03 95.26 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.521 1.161 . . . . 0.0 112.416 173.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.44 -32.27 66.16 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.492 -1.38 . . . . 0.0 111.006 -176.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -62.42 -56.0 22.41 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 126.273 1.829 . . . . 0.0 110.159 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 67.9 p -70.46 -14.95 62.75 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.5 mt -100.98 -4.58 27.26 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.234 1.013 . . . . 0.0 113.62 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.58 5.37 1.15 Allowed Glycine 0 CA--C 1.534 1.256 0 N-CA-C 117.166 1.626 . . . . 0.0 117.166 -169.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.6 126.74 22.83 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.38 1.59 . . . . 0.0 112.539 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.9 -3.91 63.24 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 124.759 1.171 . . . . 0.0 115.877 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -87.61 -59.71 2.17 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 119.254 1.527 . . . . 0.0 110.613 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 pp -140.4 175.57 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 127.317 2.247 . . . . 0.0 109.538 170.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.78 125.98 42.89 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.998 0.904 . . . . 0.0 111.547 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.4 m -90.13 151.14 3.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 124.268 1.027 . . . . 0.0 112.295 169.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.72 152.81 39.43 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.439 1.095 . . . . 0.0 111.621 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.2 p -130.26 133.1 46.26 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.348 1.459 . . . . 0.0 114.925 174.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.3 p -134.47 173.3 11.8 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 127.618 2.367 . . . . 0.0 110.399 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.8 176.89 47.83 Favored Glycine 0 CA--C 1.525 0.68 0 O-C-N 120.248 -1.533 . . . . 0.0 114.7 169.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 27.9 mt -65.84 -34.09 77.35 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.035 0.534 . . . . 0.0 111.78 -175.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -117.39 116.3 26.91 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.981 2.112 . . . . 0.0 109.63 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.2 p -77.53 48.91 0.69 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.282 2.233 . . . . 0.0 111.917 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.7 t -70.72 165.72 22.41 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.038 -1.437 . . . . 0.0 112.67 -170.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -64.99 159.14 23.71 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 125.024 1.329 . . . . 0.0 112.495 -175.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.7 m -54.39 114.44 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.093 -1.004 . . . . 0.0 109.133 169.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -66.44 129.54 94.15 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -168.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -60.01 -39.64 68.76 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.475 2.784 . . . . 0.0 113.682 -171.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.4 m -79.33 -32.23 43.3 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.86 -0.525 . . . . 0.0 110.986 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.0 -40.91 87.43 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.832 -1.168 . . . . 0.0 112.568 173.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.9 mt -53.02 -39.82 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 120.613 1.551 . . . . 0.0 110.614 172.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.55 -64.31 0.89 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.432 0.693 . . . . 0.0 112.781 172.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.8 mmt -65.11 -23.68 67.22 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -171.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 89.7 mmm -85.59 -34.55 21.42 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.584 0.754 . . . . 0.0 110.732 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -62.06 -31.04 71.42 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.698 -1.251 . . . . 0.0 111.963 171.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -55.27 -30.57 60.37 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.75 0.82 . . . . 0.0 112.891 172.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.4 m -106.45 17.28 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 175.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.0 13.14 69.75 Favored Glycine 0 CA--C 1.536 1.388 0 O-C-N 121.085 -1.009 . . . . 0.0 115.225 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.4 mt -117.13 91.63 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.123 1.369 . . . . 0.0 110.061 -169.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -77.63 114.4 16.43 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.795 -1.19 . . . . 0.0 110.615 171.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.9 pt -91.31 -5.3 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 172.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 t -63.17 -27.65 69.52 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.352 1.433 . . . . 0.0 113.558 -169.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.62 9.82 60.68 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 124.977 1.275 . . . . 0.0 115.353 173.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -89.36 148.8 23.31 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 118.838 1.319 . . . . 0.0 113.2 -169.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.7 t -61.62 146.81 47.79 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.9 t -136.78 49.95 2.04 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 122.082 0.944 . . . . 0.0 112.403 175.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -64.66 145.05 98.81 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 125.241 1.416 . . . . 0.0 113.542 -172.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.28 154.39 32.17 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.804 2.336 . . . . 0.0 112.035 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.1 tt -62.93 -21.96 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -92.6 -10.83 36.08 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -91.4 -35.24 14.49 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.484 0.714 . . . . 0.0 111.962 171.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.36 164.48 25.67 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.562 0.745 . . . . 0.0 112.045 174.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -140.8 131.36 25.45 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.89 0.876 . . . . 0.0 110.921 169.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.4 6.13 4.93 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 115.551 1.685 . . . . 0.0 115.551 -174.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -71.58 -30.07 65.42 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.007 -1.058 . . . . 0.0 112.181 -174.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -93.48 -4.92 50.31 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.905 1.282 . . . . 0.0 113.511 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -125.24 79.47 1.8 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.542 1.537 . . . . 0.0 110.431 -171.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -69.06 0.78 4.17 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -171.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.0 t -129.03 94.64 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 125.868 1.667 . . . . 0.0 108.832 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.3 t -112.43 119.03 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 121.315 -0.866 . . . . 0.0 110.457 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 mp -110.2 134.38 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 124.281 1.032 . . . . 0.0 110.112 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.8 t -94.15 145.24 24.84 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.704 1.602 . . . . 0.0 109.854 169.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.5 mt -125.05 44.44 2.79 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.305 1.042 . . . . 0.0 111.39 -173.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.8 p -148.84 -9.13 0.35 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 -170.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.55 29.54 74.95 Favored Glycine 0 CA--C 1.537 1.431 0 O-C-N 121.137 -0.977 . . . . 0.0 111.027 -168.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.8 p -142.28 9.5 1.86 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.613 1.565 . . . . 0.0 114.188 -169.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -51.81 -26.87 18.82 Favored Glycine 0 CA--C 1.536 1.359 0 N-CA-C 116.994 1.558 . . . . 0.0 116.994 -169.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.7 m -64.76 -15.93 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 118.989 1.395 . . . . 0.0 114.108 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -81.96 -10.7 59.18 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.217 1.407 . . . . 0.0 113.433 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 80.5 mt -72.26 158.99 86.59 Favored Pre-proline 0 CA--C 1.55 0.949 0 O-C-N 121.292 -0.88 . . . . 0.0 111.277 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.54 132.12 48.57 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.657 2.238 . . . . 0.0 110.755 174.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -60.62 -30.63 90.91 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.542 2.162 . . . . 0.0 113.57 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -60.19 -31.74 70.43 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.949 -1.094 . . . . 0.0 112.867 171.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -87.98 13.2 11.49 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.747 1.219 . . . . 0.0 113.631 175.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.9 t -118.86 -34.75 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 126.565 1.946 . . . . 0.0 112.168 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.0 p -80.85 12.65 3.1 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 -169.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -66.91 161.97 22.86 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.348 1.459 . . . . 0.0 112.149 170.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -60.02 -36.75 77.92 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -169.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.7 mt -115.35 117.05 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.79 0.836 . . . . 0.0 109.307 169.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -134.51 126.56 29.63 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.362 1.065 . . . . 0.0 110.372 169.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -147.24 160.46 42.46 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.802 1.641 . . . . 0.0 110.85 -173.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -126.04 133.03 51.85 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.328 0.651 . . . . 0.0 111.679 169.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -90.04 -0.42 57.58 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 63.88 39.62 8.06 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 169.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.3 mt -93.01 157.6 16.22 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -172.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -102.58 144.48 30.94 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.552 1.941 . . . . 0.0 111.223 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -73.65 121.73 85.87 Favored Pre-proline 0 N--CA 1.475 0.791 0 CA-C-N 119.463 1.029 . . . . 0.0 111.866 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -83.89 -15.32 7.05 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.702 2.268 . . . . 0.0 114.856 -172.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -51.57 109.86 0.4 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.312 1.045 . . . . 0.0 112.442 175.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.85 -0.63 84.61 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 123.804 0.716 . . . . 0.0 114.446 176.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -76.01 171.36 14.59 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 118.437 1.119 . . . . 0.0 109.863 169.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 88.1 p -65.92 156.3 33.9 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.051 -1.031 . . . . 0.0 111.707 169.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.7 mp -64.51 -28.18 69.48 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.112 -0.993 . . . . 0.0 111.725 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -59.48 -41.06 88.95 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.048 -1.032 . . . . 0.0 112.389 170.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 79.4 t -73.79 -36.69 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 O-C-N 121.24 -0.913 . . . . 0.0 110.243 175.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.02 -40.3 97.35 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.277 0.631 . . . . 0.0 111.038 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -70.45 -36.49 73.97 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 120.772 -1.205 . . . . 0.0 112.545 170.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 55.0 m -58.98 -47.63 84.46 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.866 0.867 . . . . 0.0 111.662 175.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.6 m -67.46 -29.08 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 119.784 1.175 . . . . 0.0 111.673 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -45.36 94.11 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 119.968 1.258 . . . . 0.0 110.934 169.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.23 -40.85 97.88 Favored Glycine 0 N--CA 1.474 1.232 0 CA-C-N 118.856 0.753 . . . . 0.0 112.125 174.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -67.28 -43.41 81.85 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.0 m -66.91 -40.37 85.59 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.598 0 CA-C-N 120.071 1.305 . . . . 0.0 110.53 176.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -51.43 -55.0 21.1 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 120.587 1.539 . . . . 0.0 111.464 175.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -50.33 -47.48 55.83 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.301 1.44 . . . . 0.0 112.19 177.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -89.54 -27.75 20.06 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.451 0.701 . . . . 0.0 112.423 -170.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.22 -49.85 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.027 1.331 . . . . 0.0 109.308 169.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -54.09 -54.83 34.02 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.12 0.873 . . . . 0.0 109.551 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -51.58 -37.34 49.39 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.769 1.628 . . . . 0.0 112.676 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -79.22 -61.35 2.04 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.057 0.943 . . . . 0.0 112.92 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.72 -33.76 63.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.25 1.42 . . . . 0.0 112.063 -174.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.69 -17.89 61.08 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -174.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -77.56 -15.98 58.92 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.699 1.199 . . . . 0.0 113.816 171.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.6 pt -120.88 24.72 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 126.934 2.094 . . . . 0.0 111.778 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--O 1.255 1.344 0 C-N-CA 127.824 2.45 . . . . 0.0 111.469 178.099 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 tpp . . . . . 0 N--CA 1.501 2.092 0 CA-C-O 119.362 -0.352 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -83.22 87.92 6.93 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 119.408 1.004 . . . . 0.0 111.21 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -77.94 146.87 35.26 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -171.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.2 t -108.38 143.5 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.672 1.189 . . . . 0.0 110.473 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.1 tpp -129.44 114.4 16.1 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.964 0.906 . . . . 0.0 110.919 169.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -83.31 140.89 32.2 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.642 -0.661 . . . . 0.0 110.382 169.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.5 t -135.89 127.72 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 125.165 1.386 . . . . 0.0 110.507 -175.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.0 p -144.04 -179.2 6.35 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.673 1.189 . . . . 0.0 111.932 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -60.23 -70.98 0.14 Allowed 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 119.472 1.033 . . . . 0.0 109.744 169.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.3 mtt-85 -82.8 121.39 26.85 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 169.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -66.93 -45.26 78.42 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 119.137 0.881 . . . . 0.0 108.883 169.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.4 p -48.77 -31.41 6.95 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.975 2.51 . . . . 0.0 115.829 -175.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.9 p -91.66 -96.1 0.13 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.186 1.394 . . . . 0.0 110.908 169.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -56.27 -56.25 23.35 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -168.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.2 m -69.04 -33.28 73.35 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.709 1.14 . . . . 0.0 113.034 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -66.69 -39.05 87.93 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.358 1.463 . . . . 0.0 113.17 169.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 77.2 mtp -58.85 -45.47 90.01 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.633 0.773 . . . . 0.0 110.977 170.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.56 -28.59 67.09 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 117.7 -1.143 . . . . 0.0 113.609 173.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -72.23 -46.14 57.34 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 121.464 1.938 . . . . 0.0 108.836 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.11 -50.82 62.67 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-O 118.556 -1.136 . . . . 0.0 112.343 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -61.55 -41.24 97.08 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.126 1.463 . . . . 0.0 112.782 175.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.467 ' HB1' HG11 ' A' ' 32' ' ' VAL . . . -72.69 -29.72 63.64 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 120.812 -1.18 . . . . 0.0 111.216 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -65.31 -55.89 15.77 Favored 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 125.205 1.402 . . . . 0.0 109.977 170.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.5 p -71.09 -9.54 58.23 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 49.7 mt -101.83 -1.6 31.89 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 170.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -160.57 13.59 0.17 Allowed Glycine 0 CA--C 1.536 1.402 0 N-CA-C 118.262 2.065 . . . . 0.0 118.262 -171.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.82 -30.26 68.82 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 120.673 2.237 . . . . 0.0 114.331 -171.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.97 1.13 87.5 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 124.454 1.026 . . . . 0.0 114.949 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -112.28 -107.75 0.36 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.42 1.888 . . . . 0.0 110.407 -171.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -95.73 174.55 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 126.104 1.762 . . . . 0.0 111.492 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.6 129.13 39.97 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.22 -0.925 . . . . 0.0 112.264 175.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.467 HG11 ' HB1' ' A' ' 22' ' ' ALA . 30.1 m -99.19 148.25 6.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 124.367 1.067 . . . . 0.0 112.662 170.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.48 153.79 39.97 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.254 1.022 . . . . 0.0 111.115 -174.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.6 p -137.2 136.61 38.32 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.974 1.31 . . . . 0.0 114.163 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.5 t -140.38 -178.84 5.68 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.843 2.057 . . . . 0.0 110.746 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.88 177.97 41.86 Favored Glycine 0 CA--C 1.527 0.815 0 O-C-N 120.684 -1.26 . . . . 0.0 114.834 171.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.9 mt -62.5 -34.26 76.51 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.044 0.938 . . . . 0.0 111.725 -176.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -127.02 112.39 15.18 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.21 2.204 . . . . 0.0 107.754 169.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.5 p -61.51 -36.35 80.28 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.41 -0.806 . . . . 0.0 111.886 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.2 t 52.57 -135.22 1.54 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.943 1.297 . . . . 0.0 110.41 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -127.22 -139.59 0.26 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 126.735 2.014 . . . . 0.0 110.827 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.4 m -105.77 115.08 46.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 168.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -64.62 131.1 95.02 Favored Pre-proline 0 N--CA 1.48 1.045 0 O-C-N 121.176 -0.953 . . . . 0.0 112.378 -168.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -60.06 -37.66 82.95 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.432 2.755 . . . . 0.0 113.944 -169.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.5 m -77.78 -33.37 52.66 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.933 -0.479 . . . . 0.0 110.461 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.38 -38.79 92.27 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.073 -1.017 . . . . 0.0 112.56 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 70.4 mt -53.23 -44.46 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 120.657 1.571 . . . . 0.0 110.134 174.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.0 -58.95 4.77 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.0 mmt -65.15 -21.64 66.81 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -174.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 87.8 mmm -89.9 -38.89 13.39 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.015 0.926 . . . . 0.0 110.762 176.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -58.52 -36.61 74.09 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.577 -1.327 . . . . 0.0 112.205 169.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -54.43 -32.24 57.01 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.333 1.053 . . . . 0.0 113.672 173.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.2 m -101.6 13.98 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.694 1.198 . . . . 0.0 113.973 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.29 16.38 62.64 Favored Glycine 0 CA--C 1.535 1.337 0 O-C-N 121.184 -0.947 . . . . 0.0 114.917 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.4 mt -122.08 75.7 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.727 1.611 . . . . 0.0 109.952 -169.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -68.09 105.33 2.02 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 120.283 -1.511 . . . . 0.0 110.494 173.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.0 pt -84.35 -5.52 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.542 0.737 . . . . 0.0 112.833 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 92.4 p -64.92 -28.93 69.87 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -169.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.43 7.8 77.6 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.803 1.192 . . . . 0.0 114.58 172.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -98.87 149.83 22.52 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.196 1.398 . . . . 0.0 112.522 -169.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.8 t -85.64 145.58 27.25 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -173.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.3 m -124.49 111.65 15.96 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.352 1.061 . . . . 0.0 110.381 170.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.15 158.11 50.04 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 124.001 0.92 . . . . 0.0 113.009 177.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -95.7 150.79 1.46 Allowed 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 124.176 3.251 . . . . 0.0 111.879 169.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.38 -19.15 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 115.424 1.638 . . . . 0.0 115.424 -172.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -99.68 -7.79 25.19 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -87.92 -39.43 14.76 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.379 -0.826 . . . . 0.0 111.491 169.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.98 161.12 31.68 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.559 0.743 . . . . 0.0 111.759 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -136.56 117.21 13.93 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.388 1.075 . . . . 0.0 110.452 173.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.98 -1.76 4.48 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -171.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.91 -30.49 67.92 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.083 -1.011 . . . . 0.0 112.202 -173.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -86.14 -2.57 58.46 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.781 1.232 . . . . 0.0 113.293 177.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -124.35 90.56 3.28 Favored 'General case' 0 C--N 1.343 0.326 0 C-N-CA 125.711 1.604 . . . . 0.0 110.269 -171.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -55.18 -27.84 48.72 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.196 1.398 . . . . 0.0 113.37 -177.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.29 115.74 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 125.156 1.382 . . . . 0.0 110.541 -172.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.0 t -122.91 129.08 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.913 0.885 . . . . 0.0 110.746 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.7 mm -117.58 124.15 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.455 0.702 . . . . 0.0 111.109 -172.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.1 t -88.19 105.6 17.64 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 169.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.419 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 64.0 mt -82.91 31.89 0.43 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.805 1.642 . . . . 0.0 110.966 175.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.3 t -164.7 157.2 16.44 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.866 2.466 . . . . 0.0 109.162 -169.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -73.66 34.88 0.85 Allowed Glycine 0 CA--C 1.546 1.97 0 C-N-CA 124.185 0.898 . . . . 0.0 112.385 168.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 67.3 m -90.77 -1.81 57.83 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.764 2.425 . . . . 0.0 113.225 -169.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -49.95 -35.14 24.57 Favored Glycine 0 N--CA 1.477 1.422 0 N-CA-C 116.633 1.413 . . . . 0.0 116.633 -169.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.1 m -82.34 -16.78 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 176.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -92.84 -22.22 19.42 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.501 1.52 . . . . 0.0 112.637 175.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.6 mt -62.83 150.06 88.31 Favored Pre-proline 0 CA--C 1.549 0.923 0 O-C-N 121.384 -0.822 . . . . 0.0 111.507 171.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -59.22 132.11 44.96 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.708 2.272 . . . . 0.0 110.698 169.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -59.73 -33.23 96.46 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.468 2.112 . . . . 0.0 113.522 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -66.18 -26.64 67.5 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.72 1.145 . . . . 0.0 113.538 175.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.38 -15.96 59.11 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.772 -1.205 . . . . 0.0 112.629 171.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.8 t -90.63 -40.22 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.882 1.673 . . . . 0.0 111.725 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.1 p -81.99 27.9 0.45 Allowed 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -172.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -79.61 169.7 17.63 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.084 1.354 . . . . 0.0 112.14 170.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -55.35 -39.79 70.47 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.121 0.968 . . . . 0.0 113.431 -169.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 58.9 mt -128.31 125.06 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.594 1.157 . . . . 0.0 109.545 170.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -128.52 141.46 51.37 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.436 1.094 . . . . 0.0 110.339 169.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.37 154.54 43.11 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.215 1.006 . . . . 0.0 112.121 -171.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -129.16 113.22 14.81 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.49 1.516 . . . . 0.0 110.226 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.419 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 37.0 m0 -94.0 5.32 52.07 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -173.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 63.45 -89.12 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.497 1.519 . . . . 0.0 112.026 -173.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.7 mt 53.85 -177.96 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 127.789 2.435 . . . . 0.0 115.511 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -142.0 148.26 38.27 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.8 2.04 . . . . 0.0 108.887 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.26 119.48 77.64 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 119.654 1.115 . . . . 0.0 110.575 176.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -83.94 -6.85 10.42 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 121.912 1.742 . . . . 0.0 113.881 -171.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -45.25 112.4 0.44 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.184 1.394 . . . . 0.0 112.783 174.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.42 3.14 82.04 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 123.66 0.647 . . . . 0.0 114.375 173.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -79.88 173.18 12.85 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.103 0.961 . . . . 0.0 109.927 169.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 86.2 p -63.68 153.8 35.01 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.183 -0.948 . . . . 0.0 111.732 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.47 -29.49 70.57 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.53 -0.731 . . . . 0.0 111.497 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -67.15 -34.9 78.55 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.786 -1.196 . . . . 0.0 113.144 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 78.8 t -69.46 -37.48 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 O-C-N 121.163 -0.96 . . . . 0.0 109.611 170.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.52 -39.08 93.11 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.717 0.807 . . . . 0.0 111.109 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -71.69 -38.09 70.63 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.062 1.345 . . . . 0.0 112.376 171.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 51.7 m -57.84 -48.1 80.75 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.608 1.095 . . . . 0.0 111.525 177.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.4 m -69.3 -29.92 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.937 176.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.28 -42.86 99.35 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 120.155 1.343 . . . . 0.0 111.515 169.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.76 -42.13 95.37 Favored Glycine 0 N--CA 1.476 1.331 0 C-N-CA 124.253 0.93 . . . . 0.0 112.661 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -63.32 -48.18 79.09 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.127 -0.631 . . . . 0.0 112.218 171.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.0 t -58.52 -44.9 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.633 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -52.37 -54.55 30.36 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 120.046 1.293 . . . . 0.0 111.51 175.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -61.76 -43.38 98.97 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.13 0.572 . . . . 0.0 112.209 -176.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 49.3 mtp85 -76.16 -31.86 58.76 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 36.8 t -61.87 -49.01 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.532 1.133 . . . . 0.0 110.591 170.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -53.62 -54.75 33.17 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.018 0.827 . . . . 0.0 109.701 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -55.19 -31.59 61.53 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.374 1.47 . . . . 0.0 112.9 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -81.83 -59.97 2.4 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.035 -1.04 . . . . 0.0 112.704 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.24 -32.68 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.789 1.236 . . . . 0.0 111.691 -176.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.58 -0.39 33.39 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -90.88 -15.65 29.55 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.809 1.244 . . . . 0.0 113.51 170.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.5 pt -121.31 8.43 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 126.188 1.795 . . . . 0.0 113.041 -176.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.4 p . . . . . 0 C--O 1.254 1.323 0 C-N-CA 126.446 1.898 . . . . 0.0 113.815 171.92 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.9 ttm . . . . . 0 N--CA 1.501 2.084 0 CA-C-O 119.325 -0.369 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -86.35 107.1 17.84 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 169.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -82.11 144.87 30.47 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 118.077 0.398 . . . . 0.0 110.907 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.0 t -101.66 142.22 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.672 0.789 . . . . 0.0 109.804 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 42.3 tpp -127.97 118.27 23.26 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.692 0.797 . . . . 0.0 110.754 169.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -89.67 138.51 31.41 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.88 -0.512 . . . . 0.0 110.834 169.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 t -130.17 129.32 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.546 1.538 . . . . 0.0 109.631 -171.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.7 m -141.14 171.48 14.0 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.002 1.321 . . . . 0.0 110.503 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -66.0 -49.28 68.34 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 119.91 1.232 . . . . 0.0 108.934 169.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -103.67 114.08 28.07 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 167.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.535 ' ND2' ' H ' ' A' ' 63' ' ' ASP . 31.1 t-20 -51.92 -48.51 64.17 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 120.474 1.488 . . . . 0.0 109.673 172.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.0 p -53.17 -32.85 49.91 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.1 p -78.37 -33.58 48.85 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -174.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 -140.34 -55.79 0.53 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.903 0.881 . . . . 0.0 112.488 -170.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 m -55.71 -40.86 73.0 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 120.087 1.312 . . . . 0.0 113.333 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -66.91 -35.43 79.98 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.698 1.599 . . . . 0.0 113.46 173.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.5 mtm -64.92 -50.43 66.52 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.782 -0.574 . . . . 0.0 110.565 172.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.8 -26.19 67.58 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.415 -0.803 . . . . 0.0 113.011 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -71.4 -49.44 42.0 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 119.507 1.048 . . . . 0.0 108.45 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.32 -41.62 99.43 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 119.245 -0.753 . . . . 0.0 112.953 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -62.45 -43.32 99.1 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.287 1.544 . . . . 0.0 112.22 172.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.64 -35.96 67.89 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.683 -1.26 . . . . 0.0 110.863 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -57.73 -49.6 76.0 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.344 1.858 . . . . 0.0 110.833 171.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.4 p -78.67 -24.46 45.11 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.868 1.432 . . . . 0.0 114.868 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.8 mt -89.5 -28.19 19.82 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.157 0.89 . . . . 0.0 113.045 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.74 -68.74 1.15 Allowed Glycine 0 N--CA 1.473 1.118 0 C-N-CA 124.711 1.148 . . . . 0.0 112.065 175.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 54.32 90.83 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.176 2.59 . . . . 0.0 115.462 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.85 -7.25 78.15 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 116.299 1.28 . . . . 0.0 116.299 169.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -68.85 -47.19 66.56 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 118.898 1.349 . . . . 0.0 110.817 174.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.6 pp -140.35 -176.06 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 127.749 2.42 . . . . 0.0 110.479 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.13 128.52 55.08 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.52 0.676 . . . . 0.0 112.551 172.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.5 m -95.16 151.48 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 124.592 1.157 . . . . 0.0 112.907 170.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.14 156.45 42.6 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.672 0.789 . . . . 0.0 111.41 -172.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 97.5 p -126.77 142.37 51.56 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.169 1.388 . . . . 0.0 114.023 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.6 t -145.77 170.78 15.85 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 126.897 2.079 . . . . 0.0 109.874 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.24 171.11 34.6 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 120.883 -1.136 . . . . 0.0 114.358 170.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 38.3 mt -62.17 -35.18 78.01 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 117.4 0.6 . . . . 0.0 111.812 -174.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -125.08 122.05 36.08 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.559 2.744 . . . . 0.0 106.545 169.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 55.4 p -73.07 -41.88 63.64 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.842 -1.162 . . . . 0.0 111.024 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.5 t 55.49 -167.51 0.1 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 126.282 1.833 . . . . 0.0 113.877 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -94.0 168.79 10.73 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 126.936 2.094 . . . . 0.0 112.29 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.6 m -61.15 114.16 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 169.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -71.04 132.19 86.68 Favored Pre-proline 0 N--CA 1.476 0.864 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -168.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -57.77 -39.72 84.99 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.951 3.1 . . . . 0.0 114.305 -173.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.3 m -80.31 -37.59 32.34 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.776 -0.578 . . . . 0.0 110.626 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.28 96.54 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.267 0.939 . . . . 0.0 112.076 175.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.0 mt -48.95 -49.09 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 120.132 1.333 . . . . 0.0 110.376 171.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.03 -58.13 7.6 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.6 mmt -65.71 -22.46 66.61 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -172.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 76.6 mmm -90.28 -40.01 12.41 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.372 1.469 . . . . 0.0 110.998 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -57.78 -35.47 70.84 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.83 -1.169 . . . . 0.0 112.348 170.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -53.41 -32.44 49.64 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.469 1.107 . . . . 0.0 113.064 170.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -94.85 5.98 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.703 1.201 . . . . 0.0 113.521 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.97 15.55 64.91 Favored Glycine 0 CA--C 1.538 1.498 0 O-C-N 120.916 -1.115 . . . . 0.0 114.433 -173.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.4 mt -121.04 61.64 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.95 1.7 . . . . 0.0 109.651 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -62.24 110.46 1.63 Allowed 'General case' 0 CA--C 1.548 0.893 0 O-C-N 120.082 -1.636 . . . . 0.0 110.892 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.6 pt -85.89 -4.5 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 118.496 -0.764 . . . . 0.0 112.941 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.5 t -61.79 -33.86 74.86 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.159 1.345 . . . . 0.0 112.731 -171.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.49 10.08 66.92 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.133 1.349 . . . . 0.0 115.432 172.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -101.74 163.03 12.47 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.911 1.284 . . . . 0.0 112.838 -170.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 p -72.94 158.75 34.87 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.022 1.729 . . . . 0.0 115.408 -170.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.8 t -151.31 148.14 27.8 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.153 2.181 . . . . 0.0 108.466 168.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.535 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 1.0 OUTLIER -149.36 147.91 24.79 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.672 1.189 . . . . 0.0 111.201 178.915 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -90.3 152.19 4.55 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.679 2.92 . . . . 0.0 111.854 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 tt -65.31 -18.78 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -171.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -98.22 -7.21 29.69 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -88.47 -38.98 14.56 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.585 0.629 . . . . 0.0 111.436 169.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.87 161.8 30.27 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.697 0.799 . . . . 0.0 112.241 173.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.94 123.51 17.23 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.271 1.028 . . . . 0.0 110.926 169.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.94 2.43 3.5 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -169.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -67.58 -28.6 67.91 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.341 -0.85 . . . . 0.0 112.437 -173.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -93.4 -2.31 54.82 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.157 1.383 . . . . 0.0 113.28 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -123.43 80.12 1.75 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.196 1.798 . . . . 0.0 109.878 -170.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -59.41 -21.29 59.74 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.707 1.203 . . . . 0.0 114.087 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.6 t -117.91 109.6 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.869 1.268 . . . . 0.0 110.015 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.8 t -121.21 129.37 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.819 0.848 . . . . 0.0 111.233 -176.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.1 mm -119.7 118.35 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 O-C-N 121.534 -0.729 . . . . 0.0 111.233 -171.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.3 t -82.85 105.8 14.16 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 168.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.428 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 85.4 mt -79.07 -32.38 44.74 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.622 -0.674 . . . . 0.0 111.135 177.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 31.7 p -71.58 158.29 36.46 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 122.993 0.517 . . . . 0.0 110.41 169.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.69 37.71 1.88 Allowed Glycine 0 CA--C 1.54 1.648 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 168.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 5.5 p -127.38 20.82 6.71 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.486 1.914 . . . . 0.0 114.124 -169.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -55.6 -36.3 64.31 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.699 1.143 . . . . 0.0 114.651 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.1 m -69.55 -13.51 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.03 -2.64 49.86 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.485 1.514 . . . . 0.0 112.568 176.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.5 mt -78.68 158.28 75.94 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.991 0.917 . . . . 0.0 111.371 173.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.32 133.43 54.97 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.852 2.368 . . . . 0.0 111.68 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -60.59 -31.03 91.76 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.795 2.33 . . . . 0.0 113.62 -174.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -65.48 -30.01 70.74 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.729 -1.232 . . . . 0.0 113.264 173.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.35 -19.94 49.01 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.855 -1.153 . . . . 0.0 112.688 173.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.6 t -87.73 -34.39 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.047 1.739 . . . . 0.0 112.41 176.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.6 p -88.59 25.83 1.62 Allowed 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -171.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -77.2 168.35 20.21 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.508 1.123 . . . . 0.0 112.263 169.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -55.72 -38.59 69.95 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -169.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 59.7 mt -126.03 123.51 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.717 1.207 . . . . 0.0 108.872 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -128.24 140.87 51.66 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.097 0.959 . . . . 0.0 110.702 169.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.84 154.95 44.67 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.671 1.188 . . . . 0.0 112.093 -171.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -130.13 115.45 17.07 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.9 1.28 . . . . 0.0 110.89 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.428 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 35.7 m0 -98.51 -1.63 40.72 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.457 1.103 . . . . 0.0 113.792 -175.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.32 1.2 pp0? 44.75 41.73 5.29 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 172.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.8 mt -84.42 134.25 34.47 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.984 1.313 . . . . 0.0 112.977 -177.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -64.74 153.87 38.51 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.987 1.315 . . . . 0.0 111.977 172.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -81.72 116.74 64.98 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 121.192 -0.942 . . . . 0.0 112.832 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -84.52 -27.27 1.42 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.794 2.329 . . . . 0.0 115.103 -169.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -70.97 81.7 0.66 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.667 1.987 . . . . 0.0 111.949 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 141.17 -10.66 2.78 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 126.496 1.998 . . . . 0.0 113.785 -174.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -91.39 175.8 6.79 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.845 1.658 . . . . 0.0 111.624 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 96.9 p -70.86 159.77 34.0 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.628 -0.67 . . . . 0.0 111.581 169.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.9 -31.04 72.02 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.463 -0.773 . . . . 0.0 112.194 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.08 -40.89 95.41 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.05 -1.031 . . . . 0.0 112.283 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 94.0 t -72.93 -35.91 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.626 0.77 . . . . 0.0 110.47 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -60.15 -49.76 76.38 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.781 0.832 . . . . 0.0 110.638 173.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 66.4 mtt85 -63.14 -23.54 67.48 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.307 1.443 . . . . 0.0 113.453 173.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 57.4 m -75.63 -55.32 5.78 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.624 1.169 . . . . 0.0 111.412 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 19.2 m -65.54 -32.31 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 119.82 1.191 . . . . 0.0 110.762 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.47 -43.75 89.06 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 126.606 1.962 . . . . 0.0 112.939 169.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.43 -38.4 86.83 Favored Glycine 0 N--CA 1.476 1.323 0 C-N-CA 123.964 0.792 . . . . 0.0 113.392 174.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -61.94 -43.31 99.1 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.512 -0.993 . . . . 0.0 111.814 169.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 32.5 t -58.58 -47.65 87.91 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 CA-C-O 117.861 -1.066 . . . . 0.0 109.772 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -49.81 -55.36 14.43 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.866 1.212 . . . . 0.0 111.571 175.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -61.1 -43.75 98.41 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.5 mtp85 -76.12 -33.55 59.45 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.6 t -63.56 -46.09 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.122 0.969 . . . . 0.0 111.224 172.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -52.49 -54.97 25.46 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.246 0.93 . . . . 0.0 109.943 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -55.17 -37.75 67.42 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.783 1.233 . . . . 0.0 112.676 176.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -74.79 -57.28 4.01 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.18 -0.95 . . . . 0.0 112.752 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.56 -34.53 71.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.692 1.197 . . . . 0.0 112.168 -177.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.57 -15.8 60.83 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -173.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -73.43 -31.03 63.6 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.43 1.092 . . . . 0.0 113.382 170.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.9 pt -107.64 -7.15 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.323 1.449 . . . . 0.0 113.389 -174.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.9 m . . . . . 0 C--O 1.253 1.282 0 C-N-CA 125.779 1.632 . . . . 0.0 112.711 171.007 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 ttm . . . . . 0 N--CA 1.503 2.208 0 CA-C-O 119.77 -0.157 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -85.73 82.33 8.24 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.212 1.005 . . . . 0.0 110.777 173.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -72.18 139.23 48.14 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.208 1.003 . . . . 0.0 111.714 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.9 t -113.2 146.25 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.291 1.036 . . . . 0.0 111.657 -173.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.2 tpp -132.91 122.59 24.56 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.188 0.995 . . . . 0.0 111.573 169.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -95.88 134.86 38.36 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.267 1.027 . . . . 0.0 111.387 169.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.1 t -128.63 130.16 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.968 1.307 . . . . 0.0 111.436 -170.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.0 p -149.28 179.49 7.88 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.471 1.108 . . . . 0.0 111.953 173.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -66.33 -61.92 1.75 Allowed 'General case' 0 N--CA 1.483 1.208 0 O-C-N 120.79 -1.194 . . . . 0.0 111.102 173.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.32 110.98 19.01 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.223 1.009 . . . . 0.0 109.197 169.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -61.68 -34.96 76.67 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.156 0.889 . . . . 0.0 110.331 169.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.3 p -48.47 -37.89 18.53 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.828 2.451 . . . . 0.0 115.836 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.9 p -97.62 -92.39 0.24 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.329 1.052 . . . . 0.0 111.329 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.69 -54.24 49.13 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 120.924 -1.11 . . . . 0.0 113.764 -169.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.402 ' HB3' ' HB2' ' A' ' 34' ' ' SER . 18.5 m -63.6 -42.29 98.27 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.136 0.88 . . . . 0.0 111.868 -176.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -60.74 -39.82 90.11 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.447 1.499 . . . . 0.0 114.564 169.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 78.4 mtp -64.43 -45.97 85.21 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.167 0.894 . . . . 0.0 110.748 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.0 -25.78 64.68 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 172.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -67.27 -53.27 31.4 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.051 1.296 . . . . 0.0 108.168 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.56 -43.55 96.37 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 118.714 -1.048 . . . . 0.0 112.266 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -63.27 -43.41 98.04 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.852 1.826 . . . . 0.0 112.21 172.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.86 -35.56 64.78 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.198 1.363 . . . . 0.0 110.923 -173.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -60.44 -59.22 5.74 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.38 1.472 . . . . 0.0 109.378 169.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.0 p -66.5 -13.58 61.09 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.5 mt -97.87 -5.59 34.23 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 172.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.66 15.69 0.11 Allowed Glycine 0 CA--C 1.536 1.36 0 N-CA-C 118.304 2.081 . . . . 0.0 118.304 -171.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.69 -34.54 59.1 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 119.696 1.748 . . . . 0.0 114.643 -170.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.49 -5.58 86.76 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.38 0.99 . . . . 0.0 115.319 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -99.52 -60.87 1.45 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 118.632 1.216 . . . . 0.0 111.947 -170.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -139.85 170.64 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 126.846 2.059 . . . . 0.0 110.319 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.67 125.13 39.12 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 122.122 0.963 . . . . 0.0 111.275 175.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.2 m -92.79 153.61 3.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.901 169.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.73 149.94 34.39 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.435 0.694 . . . . 0.0 111.71 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' A' ' 15' ' ' SER . 34.4 p -119.92 139.34 52.57 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.994 2.118 . . . . 0.0 113.347 171.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.9 p -144.88 172.86 12.43 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.015 1.326 . . . . 0.0 110.777 169.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.68 -179.82 44.58 Favored Glycine 0 CA--C 1.52 0.367 0 O-C-N 120.383 -1.448 . . . . 0.0 114.569 171.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 34.7 mt -63.69 -30.07 71.22 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.78 0.432 . . . . 0.0 111.532 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -121.39 123.79 42.95 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.877 2.071 . . . . 0.0 108.948 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.3 p -77.8 43.23 0.41 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.92 1.688 . . . . 0.0 111.898 175.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.9 p -63.14 155.01 29.3 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.564 1.545 . . . . 0.0 113.337 -169.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -65.68 177.66 1.19 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.819 1.647 . . . . 0.0 114.471 -169.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 m -63.45 110.33 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 119.866 -1.771 . . . . 0.0 109.617 169.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -67.9 135.46 92.06 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-O 118.413 -0.803 . . . . 0.0 112.414 -169.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -58.79 -39.92 77.38 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.367 2.711 . . . . 0.0 113.795 -174.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.7 m -77.44 -37.87 50.67 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.869 0.468 . . . . 0.0 110.581 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.04 -41.83 97.26 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 118.143 -0.932 . . . . 0.0 112.448 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 66.8 mt -50.8 -47.01 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 120.482 1.492 . . . . 0.0 110.426 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.99 -59.76 3.8 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 175.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 31.0 mmt -67.29 -20.88 65.69 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -172.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 83.9 mmm -90.15 -37.52 14.14 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.721 0.809 . . . . 0.0 110.619 175.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -58.53 -36.46 73.88 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.58 -1.325 . . . . 0.0 112.129 169.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -54.25 -32.75 56.85 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.162 0.985 . . . . 0.0 113.59 172.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.6 m -100.67 13.18 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 124.818 1.247 . . . . 0.0 114.19 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.14 17.2 59.6 Favored Glycine 0 N--CA 1.476 1.329 0 O-C-N 121.047 -1.033 . . . . 0.0 114.896 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.0 mt -126.6 64.49 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.894 1.678 . . . . 0.0 109.965 -169.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -63.47 109.16 1.54 Allowed 'General case' 0 CA--C 1.545 0.759 0 O-C-N 119.985 -1.697 . . . . 0.0 110.905 173.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.1 pt -83.98 -4.89 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 118.36 -0.828 . . . . 0.0 113.04 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -60.13 -30.1 69.07 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 120.495 1.498 . . . . 0.0 113.502 -169.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.36 5.53 71.02 Favored Glycine 0 CA--C 1.541 1.667 0 C-N-CA 124.82 1.2 . . . . 0.0 115.534 173.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -98.82 140.37 33.11 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.11 1.455 . . . . 0.0 112.324 -171.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.8 t -71.21 155.83 40.27 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -173.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.1 m -128.37 143.2 50.97 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.738 1.615 . . . . 0.0 110.49 169.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -138.15 150.86 68.46 Favored Pre-proline 0 N--CA 1.485 1.295 0 CA-C-N 119.616 1.098 . . . . 0.0 113.36 -172.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -88.92 151.03 5.88 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.533 2.155 . . . . 0.0 112.165 177.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.5 tt -62.57 -17.83 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 125.125 1.37 . . . . 0.0 114.55 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.26 -8.05 27.98 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -87.68 -38.89 15.45 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.077 0.853 . . . . 0.0 111.258 170.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.11 157.52 38.04 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.392 0.677 . . . . 0.0 111.409 172.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.25 121.24 13.66 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.721 0.809 . . . . 0.0 111.156 170.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.16 1.79 1.89 Allowed 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -170.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -67.06 -28.1 67.92 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.147 -0.97 . . . . 0.0 111.979 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -93.8 -1.13 55.39 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.41 1.484 . . . . 0.0 113.418 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -130.24 91.62 3.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.615 1.566 . . . . 0.0 110.586 -171.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -59.62 -21.25 60.17 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.7 t -123.28 108.13 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.956 1.302 . . . . 0.0 110.41 -169.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.416 ' C ' HD12 ' A' ' 77' ' ' ILE . 22.6 t -125.58 127.6 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.674 0.79 . . . . 0.0 111.452 -176.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.416 HD12 ' C ' ' A' ' 76' ' ' VAL . 1.6 mp -118.86 130.93 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.39 1.076 . . . . 0.0 110.206 -170.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.7 t -90.32 124.88 35.28 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.912 1.285 . . . . 0.0 108.092 168.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.426 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 76.1 mt -104.24 23.44 13.09 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.824 1.649 . . . . 0.0 112.572 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 27.1 p -124.26 -176.92 3.63 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.705 2.002 . . . . 0.0 108.533 169.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.47 38.87 2.94 Favored Glycine 0 CA--C 1.538 1.531 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 168.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.0 p -136.55 16.72 3.13 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -168.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -54.14 -30.34 46.87 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 119.933 1.242 . . . . 0.0 115.872 -171.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.2 m -68.87 -15.52 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 175.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -83.19 -14.19 53.9 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.87 1.268 . . . . 0.0 112.99 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.8 mt -68.81 158.29 86.38 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 123.584 0.754 . . . . 0.0 111.432 174.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.67 132.77 53.82 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.703 2.269 . . . . 0.0 111.076 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -59.71 -33.95 96.29 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.426 2.084 . . . . 0.0 113.502 -171.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -64.62 -28.6 69.73 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.704 -1.247 . . . . 0.0 113.325 174.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.64 -4.52 52.02 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.797 -1.19 . . . . 0.0 112.859 172.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 72.3 t -104.78 -41.54 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.452 1.901 . . . . 0.0 111.391 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.3 p -82.04 49.12 1.33 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.637 1.175 . . . . 0.0 113.517 -173.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -104.64 170.31 7.96 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.282 1.833 . . . . 0.0 111.945 176.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -58.38 -37.25 74.87 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.736 0.815 . . . . 0.0 112.89 -170.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 56.2 mt -128.48 120.61 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.95 1.3 . . . . 0.0 108.512 169.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -130.37 138.11 50.23 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.03 0.932 . . . . 0.0 110.857 169.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -140.08 151.06 45.07 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.88 1.272 . . . . 0.0 112.05 -175.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -123.55 99.97 6.57 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.924 1.29 . . . . 0.0 109.886 175.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.426 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 39.5 m0 -79.37 -4.55 51.51 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -170.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.372 1.1 pp0? 50.4 37.55 15.83 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.034 1.734 . . . . 0.0 115.586 170.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 69.3 mt -75.5 157.82 33.45 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.834 1.254 . . . . 0.0 112.352 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -85.19 161.48 19.59 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.961 1.304 . . . . 0.0 111.438 170.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -89.52 122.03 68.67 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.511 1.124 . . . . 0.0 112.141 175.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -93.82 -18.69 0.5 Allowed 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 121.688 1.592 . . . . 0.0 114.872 -169.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -44.15 108.11 0.11 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.007 2.123 . . . . 0.0 113.355 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.22 8.58 62.27 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.544 1.069 . . . . 0.0 115.606 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -79.24 -65.75 0.96 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.004 1.402 . . . . 0.0 111.279 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.6 t -170.44 151.71 3.78 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.603 1.961 . . . . 0.0 109.247 171.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.2 mp -59.85 -29.09 68.06 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.204 0.602 . . . . 0.0 111.218 172.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.95 -39.88 95.98 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.95 -1.094 . . . . 0.0 112.332 173.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 86.4 t -71.61 -39.45 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.655 0.782 . . . . 0.0 109.254 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.35 -44.49 94.67 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.14 0.976 . . . . 0.0 111.739 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 -68.7 -37.39 79.49 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.201 -0.937 . . . . 0.0 112.092 172.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 64.0 m -58.58 -49.46 77.38 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 119.007 0.821 . . . . 0.0 111.674 175.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.8 m -69.97 -30.17 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 117.847 -1.073 . . . . 0.0 112.186 176.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -42.66 94.94 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 120.595 1.543 . . . . 0.0 111.595 169.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.68 -42.62 95.28 Favored Glycine 0 N--CA 1.474 1.175 0 C-N-CA 124.017 0.817 . . . . 0.0 112.758 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -62.32 -47.48 84.06 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 122.172 -0.605 . . . . 0.0 112.057 171.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 36.2 t -60.25 -45.32 96.37 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.059 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -52.47 -53.96 38.71 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 119.92 1.236 . . . . 0.0 111.843 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.21 -45.89 91.34 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.863 0.465 . . . . 0.0 112.08 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.9 mtt-85 -71.61 -33.29 68.87 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.1 t -65.2 -47.62 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.941 171.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -53.64 -54.32 39.34 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.604 1.093 . . . . 0.0 109.658 174.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -54.42 -37.33 64.97 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.206 1.003 . . . . 0.0 112.704 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -78.0 -57.56 3.73 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.213 0.915 . . . . 0.0 112.278 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.71 -32.69 59.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.666 1.187 . . . . 0.0 112.281 -176.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.77 -18.44 58.44 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -174.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -72.28 -21.89 61.29 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.551 1.141 . . . . 0.0 113.42 170.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.2 pt -114.76 20.48 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 126.504 1.921 . . . . 0.0 112.287 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.255 1.361 0 C-N-CA 127.759 2.424 . . . . 0.0 111.528 176.174 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.7 ttp . . . . . 0 N--CA 1.503 2.181 0 CA-C-O 119.889 -0.1 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -85.61 106.32 16.83 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.227 0.611 . . . . 0.0 109.972 171.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -77.84 149.61 34.33 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.144 0.578 . . . . 0.0 110.973 176.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 56.8 t -107.85 143.5 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.207 1.003 . . . . 0.0 110.226 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 58.4 tpp -130.55 116.22 17.85 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.483 0.713 . . . . 0.0 109.857 169.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -86.75 142.15 28.35 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.705 -0.622 . . . . 0.0 110.541 169.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.8 t -133.06 128.92 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.663 1.185 . . . . 0.0 111.562 -174.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.3 p -145.95 175.64 10.29 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.688 0.795 . . . . 0.0 111.564 169.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -61.21 -36.35 79.67 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 120.901 -1.125 . . . . 0.0 112.212 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -108.21 136.11 48.42 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.234 1.413 . . . . 0.0 111.113 169.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -98.29 -0.15 44.49 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.792 0.724 . . . . 0.0 110.971 168.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.4 p -74.51 -24.94 59.07 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.117 1.367 . . . . 0.0 112.936 169.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 t -133.49 -164.61 1.51 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.481 1.913 . . . . 0.0 109.73 174.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 41.03 -80.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 128.685 2.794 . . . . 0.0 116.159 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.0 p -56.37 -44.26 80.01 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.148 0.979 . . . . 0.0 112.347 173.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -63.64 -35.51 80.75 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 120.068 1.304 . . . . 0.0 113.408 168.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 87.8 mtp -61.45 -47.08 87.36 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.082 0.855 . . . . 0.0 110.177 176.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.76 -29.03 68.14 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 118.043 -0.98 . . . . 0.0 113.129 175.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -65.06 -54.28 32.55 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 120.277 1.398 . . . . 0.0 108.747 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.96 -45.66 96.15 Favored Glycine 0 CA--C 1.521 0.462 0 CA-C-O 118.882 -0.955 . . . . 0.0 112.814 -176.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.48 -33.85 73.19 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.155 0.977 . . . . 0.0 112.464 172.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.506 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -77.73 -37.52 49.13 Favored 'General case' 0 C--O 1.225 -0.189 0 O-C-N 121.256 -0.903 . . . . 0.0 111.607 -175.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -69.17 -40.78 77.93 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.77 1.168 . . . . 0.0 112.358 169.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.1 p -67.52 -6.35 19.37 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 121.489 1.95 . . . . 0.0 114.516 171.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.6 mt -111.62 0.01 16.24 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 171.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.7 16.52 0.22 Allowed Glycine 0 CA--C 1.536 1.37 0 N-CA-C 116.712 1.445 . . . . 0.0 116.712 -169.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.98 129.43 41.91 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.823 1.312 . . . . 0.0 111.634 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.49 -3.65 58.59 Favored Glycine 0 CA--C 1.539 1.531 0 CA-C-O 118.526 -1.152 . . . . 0.0 115.691 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -83.84 -58.47 2.78 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 119.675 1.738 . . . . 0.0 110.892 176.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -141.03 177.4 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.936 2.095 . . . . 0.0 110.898 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.93 109.32 21.7 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.131 -0.98 . . . . 0.0 111.672 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.506 HG11 ' HB3' ' A' ' 22' ' ' ALA . 40.0 t -85.74 135.75 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 125.757 1.623 . . . . 0.0 111.65 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.85 159.29 43.71 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.173 0.989 . . . . 0.0 112.984 -176.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.8 p -141.71 154.1 45.08 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.658 1.583 . . . . 0.0 114.564 172.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.4 p -151.54 -179.18 7.18 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 126.41 1.884 . . . . 0.0 111.184 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.32 178.97 48.28 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 120.309 -1.494 . . . . 0.0 115.417 176.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 35.0 mt -71.51 -44.31 64.88 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -170.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -116.94 87.59 2.73 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.818 2.447 . . . . 0.0 106.018 169.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.2 p -54.51 -46.46 73.49 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.656 -0.653 . . . . 0.0 111.74 -171.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.7 t 56.57 -166.18 0.13 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.478 1.911 . . . . 0.0 113.476 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -78.24 -153.4 0.06 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.978 2.111 . . . . 0.0 111.863 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.8 m -98.28 125.69 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.12 1.768 . . . . 0.0 106.848 168.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -71.53 131.53 86.28 Favored Pre-proline 0 N--CA 1.478 0.938 0 O-C-N 120.516 -1.365 . . . . 0.0 113.2 -168.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -59.35 -38.82 82.22 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.338 2.692 . . . . 0.0 113.84 -172.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.402 ' HB ' ' CE2' ' A' ' 112' ' ' PHE . 9.1 m -79.64 -36.22 38.17 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.838 -0.539 . . . . 0.0 110.608 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.54 -40.2 95.17 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.956 -1.09 . . . . 0.0 112.383 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 52.1 mt -52.7 -43.68 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 120.847 1.658 . . . . 0.0 110.652 173.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.42 -59.41 4.38 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 174.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.6 mmt -65.98 -21.81 66.43 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -173.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 82.7 mmm -89.79 -37.1 14.74 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.062 0.945 . . . . 0.0 111.238 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -60.8 -35.74 77.24 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.691 1.132 . . . . 0.0 111.572 170.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -55.37 -27.95 50.73 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 171.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.9 m -108.08 20.57 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 125.01 1.324 . . . . 0.0 113.934 175.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.09 11.92 75.06 Favored Glycine 0 CA--C 1.536 1.362 0 O-C-N 121.222 -0.924 . . . . 0.0 115.291 173.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.4 mt -122.84 87.67 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.513 1.525 . . . . 0.0 109.093 -169.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -70.66 111.33 6.06 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 120.315 -1.491 . . . . 0.0 110.419 170.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.7 pt -86.34 -6.28 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 O-C-N 121.496 -0.753 . . . . 0.0 112.608 175.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.3 t -63.78 -30.78 71.84 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 120.007 1.276 . . . . 0.0 112.736 -173.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.95 4.78 75.47 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 125.318 1.437 . . . . 0.0 115.508 171.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -78.06 147.77 34.59 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.108 1.454 . . . . 0.0 111.581 -175.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 10.8 t -62.76 147.47 49.69 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.588 -0.695 . . . . 0.0 112.084 174.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.5 t -127.94 131.98 49.28 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.839 0.856 . . . . 0.0 109.874 169.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -145.33 136.22 12.36 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.899 0.88 . . . . 0.0 113.087 -169.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -84.47 154.23 12.15 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.405 2.737 . . . . 0.0 113.11 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.0 tp -61.56 -18.67 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -103.98 -8.89 19.27 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -86.27 -35.18 20.1 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.297 0.953 . . . . 0.0 110.837 169.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.02 156.0 40.15 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 122.971 0.508 . . . . 0.0 110.702 170.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.1 121.05 15.56 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.557 0.743 . . . . 0.0 110.747 170.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.72 1.68 2.35 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -170.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -69.28 -27.08 65.1 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.343 -0.848 . . . . 0.0 111.918 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -93.33 -2.58 54.71 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.576 1.55 . . . . 0.0 113.225 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -127.1 84.37 2.26 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.998 1.719 . . . . 0.0 109.955 -172.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.69 -18.39 41.92 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.4 t -120.89 111.2 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 125.515 1.526 . . . . 0.0 109.762 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.4 t -126.34 121.39 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 121.611 -0.68 . . . . 0.0 110.476 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 mp -113.15 135.05 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.277 1.031 . . . . 0.0 109.958 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.0 m -95.8 148.4 22.63 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.604 1.162 . . . . 0.0 109.972 169.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.417 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 87.6 mt -129.09 44.21 3.01 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.065 0.946 . . . . 0.0 110.169 -171.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 22.5 p -151.85 -10.03 0.2 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 -169.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.9 31.06 77.07 Favored Glycine 0 CA--C 1.539 1.558 0 CA-C-N 119.553 1.069 . . . . 0.0 111.057 -168.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 2.4 p -139.74 2.09 1.95 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.234 1.814 . . . . 0.0 114.48 -169.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -54.08 -27.27 37.68 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 116.416 1.326 . . . . 0.0 116.416 -170.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.3 m -63.97 -15.34 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 118.673 1.236 . . . . 0.0 113.954 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -80.15 -11.01 59.79 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.042 1.337 . . . . 0.0 113.417 175.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.3 mt -73.58 160.41 82.31 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.91 0.884 . . . . 0.0 111.743 177.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -54.79 138.12 76.07 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.066 2.51 . . . . 0.0 111.827 173.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -59.02 -34.26 99.02 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.359 2.039 . . . . 0.0 113.628 -172.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -65.99 -26.77 67.71 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.817 -1.177 . . . . 0.0 113.692 174.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.38 -15.81 59.18 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.631 -1.293 . . . . 0.0 113.027 170.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.6 t -93.51 -37.75 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 126.548 1.939 . . . . 0.0 112.162 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.8 p -83.97 18.13 2.16 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -172.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -70.22 162.36 28.57 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.496 1.118 . . . . 0.0 112.359 169.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -55.47 -35.19 65.23 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.108 1.363 . . . . 0.0 113.781 -169.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.9 mt -127.9 118.79 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.812 1.245 . . . . 0.0 108.15 169.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -132.57 128.01 36.29 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.121 0.968 . . . . 0.0 111.298 170.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -147.51 161.96 40.04 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.805 1.642 . . . . 0.0 111.075 -174.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -129.94 129.96 44.5 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.557 0.743 . . . . 0.0 111.672 169.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.417 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 46.3 m0 -90.06 1.93 55.79 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -177.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 71.44 -72.35 0.12 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.44 1.896 . . . . 0.0 113.256 175.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 20.5 mt 50.14 -157.97 0.09 Allowed 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 126.143 1.777 . . . . 0.0 114.221 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -144.06 156.66 44.46 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.828 2.451 . . . . 0.0 108.045 172.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -80.13 120.04 78.43 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-N 120.683 1.583 . . . . 0.0 111.887 176.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -91.31 -21.69 0.63 Allowed 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 122.249 1.966 . . . . 0.0 115.746 -169.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -53.44 110.16 0.53 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.507 1.123 . . . . 0.0 112.403 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.73 1.43 87.32 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.068 0.842 . . . . 0.0 114.749 176.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -75.05 170.07 16.75 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.584 1.192 . . . . 0.0 110.822 169.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.2 t -63.31 148.27 48.76 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.531 -0.73 . . . . 0.0 110.361 169.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 mp -61.43 -27.86 68.85 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.604 -0.685 . . . . 0.0 112.485 -173.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.85 -34.76 78.02 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.998 -1.064 . . . . 0.0 113.444 171.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.2 t -71.12 -35.72 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 O-C-N 120.975 -1.078 . . . . 0.0 109.885 172.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.402 ' CE2' ' HB ' ' A' ' 45' ' ' THR . 0.3 OUTLIER -67.7 -38.52 83.77 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.322 0.649 . . . . 0.0 111.125 177.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -70.25 -37.38 74.93 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.994 1.318 . . . . 0.0 111.739 170.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.6 m -57.51 -45.88 84.43 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 119.118 0.872 . . . . 0.0 111.66 175.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.0 m -69.33 -29.91 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 119.723 1.147 . . . . 0.0 112.609 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -62.44 -41.75 98.95 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 120.542 1.519 . . . . 0.0 111.77 170.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.07 -45.41 87.51 Favored Glycine 0 N--CA 1.474 1.195 0 C-N-CA 124.039 0.828 . . . . 0.0 112.745 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -60.56 -40.53 91.96 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 122.197 -0.59 . . . . 0.0 112.375 171.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.2 t -64.99 -46.76 90.58 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.103 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -52.03 -53.15 45.45 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 120.141 1.337 . . . . 0.0 111.593 176.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -49.81 -45.1 49.65 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.301 1.44 . . . . 0.0 112.111 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -92.16 -27.05 17.95 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.058 0.943 . . . . 0.0 112.179 -171.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.9 t -62.19 -49.8 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.042 1.337 . . . . 0.0 109.799 169.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -54.06 -53.73 49.09 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.005 0.82 . . . . 0.0 109.583 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -53.03 -37.93 61.95 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.141 1.776 . . . . 0.0 112.364 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -78.83 -59.87 2.6 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.157 -0.964 . . . . 0.0 112.781 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.18 -33.55 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.887 1.275 . . . . 0.0 112.498 -174.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.97 -18.79 61.96 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -78.42 -25.13 45.93 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.648 1.179 . . . . 0.0 113.52 174.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.1 pt -106.25 -8.18 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.498 1.519 . . . . 0.0 113.678 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 C--O 1.254 1.315 0 C-N-CA 125.493 1.517 . . . . 0.0 113.088 173.653 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.2 ttp . . . . . 0 N--CA 1.503 2.203 0 CA-C-O 119.754 -0.165 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -88.35 97.85 11.27 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.079 0.952 . . . . 0.0 110.69 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -81.24 133.73 35.49 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 121.633 -0.667 . . . . 0.0 110.811 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.5 m -100.15 146.51 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.088 0.955 . . . . 0.0 110.998 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.8 tpp -126.41 112.11 15.26 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.907 0.883 . . . . 0.0 110.876 172.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -81.54 138.07 35.48 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.967 -0.458 . . . . 0.0 110.656 169.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.2 t -137.38 129.79 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.316 1.047 . . . . 0.0 111.234 -171.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 t -145.69 -175.6 4.8 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 119.166 0.894 . . . . 0.0 113.345 169.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -60.03 -37.66 80.45 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 121.752 -0.593 . . . . 0.0 110.323 169.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.434 ' HB3' ' H ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -113.95 127.74 56.09 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.985 0.914 . . . . 0.0 110.695 168.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -66.97 -33.65 76.04 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.552 168.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.8 p -67.97 -47.51 68.41 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.136 1.774 . . . . 0.0 115.584 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.434 ' H ' ' HB3' ' A' ' 10' ' ' ARG . 56.3 p -85.42 -24.96 27.26 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -171.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.27 -60.89 1.59 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 176.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.8 m -60.19 -41.06 92.15 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.147 0.885 . . . . 0.0 112.947 -169.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -60.44 -40.05 89.71 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.847 1.659 . . . . 0.0 113.088 169.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.7 mtm -61.94 -46.06 90.95 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.852 -1.155 . . . . 0.0 111.023 174.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.89 -28.52 66.76 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 173.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -71.24 -46.04 61.93 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.227 1.376 . . . . 0.0 108.96 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.61 -44.07 97.03 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 118.602 -1.11 . . . . 0.0 112.408 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -63.15 -41.31 99.25 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.974 1.387 . . . . 0.0 111.971 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.94 -34.58 71.63 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 120.719 -1.238 . . . . 0.0 110.572 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -59.45 -57.92 10.86 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.112 1.765 . . . . 0.0 109.94 170.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.6 p -69.09 -14.64 63.13 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.1 mt -99.87 -6.38 26.88 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.5 10.77 0.52 Allowed Glycine 0 N--CA 1.476 1.357 0 N-CA-C 117.192 1.637 . . . . 0.0 117.192 -169.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.02 131.06 39.88 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.076 1.438 . . . . 0.0 112.142 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.97 -8.68 49.71 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.387 -1.229 . . . . 0.0 115.777 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -84.76 -57.08 3.26 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 120.03 1.915 . . . . 0.0 110.461 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -139.02 179.43 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 126.57 1.948 . . . . 0.0 110.597 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.76 127.39 47.2 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.341 -0.849 . . . . 0.0 112.091 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.5 m -90.99 145.26 7.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 123.989 0.916 . . . . 0.0 113.212 169.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.8 157.4 43.66 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.998 0.919 . . . . 0.0 110.88 -174.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.9 p -141.89 141.85 33.04 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.394 1.478 . . . . 0.0 112.757 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.1 t -143.46 178.15 7.96 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.414 1.486 . . . . 0.0 111.208 169.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.03 170.21 37.11 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 119.905 -1.747 . . . . 0.0 114.494 172.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.5 mt -60.53 -45.0 95.46 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.453 0.701 . . . . 0.0 111.851 -170.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -109.45 111.63 23.27 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 127.239 2.216 . . . . 0.0 106.251 169.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.4 p -66.72 -43.17 84.96 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.446 -1.409 . . . . 0.0 110.975 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 t 52.62 -170.69 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.711 2.004 . . . . 0.0 114.081 -176.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -88.63 174.37 8.09 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.587 1.955 . . . . 0.0 111.787 173.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 m -60.77 113.4 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 169.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -64.45 130.37 94.64 Favored Pre-proline 0 N--CA 1.477 0.902 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -168.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -59.98 -39.2 72.93 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.475 2.783 . . . . 0.0 114.028 -171.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 m -78.3 -37.28 45.13 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.117 0.567 . . . . 0.0 110.507 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.22 93.59 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.084 -0.96 . . . . 0.0 112.355 175.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.9 mt -52.07 -45.75 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 120.687 1.585 . . . . 0.0 110.083 173.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.2 -57.8 7.58 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.2 mmt -64.88 -23.07 67.12 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -174.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 87.7 mmm -89.97 -37.83 14.07 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.224 1.01 . . . . 0.0 110.851 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -58.75 -36.81 74.96 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 120.766 -1.209 . . . . 0.0 112.067 169.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -54.97 -30.57 59.44 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.353 1.061 . . . . 0.0 113.704 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.2 m -104.47 15.69 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 125.059 1.344 . . . . 0.0 114.113 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.86 15.43 63.16 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.131 0.872 . . . . 0.0 115.087 176.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.2 mt -124.56 74.2 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.832 1.653 . . . . 0.0 109.461 -169.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -66.39 108.06 2.24 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 119.938 -1.726 . . . . 0.0 110.498 172.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.8 pt -86.95 -0.47 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.0 p -67.71 -24.87 65.44 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.535 -1.353 . . . . 0.0 114.588 -169.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.61 6.0 64.86 Favored Glycine 0 CA--C 1.541 1.671 0 C-N-CA 125.389 1.471 . . . . 0.0 114.66 170.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -82.06 147.92 28.87 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.704 1.202 . . . . 0.0 112.029 -172.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.6 t -69.06 156.1 39.23 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 121.505 -0.747 . . . . 0.0 112.157 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.5 t -136.6 142.68 43.33 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.743 0.817 . . . . 0.0 111.243 170.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.31 140.6 21.08 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -171.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -89.96 156.48 4.91 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 124.123 3.215 . . . . 0.0 113.024 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.7 tp -61.52 -22.98 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -170.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -102.62 -5.34 23.97 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -87.87 -38.89 15.27 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.651 -0.656 . . . . 0.0 110.852 169.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.06 153.36 43.9 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.23 0.538 . . . . 0.0 111.436 171.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -136.98 120.63 17.26 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.529 1.132 . . . . 0.0 110.444 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.49 8.48 1.78 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -170.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -73.35 -29.87 62.95 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.47 -0.769 . . . . 0.0 112.305 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -93.39 -3.55 53.07 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.091 1.357 . . . . 0.0 113.642 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -125.06 89.36 3.04 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.869 1.668 . . . . 0.0 109.351 -172.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -59.7 -24.66 64.14 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -175.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.0 t -121.35 105.11 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.703 1.201 . . . . 0.0 110.106 -169.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.433 ' C ' HD12 ' A' ' 77' ' ' ILE . 37.8 t -116.05 130.49 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.584 1.154 . . . . 0.0 110.66 -174.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.433 HD12 ' C ' ' A' ' 76' ' ' VAL . 1.6 mp -119.38 124.97 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.714 0.806 . . . . 0.0 109.98 -174.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 t -85.7 124.68 32.49 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.419 1.088 . . . . 0.0 108.969 168.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.414 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 75.2 mt -111.54 37.68 2.83 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 126.673 1.989 . . . . 0.0 110.506 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 9.6 t -148.92 142.74 25.66 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.446 -0.783 . . . . 0.0 112.697 -175.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -62.92 -23.45 65.72 Favored Glycine 0 CA--C 1.547 2.069 0 O-C-N 121.617 -0.677 . . . . 0.0 111.469 168.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 16.9 p -73.44 3.99 5.34 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.267 2.227 . . . . 0.0 115.602 170.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -55.29 -26.22 43.03 Favored Glycine 0 CA--C 1.536 1.367 0 N-CA-C 116.727 1.451 . . . . 0.0 116.727 -169.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.9 m -62.84 -16.35 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 173.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -88.43 -0.29 57.04 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.025 1.33 . . . . 0.0 113.871 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.5 mt -67.94 152.8 96.11 Favored Pre-proline 0 CA--C 1.548 0.881 0 O-C-N 120.863 -1.148 . . . . 0.0 112.291 176.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.83 134.7 58.7 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.031 2.487 . . . . 0.0 111.798 176.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -61.62 -30.18 85.29 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.483 2.122 . . . . 0.0 113.557 -174.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -66.58 -30.89 71.29 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.544 -1.348 . . . . 0.0 113.183 173.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -78.61 -20.12 51.15 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.926 -1.108 . . . . 0.0 112.632 174.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.3 t -86.77 -38.65 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.801 1.64 . . . . 0.0 112.107 174.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.3 p -85.12 52.43 2.44 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 120.785 -1.197 . . . . 0.0 113.366 -172.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -110.65 171.51 7.42 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.339 1.856 . . . . 0.0 112.306 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -53.29 -42.48 66.66 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.401 1.08 . . . . 0.0 113.003 -169.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.3 mt -130.2 122.42 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.867 1.267 . . . . 0.0 108.756 169.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -122.36 132.45 54.39 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.706 0.802 . . . . 0.0 109.157 169.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.82 155.12 44.6 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.127 1.371 . . . . 0.0 111.156 -176.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -136.21 118.86 16.0 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.493 0.717 . . . . 0.0 111.92 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.414 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 31.8 m0 -97.94 3.06 49.66 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.725 1.21 . . . . 0.0 113.338 -175.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.329 1.2 pp0? 45.59 43.42 9.18 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.9 2.08 . . . . 0.0 115.905 171.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 83.9 mt -84.49 158.16 21.09 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.698 1.199 . . . . 0.0 113.917 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -79.85 164.07 23.88 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.331 1.852 . . . . 0.0 112.188 169.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -95.84 111.71 56.86 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 123.861 0.864 . . . . 0.0 108.975 169.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -85.44 -10.57 7.58 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.049 2.499 . . . . 0.0 116.067 -169.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -49.67 112.7 0.69 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.533 1.133 . . . . 0.0 112.816 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.6 -0.15 89.69 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 123.844 0.735 . . . . 0.0 114.836 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -75.79 170.68 15.75 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 118.295 1.047 . . . . 0.0 110.31 169.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.5 t -58.84 145.27 41.55 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.507 -0.746 . . . . 0.0 111.028 169.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.45 -28.32 68.22 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.15 0.58 . . . . 0.0 111.998 -176.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -65.82 -33.18 75.27 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 120.96 -1.087 . . . . 0.0 113.237 173.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.2 t -70.28 -36.47 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 O-C-N 121.037 -1.039 . . . . 0.0 109.823 171.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.87 -42.68 90.07 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.645 0.778 . . . . 0.0 110.736 176.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -67.12 -36.06 81.09 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.78 1.232 . . . . 0.0 112.367 171.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.5 m -59.53 -48.89 79.89 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 119.306 0.957 . . . . 0.0 111.427 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.3 m -68.21 -32.31 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 117.909 -1.043 . . . . 0.0 111.983 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.08 -43.4 91.8 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 120.825 1.648 . . . . 0.0 111.978 169.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.47 -41.89 89.91 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 124.388 0.994 . . . . 0.0 112.556 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -61.95 -46.14 90.59 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 122.214 -0.58 . . . . 0.0 111.897 169.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.42 -46.73 92.44 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.267 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -51.95 -54.92 23.92 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.654 1.182 . . . . 0.0 111.827 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -60.61 -41.42 94.74 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.351 0.661 . . . . 0.0 112.305 -176.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 50.7 mtp85 -79.2 -33.83 43.5 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.4 t -59.81 -47.58 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.182 0.993 . . . . 0.0 110.653 170.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -53.35 -55.3 26.0 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.11 0.868 . . . . 0.0 109.966 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -54.71 -40.63 69.4 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.881 1.273 . . . . 0.0 112.301 176.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.7 -58.81 3.07 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.183 -0.948 . . . . 0.0 112.52 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.36 -34.95 70.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.599 1.16 . . . . 0.0 111.624 -176.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.42 -15.95 61.33 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -173.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -71.17 -28.16 64.05 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.435 1.094 . . . . 0.0 113.42 170.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.7 pt -113.81 -6.95 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.189 1.796 . . . . 0.0 113.287 -173.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.7 m . . . . . 0 C--O 1.254 1.299 0 C-N-CA 125.735 1.614 . . . . 0.0 113.713 173.561 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.503 2.217 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -79.62 96.51 6.2 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.773 0.829 . . . . 0.0 110.079 171.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -77.12 144.96 38.09 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.759 -0.588 . . . . 0.0 111.191 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 p -122.43 141.72 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.524 1.13 . . . . 0.0 111.047 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 50.8 tpp -124.38 120.41 32.03 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.616 1.167 . . . . 0.0 111.774 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -88.89 130.06 35.49 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.313 0.645 . . . . 0.0 111.507 169.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.2 t -129.24 124.31 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.918 1.287 . . . . 0.0 110.188 -172.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.3 m -136.17 169.65 17.28 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.556 1.142 . . . . 0.0 111.467 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -64.92 -48.69 73.25 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 168.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -99.87 105.4 17.14 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.314 1.446 . . . . 0.0 108.366 168.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -53.58 -33.49 55.04 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 122.952 0.501 . . . . 0.0 110.884 169.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.9 p -65.37 -40.2 93.25 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.164 2.185 . . . . 0.0 115.793 176.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.4 p -97.09 -22.9 16.5 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.43 -51.14 1.75 Allowed 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 171.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.0 m -59.07 -44.57 91.89 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 121.284 1.857 . . . . 0.0 111.926 -175.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -58.23 -43.56 87.79 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.997 1.319 . . . . 0.0 113.474 169.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.415 ' HA ' ' CE ' ' A' ' 50' ' ' MET . 51.2 ttm -58.31 -50.81 72.31 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.325 1.05 . . . . 0.0 111.381 175.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.67 -27.22 66.66 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.254 1.022 . . . . 0.0 112.524 174.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -76.35 -43.55 40.51 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 120.424 1.466 . . . . 0.0 109.133 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.88 -52.99 47.65 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-O 119.152 -0.804 . . . . 0.0 111.248 174.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.513 ' HB3' HG11 ' A' ' 123' ' ' VAL . 17.3 m-85 -62.2 -41.61 98.53 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.286 1.043 . . . . 0.0 112.919 174.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.01 -40.83 97.23 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.211 1.369 . . . . 0.0 110.837 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -61.21 -50.06 74.65 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.326 1.85 . . . . 0.0 111.32 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.6 p -74.94 -22.73 58.42 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.1 mt -88.84 -23.26 22.85 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.264 0.938 . . . . 0.0 112.711 176.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -126.4 21.72 6.01 Favored Glycine 0 N--CA 1.473 1.124 0 C-N-CA 125.777 1.656 . . . . 0.0 115.431 -170.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.91 126.48 27.27 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.236 1.018 . . . . 0.0 112.531 -173.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.65 -2.6 47.22 Favored Glycine 0 CA--C 1.537 1.431 0 N-CA-C 116.024 1.17 . . . . 0.0 116.024 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -81.7 -54.77 5.11 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.587 1.694 . . . . 0.0 111.146 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.415 HD11 HD11 ' A' ' 127' ' ' ILE . 2.3 pp -143.04 -179.37 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 127.355 2.262 . . . . 0.0 110.989 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.23 121.49 42.34 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.482 0.658 . . . . 0.0 111.825 171.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.3 m -87.11 150.8 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 123.473 0.709 . . . . 0.0 111.981 169.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.68 159.77 43.05 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.265 1.026 . . . . 0.0 111.288 -174.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.5 t -144.7 127.7 16.49 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.144 1.378 . . . . 0.0 111.885 -169.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.0 p -144.09 -178.76 6.11 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.532 1.533 . . . . 0.0 111.299 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.06 172.11 35.47 Favored Glycine 0 CA--C 1.532 1.142 0 O-C-N 119.834 -1.791 . . . . 0.0 114.47 173.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 47.6 mt -61.68 -39.15 90.42 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 118.354 1.077 . . . . 0.0 112.176 -173.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -115.81 113.66 23.69 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.809 2.044 . . . . 0.0 107.843 169.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.3 p -65.88 -37.14 85.35 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.933 0.893 . . . . 0.0 112.046 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.4 t 44.09 -129.85 0.87 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 126.159 1.784 . . . . 0.0 112.786 -174.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -146.62 -175.77 4.92 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 127.139 2.176 . . . . 0.0 111.823 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.1 m -59.22 115.75 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 121.134 -0.979 . . . . 0.0 110.291 169.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.8 t-80 -73.85 131.7 81.33 Favored Pre-proline 0 N--CA 1.476 0.855 0 CA-C-O 118.501 -0.762 . . . . 0.0 113.035 -169.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -60.58 -39.74 62.2 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.488 2.792 . . . . 0.0 114.293 -171.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.1 m -80.95 -33.07 34.25 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.803 -0.56 . . . . 0.0 110.833 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.45 -42.46 87.55 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 118.087 -0.959 . . . . 0.0 112.166 174.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.0 mt -47.35 -48.22 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 119.997 1.271 . . . . 0.0 110.395 172.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.61 -61.54 2.14 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.8 mmt -66.31 -27.31 67.82 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.525 -0.735 . . . . 0.0 112.379 -171.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.415 ' CE ' ' HA ' ' A' ' 17' ' ' MET . 81.7 mtp -84.22 -38.18 20.88 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.595 0.758 . . . . 0.0 111.364 177.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -57.35 -38.05 73.54 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.715 1.143 . . . . 0.0 112.099 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -59.39 -23.39 62.55 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.0 m -108.28 15.07 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.39 16.54 58.7 Favored Glycine 0 N--CA 1.478 1.444 0 O-C-N 121.087 -1.008 . . . . 0.0 115.325 176.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.9 mt -125.43 53.31 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.892 1.677 . . . . 0.0 110.307 -169.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -60.4 113.2 2.28 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.26 -1.525 . . . . 0.0 111.435 176.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.8 pt -91.46 2.53 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.215 1.006 . . . . 0.0 113.648 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -62.19 -24.41 67.19 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 120.759 1.618 . . . . 0.0 113.262 -173.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.46 6.87 59.47 Favored Glycine 0 CA--C 1.543 1.84 0 C-N-CA 125.475 1.512 . . . . 0.0 115.77 170.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -83.24 152.21 25.29 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.089 1.445 . . . . 0.0 112.088 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.0 t -71.44 163.67 27.26 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 52.0 m -137.07 140.92 42.34 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.01 1.724 . . . . 0.0 109.49 169.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -145.96 141.89 17.17 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-N 119.548 1.067 . . . . 0.0 113.369 -175.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -86.45 148.27 8.78 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 123.221 2.614 . . . . 0.0 111.441 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.0 tt -66.48 -16.63 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 O-C-N 120.549 -1.344 . . . . 0.0 113.976 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -89.54 -10.52 45.86 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.112 -0.992 . . . . 0.0 113.485 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -88.5 -40.7 13.24 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.764 0.825 . . . . 0.0 111.453 170.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.71 153.03 43.19 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.816 0.847 . . . . 0.0 111.694 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.443 ' HA ' ' CH2' ' A' ' 90' ' ' TRP . 11.1 m120 -128.38 124.87 37.45 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.435 0.694 . . . . 0.0 110.329 169.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.405 ' HB3' ' CE3' ' A' ' 90' ' ' TRP . . . -70.29 5.71 1.62 Allowed 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -175.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -73.02 -29.02 62.7 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.983 0.913 . . . . 0.0 112.213 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -97.51 -3.79 39.17 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.81 1.244 . . . . 0.0 113.583 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -121.73 92.01 3.64 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.009 1.724 . . . . 0.0 109.353 -172.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -60.51 -28.17 68.18 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -174.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.5 t -113.67 116.74 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.383 1.073 . . . . 0.0 110.098 -177.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.1 t -126.4 132.51 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.909 0.884 . . . . 0.0 110.377 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.7 mm -123.07 127.78 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 121.771 -0.581 . . . . 0.0 111.466 -170.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.5 t -87.51 126.45 34.92 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.282 1.433 . . . . 0.0 109.964 169.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.5 mt -112.6 42.14 1.9 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.645 1.178 . . . . 0.0 113.015 -174.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 30.4 p -123.66 -162.28 1.04 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.126 2.17 . . . . 0.0 107.744 168.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -120.21 47.16 1.05 Allowed Glycine 0 CA--C 1.53 0.976 0 N-CA-C 107.729 -2.148 . . . . 0.0 107.729 168.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 16.2 p -138.42 -54.13 0.62 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -168.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.89 -43.37 0.2 Allowed Glycine 0 CA--C 1.543 1.837 0 C-N-CA 126.98 2.229 . . . . 0.0 116.04 -175.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 p -65.77 -20.69 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 126.933 2.093 . . . . 0.0 115.161 -169.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -79.24 -4.29 49.96 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.0 mt -91.65 146.98 34.18 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 125.355 1.462 . . . . 0.0 110.769 172.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -71.37 151.32 59.71 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.328 2.019 . . . . 0.0 110.863 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -58.62 -34.78 99.11 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.837 2.358 . . . . 0.0 112.613 -175.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -48.83 -46.25 41.73 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.602 1.561 . . . . 0.0 112.919 175.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.443 ' CH2' ' HA ' ' A' ' 69' ' ' ASN . 1.8 m95 -90.57 8.42 34.21 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.052 1.341 . . . . 0.0 113.072 -177.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.5 t -116.0 -39.32 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 126.868 2.067 . . . . 0.0 111.697 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.6 p -79.9 28.11 0.29 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -174.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -85.22 172.19 11.36 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.826 1.65 . . . . 0.0 111.961 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -53.69 -42.37 67.89 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -169.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.6 mt -129.4 125.67 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.463 1.105 . . . . 0.0 109.069 169.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -131.99 136.26 47.15 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.264 1.026 . . . . 0.0 111.533 169.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -143.06 154.94 44.47 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.111 1.364 . . . . 0.0 111.741 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -122.64 118.95 29.37 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.14 1.376 . . . . 0.0 109.976 171.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -84.86 3.98 35.38 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 117.788 2.514 . . . . 0.0 117.788 -169.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 58.44 51.16 8.43 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.252 1.387 . . . . 0.0 113.048 176.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 66.2 mt -107.73 165.93 11.07 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.336 1.855 . . . . 0.0 113.269 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -122.32 153.73 38.56 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.387 1.875 . . . . 0.0 110.32 173.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -74.34 118.32 68.84 Favored Pre-proline 0 CA--C 1.546 0.816 0 O-C-N 121.296 -0.878 . . . . 0.0 111.342 176.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.413 ' HB2' ' CD2' ' A' ' 112' ' ' PHE . 27.6 Cg_endo -85.27 -6.6 9.19 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.32 2.013 . . . . 0.0 114.013 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -48.67 116.03 1.46 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.231 1.013 . . . . 0.0 112.77 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.04 3.68 69.71 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.791 0.71 . . . . 0.0 114.338 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -80.94 171.58 14.82 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.463 1.105 . . . . 0.0 110.115 171.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.3 p -63.9 156.49 27.5 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.339 -0.85 . . . . 0.0 112.082 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.05 -29.06 70.03 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.578 -0.701 . . . . 0.0 111.43 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.27 -40.96 92.22 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.175 -0.953 . . . . 0.0 112.641 172.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.3 t -73.1 -39.85 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.753 0.821 . . . . 0.0 109.691 176.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.413 ' CD2' ' HB2' ' A' ' 104' ' ' PRO . 0.6 OUTLIER -63.52 -36.87 85.21 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.051 0.54 . . . . 0.0 111.189 177.553 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -70.95 -43.21 68.63 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.339 1.456 . . . . 0.0 112.199 172.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.2 m -57.69 -51.05 71.11 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.177 0.991 . . . . 0.0 111.838 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.4 m -68.1 -29.23 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 O-C-N 121.271 -0.893 . . . . 0.0 112.051 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.6 ptt-85 -70.6 -32.9 70.43 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 119.778 1.172 . . . . 0.0 113.051 173.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.11 -45.12 94.64 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 123.88 0.752 . . . . 0.0 112.262 170.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -61.97 -42.18 98.85 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.926 -0.749 . . . . 0.0 112.348 171.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.422 ' O ' HG12 ' A' ' 123' ' ' VAL . 8.3 t -60.22 -50.12 81.49 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.724 0 CA-C-O 117.139 -1.41 . . . . 0.0 110.182 174.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -51.19 -48.91 61.84 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.469 1.508 . . . . 0.0 112.158 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -55.27 -43.7 74.94 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.701 1.2 . . . . 0.0 112.492 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.0 mtt180 -91.59 -32.89 15.34 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.975 0.91 . . . . 0.0 112.75 -169.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.513 HG11 ' HB3' ' A' ' 21' ' ' PHE . 9.4 p -69.6 -36.66 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.574 1.55 . . . . 0.0 112.012 171.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -56.67 -58.76 6.7 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.81 1.186 . . . . 0.0 109.915 169.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -55.34 -27.65 48.58 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.504 1.122 . . . . 0.0 113.299 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -85.07 -59.33 2.37 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.336 0.971 . . . . 0.0 112.904 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.415 HD11 HD11 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -58.92 -33.34 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.553 1.141 . . . . 0.0 111.727 -178.063 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.83 -14.13 60.65 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -82.48 -28.38 31.22 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.501 1.121 . . . . 0.0 113.065 172.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.3 pt -98.92 -12.02 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.612 1.165 . . . . 0.0 113.817 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.2 m . . . . . 0 C--O 1.255 1.356 0 C-N-CA 124.766 1.226 . . . . 0.0 113.245 171.672 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 ttm . . . . . 0 N--CA 1.503 2.182 0 CA-C-O 119.712 -0.185 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -91.95 85.82 5.67 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.19 0.996 . . . . 0.0 110.277 177.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -77.45 150.74 34.94 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.535 -0.728 . . . . 0.0 111.351 -175.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.2 t -108.38 143.27 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.583 0.753 . . . . 0.0 111.45 -175.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 43.7 tpp -128.08 110.39 12.44 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.912 0.885 . . . . 0.0 110.156 169.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -81.83 138.51 35.09 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.635 169.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.6 t -135.62 128.39 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.083 0.953 . . . . 0.0 111.587 -174.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.7 p -147.17 -178.23 6.1 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.798 1.239 . . . . 0.0 111.813 175.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -62.35 -64.34 0.96 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 119.847 1.203 . . . . 0.0 110.124 172.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.27 107.42 16.56 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 168.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 39' ' ' SER . 13.7 t-20 -56.67 -41.73 77.78 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.748 0.704 . . . . 0.0 109.556 169.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.2 p -53.22 -29.57 33.08 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 127.446 2.299 . . . . 0.0 115.849 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.1 p -97.97 -97.47 0.21 Allowed 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 123.571 0.748 . . . . 0.0 109.82 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -53.19 -50.7 64.11 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.391 1.476 . . . . 0.0 113.38 -169.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.533 ' HB3' ' HB2' ' A' ' 34' ' ' SER . 69.9 m -71.36 -40.2 70.78 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -174.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -64.25 -37.2 86.63 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 168.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 77.0 mtp -58.38 -51.36 70.14 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.108 0.867 . . . . 0.0 109.592 172.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.24 -36.18 82.82 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -66.38 -40.22 89.57 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 119.524 1.056 . . . . 0.0 108.882 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.404 ' HA3' ' CG2' ' A' ' 55' ' ' ILE . . . -68.16 -45.05 73.65 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-O 118.961 -0.911 . . . . 0.0 111.989 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -62.28 -38.88 91.04 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.305 1.052 . . . . 0.0 111.458 170.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.401 ' HB1' HG11 ' A' ' 32' ' ' VAL . . . -70.24 -33.46 71.68 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 120.587 -1.32 . . . . 0.0 111.368 -178.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -62.8 -55.5 25.87 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.443 1.897 . . . . 0.0 109.369 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.8 p -71.46 -15.51 62.33 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.6 mt -97.4 -11.12 24.3 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 173.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.99 9.2 2.01 Favored Glycine 0 N--CA 1.477 1.376 0 N-CA-C 117.227 1.651 . . . . 0.0 117.227 -169.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.5 128.98 27.58 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.155 1.478 . . . . 0.0 112.342 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.12 -6.89 55.28 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-O 118.319 -1.267 . . . . 0.0 115.888 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -85.68 -57.16 3.16 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.02 1.91 . . . . 0.0 110.286 175.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 pp -139.71 173.4 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 127.433 2.293 . . . . 0.0 109.141 171.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.37 131.2 44.27 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.522 -0.736 . . . . 0.0 111.833 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.401 HG11 ' HB1' ' A' ' 22' ' ' ALA . 32.7 m -100.11 143.8 13.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 123.709 0.804 . . . . 0.0 112.805 170.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 m -145.98 162.59 37.48 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.615 1.566 . . . . 0.0 109.467 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.533 ' HB2' ' HB3' ' A' ' 15' ' ' SER . 91.0 p -143.91 148.69 35.76 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.061 0.944 . . . . 0.0 113.097 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.5 p -138.39 -170.38 2.8 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.025 1.33 . . . . 0.0 110.914 171.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.93 173.44 37.36 Favored Glycine 0 CA--C 1.528 0.891 0 O-C-N 121.078 -1.013 . . . . 0.0 113.85 175.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.8 mt -64.78 -35.92 82.64 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.409 0.684 . . . . 0.0 112.253 -172.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -123.24 105.69 10.09 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 128.449 2.699 . . . . 0.0 107.09 172.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.408 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 11.2 p -60.9 -46.9 88.82 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.437 -0.79 . . . . 0.0 111.633 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.1 t 49.72 -171.83 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 127.898 2.479 . . . . 0.0 114.415 -174.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -77.98 166.74 22.47 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.65 1.58 . . . . 0.0 110.214 169.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.1 m -56.99 120.13 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 119.949 1.25 . . . . 0.0 108.098 169.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -65.15 127.56 92.96 Favored Pre-proline 0 N--CA 1.479 0.998 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -167.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -61.73 -39.48 52.75 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.256 2.637 . . . . 0.0 113.845 -169.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.1 m -77.85 -35.66 50.81 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.937 -0.477 . . . . 0.0 110.318 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.17 -38.1 87.24 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 117.956 -1.021 . . . . 0.0 112.407 174.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.0 mt -55.31 -41.64 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 121.455 1.934 . . . . 0.0 110.501 173.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.73 -59.77 4.15 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.0 mmt -63.69 -27.29 69.11 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.483 -0.761 . . . . 0.0 112.66 -174.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 88.0 mmm -85.01 -33.12 22.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.773 0.829 . . . . 0.0 110.561 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -61.86 -33.61 74.49 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.888 -1.133 . . . . 0.0 111.817 171.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -55.06 -33.6 62.87 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.088 0.955 . . . . 0.0 112.763 172.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.4 m -105.49 19.11 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.259 1.424 . . . . 0.0 113.859 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.34 17.01 74.89 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 115.528 0.971 . . . . 0.0 115.528 173.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.404 ' CG2' ' HA3' ' A' ' 20' ' ' GLY . 71.6 mt -115.36 125.93 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.206 1.402 . . . . 0.0 111.417 -169.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -100.43 73.41 1.65 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.558 1.943 . . . . 0.0 112.727 -172.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.33 -10.23 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 120.373 -1.454 . . . . 0.0 111.672 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.1 p -60.95 -32.03 71.56 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.888 2.475 . . . . 0.0 113.833 169.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.45 47.55 1.02 Allowed Glycine 0 N--CA 1.474 1.224 0 C-N-CA 126.418 1.961 . . . . 0.0 112.168 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -135.87 171.94 13.73 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.668 1.587 . . . . 0.0 113.287 -169.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -76.56 137.26 39.44 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 121.37 -0.832 . . . . 0.0 112.944 -169.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.7 m -125.59 45.58 2.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.189 1.396 . . . . 0.0 111.004 -170.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.83 140.22 54.4 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -169.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -83.11 151.1 13.9 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.186 2.591 . . . . 0.0 111.008 169.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.9 tt -63.33 -21.57 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 -171.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -99.24 -4.71 31.32 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -88.51 -41.55 12.66 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.044 0.838 . . . . 0.0 112.117 171.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.35 164.33 24.73 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.229 0.538 . . . . 0.0 112.077 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -136.48 120.18 17.26 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.046 0.938 . . . . 0.0 111.069 171.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.96 2.86 1.79 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 -172.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -70.27 -31.78 69.31 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.406 1.003 . . . . 0.0 112.179 -174.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -90.27 -8.87 49.87 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.56 1.144 . . . . 0.0 113.364 176.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -120.79 72.23 0.96 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.921 1.689 . . . . 0.0 109.378 -173.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -65.37 -6.47 10.23 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -170.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.2 t -120.87 96.64 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 125.938 1.695 . . . . 0.0 109.055 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.4 t -109.63 135.15 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 121.376 -0.828 . . . . 0.0 110.211 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.462 HG21 ' CE2' ' A' ' 99' ' ' TRP . 12.5 mm -128.6 136.13 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 123.27 0.628 . . . . 0.0 110.297 -176.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.4 t -97.26 130.17 44.49 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.545 1.538 . . . . 0.0 110.736 172.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.8 mp -115.51 49.03 1.12 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.148 1.379 . . . . 0.0 110.295 -171.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.1 p -154.53 -9.17 0.14 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 117.27 2.322 . . . . 0.0 117.27 -170.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.01 30.9 76.61 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-N 119.685 1.13 . . . . 0.0 111.482 -169.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 3.9 p -139.68 10.24 2.44 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.879 1.671 . . . . 0.0 114.39 -169.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -55.1 -27.1 44.65 Favored Glycine 0 CA--C 1.533 1.157 0 N-CA-C 116.287 1.275 . . . . 0.0 116.287 -169.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 p -61.13 -21.73 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-N 118.505 1.152 . . . . 0.0 113.267 174.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -84.15 -6.77 59.45 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.038 1.335 . . . . 0.0 113.768 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.2 mt -76.66 160.94 75.9 Favored Pre-proline 0 CA--C 1.554 1.115 0 O-C-N 121.06 -1.025 . . . . 0.0 111.792 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -58.12 145.97 90.09 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.178 2.585 . . . . 0.0 114.394 -177.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -75.41 41.25 0.76 Allowed 'Trans proline' 0 CA--C 1.551 1.357 1 C-N-CA 126.062 4.508 . . . . 0.0 113.924 -175.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -156.7 -35.56 0.08 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.931 2.492 . . . . 0.0 111.023 -176.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.18 -22.66 61.25 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.49 -1.381 . . . . 0.0 111.346 169.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 m -89.69 -10.22 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 175.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.4 p -98.02 4.32 49.31 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -170.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -69.44 164.68 22.51 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.87 0.868 . . . . 0.0 111.86 175.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -57.32 -36.56 71.27 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -169.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.9 mt -116.61 118.19 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.684 0.793 . . . . 0.0 109.073 169.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -134.08 127.33 31.95 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.35 1.06 . . . . 0.0 110.521 169.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -147.03 157.47 43.62 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.054 1.342 . . . . 0.0 111.376 -172.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -122.62 131.27 53.74 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.413 0.685 . . . . 0.0 110.853 168.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.462 ' CE2' HG21 ' A' ' 77' ' ' ILE . 47.8 m0 -87.37 1.16 54.15 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.404 1.482 . . . . 0.0 114.999 -178.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 62.45 27.37 16.27 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.789 1.235 . . . . 0.0 113.98 170.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 75.5 mt -80.15 152.62 29.14 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -170.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -86.1 157.88 19.94 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.822 1.249 . . . . 0.0 111.131 170.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.68 137.21 77.13 Favored Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 120.658 -1.276 . . . . 0.0 113.1 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -99.91 -30.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.156 2.571 . . . . 0.0 113.842 171.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.97 100.25 0.06 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.942 1.697 . . . . 0.0 112.663 -176.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.48 -0.6 53.3 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.033 1.302 . . . . 0.0 114.689 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -87.68 171.76 10.2 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.06 1.344 . . . . 0.0 111.999 172.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.1 t -62.09 149.71 40.47 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.264 0.626 . . . . 0.0 111.753 171.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 mp -60.62 -28.83 68.83 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.943 0.897 . . . . 0.0 112.514 -174.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -67.56 -34.34 76.86 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.847 -1.158 . . . . 0.0 113.17 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.5 t -70.35 -37.04 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 O-C-N 121.209 -0.932 . . . . 0.0 109.524 171.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.35 -42.38 99.35 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.5 1.12 . . . . 0.0 111.384 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -71.73 -38.61 70.43 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.973 1.309 . . . . 0.0 112.291 173.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.0 m -55.38 -48.77 73.8 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.646 0.779 . . . . 0.0 111.263 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.3 m -73.11 -29.01 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 117.671 -1.157 . . . . 0.0 112.547 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . 0.252 0.0 OUTLIER -63.03 -36.8 84.78 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 121.21 1.823 . . . . 0.0 112.227 169.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.76 -45.75 91.79 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 124.556 1.074 . . . . 0.0 112.894 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -60.01 -42.46 94.36 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 117.767 0.783 . . . . 0.0 112.473 171.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.8 t -63.7 -47.44 91.08 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 C-N-CA 124.643 1.177 . . . . 0.0 110.155 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -49.6 -53.37 24.3 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 120.417 1.462 . . . . 0.0 111.648 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -58.48 -40.18 82.02 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.463 1.105 . . . . 0.0 112.602 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.6 mtt85 -82.55 -31.07 29.28 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.16 0.984 . . . . 0.0 112.931 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.78 -48.52 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.104 1.362 . . . . 0.0 109.947 169.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -54.35 -54.99 33.03 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.397 0.999 . . . . 0.0 109.497 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -50.63 -36.92 37.68 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.392 1.477 . . . . 0.0 112.67 176.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -81.06 -60.73 2.18 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.091 0.956 . . . . 0.0 112.976 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.17 -35.03 70.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.94 1.296 . . . . 0.0 111.856 -175.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.97 -20.73 61.69 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.112 -0.993 . . . . 0.0 113.443 -172.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -74.38 -20.46 60.06 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.822 1.249 . . . . 0.0 113.52 173.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.9 pt -118.07 1.48 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.086 1.754 . . . . 0.0 113.162 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 C--O 1.252 1.228 0 C-N-CA 125.932 1.693 . . . . 0.0 113.501 173.197 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.505 2.315 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -79.54 102.4 8.82 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.894 0.77 . . . . 0.0 109.557 169.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -77.25 144.13 38.43 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.677 0.791 . . . . 0.0 111.541 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 91.1 t -113.54 143.5 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.253 1.421 . . . . 0.0 110.107 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 45.1 ttm -130.72 130.76 44.22 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.18 0.592 . . . . 0.0 111.617 168.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -98.07 136.49 38.25 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.175 0.99 . . . . 0.0 110.612 169.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.1 t -129.73 126.03 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.974 1.31 . . . . 0.0 110.898 -169.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.3 m -143.34 176.6 9.03 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.217 1.007 . . . . 0.0 111.547 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -67.38 -65.21 0.71 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 169.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.13 113.15 19.79 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 168.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.461 HD21 ' HA ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -70.37 -22.35 62.78 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 120.271 1.396 . . . . 0.0 110.294 169.464 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.4 p -57.63 -53.27 60.02 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 127.551 2.34 . . . . 0.0 116.17 173.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.4 p -93.19 -14.67 26.84 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.885 1.274 . . . . 0.0 113.376 -171.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -124.47 -68.88 0.83 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.406 1.082 . . . . 0.0 113.2 -176.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.1 m -57.24 -43.28 82.8 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 120.05 1.296 . . . . 0.0 113.044 -176.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -55.95 -34.77 65.98 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.757 1.623 . . . . 0.0 113.4 173.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 59.2 mtp -64.18 -48.27 76.61 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 119.399 1.0 . . . . 0.0 111.57 174.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.07 -23.48 63.08 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 118.656 -0.688 . . . . 0.0 112.551 173.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -73.23 -49.16 29.39 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 120.024 1.284 . . . . 0.0 108.598 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.06 -52.2 53.78 Favored Glycine 0 C--O 1.222 -0.628 0 CA-C-O 118.429 -1.206 . . . . 0.0 111.049 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.544 ' HB3' HG11 ' A' ' 123' ' ' VAL . 13.4 m-85 -62.36 -43.47 98.74 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.748 1.274 . . . . 0.0 112.948 176.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.13 -37.0 83.09 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.676 1.58 . . . . 0.0 111.165 -177.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -59.59 -62.48 1.84 Allowed 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 125.125 1.37 . . . . 0.0 109.925 169.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.9 p -67.71 -14.28 62.81 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -175.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.5 mt -92.59 -10.7 36.58 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 172.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.24 19.08 0.1 Allowed Glycine 0 CA--C 1.539 1.573 0 N-CA-C 118.715 2.246 . . . . 0.0 118.715 -172.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.83 -33.76 62.04 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.856 1.828 . . . . 0.0 114.803 -172.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.45 -8.95 87.05 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 124.069 0.842 . . . . 0.0 114.998 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -98.76 -55.33 2.76 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 118.625 1.212 . . . . 0.0 112.312 -171.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.5 pp -141.45 171.11 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 126.619 1.968 . . . . 0.0 111.053 -174.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.22 125.49 44.83 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 175.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.1 m -94.64 155.63 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.535 1.534 . . . . 0.0 112.896 169.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.34 123.0 11.82 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.1 t -89.18 123.5 33.49 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 120.74 -1.225 . . . . 0.0 113.074 173.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.5 t -148.72 169.61 20.02 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.764 0.711 . . . . 0.0 112.39 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.36 179.27 48.89 Favored Glycine 0 CA--C 1.521 0.457 0 O-C-N 120.577 -1.327 . . . . 0.0 114.27 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.2 mt -65.39 -30.42 71.24 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 122.86 0.464 . . . . 0.0 111.413 176.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -117.22 122.61 44.48 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.651 1.981 . . . . 0.0 108.958 169.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.8 p -78.24 44.69 0.51 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.998 1.719 . . . . 0.0 111.987 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 p -64.9 158.56 24.93 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.771 1.628 . . . . 0.0 114.149 -169.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -64.2 174.16 1.7 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -169.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 m -65.98 109.08 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 120.295 -1.503 . . . . 0.0 107.552 168.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.7 t-80 -65.37 132.68 95.23 Favored Pre-proline 0 N--CA 1.476 0.874 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -169.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -59.55 -40.53 65.14 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.158 2.572 . . . . 0.0 113.334 -172.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.4 m -78.17 -30.62 49.18 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.053 -0.404 . . . . 0.0 110.911 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.5 -44.43 78.47 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.79 -1.194 . . . . 0.0 112.552 172.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.5 mt -52.85 -40.37 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 120.177 1.353 . . . . 0.0 110.463 173.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.58 -65.5 0.67 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 174.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.3 mmt -65.92 -24.92 66.93 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -170.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 85.3 mtp -84.91 -30.72 24.15 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 122.938 0.495 . . . . 0.0 111.484 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -61.14 -31.42 71.14 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.556 -1.34 . . . . 0.0 111.629 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -57.07 -31.95 65.74 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 121.085 -1.009 . . . . 0.0 112.819 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.28 7.61 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.413 1.485 . . . . 0.0 113.396 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.94 19.87 52.06 Favored Glycine 0 N--CA 1.479 1.501 0 O-C-N 120.286 -1.509 . . . . 0.0 115.038 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 25.1 mt -123.43 66.0 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.68 1.592 . . . . 0.0 110.313 -169.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -64.12 112.82 3.17 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 120.605 -1.309 . . . . 0.0 110.962 173.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.0 pt -90.34 -1.11 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 175.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.4 p -64.86 124.46 22.04 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 120.564 1.529 . . . . 0.0 110.36 -174.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.85 1.38 87.16 Favored Glycine 0 CA--C 1.546 2.023 0 N-CA-C 116.191 1.236 . . . . 0.0 116.191 -169.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -74.03 145.93 44.13 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.742 1.771 . . . . 0.0 111.916 177.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.9 t -61.21 145.35 51.52 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -175.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.461 ' HA ' HD21 ' A' ' 11' ' ' ASN . 2.0 m -137.42 117.64 13.55 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.623 1.569 . . . . 0.0 109.941 174.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -114.08 150.91 44.36 Favored Pre-proline 0 CA--C 1.557 1.214 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -169.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -91.84 126.51 0.92 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.618 2.879 . . . . 0.0 111.603 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.5 tt -77.11 -4.98 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -172.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -86.41 -13.1 47.27 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 120.654 -1.279 . . . . 0.0 113.149 170.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -91.86 -37.4 12.94 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.948 0.899 . . . . 0.0 112.569 174.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.08 169.38 15.12 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.37 1.068 . . . . 0.0 112.763 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.01 126.4 28.46 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.309 1.444 . . . . 0.0 109.785 169.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.48 3.34 3.93 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -175.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -66.44 -29.01 69.05 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.894 0.878 . . . . 0.0 112.887 -170.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -94.75 2.04 55.5 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.556 1.542 . . . . 0.0 113.671 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -122.91 93.13 3.87 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.353 1.461 . . . . 0.0 111.089 -169.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -61.58 -23.74 66.19 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.3 t -124.83 120.84 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.449 1.099 . . . . 0.0 110.697 -174.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.6 t -131.74 133.05 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.031 0.932 . . . . 0.0 109.956 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.0 mm -121.67 122.06 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 123.836 0.854 . . . . 0.0 110.716 -171.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.3 t -85.97 113.56 22.17 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 168.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.5 mt -83.77 45.11 1.04 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.238 1.015 . . . . 0.0 110.623 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.9 t -141.26 153.89 45.46 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.536 2.734 . . . . 0.0 109.42 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -73.67 -9.5 78.74 Favored Glycine 0 CA--C 1.541 1.701 0 O-C-N 121.477 -0.765 . . . . 0.0 112.885 169.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 24.5 p -80.79 -62.14 1.76 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.073 1.749 . . . . 0.0 113.985 -174.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.43 -56.03 0.66 Allowed Glycine 0 CA--C 1.54 1.61 0 C-N-CA 126.002 1.763 . . . . 0.0 115.031 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.3 p -59.53 -19.85 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 127.347 2.259 . . . . 0.0 114.928 -173.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -69.1 -19.83 64.06 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.233 1.013 . . . . 0.0 113.49 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.9 mt -79.51 159.95 71.01 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 124.363 1.065 . . . . 0.0 112.96 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -59.18 145.7 96.89 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.326 2.684 . . . . 0.0 113.913 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.11 44.04 1.11 Allowed 'Trans proline' 0 CA--C 1.548 1.213 1 C-N-CA 125.951 4.434 . . . . 0.0 113.324 -178.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -156.81 -36.66 0.08 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.601 2.36 . . . . 0.0 111.252 -174.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -75.93 -24.26 55.51 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.643 -1.285 . . . . 0.0 111.518 170.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.1 m -89.43 -11.29 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.395 1.478 . . . . 0.0 114.781 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.8 p -95.85 5.96 50.03 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -172.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -70.93 166.19 21.75 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.335 1.054 . . . . 0.0 112.285 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -52.08 -37.4 53.81 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -169.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 63.2 mt -125.15 122.3 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.656 1.182 . . . . 0.0 109.337 169.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -131.21 136.2 48.05 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.539 1.135 . . . . 0.0 111.091 169.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -140.25 146.86 39.17 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.175 0.99 . . . . 0.0 113.357 -173.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -103.18 95.72 6.3 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.189 2.196 . . . . 0.0 111.636 170.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 20.6 m0 -85.13 92.79 8.48 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 169.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.18 77.58 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 127.661 2.384 . . . . 0.0 113.688 169.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.5 mt -116.82 159.88 21.68 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.97 2.108 . . . . 0.0 112.067 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -95.53 148.92 21.99 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.256 1.422 . . . . 0.0 111.484 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -80.99 110.73 18.85 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.056 0.942 . . . . 0.0 109.908 169.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.415 ' HB2' ' CD2' ' A' ' 112' ' ' PHE . 15.1 Cg_endo -87.03 -5.03 7.84 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.519 2.146 . . . . 0.0 113.739 -169.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -48.26 105.59 0.08 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.66 1.584 . . . . 0.0 113.36 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.43 1.3 90.04 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 123.815 0.722 . . . . 0.0 114.758 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -77.79 168.79 19.38 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.17 0.985 . . . . 0.0 110.562 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 23.2 t -62.37 149.83 41.31 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.638 -0.664 . . . . 0.0 111.45 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 mp -60.04 -28.46 67.78 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.733 0.813 . . . . 0.0 111.787 -172.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -64.89 -35.8 82.3 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 173.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.6 t -66.32 -31.95 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.545 0.738 . . . . 0.0 109.452 170.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.415 ' CD2' ' HB2' ' A' ' 104' ' ' PRO . 0.4 OUTLIER -77.16 -39.54 48.68 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.732 0.813 . . . . 0.0 110.739 -177.16 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -68.42 -36.73 79.5 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.939 1.296 . . . . 0.0 112.457 170.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 50.6 m -59.86 -49.12 78.95 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.705 1.202 . . . . 0.0 111.259 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.6 m -67.02 -30.28 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 118.055 -0.974 . . . . 0.0 111.952 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.07 -47.83 84.23 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 120.189 1.359 . . . . 0.0 110.849 169.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.07 -41.57 99.78 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.552 1.072 . . . . 0.0 113.181 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -63.97 -48.76 75.19 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 122.148 -0.619 . . . . 0.0 112.223 171.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.422 ' O ' HG12 ' A' ' 123' ' ' VAL . 21.7 t -53.98 -51.86 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 116.939 -1.505 . . . . 0.0 111.086 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -46.14 -47.5 17.49 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 120.33 1.423 . . . . 0.0 113.286 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -66.07 -47.99 72.49 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.815 0.846 . . . . 0.0 112.029 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.8 mtp180 -71.09 -40.49 71.5 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.522 0.729 . . . . 0.0 112.642 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.544 HG11 ' HB3' ' A' ' 21' ' ' PHE . 8.0 p -72.23 -36.26 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.538 1.535 . . . . 0.0 112.021 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -58.51 -55.34 36.28 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.777 1.172 . . . . 0.0 109.406 169.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -55.16 -36.59 66.0 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.217 1.007 . . . . 0.0 112.03 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.42 -59.48 2.74 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.473 -0.767 . . . . 0.0 112.651 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.25 -34.53 67.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.968 0.907 . . . . 0.0 112.139 -175.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.48 -6.67 52.77 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -174.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -82.41 -20.41 37.13 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.664 1.186 . . . . 0.0 113.319 169.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.7 pt -119.18 -7.69 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.293 1.437 . . . . 0.0 113.837 -173.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.3 p . . . . . 0 C--O 1.254 1.298 0 C-N-CA 125.442 1.497 . . . . 0.0 113.249 170.783 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 tpp . . . . . 0 N--CA 1.5 2.059 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -76.72 105.84 8.03 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 119.621 1.1 . . . . 0.0 110.544 169.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -79.91 136.22 36.61 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 173.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.1 t -97.96 147.0 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.273 1.029 . . . . 0.0 109.95 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 42.6 tpp -130.26 112.29 13.2 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.869 0.868 . . . . 0.0 111.296 169.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -83.68 120.88 26.53 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.301 0.64 . . . . 0.0 111.04 169.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.7 t -118.84 135.52 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.492 1.517 . . . . 0.0 109.672 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.7 p -151.9 178.0 9.86 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 121.419 -0.8 . . . . 0.0 112.537 177.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -63.57 -42.96 98.29 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 121.512 -0.743 . . . . 0.0 111.067 169.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.484 ' HB3' ' H ' ' A' ' 13' ' ' SER . 1.1 mpt_? -117.69 103.6 10.18 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.953 1.301 . . . . 0.0 110.835 172.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -55.66 -33.62 64.25 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.287 -0.883 . . . . 0.0 110.223 169.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.4 p -57.01 -53.6 56.28 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.238 2.215 . . . . 0.0 115.303 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.484 ' H ' ' HB3' ' A' ' 10' ' ' ARG . 89.0 p -103.22 -1.67 28.52 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.09 1.356 . . . . 0.0 114.133 -176.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -126.68 -76.25 0.58 Allowed 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.076 -1.64 . . . . 0.0 111.283 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.424 ' HB3' ' HB2' ' A' ' 34' ' ' SER . 4.9 m -59.59 -39.04 82.82 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -172.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -56.13 -30.63 62.4 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.467 1.507 . . . . 0.0 114.499 171.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 93.2 mtp -69.73 -45.12 68.89 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.308 0.958 . . . . 0.0 110.358 174.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.35 -27.79 66.57 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 171.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -68.0 -49.01 64.15 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.99 1.268 . . . . 0.0 108.25 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.63 -52.3 51.86 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-O 118.814 -0.992 . . . . 0.0 111.854 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.491 ' HB3' HG11 ' A' ' 123' ' ' VAL . 12.7 m-85 -61.35 -42.64 99.02 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.507 1.153 . . . . 0.0 112.848 175.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.59 -37.17 85.88 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 120.082 -1.636 . . . . 0.0 111.104 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -62.51 -48.63 78.7 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.021 1.329 . . . . 0.0 111.489 174.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.5 p -80.27 -14.19 58.6 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 51.0 mt -97.83 -10.79 24.13 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.08 0.952 . . . . 0.0 113.393 174.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.66 25.3 1.34 Allowed Glycine 0 CA--C 1.534 1.22 0 N-CA-C 115.851 1.1 . . . . 0.0 115.851 -169.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.89 122.78 11.56 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.602 1.201 . . . . 0.0 112.792 -175.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.29 -2.47 36.69 Favored Glycine 0 CA--C 1.538 1.497 0 N-CA-C 116.138 1.215 . . . . 0.0 116.138 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -78.64 -46.58 18.88 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.429 1.615 . . . . 0.0 111.314 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -141.98 -177.78 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 128.265 2.626 . . . . 0.0 109.375 169.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.61 120.59 40.27 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.075 -1.016 . . . . 0.0 112.449 171.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.96 144.15 9.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 122.87 0.468 . . . . 0.0 111.796 169.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.47 163.64 35.05 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.943 1.297 . . . . 0.0 110.371 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.424 ' HB2' ' HB3' ' A' ' 15' ' ' SER . 88.2 p -148.68 150.19 32.78 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.467 1.107 . . . . 0.0 113.723 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 82.5 p -143.22 -175.36 4.5 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.39 1.876 . . . . 0.0 110.433 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.23 177.25 40.91 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-N 120.047 1.294 . . . . 0.0 115.23 172.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 35.6 mt -73.65 -43.78 58.59 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 118.515 1.157 . . . . 0.0 113.493 -169.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -130.42 70.65 1.45 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.387 2.275 . . . . 0.0 107.826 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.1 m -72.44 -20.33 61.42 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -169.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.2 m 37.54 -93.44 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 128.17 2.588 . . . . 0.0 117.316 172.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.1 ptp85 -154.73 -177.99 6.89 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 126.387 1.875 . . . . 0.0 112.228 -169.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.6 m -65.8 118.4 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.04 -1.038 . . . . 0.0 110.558 169.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -74.46 133.28 77.51 Favored Pre-proline 0 N--CA 1.478 0.968 0 O-C-N 121.058 -1.026 . . . . 0.0 113.0 -169.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -59.78 -40.9 59.66 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.543 2.829 . . . . 0.0 114.137 -171.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.1 m -78.29 -38.28 42.87 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 122.061 -0.399 . . . . 0.0 110.48 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.27 -40.35 97.14 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 118.123 -0.942 . . . . 0.0 112.467 176.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 66.7 mt -49.88 -47.69 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 120.197 1.362 . . . . 0.0 110.413 172.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.84 -58.79 4.8 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.5 mmt -66.25 -26.56 67.41 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.413 -0.805 . . . . 0.0 112.741 -173.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 72.2 mmm -84.2 -38.9 20.0 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.713 0.805 . . . . 0.0 110.563 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -59.59 -37.46 78.59 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.718 -1.239 . . . . 0.0 112.097 170.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -56.62 -22.32 33.24 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.538 1.135 . . . . 0.0 113.634 173.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.1 m -113.18 17.83 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 125.044 1.338 . . . . 0.0 114.576 175.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.2 13.63 61.62 Favored Glycine 0 N--CA 1.477 1.39 0 N-CA-C 115.597 0.999 . . . . 0.0 115.597 176.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 29.6 mt -126.67 62.78 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.62 1.568 . . . . 0.0 109.85 -169.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -60.67 110.69 1.37 Allowed 'General case' 0 CA--C 1.548 0.899 0 O-C-N 120.031 -1.668 . . . . 0.0 110.45 172.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.8 pt -89.58 4.2 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.7 p -67.36 -18.53 65.18 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.851 1.659 . . . . 0.0 114.648 -172.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -102.22 8.57 55.55 Favored Glycine 0 CA--C 1.542 1.728 0 C-N-CA 125.413 1.483 . . . . 0.0 114.634 169.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -79.57 143.04 35.14 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.379 1.472 . . . . 0.0 111.927 -171.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 10.8 t -66.05 153.68 41.59 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 121.53 -0.731 . . . . 0.0 112.734 172.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.4 p -147.06 133.7 19.9 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.316 1.446 . . . . 0.0 109.926 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -141.34 135.0 14.67 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.282 0.633 . . . . 0.0 112.049 -169.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -71.61 154.88 59.74 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.384 2.723 . . . . 0.0 112.903 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.1 tt -62.78 -18.96 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.022 1.329 . . . . 0.0 114.566 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -95.55 -9.11 33.25 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -80.39 -43.74 20.55 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.055 0.843 . . . . 0.0 109.236 169.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.31 159.71 32.96 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.889 1.276 . . . . 0.0 112.3 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -142.47 134.91 27.86 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.486 1.114 . . . . 0.0 110.36 169.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.2 9.33 4.65 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 -172.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.35 -28.8 63.26 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.11 -0.993 . . . . 0.0 112.318 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -97.49 -3.65 39.51 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.065 1.346 . . . . 0.0 113.662 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -123.71 90.62 3.31 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.456 1.502 . . . . 0.0 110.039 -172.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -66.91 -12.34 59.14 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.5 t -123.99 116.49 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 126.005 1.722 . . . . 0.0 109.731 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.5 t -131.57 134.76 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.762 0.825 . . . . 0.0 111.016 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.509 HG21 ' CE2' ' A' ' 99' ' ' TRP . 10.5 mm -126.59 137.0 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.319 0.648 . . . . 0.0 111.333 -172.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.2 t -95.49 117.93 31.28 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.431 1.493 . . . . 0.0 108.989 169.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 mp -99.93 61.38 1.11 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.768 1.627 . . . . 0.0 107.816 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.8 t -155.39 -30.94 0.1 Allowed 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 -169.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.91 22.34 78.16 Favored Glycine 0 CA--C 1.54 1.628 0 O-C-N 120.798 -1.189 . . . . 0.0 111.223 -168.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 14.8 p -135.34 28.58 3.37 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.621 1.968 . . . . 0.0 112.411 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -55.74 -31.29 57.8 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 120.877 -1.139 . . . . 0.0 115.224 -169.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.6 m -67.98 -14.3 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -84.97 -11.02 56.42 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.858 1.263 . . . . 0.0 112.87 174.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.9 mt -72.03 157.47 89.39 Favored Pre-proline 0 CA--C 1.553 1.069 0 O-C-N 121.452 -0.78 . . . . 0.0 110.762 170.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -55.34 143.71 75.27 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.06 2.507 . . . . 0.0 113.174 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -75.62 41.36 0.79 Allowed 'Trans proline' 0 CA--C 1.549 1.256 1 C-N-CA 125.46 4.106 . . . . 0.0 113.624 -173.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -156.07 -30.84 0.09 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.995 2.518 . . . . 0.0 111.075 -175.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -82.21 14.82 2.68 Favored 'General case' 0 CA--C 1.553 1.073 0 O-C-N 120.918 -1.113 . . . . 0.0 113.415 169.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.5 m -131.48 -3.96 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 126.399 1.88 . . . . 0.0 113.387 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.6 p -95.68 -6.06 40.83 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.602 1.561 . . . . 0.0 113.667 -171.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -65.04 154.12 38.73 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.802 2.041 . . . . 0.0 111.932 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -53.74 -35.73 61.55 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.372 1.469 . . . . 0.0 114.304 -169.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 54.1 mt -119.02 107.38 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 169.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -121.44 131.69 54.3 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.29 1.036 . . . . 0.0 110.074 169.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -133.46 147.42 51.68 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.566 1.146 . . . . 0.0 111.647 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -115.42 95.41 5.15 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.444 1.116 . . . . 0.0 110.814 172.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.509 ' CE2' HG21 ' A' ' 77' ' ' ILE . 30.3 m0 -74.25 93.99 2.43 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 169.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.8 73.83 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.286 2.635 . . . . 0.0 113.403 169.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 71.1 mt -113.83 147.72 37.89 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.574 2.35 . . . . 0.0 111.616 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -84.47 158.88 20.88 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.369 1.068 . . . . 0.0 111.945 175.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -88.12 110.21 34.03 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 126.262 1.825 . . . . 0.0 111.765 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -84.95 -13.7 6.52 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 123.139 2.56 . . . . 0.0 116.21 -169.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -50.92 107.34 0.17 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.807 1.243 . . . . 0.0 112.527 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.18 11.54 85.45 Favored Glycine 0 CA--C 1.538 1.504 0 CA-C-O 118.837 -0.98 . . . . 0.0 115.487 177.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -74.42 -71.68 0.33 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.33 1.565 . . . . 0.0 110.625 176.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.5 t -173.89 150.1 1.61 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.891 2.476 . . . . 0.0 108.285 174.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.7 mp -60.4 -32.5 71.39 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.62 0.645 . . . . 0.0 111.799 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -70.59 -33.64 71.29 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.936 -1.103 . . . . 0.0 112.923 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 83.3 t -68.85 -37.38 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.398 -0.814 . . . . 0.0 109.527 170.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -45.09 92.06 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.58 1.152 . . . . 0.0 110.888 176.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -65.95 -23.88 66.69 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.868 1.667 . . . . 0.0 113.993 172.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.9 m -78.75 -51.74 9.36 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.672 1.589 . . . . 0.0 111.098 177.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.0 m -66.34 -26.52 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 121.104 -0.997 . . . . 0.0 111.628 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.78 -44.18 94.03 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.429 1.892 . . . . 0.0 111.203 169.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.84 -41.57 88.12 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 124.106 0.86 . . . . 0.0 112.771 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -60.87 -48.32 82.36 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 122.185 -0.597 . . . . 0.0 111.757 172.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.424 ' O ' HG12 ' A' ' 123' ' ' VAL . 38.2 t -57.65 -47.58 85.23 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-O 117.249 -1.358 . . . . 0.0 110.232 176.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -52.29 -48.61 65.24 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 120.423 1.465 . . . . 0.0 112.327 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -63.51 -48.01 79.36 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.935 0.494 . . . . 0.0 112.19 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -70.74 -36.79 73.31 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.491 HG11 ' HB3' ' A' ' 21' ' ' PHE . 6.0 p -74.54 -36.37 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.682 1.193 . . . . 0.0 111.831 177.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -56.53 -54.82 41.44 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.649 1.113 . . . . 0.0 108.334 168.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -59.81 -17.02 32.78 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -92.23 -60.46 1.84 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.381 1.446 . . . . 0.0 112.37 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -57.76 -33.79 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.17 0.988 . . . . 0.0 111.283 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.12 -6.97 53.65 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -176.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -74.37 -23.12 58.96 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.319 1.047 . . . . 0.0 112.165 169.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.5 pt -130.42 -0.87 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 125.717 1.607 . . . . 0.0 114.983 -168.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 60.9 p . . . . . 0 C--O 1.255 1.362 0 C-N-CA 125.052 1.341 . . . . 0.0 113.509 170.424 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttm . . . . . 0 N--CA 1.503 2.213 0 CA-C-O 119.429 -0.319 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -95.59 97.27 9.62 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.467 1.107 . . . . 0.0 110.519 174.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -86.61 149.26 25.05 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.594 -0.691 . . . . 0.0 112.693 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.3 t -117.97 143.39 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.652 1.181 . . . . 0.0 111.777 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 42.9 tpp -131.9 125.35 31.49 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.419 1.087 . . . . 0.0 110.865 169.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -94.59 142.35 27.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.221 0.608 . . . . 0.0 109.985 169.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.6 t -135.42 119.79 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.11 1.364 . . . . 0.0 111.093 -174.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 p -135.37 178.06 7.33 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.294 1.438 . . . . 0.0 111.823 175.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -58.53 -57.37 13.27 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 120.751 -1.218 . . . . 0.0 110.581 174.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -101.45 120.07 39.73 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 168.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -54.14 -50.54 66.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 120.41 1.459 . . . . 0.0 110.876 175.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.1 p -64.99 -16.61 63.6 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -174.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.5 p -77.48 -37.81 50.51 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.7 ptt-85 -152.19 -32.47 0.14 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 117.279 2.326 . . . . 0.0 117.279 -174.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.407 ' HA ' HD12 ' A' ' 79' ' ' LEU . 58.4 m -68.13 -38.11 81.85 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 121.503 1.956 . . . . 0.0 113.388 171.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -67.22 -31.81 72.43 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.187 0.995 . . . . 0.0 111.724 168.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.464 ' HA ' ' CE ' ' A' ' 50' ' ' MET . 45.6 ttm -62.27 -52.44 63.7 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.328 1.051 . . . . 0.0 111.532 173.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.43 -27.6 69.4 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 124.485 1.114 . . . . 0.0 112.327 172.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -73.0 -47.83 41.74 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.928 1.694 . . . . 0.0 109.465 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.89 -54.76 31.51 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-O 118.797 -1.002 . . . . 0.0 111.344 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.486 ' HB3' HG11 ' A' ' 123' ' ' VAL . 9.6 m-85 -57.58 -41.58 81.41 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.955 0.878 . . . . 0.0 112.379 174.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.73 ' HB1' HG11 ' A' ' 32' ' ' VAL . . . -65.68 -39.87 91.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.86 1.209 . . . . 0.0 112.187 -179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -71.31 -44.15 65.69 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.951 1.25 . . . . 0.0 112.325 173.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.6 p -65.93 -5.96 10.95 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 120.735 1.607 . . . . 0.0 114.632 173.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.8 mt -110.01 -5.43 15.43 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.847 1.259 . . . . 0.0 114.083 171.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.68 17.49 0.28 Allowed Glycine 0 N--CA 1.478 1.442 0 N-CA-C 116.841 1.496 . . . . 0.0 116.841 -170.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.11 135.22 56.99 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.923 1.362 . . . . 0.0 112.176 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.6 -6.33 46.72 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-O 118.62 -1.1 . . . . 0.0 115.588 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -85.52 -60.54 2.0 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.608 1.704 . . . . 0.0 110.672 175.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -141.37 172.53 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 127.359 2.264 . . . . 0.0 110.44 177.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.8 130.77 44.72 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.898 0.856 . . . . 0.0 112.831 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.73 HG11 ' HB1' ' A' ' 22' ' ' ALA . 15.9 m -105.34 151.76 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 124.744 1.218 . . . . 0.0 112.024 169.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.83 144.03 30.0 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.262 0.625 . . . . 0.0 111.369 -171.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.3 p -112.87 136.39 52.56 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.61 1.564 . . . . 0.0 113.46 176.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.0 t -152.61 177.26 10.85 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.866 1.266 . . . . 0.0 111.88 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.92 -175.72 47.05 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 120.671 -1.268 . . . . 0.0 114.294 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.2 mt -72.09 -33.57 67.98 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -175.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -134.44 73.32 1.49 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.535 2.334 . . . . 0.0 108.565 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.5 m -65.74 -22.7 66.62 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -172.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.9 t 43.96 -106.59 0.1 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.665 1.986 . . . . 0.0 114.607 169.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -149.34 171.55 16.35 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 127.002 2.121 . . . . 0.0 111.169 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.7 m -53.74 120.16 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.608 1.163 . . . . 0.0 110.758 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -82.52 136.03 45.98 Favored Pre-proline 0 N--CA 1.478 0.931 0 CA-C-O 118.053 -0.975 . . . . 0.0 112.237 -169.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -57.99 -44.65 38.01 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.455 2.77 . . . . 0.0 113.913 -173.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.9 m -76.98 -28.43 55.12 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.674 -0.641 . . . . 0.0 110.812 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.89 -47.09 66.71 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.223 -0.923 . . . . 0.0 111.973 169.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 57.6 mt -51.68 -48.3 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 120.27 1.396 . . . . 0.0 109.66 171.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.07 -65.13 0.65 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 177.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.44 -27.2 66.85 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -174.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.464 ' CE ' ' HA ' ' A' ' 17' ' ' MET . 87.4 mtp -80.62 -29.59 36.81 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.438 1.017 . . . . 0.0 111.669 178.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -63.93 -28.05 69.56 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.897 -1.127 . . . . 0.0 112.875 169.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -57.65 -34.71 69.64 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 119.307 0.958 . . . . 0.0 112.27 174.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.2 8.24 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.62 1.568 . . . . 0.0 113.232 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.14 23.7 43.7 Favored Glycine 0 N--CA 1.477 1.403 0 O-C-N 120.58 -1.325 . . . . 0.0 115.074 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.6 mt -123.83 60.66 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.678 1.591 . . . . 0.0 110.54 -169.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -62.34 109.82 1.46 Allowed 'General case' 0 CA--C 1.546 0.823 0 O-C-N 120.469 -1.394 . . . . 0.0 111.833 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 pt -85.87 -5.27 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 117.735 -1.126 . . . . 0.0 113.479 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.3 t -60.07 -28.54 67.89 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 120.917 1.69 . . . . 0.0 113.267 -170.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -101.34 8.52 57.08 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 125.405 1.479 . . . . 0.0 115.799 171.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -95.6 150.55 20.22 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.601 1.56 . . . . 0.0 112.034 -171.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.0 t -68.47 159.39 31.8 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -172.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.8 t -150.08 135.08 17.82 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.831 1.653 . . . . 0.0 109.625 169.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -144.02 138.78 15.31 Favored Pre-proline 0 N--CA 1.475 0.784 0 C-N-CA 123.659 0.784 . . . . 0.0 111.046 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -77.85 152.59 28.8 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.459 2.773 . . . . 0.0 113.382 -174.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.4 tt -59.21 -23.89 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -173.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -96.58 -8.2 32.42 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -94.27 -36.1 12.14 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.487 0.715 . . . . 0.0 111.439 170.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.28 161.26 30.7 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.146 0.498 . . . . 0.0 111.165 170.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.86 127.86 25.73 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.522 0.729 . . . . 0.0 111.431 169.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.23 2.61 4.46 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -173.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.8 -30.64 69.26 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.005 -1.059 . . . . 0.0 112.602 -170.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -89.37 -1.45 58.06 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.779 1.231 . . . . 0.0 113.422 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -120.66 97.06 5.38 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.224 1.41 . . . . 0.0 111.361 -169.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -55.35 -31.52 61.8 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.044 1.337 . . . . 0.0 112.85 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.6 120.23 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 124.544 1.138 . . . . 0.0 110.633 -172.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.6 t -124.92 132.83 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.14 0.976 . . . . 0.0 109.813 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.4 mm -123.51 123.51 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 123.581 0.752 . . . . 0.0 110.678 -172.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.4 t -82.55 123.55 29.31 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.968 0.907 . . . . 0.0 109.862 169.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 15' ' ' SER . 30.4 mt -114.34 34.55 4.65 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.853 1.661 . . . . 0.0 110.775 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 30.4 p -158.16 162.57 37.95 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.536 1.134 . . . . 0.0 113.194 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.39 -19.94 67.07 Favored Glycine 0 CA--C 1.544 1.854 0 O-C-N 121.388 -0.82 . . . . 0.0 111.532 168.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 11.6 p -64.49 0.07 1.18 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.977 2.111 . . . . 0.0 115.698 170.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -54.38 -33.68 53.52 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.671 1.129 . . . . 0.0 114.855 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.0 m -73.25 -13.8 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -101.75 -0.73 33.88 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.54 1.536 . . . . 0.0 113.124 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.3 mt -68.59 155.38 93.02 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 123.691 0.797 . . . . 0.0 111.703 176.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -58.99 145.07 98.83 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.031 2.488 . . . . 0.0 113.848 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.02 41.9 0.79 Allowed 'Trans proline' 0 CA--C 1.55 1.293 1 C-N-CA 125.979 4.453 . . . . 0.0 113.483 -177.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -156.75 -35.74 0.08 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.921 2.489 . . . . 0.0 111.084 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.06 -26.07 61.15 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.247 -1.533 . . . . 0.0 111.698 169.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.2 m -85.8 -11.25 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 79.6 p -98.36 5.57 48.08 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -172.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -69.6 164.79 22.54 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.367 1.067 . . . . 0.0 112.505 177.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -50.2 -39.98 45.8 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.752 1.221 . . . . 0.0 114.25 -169.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.8 mt -124.03 120.01 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.383 1.073 . . . . 0.0 109.011 169.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -129.35 125.39 36.55 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.126 0.97 . . . . 0.0 110.206 169.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -139.56 158.75 43.6 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.957 1.303 . . . . 0.0 111.647 -174.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -128.21 126.18 40.45 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.49 1.116 . . . . 0.0 112.121 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -100.48 7.04 44.4 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -174.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 62.06 22.73 13.31 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 169.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 68.3 mt -78.62 142.37 37.3 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -169.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -78.03 159.03 28.99 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.059 1.744 . . . . 0.0 111.866 173.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -85.31 113.29 49.72 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 124.214 1.006 . . . . 0.0 111.247 173.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -87.06 -17.26 3.11 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.203 2.602 . . . . 0.0 114.88 -170.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -61.6 120.33 10.37 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.888 -1.132 . . . . 0.0 111.366 178.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.57 -4.77 85.13 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 123.994 0.807 . . . . 0.0 113.967 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -80.89 171.19 15.32 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 118.083 0.941 . . . . 0.0 109.577 169.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 39.4 m -62.96 151.03 40.75 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.169 -0.957 . . . . 0.0 111.419 170.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.25 -29.22 68.64 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.241 -0.912 . . . . 0.0 112.439 -175.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -62.31 -33.56 74.9 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.988 0.915 . . . . 0.0 113.317 172.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 50.3 t -72.87 -35.27 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 121.048 -1.032 . . . . 0.0 110.219 172.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -66.43 -38.26 87.02 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.003 0.521 . . . . 0.0 111.093 175.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -68.69 -39.68 80.43 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.554 1.142 . . . . 0.0 112.249 169.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 42.8 m -58.48 -47.76 83.0 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.397 1.079 . . . . 0.0 111.951 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.0 m -66.39 -30.69 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 119.382 0.992 . . . . 0.0 111.816 176.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -41.06 95.26 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 120.111 1.323 . . . . 0.0 112.633 170.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.88 -44.73 97.0 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.174 0.892 . . . . 0.0 112.591 174.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -61.81 -47.3 85.75 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 122.171 -0.605 . . . . 0.0 111.931 172.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.4 t -57.06 -48.01 82.62 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.517 0 CA-C-O 117.495 -1.24 . . . . 0.0 110.442 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -53.55 -50.69 64.98 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 120.115 1.325 . . . . 0.0 112.221 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -59.25 -44.51 92.39 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.044 0.538 . . . . 0.0 112.397 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.8 mtp85 -79.57 -35.99 38.9 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -176.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.486 HG11 ' HB3' ' A' ' 21' ' ' PHE . 4.4 p -74.01 -33.89 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.212 1.405 . . . . 0.0 112.417 178.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -55.47 -55.33 33.03 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.162 0.892 . . . . 0.0 108.855 169.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.94 -32.11 52.62 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.586 1.554 . . . . 0.0 112.894 176.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -79.02 -56.57 4.29 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.949 0.795 . . . . 0.0 112.256 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -65.45 -35.35 75.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.553 0.741 . . . . 0.0 112.038 -177.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.18 -8.59 55.56 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -174.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -84.65 -15.46 45.32 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.145 1.378 . . . . 0.0 113.538 171.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 21.2 pt -127.34 -8.38 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.544 1.538 . . . . 0.0 113.923 -173.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.7 p . . . . . 0 C--O 1.255 1.371 0 C-N-CA 125.227 1.411 . . . . 0.0 113.358 169.866 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.8 ttm . . . . . 0 N--CA 1.503 2.198 0 CA-C-O 119.479 -0.296 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -84.93 91.29 8.01 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.064 0.946 . . . . 0.0 111.261 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -77.75 145.85 36.24 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 121.605 -0.684 . . . . 0.0 112.376 -173.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.0 t -110.09 143.48 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.707 1.203 . . . . 0.0 110.397 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.4 tpp -128.91 118.37 22.55 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.852 0.861 . . . . 0.0 111.024 170.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -89.16 135.55 33.5 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.943 0.497 . . . . 0.0 111.124 169.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.9 129.11 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.755 1.222 . . . . 0.0 110.467 -171.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 t -144.3 -177.09 5.29 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.281 0.632 . . . . 0.0 112.449 172.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -64.44 -47.51 78.81 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 121.468 -0.77 . . . . 0.0 110.152 169.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.66 116.75 32.49 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.903 1.281 . . . . 0.0 109.312 169.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.69 -37.04 85.37 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 168.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.8 p -56.41 -29.47 61.58 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 128.034 2.534 . . . . 0.0 115.067 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.2 p -102.33 -101.92 0.28 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.43 1.092 . . . . 0.0 111.98 176.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.14 -44.4 71.35 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 120.227 1.376 . . . . 0.0 113.947 -168.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 m -63.16 -51.63 65.65 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.169 0.895 . . . . 0.0 112.067 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -64.6 -33.76 76.67 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 96.4 mtp -60.08 -50.35 74.04 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.725 0.693 . . . . 0.0 110.478 171.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.86 -31.16 70.78 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.28 -45.73 72.29 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 120.119 1.327 . . . . 0.0 108.642 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.35 -39.67 91.73 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 118.631 -1.094 . . . . 0.0 112.7 -178.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -65.02 -39.85 93.99 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.109 1.454 . . . . 0.0 111.783 170.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.72 -33.26 70.67 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.503 -1.373 . . . . 0.0 111.385 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -59.89 -56.95 15.43 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.32 1.848 . . . . 0.0 109.61 170.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.6 p -70.16 -15.69 62.98 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.0 mt -99.24 -1.95 37.86 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 173.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.32 4.34 0.59 Allowed Glycine 0 CA--C 1.536 1.387 0 N-CA-C 117.226 1.651 . . . . 0.0 117.226 -169.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.44 133.92 56.2 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.9 1.85 . . . . 0.0 111.869 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.87 -2.36 74.83 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 124.676 1.131 . . . . 0.0 115.386 -174.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -94.35 -76.48 0.48 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.881 1.341 . . . . 0.0 110.111 175.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -128.39 176.18 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 126.608 1.963 . . . . 0.0 111.349 173.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.1 125.56 40.71 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.3 -0.875 . . . . 0.0 112.129 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.8 m -92.93 147.97 5.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 123.787 0.835 . . . . 0.0 111.664 169.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.49 159.27 43.62 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.747 0.819 . . . . 0.0 110.591 -172.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.63 133.21 34.07 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.111 1.364 . . . . 0.0 113.153 -171.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.3 p -144.7 176.17 9.63 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.305 1.442 . . . . 0.0 111.465 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.85 175.85 43.59 Favored Glycine 0 CA--C 1.526 0.774 0 O-C-N 120.396 -1.44 . . . . 0.0 114.552 169.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.4 mt -63.69 -37.79 88.66 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.112 0.565 . . . . 0.0 111.263 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -121.39 113.35 19.75 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.964 2.105 . . . . 0.0 107.829 169.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.6 p -66.74 -35.3 79.78 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.799 0.84 . . . . 0.0 112.085 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.7 t 46.59 -127.29 1.5 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 126.324 1.849 . . . . 0.0 112.293 -177.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -141.41 -176.58 4.78 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 127.511 2.324 . . . . 0.0 111.26 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.8 m -66.42 113.51 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 120.162 -1.587 . . . . 0.0 108.886 169.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -68.56 133.61 90.8 Favored Pre-proline 0 N--CA 1.477 0.917 0 O-C-N 121.48 -0.762 . . . . 0.0 112.304 -169.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.39 -38.27 85.16 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.26 2.64 . . . . 0.0 113.543 -172.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.407 ' HB ' ' CE2' ' A' ' 112' ' ' PHE . 8.7 m -79.45 -35.39 40.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.996 0.519 . . . . 0.0 110.667 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.13 -42.25 99.46 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.268 0.94 . . . . 0.0 112.133 174.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.7 mt -52.88 -44.79 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 120.287 1.403 . . . . 0.0 110.436 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.72 -60.67 2.65 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 33.5 mmt -68.03 -19.57 64.92 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.767 0.827 . . . . 0.0 113.192 -172.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 84.1 mmm -89.47 -38.04 14.34 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.896 0.878 . . . . 0.0 110.553 173.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -59.39 -35.32 73.71 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.538 -1.351 . . . . 0.0 112.399 170.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -55.19 -31.76 61.67 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.123 0.969 . . . . 0.0 113.492 171.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.9 m -103.15 20.77 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.888 1.275 . . . . 0.0 113.978 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.56 12.13 78.62 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.329 0.966 . . . . 0.0 115.255 174.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.3 mt -120.38 78.25 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.21 1.804 . . . . 0.0 108.934 -170.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -69.06 106.88 2.94 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.044 -1.66 . . . . 0.0 110.276 171.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.7 pt -84.75 -0.89 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 121.578 -0.701 . . . . 0.0 112.832 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.9 t -64.23 -28.76 69.96 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 120.157 1.344 . . . . 0.0 112.827 -172.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.32 4.22 73.43 Favored Glycine 0 CA--C 1.541 1.7 0 C-N-CA 125.102 1.334 . . . . 0.0 115.368 172.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -92.31 160.07 15.3 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.268 1.427 . . . . 0.0 112.634 -176.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.0 t -95.59 156.91 16.13 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -170.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.8 m -137.15 140.72 42.02 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.925 1.69 . . . . 0.0 108.21 169.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -141.49 134.4 14.22 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.636 1.174 . . . . 0.0 111.393 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.15 145.91 50.4 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.305 2.003 . . . . 0.0 110.297 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.5 tt -56.07 -30.72 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -169.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -94.44 -9.18 36.39 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -82.4 -41.22 20.21 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.003 0.82 . . . . 0.0 109.958 169.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.75 159.17 34.23 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.244 0.545 . . . . 0.0 110.777 170.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -139.75 135.77 33.44 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.589 -0.694 . . . . 0.0 111.223 169.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.3 -0.73 8.61 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -169.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -68.02 -33.51 74.73 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.759 1.163 . . . . 0.0 113.006 -171.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -84.68 -3.03 58.34 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.224 1.01 . . . . 0.0 113.598 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -120.97 92.62 3.8 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.417 1.487 . . . . 0.0 110.163 -170.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -54.29 -27.47 35.52 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.115 1.366 . . . . 0.0 113.201 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.1 118.44 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 125.209 1.404 . . . . 0.0 110.126 -174.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.2 t -127.01 132.52 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.634 0.774 . . . . 0.0 110.268 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.3 mm -124.94 122.45 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 123.715 0.806 . . . . 0.0 111.61 -169.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.2 t -81.58 130.75 35.17 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.803 0.841 . . . . 0.0 109.962 169.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.0 mt -121.19 32.72 5.82 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.161 1.784 . . . . 0.0 111.282 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.3 p -158.54 162.24 37.4 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.575 1.15 . . . . 0.0 112.779 -176.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -64.96 -19.96 66.24 Favored Glycine 0 CA--C 1.545 1.931 0 O-C-N 121.215 -0.928 . . . . 0.0 111.307 168.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.6 p -63.92 -0.61 1.14 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.915 2.086 . . . . 0.0 115.547 170.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -54.22 -31.9 50.21 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 119.842 1.201 . . . . 0.0 114.748 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.7 m -75.18 -14.53 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 175.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -93.95 -9.08 38.21 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.434 1.494 . . . . 0.0 112.98 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.0 mt -61.02 139.9 94.11 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.091 0.956 . . . . 0.0 111.107 174.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -58.68 162.94 11.78 Favored 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 123.528 2.819 . . . . 0.0 113.728 174.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.05 -51.73 2.05 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.563 2.175 . . . . 0.0 113.663 -172.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -62.12 -35.42 78.69 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 120.653 -1.279 . . . . 0.0 112.28 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -64.89 5.64 0.31 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 127.298 2.239 . . . . 0.0 114.926 169.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.0 t -131.08 -43.01 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 127.26 2.224 . . . . 0.0 111.116 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.4 p -80.57 29.48 0.31 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -170.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -77.15 167.59 21.51 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.057 -1.027 . . . . 0.0 112.002 170.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -56.74 -36.12 69.38 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -169.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.7 mt -125.95 123.86 64.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.741 1.216 . . . . 0.0 108.88 169.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -131.76 138.56 48.65 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.758 0.823 . . . . 0.0 111.089 169.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -138.94 151.87 47.25 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.897 1.279 . . . . 0.0 110.517 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -122.41 114.3 20.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.482 0.713 . . . . 0.0 110.536 169.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 32.8 m0 -89.4 -2.36 58.38 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.205 1.002 . . . . 0.0 113.053 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.305 1.5 pp0? 47.35 37.64 6.26 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 171.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 81.7 mt -74.09 148.99 41.35 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.286 1.034 . . . . 0.0 112.686 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -75.0 153.46 38.5 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.537 1.135 . . . . 0.0 111.666 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -79.65 122.36 83.54 Favored Pre-proline 0 CA--C 1.542 0.673 0 O-C-N 121.126 -0.984 . . . . 0.0 111.858 173.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -93.86 -21.5 0.33 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.091 1.861 . . . . 0.0 113.847 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.6 104.59 0.07 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.891 2.076 . . . . 0.0 112.636 -176.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.5 8.6 87.11 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.517 1.056 . . . . 0.0 114.96 175.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -84.27 -64.78 1.1 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.711 1.256 . . . . 0.0 111.343 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.7 t -169.3 152.37 4.91 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.174 1.789 . . . . 0.0 109.592 171.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.92 -30.89 68.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.322 0.649 . . . . 0.0 111.041 172.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -62.81 -39.94 95.83 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.173 -0.955 . . . . 0.0 112.565 174.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 79.0 t -71.1 -39.6 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.41 -0.806 . . . . 0.0 109.083 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.407 ' CE2' ' HB ' ' A' ' 45' ' ' THR . 0.2 OUTLIER -59.32 -49.88 76.11 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.398 1.079 . . . . 0.0 112.097 176.719 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -69.45 -34.46 74.43 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.667 -0.646 . . . . 0.0 111.979 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 65.2 m -59.06 -52.59 65.11 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.286 0.634 . . . . 0.0 111.199 172.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.1 m -73.5 -27.55 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 117.74 -1.124 . . . . 0.0 112.664 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.7 ptt180 -61.27 -38.71 87.74 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 121.227 1.83 . . . . 0.0 111.88 170.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.94 -43.08 96.48 Favored Glycine 0 N--CA 1.473 1.156 0 C-N-CA 123.847 0.737 . . . . 0.0 112.739 176.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -61.19 -46.75 89.19 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.406 0.682 . . . . 0.0 111.929 170.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 25.5 t -60.45 -45.05 97.42 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.302 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -52.86 -54.5 33.51 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.093 1.315 . . . . 0.0 111.69 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -62.6 -43.47 98.74 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.067 0.547 . . . . 0.0 112.36 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.9 mtt-85 -74.8 -31.85 61.84 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 39.6 t -64.37 -47.98 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.489 169.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -53.92 -55.18 29.31 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.3 0.955 . . . . 0.0 109.239 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -49.34 -38.95 29.79 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.81 1.644 . . . . 0.0 112.242 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -81.19 -62.08 1.76 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.5 -30.32 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.545 1.138 . . . . 0.0 111.588 -175.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -78.11 -2.86 39.49 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -79.2 -20.51 48.18 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.339 1.056 . . . . 0.0 112.568 169.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.3 pt -126.89 13.38 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 126.303 1.841 . . . . 0.0 113.408 -169.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 47.1 p . . . . . 0 C--O 1.256 1.425 0 C-N-CA 125.748 1.619 . . . . 0.0 113.966 172.561 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.6 ttm . . . . . 0 N--CA 1.501 2.111 0 CA-C-O 119.596 -0.24 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -88.19 92.05 9.01 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.887 0.875 . . . . 0.0 109.958 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -79.85 151.2 30.36 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.49 -0.756 . . . . 0.0 111.607 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.6 p -118.84 142.09 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.045 0.938 . . . . 0.0 112.209 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.459 ' HE1' ' HB ' ' A' ' 33' ' ' THR . 62.0 tpp -122.33 132.66 54.5 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.372 1.069 . . . . 0.0 110.881 171.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -105.09 138.8 40.73 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.78 0.718 . . . . 0.0 110.894 169.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.8 t -131.31 138.84 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.537 1.135 . . . . 0.0 112.272 -169.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 54.7 p -155.72 -169.81 3.22 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.282 1.033 . . . . 0.0 110.147 169.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -68.0 -40.74 82.98 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 120.354 -1.466 . . . . 0.0 110.102 168.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 51.7 mtp85 -124.0 101.76 7.4 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.925 1.69 . . . . 0.0 111.341 -176.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.549 ' H ' ' HA ' ' A' ' 39' ' ' SER . 19.7 t30 -52.53 -54.25 35.27 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 169.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.4 p -30.83 -57.25 0.22 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.018 2.127 . . . . 0.0 115.551 175.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.1 p -88.98 -41.95 12.07 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.27 1.028 . . . . 0.0 113.085 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -103.0 -73.87 0.65 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.047 1.339 . . . . 0.0 112.998 -174.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.11 -37.22 84.28 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -169.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -50.65 -37.89 43.33 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.734 2.014 . . . . 0.0 113.17 170.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 60.2 ttm -66.3 -46.14 77.96 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.09 -1.006 . . . . 0.0 111.183 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.51 -21.94 65.47 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 118.524 -0.751 . . . . 0.0 111.957 170.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -73.34 -53.1 11.6 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 120.402 1.455 . . . . 0.0 108.461 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.99 -50.23 62.67 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.24 0.924 . . . . 0.0 112.424 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.594 ' HB3' HG11 ' A' ' 123' ' ' VAL . 5.8 m-85 -66.55 -41.39 88.75 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.808 1.304 . . . . 0.0 113.078 176.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.38 -36.19 83.35 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.541 1.519 . . . . 0.0 110.091 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -64.3 -55.98 17.61 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.444 1.498 . . . . 0.0 109.916 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.7 p -70.59 -13.42 62.09 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 120.467 -1.395 . . . . 0.0 114.435 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.6 mt -96.82 -7.0 34.71 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.72 9.35 0.09 OUTLIER Glycine 0 N--CA 1.477 1.416 0 N-CA-C 119.028 2.371 . . . . 0.0 119.028 -172.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.53 -29.09 64.06 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.006 1.903 . . . . 0.0 114.464 -174.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.73 -9.33 86.92 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-O 119.247 -0.752 . . . . 0.0 114.891 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -101.75 -60.17 1.58 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.811 1.245 . . . . 0.0 111.968 -172.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.47 174.38 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 127.048 2.139 . . . . 0.0 110.483 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.26 129.23 42.46 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 121.384 -0.823 . . . . 0.0 110.926 176.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 m -101.68 148.42 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.014 0.926 . . . . 0.0 110.436 170.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.459 ' HB ' ' HE1' ' A' ' 5' ' ' MET . 3.3 m -146.94 157.35 43.61 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.011 0.924 . . . . 0.0 110.367 173.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -135.45 152.03 50.98 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 170.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 88.8 p -152.32 179.24 8.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.285 1.834 . . . . 0.0 111.886 -170.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.13 -178.78 48.51 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 115.639 1.015 . . . . 0.0 115.639 169.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.9 mt -64.81 -52.08 58.7 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.849 0.86 . . . . 0.0 112.069 -174.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -91.12 -38.14 12.95 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.561 1.544 . . . . 0.0 110.86 170.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.549 ' HA ' ' H ' ' A' ' 11' ' ' ASN . 0.6 OUTLIER 62.69 -46.46 0.19 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 127.727 2.411 . . . . 0.0 115.996 -177.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . 0.256 38.2 t 63.5 -123.86 0.56 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 127.247 2.219 . . . . 0.0 113.391 174.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -143.91 -178.23 5.82 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 126.447 1.899 . . . . 0.0 113.71 -171.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.5 m -64.79 111.18 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 120.853 -1.154 . . . . 0.0 109.793 169.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -77.97 137.69 61.54 Favored Pre-proline 0 N--CA 1.476 0.83 0 O-C-N 121.092 -1.005 . . . . 0.0 112.988 -169.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -57.59 -43.43 50.77 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.538 2.825 . . . . 0.0 113.768 -175.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.9 m -75.75 -31.6 59.62 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.763 -0.586 . . . . 0.0 110.795 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.46 -43.11 81.88 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.172 -0.955 . . . . 0.0 112.408 171.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.9 mt -55.47 -40.58 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 121.268 1.849 . . . . 0.0 109.913 175.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.17 -62.53 1.56 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 173.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.95 -11.96 61.27 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -174.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 96.3 mmm -91.86 -42.49 10.04 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.177 0.899 . . . . 0.0 110.325 171.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -60.73 -37.52 82.03 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.673 -1.267 . . . . 0.0 112.518 174.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -60.66 -25.66 66.51 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.25 7.8 p -105.19 15.67 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 125.525 1.53 . . . . 0.0 113.399 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.13 18.58 49.61 Favored Glycine 0 N--CA 1.477 1.37 0 O-C-N 120.796 -1.19 . . . . 0.0 115.555 173.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.7 mt -125.78 90.65 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.974 1.31 . . . . 0.0 110.853 -169.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -70.58 114.61 8.85 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.863 -1.148 . . . . 0.0 110.657 171.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.3 pt -101.37 0.29 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 123.73 0.812 . . . . 0.0 112.756 172.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.1 p -69.51 -17.63 63.61 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -169.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -101.89 8.98 56.48 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 125.344 1.45 . . . . 0.0 114.548 169.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -87.49 156.15 19.67 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.348 1.459 . . . . 0.0 112.295 -169.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.8 t -86.89 165.4 15.95 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -175.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.5 m -135.31 93.66 3.01 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.495 1.518 . . . . 0.0 109.103 169.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -88.97 133.37 35.61 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-O 118.469 -0.777 . . . . 0.0 111.806 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.09 153.94 22.14 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.655 2.237 . . . . 0.0 112.922 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.9 tp -55.96 -32.46 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -169.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -89.22 -13.83 37.33 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 120.786 -1.196 . . . . 0.0 113.267 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -90.1 -26.28 20.31 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.102 0.961 . . . . 0.0 112.832 175.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -52.81 46.72 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -169.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.1 m120 59.47 106.0 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.547 2.739 . . . . 0.0 114.561 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.05 13.85 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.97 1.708 . . . . 0.0 115.474 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -73.87 -29.28 62.01 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.069 0.948 . . . . 0.0 111.138 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -100.15 -5.67 27.42 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -124.89 94.46 4.19 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.27 1.428 . . . . 0.0 110.152 -172.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -73.12 -5.08 36.75 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -174.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.3 t -128.39 121.85 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 125.601 1.561 . . . . 0.0 109.451 173.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.2 t -132.31 119.35 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.052 0.541 . . . . 0.0 110.852 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 mp -110.24 134.35 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.001 0.92 . . . . 0.0 110.564 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.0 m -89.79 147.73 23.63 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.301 1.041 . . . . 0.0 108.253 168.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.9 mt -127.13 43.59 3.09 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.395 1.078 . . . . 0.0 110.728 -173.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 24.3 p -151.57 -16.56 0.2 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 117.59 2.441 . . . . 0.0 117.59 -169.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.08 34.42 70.31 Favored Glycine 0 CA--C 1.539 1.547 0 CA-C-N 119.898 1.226 . . . . 0.0 111.118 -168.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 4.0 p -141.97 -1.03 1.27 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.578 1.951 . . . . 0.0 114.756 -169.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -55.88 -21.47 30.42 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.064 1.792 . . . . 0.0 116.709 -169.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.09 -22.33 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 CA-C-N 118.692 1.246 . . . . 0.0 112.022 173.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -78.5 -10.19 59.62 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 176.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.7 mt -74.26 157.86 86.11 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-N 119.054 0.843 . . . . 0.0 111.707 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.91 141.01 93.43 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.641 2.227 . . . . 0.0 111.522 172.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -63.07 -29.73 75.18 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.477 2.118 . . . . 0.0 112.666 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -62.79 -25.71 68.37 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 173.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -87.14 4.08 43.74 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 170.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.8 t -112.51 -36.63 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.949 1.7 . . . . 0.0 112.544 -175.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.9 p -79.28 10.09 4.01 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 -169.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -66.16 166.54 11.65 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.342 1.457 . . . . 0.0 112.056 169.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -56.78 -37.94 71.8 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -169.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 74.3 mt -127.07 119.8 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.52 1.128 . . . . 0.0 109.674 174.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -133.2 128.23 35.51 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.825 1.25 . . . . 0.0 110.57 169.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -146.81 161.19 41.18 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.809 1.644 . . . . 0.0 110.759 -174.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -127.47 117.02 21.32 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.384 -0.822 . . . . 0.0 112.93 173.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -88.36 94.17 9.76 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 169.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.405 ' H ' ' HG3' ' A' ' 100' ' ' GLN . 2.0 pp0? -51.79 59.82 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 128.823 2.849 . . . . 0.0 116.167 169.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 93.2 mt -84.24 153.35 23.65 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.735 2.414 . . . . 0.0 111.842 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -70.91 162.53 29.14 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.853 0.861 . . . . 0.0 111.408 169.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -88.28 107.79 18.44 Favored Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 120.76 -1.212 . . . . 0.0 108.136 169.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -79.05 -11.96 14.7 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 121.346 1.364 . . . . 0.0 114.643 -169.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -46.2 105.34 0.06 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.745 2.018 . . . . 0.0 113.792 -173.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.04 10.85 53.25 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.331 0.967 . . . . 0.0 115.507 174.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -74.87 -59.21 2.84 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.024 1.412 . . . . 0.0 111.141 -175.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.1 t -172.08 152.44 2.89 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.061 2.145 . . . . 0.0 108.542 170.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.4 mp -60.05 -30.95 69.53 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.75 -0.594 . . . . 0.0 111.117 172.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.0 -38.05 89.66 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.324 -0.86 . . . . 0.0 112.397 173.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.5 t -72.84 -39.85 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.568 0.747 . . . . 0.0 109.194 177.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -45.81 92.1 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.745 0.818 . . . . 0.0 111.406 176.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -69.09 -36.01 77.12 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.367 1.067 . . . . 0.0 112.273 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 62.3 m -59.6 -51.28 70.48 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 118.8 0.727 . . . . 0.0 111.286 174.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.0 m -70.39 -28.92 36.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 CA-C-O 117.206 -1.378 . . . . 0.0 112.553 177.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . 0.255 0.0 OUTLIER -67.06 -37.25 83.71 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 121.21 1.823 . . . . 0.0 112.46 172.249 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.55 -44.15 95.54 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.039 0.828 . . . . 0.0 112.446 173.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -61.65 -46.93 87.64 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 117.61 0.705 . . . . 0.0 112.129 171.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.7 t -58.63 -47.45 88.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 CA-C-O 117.042 -1.456 . . . . 0.0 110.593 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -51.53 -47.06 63.49 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 120.695 1.589 . . . . 0.0 112.79 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.21 -48.06 77.35 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.407 0.683 . . . . 0.0 112.265 177.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 63.8 mtt-85 -76.15 -32.24 59.0 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -176.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.594 HG11 ' HB3' ' A' ' 21' ' ' PHE . 4.0 p -73.93 -34.44 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.697 1.199 . . . . 0.0 111.427 175.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -60.97 -56.09 25.2 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.34 0.973 . . . . 0.0 108.621 168.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -50.25 -38.72 42.22 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.052 1.741 . . . . 0.0 112.487 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -78.16 -60.52 2.34 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.29 -0.882 . . . . 0.0 113.134 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.61 -34.54 51.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 123.981 0.913 . . . . 0.0 111.63 -175.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.91 -0.17 17.69 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.774 1.229 . . . . 0.0 114.239 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -98.27 -10.97 23.11 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.215 1.406 . . . . 0.0 113.312 169.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.7 pt -118.47 -0.25 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.66 1.584 . . . . 0.0 113.359 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 51.2 p . . . . . 0 C--O 1.256 1.429 0 C-N-CA 125.225 1.41 . . . . 0.0 113.69 169.824 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.3 ttm . . . . . 0 N--CA 1.503 2.214 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.795 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -83.96 92.53 7.85 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 119.273 0.942 . . . . 0.0 111.29 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -78.33 145.29 35.38 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.55 -0.719 . . . . 0.0 112.704 -173.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.2 t -113.63 142.65 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 125.117 1.367 . . . . 0.0 111.252 178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.444 ' HE3' ' CD1' ' A' ' 68' ' ' PHE . 62.8 tpp -131.02 122.35 26.65 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.015 0.926 . . . . 0.0 111.279 169.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -92.85 143.35 26.35 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.158 0.583 . . . . 0.0 109.611 168.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.0 t -135.42 130.69 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.905 1.282 . . . . 0.0 109.578 -173.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 p -144.33 174.2 11.12 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.19 0.996 . . . . 0.0 111.606 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -61.26 -56.62 18.49 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.904 -1.122 . . . . 0.0 109.663 173.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -94.5 123.69 38.08 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 106.503 -1.665 . . . . 0.0 106.503 168.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -63.29 -48.77 76.7 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 120.363 1.438 . . . . 0.0 108.89 169.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 94.1 p -47.53 -35.08 8.36 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.822 2.449 . . . . 0.0 115.273 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.6 p -91.03 -27.87 18.34 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.69 1.196 . . . . 0.0 114.139 -173.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 -136.97 -63.09 0.62 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -169.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 95.2 p -62.87 -30.34 71.44 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 120.757 1.617 . . . . 0.0 112.135 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -63.1 -41.84 99.45 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.86 1.264 . . . . 0.0 112.507 169.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.8 mtm -62.14 -45.54 92.98 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.827 -0.546 . . . . 0.0 111.08 174.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.39 -24.01 65.64 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.827 -1.083 . . . . 0.0 113.522 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -74.1 -48.66 28.15 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 121.656 2.025 . . . . 0.0 108.35 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.66 -43.15 99.41 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-O 119.024 -0.875 . . . . 0.0 112.829 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -64.47 -42.86 95.65 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.636 1.718 . . . . 0.0 112.267 173.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.31 -31.05 63.79 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.622 1.101 . . . . 0.0 111.135 -176.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -65.24 -53.9 37.4 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 125.354 1.462 . . . . 0.0 109.919 171.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.1 p -69.62 -11.07 60.55 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.6 mt -103.89 -1.68 27.35 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.551 1.141 . . . . 0.0 113.88 171.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.6 9.06 0.47 Allowed Glycine 0 N--CA 1.477 1.399 0 N-CA-C 117.288 1.675 . . . . 0.0 117.288 -169.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.98 133.8 55.82 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 119.249 1.525 . . . . 0.0 111.886 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.87 -6.83 54.02 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.473 1.035 . . . . 0.0 115.332 -175.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -87.59 -63.55 1.29 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.349 1.575 . . . . 0.0 110.6 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -142.98 173.94 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 127.222 2.209 . . . . 0.0 110.946 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.0 130.34 41.71 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.369 -0.832 . . . . 0.0 112.61 176.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -105.48 154.03 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.73 1.212 . . . . 0.0 112.974 171.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.5 147.0 25.7 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -172.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.7 p -108.75 139.76 43.11 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 127.107 2.163 . . . . 0.0 114.031 170.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.5 t -143.05 177.37 8.42 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.498 1.519 . . . . 0.0 110.463 169.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.69 173.26 39.76 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 120.122 -1.611 . . . . 0.0 115.06 173.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.1 mt -61.76 -35.52 78.35 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.457 0.703 . . . . 0.0 111.752 -174.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -125.19 111.56 15.42 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.836 2.455 . . . . 0.0 107.565 169.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.4 p -65.51 -33.79 76.75 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.179 -0.95 . . . . 0.0 112.064 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.5 t 48.72 -120.63 1.36 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.386 1.474 . . . . 0.0 111.814 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -144.28 -151.54 0.37 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.594 1.957 . . . . 0.0 111.008 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.2 m -91.18 116.26 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 168.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -68.66 133.77 90.58 Favored Pre-proline 0 N--CA 1.481 1.11 0 O-C-N 120.963 -1.086 . . . . 0.0 111.686 -169.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -59.82 -37.61 85.3 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.446 2.764 . . . . 0.0 113.736 -171.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.9 m -79.02 -35.68 42.35 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.912 -0.492 . . . . 0.0 110.364 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.13 93.8 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.903 -1.123 . . . . 0.0 112.422 174.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.3 mt -53.32 -44.84 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 120.944 1.702 . . . . 0.0 110.71 172.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.67 -56.23 17.31 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.972 0.731 . . . . 0.0 112.972 175.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 30.1 mmt -68.66 -19.21 64.4 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -174.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 87.0 mmm -91.86 -40.23 11.3 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.888 0.875 . . . . 0.0 110.659 176.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -60.49 -39.83 89.12 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.741 -1.224 . . . . 0.0 112.404 174.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -60.31 -26.86 66.87 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.173 -0.954 . . . . 0.0 113.533 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.7 p -100.34 12.83 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 124.894 1.277 . . . . 0.0 113.103 174.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.39 18.59 48.63 Favored Glycine 0 N--CA 1.475 1.286 0 C-N-CA 124.795 1.188 . . . . 0.0 115.263 172.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.4 mt -127.22 85.5 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.426 1.49 . . . . 0.0 110.048 -169.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -71.27 109.81 5.52 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.133 -1.604 . . . . 0.0 110.831 173.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.5 pt -87.5 -9.31 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 118.251 -0.88 . . . . 0.0 112.512 173.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.3 t -62.36 -34.55 76.9 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 120.552 1.524 . . . . 0.0 113.149 -169.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.86 3.99 85.81 Favored Glycine 0 CA--C 1.541 1.683 0 C-N-CA 124.782 1.182 . . . . 0.0 115.282 173.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -97.26 150.68 20.66 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.41 1.484 . . . . 0.0 111.895 -173.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.3 t -84.87 149.62 25.55 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.268 -0.895 . . . . 0.0 112.886 -175.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 71.1 m -121.8 111.45 17.15 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.04 0.936 . . . . 0.0 109.914 169.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -89.17 152.58 48.18 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.039 0.936 . . . . 0.0 112.825 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -91.83 150.84 3.35 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.268 3.312 . . . . 0.0 112.0 171.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 tt -63.18 -27.87 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -170.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -82.1 -11.41 58.78 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.0 -1.063 . . . . 0.0 113.246 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -96.81 -27.97 14.47 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.436 1.094 . . . . 0.0 113.323 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.444 ' CD1' ' HE3' ' A' ' 5' ' ' MET . 0.0 OUTLIER -62.54 -41.72 99.07 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -168.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.4 ' HA ' ' CH2' ' A' ' 90' ' ' TRP 0.341 0.0 OUTLIER 53.97 99.44 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.662 2.785 . . . . 0.0 115.043 -176.834 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 68' ' ' PHE . . . -67.66 5.31 0.85 Allowed 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -175.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -72.2 -27.13 62.36 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.023 1.329 . . . . 0.0 112.27 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -90.07 -2.47 58.11 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -119.79 140.2 51.12 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.982 1.313 . . . . 0.0 112.604 -169.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -88.74 -28.83 20.26 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.894 0.877 . . . . 0.0 111.83 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.6 t -130.08 120.42 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.516 1.127 . . . . 0.0 110.003 -170.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.6 t -126.42 129.34 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.573 0.749 . . . . 0.0 110.193 177.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.8 mm -121.73 126.94 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.086 0.954 . . . . 0.0 110.632 -171.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.6 t -89.45 121.7 31.94 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.863 0.465 . . . . 0.0 109.835 169.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.416 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 75.9 mt -98.6 13.42 32.07 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.496 1.518 . . . . 0.0 112.024 175.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.5 p -133.22 157.99 44.0 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.799 2.039 . . . . 0.0 109.032 169.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.71 72.84 0.36 Allowed Glycine 0 N--CA 1.476 1.364 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 171.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 82.3 m -129.93 5.27 4.97 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.403 1.881 . . . . 0.0 114.872 -168.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -54.84 -28.09 46.23 Favored Glycine 0 CA--C 1.538 1.507 0 CA-C-N 120.321 1.419 . . . . 0.0 116.098 -173.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.2 m -99.05 -8.71 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 174.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -95.36 -28.56 14.89 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.093 1.357 . . . . 0.0 112.452 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.6 mt -63.22 150.07 89.84 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.585 1.154 . . . . 0.0 111.814 174.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -58.82 133.29 52.86 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.673 2.249 . . . . 0.0 111.081 173.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -61.18 -31.6 90.18 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.393 2.062 . . . . 0.0 113.184 -176.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -59.17 -32.86 70.28 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.059 -1.026 . . . . 0.0 112.959 171.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.4 ' CH2' ' HA ' ' A' ' 69' ' ' ASN . 0.4 OUTLIER -86.0 12.03 10.31 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.35 1.06 . . . . 0.0 113.821 174.633 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.9 t -116.48 -36.5 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.856 1.662 . . . . 0.0 111.74 178.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.8 p -79.59 25.31 0.34 Allowed 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 -169.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -76.17 167.02 22.62 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.858 1.663 . . . . 0.0 111.975 171.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -57.94 -37.09 73.48 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.932 0.893 . . . . 0.0 112.837 -171.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 67.4 mt -126.81 123.74 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.636 1.175 . . . . 0.0 109.215 169.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -131.52 134.25 45.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.208 1.003 . . . . 0.0 110.597 169.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -141.43 153.97 45.32 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.542 1.137 . . . . 0.0 112.155 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -120.92 117.67 27.92 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.74 1.216 . . . . 0.0 110.157 173.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.416 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 37.0 m0 -95.32 -0.79 52.43 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.669 1.188 . . . . 0.0 113.612 -177.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.308 1.3 pp0? 46.44 39.21 6.26 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 171.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.8 mt -79.4 159.64 26.99 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.8 0.84 . . . . 0.0 112.765 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -87.04 150.81 23.77 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.624 1.569 . . . . 0.0 111.958 173.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.44 116.26 59.32 Favored Pre-proline 0 CA--C 1.546 0.815 0 O-C-N 121.298 -0.877 . . . . 0.0 110.574 172.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -83.23 -14.82 8.13 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.496 2.131 . . . . 0.0 115.457 -169.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -46.59 108.08 0.13 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.759 1.624 . . . . 0.0 112.98 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.69 9.34 78.61 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-O 118.878 -0.957 . . . . 0.0 115.407 175.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -73.81 -68.17 0.54 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.04 1.42 . . . . 0.0 110.431 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.6 t -177.23 152.26 0.86 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 128.505 2.722 . . . . 0.0 108.106 173.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.8 mp -60.36 -29.94 69.23 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.822 0.737 . . . . 0.0 111.549 174.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -64.23 -38.65 91.81 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.091 -1.006 . . . . 0.0 112.423 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.2 t -73.61 -37.63 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.016 0.926 . . . . 0.0 109.476 176.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.8 -45.22 95.23 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.23 1.012 . . . . 0.0 111.177 175.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -67.79 -38.05 82.84 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.638 1.175 . . . . 0.0 112.491 173.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.4 m -58.86 -50.36 74.29 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 118.778 0.717 . . . . 0.0 110.886 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.6 m -71.25 -30.97 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 117.643 -1.17 . . . . 0.0 112.266 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -40.33 97.08 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 121.21 1.823 . . . . 0.0 111.966 171.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.49 -42.83 95.56 Favored Glycine 0 N--CA 1.474 1.183 0 C-N-CA 124.391 0.996 . . . . 0.0 112.579 176.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -60.75 -45.64 93.53 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.915 -0.756 . . . . 0.0 111.947 170.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 29.3 t -58.67 -48.73 84.94 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.807 177.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -51.56 -55.13 20.84 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.856 1.207 . . . . 0.0 111.487 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -59.69 -42.05 92.1 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.619 0.768 . . . . 0.0 112.572 -176.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -78.06 -35.01 50.08 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 39.1 t -61.19 -48.25 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.185 1.394 . . . . 0.0 111.19 172.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -51.88 -55.22 21.41 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.06 0.845 . . . . 0.0 109.606 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -56.93 -37.46 71.52 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.191 1.397 . . . . 0.0 112.276 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -74.25 -56.28 5.07 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.33 -0.856 . . . . 0.0 112.556 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.63 -34.44 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.775 1.23 . . . . 0.0 112.363 -175.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.14 -22.78 62.02 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 121.118 -0.989 . . . . 0.0 113.486 -174.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -70.2 -19.73 63.15 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.593 1.157 . . . . 0.0 113.849 173.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 28.7 pt -118.89 17.15 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 126.259 1.824 . . . . 0.0 112.652 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--O 1.256 1.401 0 C-N-CA 126.459 1.904 . . . . 0.0 111.313 172.158 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.6 tpp . . . . . 0 N--CA 1.502 2.139 0 CA-C-O 118.989 -0.529 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -82.7 85.42 7.04 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 119.873 1.215 . . . . 0.0 111.338 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -77.42 147.55 35.93 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -171.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.64 139.5 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.938 1.295 . . . . 0.0 111.074 176.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 49.4 tpp -127.36 115.36 18.85 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.499 0.72 . . . . 0.0 111.093 169.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -81.53 142.58 32.73 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.624 -0.673 . . . . 0.0 110.331 169.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.92 128.17 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 119.187 0.903 . . . . 0.0 111.66 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.5 p -144.76 178.02 8.3 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.462 1.105 . . . . 0.0 111.757 175.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -59.8 -61.46 2.6 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 120.083 1.31 . . . . 0.0 109.617 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.463 ' HB3' ' H ' ' A' ' 13' ' ' SER . 2.4 mpt_? -83.72 125.18 31.63 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 167.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -59.68 -43.25 94.08 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 120.029 1.286 . . . . 0.0 108.476 169.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.0 p -65.49 -48.58 72.13 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 115.848 1.795 . . . . 0.0 115.848 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.463 ' H ' ' HB3' ' A' ' 10' ' ' ARG . 4.3 m -71.8 -15.51 62.15 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -169.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.82 -55.05 0.82 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 120.325 1.421 . . . . 0.0 113.258 168.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.8 m -61.97 -38.2 87.64 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -171.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -62.71 -36.14 82.0 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.377 0.99 . . . . 0.0 113.214 169.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 82.5 mtp -59.83 -45.58 91.96 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.161 -0.962 . . . . 0.0 110.3 173.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.62 -31.38 69.47 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 117.954 -1.022 . . . . 0.0 113.555 174.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -68.61 -46.17 69.99 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 121.553 1.979 . . . . 0.0 109.033 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.49 -42.99 97.29 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 118.527 -1.152 . . . . 0.0 112.668 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.529 ' HB3' HG11 ' A' ' 123' ' ' VAL . 3.5 m-85 -66.13 -42.3 89.33 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.202 1.501 . . . . 0.0 112.144 171.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.501 ' HB1' HG11 ' A' ' 32' ' ' VAL . . . -63.93 -35.75 81.68 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.61 -1.306 . . . . 0.0 111.114 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -63.53 -55.78 21.18 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.135 1.774 . . . . 0.0 109.976 174.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.7 p -68.41 -14.47 63.02 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 178.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 50.8 mt -99.14 -6.68 27.83 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.384 1.074 . . . . 0.0 113.864 174.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -152.13 9.56 0.62 Allowed Glycine 0 N--CA 1.476 1.311 0 N-CA-C 117.185 1.634 . . . . 0.0 117.185 -169.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.36 132.21 50.37 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 119.514 1.657 . . . . 0.0 111.609 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.37 -6.22 57.92 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.803 1.192 . . . . 0.0 115.475 -176.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -86.46 -59.16 2.36 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 119.459 1.629 . . . . 0.0 110.813 175.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.6 pp -144.7 175.71 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 128.226 2.61 . . . . 0.0 110.118 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.35 132.5 41.79 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.22 -0.925 . . . . 0.0 112.788 174.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.501 HG11 ' HB1' ' A' ' 22' ' ' ALA . 30.7 m -104.02 145.93 12.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 124.667 1.187 . . . . 0.0 112.704 171.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.8 m -146.94 156.35 43.0 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.217 1.007 . . . . 0.0 111.707 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.9 p -126.02 139.83 53.1 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.885 2.074 . . . . 0.0 113.9 175.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.7 t -133.66 172.1 13.21 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 129.567 3.147 . . . . 0.0 109.322 -176.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.64 173.56 44.84 Favored Glycine 0 CA--C 1.523 0.587 0 O-C-N 120.551 -1.343 . . . . 0.0 115.094 169.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.1 mt -66.46 -28.43 68.58 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.291 0.636 . . . . 0.0 111.723 -178.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -121.26 127.91 51.86 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.48 1.912 . . . . 0.0 108.383 170.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.5 p -78.02 55.99 1.54 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.675 1.59 . . . . 0.0 110.381 171.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.5 p -68.13 149.2 49.89 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.29 1.436 . . . . 0.0 112.037 -169.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -58.24 155.3 11.7 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.395 0.678 . . . . 0.0 111.673 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.1 m -50.91 109.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 169.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -65.95 130.63 94.44 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 118.478 -0.772 . . . . 0.0 112.319 -168.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.03 -38.79 85.65 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.489 2.793 . . . . 0.0 113.391 -172.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.9 m -77.55 -34.02 53.95 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 119.224 -0.417 . . . . 0.0 110.684 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.82 -43.48 96.09 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.844 -1.16 . . . . 0.0 111.986 172.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.7 mt -54.72 -40.3 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 120.795 1.634 . . . . 0.0 110.328 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.62 -62.87 1.27 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 173.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 30.4 mmt -67.11 -21.69 65.84 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.951 0.9 . . . . 0.0 113.415 -172.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 86.4 mmm -85.36 -37.78 19.5 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.616 0.767 . . . . 0.0 110.524 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -63.75 -33.44 75.67 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.665 -1.272 . . . . 0.0 111.983 173.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -55.26 -28.49 53.75 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 170.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.1 m -107.11 19.48 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 125.328 1.451 . . . . 0.0 113.525 174.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.64 13.73 74.98 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.65 1.119 . . . . 0.0 115.37 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.3 mt -117.67 97.19 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.448 1.499 . . . . 0.0 109.855 -170.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -78.35 112.09 15.0 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.958 -1.089 . . . . 0.0 110.438 171.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.0 pt -93.09 -4.22 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 172.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.4 p -65.98 -26.33 67.51 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -169.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -100.58 9.29 58.77 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.362 1.458 . . . . 0.0 114.445 172.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -86.72 149.11 25.11 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.983 1.313 . . . . 0.0 112.266 -170.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.9 t -63.59 148.16 49.58 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.459 -0.776 . . . . 0.0 112.109 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.5 t -138.96 54.95 1.72 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.046 0.927 . . . . 0.0 111.689 174.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -68.88 147.45 97.84 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 125.192 1.397 . . . . 0.0 113.185 -170.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -82.75 151.81 14.77 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.635 2.224 . . . . 0.0 112.442 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.8 tt -60.48 -21.83 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -91.99 -9.42 43.02 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 177.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -97.58 -35.2 10.69 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.781 0.832 . . . . 0.0 111.913 171.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -68.43 160.41 29.73 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.18 0.592 . . . . 0.0 111.571 175.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.416 ' HA ' ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -136.63 119.38 16.16 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.666 0.786 . . . . 0.0 111.985 170.479 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.423 ' HB3' ' CE3' ' A' ' 90' ' ' TRP . . . -66.54 0.8 2.01 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -175.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -70.59 -29.26 65.63 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.906 0.882 . . . . 0.0 112.209 -175.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -88.78 -2.36 58.55 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.116 1.366 . . . . 0.0 113.322 177.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -124.67 95.15 4.41 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.706 1.602 . . . . 0.0 110.498 -171.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -55.13 -29.48 57.81 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.768 1.227 . . . . 0.0 112.83 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 t -121.55 118.3 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 125.111 1.364 . . . . 0.0 110.19 -172.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.8 t -130.17 134.38 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.818 0.847 . . . . 0.0 110.644 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.406 HG21 ' CE2' ' A' ' 99' ' ' TRP . 19.0 mm -128.71 132.64 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 121.434 -0.791 . . . . 0.0 111.399 -170.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.4 t -87.87 117.59 26.82 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.521 0.728 . . . . 0.0 111.116 169.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 mp -97.68 37.07 1.42 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.734 1.614 . . . . 0.0 109.177 173.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.2 t -135.63 146.2 47.63 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.192 1.797 . . . . 0.0 111.647 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.16 -16.58 80.59 Favored Glycine 0 CA--C 1.542 1.723 0 O-C-N 121.946 -0.471 . . . . 0.0 112.798 169.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 24.5 p -63.35 -56.46 16.16 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.652 1.581 . . . . 0.0 114.173 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.27 -60.7 0.82 Allowed Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.69 1.614 . . . . 0.0 114.908 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.9 m -59.74 -21.62 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 126.23 1.812 . . . . 0.0 115.468 -170.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -76.79 -11.11 59.78 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.6 mt -80.82 135.97 51.61 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.615 0.766 . . . . 0.0 110.685 170.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.96 153.73 47.46 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.47 2.114 . . . . 0.0 110.675 174.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -59.82 -34.0 95.87 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.859 2.372 . . . . 0.0 112.222 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -48.89 -46.25 42.38 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.499 1.52 . . . . 0.0 112.938 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.423 ' CE3' ' HB3' ' A' ' 70' ' ' ALA . 1.8 m95 -90.75 8.2 35.77 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.747 1.219 . . . . 0.0 112.961 -177.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.7 t -114.94 -38.53 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 127.03 2.132 . . . . 0.0 111.704 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.9 p -81.39 26.71 0.45 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -174.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -80.89 169.34 17.67 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.31 1.444 . . . . 0.0 111.896 174.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -53.58 -41.79 66.92 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 -169.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 59.9 mt -125.71 123.46 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.591 1.157 . . . . 0.0 109.373 170.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -133.49 135.06 44.23 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.007 0.923 . . . . 0.0 111.44 169.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -142.84 153.12 42.87 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.69 1.196 . . . . 0.0 112.42 -175.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -113.36 125.88 54.75 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.279 1.432 . . . . 0.0 111.133 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.406 ' CE2' HG21 ' A' ' 77' ' ' ILE . 44.3 m0 -100.91 -5.69 25.67 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 177.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.355 1.2 pp0? 50.3 31.89 5.71 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.3 mt -75.52 151.87 37.89 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -87.28 160.6 18.36 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.704 2.002 . . . . 0.0 112.511 178.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.61 115.02 60.75 Favored Pre-proline 0 CA--C 1.547 0.83 0 O-C-N 121.282 -0.886 . . . . 0.0 111.4 169.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.87 -13.74 9.14 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.471 2.114 . . . . 0.0 114.822 -170.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -44.05 113.7 0.56 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.506 1.922 . . . . 0.0 113.556 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.81 6.46 55.88 Favored Glycine 0 CA--C 1.534 1.234 0 N-CA-C 115.86 1.104 . . . . 0.0 115.86 173.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -78.04 -63.63 1.35 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.921 1.361 . . . . 0.0 110.881 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.6 t -174.24 152.47 1.82 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.391 2.277 . . . . 0.0 108.889 169.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.1 mp -59.96 -29.92 68.75 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.624 -0.672 . . . . 0.0 111.299 171.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -63.09 -39.75 95.63 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.056 -1.028 . . . . 0.0 112.483 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.3 t -71.43 -37.1 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.843 0.857 . . . . 0.0 109.733 175.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -41.9 92.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.914 0.885 . . . . 0.0 111.699 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -70.09 -36.8 75.17 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 121.22 -0.925 . . . . 0.0 111.987 171.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.3 m -58.06 -48.94 78.58 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.087 0.858 . . . . 0.0 111.639 174.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 23.8 m -68.25 -31.25 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 117.802 -1.094 . . . . 0.0 112.09 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.26 -42.22 98.27 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 120.867 1.667 . . . . 0.0 111.786 170.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.74 -43.82 93.44 Favored Glycine 0 N--CA 1.473 1.158 0 C-N-CA 124.256 0.932 . . . . 0.0 112.785 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -60.51 -45.21 94.65 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 122.166 -0.608 . . . . 0.0 112.032 170.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.9 t -59.67 -50.35 80.33 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 CA-C-O 117.518 -1.23 . . . . 0.0 109.434 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -50.81 -49.89 57.59 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.045 1.293 . . . . 0.0 112.068 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -60.48 -44.37 95.99 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.528 0.731 . . . . 0.0 112.948 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 46.4 mtp85 -81.92 -35.93 28.6 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.529 HG11 ' HB3' ' A' ' 21' ' ' PHE . 4.0 p -72.51 -34.07 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.17 1.388 . . . . 0.0 111.747 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -56.44 -56.98 14.48 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.249 0.931 . . . . 0.0 109.535 169.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -55.64 -35.68 66.18 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.885 1.274 . . . . 0.0 111.877 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -73.45 -57.16 4.19 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.631 -0.668 . . . . 0.0 112.385 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.96 -33.07 61.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.848 0.859 . . . . 0.0 112.211 -176.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.32 -23.25 60.23 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -173.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -68.57 -21.35 64.53 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.693 1.197 . . . . 0.0 113.811 173.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 29.0 pt -117.77 15.28 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 126.452 1.901 . . . . 0.0 112.634 -177.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--O 1.255 1.358 0 C-N-CA 126.501 1.92 . . . . 0.0 111.753 173.522 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.505 2.295 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -81.23 98.01 7.9 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.0 0.92 . . . . 0.0 110.147 175.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -80.47 146.46 31.37 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.647 -0.658 . . . . 0.0 112.324 -174.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.0 t -111.95 146.59 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.673 1.189 . . . . 0.0 110.743 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 45.3 tpp -130.83 112.81 13.36 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.226 1.011 . . . . 0.0 111.448 169.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -82.2 129.57 34.87 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.31 1.044 . . . . 0.0 110.362 169.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.3 t -127.22 136.23 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.069 1.348 . . . . 0.0 110.925 -176.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 t -149.78 -176.81 5.57 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 121.443 -0.786 . . . . 0.0 111.919 169.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -61.15 -45.0 96.43 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.412 -0.805 . . . . 0.0 110.617 170.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.56 129.59 56.68 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.435 1.494 . . . . 0.0 110.787 169.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -72.78 -55.79 6.21 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 169.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.0 p -27.35 -52.22 0.07 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 128.882 2.873 . . . . 0.0 116.758 173.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.4 p -100.96 -24.47 14.33 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.857 1.263 . . . . 0.0 113.898 -174.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -118.04 -71.46 0.74 Allowed 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 119.643 1.111 . . . . 0.0 111.98 -173.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.96 -30.38 70.88 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 121.256 -0.903 . . . . 0.0 112.924 -175.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -66.42 -34.25 77.52 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 126.405 1.882 . . . . 0.0 113.801 172.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 27.3 mmm -65.73 -36.4 83.5 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.656 -0.652 . . . . 0.0 110.27 172.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.41 -26.69 61.07 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.263 -0.898 . . . . 0.0 113.394 169.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -68.96 -53.25 21.8 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.395 1.452 . . . . 0.0 108.439 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.67 -49.07 77.0 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-O 118.935 -0.925 . . . . 0.0 112.488 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.575 ' HB3' HG11 ' A' ' 123' ' ' VAL . 8.4 m-85 -66.71 -38.34 86.51 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.586 1.193 . . . . 0.0 112.49 175.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.65 -38.07 80.16 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 120.024 1.283 . . . . 0.0 110.215 -178.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -57.74 -57.48 12.58 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 125.796 1.639 . . . . 0.0 110.889 171.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.9 p -71.35 -15.4 62.39 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -177.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.1 mt -95.14 -13.24 25.23 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -142.84 8.88 2.27 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 117.783 1.873 . . . . 0.0 117.783 -169.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.14 129.52 38.48 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.771 1.786 . . . . 0.0 111.784 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.33 -6.55 56.89 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 124.677 1.132 . . . . 0.0 115.571 -177.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -86.78 -57.37 3.01 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 119.471 1.636 . . . . 0.0 110.603 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.6 pp -142.17 177.13 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 127.504 2.322 . . . . 0.0 110.161 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.28 122.17 43.21 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.725 0.774 . . . . 0.0 111.591 173.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.9 m -87.74 149.92 3.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 123.781 0.833 . . . . 0.0 111.746 169.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.42 152.04 38.42 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.728 0.811 . . . . 0.0 110.93 176.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.0 p -133.44 145.65 50.45 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.941 1.696 . . . . 0.0 112.541 175.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.4 t -150.01 178.46 8.91 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.884 1.674 . . . . 0.0 110.573 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.26 -179.57 46.42 Favored Glycine 0 CA--C 1.527 0.794 0 O-C-N 120.92 -1.112 . . . . 0.0 114.185 170.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.1 mt -71.95 -44.39 63.65 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -169.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -90.73 -25.57 19.95 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.747 1.619 . . . . 0.0 112.473 173.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 60.3 p 58.84 -65.1 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 127.814 2.445 . . . . 0.0 113.128 -169.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 t 56.59 -174.58 0.06 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 130.22 3.408 . . . . 0.0 114.095 -177.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 54.6 ttt85 -79.83 147.51 31.75 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.873 1.669 . . . . 0.0 111.034 174.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.0 m -47.35 112.92 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.794 1.238 . . . . 0.0 109.739 169.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -63.12 137.56 97.1 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -167.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.4 -40.01 61.62 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.716 2.944 . . . . 0.0 113.518 -175.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.1 m -77.23 -33.04 56.19 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.978 -0.451 . . . . 0.0 110.513 176.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.3 -47.88 83.91 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.403 1.001 . . . . 0.0 111.706 171.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 68.7 mt -49.25 -44.56 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 120.388 1.449 . . . . 0.0 110.823 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.84 -59.44 5.14 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 174.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.2 mmt -67.11 -22.17 65.82 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -175.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.2 mtp -80.88 -45.16 17.24 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.993 1.317 . . . . 0.0 110.665 173.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -61.69 -33.45 74.02 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.804 -1.185 . . . . 0.0 112.532 176.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -55.53 -30.23 60.35 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.264 1.026 . . . . 0.0 113.455 172.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.0 m -105.87 14.98 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 125.146 1.379 . . . . 0.0 113.792 177.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.93 17.79 64.65 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.166 0.889 . . . . 0.0 115.124 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.6 mt -112.68 114.86 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.91 1.284 . . . . 0.0 110.944 -169.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -90.81 110.83 22.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.7 1.2 . . . . 0.0 111.783 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.3 pt -110.62 -5.89 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 169.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.8 p -67.32 -25.6 66.09 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 120.548 -1.345 . . . . 0.0 114.44 -169.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -106.99 14.12 40.84 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 125.683 1.611 . . . . 0.0 114.378 170.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -95.51 151.23 19.5 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.307 1.443 . . . . 0.0 112.128 -170.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.7 t -77.32 146.8 36.54 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 121.247 -0.908 . . . . 0.0 112.856 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.6 m -126.21 98.58 5.53 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.787 1.235 . . . . 0.0 109.069 169.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.79 155.99 75.3 Favored Pre-proline 0 CA--C 1.553 1.088 0 O-C-N 121.223 -0.923 . . . . 0.0 113.388 -174.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -97.63 152.45 0.92 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.866 3.711 . . . . 0.0 113.708 171.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.6 tp -60.81 -21.1 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 -169.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -103.15 -6.88 21.75 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -84.28 -37.91 21.11 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.97 0.804 . . . . 0.0 111.674 171.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.45 159.32 34.16 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.803 0.841 . . . . 0.0 111.574 173.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.449 ' HA ' ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -138.29 112.9 8.9 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.528 0.731 . . . . 0.0 111.728 171.428 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.7 -3.67 2.48 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -169.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.86 -27.62 67.67 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.004 -1.06 . . . . 0.0 112.214 -174.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -91.86 -0.87 57.53 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.087 1.355 . . . . 0.0 113.655 176.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -122.54 95.12 4.51 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.359 1.464 . . . . 0.0 110.597 -170.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -56.2 -31.3 63.33 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.878 1.271 . . . . 0.0 112.968 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.3 t -121.43 121.43 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 124.527 1.131 . . . . 0.0 110.494 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.7 t -127.1 133.59 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.079 0.952 . . . . 0.0 110.169 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.8 mm -122.84 136.7 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.909 0.883 . . . . 0.0 110.375 -175.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.7 t -96.96 127.23 42.73 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.042 0.937 . . . . 0.0 110.464 169.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -108.95 25.86 11.3 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.542 1.537 . . . . 0.0 110.173 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 31.3 p -150.56 165.28 33.76 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.138 2.575 . . . . 0.0 111.837 177.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.31 -19.25 75.8 Favored Glycine 0 CA--C 1.541 1.672 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 168.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 11.0 p -61.99 -6.39 2.84 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 127.235 2.214 . . . . 0.0 115.431 174.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.1 -31.96 59.4 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.613 1.102 . . . . 0.0 114.633 177.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.2 m -67.81 -16.09 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 176.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -97.61 2.25 49.69 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.256 1.422 . . . . 0.0 113.195 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.2 mt -71.92 155.3 92.15 Favored Pre-proline 0 CA--C 1.549 0.941 0 O-C-N 121.148 -0.97 . . . . 0.0 111.538 173.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -64.28 149.27 90.51 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.751 2.301 . . . . 0.0 113.954 -175.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -72.89 56.82 3.06 Favored 'Trans proline' 0 CA--C 1.549 1.261 1 C-N-CA 125.879 4.386 . . . . 0.0 111.183 171.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -157.03 -51.0 0.07 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.671 2.388 . . . . 0.0 109.431 -169.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.449 ' CH2' ' HA ' ' A' ' 69' ' ' ASN . 1.0 OUTLIER -85.39 -28.1 25.36 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.112 0.965 . . . . 0.0 111.899 177.907 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.4 m -84.16 -12.95 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 175.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.9 p -94.37 8.71 41.02 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.042 1.337 . . . . 0.0 114.202 -172.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -74.61 169.15 18.37 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.797 1.239 . . . . 0.0 112.98 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -52.07 -39.98 60.49 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -169.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.2 mt -126.3 122.98 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.553 1.141 . . . . 0.0 109.429 169.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -129.38 124.56 34.52 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.391 1.076 . . . . 0.0 110.143 169.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -141.79 167.61 21.74 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.334 1.454 . . . . 0.0 111.017 -174.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -135.27 146.84 48.94 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 172.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 36.7 m0 -109.38 7.68 25.13 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 64.46 -78.76 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.097 1.759 . . . . 0.0 112.983 -177.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 27.0 mt 49.94 -163.89 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 127.585 2.354 . . . . 0.0 113.852 -175.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -141.58 160.49 40.04 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.953 2.101 . . . . 0.0 108.105 171.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -81.1 110.53 18.3 Favored Pre-proline 0 N--CA 1.471 0.625 0 CA-C-N 119.764 1.166 . . . . 0.0 109.689 169.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -81.63 -10.77 11.83 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 121.249 1.3 . . . . 0.0 114.273 -169.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -45.47 109.26 0.16 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.666 1.586 . . . . 0.0 113.568 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.52 9.77 62.2 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 118.767 -1.018 . . . . 0.0 115.478 172.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -78.46 -64.8 1.09 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.877 1.338 . . . . 0.0 111.079 -176.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 21.4 t -173.74 151.62 1.88 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.372 2.269 . . . . 0.0 108.429 170.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.8 mp -60.81 -28.2 68.61 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.577 -0.702 . . . . 0.0 111.119 172.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.18 -39.6 95.1 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.027 -1.046 . . . . 0.0 112.334 173.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.5 t -71.68 -38.9 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.084 0.954 . . . . 0.0 109.654 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.34 -40.0 95.01 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.259 1.024 . . . . 0.0 111.608 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.8 mtt85 -73.23 -36.46 66.44 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 121.062 -1.024 . . . . 0.0 112.185 170.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 55.2 m -58.02 -47.73 82.17 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 119.147 0.885 . . . . 0.0 111.646 175.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.6 m -68.39 -30.24 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 119.589 1.086 . . . . 0.0 111.778 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.66 -43.52 98.59 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 120.236 1.38 . . . . 0.0 111.76 169.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.74 -44.33 94.99 Favored Glycine 0 N--CA 1.473 1.11 0 C-N-CA 124.47 1.033 . . . . 0.0 112.68 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -59.87 -46.41 89.4 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.242 0.617 . . . . 0.0 112.069 170.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.459 ' O ' HG12 ' A' ' 123' ' ' VAL . 3.9 t -59.42 -52.06 65.39 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.506 0 CA-C-O 117.136 -1.411 . . . . 0.0 110.3 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -49.52 -44.23 46.15 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.122 1.369 . . . . 0.0 113.215 -175.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -65.91 -45.59 81.4 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.416 0.686 . . . . 0.0 112.556 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 53.8 mtp85 -82.05 -34.46 29.46 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.752 0.821 . . . . 0.0 112.823 -173.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.575 HG11 ' HB3' ' A' ' 21' ' ' PHE . 9.4 p -68.64 -38.61 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.327 1.451 . . . . 0.0 111.785 173.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -57.54 -56.16 25.53 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.607 1.094 . . . . 0.0 109.631 169.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -55.23 -32.65 62.45 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.723 1.209 . . . . 0.0 112.342 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -77.04 -58.71 3.13 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.228 -0.92 . . . . 0.0 112.68 176.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.75 -32.64 58.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.88 1.272 . . . . 0.0 112.36 -174.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.93 -15.06 59.78 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -172.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -74.51 -26.54 60.06 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.529 1.131 . . . . 0.0 113.446 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 23.8 pt -110.23 -7.41 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.544 1.538 . . . . 0.0 113.589 -177.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.0 m . . . . . 0 C--O 1.252 1.207 0 C-N-CA 125.103 1.361 . . . . 0.0 113.117 173.83 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.9 ttm . . . . . 0 N--CA 1.502 2.138 0 CA-C-O 119.519 -0.277 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -93.92 91.11 6.75 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.658 1.183 . . . . 0.0 110.756 173.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.34 144.47 42.35 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 121.444 -0.785 . . . . 0.0 111.276 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 p -125.3 145.2 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.249 1.02 . . . . 0.0 112.199 -176.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 40.3 tpp -133.45 117.19 16.91 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.939 1.296 . . . . 0.0 112.071 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -84.19 141.08 31.3 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 119.198 -0.429 . . . . 0.0 111.138 169.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.7 t -134.23 124.73 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.297 1.439 . . . . 0.0 111.622 -176.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.9 p -145.8 -179.4 6.66 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.009 1.324 . . . . 0.0 111.608 175.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.79 -59.96 4.15 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 119.947 -1.721 . . . . 0.0 110.803 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -87.31 136.07 33.08 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 168.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -72.57 -55.92 6.17 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 169.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.479 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 24.9 p -50.8 -49.29 58.77 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.681 1.364 . . . . 0.0 114.681 -176.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 m -74.96 -10.88 59.9 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 -143.12 -68.25 0.35 Allowed 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 119.841 1.2 . . . . 0.0 113.571 177.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 44.5 m -65.43 -35.72 81.77 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.456 -1.402 . . . . 0.0 114.472 -172.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -68.97 -29.72 67.99 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 120.922 -1.111 . . . . 0.0 112.887 169.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.2 mtm -61.96 -46.97 86.94 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 169.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.31 -31.2 71.86 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 34' ' ' SER . 27.4 tt0 -69.58 -45.9 67.59 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 120.431 1.469 . . . . 0.0 109.531 176.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.05 -43.84 98.2 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 118.939 -0.923 . . . . 0.0 111.767 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -63.69 -42.97 97.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.47 1.135 . . . . 0.0 112.409 170.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.43 -31.7 72.07 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 120.515 -1.365 . . . . 0.0 111.056 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -67.86 -55.1 14.18 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 126.502 1.921 . . . . 0.0 109.296 174.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.8 p -68.69 -14.54 63.09 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 177.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 39.8 mt -101.05 1.51 39.55 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.66 1.184 . . . . 0.0 113.83 172.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.97 9.97 0.22 Allowed Glycine 0 CA--C 1.535 1.322 0 N-CA-C 117.402 1.721 . . . . 0.0 117.402 -169.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.96 131.35 50.79 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.763 1.782 . . . . 0.0 111.71 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.54 -3.39 59.66 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.491 1.043 . . . . 0.0 115.469 -175.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -87.11 -63.38 1.32 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 119.102 1.451 . . . . 0.0 110.329 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -142.09 173.9 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 127.44 2.296 . . . . 0.0 110.203 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.18 120.81 33.11 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 121.232 -0.917 . . . . 0.0 111.302 176.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 m -94.31 148.13 5.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.791 169.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.55 157.78 43.69 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.758 0.823 . . . . 0.0 110.741 -172.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.423 ' HB3' ' HB2' ' A' ' 19' ' ' GLU . 93.7 p -145.06 146.42 31.86 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 175.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 79.7 p -150.56 -179.04 6.91 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.676 1.591 . . . . 0.0 110.691 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.37 -174.3 43.63 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 116.46 1.344 . . . . 0.0 116.46 170.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.7 mt -71.49 -47.63 54.2 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.261 0.624 . . . . 0.0 111.822 -172.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -92.81 -32.8 14.52 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.26 1.824 . . . . 0.0 111.412 170.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . 0.282 26.0 p 61.22 -53.53 0.11 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 128.177 2.591 . . . . 0.0 114.813 -171.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.0 t 60.36 -178.82 0.1 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 127.579 2.352 . . . . 0.0 115.07 173.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -71.6 166.18 22.4 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 126.531 1.933 . . . . 0.0 112.375 172.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.1 m -62.54 117.83 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 169.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.479 ' H ' ' HB2' ' A' ' 12' ' ' SER . 56.0 t-80 -76.14 132.46 73.61 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 124.033 0.933 . . . . 0.0 113.141 -168.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -57.73 -41.93 65.07 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.484 2.789 . . . . 0.0 114.059 -170.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.6 m -77.68 -35.46 52.24 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.797 -0.564 . . . . 0.0 110.864 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.74 -43.14 94.33 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.327 -0.844 . . . . 0.0 111.942 173.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.7 mt -54.06 -46.54 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 120.34 1.427 . . . . 0.0 109.717 174.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.38 -60.01 4.38 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.4 mmt -66.71 -29.7 69.75 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.414 -0.804 . . . . 0.0 112.13 -172.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 75.4 mmm -80.43 -40.0 27.17 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.668 0.787 . . . . 0.0 110.364 178.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -58.33 -37.31 74.87 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.588 -1.32 . . . . 0.0 112.315 171.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -59.71 -23.8 63.46 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.3 m -105.19 16.0 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 124.715 1.206 . . . . 0.0 114.021 172.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.01 13.65 66.04 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.398 0.999 . . . . 0.0 115.029 177.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.9 mt -120.72 68.81 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.032 1.733 . . . . 0.0 109.601 -169.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -65.17 105.14 1.02 Allowed 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.231 -1.543 . . . . 0.0 110.668 174.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.1 pt -81.2 -0.42 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 O-C-N 121.528 -0.733 . . . . 0.0 112.815 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 85.1 p -71.67 -28.35 63.67 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.399 -1.438 . . . . 0.0 114.043 -172.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.28 2.93 71.88 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 125.332 1.444 . . . . 0.0 114.432 171.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -86.4 159.16 19.44 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.463 1.505 . . . . 0.0 112.202 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.8 t -87.73 152.63 21.99 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -170.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.3 m -139.36 134.8 32.99 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.362 1.465 . . . . 0.0 110.398 169.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -142.26 142.69 24.81 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 123.979 0.912 . . . . 0.0 111.066 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -81.0 150.52 18.07 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.186 2.591 . . . . 0.0 112.714 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.3 tt -64.5 -18.25 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -172.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -95.86 -9.1 32.32 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -95.68 -36.32 11.25 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.095 0.958 . . . . 0.0 111.2 169.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -67.9 161.49 26.3 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.315 0.579 . . . . 0.0 111.609 174.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -135.78 122.23 20.66 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.338 1.055 . . . . 0.0 110.505 174.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.44 -0.35 10.16 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -171.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -70.49 -32.88 70.57 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.265 0.939 . . . . 0.0 113.421 -169.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -77.34 -21.01 54.02 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -105.27 90.9 3.57 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.003 1.321 . . . . 0.0 110.448 -169.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -58.08 -30.13 65.99 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.21 108.26 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.385 1.074 . . . . 0.0 109.874 -177.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.8 t -112.13 132.65 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.16 0.984 . . . . 0.0 109.81 177.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.6 mm -128.59 118.22 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 123.556 0.742 . . . . 0.0 110.374 -170.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 t -78.88 136.16 37.22 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.536 0.684 . . . . 0.0 109.346 168.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.6 mt -108.58 23.8 13.99 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.342 1.057 . . . . 0.0 109.848 169.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.8 p -151.05 2.36 0.43 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 -174.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.81 26.93 69.29 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-N 119.642 1.11 . . . . 0.0 113.57 -171.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 74.0 m -80.48 -2.04 44.24 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -169.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.88 -22.15 46.96 Favored Glycine 0 CA--C 1.538 1.489 0 O-C-N 120.291 -1.506 . . . . 0.0 115.162 -171.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.8 m -72.71 -13.8 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 172.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -113.57 -17.15 12.24 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.44 1.496 . . . . 0.0 112.135 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.8 mp -67.03 153.72 93.98 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 124.403 1.081 . . . . 0.0 113.039 176.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -59.57 137.34 76.98 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.902 2.401 . . . . 0.0 110.074 169.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -59.0 -33.86 98.94 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.241 1.961 . . . . 0.0 113.33 -174.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -65.41 -25.69 67.65 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.774 1.17 . . . . 0.0 113.974 176.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.72 -19.8 54.6 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.761 -1.212 . . . . 0.0 112.573 171.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.7 t -89.63 -37.28 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.834 1.654 . . . . 0.0 112.087 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.7 p -83.46 18.14 1.93 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -173.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -69.0 166.49 17.9 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.147 0.979 . . . . 0.0 111.519 169.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -53.16 -40.84 64.61 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -169.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 63.4 mt -129.4 126.65 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.664 1.186 . . . . 0.0 109.791 169.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -131.03 125.21 32.67 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.671 1.188 . . . . 0.0 109.929 169.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -140.96 166.16 25.56 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.906 1.282 . . . . 0.0 112.115 -175.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -129.81 134.38 47.52 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.087 1.355 . . . . 0.0 112.306 173.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 46.8 m0 -96.29 0.71 51.23 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 64.63 33.45 10.63 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.829 1.251 . . . . 0.0 114.275 170.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 26.7 mt -90.66 166.43 13.17 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -119.65 148.9 42.81 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.684 1.994 . . . . 0.0 111.178 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.74 119.13 76.12 Favored Pre-proline 0 CA--C 1.55 0.971 0 O-C-N 121.402 -0.812 . . . . 0.0 110.984 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -85.85 -10.19 7.29 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.234 1.956 . . . . 0.0 115.338 -173.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -47.74 113.81 0.78 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.927 1.291 . . . . 0.0 112.938 177.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.04 -3.65 84.57 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 123.978 0.799 . . . . 0.0 114.289 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -78.45 169.52 18.11 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.143 0.972 . . . . 0.0 110.044 169.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 97.2 p -64.13 156.82 27.22 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.383 -0.823 . . . . 0.0 111.903 173.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.9 -30.96 70.49 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.413 -0.804 . . . . 0.0 111.695 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -64.48 -36.34 83.87 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 120.957 -1.089 . . . . 0.0 113.388 173.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.5 t -73.7 -36.65 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 O-C-N 121.061 -1.024 . . . . 0.0 110.272 173.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.54 -40.03 95.95 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.805 0.842 . . . . 0.0 110.675 175.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -67.03 -42.49 84.77 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.046 1.738 . . . . 0.0 111.961 172.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.9 m -58.5 -50.72 72.74 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.402 1.081 . . . . 0.0 111.938 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 19.7 m -67.7 -31.81 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 119.389 0.995 . . . . 0.0 111.699 179.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.2 ptt-85 -70.44 -30.72 67.63 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 120.255 1.389 . . . . 0.0 112.954 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.58 -43.64 96.22 Favored Glycine 0 N--CA 1.477 1.429 0 C-N-CA 123.797 0.713 . . . . 0.0 111.998 169.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -62.61 -38.25 89.47 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.63 -0.923 . . . . 0.0 112.456 170.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.7 t -60.23 -50.41 80.34 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.595 173.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -53.13 -52.73 57.77 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 120.177 1.353 . . . . 0.0 111.79 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -48.31 -44.81 34.36 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.468 1.507 . . . . 0.0 112.352 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -90.91 -28.87 17.82 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.125 0.97 . . . . 0.0 112.022 -171.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.8 t -63.91 -50.07 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.916 1.286 . . . . 0.0 109.569 169.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -53.4 -55.27 26.44 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.663 0.665 . . . . 0.0 109.292 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -50.89 -36.69 39.45 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.107 1.763 . . . . 0.0 113.376 174.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -84.78 -61.53 1.76 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.609 1.095 . . . . 0.0 113.513 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -57.49 -33.33 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.751 1.62 . . . . 0.0 111.599 -177.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.5 -10.48 59.84 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 44.7 mttm -80.15 -20.12 45.66 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.596 1.158 . . . . 0.0 112.425 169.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.1 pt -122.23 28.27 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 127.309 2.243 . . . . 0.0 111.569 -176.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 24.3 t . . . . . 0 C--O 1.252 1.228 0 C-N-CA 127.633 2.373 . . . . 0.0 111.114 179.141 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.502 2.166 0 CA-C-O 119.378 -0.344 . . . . 0.0 111.87 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -84.51 99.66 10.86 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 118.995 0.816 . . . . 0.0 110.115 174.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -75.41 147.85 39.63 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.741 0.417 . . . . 0.0 111.855 -174.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.6 t -104.92 140.08 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.464 1.106 . . . . 0.0 110.635 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 49.3 tpp -127.15 113.97 17.08 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.586 0.755 . . . . 0.0 110.331 169.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -81.49 143.35 32.13 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.39 0.676 . . . . 0.0 110.315 169.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.4 t -134.86 123.95 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.443 1.497 . . . . 0.0 110.558 -178.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 p -136.32 170.9 15.28 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.472 1.109 . . . . 0.0 111.162 171.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -58.46 -53.94 52.66 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 120.342 1.428 . . . . 0.0 110.16 175.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -93.87 121.76 35.66 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 168.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.589 ' ND2' ' H ' ' A' ' 63' ' ' ASP . 23.0 t-20 -47.12 -41.36 17.29 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 121.406 1.912 . . . . 0.0 110.713 169.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.6 p -66.59 -35.89 81.31 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.888 1.675 . . . . 0.0 114.868 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 95.1 p -65.69 -37.07 85.45 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -169.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.27 -43.92 0.41 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.8 m -63.11 -42.68 99.62 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 119.731 1.15 . . . . 0.0 113.009 -169.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -57.63 -40.96 80.37 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.292 1.837 . . . . 0.0 112.456 169.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 94.7 mtp -64.87 -43.03 94.31 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.283 0.633 . . . . 0.0 110.488 175.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.14 -29.69 67.78 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 117.701 -1.142 . . . . 0.0 113.409 173.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -70.43 -48.3 56.67 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 121.45 1.932 . . . . 0.0 108.48 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.73 -46.24 94.37 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.607 -1.107 . . . . 0.0 113.676 176.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -66.96 -34.12 77.06 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.542 1.671 . . . . 0.0 112.378 175.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.447 ' HB1' HG11 ' A' ' 32' ' ' VAL . . . -75.05 -33.6 61.74 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.88 -1.137 . . . . 0.0 110.639 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -60.41 -56.21 24.24 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 125.621 1.569 . . . . 0.0 109.444 170.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.0 p -70.3 -11.01 60.61 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.6 mt -98.1 -5.47 33.66 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 171.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.59 17.4 0.08 OUTLIER Glycine 0 CA--C 1.536 1.368 0 N-CA-C 118.661 2.224 . . . . 0.0 118.661 -172.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.73 -33.25 64.08 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.848 1.824 . . . . 0.0 114.511 -173.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.36 -6.15 88.95 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 124.161 0.886 . . . . 0.0 115.043 177.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -101.1 -59.17 1.74 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.958 1.303 . . . . 0.0 112.003 -170.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.5 pp -143.84 171.91 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 127.345 2.258 . . . . 0.0 110.536 -174.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.53 131.99 42.58 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.409 -0.807 . . . . 0.0 112.9 175.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.447 HG11 ' HB1' ' A' ' 22' ' ' ALA . 28.9 m -104.28 149.37 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 C-N-CA 125.09 1.356 . . . . 0.0 113.259 171.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.53 144.87 27.6 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.413 0.685 . . . . 0.0 112.382 -173.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.0 t -114.24 129.44 56.63 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.976 2.111 . . . . 0.0 113.799 175.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 t -132.33 177.02 7.91 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.505 1.922 . . . . 0.0 110.764 171.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.55 175.08 46.11 Favored Glycine 0 CA--C 1.523 0.557 0 O-C-N 120.572 -1.33 . . . . 0.0 114.286 171.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.0 mt -67.39 -27.39 67.05 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 122.275 -0.544 . . . . 0.0 111.829 -176.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -123.48 115.56 21.76 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.157 2.183 . . . . 0.0 105.765 169.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 77.3 p -62.31 -20.37 64.25 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.314 -0.866 . . . . 0.0 113.076 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.6 t 54.83 -149.91 0.43 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.773 1.629 . . . . 0.0 113.905 168.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.68 165.11 28.39 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 128.244 2.618 . . . . 0.0 110.052 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 m -67.34 102.12 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 169.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -70.26 135.59 86.79 Favored Pre-proline 0 N--CA 1.476 0.841 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.936 -169.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -60.31 -36.79 86.2 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.911 2.407 . . . . 0.0 113.618 -171.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.2 m -77.56 -33.44 54.04 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.543 -0.723 . . . . 0.0 111.193 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.75 -44.32 81.79 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.053 0.842 . . . . 0.0 111.761 170.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 74.7 mt -50.97 -47.07 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 120.343 1.429 . . . . 0.0 110.337 173.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.54 -63.74 1.13 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 31.9 mmt -68.81 -24.43 64.39 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.45 -0.781 . . . . 0.0 112.942 -170.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 80.7 mmm -79.54 -35.74 39.43 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.732 0.696 . . . . 0.0 110.803 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -61.09 -30.88 70.62 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.631 -1.293 . . . . 0.0 112.693 171.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -54.35 -37.31 64.77 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.207 0.912 . . . . 0.0 112.755 172.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.2 m -98.16 15.2 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.58 1.152 . . . . 0.0 113.914 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.03 13.01 67.16 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.115 0.864 . . . . 0.0 115.029 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.6 mt -119.49 70.34 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.63 1.572 . . . . 0.0 109.709 -169.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -66.13 108.96 2.43 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 119.995 -1.691 . . . . 0.0 110.56 171.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.7 pt -84.52 -4.74 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.0 t -61.86 -32.68 73.05 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 120.382 1.446 . . . . 0.0 112.912 -170.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.32 4.51 80.49 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.03 1.3 . . . . 0.0 115.383 173.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -87.77 149.0 24.45 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.017 1.408 . . . . 0.0 112.36 -172.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.8 t -76.08 157.08 33.3 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.0 p -139.21 154.7 48.06 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.185 1.394 . . . . 0.0 109.847 169.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.589 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -146.88 149.98 37.7 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.387 1.075 . . . . 0.0 111.62 -175.099 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -88.79 152.61 6.07 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.637 2.891 . . . . 0.0 111.335 174.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.6 tp -60.23 -21.53 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.31 1.444 . . . . 0.0 114.863 -177.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -97.6 -9.1 27.53 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -92.08 -38.77 12.0 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 118.891 0.769 . . . . 0.0 111.609 172.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.0 158.24 36.0 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.388 0.613 . . . . 0.0 111.192 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -138.13 115.82 11.4 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.778 1.231 . . . . 0.0 109.476 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.5 0.18 5.65 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 -169.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -70.04 -29.12 66.08 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.715 1.143 . . . . 0.0 112.328 -172.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -87.43 -2.8 58.87 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.008 1.323 . . . . 0.0 113.062 175.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -124.88 83.29 2.14 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.106 1.762 . . . . 0.0 109.5 -171.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -57.76 -19.13 25.78 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.18 0.992 . . . . 0.0 113.404 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.3 t -121.03 113.9 41.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.46 1.504 . . . . 0.0 109.931 -177.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.6 t -127.42 133.79 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 121.501 -0.749 . . . . 0.0 110.199 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.454 HG21 ' CE2' ' A' ' 99' ' ' TRP . 24.2 mm -129.09 133.21 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 121.567 -0.708 . . . . 0.0 111.21 -169.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.7 t -92.7 119.4 32.06 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.798 1.639 . . . . 0.0 110.835 173.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.435 ' CD1' HG22 ' A' ' 77' ' ' ILE . 1.3 mp -103.33 27.96 6.82 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.21 1.804 . . . . 0.0 111.327 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.4 p -146.23 173.37 12.29 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.465 1.906 . . . . 0.0 109.827 169.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.82 58.47 4.24 Favored Glycine 0 N--CA 1.478 1.493 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 168.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 27.4 p -133.32 -3.93 3.04 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -167.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.14 -36.86 76.84 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 120.463 1.483 . . . . 0.0 114.997 -170.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.9 m -68.69 -14.59 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 176.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -99.11 -4.23 32.77 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.2 1.4 . . . . 0.0 113.177 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.6 mt -74.67 158.92 84.34 Favored Pre-proline 0 CA--C 1.549 0.905 0 O-C-N 121.239 -0.913 . . . . 0.0 111.394 173.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.65 138.57 86.73 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.747 2.298 . . . . 0.0 111.51 172.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.1 -38.48 45.42 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.466 2.111 . . . . 0.0 112.595 -169.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.93 -23.96 65.13 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.121 -0.987 . . . . 0.0 113.586 176.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -78.69 -9.6 59.46 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.699 -1.251 . . . . 0.0 112.949 169.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.5 t -100.78 -41.66 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 126.513 1.925 . . . . 0.0 111.481 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.1 p -80.52 28.98 0.31 Allowed 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -172.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -79.29 170.47 16.58 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.955 1.302 . . . . 0.0 111.99 170.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -57.79 -36.6 72.4 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.125 0.97 . . . . 0.0 113.496 -170.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 61.9 mt -128.01 125.65 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.909 1.284 . . . . 0.0 109.59 170.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -135.71 138.96 43.28 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.041 0.937 . . . . 0.0 111.479 169.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -143.26 146.71 33.86 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.128 1.371 . . . . 0.0 112.03 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -109.35 116.84 32.6 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.175 1.39 . . . . 0.0 109.586 169.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.454 ' CE2' HG21 ' A' ' 77' ' ' ILE . 45.8 m0 -94.08 -6.95 43.92 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.331 1.2 pp0? 50.12 30.28 4.12 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 176.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.5 mt -73.04 150.05 42.69 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -86.07 158.9 19.71 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.872 1.669 . . . . 0.0 113.016 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -81.89 128.42 68.67 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.848 1.259 . . . . 0.0 112.866 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -88.24 -38.58 0.06 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.61 2.207 . . . . 0.0 113.595 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 19.43 51.35 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 131.622 3.969 . . . . 0.0 117.786 169.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.36 11.56 79.79 Favored Glycine 0 CA--C 1.539 1.588 0 O-C-N 120.797 -1.189 . . . . 0.0 115.046 176.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -63.37 -52.89 59.82 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.807 1.243 . . . . 0.0 111.076 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 34.1 t -168.48 153.56 6.38 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.742 2.017 . . . . 0.0 109.627 169.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.5 mp -56.85 -31.84 65.2 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.982 0.913 . . . . 0.0 110.999 172.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.56 -39.83 74.12 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.978 1.311 . . . . 0.0 112.568 173.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.6 t -73.16 -38.11 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 121.503 -0.748 . . . . 0.0 109.668 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -63.86 -44.58 92.67 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.265 0.484 . . . . 0.0 111.463 175.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -64.35 -39.12 93.27 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.514 1.126 . . . . 0.0 111.74 176.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.1 m -62.51 -52.84 61.88 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.012 0.925 . . . . 0.0 111.469 173.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.5 m -72.69 -29.71 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 117.047 -1.454 . . . . 0.0 112.78 -177.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.9 ptt85 -64.16 -37.12 86.33 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 121.805 2.093 . . . . 0.0 112.181 171.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.55 -48.99 77.65 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.886 0.755 . . . . 0.0 112.316 173.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -59.81 -45.58 91.89 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 117.586 0.693 . . . . 0.0 112.407 173.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.9 t -58.67 -46.88 90.2 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.495 0 CA-C-O 117.843 -1.075 . . . . 0.0 110.169 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -52.12 -53.57 41.08 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.044 1.293 . . . . 0.0 111.853 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -58.3 -45.66 87.59 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.098 0.475 . . . . 0.0 111.854 -178.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -75.11 -33.5 61.61 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 36.4 t -63.13 -47.91 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.97 1.308 . . . . 0.0 111.03 169.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -53.77 -55.71 23.95 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.523 1.056 . . . . 0.0 109.481 174.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -53.33 -26.2 17.99 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.059 1.344 . . . . 0.0 113.545 177.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -91.68 -62.27 1.46 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.277 1.431 . . . . 0.0 112.945 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.84 -31.03 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.581 1.552 . . . . 0.0 111.551 -176.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.52 -7.22 54.7 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -74.06 -27.79 61.09 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.6 1.16 . . . . 0.0 112.693 169.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.4 pt -117.26 -7.91 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.616 1.966 . . . . 0.0 113.555 -171.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 C--O 1.255 1.391 0 C-N-CA 125.261 1.424 . . . . 0.0 112.458 172.426 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 ttm . . . . . 0 N--CA 1.502 2.159 0 CA-C-O 119.653 -0.213 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -90.32 90.25 7.98 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.257 1.023 . . . . 0.0 110.487 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -80.94 149.24 29.47 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 121.573 -0.704 . . . . 0.0 112.232 -174.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.2 t -115.09 143.41 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.663 1.185 . . . . 0.0 111.124 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.1 tpp -130.62 122.68 27.88 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.248 1.019 . . . . 0.0 111.019 169.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -93.22 138.67 31.39 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.509 -0.744 . . . . 0.0 110.597 169.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.8 t -134.41 130.5 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.984 1.314 . . . . 0.0 110.384 -171.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 t -151.8 -165.67 2.29 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.439 0.696 . . . . 0.0 112.542 169.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -63.0 -70.54 0.2 Allowed 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 119.406 1.003 . . . . 0.0 111.045 170.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 56.6 mtt-85 -79.07 127.76 32.41 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 118.569 0.622 . . . . 0.0 109.955 169.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.598 ' ND2' ' H ' ' A' ' 63' ' ' ASP . 19.2 t-20 -61.06 -43.37 98.98 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 168.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 99.3 p -73.97 -48.26 31.69 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -169.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.0 p -83.29 -11.23 57.95 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.763 -1.211 . . . . 0.0 113.695 -173.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 -126.63 -67.42 0.86 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.788 1.235 . . . . 0.0 111.734 -176.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.3 m -64.21 -44.51 91.68 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.16 1.171 . . . . 0.0 114.16 -175.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -57.5 -30.68 65.31 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.832 1.253 . . . . 0.0 113.792 170.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.1 mtm -68.17 -49.36 61.44 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.072 0.851 . . . . 0.0 110.92 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.72 -29.93 70.04 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.622 -0.674 . . . . 0.0 112.686 172.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -71.23 -44.22 65.78 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 119.691 1.132 . . . . 0.0 109.269 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.96 -41.31 98.7 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 119.299 -0.723 . . . . 0.0 112.073 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -62.73 -44.24 96.73 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.885 1.342 . . . . 0.0 111.719 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.82 -32.79 69.97 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 120.574 -1.329 . . . . 0.0 111.224 -174.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -64.91 -56.3 14.14 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 126.432 1.893 . . . . 0.0 109.449 171.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.3 p -68.08 -14.93 63.35 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 52.7 mt -100.74 -8.16 23.04 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.454 1.102 . . . . 0.0 113.816 174.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.58 10.55 1.27 Allowed Glycine 0 CA--C 1.534 1.273 0 N-CA-C 117.181 1.632 . . . . 0.0 117.181 -169.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.98 131.01 46.19 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.16 1.48 . . . . 0.0 112.067 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.47 -6.44 57.66 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.528 1.061 . . . . 0.0 115.531 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -86.25 -61.32 1.77 Allowed 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 119.296 1.548 . . . . 0.0 110.339 175.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -142.75 173.01 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 127.667 2.387 . . . . 0.0 110.316 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.75 130.02 41.45 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.366 -0.834 . . . . 0.0 112.314 175.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.7 m -104.15 153.04 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.716 1.206 . . . . 0.0 112.478 170.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.19 145.7 27.27 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -171.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.1 t -110.33 133.49 53.2 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.835 2.054 . . . . 0.0 113.615 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.8 t -141.84 171.33 14.2 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.521 1.928 . . . . 0.0 110.949 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.59 -179.82 45.66 Favored Glycine 0 CA--C 1.526 0.778 0 O-C-N 120.883 -1.136 . . . . 0.0 114.567 169.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 38.0 mt -63.19 -26.7 68.93 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.23 1.012 . . . . 0.0 112.074 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -128.34 127.43 42.67 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.19 1.396 . . . . 0.0 109.09 170.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.6 p -77.48 58.04 1.65 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.262 1.425 . . . . 0.0 110.492 171.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.4 p -65.9 156.62 32.87 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 114.146 -1.388 . . . . 0.0 112.818 -169.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -64.74 144.64 57.1 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.251 1.02 . . . . 0.0 109.981 177.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.7 m -41.23 109.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.852 1.661 . . . . 0.0 109.082 170.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -68.03 132.31 92.06 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-O 118.383 -0.817 . . . . 0.0 112.82 -167.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.31 -39.15 80.17 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.372 2.715 . . . . 0.0 113.566 -170.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.0 m -78.05 -37.06 47.66 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 119.151 -0.452 . . . . 0.0 110.496 177.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.67 -40.78 96.02 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.626 1.103 . . . . 0.0 112.475 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.4 mt -52.38 -47.17 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 120.98 1.718 . . . . 0.0 109.927 172.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.82 -58.38 8.68 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 175.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.6 mmt -66.18 -22.0 66.34 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 88.5 mmm -90.93 -37.36 13.58 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.941 0.896 . . . . 0.0 110.592 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -60.89 -33.89 73.81 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.407 -1.433 . . . . 0.0 112.319 169.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -56.0 -30.06 61.26 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.036 0.934 . . . . 0.0 113.313 173.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.4 m -103.41 13.64 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.857 1.263 . . . . 0.0 114.155 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.13 17.2 63.32 Favored Glycine 0 CA--C 1.537 1.467 0 O-C-N 121.209 -0.932 . . . . 0.0 115.106 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.1 mt -122.54 79.68 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.977 1.711 . . . . 0.0 109.631 -169.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -70.28 106.59 3.4 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.053 -1.655 . . . . 0.0 111.185 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.1 pt -82.3 -10.14 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 118.166 -0.921 . . . . 0.0 112.576 175.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.5 t -61.85 -33.15 73.66 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 120.3 1.409 . . . . 0.0 113.029 -169.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -95.94 6.52 66.91 Favored Glycine 0 CA--C 1.541 1.674 0 C-N-CA 125.098 1.333 . . . . 0.0 115.294 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -93.32 151.27 19.89 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.028 1.414 . . . . 0.0 111.477 -171.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.6 t -68.25 149.98 48.83 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -170.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.8 t -135.81 133.24 37.67 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.36 1.464 . . . . 0.0 109.183 169.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.598 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 4.1 t70 -148.21 146.22 22.65 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.696 1.598 . . . . 0.0 110.836 -172.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -91.15 154.46 3.82 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.574 2.183 . . . . 0.0 112.65 -173.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.3 tt -60.66 -21.42 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -94.06 -9.58 36.24 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -94.51 -37.44 11.39 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.785 0.834 . . . . 0.0 111.816 170.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.58 163.18 27.5 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.26 0.552 . . . . 0.0 111.644 174.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -139.38 134.1 31.99 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.015 0.926 . . . . 0.0 110.633 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.62 6.87 6.41 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -174.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -74.31 -30.86 62.25 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.068 -1.02 . . . . 0.0 112.594 -173.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -88.86 -3.74 58.67 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.657 1.183 . . . . 0.0 113.6 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -123.72 94.01 4.11 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.739 1.616 . . . . 0.0 110.151 -171.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -62.75 -18.9 63.37 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.0 t -120.09 114.74 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.812 1.245 . . . . 0.0 110.472 -176.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.3 t -127.9 129.88 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.995 0.918 . . . . 0.0 110.814 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.5 mm -116.35 125.29 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.301 0.641 . . . . 0.0 111.56 -172.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.0 t -86.11 92.12 8.63 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.379 1.472 . . . . 0.0 109.155 169.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.9 mt -76.94 -11.04 59.75 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.884 0.873 . . . . 0.0 112.158 171.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 27.5 p -75.71 -22.88 56.19 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.586 0.755 . . . . 0.0 111.673 169.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.88 21.86 65.91 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 123.587 0.613 . . . . 0.0 112.503 -169.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 31.3 p -98.06 -54.28 3.13 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.163 1.385 . . . . 0.0 113.028 -169.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.29 -65.02 1.0 Allowed Glycine 0 N--CA 1.476 1.344 0 C-N-CA 124.791 1.186 . . . . 0.0 114.002 177.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.5 m -64.24 -22.09 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.444 1.498 . . . . 0.0 114.175 -176.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -87.98 -0.96 57.67 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.177 0.991 . . . . 0.0 112.998 175.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.0 mt -94.43 151.31 39.26 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 124.958 1.303 . . . . 0.0 109.867 170.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.86 136.68 75.26 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.326 2.018 . . . . 0.0 110.645 169.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -64.22 -29.55 64.43 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.485 2.123 . . . . 0.0 112.63 -176.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -61.37 -28.68 69.41 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 171.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.35 13.28 13.95 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.829 1.252 . . . . 0.0 114.163 171.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.6 t -114.1 -37.19 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.666 1.587 . . . . 0.0 111.416 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -81.04 27.09 0.41 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 115.297 1.592 . . . . 0.0 115.297 -169.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -77.11 165.7 24.25 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.822 1.649 . . . . 0.0 112.64 173.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -56.23 -38.23 70.8 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.776 1.23 . . . . 0.0 113.008 -172.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.0 mt -127.48 116.99 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.14 1.376 . . . . 0.0 108.704 169.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -128.14 128.44 44.82 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.191 0.997 . . . . 0.0 109.881 169.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -137.29 140.0 41.28 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.613 0.765 . . . . 0.0 113.007 -170.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -97.9 104.59 16.63 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.265 1.826 . . . . 0.0 112.173 176.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 16.2 m0 -95.2 92.14 6.63 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 169.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -60.92 54.43 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 128.277 2.631 . . . . 0.0 115.718 176.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 77.3 mt -76.43 167.71 21.37 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.036 2.134 . . . . 0.0 111.841 175.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -96.73 153.89 17.61 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.748 1.219 . . . . 0.0 110.628 169.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -77.31 120.24 80.75 Favored Pre-proline 0 CA--C 1.546 0.809 0 O-C-N 120.88 -1.138 . . . . 0.0 111.114 172.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -87.13 -19.29 2.54 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.466 1.444 . . . . 0.0 114.957 -170.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -53.42 107.41 0.24 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.635 1.174 . . . . 0.0 112.092 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.04 -0.94 69.78 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.288 0.947 . . . . 0.0 114.62 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -77.95 172.15 13.91 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 118.316 1.058 . . . . 0.0 110.18 169.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 90.4 p -66.35 156.68 33.8 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.045 -1.034 . . . . 0.0 111.557 169.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.92 -27.58 68.95 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.306 -0.871 . . . . 0.0 111.862 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.2 -40.73 86.69 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.128 -0.983 . . . . 0.0 112.354 170.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 78.7 t -74.04 -37.73 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.371 -0.831 . . . . 0.0 110.416 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.59 -41.56 99.03 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.515 0.726 . . . . 0.0 111.075 176.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -69.55 -37.54 77.1 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.715 1.206 . . . . 0.0 112.29 171.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 55.3 m -58.3 -49.09 78.38 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 119.157 0.89 . . . . 0.0 111.589 176.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 31.2 m -67.22 -30.68 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 119.934 1.243 . . . . 0.0 111.719 177.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.416 ' HA ' HG22 ' A' ' 119' ' ' VAL . 0.1 OUTLIER -60.37 -46.54 89.58 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 119.811 1.187 . . . . 0.0 111.318 169.592 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.53 -35.66 92.33 Favored Glycine 0 N--CA 1.472 1.054 0 C-N-CA 123.823 0.725 . . . . 0.0 112.153 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -68.46 -51.43 43.57 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 171.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.416 HG22 ' HA ' ' A' ' 116' ' ' ARG . 3.6 m -61.26 -39.68 83.43 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 CA-C-O 117.372 -1.299 . . . . 0.0 111.179 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -47.92 -57.5 5.63 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.331 1.423 . . . . 0.0 111.898 174.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -63.67 -41.78 98.15 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.274 0.629 . . . . 0.0 112.387 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 59.1 mtp85 -73.77 -34.74 64.82 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.87 -47.97 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.271 1.428 . . . . 0.0 111.465 171.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -52.63 -54.41 33.66 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.454 1.025 . . . . 0.0 109.563 177.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -55.56 -38.83 69.83 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.063 1.345 . . . . 0.0 112.668 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -73.1 -56.93 4.44 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.169 -0.957 . . . . 0.0 112.454 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -67.77 -34.22 66.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.014 1.326 . . . . 0.0 112.115 -176.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.21 -17.02 60.95 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -173.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -72.94 -22.07 60.78 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.39 1.076 . . . . 0.0 113.649 171.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.0 pt -118.37 11.29 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.3 1.84 . . . . 0.0 112.925 -175.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.19 1.796 . . . . 0.0 112.332 177.572 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.5 ttm . . . . . 0 N--CA 1.504 2.249 0 CA-C-O 119.246 -0.407 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -77.64 100.89 6.34 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 119.117 0.871 . . . . 0.0 110.74 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -86.6 136.06 33.19 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.111 1.764 . . . . 0.0 111.763 -172.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.4 t -114.64 143.06 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 124.176 0.991 . . . . 0.0 111.793 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.4 ' HG2' ' CZ ' ' A' ' 68' ' ' PHE . 48.2 tpp -131.05 125.06 32.23 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.277 1.031 . . . . 0.0 111.602 169.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -93.05 136.84 32.94 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.533 0.733 . . . . 0.0 110.48 169.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 t -130.61 130.15 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.38 1.472 . . . . 0.0 110.2 -174.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.8 p -149.14 176.42 10.5 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.989 0.916 . . . . 0.0 112.628 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -63.93 -46.79 83.21 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.904 -1.122 . . . . 0.0 111.251 171.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.406 ' HB3' ' H ' ' A' ' 13' ' ' SER . 1.0 OUTLIER -109.26 111.66 23.38 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.358 1.463 . . . . 0.0 109.791 169.326 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.515 ' ND2' ' H ' ' A' ' 63' ' ' ASP . 58.8 t-20 -57.56 -46.95 83.32 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 169.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.6 p -43.48 -46.59 6.91 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 174.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.406 ' H ' ' HB3' ' A' ' 10' ' ' ARG . 27.3 p -97.44 -16.12 20.32 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.05 1.129 . . . . 0.0 114.05 -172.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -130.94 -62.63 0.89 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 119.738 1.153 . . . . 0.0 113.979 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.8 m -61.34 -35.08 76.42 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 120.118 1.326 . . . . 0.0 112.953 -177.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -62.98 -38.19 90.15 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.722 1.209 . . . . 0.0 113.446 169.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 84.9 mtp -64.29 -48.79 74.35 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.445 1.021 . . . . 0.0 110.714 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.07 -28.45 68.85 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 175.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -75.27 -41.52 57.03 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 119.72 1.145 . . . . 0.0 109.067 -178.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.66 -45.0 96.7 Favored Glycine 0 CA--C 1.52 0.37 0 CA-C-O 119.345 -0.697 . . . . 0.0 112.425 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -64.55 -43.81 92.79 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.851 1.326 . . . . 0.0 112.065 172.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.56 -32.49 69.92 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.454 -1.404 . . . . 0.0 111.767 -175.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -64.89 -55.63 18.17 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 125.332 1.453 . . . . 0.0 109.425 170.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.1 p -73.12 -8.92 57.9 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.587 -1.32 . . . . 0.0 114.523 -176.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 51.7 mt -100.28 -5.75 27.0 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.48 1.112 . . . . 0.0 113.701 170.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.29 15.2 0.1 OUTLIER Glycine 0 CA--C 1.537 1.417 0 N-CA-C 118.609 2.204 . . . . 0.0 118.609 -171.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.22 -33.67 67.77 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.162 1.981 . . . . 0.0 114.308 -172.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.43 -5.5 89.93 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.257 0.932 . . . . 0.0 115.029 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -100.77 -63.01 1.17 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.862 1.265 . . . . 0.0 111.409 -172.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -141.87 173.34 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 126.128 1.771 . . . . 0.0 112.122 -175.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.93 123.22 36.04 Favored 'General case' 0 C--N 1.343 0.291 0 O-C-N 121.368 -0.832 . . . . 0.0 112.502 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.0 m -101.47 151.97 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.05 0.94 . . . . 0.0 111.67 169.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.65 152.38 37.76 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.15 0.58 . . . . 0.0 111.544 -173.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.5 p -120.69 141.47 50.38 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.661 1.585 . . . . 0.0 114.731 175.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.3 t -145.99 167.54 23.07 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 127.308 2.243 . . . . 0.0 110.005 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.87 171.46 38.32 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 120.73 -1.231 . . . . 0.0 114.803 169.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 35.0 mt -62.12 -40.28 95.38 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.738 0.815 . . . . 0.0 111.477 -173.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -120.55 116.6 25.7 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 127.879 2.472 . . . . 0.0 105.874 169.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.7 p -67.21 -49.19 65.5 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.128 -0.982 . . . . 0.0 110.41 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.4 t 53.64 -173.26 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 127.031 2.132 . . . . 0.0 113.838 -174.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -80.86 177.8 8.81 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 127.051 2.14 . . . . 0.0 113.005 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.4 m -66.44 116.69 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 120.596 -1.315 . . . . 0.0 107.639 168.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -66.36 128.09 93.65 Favored Pre-proline 0 N--CA 1.478 0.934 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -168.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.64 -39.23 55.53 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.265 2.644 . . . . 0.0 113.994 -169.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.4 ' HB ' ' CE2' ' A' ' 112' ' ' PHE . 28.4 m -80.48 -32.65 37.01 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 122.023 -0.423 . . . . 0.0 110.629 178.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.67 -38.07 86.06 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.011 -1.056 . . . . 0.0 112.375 174.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 65.1 mt -53.02 -42.18 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 120.634 1.561 . . . . 0.0 110.559 172.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.86 -61.23 2.3 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.355 0.662 . . . . 0.0 112.702 173.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.4 mmt -66.08 -24.18 66.66 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -172.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 79.3 mmm -87.78 -33.9 18.5 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.976 0.91 . . . . 0.0 110.95 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -60.84 -32.74 72.13 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.704 -1.247 . . . . 0.0 111.901 169.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -54.41 -31.58 55.41 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.326 -0.859 . . . . 0.0 113.232 173.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.1 m -104.0 14.27 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 175.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.52 13.35 65.51 Favored Glycine 0 CA--C 1.536 1.365 0 O-C-N 120.984 -1.072 . . . . 0.0 115.224 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.5 mt -118.36 71.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.803 1.641 . . . . 0.0 109.411 -169.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -64.07 110.69 2.24 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 120.34 -1.475 . . . . 0.0 110.218 172.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 pt -92.73 4.33 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.326 0.65 . . . . 0.0 112.627 178.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.3 p -68.4 -22.62 64.62 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.492 1.496 . . . . 0.0 113.855 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.5 8.24 62.03 Favored Glycine 0 CA--C 1.541 1.712 0 C-N-CA 125.548 1.547 . . . . 0.0 114.353 169.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -76.0 139.71 41.63 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.556 1.178 . . . . 0.0 111.274 -174.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.1 t -64.78 156.35 30.87 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.262 0.553 . . . . 0.0 111.588 169.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.0 t -143.57 127.99 17.89 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 169.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.515 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -124.64 142.23 40.07 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.593 1.157 . . . . 0.0 111.305 -174.978 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -87.58 152.87 7.63 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.611 2.874 . . . . 0.0 111.368 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.0 tt -60.91 -29.86 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -169.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -94.85 -6.92 41.67 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -80.91 -38.51 27.81 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.477 -0.764 . . . . 0.0 110.592 169.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.4 ' CZ ' ' HG2' ' A' ' 5' ' ' MET . 0.0 OUTLIER -77.22 160.09 29.18 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.375 1.07 . . . . 0.0 111.716 172.45 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.63 116.5 14.12 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.899 1.28 . . . . 0.0 109.612 174.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.97 -3.85 6.01 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 -169.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -67.44 -30.56 70.33 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.3 0.954 . . . . 0.0 113.431 -169.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -84.3 -8.78 58.91 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 176.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -104.72 100.4 10.05 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 120.898 -1.127 . . . . 0.0 110.12 -169.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -52.19 -33.74 42.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.279 1.431 . . . . 0.0 112.736 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.0 t -125.41 122.75 63.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 125.385 1.474 . . . . 0.0 110.003 -174.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.0 t -124.05 130.43 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.671 0.788 . . . . 0.0 109.86 175.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 50.1 mm -125.45 123.12 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 123.927 0.891 . . . . 0.0 110.687 -169.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.8 t -82.2 137.4 34.92 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 168.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.401 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 76.5 mt -110.03 28.25 8.79 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.871 1.268 . . . . 0.0 109.857 170.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.1 t -155.11 140.02 17.27 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.322 1.449 . . . . 0.0 113.307 -169.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.05 -21.57 59.37 Favored Glycine 0 CA--C 1.541 1.667 0 O-C-N 121.418 -0.801 . . . . 0.0 112.921 169.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.1 p -66.41 -0.19 2.54 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.154 1.782 . . . . 0.0 114.915 169.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.0 -23.93 40.76 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.843 1.211 . . . . 0.0 114.878 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.3 m -64.05 -17.09 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 O-C-N 121.272 -1.134 . . . . 0.0 113.969 172.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.16 5.09 51.85 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.215 1.406 . . . . 0.0 113.073 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.3 mt -70.0 145.64 94.29 Favored Pre-proline 0 CA--C 1.55 0.975 0 O-C-N 120.828 -1.17 . . . . 0.0 111.721 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -58.77 163.69 10.8 Favored 'Trans proline' 0 CA--C 1.551 1.34 0 C-N-CA 123.716 2.944 . . . . 0.0 113.608 171.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.81 -52.74 1.16 Allowed 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.521 2.147 . . . . 0.0 113.784 -171.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -60.18 -36.61 78.01 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 120.664 -1.272 . . . . 0.0 111.897 177.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -63.89 7.01 0.13 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 127.928 2.491 . . . . 0.0 115.046 170.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.1 t -134.86 -42.7 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 127.109 2.164 . . . . 0.0 111.525 175.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.7 p -79.9 32.64 0.26 Allowed 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -169.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -85.47 168.8 14.22 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.374 1.069 . . . . 0.0 112.187 172.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -57.06 -36.1 70.13 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -169.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.4 mt -125.87 125.58 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.772 1.229 . . . . 0.0 108.813 169.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -133.33 131.14 39.78 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.172 0.989 . . . . 0.0 111.536 169.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -145.96 162.0 38.79 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.196 1.398 . . . . 0.0 111.757 -175.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -125.52 122.53 36.85 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.679 1.192 . . . . 0.0 111.422 170.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.401 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 44.1 m0 -82.54 -4.55 57.75 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 61.43 47.57 6.63 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.328 1.451 . . . . 0.0 113.62 169.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.0 mt -99.89 149.02 23.84 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -171.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -82.69 152.89 25.61 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.327 1.451 . . . . 0.0 111.336 170.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -80.85 120.67 79.56 Favored Pre-proline 0 CA--C 1.545 0.786 0 O-C-N 121.27 -0.894 . . . . 0.0 111.232 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -82.17 -10.6 11.25 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.231 1.954 . . . . 0.0 114.564 -176.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -53.23 107.63 0.25 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.754 1.161 . . . . 0.0 112.583 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.37 3.36 90.02 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 119.306 -0.719 . . . . 0.0 114.803 177.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -73.66 165.21 25.52 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.501 1.151 . . . . 0.0 110.437 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.2 m -60.66 147.84 40.59 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.42 -0.8 . . . . 0.0 111.171 170.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.83 -27.85 69.61 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.413 -0.805 . . . . 0.0 112.916 -172.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -59.04 -39.4 81.89 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.053 -1.029 . . . . 0.0 112.648 170.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.7 t -72.19 -37.03 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.907 0.883 . . . . 0.0 110.032 175.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.4 ' CE2' ' HB ' ' A' ' 45' ' ' THR . 0.3 OUTLIER -64.07 -40.93 97.35 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.435 0.694 . . . . 0.0 111.172 177.003 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -69.64 -37.2 76.67 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 120.778 -1.201 . . . . 0.0 112.521 171.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 55.1 m -59.15 -48.7 80.64 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.135 0.974 . . . . 0.0 111.558 175.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 19.7 m -66.51 -29.96 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 119.743 1.156 . . . . 0.0 111.947 175.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -45.94 89.61 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 120.086 1.312 . . . . 0.0 110.875 169.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.91 -41.33 97.73 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 118.955 0.798 . . . . 0.0 112.393 174.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -67.24 -43.04 82.93 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 175.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.3 m -67.15 -41.2 86.65 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.695 0 CA-C-N 119.807 1.185 . . . . 0.0 110.547 176.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -51.55 -54.13 30.7 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.689 1.586 . . . . 0.0 111.581 175.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -50.6 -49.64 55.99 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.779 1.631 . . . . 0.0 112.347 176.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -87.41 -27.95 22.44 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.661 0.784 . . . . 0.0 112.248 -170.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.4 t -63.53 -51.79 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.201 1.4 . . . . 0.0 109.187 169.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -54.01 -53.77 48.41 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.312 0.96 . . . . 0.0 109.613 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -52.01 -37.78 54.53 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.803 1.641 . . . . 0.0 112.49 176.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -79.07 -59.09 2.92 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.007 -1.058 . . . . 0.0 113.357 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.54 -33.89 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.789 1.636 . . . . 0.0 112.14 -174.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.53 -17.01 60.81 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.085 -1.009 . . . . 0.0 113.57 -174.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -74.03 -21.25 60.03 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.537 1.135 . . . . 0.0 113.786 171.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.5 pt -118.19 10.42 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.144 1.778 . . . . 0.0 113.006 -175.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.6 m . . . . . 0 C--O 1.253 1.283 0 C-N-CA 126.473 1.909 . . . . 0.0 112.024 177.721 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.8 ttm . . . . . 0 N--CA 1.503 2.207 0 CA-C-O 119.739 -0.172 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -88.01 83.2 7.06 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.3 1.04 . . . . 0.0 110.207 176.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -73.44 150.16 41.87 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 121.764 -0.585 . . . . 0.0 111.563 -175.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.6 t -109.7 146.86 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.346 1.058 . . . . 0.0 111.124 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.2 tpp -131.36 118.39 20.22 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.747 0.819 . . . . 0.0 110.643 168.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -88.41 131.32 34.9 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.302 1.041 . . . . 0.0 111.185 169.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.3 t -127.06 126.37 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.981 1.312 . . . . 0.0 110.643 -173.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.1 m -140.66 172.0 13.32 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.46 1.104 . . . . 0.0 111.303 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.95 -46.3 82.16 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.779 -1.201 . . . . 0.0 109.986 169.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -98.66 113.71 25.89 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.126 1.371 . . . . 0.0 109.821 169.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -62.28 -41.84 98.83 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 119.474 1.034 . . . . 0.0 109.43 169.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.2 p -46.35 -32.97 3.49 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.972 2.509 . . . . 0.0 116.894 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.4 p -98.99 -97.39 0.23 Allowed 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 123.832 0.853 . . . . 0.0 110.233 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -64.22 -44.1 92.95 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.859 1.264 . . . . 0.0 113.792 -169.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.9 m -63.11 -45.39 92.25 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.789 1.177 . . . . 0.0 111.889 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -63.81 -39.57 94.56 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 171.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 71.7 mtp -61.44 -44.76 96.55 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 120.769 -1.207 . . . . 0.0 110.994 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.52 -31.53 69.81 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 173.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -66.52 -50.44 63.19 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 119.478 1.036 . . . . 0.0 109.196 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.02 -45.48 95.85 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 118.868 -0.962 . . . . 0.0 112.634 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -64.17 -40.03 95.26 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.521 1.161 . . . . 0.0 112.416 173.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.44 -32.27 66.16 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.492 -1.38 . . . . 0.0 111.006 -176.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -62.42 -56.0 22.41 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 126.273 1.829 . . . . 0.0 110.159 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 67.9 p -70.46 -14.95 62.75 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.5 mt -100.98 -4.58 27.26 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.234 1.013 . . . . 0.0 113.62 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.58 5.37 1.15 Allowed Glycine 0 CA--C 1.534 1.256 0 N-CA-C 117.166 1.626 . . . . 0.0 117.166 -169.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.6 126.74 22.83 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.38 1.59 . . . . 0.0 112.539 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.9 -3.91 63.24 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 124.759 1.171 . . . . 0.0 115.877 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -87.61 -59.71 2.17 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 119.254 1.527 . . . . 0.0 110.613 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 pp -140.4 175.57 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 127.317 2.247 . . . . 0.0 109.538 170.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.78 125.98 42.89 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.998 0.904 . . . . 0.0 111.547 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.4 m -90.13 151.14 3.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 124.268 1.027 . . . . 0.0 112.295 169.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.72 152.81 39.43 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.439 1.095 . . . . 0.0 111.621 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.2 p -130.26 133.1 46.26 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.348 1.459 . . . . 0.0 114.925 174.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.3 p -134.47 173.3 11.8 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 127.618 2.367 . . . . 0.0 110.399 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.8 176.89 47.83 Favored Glycine 0 CA--C 1.525 0.68 0 O-C-N 120.248 -1.533 . . . . 0.0 114.7 169.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 27.9 mt -65.84 -34.09 77.35 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.035 0.534 . . . . 0.0 111.78 -175.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -117.39 116.3 26.91 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.981 2.112 . . . . 0.0 109.63 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.2 p -77.53 48.91 0.69 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.282 2.233 . . . . 0.0 111.917 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.7 t -70.72 165.72 22.41 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.038 -1.437 . . . . 0.0 112.67 -170.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -64.99 159.14 23.71 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 125.024 1.329 . . . . 0.0 112.495 -175.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.7 m -54.39 114.44 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.093 -1.004 . . . . 0.0 109.133 169.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -66.44 129.54 94.15 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -168.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -60.01 -39.64 68.76 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.475 2.784 . . . . 0.0 113.682 -171.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.4 m -79.33 -32.23 43.3 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.86 -0.525 . . . . 0.0 110.986 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.0 -40.91 87.43 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.832 -1.168 . . . . 0.0 112.568 173.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.9 mt -53.02 -39.82 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 120.613 1.551 . . . . 0.0 110.614 172.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.55 -64.31 0.89 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.432 0.693 . . . . 0.0 112.781 172.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.8 mmt -65.11 -23.68 67.22 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -171.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 89.7 mmm -85.59 -34.55 21.42 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.584 0.754 . . . . 0.0 110.732 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -62.06 -31.04 71.42 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.698 -1.251 . . . . 0.0 111.963 171.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -55.27 -30.57 60.37 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.75 0.82 . . . . 0.0 112.891 172.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.4 m -106.45 17.28 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 175.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.0 13.14 69.75 Favored Glycine 0 CA--C 1.536 1.388 0 O-C-N 121.085 -1.009 . . . . 0.0 115.225 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.4 mt -117.13 91.63 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.123 1.369 . . . . 0.0 110.061 -169.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -77.63 114.4 16.43 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.795 -1.19 . . . . 0.0 110.615 171.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.9 pt -91.31 -5.3 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 172.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 t -63.17 -27.65 69.52 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.352 1.433 . . . . 0.0 113.558 -169.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.62 9.82 60.68 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 124.977 1.275 . . . . 0.0 115.353 173.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -89.36 148.8 23.31 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 118.838 1.319 . . . . 0.0 113.2 -169.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.7 t -61.62 146.81 47.79 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.9 t -136.78 49.95 2.04 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 122.082 0.944 . . . . 0.0 112.403 175.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -64.66 145.05 98.81 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 125.241 1.416 . . . . 0.0 113.542 -172.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.28 154.39 32.17 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.804 2.336 . . . . 0.0 112.035 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.1 tt -62.93 -21.96 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -92.6 -10.83 36.08 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -91.4 -35.24 14.49 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.484 0.714 . . . . 0.0 111.962 171.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.36 164.48 25.67 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.562 0.745 . . . . 0.0 112.045 174.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -140.8 131.36 25.45 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.89 0.876 . . . . 0.0 110.921 169.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.4 6.13 4.93 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 115.551 1.685 . . . . 0.0 115.551 -174.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -71.58 -30.07 65.42 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.007 -1.058 . . . . 0.0 112.181 -174.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -93.48 -4.92 50.31 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.905 1.282 . . . . 0.0 113.511 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -125.24 79.47 1.8 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.542 1.537 . . . . 0.0 110.431 -171.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -69.06 0.78 4.17 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -171.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.0 t -129.03 94.64 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 125.868 1.667 . . . . 0.0 108.832 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.3 t -112.43 119.03 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 121.315 -0.866 . . . . 0.0 110.457 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 mp -110.2 134.38 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 124.281 1.032 . . . . 0.0 110.112 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.8 t -94.15 145.24 24.84 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.704 1.602 . . . . 0.0 109.854 169.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.5 mt -125.05 44.44 2.79 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.305 1.042 . . . . 0.0 111.39 -173.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.8 p . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 -170.185 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 80.5 mt . . . . . 0 CA--C 1.55 0.949 0 CA-C-O 119.247 -0.406 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.54 132.12 48.57 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.657 2.238 . . . . 0.0 110.755 174.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -60.62 -30.63 90.91 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.542 2.162 . . . . 0.0 113.57 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -60.19 -31.74 70.43 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.949 -1.094 . . . . 0.0 112.867 171.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -87.98 13.2 11.49 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.747 1.219 . . . . 0.0 113.631 175.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.9 t -118.86 -34.75 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 126.565 1.946 . . . . 0.0 112.168 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.0 p -80.85 12.65 3.1 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 -169.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -66.91 161.97 22.86 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.348 1.459 . . . . 0.0 112.149 170.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -60.02 -36.75 77.92 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -169.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.7 mt -115.35 117.05 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.79 0.836 . . . . 0.0 109.307 169.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -134.51 126.56 29.63 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.362 1.065 . . . . 0.0 110.372 169.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -147.24 160.46 42.46 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.802 1.641 . . . . 0.0 110.85 -173.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -126.04 133.03 51.85 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.328 0.651 . . . . 0.0 111.679 169.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -90.04 -0.42 57.58 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 63.88 39.62 8.06 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 169.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.3 mt -93.01 157.6 16.22 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -172.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -102.58 144.48 30.94 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.552 1.941 . . . . 0.0 111.223 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -73.65 121.73 85.87 Favored Pre-proline 0 N--CA 1.475 0.791 0 CA-C-N 119.463 1.029 . . . . 0.0 111.866 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -83.89 -15.32 7.05 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.702 2.268 . . . . 0.0 114.856 -172.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -51.57 109.86 0.4 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.312 1.045 . . . . 0.0 112.442 175.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.85 -0.63 84.61 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 123.804 0.716 . . . . 0.0 114.446 176.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -76.01 171.36 14.59 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 118.437 1.119 . . . . 0.0 109.863 169.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 88.1 p -65.92 156.3 33.9 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.051 -1.031 . . . . 0.0 111.707 169.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.7 mp -64.51 -28.18 69.48 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.112 -0.993 . . . . 0.0 111.725 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -59.48 -41.06 88.95 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.048 -1.032 . . . . 0.0 112.389 170.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 79.4 t -73.79 -36.69 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 O-C-N 121.24 -0.913 . . . . 0.0 110.243 175.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.02 -40.3 97.35 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.277 0.631 . . . . 0.0 111.038 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -70.45 -36.49 73.97 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 120.772 -1.205 . . . . 0.0 112.545 170.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 55.0 m -58.98 -47.63 84.46 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.866 0.867 . . . . 0.0 111.662 175.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.6 m -67.46 -29.08 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 119.784 1.175 . . . . 0.0 111.673 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -45.36 94.11 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 119.968 1.258 . . . . 0.0 110.934 169.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.23 -40.85 97.88 Favored Glycine 0 N--CA 1.474 1.232 0 CA-C-N 118.856 0.753 . . . . 0.0 112.125 174.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -67.28 -43.41 81.85 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.0 m -66.91 -40.37 85.59 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.598 0 CA-C-N 120.071 1.305 . . . . 0.0 110.53 176.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -51.43 -55.0 21.1 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 120.587 1.539 . . . . 0.0 111.464 175.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -50.33 -47.48 55.83 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.301 1.44 . . . . 0.0 112.19 177.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -89.54 -27.75 20.06 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.451 0.701 . . . . 0.0 112.423 -170.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.22 -49.85 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.027 1.331 . . . . 0.0 109.308 169.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -54.09 -54.83 34.02 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.12 0.873 . . . . 0.0 109.551 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -51.58 -37.34 49.39 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.769 1.628 . . . . 0.0 112.676 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -79.22 -61.35 2.04 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.057 0.943 . . . . 0.0 112.92 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.72 -33.76 63.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.25 1.42 . . . . 0.0 112.063 -174.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.69 -17.89 61.08 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -174.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -77.56 -15.98 58.92 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.699 1.199 . . . . 0.0 113.816 171.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.6 pt -120.88 24.72 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 126.934 2.094 . . . . 0.0 111.778 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--O 1.255 1.344 0 C-N-CA 127.824 2.45 . . . . 0.0 111.469 178.099 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 tpp . . . . . 0 N--CA 1.501 2.092 0 CA-C-O 119.362 -0.352 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -83.22 87.92 6.93 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 119.408 1.004 . . . . 0.0 111.21 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -77.94 146.87 35.26 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -171.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.2 t -108.38 143.5 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.672 1.189 . . . . 0.0 110.473 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.1 tpp -129.44 114.4 16.1 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.964 0.906 . . . . 0.0 110.919 169.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -83.31 140.89 32.2 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.642 -0.661 . . . . 0.0 110.382 169.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.5 t -135.89 127.72 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 125.165 1.386 . . . . 0.0 110.507 -175.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.0 p -144.04 -179.2 6.35 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.673 1.189 . . . . 0.0 111.932 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -60.23 -70.98 0.14 Allowed 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 119.472 1.033 . . . . 0.0 109.744 169.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.3 mtt-85 -82.8 121.39 26.85 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 169.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -66.93 -45.26 78.42 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 119.137 0.881 . . . . 0.0 108.883 169.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.4 p -48.77 -31.41 6.95 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.975 2.51 . . . . 0.0 115.829 -175.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.9 p -91.66 -96.1 0.13 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.186 1.394 . . . . 0.0 110.908 169.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -56.27 -56.25 23.35 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -168.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.2 m -69.04 -33.28 73.35 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.709 1.14 . . . . 0.0 113.034 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -66.69 -39.05 87.93 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.358 1.463 . . . . 0.0 113.17 169.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 77.2 mtp -58.85 -45.47 90.01 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.633 0.773 . . . . 0.0 110.977 170.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.56 -28.59 67.09 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 117.7 -1.143 . . . . 0.0 113.609 173.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -72.23 -46.14 57.34 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 121.464 1.938 . . . . 0.0 108.836 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.11 -50.82 62.67 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-O 118.556 -1.136 . . . . 0.0 112.343 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -61.55 -41.24 97.08 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.126 1.463 . . . . 0.0 112.782 175.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.467 ' HB1' HG11 ' A' ' 32' ' ' VAL . . . -72.69 -29.72 63.64 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 120.812 -1.18 . . . . 0.0 111.216 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -65.31 -55.89 15.77 Favored 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 125.205 1.402 . . . . 0.0 109.977 170.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.5 p -71.09 -9.54 58.23 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 49.7 mt -101.83 -1.6 31.89 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 170.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -160.57 13.59 0.17 Allowed Glycine 0 CA--C 1.536 1.402 0 N-CA-C 118.262 2.065 . . . . 0.0 118.262 -171.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.82 -30.26 68.82 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 120.673 2.237 . . . . 0.0 114.331 -171.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.97 1.13 87.5 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 124.454 1.026 . . . . 0.0 114.949 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -112.28 -107.75 0.36 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.42 1.888 . . . . 0.0 110.407 -171.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -95.73 174.55 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 126.104 1.762 . . . . 0.0 111.492 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.6 129.13 39.97 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.22 -0.925 . . . . 0.0 112.264 175.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.467 HG11 ' HB1' ' A' ' 22' ' ' ALA . 30.1 m -99.19 148.25 6.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 124.367 1.067 . . . . 0.0 112.662 170.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.48 153.79 39.97 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.254 1.022 . . . . 0.0 111.115 -174.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.6 p -137.2 136.61 38.32 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.974 1.31 . . . . 0.0 114.163 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.5 t -140.38 -178.84 5.68 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.843 2.057 . . . . 0.0 110.746 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.88 177.97 41.86 Favored Glycine 0 CA--C 1.527 0.815 0 O-C-N 120.684 -1.26 . . . . 0.0 114.834 171.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.9 mt -62.5 -34.26 76.51 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.044 0.938 . . . . 0.0 111.725 -176.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -127.02 112.39 15.18 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.21 2.204 . . . . 0.0 107.754 169.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.5 p -61.51 -36.35 80.28 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.41 -0.806 . . . . 0.0 111.886 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.2 t 52.57 -135.22 1.54 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.943 1.297 . . . . 0.0 110.41 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -127.22 -139.59 0.26 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 126.735 2.014 . . . . 0.0 110.827 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.4 m -105.77 115.08 46.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 168.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -64.62 131.1 95.02 Favored Pre-proline 0 N--CA 1.48 1.045 0 O-C-N 121.176 -0.953 . . . . 0.0 112.378 -168.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -60.06 -37.66 82.95 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.432 2.755 . . . . 0.0 113.944 -169.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.5 m -77.78 -33.37 52.66 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.933 -0.479 . . . . 0.0 110.461 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.38 -38.79 92.27 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.073 -1.017 . . . . 0.0 112.56 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 70.4 mt -53.23 -44.46 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 120.657 1.571 . . . . 0.0 110.134 174.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.0 -58.95 4.77 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.0 mmt -65.15 -21.64 66.81 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -174.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 87.8 mmm -89.9 -38.89 13.39 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.015 0.926 . . . . 0.0 110.762 176.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -58.52 -36.61 74.09 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.577 -1.327 . . . . 0.0 112.205 169.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -54.43 -32.24 57.01 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.333 1.053 . . . . 0.0 113.672 173.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.2 m -101.6 13.98 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.694 1.198 . . . . 0.0 113.973 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.29 16.38 62.64 Favored Glycine 0 CA--C 1.535 1.337 0 O-C-N 121.184 -0.947 . . . . 0.0 114.917 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.4 mt -122.08 75.7 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.727 1.611 . . . . 0.0 109.952 -169.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -68.09 105.33 2.02 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 120.283 -1.511 . . . . 0.0 110.494 173.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.0 pt -84.35 -5.52 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.542 0.737 . . . . 0.0 112.833 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 92.4 p -64.92 -28.93 69.87 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -169.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.43 7.8 77.6 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.803 1.192 . . . . 0.0 114.58 172.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -98.87 149.83 22.52 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.196 1.398 . . . . 0.0 112.522 -169.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.8 t -85.64 145.58 27.25 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -173.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.3 m -124.49 111.65 15.96 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.352 1.061 . . . . 0.0 110.381 170.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.15 158.11 50.04 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 124.001 0.92 . . . . 0.0 113.009 177.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -95.7 150.79 1.46 Allowed 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 124.176 3.251 . . . . 0.0 111.879 169.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.38 -19.15 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 115.424 1.638 . . . . 0.0 115.424 -172.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -99.68 -7.79 25.19 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -87.92 -39.43 14.76 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.379 -0.826 . . . . 0.0 111.491 169.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.98 161.12 31.68 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.559 0.743 . . . . 0.0 111.759 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -136.56 117.21 13.93 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.388 1.075 . . . . 0.0 110.452 173.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.98 -1.76 4.48 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -171.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.91 -30.49 67.92 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.083 -1.011 . . . . 0.0 112.202 -173.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -86.14 -2.57 58.46 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.781 1.232 . . . . 0.0 113.293 177.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -124.35 90.56 3.28 Favored 'General case' 0 C--N 1.343 0.326 0 C-N-CA 125.711 1.604 . . . . 0.0 110.269 -171.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -55.18 -27.84 48.72 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.196 1.398 . . . . 0.0 113.37 -177.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.29 115.74 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 125.156 1.382 . . . . 0.0 110.541 -172.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.0 t -122.91 129.08 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.913 0.885 . . . . 0.0 110.746 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.7 mm -117.58 124.15 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.455 0.702 . . . . 0.0 111.109 -172.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.1 t -88.19 105.6 17.64 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 169.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.419 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 64.0 mt -82.91 31.89 0.43 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.805 1.642 . . . . 0.0 110.966 175.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.3 t . . . . . 0 CA--C 1.538 0.488 0 C-N-CA 127.866 2.466 . . . . 0.0 109.162 -169.678 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.6 mt . . . . . 0 CA--C 1.549 0.923 0 CA-C-O 119.232 -0.413 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -59.22 132.11 44.96 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.708 2.272 . . . . 0.0 110.698 169.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -59.73 -33.23 96.46 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.468 2.112 . . . . 0.0 113.522 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -66.18 -26.64 67.5 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.72 1.145 . . . . 0.0 113.538 175.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.38 -15.96 59.11 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.772 -1.205 . . . . 0.0 112.629 171.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.8 t -90.63 -40.22 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.882 1.673 . . . . 0.0 111.725 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.1 p -81.99 27.9 0.45 Allowed 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -172.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -79.61 169.7 17.63 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.084 1.354 . . . . 0.0 112.14 170.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -55.35 -39.79 70.47 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.121 0.968 . . . . 0.0 113.431 -169.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 58.9 mt -128.31 125.06 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.594 1.157 . . . . 0.0 109.545 170.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -128.52 141.46 51.37 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.436 1.094 . . . . 0.0 110.339 169.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.37 154.54 43.11 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.215 1.006 . . . . 0.0 112.121 -171.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -129.16 113.22 14.81 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.49 1.516 . . . . 0.0 110.226 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.419 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 37.0 m0 -94.0 5.32 52.07 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -173.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 63.45 -89.12 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.497 1.519 . . . . 0.0 112.026 -173.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.7 mt 53.85 -177.96 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 127.789 2.435 . . . . 0.0 115.511 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -142.0 148.26 38.27 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.8 2.04 . . . . 0.0 108.887 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.26 119.48 77.64 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 119.654 1.115 . . . . 0.0 110.575 176.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -83.94 -6.85 10.42 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 121.912 1.742 . . . . 0.0 113.881 -171.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -45.25 112.4 0.44 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.184 1.394 . . . . 0.0 112.783 174.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.42 3.14 82.04 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 123.66 0.647 . . . . 0.0 114.375 173.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -79.88 173.18 12.85 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.103 0.961 . . . . 0.0 109.927 169.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 86.2 p -63.68 153.8 35.01 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.183 -0.948 . . . . 0.0 111.732 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.47 -29.49 70.57 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.53 -0.731 . . . . 0.0 111.497 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -67.15 -34.9 78.55 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.786 -1.196 . . . . 0.0 113.144 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 78.8 t -69.46 -37.48 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 O-C-N 121.163 -0.96 . . . . 0.0 109.611 170.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.52 -39.08 93.11 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.717 0.807 . . . . 0.0 111.109 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -71.69 -38.09 70.63 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.062 1.345 . . . . 0.0 112.376 171.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 51.7 m -57.84 -48.1 80.75 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.608 1.095 . . . . 0.0 111.525 177.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.4 m -69.3 -29.92 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.937 176.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.28 -42.86 99.35 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 120.155 1.343 . . . . 0.0 111.515 169.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.76 -42.13 95.37 Favored Glycine 0 N--CA 1.476 1.331 0 C-N-CA 124.253 0.93 . . . . 0.0 112.661 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -63.32 -48.18 79.09 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.127 -0.631 . . . . 0.0 112.218 171.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.0 t -58.52 -44.9 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.633 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -52.37 -54.55 30.36 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 120.046 1.293 . . . . 0.0 111.51 175.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -61.76 -43.38 98.97 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.13 0.572 . . . . 0.0 112.209 -176.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 49.3 mtp85 -76.16 -31.86 58.76 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 36.8 t -61.87 -49.01 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.532 1.133 . . . . 0.0 110.591 170.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -53.62 -54.75 33.17 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.018 0.827 . . . . 0.0 109.701 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -55.19 -31.59 61.53 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.374 1.47 . . . . 0.0 112.9 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -81.83 -59.97 2.4 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.035 -1.04 . . . . 0.0 112.704 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.24 -32.68 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.789 1.236 . . . . 0.0 111.691 -176.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.58 -0.39 33.39 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -90.88 -15.65 29.55 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.809 1.244 . . . . 0.0 113.51 170.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.5 pt -121.31 8.43 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 126.188 1.795 . . . . 0.0 113.041 -176.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.4 p . . . . . 0 C--O 1.254 1.323 0 C-N-CA 126.446 1.898 . . . . 0.0 113.815 171.92 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.9 ttm . . . . . 0 N--CA 1.501 2.084 0 CA-C-O 119.325 -0.369 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -86.35 107.1 17.84 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 169.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -82.11 144.87 30.47 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 118.077 0.398 . . . . 0.0 110.907 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.0 t -101.66 142.22 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.672 0.789 . . . . 0.0 109.804 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 42.3 tpp -127.97 118.27 23.26 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.692 0.797 . . . . 0.0 110.754 169.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -89.67 138.51 31.41 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.88 -0.512 . . . . 0.0 110.834 169.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 t -130.17 129.32 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.546 1.538 . . . . 0.0 109.631 -171.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.7 m -141.14 171.48 14.0 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.002 1.321 . . . . 0.0 110.503 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -66.0 -49.28 68.34 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 119.91 1.232 . . . . 0.0 108.934 169.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -103.67 114.08 28.07 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 167.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.535 ' ND2' ' H ' ' A' ' 63' ' ' ASP . 31.1 t-20 -51.92 -48.51 64.17 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 120.474 1.488 . . . . 0.0 109.673 172.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.0 p -53.17 -32.85 49.91 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.1 p -78.37 -33.58 48.85 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -174.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 -140.34 -55.79 0.53 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.903 0.881 . . . . 0.0 112.488 -170.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 m -55.71 -40.86 73.0 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 120.087 1.312 . . . . 0.0 113.333 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -66.91 -35.43 79.98 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.698 1.599 . . . . 0.0 113.46 173.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.5 mtm -64.92 -50.43 66.52 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.782 -0.574 . . . . 0.0 110.565 172.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.8 -26.19 67.58 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.415 -0.803 . . . . 0.0 113.011 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -71.4 -49.44 42.0 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 119.507 1.048 . . . . 0.0 108.45 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.458 ' CA ' HE22 ' A' ' 60' ' ' GLN . . . -63.32 -41.62 99.43 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 119.245 -0.753 . . . . 0.0 112.953 177.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -62.45 -43.32 99.1 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.287 1.544 . . . . 0.0 112.22 172.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.64 -35.96 67.89 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.683 -1.26 . . . . 0.0 110.863 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -57.73 -49.6 76.0 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.344 1.858 . . . . 0.0 110.833 171.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.4 p -78.67 -24.46 45.11 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.868 1.432 . . . . 0.0 114.868 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.8 mt -89.5 -28.19 19.82 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.157 0.89 . . . . 0.0 113.045 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.74 -68.74 1.15 Allowed Glycine 0 N--CA 1.473 1.118 0 C-N-CA 124.711 1.148 . . . . 0.0 112.065 175.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 54.32 90.83 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.176 2.59 . . . . 0.0 115.462 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.85 -7.25 78.15 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 116.299 1.28 . . . . 0.0 116.299 169.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -68.85 -47.19 66.56 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 118.898 1.349 . . . . 0.0 110.817 174.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.6 pp -140.35 -176.06 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 127.749 2.42 . . . . 0.0 110.479 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.13 128.52 55.08 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.52 0.676 . . . . 0.0 112.551 172.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.5 m -95.16 151.48 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 124.592 1.157 . . . . 0.0 112.907 170.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.14 156.45 42.6 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.672 0.789 . . . . 0.0 111.41 -172.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 97.5 p -126.77 142.37 51.56 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.169 1.388 . . . . 0.0 114.023 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.6 t -145.77 170.78 15.85 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 126.897 2.079 . . . . 0.0 109.874 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.24 171.11 34.6 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 120.883 -1.136 . . . . 0.0 114.358 170.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 38.3 mt -62.17 -35.18 78.01 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 117.4 0.6 . . . . 0.0 111.812 -174.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -125.08 122.05 36.08 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.559 2.744 . . . . 0.0 106.545 169.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 55.4 p -73.07 -41.88 63.64 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.842 -1.162 . . . . 0.0 111.024 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.5 t 55.49 -167.51 0.1 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 126.282 1.833 . . . . 0.0 113.877 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -94.0 168.79 10.73 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 126.936 2.094 . . . . 0.0 112.29 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.6 m -61.15 114.16 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 169.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -71.04 132.19 86.68 Favored Pre-proline 0 N--CA 1.476 0.864 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -168.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -57.77 -39.72 84.99 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.951 3.1 . . . . 0.0 114.305 -173.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.3 m -80.31 -37.59 32.34 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.776 -0.578 . . . . 0.0 110.626 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.28 96.54 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.267 0.939 . . . . 0.0 112.076 175.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.0 mt -48.95 -49.09 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 120.132 1.333 . . . . 0.0 110.376 171.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.03 -58.13 7.6 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.6 mmt -65.71 -22.46 66.61 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -172.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 76.6 mmm -90.28 -40.01 12.41 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.372 1.469 . . . . 0.0 110.998 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -57.78 -35.47 70.84 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.83 -1.169 . . . . 0.0 112.348 170.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -53.41 -32.44 49.64 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.469 1.107 . . . . 0.0 113.064 170.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -94.85 5.98 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.703 1.201 . . . . 0.0 113.521 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.97 15.55 64.91 Favored Glycine 0 CA--C 1.538 1.498 0 O-C-N 120.916 -1.115 . . . . 0.0 114.433 -173.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.4 mt -121.04 61.64 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.95 1.7 . . . . 0.0 109.651 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -62.24 110.46 1.63 Allowed 'General case' 0 CA--C 1.548 0.893 0 O-C-N 120.082 -1.636 . . . . 0.0 110.892 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.6 pt -85.89 -4.5 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 118.496 -0.764 . . . . 0.0 112.941 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.5 t -61.79 -33.86 74.86 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.159 1.345 . . . . 0.0 112.731 -171.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.49 10.08 66.92 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.133 1.349 . . . . 0.0 115.432 172.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.458 HE22 ' CA ' ' A' ' 20' ' ' GLY . 5.8 tt0 -101.74 163.03 12.47 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.911 1.284 . . . . 0.0 112.838 -170.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 p -72.94 158.75 34.87 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.022 1.729 . . . . 0.0 115.408 -170.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.8 t -151.31 148.14 27.8 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.153 2.181 . . . . 0.0 108.466 168.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.535 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 1.0 OUTLIER -149.36 147.91 24.79 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.672 1.189 . . . . 0.0 111.201 178.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -90.3 152.19 4.55 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.679 2.92 . . . . 0.0 111.854 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 tt -65.31 -18.78 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -171.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -98.22 -7.21 29.69 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -88.47 -38.98 14.56 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.585 0.629 . . . . 0.0 111.436 169.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.87 161.8 30.27 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.697 0.799 . . . . 0.0 112.241 173.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.94 123.51 17.23 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.271 1.028 . . . . 0.0 110.926 169.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.94 2.43 3.5 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -169.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -67.58 -28.6 67.91 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.341 -0.85 . . . . 0.0 112.437 -173.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -93.4 -2.31 54.82 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.157 1.383 . . . . 0.0 113.28 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -123.43 80.12 1.75 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.196 1.798 . . . . 0.0 109.878 -170.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -59.41 -21.29 59.74 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.707 1.203 . . . . 0.0 114.087 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.6 t -117.91 109.6 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.869 1.268 . . . . 0.0 110.015 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.8 t -121.21 129.37 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.819 0.848 . . . . 0.0 111.233 -176.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.1 mm -119.7 118.35 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 O-C-N 121.534 -0.729 . . . . 0.0 111.233 -171.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.3 t -82.85 105.8 14.16 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 168.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.428 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 85.4 mt -79.07 -32.38 44.74 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.622 -0.674 . . . . 0.0 111.135 177.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 31.7 p . . . . . 0 CA--C 1.539 0.55 0 C-N-CA 122.993 0.517 . . . . 0.0 110.41 169.004 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.5 mt . . . . . 0 CA--C 1.547 0.856 0 CA-C-O 119.149 -0.453 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.32 133.43 54.97 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.852 2.368 . . . . 0.0 111.68 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -60.59 -31.03 91.76 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.795 2.33 . . . . 0.0 113.62 -174.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -65.48 -30.01 70.74 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.729 -1.232 . . . . 0.0 113.264 173.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.35 -19.94 49.01 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.855 -1.153 . . . . 0.0 112.688 173.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.6 t -87.73 -34.39 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.047 1.739 . . . . 0.0 112.41 176.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.6 p -88.59 25.83 1.62 Allowed 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -171.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -77.2 168.35 20.21 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.508 1.123 . . . . 0.0 112.263 169.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -55.72 -38.59 69.95 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -169.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 59.7 mt -126.03 123.51 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.717 1.207 . . . . 0.0 108.872 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -128.24 140.87 51.66 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.097 0.959 . . . . 0.0 110.702 169.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.84 154.95 44.67 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.671 1.188 . . . . 0.0 112.093 -171.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -130.13 115.45 17.07 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.9 1.28 . . . . 0.0 110.89 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.428 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 35.7 m0 -98.51 -1.63 40.72 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.457 1.103 . . . . 0.0 113.792 -175.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.32 1.2 pp0? 44.75 41.73 5.29 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 172.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.8 mt -84.42 134.25 34.47 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.984 1.313 . . . . 0.0 112.977 -177.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -64.74 153.87 38.51 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.987 1.315 . . . . 0.0 111.977 172.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -81.72 116.74 64.98 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 121.192 -0.942 . . . . 0.0 112.832 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -84.52 -27.27 1.42 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.794 2.329 . . . . 0.0 115.103 -169.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -70.97 81.7 0.66 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.667 1.987 . . . . 0.0 111.949 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 141.17 -10.66 2.78 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 126.496 1.998 . . . . 0.0 113.785 -174.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -91.39 175.8 6.79 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.845 1.658 . . . . 0.0 111.624 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 96.9 p -70.86 159.77 34.0 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.628 -0.67 . . . . 0.0 111.581 169.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.9 -31.04 72.02 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.463 -0.773 . . . . 0.0 112.194 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.08 -40.89 95.41 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.05 -1.031 . . . . 0.0 112.283 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 94.0 t -72.93 -35.91 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.626 0.77 . . . . 0.0 110.47 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -60.15 -49.76 76.38 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.781 0.832 . . . . 0.0 110.638 173.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 66.4 mtt85 -63.14 -23.54 67.48 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.307 1.443 . . . . 0.0 113.453 173.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 57.4 m -75.63 -55.32 5.78 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.624 1.169 . . . . 0.0 111.412 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 19.2 m -65.54 -32.31 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 119.82 1.191 . . . . 0.0 110.762 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.47 -43.75 89.06 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 126.606 1.962 . . . . 0.0 112.939 169.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.43 -38.4 86.83 Favored Glycine 0 N--CA 1.476 1.323 0 C-N-CA 123.964 0.792 . . . . 0.0 113.392 174.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -61.94 -43.31 99.1 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.512 -0.993 . . . . 0.0 111.814 169.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 32.5 t -58.58 -47.65 87.91 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 CA-C-O 117.861 -1.066 . . . . 0.0 109.772 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -49.81 -55.36 14.43 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.866 1.212 . . . . 0.0 111.571 175.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -61.1 -43.75 98.41 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.5 mtp85 -76.12 -33.55 59.45 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.6 t -63.56 -46.09 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.122 0.969 . . . . 0.0 111.224 172.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -52.49 -54.97 25.46 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.246 0.93 . . . . 0.0 109.943 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -55.17 -37.75 67.42 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.783 1.233 . . . . 0.0 112.676 176.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -74.79 -57.28 4.01 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.18 -0.95 . . . . 0.0 112.752 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.56 -34.53 71.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.692 1.197 . . . . 0.0 112.168 -177.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.57 -15.8 60.83 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -173.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -73.43 -31.03 63.6 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.43 1.092 . . . . 0.0 113.382 170.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.9 pt -107.64 -7.15 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.323 1.449 . . . . 0.0 113.389 -174.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.9 m . . . . . 0 C--O 1.253 1.282 0 C-N-CA 125.779 1.632 . . . . 0.0 112.711 171.007 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 ttm . . . . . 0 N--CA 1.503 2.208 0 CA-C-O 119.77 -0.157 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -85.73 82.33 8.24 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.212 1.005 . . . . 0.0 110.777 173.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -72.18 139.23 48.14 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.208 1.003 . . . . 0.0 111.714 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.9 t -113.2 146.25 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.291 1.036 . . . . 0.0 111.657 -173.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.2 tpp -132.91 122.59 24.56 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.188 0.995 . . . . 0.0 111.573 169.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -95.88 134.86 38.36 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.267 1.027 . . . . 0.0 111.387 169.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.1 t -128.63 130.16 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.968 1.307 . . . . 0.0 111.436 -170.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.0 p -149.28 179.49 7.88 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.471 1.108 . . . . 0.0 111.953 173.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -66.33 -61.92 1.75 Allowed 'General case' 0 N--CA 1.483 1.208 0 O-C-N 120.79 -1.194 . . . . 0.0 111.102 173.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.32 110.98 19.01 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.223 1.009 . . . . 0.0 109.197 169.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -61.68 -34.96 76.67 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.156 0.889 . . . . 0.0 110.331 169.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.3 p -48.47 -37.89 18.53 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.828 2.451 . . . . 0.0 115.836 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.9 p -97.62 -92.39 0.24 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.329 1.052 . . . . 0.0 111.329 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.69 -54.24 49.13 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 120.924 -1.11 . . . . 0.0 113.764 -169.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.402 ' HB3' ' HB2' ' A' ' 34' ' ' SER . 18.5 m -63.6 -42.29 98.27 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.136 0.88 . . . . 0.0 111.868 -176.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -60.74 -39.82 90.11 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.447 1.499 . . . . 0.0 114.564 169.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 78.4 mtp -64.43 -45.97 85.21 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.167 0.894 . . . . 0.0 110.748 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.0 -25.78 64.68 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 172.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -67.27 -53.27 31.4 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.051 1.296 . . . . 0.0 108.168 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.56 -43.55 96.37 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 118.714 -1.048 . . . . 0.0 112.266 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -63.27 -43.41 98.04 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.852 1.826 . . . . 0.0 112.21 172.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.86 -35.56 64.78 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.198 1.363 . . . . 0.0 110.923 -173.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -60.44 -59.22 5.74 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.38 1.472 . . . . 0.0 109.378 169.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.0 p -66.5 -13.58 61.09 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.5 mt -97.87 -5.59 34.23 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 172.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.66 15.69 0.11 Allowed Glycine 0 CA--C 1.536 1.36 0 N-CA-C 118.304 2.081 . . . . 0.0 118.304 -171.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.69 -34.54 59.1 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 119.696 1.748 . . . . 0.0 114.643 -170.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.49 -5.58 86.76 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.38 0.99 . . . . 0.0 115.319 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -99.52 -60.87 1.45 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 118.632 1.216 . . . . 0.0 111.947 -170.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -139.85 170.64 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 126.846 2.059 . . . . 0.0 110.319 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.67 125.13 39.12 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 122.122 0.963 . . . . 0.0 111.275 175.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.2 m -92.79 153.61 3.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.901 169.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.73 149.94 34.39 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.435 0.694 . . . . 0.0 111.71 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' A' ' 15' ' ' SER . 34.4 p -119.92 139.34 52.57 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.994 2.118 . . . . 0.0 113.347 171.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.9 p -144.88 172.86 12.43 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.015 1.326 . . . . 0.0 110.777 169.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.68 -179.82 44.58 Favored Glycine 0 CA--C 1.52 0.367 0 O-C-N 120.383 -1.448 . . . . 0.0 114.569 171.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 34.7 mt -63.69 -30.07 71.22 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.78 0.432 . . . . 0.0 111.532 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -121.39 123.79 42.95 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.877 2.071 . . . . 0.0 108.948 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.3 p -77.8 43.23 0.41 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.92 1.688 . . . . 0.0 111.898 175.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.9 p -63.14 155.01 29.3 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.564 1.545 . . . . 0.0 113.337 -169.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -65.68 177.66 1.19 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.819 1.647 . . . . 0.0 114.471 -169.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 m -63.45 110.33 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 119.866 -1.771 . . . . 0.0 109.617 169.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -67.9 135.46 92.06 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-O 118.413 -0.803 . . . . 0.0 112.414 -169.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -58.79 -39.92 77.38 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.367 2.711 . . . . 0.0 113.795 -174.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.7 m -77.44 -37.87 50.67 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.869 0.468 . . . . 0.0 110.581 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.04 -41.83 97.26 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 118.143 -0.932 . . . . 0.0 112.448 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 66.8 mt -50.8 -47.01 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 120.482 1.492 . . . . 0.0 110.426 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.99 -59.76 3.8 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 175.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 31.0 mmt -67.29 -20.88 65.69 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -172.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 83.9 mmm -90.15 -37.52 14.14 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.721 0.809 . . . . 0.0 110.619 175.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -58.53 -36.46 73.88 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.58 -1.325 . . . . 0.0 112.129 169.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -54.25 -32.75 56.85 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.162 0.985 . . . . 0.0 113.59 172.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.6 m -100.67 13.18 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 124.818 1.247 . . . . 0.0 114.19 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.14 17.2 59.6 Favored Glycine 0 N--CA 1.476 1.329 0 O-C-N 121.047 -1.033 . . . . 0.0 114.896 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.0 mt -126.6 64.49 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.894 1.678 . . . . 0.0 109.965 -169.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -63.47 109.16 1.54 Allowed 'General case' 0 CA--C 1.545 0.759 0 O-C-N 119.985 -1.697 . . . . 0.0 110.905 173.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.1 pt -83.98 -4.89 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 118.36 -0.828 . . . . 0.0 113.04 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -60.13 -30.1 69.07 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 120.495 1.498 . . . . 0.0 113.502 -169.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.36 5.53 71.02 Favored Glycine 0 CA--C 1.541 1.667 0 C-N-CA 124.82 1.2 . . . . 0.0 115.534 173.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -98.82 140.37 33.11 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.11 1.455 . . . . 0.0 112.324 -171.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.8 t -71.21 155.83 40.27 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -173.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.1 m -128.37 143.2 50.97 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.738 1.615 . . . . 0.0 110.49 169.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -138.15 150.86 68.46 Favored Pre-proline 0 N--CA 1.485 1.295 0 CA-C-N 119.616 1.098 . . . . 0.0 113.36 -172.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -88.92 151.03 5.88 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.533 2.155 . . . . 0.0 112.165 177.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.5 tt -62.57 -17.83 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 125.125 1.37 . . . . 0.0 114.55 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.26 -8.05 27.98 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -87.68 -38.89 15.45 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.077 0.853 . . . . 0.0 111.258 170.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.11 157.52 38.04 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.392 0.677 . . . . 0.0 111.409 172.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.25 121.24 13.66 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.721 0.809 . . . . 0.0 111.156 170.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.16 1.79 1.89 Allowed 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -170.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -67.06 -28.1 67.92 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.147 -0.97 . . . . 0.0 111.979 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -93.8 -1.13 55.39 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.41 1.484 . . . . 0.0 113.418 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -130.24 91.62 3.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.615 1.566 . . . . 0.0 110.586 -171.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -59.62 -21.25 60.17 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.7 t -123.28 108.13 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.956 1.302 . . . . 0.0 110.41 -169.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.416 ' C ' HD12 ' A' ' 77' ' ' ILE . 22.6 t -125.58 127.6 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.674 0.79 . . . . 0.0 111.452 -176.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.416 HD12 ' C ' ' A' ' 76' ' ' VAL . 1.6 mp -118.86 130.93 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.39 1.076 . . . . 0.0 110.206 -170.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.7 t -90.32 124.88 35.28 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.912 1.285 . . . . 0.0 108.092 168.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.426 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 76.1 mt -104.24 23.44 13.09 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.824 1.649 . . . . 0.0 112.572 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 27.1 p . . . . . 0 CA--C 1.54 0.576 0 C-N-CA 126.705 2.002 . . . . 0.0 108.533 169.661 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.8 mt . . . . . 0 CA--C 1.551 1.01 0 CA-C-O 119.214 -0.422 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.67 132.77 53.82 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.703 2.269 . . . . 0.0 111.076 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -59.71 -33.95 96.29 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.426 2.084 . . . . 0.0 113.502 -171.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -64.62 -28.6 69.73 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.704 -1.247 . . . . 0.0 113.325 174.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.64 -4.52 52.02 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.797 -1.19 . . . . 0.0 112.859 172.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 72.3 t -104.78 -41.54 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.452 1.901 . . . . 0.0 111.391 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.3 p -82.04 49.12 1.33 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.637 1.175 . . . . 0.0 113.517 -173.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -104.64 170.31 7.96 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.282 1.833 . . . . 0.0 111.945 176.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -58.38 -37.25 74.87 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.736 0.815 . . . . 0.0 112.89 -170.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 56.2 mt -128.48 120.61 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.95 1.3 . . . . 0.0 108.512 169.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -130.37 138.11 50.23 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.03 0.932 . . . . 0.0 110.857 169.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -140.08 151.06 45.07 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.88 1.272 . . . . 0.0 112.05 -175.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -123.55 99.97 6.57 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.924 1.29 . . . . 0.0 109.886 175.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.426 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 39.5 m0 -79.37 -4.55 51.51 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -170.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.372 1.1 pp0? 50.4 37.55 15.83 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.034 1.734 . . . . 0.0 115.586 170.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 69.3 mt -75.5 157.82 33.45 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.834 1.254 . . . . 0.0 112.352 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -85.19 161.48 19.59 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.961 1.304 . . . . 0.0 111.438 170.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -89.52 122.03 68.67 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.511 1.124 . . . . 0.0 112.141 175.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -93.82 -18.69 0.5 Allowed 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 121.688 1.592 . . . . 0.0 114.872 -169.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -44.15 108.11 0.11 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.007 2.123 . . . . 0.0 113.355 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.22 8.58 62.27 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.544 1.069 . . . . 0.0 115.606 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -79.24 -65.75 0.96 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.004 1.402 . . . . 0.0 111.279 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.6 t -170.44 151.71 3.78 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.603 1.961 . . . . 0.0 109.247 171.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.2 mp -59.85 -29.09 68.06 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.204 0.602 . . . . 0.0 111.218 172.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.95 -39.88 95.98 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.95 -1.094 . . . . 0.0 112.332 173.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 86.4 t -71.61 -39.45 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.655 0.782 . . . . 0.0 109.254 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.35 -44.49 94.67 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.14 0.976 . . . . 0.0 111.739 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 -68.7 -37.39 79.49 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.201 -0.937 . . . . 0.0 112.092 172.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 64.0 m -58.58 -49.46 77.38 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 119.007 0.821 . . . . 0.0 111.674 175.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.8 m -69.97 -30.17 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 117.847 -1.073 . . . . 0.0 112.186 176.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -42.66 94.94 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 120.595 1.543 . . . . 0.0 111.595 169.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.68 -42.62 95.28 Favored Glycine 0 N--CA 1.474 1.175 0 C-N-CA 124.017 0.817 . . . . 0.0 112.758 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -62.32 -47.48 84.06 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 122.172 -0.605 . . . . 0.0 112.057 171.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 36.2 t -60.25 -45.32 96.37 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.059 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -52.47 -53.96 38.71 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 119.92 1.236 . . . . 0.0 111.843 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.21 -45.89 91.34 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.863 0.465 . . . . 0.0 112.08 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.9 mtt-85 -71.61 -33.29 68.87 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.1 t -65.2 -47.62 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.941 171.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -53.64 -54.32 39.34 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.604 1.093 . . . . 0.0 109.658 174.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -54.42 -37.33 64.97 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.206 1.003 . . . . 0.0 112.704 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -78.0 -57.56 3.73 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.213 0.915 . . . . 0.0 112.278 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.71 -32.69 59.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.666 1.187 . . . . 0.0 112.281 -176.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.77 -18.44 58.44 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -174.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -72.28 -21.89 61.29 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.551 1.141 . . . . 0.0 113.42 170.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.2 pt -114.76 20.48 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 126.504 1.921 . . . . 0.0 112.287 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.255 1.361 0 C-N-CA 127.759 2.424 . . . . 0.0 111.528 176.174 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.7 ttp . . . . . 0 N--CA 1.503 2.181 0 CA-C-O 119.889 -0.1 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -85.61 106.32 16.83 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.227 0.611 . . . . 0.0 109.972 171.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -77.84 149.61 34.33 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.144 0.578 . . . . 0.0 110.973 176.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 56.8 t -107.85 143.5 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.207 1.003 . . . . 0.0 110.226 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 58.4 tpp -130.55 116.22 17.85 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.483 0.713 . . . . 0.0 109.857 169.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -86.75 142.15 28.35 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.705 -0.622 . . . . 0.0 110.541 169.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.8 t -133.06 128.92 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.663 1.185 . . . . 0.0 111.562 -174.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.3 p -145.95 175.64 10.29 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.688 0.795 . . . . 0.0 111.564 169.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -61.21 -36.35 79.67 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 120.901 -1.125 . . . . 0.0 112.212 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -108.21 136.11 48.42 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.234 1.413 . . . . 0.0 111.113 169.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -98.29 -0.15 44.49 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.792 0.724 . . . . 0.0 110.971 168.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.4 p -74.51 -24.94 59.07 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.117 1.367 . . . . 0.0 112.936 169.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 t -133.49 -164.61 1.51 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.481 1.913 . . . . 0.0 109.73 174.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 41.03 -80.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 128.685 2.794 . . . . 0.0 116.159 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.0 p -56.37 -44.26 80.01 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.148 0.979 . . . . 0.0 112.347 173.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -63.64 -35.51 80.75 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 120.068 1.304 . . . . 0.0 113.408 168.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 87.8 mtp -61.45 -47.08 87.36 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.082 0.855 . . . . 0.0 110.177 176.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.76 -29.03 68.14 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 118.043 -0.98 . . . . 0.0 113.129 175.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -65.06 -54.28 32.55 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 120.277 1.398 . . . . 0.0 108.747 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.96 -45.66 96.15 Favored Glycine 0 CA--C 1.521 0.462 0 CA-C-O 118.882 -0.955 . . . . 0.0 112.814 -176.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.48 -33.85 73.19 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.155 0.977 . . . . 0.0 112.464 172.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.506 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -77.73 -37.52 49.13 Favored 'General case' 0 C--O 1.225 -0.189 0 O-C-N 121.256 -0.903 . . . . 0.0 111.607 -175.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -69.17 -40.78 77.93 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.77 1.168 . . . . 0.0 112.358 169.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.1 p -67.52 -6.35 19.37 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 121.489 1.95 . . . . 0.0 114.516 171.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.6 mt -111.62 0.01 16.24 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 171.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.7 16.52 0.22 Allowed Glycine 0 CA--C 1.536 1.37 0 N-CA-C 116.712 1.445 . . . . 0.0 116.712 -169.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.98 129.43 41.91 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.823 1.312 . . . . 0.0 111.634 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.49 -3.65 58.59 Favored Glycine 0 CA--C 1.539 1.531 0 CA-C-O 118.526 -1.152 . . . . 0.0 115.691 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -83.84 -58.47 2.78 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 119.675 1.738 . . . . 0.0 110.892 176.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -141.03 177.4 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.936 2.095 . . . . 0.0 110.898 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.93 109.32 21.7 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.131 -0.98 . . . . 0.0 111.672 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.506 HG11 ' HB3' ' A' ' 22' ' ' ALA . 40.0 t -85.74 135.75 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 125.757 1.623 . . . . 0.0 111.65 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.85 159.29 43.71 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.173 0.989 . . . . 0.0 112.984 -176.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.8 p -141.71 154.1 45.08 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.658 1.583 . . . . 0.0 114.564 172.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.4 p -151.54 -179.18 7.18 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 126.41 1.884 . . . . 0.0 111.184 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.32 178.97 48.28 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 120.309 -1.494 . . . . 0.0 115.417 176.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 35.0 mt -71.51 -44.31 64.88 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -170.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -116.94 87.59 2.73 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.818 2.447 . . . . 0.0 106.018 169.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.2 p -54.51 -46.46 73.49 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.656 -0.653 . . . . 0.0 111.74 -171.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.7 t 56.57 -166.18 0.13 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.478 1.911 . . . . 0.0 113.476 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -78.24 -153.4 0.06 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.978 2.111 . . . . 0.0 111.863 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.8 m -98.28 125.69 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.12 1.768 . . . . 0.0 106.848 168.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -71.53 131.53 86.28 Favored Pre-proline 0 N--CA 1.478 0.938 0 O-C-N 120.516 -1.365 . . . . 0.0 113.2 -168.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -59.35 -38.82 82.22 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.338 2.692 . . . . 0.0 113.84 -172.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.402 ' HB ' ' CE2' ' A' ' 112' ' ' PHE . 9.1 m -79.64 -36.22 38.17 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.838 -0.539 . . . . 0.0 110.608 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.54 -40.2 95.17 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.956 -1.09 . . . . 0.0 112.383 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 52.1 mt -52.7 -43.68 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 120.847 1.658 . . . . 0.0 110.652 173.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.42 -59.41 4.38 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 174.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.6 mmt -65.98 -21.81 66.43 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -173.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 82.7 mmm -89.79 -37.1 14.74 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.062 0.945 . . . . 0.0 111.238 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -60.8 -35.74 77.24 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.691 1.132 . . . . 0.0 111.572 170.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -55.37 -27.95 50.73 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 171.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.9 m -108.08 20.57 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 125.01 1.324 . . . . 0.0 113.934 175.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.09 11.92 75.06 Favored Glycine 0 CA--C 1.536 1.362 0 O-C-N 121.222 -0.924 . . . . 0.0 115.291 173.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.4 mt -122.84 87.67 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.513 1.525 . . . . 0.0 109.093 -169.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -70.66 111.33 6.06 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 120.315 -1.491 . . . . 0.0 110.419 170.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.7 pt -86.34 -6.28 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 O-C-N 121.496 -0.753 . . . . 0.0 112.608 175.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.3 t -63.78 -30.78 71.84 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 120.007 1.276 . . . . 0.0 112.736 -173.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.95 4.78 75.47 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 125.318 1.437 . . . . 0.0 115.508 171.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -78.06 147.77 34.59 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.108 1.454 . . . . 0.0 111.581 -175.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 10.8 t -62.76 147.47 49.69 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.588 -0.695 . . . . 0.0 112.084 174.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.5 t -127.94 131.98 49.28 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.839 0.856 . . . . 0.0 109.874 169.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -145.33 136.22 12.36 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.899 0.88 . . . . 0.0 113.087 -169.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -84.47 154.23 12.15 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.405 2.737 . . . . 0.0 113.11 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.0 tp -61.56 -18.67 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -103.98 -8.89 19.27 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -86.27 -35.18 20.1 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.297 0.953 . . . . 0.0 110.837 169.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.02 156.0 40.15 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 122.971 0.508 . . . . 0.0 110.702 170.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.1 121.05 15.56 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.557 0.743 . . . . 0.0 110.747 170.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.72 1.68 2.35 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -170.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -69.28 -27.08 65.1 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.343 -0.848 . . . . 0.0 111.918 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -93.33 -2.58 54.71 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.576 1.55 . . . . 0.0 113.225 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -127.1 84.37 2.26 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.998 1.719 . . . . 0.0 109.955 -172.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.69 -18.39 41.92 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.4 t -120.89 111.2 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 125.515 1.526 . . . . 0.0 109.762 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.4 t -126.34 121.39 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 121.611 -0.68 . . . . 0.0 110.476 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 mp -113.15 135.05 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.277 1.031 . . . . 0.0 109.958 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.0 m -95.8 148.4 22.63 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.604 1.162 . . . . 0.0 109.972 169.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.417 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 87.6 mt -129.09 44.21 3.01 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.065 0.946 . . . . 0.0 110.169 -171.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 22.5 p . . . . . 0 CA--C 1.544 0.734 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 -169.062 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 CA--C 1.549 0.911 0 CA-C-O 119.484 -0.293 . . . . 0.0 111.743 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -54.79 138.12 76.07 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.066 2.51 . . . . 0.0 111.827 173.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -59.02 -34.26 99.02 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.359 2.039 . . . . 0.0 113.628 -172.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -65.99 -26.77 67.71 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.817 -1.177 . . . . 0.0 113.692 174.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.38 -15.81 59.18 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.631 -1.293 . . . . 0.0 113.027 170.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.6 t -93.51 -37.75 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 126.548 1.939 . . . . 0.0 112.162 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.8 p -83.97 18.13 2.16 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -172.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -70.22 162.36 28.57 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.496 1.118 . . . . 0.0 112.359 169.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -55.47 -35.19 65.23 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.108 1.363 . . . . 0.0 113.781 -169.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.9 mt -127.9 118.79 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.812 1.245 . . . . 0.0 108.15 169.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -132.57 128.01 36.29 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.121 0.968 . . . . 0.0 111.298 170.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -147.51 161.96 40.04 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.805 1.642 . . . . 0.0 111.075 -174.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -129.94 129.96 44.5 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.557 0.743 . . . . 0.0 111.672 169.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.417 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 46.3 m0 -90.06 1.93 55.79 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -177.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 71.44 -72.35 0.12 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.44 1.896 . . . . 0.0 113.256 175.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 20.5 mt 50.14 -157.97 0.09 Allowed 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 126.143 1.777 . . . . 0.0 114.221 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -144.06 156.66 44.46 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.828 2.451 . . . . 0.0 108.045 172.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -80.13 120.04 78.43 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-N 120.683 1.583 . . . . 0.0 111.887 176.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -91.31 -21.69 0.63 Allowed 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 122.249 1.966 . . . . 0.0 115.746 -169.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -53.44 110.16 0.53 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.507 1.123 . . . . 0.0 112.403 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.73 1.43 87.32 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.068 0.842 . . . . 0.0 114.749 176.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -75.05 170.07 16.75 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.584 1.192 . . . . 0.0 110.822 169.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.2 t -63.31 148.27 48.76 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.531 -0.73 . . . . 0.0 110.361 169.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 mp -61.43 -27.86 68.85 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.604 -0.685 . . . . 0.0 112.485 -173.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.85 -34.76 78.02 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.998 -1.064 . . . . 0.0 113.444 171.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.2 t -71.12 -35.72 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 O-C-N 120.975 -1.078 . . . . 0.0 109.885 172.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.402 ' CE2' ' HB ' ' A' ' 45' ' ' THR . 0.3 OUTLIER -67.7 -38.52 83.77 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.322 0.649 . . . . 0.0 111.125 177.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -70.25 -37.38 74.93 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.994 1.318 . . . . 0.0 111.739 170.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.6 m -57.51 -45.88 84.43 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 119.118 0.872 . . . . 0.0 111.66 175.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.0 m -69.33 -29.91 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 119.723 1.147 . . . . 0.0 112.609 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -62.44 -41.75 98.95 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 120.542 1.519 . . . . 0.0 111.77 170.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.07 -45.41 87.51 Favored Glycine 0 N--CA 1.474 1.195 0 C-N-CA 124.039 0.828 . . . . 0.0 112.745 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -60.56 -40.53 91.96 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 122.197 -0.59 . . . . 0.0 112.375 171.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.2 t -64.99 -46.76 90.58 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.103 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -52.03 -53.15 45.45 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 120.141 1.337 . . . . 0.0 111.593 176.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -49.81 -45.1 49.65 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.301 1.44 . . . . 0.0 112.111 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -92.16 -27.05 17.95 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.058 0.943 . . . . 0.0 112.179 -171.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.9 t -62.19 -49.8 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.042 1.337 . . . . 0.0 109.799 169.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -54.06 -53.73 49.09 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.005 0.82 . . . . 0.0 109.583 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -53.03 -37.93 61.95 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.141 1.776 . . . . 0.0 112.364 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -78.83 -59.87 2.6 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.157 -0.964 . . . . 0.0 112.781 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.18 -33.55 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.887 1.275 . . . . 0.0 112.498 -174.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.97 -18.79 61.96 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -78.42 -25.13 45.93 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.648 1.179 . . . . 0.0 113.52 174.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.1 pt -106.25 -8.18 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.498 1.519 . . . . 0.0 113.678 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 C--O 1.254 1.315 0 C-N-CA 125.493 1.517 . . . . 0.0 113.088 173.653 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.2 ttp . . . . . 0 N--CA 1.503 2.203 0 CA-C-O 119.754 -0.165 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -88.35 97.85 11.27 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.079 0.952 . . . . 0.0 110.69 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -81.24 133.73 35.49 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 121.633 -0.667 . . . . 0.0 110.811 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.5 m -100.15 146.51 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.088 0.955 . . . . 0.0 110.998 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.8 tpp -126.41 112.11 15.26 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.907 0.883 . . . . 0.0 110.876 172.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -81.54 138.07 35.48 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.967 -0.458 . . . . 0.0 110.656 169.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.2 t -137.38 129.79 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.316 1.047 . . . . 0.0 111.234 -171.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 t -145.69 -175.6 4.8 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 119.166 0.894 . . . . 0.0 113.345 169.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -60.03 -37.66 80.45 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 121.752 -0.593 . . . . 0.0 110.323 169.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.434 ' HB3' ' H ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -113.95 127.74 56.09 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.985 0.914 . . . . 0.0 110.695 168.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -66.97 -33.65 76.04 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.552 168.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.8 p -67.97 -47.51 68.41 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.136 1.774 . . . . 0.0 115.584 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.434 ' H ' ' HB3' ' A' ' 10' ' ' ARG . 56.3 p -85.42 -24.96 27.26 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -171.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.27 -60.89 1.59 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 176.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.8 m -60.19 -41.06 92.15 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.147 0.885 . . . . 0.0 112.947 -169.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -60.44 -40.05 89.71 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.847 1.659 . . . . 0.0 113.088 169.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.7 mtm -61.94 -46.06 90.95 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.852 -1.155 . . . . 0.0 111.023 174.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.89 -28.52 66.76 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 173.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -71.24 -46.04 61.93 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.227 1.376 . . . . 0.0 108.96 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.61 -44.07 97.03 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 118.602 -1.11 . . . . 0.0 112.408 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -63.15 -41.31 99.25 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.974 1.387 . . . . 0.0 111.971 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.94 -34.58 71.63 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 120.719 -1.238 . . . . 0.0 110.572 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -59.45 -57.92 10.86 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.112 1.765 . . . . 0.0 109.94 170.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.6 p -69.09 -14.64 63.13 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.1 mt -99.87 -6.38 26.88 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.5 10.77 0.52 Allowed Glycine 0 N--CA 1.476 1.357 0 N-CA-C 117.192 1.637 . . . . 0.0 117.192 -169.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.02 131.06 39.88 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.076 1.438 . . . . 0.0 112.142 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.97 -8.68 49.71 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.387 -1.229 . . . . 0.0 115.777 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -84.76 -57.08 3.26 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 120.03 1.915 . . . . 0.0 110.461 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -139.02 179.43 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 126.57 1.948 . . . . 0.0 110.597 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.76 127.39 47.2 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.341 -0.849 . . . . 0.0 112.091 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.5 m -90.99 145.26 7.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 123.989 0.916 . . . . 0.0 113.212 169.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.8 157.4 43.66 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.998 0.919 . . . . 0.0 110.88 -174.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.9 p -141.89 141.85 33.04 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.394 1.478 . . . . 0.0 112.757 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.1 t -143.46 178.15 7.96 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.414 1.486 . . . . 0.0 111.208 169.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.03 170.21 37.11 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 119.905 -1.747 . . . . 0.0 114.494 172.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.5 mt -60.53 -45.0 95.46 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.453 0.701 . . . . 0.0 111.851 -170.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -109.45 111.63 23.27 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 127.239 2.216 . . . . 0.0 106.251 169.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.4 p -66.72 -43.17 84.96 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.446 -1.409 . . . . 0.0 110.975 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 t 52.62 -170.69 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.711 2.004 . . . . 0.0 114.081 -176.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -88.63 174.37 8.09 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.587 1.955 . . . . 0.0 111.787 173.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 m -60.77 113.4 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 169.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -64.45 130.37 94.64 Favored Pre-proline 0 N--CA 1.477 0.902 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -168.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -59.98 -39.2 72.93 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.475 2.783 . . . . 0.0 114.028 -171.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 m -78.3 -37.28 45.13 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.117 0.567 . . . . 0.0 110.507 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.22 93.59 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.084 -0.96 . . . . 0.0 112.355 175.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.9 mt -52.07 -45.75 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 120.687 1.585 . . . . 0.0 110.083 173.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.2 -57.8 7.58 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.2 mmt -64.88 -23.07 67.12 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -174.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 87.7 mmm -89.97 -37.83 14.07 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.224 1.01 . . . . 0.0 110.851 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -58.75 -36.81 74.96 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 120.766 -1.209 . . . . 0.0 112.067 169.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -54.97 -30.57 59.44 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.353 1.061 . . . . 0.0 113.704 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.2 m -104.47 15.69 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 125.059 1.344 . . . . 0.0 114.113 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.86 15.43 63.16 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.131 0.872 . . . . 0.0 115.087 176.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.2 mt -124.56 74.2 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.832 1.653 . . . . 0.0 109.461 -169.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -66.39 108.06 2.24 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 119.938 -1.726 . . . . 0.0 110.498 172.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.8 pt -86.95 -0.47 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.0 p -67.71 -24.87 65.44 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.535 -1.353 . . . . 0.0 114.588 -169.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.61 6.0 64.86 Favored Glycine 0 CA--C 1.541 1.671 0 C-N-CA 125.389 1.471 . . . . 0.0 114.66 170.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -82.06 147.92 28.87 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.704 1.202 . . . . 0.0 112.029 -172.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.6 t -69.06 156.1 39.23 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 121.505 -0.747 . . . . 0.0 112.157 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.5 t -136.6 142.68 43.33 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.743 0.817 . . . . 0.0 111.243 170.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.31 140.6 21.08 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -171.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -89.96 156.48 4.91 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 124.123 3.215 . . . . 0.0 113.024 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.7 tp -61.52 -22.98 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -170.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -102.62 -5.34 23.97 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -87.87 -38.89 15.27 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.651 -0.656 . . . . 0.0 110.852 169.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.06 153.36 43.9 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.23 0.538 . . . . 0.0 111.436 171.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -136.98 120.63 17.26 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.529 1.132 . . . . 0.0 110.444 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.49 8.48 1.78 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -170.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -73.35 -29.87 62.95 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.47 -0.769 . . . . 0.0 112.305 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -93.39 -3.55 53.07 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.091 1.357 . . . . 0.0 113.642 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -125.06 89.36 3.04 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.869 1.668 . . . . 0.0 109.351 -172.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -59.7 -24.66 64.14 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -175.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.0 t -121.35 105.11 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.703 1.201 . . . . 0.0 110.106 -169.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.433 ' C ' HD12 ' A' ' 77' ' ' ILE . 37.8 t -116.05 130.49 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.584 1.154 . . . . 0.0 110.66 -174.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.433 HD12 ' C ' ' A' ' 76' ' ' VAL . 1.6 mp -119.38 124.97 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.714 0.806 . . . . 0.0 109.98 -174.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 t -85.7 124.68 32.49 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.419 1.088 . . . . 0.0 108.969 168.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.414 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 75.2 mt -111.54 37.68 2.83 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 126.673 1.989 . . . . 0.0 110.506 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 9.6 t . . . . . 0 CA--C 1.536 0.433 0 O-C-N 121.446 -0.783 . . . . 0.0 112.697 -175.924 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.5 mt . . . . . 0 CA--C 1.548 0.881 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.83 134.7 58.7 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.031 2.487 . . . . 0.0 111.798 176.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -61.62 -30.18 85.29 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.483 2.122 . . . . 0.0 113.557 -174.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -66.58 -30.89 71.29 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.544 -1.348 . . . . 0.0 113.183 173.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -78.61 -20.12 51.15 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.926 -1.108 . . . . 0.0 112.632 174.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.3 t -86.77 -38.65 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.801 1.64 . . . . 0.0 112.107 174.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.3 p -85.12 52.43 2.44 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 120.785 -1.197 . . . . 0.0 113.366 -172.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -110.65 171.51 7.42 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.339 1.856 . . . . 0.0 112.306 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -53.29 -42.48 66.66 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.401 1.08 . . . . 0.0 113.003 -169.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.3 mt -130.2 122.42 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.867 1.267 . . . . 0.0 108.756 169.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -122.36 132.45 54.39 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.706 0.802 . . . . 0.0 109.157 169.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.82 155.12 44.6 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.127 1.371 . . . . 0.0 111.156 -176.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -136.21 118.86 16.0 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.493 0.717 . . . . 0.0 111.92 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.414 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 31.8 m0 -97.94 3.06 49.66 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.725 1.21 . . . . 0.0 113.338 -175.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.329 1.2 pp0? 45.59 43.42 9.18 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.9 2.08 . . . . 0.0 115.905 171.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 83.9 mt -84.49 158.16 21.09 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.698 1.199 . . . . 0.0 113.917 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -79.85 164.07 23.88 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.331 1.852 . . . . 0.0 112.188 169.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -95.84 111.71 56.86 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 123.861 0.864 . . . . 0.0 108.975 169.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -85.44 -10.57 7.58 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.049 2.499 . . . . 0.0 116.067 -169.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -49.67 112.7 0.69 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.533 1.133 . . . . 0.0 112.816 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.6 -0.15 89.69 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 123.844 0.735 . . . . 0.0 114.836 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -75.79 170.68 15.75 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 118.295 1.047 . . . . 0.0 110.31 169.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.5 t -58.84 145.27 41.55 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.507 -0.746 . . . . 0.0 111.028 169.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.45 -28.32 68.22 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.15 0.58 . . . . 0.0 111.998 -176.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -65.82 -33.18 75.27 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 120.96 -1.087 . . . . 0.0 113.237 173.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.2 t -70.28 -36.47 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 O-C-N 121.037 -1.039 . . . . 0.0 109.823 171.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.87 -42.68 90.07 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.645 0.778 . . . . 0.0 110.736 176.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -67.12 -36.06 81.09 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.78 1.232 . . . . 0.0 112.367 171.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.5 m -59.53 -48.89 79.89 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 119.306 0.957 . . . . 0.0 111.427 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.3 m -68.21 -32.31 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 117.909 -1.043 . . . . 0.0 111.983 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.08 -43.4 91.8 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 120.825 1.648 . . . . 0.0 111.978 169.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.47 -41.89 89.91 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 124.388 0.994 . . . . 0.0 112.556 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -61.95 -46.14 90.59 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 122.214 -0.58 . . . . 0.0 111.897 169.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.42 -46.73 92.44 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.267 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -51.95 -54.92 23.92 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.654 1.182 . . . . 0.0 111.827 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -60.61 -41.42 94.74 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.351 0.661 . . . . 0.0 112.305 -176.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 50.7 mtp85 -79.2 -33.83 43.5 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.4 t -59.81 -47.58 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.182 0.993 . . . . 0.0 110.653 170.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -53.35 -55.3 26.0 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.11 0.868 . . . . 0.0 109.966 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -54.71 -40.63 69.4 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.881 1.273 . . . . 0.0 112.301 176.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.7 -58.81 3.07 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.183 -0.948 . . . . 0.0 112.52 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.36 -34.95 70.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.599 1.16 . . . . 0.0 111.624 -176.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.42 -15.95 61.33 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -173.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -71.17 -28.16 64.05 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.435 1.094 . . . . 0.0 113.42 170.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.7 pt -113.81 -6.95 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.189 1.796 . . . . 0.0 113.287 -173.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.7 m . . . . . 0 C--O 1.254 1.299 0 C-N-CA 125.735 1.614 . . . . 0.0 113.713 173.561 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.503 2.217 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -79.62 96.51 6.2 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.773 0.829 . . . . 0.0 110.079 171.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -77.12 144.96 38.09 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.759 -0.588 . . . . 0.0 111.191 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 p -122.43 141.72 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.524 1.13 . . . . 0.0 111.047 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 50.8 tpp -124.38 120.41 32.03 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.616 1.167 . . . . 0.0 111.774 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -88.89 130.06 35.49 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.313 0.645 . . . . 0.0 111.507 169.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.2 t -129.24 124.31 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.918 1.287 . . . . 0.0 110.188 -172.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.3 m -136.17 169.65 17.28 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.556 1.142 . . . . 0.0 111.467 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -64.92 -48.69 73.25 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 168.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -99.87 105.4 17.14 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.314 1.446 . . . . 0.0 108.366 168.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -53.58 -33.49 55.04 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 122.952 0.501 . . . . 0.0 110.884 169.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.9 p -65.37 -40.2 93.25 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.164 2.185 . . . . 0.0 115.793 176.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.4 p -97.09 -22.9 16.5 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.43 -51.14 1.75 Allowed 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 171.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.0 m -59.07 -44.57 91.89 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 121.284 1.857 . . . . 0.0 111.926 -175.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -58.23 -43.56 87.79 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.997 1.319 . . . . 0.0 113.474 169.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.415 ' HA ' ' CE ' ' A' ' 50' ' ' MET . 51.2 ttm -58.31 -50.81 72.31 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.325 1.05 . . . . 0.0 111.381 175.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.67 -27.22 66.66 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.254 1.022 . . . . 0.0 112.524 174.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -76.35 -43.55 40.51 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 120.424 1.466 . . . . 0.0 109.133 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.88 -52.99 47.65 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-O 119.152 -0.804 . . . . 0.0 111.248 174.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.513 ' HB3' HG11 ' A' ' 123' ' ' VAL . 17.3 m-85 -62.2 -41.61 98.53 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.286 1.043 . . . . 0.0 112.919 174.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.01 -40.83 97.23 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.211 1.369 . . . . 0.0 110.837 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -61.21 -50.06 74.65 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.326 1.85 . . . . 0.0 111.32 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.6 p -74.94 -22.73 58.42 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.1 mt -88.84 -23.26 22.85 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.264 0.938 . . . . 0.0 112.711 176.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -126.4 21.72 6.01 Favored Glycine 0 N--CA 1.473 1.124 0 C-N-CA 125.777 1.656 . . . . 0.0 115.431 -170.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.91 126.48 27.27 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.236 1.018 . . . . 0.0 112.531 -173.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.65 -2.6 47.22 Favored Glycine 0 CA--C 1.537 1.431 0 N-CA-C 116.024 1.17 . . . . 0.0 116.024 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -81.7 -54.77 5.11 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.587 1.694 . . . . 0.0 111.146 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.415 HD11 HD11 ' A' ' 127' ' ' ILE . 2.3 pp -143.04 -179.37 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 127.355 2.262 . . . . 0.0 110.989 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.23 121.49 42.34 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.482 0.658 . . . . 0.0 111.825 171.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.3 m -87.11 150.8 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 123.473 0.709 . . . . 0.0 111.981 169.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.68 159.77 43.05 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.265 1.026 . . . . 0.0 111.288 -174.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.5 t -144.7 127.7 16.49 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.144 1.378 . . . . 0.0 111.885 -169.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.0 p -144.09 -178.76 6.11 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.532 1.533 . . . . 0.0 111.299 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.06 172.11 35.47 Favored Glycine 0 CA--C 1.532 1.142 0 O-C-N 119.834 -1.791 . . . . 0.0 114.47 173.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 47.6 mt -61.68 -39.15 90.42 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 118.354 1.077 . . . . 0.0 112.176 -173.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -115.81 113.66 23.69 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.809 2.044 . . . . 0.0 107.843 169.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.3 p -65.88 -37.14 85.35 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.933 0.893 . . . . 0.0 112.046 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.4 t 44.09 -129.85 0.87 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 126.159 1.784 . . . . 0.0 112.786 -174.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -146.62 -175.77 4.92 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 127.139 2.176 . . . . 0.0 111.823 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.1 m -59.22 115.75 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 121.134 -0.979 . . . . 0.0 110.291 169.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.8 t-80 -73.85 131.7 81.33 Favored Pre-proline 0 N--CA 1.476 0.855 0 CA-C-O 118.501 -0.762 . . . . 0.0 113.035 -169.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -60.58 -39.74 62.2 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.488 2.792 . . . . 0.0 114.293 -171.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.1 m -80.95 -33.07 34.25 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.803 -0.56 . . . . 0.0 110.833 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.45 -42.46 87.55 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 118.087 -0.959 . . . . 0.0 112.166 174.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.0 mt -47.35 -48.22 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 119.997 1.271 . . . . 0.0 110.395 172.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.61 -61.54 2.14 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.8 mmt -66.31 -27.31 67.82 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.525 -0.735 . . . . 0.0 112.379 -171.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.415 ' CE ' ' HA ' ' A' ' 17' ' ' MET . 81.7 mtp -84.22 -38.18 20.88 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.595 0.758 . . . . 0.0 111.364 177.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -57.35 -38.05 73.54 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.715 1.143 . . . . 0.0 112.099 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -59.39 -23.39 62.55 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.0 m -108.28 15.07 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.39 16.54 58.7 Favored Glycine 0 N--CA 1.478 1.444 0 O-C-N 121.087 -1.008 . . . . 0.0 115.325 176.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.9 mt -125.43 53.31 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.892 1.677 . . . . 0.0 110.307 -169.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -60.4 113.2 2.28 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.26 -1.525 . . . . 0.0 111.435 176.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.8 pt -91.46 2.53 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.215 1.006 . . . . 0.0 113.648 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -62.19 -24.41 67.19 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 120.759 1.618 . . . . 0.0 113.262 -173.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.46 6.87 59.47 Favored Glycine 0 CA--C 1.543 1.84 0 C-N-CA 125.475 1.512 . . . . 0.0 115.77 170.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -83.24 152.21 25.29 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.089 1.445 . . . . 0.0 112.088 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.0 t -71.44 163.67 27.26 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 52.0 m -137.07 140.92 42.34 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.01 1.724 . . . . 0.0 109.49 169.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -145.96 141.89 17.17 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-N 119.548 1.067 . . . . 0.0 113.369 -175.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -86.45 148.27 8.78 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 123.221 2.614 . . . . 0.0 111.441 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.0 tt -66.48 -16.63 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 O-C-N 120.549 -1.344 . . . . 0.0 113.976 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -89.54 -10.52 45.86 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.112 -0.992 . . . . 0.0 113.485 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -88.5 -40.7 13.24 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.764 0.825 . . . . 0.0 111.453 170.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.71 153.03 43.19 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.816 0.847 . . . . 0.0 111.694 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.443 ' HA ' ' CH2' ' A' ' 90' ' ' TRP . 11.1 m120 -128.38 124.87 37.45 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.435 0.694 . . . . 0.0 110.329 169.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.405 ' HB3' ' CE3' ' A' ' 90' ' ' TRP . . . -70.29 5.71 1.62 Allowed 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -175.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -73.02 -29.02 62.7 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.983 0.913 . . . . 0.0 112.213 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -97.51 -3.79 39.17 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.81 1.244 . . . . 0.0 113.583 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -121.73 92.01 3.64 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.009 1.724 . . . . 0.0 109.353 -172.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -60.51 -28.17 68.18 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -174.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.5 t -113.67 116.74 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.383 1.073 . . . . 0.0 110.098 -177.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.1 t -126.4 132.51 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.909 0.884 . . . . 0.0 110.377 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.7 mm -123.07 127.78 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 121.771 -0.581 . . . . 0.0 111.466 -170.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.5 t -87.51 126.45 34.92 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.282 1.433 . . . . 0.0 109.964 169.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.5 mt -112.6 42.14 1.9 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.645 1.178 . . . . 0.0 113.015 -174.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 30.4 p . . . . . 0 CA--C 1.545 0.777 0 C-N-CA 127.126 2.17 . . . . 0.0 107.744 168.972 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.0 mt . . . . . 0 CA--C 1.546 0.801 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -71.37 151.32 59.71 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.328 2.019 . . . . 0.0 110.863 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -58.62 -34.78 99.11 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.837 2.358 . . . . 0.0 112.613 -175.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -48.83 -46.25 41.73 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.602 1.561 . . . . 0.0 112.919 175.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.443 ' CH2' ' HA ' ' A' ' 69' ' ' ASN . 1.8 m95 -90.57 8.42 34.21 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.052 1.341 . . . . 0.0 113.072 -177.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.5 t -116.0 -39.32 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 126.868 2.067 . . . . 0.0 111.697 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.6 p -79.9 28.11 0.29 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -174.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -85.22 172.19 11.36 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.826 1.65 . . . . 0.0 111.961 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -53.69 -42.37 67.89 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -169.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.6 mt -129.4 125.67 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.463 1.105 . . . . 0.0 109.069 169.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -131.99 136.26 47.15 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.264 1.026 . . . . 0.0 111.533 169.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -143.06 154.94 44.47 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.111 1.364 . . . . 0.0 111.741 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -122.64 118.95 29.37 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.14 1.376 . . . . 0.0 109.976 171.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -84.86 3.98 35.38 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 117.788 2.514 . . . . 0.0 117.788 -169.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 58.44 51.16 8.43 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.252 1.387 . . . . 0.0 113.048 176.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 66.2 mt -107.73 165.93 11.07 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.336 1.855 . . . . 0.0 113.269 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -122.32 153.73 38.56 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.387 1.875 . . . . 0.0 110.32 173.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -74.34 118.32 68.84 Favored Pre-proline 0 CA--C 1.546 0.816 0 O-C-N 121.296 -0.878 . . . . 0.0 111.342 176.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.413 ' HB2' ' CD2' ' A' ' 112' ' ' PHE . 27.6 Cg_endo -85.27 -6.6 9.19 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.32 2.013 . . . . 0.0 114.013 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -48.67 116.03 1.46 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.231 1.013 . . . . 0.0 112.77 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.04 3.68 69.71 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.791 0.71 . . . . 0.0 114.338 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -80.94 171.58 14.82 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.463 1.105 . . . . 0.0 110.115 171.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.3 p -63.9 156.49 27.5 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.339 -0.85 . . . . 0.0 112.082 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.05 -29.06 70.03 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.578 -0.701 . . . . 0.0 111.43 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.27 -40.96 92.22 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.175 -0.953 . . . . 0.0 112.641 172.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.3 t -73.1 -39.85 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.753 0.821 . . . . 0.0 109.691 176.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.413 ' CD2' ' HB2' ' A' ' 104' ' ' PRO . 0.6 OUTLIER -63.52 -36.87 85.21 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.051 0.54 . . . . 0.0 111.189 177.553 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -70.95 -43.21 68.63 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.339 1.456 . . . . 0.0 112.199 172.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.2 m -57.69 -51.05 71.11 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.177 0.991 . . . . 0.0 111.838 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.4 m -68.1 -29.23 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 O-C-N 121.271 -0.893 . . . . 0.0 112.051 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.6 ptt-85 -70.6 -32.9 70.43 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 119.778 1.172 . . . . 0.0 113.051 173.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.11 -45.12 94.64 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 123.88 0.752 . . . . 0.0 112.262 170.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -61.97 -42.18 98.85 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.926 -0.749 . . . . 0.0 112.348 171.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.422 ' O ' HG12 ' A' ' 123' ' ' VAL . 8.3 t -60.22 -50.12 81.49 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.724 0 CA-C-O 117.139 -1.41 . . . . 0.0 110.182 174.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -51.19 -48.91 61.84 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.469 1.508 . . . . 0.0 112.158 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -55.27 -43.7 74.94 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.701 1.2 . . . . 0.0 112.492 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.0 mtt180 -91.59 -32.89 15.34 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.975 0.91 . . . . 0.0 112.75 -169.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.513 HG11 ' HB3' ' A' ' 21' ' ' PHE . 9.4 p -69.6 -36.66 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.574 1.55 . . . . 0.0 112.012 171.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -56.67 -58.76 6.7 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.81 1.186 . . . . 0.0 109.915 169.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -55.34 -27.65 48.58 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.504 1.122 . . . . 0.0 113.299 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -85.07 -59.33 2.37 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.336 0.971 . . . . 0.0 112.904 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.415 HD11 HD11 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -58.92 -33.34 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.553 1.141 . . . . 0.0 111.727 -178.063 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.83 -14.13 60.65 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -82.48 -28.38 31.22 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.501 1.121 . . . . 0.0 113.065 172.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.3 pt -98.92 -12.02 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.612 1.165 . . . . 0.0 113.817 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.2 m . . . . . 0 C--O 1.255 1.356 0 C-N-CA 124.766 1.226 . . . . 0.0 113.245 171.672 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 ttm . . . . . 0 N--CA 1.503 2.182 0 CA-C-O 119.712 -0.185 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -91.95 85.82 5.67 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.19 0.996 . . . . 0.0 110.277 177.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -77.45 150.74 34.94 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.535 -0.728 . . . . 0.0 111.351 -175.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.2 t -108.38 143.27 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.583 0.753 . . . . 0.0 111.45 -175.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 43.7 tpp -128.08 110.39 12.44 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.912 0.885 . . . . 0.0 110.156 169.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -81.83 138.51 35.09 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.635 169.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.6 t -135.62 128.39 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.083 0.953 . . . . 0.0 111.587 -174.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.7 p -147.17 -178.23 6.1 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.798 1.239 . . . . 0.0 111.813 175.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -62.35 -64.34 0.96 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 119.847 1.203 . . . . 0.0 110.124 172.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.27 107.42 16.56 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 168.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 39' ' ' SER . 13.7 t-20 -56.67 -41.73 77.78 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.748 0.704 . . . . 0.0 109.556 169.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.2 p -53.22 -29.57 33.08 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 127.446 2.299 . . . . 0.0 115.849 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.1 p -97.97 -97.47 0.21 Allowed 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 123.571 0.748 . . . . 0.0 109.82 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -53.19 -50.7 64.11 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.391 1.476 . . . . 0.0 113.38 -169.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.533 ' HB3' ' HB2' ' A' ' 34' ' ' SER . 69.9 m -71.36 -40.2 70.78 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -174.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -64.25 -37.2 86.63 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 168.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 77.0 mtp -58.38 -51.36 70.14 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.108 0.867 . . . . 0.0 109.592 172.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.24 -36.18 82.82 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -66.38 -40.22 89.57 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 119.524 1.056 . . . . 0.0 108.882 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.497 ' N ' HE22 ' A' ' 60' ' ' GLN . . . -68.16 -45.05 73.65 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-O 118.961 -0.911 . . . . 0.0 111.989 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -62.28 -38.88 91.04 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.305 1.052 . . . . 0.0 111.458 170.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.401 ' HB1' HG11 ' A' ' 32' ' ' VAL . . . -70.24 -33.46 71.68 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 120.587 -1.32 . . . . 0.0 111.368 -178.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -62.8 -55.5 25.87 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.443 1.897 . . . . 0.0 109.369 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.8 p -71.46 -15.51 62.33 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.6 mt -97.4 -11.12 24.3 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 173.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.99 9.2 2.01 Favored Glycine 0 N--CA 1.477 1.376 0 N-CA-C 117.227 1.651 . . . . 0.0 117.227 -169.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.5 128.98 27.58 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.155 1.478 . . . . 0.0 112.342 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.12 -6.89 55.28 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-O 118.319 -1.267 . . . . 0.0 115.888 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -85.68 -57.16 3.16 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.02 1.91 . . . . 0.0 110.286 175.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 pp -139.71 173.4 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 127.433 2.293 . . . . 0.0 109.141 171.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.37 131.2 44.27 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.522 -0.736 . . . . 0.0 111.833 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.401 HG11 ' HB1' ' A' ' 22' ' ' ALA . 32.7 m -100.11 143.8 13.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 123.709 0.804 . . . . 0.0 112.805 170.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 m -145.98 162.59 37.48 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.615 1.566 . . . . 0.0 109.467 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.533 ' HB2' ' HB3' ' A' ' 15' ' ' SER . 91.0 p -143.91 148.69 35.76 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.061 0.944 . . . . 0.0 113.097 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.5 p -138.39 -170.38 2.8 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.025 1.33 . . . . 0.0 110.914 171.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.93 173.44 37.36 Favored Glycine 0 CA--C 1.528 0.891 0 O-C-N 121.078 -1.013 . . . . 0.0 113.85 175.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.8 mt -64.78 -35.92 82.64 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.409 0.684 . . . . 0.0 112.253 -172.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -123.24 105.69 10.09 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 128.449 2.699 . . . . 0.0 107.09 172.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.408 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 11.2 p -60.9 -46.9 88.82 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.437 -0.79 . . . . 0.0 111.633 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.1 t 49.72 -171.83 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 127.898 2.479 . . . . 0.0 114.415 -174.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -77.98 166.74 22.47 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.65 1.58 . . . . 0.0 110.214 169.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.1 m -56.99 120.13 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 119.949 1.25 . . . . 0.0 108.098 169.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -65.15 127.56 92.96 Favored Pre-proline 0 N--CA 1.479 0.998 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -167.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -61.73 -39.48 52.75 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.256 2.637 . . . . 0.0 113.845 -169.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.1 m -77.85 -35.66 50.81 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.937 -0.477 . . . . 0.0 110.318 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.17 -38.1 87.24 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 117.956 -1.021 . . . . 0.0 112.407 174.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.0 mt -55.31 -41.64 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 121.455 1.934 . . . . 0.0 110.501 173.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.73 -59.77 4.15 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.0 mmt -63.69 -27.29 69.11 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.483 -0.761 . . . . 0.0 112.66 -174.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 88.0 mmm -85.01 -33.12 22.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.773 0.829 . . . . 0.0 110.561 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -61.86 -33.61 74.49 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.888 -1.133 . . . . 0.0 111.817 171.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -55.06 -33.6 62.87 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.088 0.955 . . . . 0.0 112.763 172.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.4 m -105.49 19.11 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.259 1.424 . . . . 0.0 113.859 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.34 17.01 74.89 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 115.528 0.971 . . . . 0.0 115.528 173.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.404 ' CG2' ' HA3' ' A' ' 20' ' ' GLY . 71.6 mt -115.36 125.93 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.206 1.402 . . . . 0.0 111.417 -169.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -100.43 73.41 1.65 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.558 1.943 . . . . 0.0 112.727 -172.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.33 -10.23 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 120.373 -1.454 . . . . 0.0 111.672 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.1 p -60.95 -32.03 71.56 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.888 2.475 . . . . 0.0 113.833 169.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.45 47.55 1.02 Allowed Glycine 0 N--CA 1.474 1.224 0 C-N-CA 126.418 1.961 . . . . 0.0 112.168 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.497 HE22 ' N ' ' A' ' 20' ' ' GLY . 11.0 mt-30 -135.87 171.94 13.73 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.668 1.587 . . . . 0.0 113.287 -169.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -76.56 137.26 39.44 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 121.37 -0.832 . . . . 0.0 112.944 -169.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.7 m -125.59 45.58 2.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.189 1.396 . . . . 0.0 111.004 -170.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.83 140.22 54.4 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -169.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -83.11 151.1 13.9 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.186 2.591 . . . . 0.0 111.008 169.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.9 tt -63.33 -21.57 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 -171.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -99.24 -4.71 31.32 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -88.51 -41.55 12.66 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.044 0.838 . . . . 0.0 112.117 171.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.35 164.33 24.73 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.229 0.538 . . . . 0.0 112.077 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -136.48 120.18 17.26 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.046 0.938 . . . . 0.0 111.069 171.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.96 2.86 1.79 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 -172.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -70.27 -31.78 69.31 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.406 1.003 . . . . 0.0 112.179 -174.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -90.27 -8.87 49.87 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.56 1.144 . . . . 0.0 113.364 176.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -120.79 72.23 0.96 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.921 1.689 . . . . 0.0 109.378 -173.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -65.37 -6.47 10.23 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -170.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.2 t -120.87 96.64 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 125.938 1.695 . . . . 0.0 109.055 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.4 t -109.63 135.15 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 121.376 -0.828 . . . . 0.0 110.211 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.462 HG21 ' CE2' ' A' ' 99' ' ' TRP . 12.5 mm -128.6 136.13 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 123.27 0.628 . . . . 0.0 110.297 -176.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.4 t -97.26 130.17 44.49 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.545 1.538 . . . . 0.0 110.736 172.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.8 mp -115.51 49.03 1.12 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.148 1.379 . . . . 0.0 110.295 -171.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.1 p . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 117.27 2.322 . . . . 0.0 117.27 -170.447 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.2 mt . . . . . 0 CA--C 1.554 1.115 0 CA-C-O 119.267 -0.397 . . . . 0.0 111.792 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -58.12 145.97 90.09 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.178 2.585 . . . . 0.0 114.394 -177.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -75.41 41.25 0.76 Allowed 'Trans proline' 0 CA--C 1.551 1.357 1 C-N-CA 126.062 4.508 . . . . 0.0 113.924 -175.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -156.7 -35.56 0.08 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.931 2.492 . . . . 0.0 111.023 -176.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.18 -22.66 61.25 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.49 -1.381 . . . . 0.0 111.346 169.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 m -89.69 -10.22 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 175.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.4 p -98.02 4.32 49.31 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -170.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -69.44 164.68 22.51 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.87 0.868 . . . . 0.0 111.86 175.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -57.32 -36.56 71.27 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -169.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.9 mt -116.61 118.19 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.684 0.793 . . . . 0.0 109.073 169.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -134.08 127.33 31.95 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.35 1.06 . . . . 0.0 110.521 169.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -147.03 157.47 43.62 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.054 1.342 . . . . 0.0 111.376 -172.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -122.62 131.27 53.74 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.413 0.685 . . . . 0.0 110.853 168.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.462 ' CE2' HG21 ' A' ' 77' ' ' ILE . 47.8 m0 -87.37 1.16 54.15 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.404 1.482 . . . . 0.0 114.999 -178.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 62.45 27.37 16.27 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.789 1.235 . . . . 0.0 113.98 170.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 75.5 mt -80.15 152.62 29.14 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -170.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -86.1 157.88 19.94 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.822 1.249 . . . . 0.0 111.131 170.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.68 137.21 77.13 Favored Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 120.658 -1.276 . . . . 0.0 113.1 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -99.91 -30.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.156 2.571 . . . . 0.0 113.842 171.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.97 100.25 0.06 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.942 1.697 . . . . 0.0 112.663 -176.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.48 -0.6 53.3 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.033 1.302 . . . . 0.0 114.689 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -87.68 171.76 10.2 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.06 1.344 . . . . 0.0 111.999 172.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.1 t -62.09 149.71 40.47 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.264 0.626 . . . . 0.0 111.753 171.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 mp -60.62 -28.83 68.83 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.943 0.897 . . . . 0.0 112.514 -174.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -67.56 -34.34 76.86 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.847 -1.158 . . . . 0.0 113.17 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.5 t -70.35 -37.04 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 O-C-N 121.209 -0.932 . . . . 0.0 109.524 171.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.35 -42.38 99.35 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.5 1.12 . . . . 0.0 111.384 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -71.73 -38.61 70.43 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.973 1.309 . . . . 0.0 112.291 173.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.0 m -55.38 -48.77 73.8 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.646 0.779 . . . . 0.0 111.263 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.3 m -73.11 -29.01 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 117.671 -1.157 . . . . 0.0 112.547 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . 0.252 0.0 OUTLIER -63.03 -36.8 84.78 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 121.21 1.823 . . . . 0.0 112.227 169.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.76 -45.75 91.79 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 124.556 1.074 . . . . 0.0 112.894 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -60.01 -42.46 94.36 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 117.767 0.783 . . . . 0.0 112.473 171.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.8 t -63.7 -47.44 91.08 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 C-N-CA 124.643 1.177 . . . . 0.0 110.155 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -49.6 -53.37 24.3 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 120.417 1.462 . . . . 0.0 111.648 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -58.48 -40.18 82.02 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.463 1.105 . . . . 0.0 112.602 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.6 mtt85 -82.55 -31.07 29.28 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.16 0.984 . . . . 0.0 112.931 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.78 -48.52 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.104 1.362 . . . . 0.0 109.947 169.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -54.35 -54.99 33.03 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.397 0.999 . . . . 0.0 109.497 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -50.63 -36.92 37.68 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.392 1.477 . . . . 0.0 112.67 176.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -81.06 -60.73 2.18 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.091 0.956 . . . . 0.0 112.976 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.17 -35.03 70.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.94 1.296 . . . . 0.0 111.856 -175.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.97 -20.73 61.69 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.112 -0.993 . . . . 0.0 113.443 -172.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -74.38 -20.46 60.06 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.822 1.249 . . . . 0.0 113.52 173.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.9 pt -118.07 1.48 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.086 1.754 . . . . 0.0 113.162 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 C--O 1.252 1.228 0 C-N-CA 125.932 1.693 . . . . 0.0 113.501 173.197 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.505 2.315 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -79.54 102.4 8.82 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.894 0.77 . . . . 0.0 109.557 169.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -77.25 144.13 38.43 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.677 0.791 . . . . 0.0 111.541 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 91.1 t -113.54 143.5 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.253 1.421 . . . . 0.0 110.107 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 45.1 ttm -130.72 130.76 44.22 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.18 0.592 . . . . 0.0 111.617 168.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -98.07 136.49 38.25 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.175 0.99 . . . . 0.0 110.612 169.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.1 t -129.73 126.03 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.974 1.31 . . . . 0.0 110.898 -169.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.3 m -143.34 176.6 9.03 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.217 1.007 . . . . 0.0 111.547 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -67.38 -65.21 0.71 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 169.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.13 113.15 19.79 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 168.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.461 HD21 ' HA ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -70.37 -22.35 62.78 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 120.271 1.396 . . . . 0.0 110.294 169.464 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.4 p -57.63 -53.27 60.02 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 127.551 2.34 . . . . 0.0 116.17 173.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.4 p -93.19 -14.67 26.84 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.885 1.274 . . . . 0.0 113.376 -171.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -124.47 -68.88 0.83 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.406 1.082 . . . . 0.0 113.2 -176.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.1 m -57.24 -43.28 82.8 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 120.05 1.296 . . . . 0.0 113.044 -176.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -55.95 -34.77 65.98 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.757 1.623 . . . . 0.0 113.4 173.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 59.2 mtp -64.18 -48.27 76.61 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 119.399 1.0 . . . . 0.0 111.57 174.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.07 -23.48 63.08 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 118.656 -0.688 . . . . 0.0 112.551 173.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -73.23 -49.16 29.39 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 120.024 1.284 . . . . 0.0 108.598 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.06 -52.2 53.78 Favored Glycine 0 C--O 1.222 -0.628 0 CA-C-O 118.429 -1.206 . . . . 0.0 111.049 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.544 ' HB3' HG11 ' A' ' 123' ' ' VAL . 13.4 m-85 -62.36 -43.47 98.74 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.748 1.274 . . . . 0.0 112.948 176.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.13 -37.0 83.09 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.676 1.58 . . . . 0.0 111.165 -177.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -59.59 -62.48 1.84 Allowed 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 125.125 1.37 . . . . 0.0 109.925 169.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.9 p -67.71 -14.28 62.81 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -175.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.5 mt -92.59 -10.7 36.58 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 172.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.24 19.08 0.1 Allowed Glycine 0 CA--C 1.539 1.573 0 N-CA-C 118.715 2.246 . . . . 0.0 118.715 -172.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.83 -33.76 62.04 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.856 1.828 . . . . 0.0 114.803 -172.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.45 -8.95 87.05 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 124.069 0.842 . . . . 0.0 114.998 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -98.76 -55.33 2.76 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 118.625 1.212 . . . . 0.0 112.312 -171.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.5 pp -141.45 171.11 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 126.619 1.968 . . . . 0.0 111.053 -174.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.22 125.49 44.83 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 175.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.1 m -94.64 155.63 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.535 1.534 . . . . 0.0 112.896 169.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.34 123.0 11.82 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.1 t -89.18 123.5 33.49 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 120.74 -1.225 . . . . 0.0 113.074 173.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.5 t -148.72 169.61 20.02 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.764 0.711 . . . . 0.0 112.39 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.36 179.27 48.89 Favored Glycine 0 CA--C 1.521 0.457 0 O-C-N 120.577 -1.327 . . . . 0.0 114.27 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.2 mt -65.39 -30.42 71.24 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 122.86 0.464 . . . . 0.0 111.413 176.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -117.22 122.61 44.48 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.651 1.981 . . . . 0.0 108.958 169.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.8 p -78.24 44.69 0.51 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.998 1.719 . . . . 0.0 111.987 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 p -64.9 158.56 24.93 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.771 1.628 . . . . 0.0 114.149 -169.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -64.2 174.16 1.7 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -169.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 m -65.98 109.08 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 120.295 -1.503 . . . . 0.0 107.552 168.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.7 t-80 -65.37 132.68 95.23 Favored Pre-proline 0 N--CA 1.476 0.874 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -169.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -59.55 -40.53 65.14 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.158 2.572 . . . . 0.0 113.334 -172.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.4 m -78.17 -30.62 49.18 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.053 -0.404 . . . . 0.0 110.911 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.5 -44.43 78.47 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.79 -1.194 . . . . 0.0 112.552 172.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.5 mt -52.85 -40.37 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 120.177 1.353 . . . . 0.0 110.463 173.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.58 -65.5 0.67 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 174.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.3 mmt -65.92 -24.92 66.93 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -170.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 85.3 mtp -84.91 -30.72 24.15 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 122.938 0.495 . . . . 0.0 111.484 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -61.14 -31.42 71.14 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.556 -1.34 . . . . 0.0 111.629 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -57.07 -31.95 65.74 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 121.085 -1.009 . . . . 0.0 112.819 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.28 7.61 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.413 1.485 . . . . 0.0 113.396 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.94 19.87 52.06 Favored Glycine 0 N--CA 1.479 1.501 0 O-C-N 120.286 -1.509 . . . . 0.0 115.038 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 25.1 mt -123.43 66.0 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.68 1.592 . . . . 0.0 110.313 -169.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -64.12 112.82 3.17 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 120.605 -1.309 . . . . 0.0 110.962 173.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.0 pt -90.34 -1.11 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 175.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.4 p -64.86 124.46 22.04 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 120.564 1.529 . . . . 0.0 110.36 -174.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.85 1.38 87.16 Favored Glycine 0 CA--C 1.546 2.023 0 N-CA-C 116.191 1.236 . . . . 0.0 116.191 -169.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -74.03 145.93 44.13 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.742 1.771 . . . . 0.0 111.916 177.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.9 t -61.21 145.35 51.52 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -175.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.461 ' HA ' HD21 ' A' ' 11' ' ' ASN . 2.0 m -137.42 117.64 13.55 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.623 1.569 . . . . 0.0 109.941 174.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -114.08 150.91 44.36 Favored Pre-proline 0 CA--C 1.557 1.214 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -169.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -91.84 126.51 0.92 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.618 2.879 . . . . 0.0 111.603 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.5 tt -77.11 -4.98 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -172.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -86.41 -13.1 47.27 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 120.654 -1.279 . . . . 0.0 113.149 170.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -91.86 -37.4 12.94 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.948 0.899 . . . . 0.0 112.569 174.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.08 169.38 15.12 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.37 1.068 . . . . 0.0 112.763 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.01 126.4 28.46 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.309 1.444 . . . . 0.0 109.785 169.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.48 3.34 3.93 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -175.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -66.44 -29.01 69.05 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.894 0.878 . . . . 0.0 112.887 -170.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -94.75 2.04 55.5 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.556 1.542 . . . . 0.0 113.671 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -122.91 93.13 3.87 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.353 1.461 . . . . 0.0 111.089 -169.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -61.58 -23.74 66.19 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.3 t -124.83 120.84 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.449 1.099 . . . . 0.0 110.697 -174.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.6 t -131.74 133.05 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.031 0.932 . . . . 0.0 109.956 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.0 mm -121.67 122.06 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 123.836 0.854 . . . . 0.0 110.716 -171.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.3 t -85.97 113.56 22.17 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 168.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.5 mt -83.77 45.11 1.04 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.238 1.015 . . . . 0.0 110.623 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.9 t . . . . . 0 CA--C 1.539 0.533 0 C-N-CA 128.536 2.734 . . . . 0.0 109.42 -178.912 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 CA--C 1.55 0.965 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -59.18 145.7 96.89 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.326 2.684 . . . . 0.0 113.913 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.11 44.04 1.11 Allowed 'Trans proline' 0 CA--C 1.548 1.213 1 C-N-CA 125.951 4.434 . . . . 0.0 113.324 -178.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -156.81 -36.66 0.08 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.601 2.36 . . . . 0.0 111.252 -174.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -75.93 -24.26 55.51 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.643 -1.285 . . . . 0.0 111.518 170.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.1 m -89.43 -11.29 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.395 1.478 . . . . 0.0 114.781 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.8 p -95.85 5.96 50.03 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -172.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -70.93 166.19 21.75 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.335 1.054 . . . . 0.0 112.285 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -52.08 -37.4 53.81 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -169.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 63.2 mt -125.15 122.3 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.656 1.182 . . . . 0.0 109.337 169.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -131.21 136.2 48.05 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.539 1.135 . . . . 0.0 111.091 169.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -140.25 146.86 39.17 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.175 0.99 . . . . 0.0 113.357 -173.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -103.18 95.72 6.3 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.189 2.196 . . . . 0.0 111.636 170.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 20.6 m0 -85.13 92.79 8.48 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 169.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.18 77.58 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 127.661 2.384 . . . . 0.0 113.688 169.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.5 mt -116.82 159.88 21.68 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.97 2.108 . . . . 0.0 112.067 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -95.53 148.92 21.99 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.256 1.422 . . . . 0.0 111.484 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -80.99 110.73 18.85 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.056 0.942 . . . . 0.0 109.908 169.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.415 ' HB2' ' CD2' ' A' ' 112' ' ' PHE . 15.1 Cg_endo -87.03 -5.03 7.84 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.519 2.146 . . . . 0.0 113.739 -169.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -48.26 105.59 0.08 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.66 1.584 . . . . 0.0 113.36 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.43 1.3 90.04 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 123.815 0.722 . . . . 0.0 114.758 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -77.79 168.79 19.38 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.17 0.985 . . . . 0.0 110.562 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 23.2 t -62.37 149.83 41.31 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.638 -0.664 . . . . 0.0 111.45 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 mp -60.04 -28.46 67.78 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.733 0.813 . . . . 0.0 111.787 -172.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -64.89 -35.8 82.3 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 173.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.6 t -66.32 -31.95 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.545 0.738 . . . . 0.0 109.452 170.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.415 ' CD2' ' HB2' ' A' ' 104' ' ' PRO . 0.4 OUTLIER -77.16 -39.54 48.68 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.732 0.813 . . . . 0.0 110.739 -177.16 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -68.42 -36.73 79.5 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.939 1.296 . . . . 0.0 112.457 170.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 50.6 m -59.86 -49.12 78.95 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.705 1.202 . . . . 0.0 111.259 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.6 m -67.02 -30.28 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 118.055 -0.974 . . . . 0.0 111.952 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.07 -47.83 84.23 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 120.189 1.359 . . . . 0.0 110.849 169.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.07 -41.57 99.78 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.552 1.072 . . . . 0.0 113.181 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -63.97 -48.76 75.19 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 122.148 -0.619 . . . . 0.0 112.223 171.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.422 ' O ' HG12 ' A' ' 123' ' ' VAL . 21.7 t -53.98 -51.86 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 116.939 -1.505 . . . . 0.0 111.086 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -46.14 -47.5 17.49 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 120.33 1.423 . . . . 0.0 113.286 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -66.07 -47.99 72.49 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.815 0.846 . . . . 0.0 112.029 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.8 mtp180 -71.09 -40.49 71.5 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.522 0.729 . . . . 0.0 112.642 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.544 HG11 ' HB3' ' A' ' 21' ' ' PHE . 8.0 p -72.23 -36.26 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.538 1.535 . . . . 0.0 112.021 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -58.51 -55.34 36.28 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.777 1.172 . . . . 0.0 109.406 169.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -55.16 -36.59 66.0 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.217 1.007 . . . . 0.0 112.03 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.42 -59.48 2.74 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.473 -0.767 . . . . 0.0 112.651 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.25 -34.53 67.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.968 0.907 . . . . 0.0 112.139 -175.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.48 -6.67 52.77 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -174.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -82.41 -20.41 37.13 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.664 1.186 . . . . 0.0 113.319 169.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.7 pt -119.18 -7.69 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.293 1.437 . . . . 0.0 113.837 -173.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.3 p . . . . . 0 C--O 1.254 1.298 0 C-N-CA 125.442 1.497 . . . . 0.0 113.249 170.783 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 tpp . . . . . 0 N--CA 1.5 2.059 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -76.72 105.84 8.03 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 119.621 1.1 . . . . 0.0 110.544 169.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -79.91 136.22 36.61 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 173.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.1 t -97.96 147.0 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.273 1.029 . . . . 0.0 109.95 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 42.6 tpp -130.26 112.29 13.2 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.869 0.868 . . . . 0.0 111.296 169.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -83.68 120.88 26.53 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.301 0.64 . . . . 0.0 111.04 169.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.7 t -118.84 135.52 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.492 1.517 . . . . 0.0 109.672 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.7 p -151.9 178.0 9.86 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 121.419 -0.8 . . . . 0.0 112.537 177.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -63.57 -42.96 98.29 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 121.512 -0.743 . . . . 0.0 111.067 169.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.484 ' HB3' ' H ' ' A' ' 13' ' ' SER . 1.1 mpt_? -117.69 103.6 10.18 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.953 1.301 . . . . 0.0 110.835 172.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -55.66 -33.62 64.25 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.287 -0.883 . . . . 0.0 110.223 169.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.4 p -57.01 -53.6 56.28 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.238 2.215 . . . . 0.0 115.303 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.484 ' H ' ' HB3' ' A' ' 10' ' ' ARG . 89.0 p -103.22 -1.67 28.52 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.09 1.356 . . . . 0.0 114.133 -176.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -126.68 -76.25 0.58 Allowed 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.076 -1.64 . . . . 0.0 111.283 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.424 ' HB3' ' HB2' ' A' ' 34' ' ' SER . 4.9 m -59.59 -39.04 82.82 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -172.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -56.13 -30.63 62.4 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.467 1.507 . . . . 0.0 114.499 171.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 93.2 mtp -69.73 -45.12 68.89 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.308 0.958 . . . . 0.0 110.358 174.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.35 -27.79 66.57 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 171.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -68.0 -49.01 64.15 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.99 1.268 . . . . 0.0 108.25 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.63 -52.3 51.86 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-O 118.814 -0.992 . . . . 0.0 111.854 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.491 ' HB3' HG11 ' A' ' 123' ' ' VAL . 12.7 m-85 -61.35 -42.64 99.02 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.507 1.153 . . . . 0.0 112.848 175.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.59 -37.17 85.88 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 120.082 -1.636 . . . . 0.0 111.104 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -62.51 -48.63 78.7 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.021 1.329 . . . . 0.0 111.489 174.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.5 p -80.27 -14.19 58.6 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 51.0 mt -97.83 -10.79 24.13 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.08 0.952 . . . . 0.0 113.393 174.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.66 25.3 1.34 Allowed Glycine 0 CA--C 1.534 1.22 0 N-CA-C 115.851 1.1 . . . . 0.0 115.851 -169.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.89 122.78 11.56 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.602 1.201 . . . . 0.0 112.792 -175.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.29 -2.47 36.69 Favored Glycine 0 CA--C 1.538 1.497 0 N-CA-C 116.138 1.215 . . . . 0.0 116.138 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -78.64 -46.58 18.88 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.429 1.615 . . . . 0.0 111.314 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -141.98 -177.78 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 128.265 2.626 . . . . 0.0 109.375 169.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.61 120.59 40.27 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.075 -1.016 . . . . 0.0 112.449 171.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.96 144.15 9.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 122.87 0.468 . . . . 0.0 111.796 169.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.47 163.64 35.05 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.943 1.297 . . . . 0.0 110.371 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.424 ' HB2' ' HB3' ' A' ' 15' ' ' SER . 88.2 p -148.68 150.19 32.78 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.467 1.107 . . . . 0.0 113.723 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 82.5 p -143.22 -175.36 4.5 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.39 1.876 . . . . 0.0 110.433 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.23 177.25 40.91 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-N 120.047 1.294 . . . . 0.0 115.23 172.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 35.6 mt -73.65 -43.78 58.59 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 118.515 1.157 . . . . 0.0 113.493 -169.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -130.42 70.65 1.45 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.387 2.275 . . . . 0.0 107.826 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.1 m -72.44 -20.33 61.42 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -169.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.2 m 37.54 -93.44 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 128.17 2.588 . . . . 0.0 117.316 172.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.1 ptp85 -154.73 -177.99 6.89 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 126.387 1.875 . . . . 0.0 112.228 -169.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.6 m -65.8 118.4 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.04 -1.038 . . . . 0.0 110.558 169.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -74.46 133.28 77.51 Favored Pre-proline 0 N--CA 1.478 0.968 0 O-C-N 121.058 -1.026 . . . . 0.0 113.0 -169.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -59.78 -40.9 59.66 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.543 2.829 . . . . 0.0 114.137 -171.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.1 m -78.29 -38.28 42.87 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 122.061 -0.399 . . . . 0.0 110.48 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.27 -40.35 97.14 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 118.123 -0.942 . . . . 0.0 112.467 176.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 66.7 mt -49.88 -47.69 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 120.197 1.362 . . . . 0.0 110.413 172.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.84 -58.79 4.8 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.5 mmt -66.25 -26.56 67.41 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.413 -0.805 . . . . 0.0 112.741 -173.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 72.2 mmm -84.2 -38.9 20.0 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.713 0.805 . . . . 0.0 110.563 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -59.59 -37.46 78.59 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.718 -1.239 . . . . 0.0 112.097 170.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -56.62 -22.32 33.24 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.538 1.135 . . . . 0.0 113.634 173.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.1 m -113.18 17.83 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 125.044 1.338 . . . . 0.0 114.576 175.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.2 13.63 61.62 Favored Glycine 0 N--CA 1.477 1.39 0 N-CA-C 115.597 0.999 . . . . 0.0 115.597 176.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 29.6 mt -126.67 62.78 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.62 1.568 . . . . 0.0 109.85 -169.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -60.67 110.69 1.37 Allowed 'General case' 0 CA--C 1.548 0.899 0 O-C-N 120.031 -1.668 . . . . 0.0 110.45 172.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.8 pt -89.58 4.2 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.7 p -67.36 -18.53 65.18 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.851 1.659 . . . . 0.0 114.648 -172.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -102.22 8.57 55.55 Favored Glycine 0 CA--C 1.542 1.728 0 C-N-CA 125.413 1.483 . . . . 0.0 114.634 169.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -79.57 143.04 35.14 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.379 1.472 . . . . 0.0 111.927 -171.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 10.8 t -66.05 153.68 41.59 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 121.53 -0.731 . . . . 0.0 112.734 172.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.4 p -147.06 133.7 19.9 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.316 1.446 . . . . 0.0 109.926 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -141.34 135.0 14.67 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.282 0.633 . . . . 0.0 112.049 -169.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -71.61 154.88 59.74 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.384 2.723 . . . . 0.0 112.903 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.1 tt -62.78 -18.96 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.022 1.329 . . . . 0.0 114.566 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -95.55 -9.11 33.25 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -80.39 -43.74 20.55 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.055 0.843 . . . . 0.0 109.236 169.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.31 159.71 32.96 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.889 1.276 . . . . 0.0 112.3 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -142.47 134.91 27.86 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.486 1.114 . . . . 0.0 110.36 169.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.2 9.33 4.65 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 -172.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.35 -28.8 63.26 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.11 -0.993 . . . . 0.0 112.318 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -97.49 -3.65 39.51 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.065 1.346 . . . . 0.0 113.662 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -123.71 90.62 3.31 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.456 1.502 . . . . 0.0 110.039 -172.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -66.91 -12.34 59.14 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.5 t -123.99 116.49 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 126.005 1.722 . . . . 0.0 109.731 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.5 t -131.57 134.76 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.762 0.825 . . . . 0.0 111.016 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.509 HG21 ' CE2' ' A' ' 99' ' ' TRP . 10.5 mm -126.59 137.0 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.319 0.648 . . . . 0.0 111.333 -172.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.2 t -95.49 117.93 31.28 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.431 1.493 . . . . 0.0 108.989 169.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 mp -99.93 61.38 1.11 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.768 1.627 . . . . 0.0 107.816 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.8 t . . . . . 0 CA--C 1.542 0.665 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 -169.506 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.9 mt . . . . . 0 CA--C 1.553 1.069 0 CA-C-O 119.267 -0.397 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -55.34 143.71 75.27 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.06 2.507 . . . . 0.0 113.174 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -75.62 41.36 0.79 Allowed 'Trans proline' 0 CA--C 1.549 1.256 1 C-N-CA 125.46 4.106 . . . . 0.0 113.624 -173.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -156.07 -30.84 0.09 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.995 2.518 . . . . 0.0 111.075 -175.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -82.21 14.82 2.68 Favored 'General case' 0 CA--C 1.553 1.073 0 O-C-N 120.918 -1.113 . . . . 0.0 113.415 169.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.5 m -131.48 -3.96 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 126.399 1.88 . . . . 0.0 113.387 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.6 p -95.68 -6.06 40.83 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.602 1.561 . . . . 0.0 113.667 -171.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -65.04 154.12 38.73 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.802 2.041 . . . . 0.0 111.932 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -53.74 -35.73 61.55 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.372 1.469 . . . . 0.0 114.304 -169.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 54.1 mt -119.02 107.38 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 169.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -121.44 131.69 54.3 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.29 1.036 . . . . 0.0 110.074 169.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -133.46 147.42 51.68 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.566 1.146 . . . . 0.0 111.647 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -115.42 95.41 5.15 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.444 1.116 . . . . 0.0 110.814 172.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.509 ' CE2' HG21 ' A' ' 77' ' ' ILE . 30.3 m0 -74.25 93.99 2.43 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 169.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.8 73.83 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.286 2.635 . . . . 0.0 113.403 169.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 71.1 mt -113.83 147.72 37.89 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.574 2.35 . . . . 0.0 111.616 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -84.47 158.88 20.88 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.369 1.068 . . . . 0.0 111.945 175.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -88.12 110.21 34.03 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 126.262 1.825 . . . . 0.0 111.765 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -84.95 -13.7 6.52 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 123.139 2.56 . . . . 0.0 116.21 -169.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -50.92 107.34 0.17 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.807 1.243 . . . . 0.0 112.527 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.18 11.54 85.45 Favored Glycine 0 CA--C 1.538 1.504 0 CA-C-O 118.837 -0.98 . . . . 0.0 115.487 177.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -74.42 -71.68 0.33 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.33 1.565 . . . . 0.0 110.625 176.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.5 t -173.89 150.1 1.61 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.891 2.476 . . . . 0.0 108.285 174.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.7 mp -60.4 -32.5 71.39 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.62 0.645 . . . . 0.0 111.799 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -70.59 -33.64 71.29 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.936 -1.103 . . . . 0.0 112.923 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 83.3 t -68.85 -37.38 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.398 -0.814 . . . . 0.0 109.527 170.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -45.09 92.06 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.58 1.152 . . . . 0.0 110.888 176.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -65.95 -23.88 66.69 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.868 1.667 . . . . 0.0 113.993 172.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.9 m -78.75 -51.74 9.36 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.672 1.589 . . . . 0.0 111.098 177.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.0 m -66.34 -26.52 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 121.104 -0.997 . . . . 0.0 111.628 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.78 -44.18 94.03 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.429 1.892 . . . . 0.0 111.203 169.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.84 -41.57 88.12 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 124.106 0.86 . . . . 0.0 112.771 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -60.87 -48.32 82.36 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 122.185 -0.597 . . . . 0.0 111.757 172.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.424 ' O ' HG12 ' A' ' 123' ' ' VAL . 38.2 t -57.65 -47.58 85.23 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-O 117.249 -1.358 . . . . 0.0 110.232 176.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -52.29 -48.61 65.24 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 120.423 1.465 . . . . 0.0 112.327 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -63.51 -48.01 79.36 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.935 0.494 . . . . 0.0 112.19 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -70.74 -36.79 73.31 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.491 HG11 ' HB3' ' A' ' 21' ' ' PHE . 6.0 p -74.54 -36.37 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.682 1.193 . . . . 0.0 111.831 177.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -56.53 -54.82 41.44 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.649 1.113 . . . . 0.0 108.334 168.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -59.81 -17.02 32.78 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -92.23 -60.46 1.84 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.381 1.446 . . . . 0.0 112.37 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -57.76 -33.79 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.17 0.988 . . . . 0.0 111.283 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.12 -6.97 53.65 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -176.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -74.37 -23.12 58.96 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.319 1.047 . . . . 0.0 112.165 169.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.5 pt -130.42 -0.87 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 125.717 1.607 . . . . 0.0 114.983 -168.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 60.9 p . . . . . 0 C--O 1.255 1.362 0 C-N-CA 125.052 1.341 . . . . 0.0 113.509 170.424 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttm . . . . . 0 N--CA 1.503 2.213 0 CA-C-O 119.429 -0.319 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -95.59 97.27 9.62 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.467 1.107 . . . . 0.0 110.519 174.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -86.61 149.26 25.05 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.594 -0.691 . . . . 0.0 112.693 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.3 t -117.97 143.39 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.652 1.181 . . . . 0.0 111.777 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 42.9 tpp -131.9 125.35 31.49 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.419 1.087 . . . . 0.0 110.865 169.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -94.59 142.35 27.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.221 0.608 . . . . 0.0 109.985 169.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.6 t -135.42 119.79 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.11 1.364 . . . . 0.0 111.093 -174.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 p -135.37 178.06 7.33 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.294 1.438 . . . . 0.0 111.823 175.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -58.53 -57.37 13.27 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 120.751 -1.218 . . . . 0.0 110.581 174.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -101.45 120.07 39.73 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 168.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -54.14 -50.54 66.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 120.41 1.459 . . . . 0.0 110.876 175.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.1 p -64.99 -16.61 63.6 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -174.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.5 p -77.48 -37.81 50.51 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.7 ptt-85 -152.19 -32.47 0.14 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 117.279 2.326 . . . . 0.0 117.279 -174.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.407 ' HA ' HD12 ' A' ' 79' ' ' LEU . 58.4 m -68.13 -38.11 81.85 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 121.503 1.956 . . . . 0.0 113.388 171.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -67.22 -31.81 72.43 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.187 0.995 . . . . 0.0 111.724 168.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.464 ' HA ' ' CE ' ' A' ' 50' ' ' MET . 45.6 ttm -62.27 -52.44 63.7 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.328 1.051 . . . . 0.0 111.532 173.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.43 -27.6 69.4 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 124.485 1.114 . . . . 0.0 112.327 172.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -73.0 -47.83 41.74 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.928 1.694 . . . . 0.0 109.465 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.89 -54.76 31.51 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-O 118.797 -1.002 . . . . 0.0 111.344 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.486 ' HB3' HG11 ' A' ' 123' ' ' VAL . 9.6 m-85 -57.58 -41.58 81.41 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.955 0.878 . . . . 0.0 112.379 174.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.73 ' HB1' HG11 ' A' ' 32' ' ' VAL . . . -65.68 -39.87 91.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.86 1.209 . . . . 0.0 112.187 -179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -71.31 -44.15 65.69 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.951 1.25 . . . . 0.0 112.325 173.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.6 p -65.93 -5.96 10.95 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 120.735 1.607 . . . . 0.0 114.632 173.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.8 mt -110.01 -5.43 15.43 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.847 1.259 . . . . 0.0 114.083 171.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.68 17.49 0.28 Allowed Glycine 0 N--CA 1.478 1.442 0 N-CA-C 116.841 1.496 . . . . 0.0 116.841 -170.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.11 135.22 56.99 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.923 1.362 . . . . 0.0 112.176 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.6 -6.33 46.72 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-O 118.62 -1.1 . . . . 0.0 115.588 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -85.52 -60.54 2.0 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.608 1.704 . . . . 0.0 110.672 175.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -141.37 172.53 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 127.359 2.264 . . . . 0.0 110.44 177.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.8 130.77 44.72 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.898 0.856 . . . . 0.0 112.831 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.73 HG11 ' HB1' ' A' ' 22' ' ' ALA . 15.9 m -105.34 151.76 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 124.744 1.218 . . . . 0.0 112.024 169.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.83 144.03 30.0 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.262 0.625 . . . . 0.0 111.369 -171.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.3 p -112.87 136.39 52.56 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.61 1.564 . . . . 0.0 113.46 176.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.0 t -152.61 177.26 10.85 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.866 1.266 . . . . 0.0 111.88 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.92 -175.72 47.05 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 120.671 -1.268 . . . . 0.0 114.294 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.2 mt -72.09 -33.57 67.98 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -175.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -134.44 73.32 1.49 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.535 2.334 . . . . 0.0 108.565 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.5 m -65.74 -22.7 66.62 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -172.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.9 t 43.96 -106.59 0.1 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.665 1.986 . . . . 0.0 114.607 169.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -149.34 171.55 16.35 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 127.002 2.121 . . . . 0.0 111.169 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.7 m -53.74 120.16 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.608 1.163 . . . . 0.0 110.758 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -82.52 136.03 45.98 Favored Pre-proline 0 N--CA 1.478 0.931 0 CA-C-O 118.053 -0.975 . . . . 0.0 112.237 -169.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -57.99 -44.65 38.01 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.455 2.77 . . . . 0.0 113.913 -173.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.9 m -76.98 -28.43 55.12 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.674 -0.641 . . . . 0.0 110.812 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.89 -47.09 66.71 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.223 -0.923 . . . . 0.0 111.973 169.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 57.6 mt -51.68 -48.3 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 120.27 1.396 . . . . 0.0 109.66 171.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.07 -65.13 0.65 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 177.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.44 -27.2 66.85 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -174.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.464 ' CE ' ' HA ' ' A' ' 17' ' ' MET . 87.4 mtp -80.62 -29.59 36.81 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.438 1.017 . . . . 0.0 111.669 178.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -63.93 -28.05 69.56 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.897 -1.127 . . . . 0.0 112.875 169.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -57.65 -34.71 69.64 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 119.307 0.958 . . . . 0.0 112.27 174.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.2 8.24 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.62 1.568 . . . . 0.0 113.232 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.14 23.7 43.7 Favored Glycine 0 N--CA 1.477 1.403 0 O-C-N 120.58 -1.325 . . . . 0.0 115.074 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.6 mt -123.83 60.66 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.678 1.591 . . . . 0.0 110.54 -169.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -62.34 109.82 1.46 Allowed 'General case' 0 CA--C 1.546 0.823 0 O-C-N 120.469 -1.394 . . . . 0.0 111.833 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 pt -85.87 -5.27 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 117.735 -1.126 . . . . 0.0 113.479 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.3 t -60.07 -28.54 67.89 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 120.917 1.69 . . . . 0.0 113.267 -170.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -101.34 8.52 57.08 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 125.405 1.479 . . . . 0.0 115.799 171.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -95.6 150.55 20.22 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.601 1.56 . . . . 0.0 112.034 -171.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.0 t -68.47 159.39 31.8 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -172.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.8 t -150.08 135.08 17.82 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.831 1.653 . . . . 0.0 109.625 169.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -144.02 138.78 15.31 Favored Pre-proline 0 N--CA 1.475 0.784 0 C-N-CA 123.659 0.784 . . . . 0.0 111.046 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -77.85 152.59 28.8 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.459 2.773 . . . . 0.0 113.382 -174.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.4 tt -59.21 -23.89 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -173.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -96.58 -8.2 32.42 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -94.27 -36.1 12.14 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.487 0.715 . . . . 0.0 111.439 170.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.28 161.26 30.7 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.146 0.498 . . . . 0.0 111.165 170.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.86 127.86 25.73 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.522 0.729 . . . . 0.0 111.431 169.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.23 2.61 4.46 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -173.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.8 -30.64 69.26 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.005 -1.059 . . . . 0.0 112.602 -170.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -89.37 -1.45 58.06 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.779 1.231 . . . . 0.0 113.422 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -120.66 97.06 5.38 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.224 1.41 . . . . 0.0 111.361 -169.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -55.35 -31.52 61.8 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.044 1.337 . . . . 0.0 112.85 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.6 120.23 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 124.544 1.138 . . . . 0.0 110.633 -172.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.6 t -124.92 132.83 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.14 0.976 . . . . 0.0 109.813 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.4 mm -123.51 123.51 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 123.581 0.752 . . . . 0.0 110.678 -172.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.4 t -82.55 123.55 29.31 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.968 0.907 . . . . 0.0 109.862 169.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 15' ' ' SER . 30.4 mt -114.34 34.55 4.65 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.853 1.661 . . . . 0.0 110.775 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 30.4 p . . . . . 0 CA--C 1.541 0.604 0 C-N-CA 124.536 1.134 . . . . 0.0 113.194 -178.877 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.3 mt . . . . . 0 CA--C 1.552 1.023 0 CA-C-O 119.245 -0.407 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -58.99 145.07 98.83 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.031 2.488 . . . . 0.0 113.848 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.02 41.9 0.79 Allowed 'Trans proline' 0 CA--C 1.55 1.293 1 C-N-CA 125.979 4.453 . . . . 0.0 113.483 -177.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -156.75 -35.74 0.08 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.921 2.489 . . . . 0.0 111.084 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.06 -26.07 61.15 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.247 -1.533 . . . . 0.0 111.698 169.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.2 m -85.8 -11.25 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 79.6 p -98.36 5.57 48.08 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -172.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -69.6 164.79 22.54 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.367 1.067 . . . . 0.0 112.505 177.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -50.2 -39.98 45.8 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.752 1.221 . . . . 0.0 114.25 -169.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.8 mt -124.03 120.01 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.383 1.073 . . . . 0.0 109.011 169.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -129.35 125.39 36.55 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.126 0.97 . . . . 0.0 110.206 169.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -139.56 158.75 43.6 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.957 1.303 . . . . 0.0 111.647 -174.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -128.21 126.18 40.45 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.49 1.116 . . . . 0.0 112.121 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -100.48 7.04 44.4 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -174.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 62.06 22.73 13.31 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 169.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 68.3 mt -78.62 142.37 37.3 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -169.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -78.03 159.03 28.99 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.059 1.744 . . . . 0.0 111.866 173.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -85.31 113.29 49.72 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 124.214 1.006 . . . . 0.0 111.247 173.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -87.06 -17.26 3.11 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.203 2.602 . . . . 0.0 114.88 -170.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -61.6 120.33 10.37 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.888 -1.132 . . . . 0.0 111.366 178.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.57 -4.77 85.13 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 123.994 0.807 . . . . 0.0 113.967 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -80.89 171.19 15.32 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 118.083 0.941 . . . . 0.0 109.577 169.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 39.4 m -62.96 151.03 40.75 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.169 -0.957 . . . . 0.0 111.419 170.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.25 -29.22 68.64 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.241 -0.912 . . . . 0.0 112.439 -175.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -62.31 -33.56 74.9 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.988 0.915 . . . . 0.0 113.317 172.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 50.3 t -72.87 -35.27 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 121.048 -1.032 . . . . 0.0 110.219 172.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -66.43 -38.26 87.02 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.003 0.521 . . . . 0.0 111.093 175.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -68.69 -39.68 80.43 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.554 1.142 . . . . 0.0 112.249 169.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 42.8 m -58.48 -47.76 83.0 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.397 1.079 . . . . 0.0 111.951 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.0 m -66.39 -30.69 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 119.382 0.992 . . . . 0.0 111.816 176.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -41.06 95.26 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 120.111 1.323 . . . . 0.0 112.633 170.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.88 -44.73 97.0 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.174 0.892 . . . . 0.0 112.591 174.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -61.81 -47.3 85.75 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 122.171 -0.605 . . . . 0.0 111.931 172.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.4 t -57.06 -48.01 82.62 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.517 0 CA-C-O 117.495 -1.24 . . . . 0.0 110.442 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -53.55 -50.69 64.98 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 120.115 1.325 . . . . 0.0 112.221 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -59.25 -44.51 92.39 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.044 0.538 . . . . 0.0 112.397 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.8 mtp85 -79.57 -35.99 38.9 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -176.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.486 HG11 ' HB3' ' A' ' 21' ' ' PHE . 4.4 p -74.01 -33.89 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.212 1.405 . . . . 0.0 112.417 178.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -55.47 -55.33 33.03 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.162 0.892 . . . . 0.0 108.855 169.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.94 -32.11 52.62 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.586 1.554 . . . . 0.0 112.894 176.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -79.02 -56.57 4.29 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.949 0.795 . . . . 0.0 112.256 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -65.45 -35.35 75.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.553 0.741 . . . . 0.0 112.038 -177.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.18 -8.59 55.56 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -174.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -84.65 -15.46 45.32 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.145 1.378 . . . . 0.0 113.538 171.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 21.2 pt -127.34 -8.38 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.544 1.538 . . . . 0.0 113.923 -173.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.7 p . . . . . 0 C--O 1.255 1.371 0 C-N-CA 125.227 1.411 . . . . 0.0 113.358 169.866 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.8 ttm . . . . . 0 N--CA 1.503 2.198 0 CA-C-O 119.479 -0.296 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -84.93 91.29 8.01 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.064 0.946 . . . . 0.0 111.261 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -77.75 145.85 36.24 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 121.605 -0.684 . . . . 0.0 112.376 -173.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.0 t -110.09 143.48 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.707 1.203 . . . . 0.0 110.397 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.4 tpp -128.91 118.37 22.55 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.852 0.861 . . . . 0.0 111.024 170.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -89.16 135.55 33.5 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.943 0.497 . . . . 0.0 111.124 169.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.9 129.11 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.755 1.222 . . . . 0.0 110.467 -171.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 t -144.3 -177.09 5.29 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.281 0.632 . . . . 0.0 112.449 172.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -64.44 -47.51 78.81 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 121.468 -0.77 . . . . 0.0 110.152 169.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.66 116.75 32.49 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.903 1.281 . . . . 0.0 109.312 169.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.69 -37.04 85.37 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 168.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.8 p -56.41 -29.47 61.58 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 128.034 2.534 . . . . 0.0 115.067 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.2 p -102.33 -101.92 0.28 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.43 1.092 . . . . 0.0 111.98 176.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.14 -44.4 71.35 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 120.227 1.376 . . . . 0.0 113.947 -168.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 m -63.16 -51.63 65.65 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.169 0.895 . . . . 0.0 112.067 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -64.6 -33.76 76.67 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 96.4 mtp -60.08 -50.35 74.04 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.725 0.693 . . . . 0.0 110.478 171.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.86 -31.16 70.78 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.28 -45.73 72.29 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 120.119 1.327 . . . . 0.0 108.642 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.446 ' CA ' HE22 ' A' ' 60' ' ' GLN . . . -67.35 -39.67 91.73 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 118.631 -1.094 . . . . 0.0 112.7 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -65.02 -39.85 93.99 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.109 1.454 . . . . 0.0 111.783 170.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.72 -33.26 70.67 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.503 -1.373 . . . . 0.0 111.385 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -59.89 -56.95 15.43 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.32 1.848 . . . . 0.0 109.61 170.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.6 p -70.16 -15.69 62.98 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.0 mt -99.24 -1.95 37.86 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 173.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.32 4.34 0.59 Allowed Glycine 0 CA--C 1.536 1.387 0 N-CA-C 117.226 1.651 . . . . 0.0 117.226 -169.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.44 133.92 56.2 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.9 1.85 . . . . 0.0 111.869 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.87 -2.36 74.83 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 124.676 1.131 . . . . 0.0 115.386 -174.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -94.35 -76.48 0.48 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.881 1.341 . . . . 0.0 110.111 175.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -128.39 176.18 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 126.608 1.963 . . . . 0.0 111.349 173.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.1 125.56 40.71 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.3 -0.875 . . . . 0.0 112.129 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.8 m -92.93 147.97 5.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 123.787 0.835 . . . . 0.0 111.664 169.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.49 159.27 43.62 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.747 0.819 . . . . 0.0 110.591 -172.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.63 133.21 34.07 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.111 1.364 . . . . 0.0 113.153 -171.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.3 p -144.7 176.17 9.63 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.305 1.442 . . . . 0.0 111.465 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.85 175.85 43.59 Favored Glycine 0 CA--C 1.526 0.774 0 O-C-N 120.396 -1.44 . . . . 0.0 114.552 169.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.4 mt -63.69 -37.79 88.66 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.112 0.565 . . . . 0.0 111.263 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -121.39 113.35 19.75 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.964 2.105 . . . . 0.0 107.829 169.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.6 p -66.74 -35.3 79.78 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.799 0.84 . . . . 0.0 112.085 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.7 t 46.59 -127.29 1.5 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 126.324 1.849 . . . . 0.0 112.293 -177.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -141.41 -176.58 4.78 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 127.511 2.324 . . . . 0.0 111.26 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.8 m -66.42 113.51 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 120.162 -1.587 . . . . 0.0 108.886 169.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -68.56 133.61 90.8 Favored Pre-proline 0 N--CA 1.477 0.917 0 O-C-N 121.48 -0.762 . . . . 0.0 112.304 -169.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.39 -38.27 85.16 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.26 2.64 . . . . 0.0 113.543 -172.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.407 ' HB ' ' CE2' ' A' ' 112' ' ' PHE . 8.7 m -79.45 -35.39 40.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.996 0.519 . . . . 0.0 110.667 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.13 -42.25 99.46 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.268 0.94 . . . . 0.0 112.133 174.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.7 mt -52.88 -44.79 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 120.287 1.403 . . . . 0.0 110.436 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.72 -60.67 2.65 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 33.5 mmt -68.03 -19.57 64.92 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.767 0.827 . . . . 0.0 113.192 -172.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 84.1 mmm -89.47 -38.04 14.34 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.896 0.878 . . . . 0.0 110.553 173.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -59.39 -35.32 73.71 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.538 -1.351 . . . . 0.0 112.399 170.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -55.19 -31.76 61.67 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.123 0.969 . . . . 0.0 113.492 171.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.9 m -103.15 20.77 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.888 1.275 . . . . 0.0 113.978 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.56 12.13 78.62 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.329 0.966 . . . . 0.0 115.255 174.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.3 mt -120.38 78.25 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.21 1.804 . . . . 0.0 108.934 -170.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -69.06 106.88 2.94 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.044 -1.66 . . . . 0.0 110.276 171.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.7 pt -84.75 -0.89 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 121.578 -0.701 . . . . 0.0 112.832 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.9 t -64.23 -28.76 69.96 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 120.157 1.344 . . . . 0.0 112.827 -172.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.32 4.22 73.43 Favored Glycine 0 CA--C 1.541 1.7 0 C-N-CA 125.102 1.334 . . . . 0.0 115.368 172.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.446 HE22 ' CA ' ' A' ' 20' ' ' GLY . 9.8 mt-30 -92.31 160.07 15.3 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.268 1.427 . . . . 0.0 112.634 -176.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.0 t -95.59 156.91 16.13 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -170.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.8 m -137.15 140.72 42.02 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.925 1.69 . . . . 0.0 108.21 169.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -141.49 134.4 14.22 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.636 1.174 . . . . 0.0 111.393 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.15 145.91 50.4 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.305 2.003 . . . . 0.0 110.297 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.5 tt -56.07 -30.72 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -169.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -94.44 -9.18 36.39 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -82.4 -41.22 20.21 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.003 0.82 . . . . 0.0 109.958 169.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.75 159.17 34.23 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.244 0.545 . . . . 0.0 110.777 170.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -139.75 135.77 33.44 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.589 -0.694 . . . . 0.0 111.223 169.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.3 -0.73 8.61 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -169.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -68.02 -33.51 74.73 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.759 1.163 . . . . 0.0 113.006 -171.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -84.68 -3.03 58.34 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.224 1.01 . . . . 0.0 113.598 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -120.97 92.62 3.8 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.417 1.487 . . . . 0.0 110.163 -170.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -54.29 -27.47 35.52 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.115 1.366 . . . . 0.0 113.201 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.1 118.44 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 125.209 1.404 . . . . 0.0 110.126 -174.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.2 t -127.01 132.52 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.634 0.774 . . . . 0.0 110.268 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.3 mm -124.94 122.45 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 123.715 0.806 . . . . 0.0 111.61 -169.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.2 t -81.58 130.75 35.17 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.803 0.841 . . . . 0.0 109.962 169.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.0 mt -121.19 32.72 5.82 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.161 1.784 . . . . 0.0 111.282 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.3 p . . . . . 0 CA--C 1.54 0.588 0 C-N-CA 124.575 1.15 . . . . 0.0 112.779 -176.28 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 CA--C 1.553 1.069 0 CA-C-O 118.987 -0.53 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -58.68 162.94 11.78 Favored 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 123.528 2.819 . . . . 0.0 113.728 174.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.05 -51.73 2.05 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.563 2.175 . . . . 0.0 113.663 -172.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -62.12 -35.42 78.69 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 120.653 -1.279 . . . . 0.0 112.28 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -64.89 5.64 0.31 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 127.298 2.239 . . . . 0.0 114.926 169.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.0 t -131.08 -43.01 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 127.26 2.224 . . . . 0.0 111.116 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.4 p -80.57 29.48 0.31 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -170.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -77.15 167.59 21.51 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.057 -1.027 . . . . 0.0 112.002 170.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -56.74 -36.12 69.38 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -169.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.7 mt -125.95 123.86 64.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.741 1.216 . . . . 0.0 108.88 169.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -131.76 138.56 48.65 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.758 0.823 . . . . 0.0 111.089 169.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -138.94 151.87 47.25 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.897 1.279 . . . . 0.0 110.517 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -122.41 114.3 20.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.482 0.713 . . . . 0.0 110.536 169.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 32.8 m0 -89.4 -2.36 58.38 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.205 1.002 . . . . 0.0 113.053 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.305 1.5 pp0? 47.35 37.64 6.26 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 171.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 81.7 mt -74.09 148.99 41.35 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.286 1.034 . . . . 0.0 112.686 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -75.0 153.46 38.5 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.537 1.135 . . . . 0.0 111.666 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -79.65 122.36 83.54 Favored Pre-proline 0 CA--C 1.542 0.673 0 O-C-N 121.126 -0.984 . . . . 0.0 111.858 173.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -93.86 -21.5 0.33 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.091 1.861 . . . . 0.0 113.847 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.6 104.59 0.07 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.891 2.076 . . . . 0.0 112.636 -176.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.5 8.6 87.11 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.517 1.056 . . . . 0.0 114.96 175.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -84.27 -64.78 1.1 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.711 1.256 . . . . 0.0 111.343 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.7 t -169.3 152.37 4.91 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.174 1.789 . . . . 0.0 109.592 171.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.92 -30.89 68.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.322 0.649 . . . . 0.0 111.041 172.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -62.81 -39.94 95.83 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.173 -0.955 . . . . 0.0 112.565 174.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 79.0 t -71.1 -39.6 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.41 -0.806 . . . . 0.0 109.083 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.407 ' CE2' ' HB ' ' A' ' 45' ' ' THR . 0.2 OUTLIER -59.32 -49.88 76.11 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.398 1.079 . . . . 0.0 112.097 176.719 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -69.45 -34.46 74.43 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.667 -0.646 . . . . 0.0 111.979 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 65.2 m -59.06 -52.59 65.11 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.286 0.634 . . . . 0.0 111.199 172.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.1 m -73.5 -27.55 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 117.74 -1.124 . . . . 0.0 112.664 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.7 ptt180 -61.27 -38.71 87.74 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 121.227 1.83 . . . . 0.0 111.88 170.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.94 -43.08 96.48 Favored Glycine 0 N--CA 1.473 1.156 0 C-N-CA 123.847 0.737 . . . . 0.0 112.739 176.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -61.19 -46.75 89.19 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.406 0.682 . . . . 0.0 111.929 170.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 25.5 t -60.45 -45.05 97.42 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.302 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -52.86 -54.5 33.51 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.093 1.315 . . . . 0.0 111.69 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -62.6 -43.47 98.74 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.067 0.547 . . . . 0.0 112.36 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.9 mtt-85 -74.8 -31.85 61.84 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 39.6 t -64.37 -47.98 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.489 169.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -53.92 -55.18 29.31 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.3 0.955 . . . . 0.0 109.239 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -49.34 -38.95 29.79 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.81 1.644 . . . . 0.0 112.242 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -81.19 -62.08 1.76 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.5 -30.32 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.545 1.138 . . . . 0.0 111.588 -175.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -78.11 -2.86 39.49 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -79.2 -20.51 48.18 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.339 1.056 . . . . 0.0 112.568 169.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.3 pt -126.89 13.38 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 126.303 1.841 . . . . 0.0 113.408 -169.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 47.1 p . . . . . 0 C--O 1.256 1.425 0 C-N-CA 125.748 1.619 . . . . 0.0 113.966 172.561 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.6 ttm . . . . . 0 N--CA 1.501 2.111 0 CA-C-O 119.596 -0.24 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -88.19 92.05 9.01 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.887 0.875 . . . . 0.0 109.958 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -79.85 151.2 30.36 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.49 -0.756 . . . . 0.0 111.607 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.6 p -118.84 142.09 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.045 0.938 . . . . 0.0 112.209 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.459 ' HE1' ' HB ' ' A' ' 33' ' ' THR . 62.0 tpp -122.33 132.66 54.5 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.372 1.069 . . . . 0.0 110.881 171.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -105.09 138.8 40.73 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.78 0.718 . . . . 0.0 110.894 169.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.8 t -131.31 138.84 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.537 1.135 . . . . 0.0 112.272 -169.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 54.7 p -155.72 -169.81 3.22 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.282 1.033 . . . . 0.0 110.147 169.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -68.0 -40.74 82.98 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 120.354 -1.466 . . . . 0.0 110.102 168.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 51.7 mtp85 -124.0 101.76 7.4 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.925 1.69 . . . . 0.0 111.341 -176.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.549 ' H ' ' HA ' ' A' ' 39' ' ' SER . 19.7 t30 -52.53 -54.25 35.27 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 169.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.4 p -30.83 -57.25 0.22 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.018 2.127 . . . . 0.0 115.551 175.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.1 p -88.98 -41.95 12.07 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.27 1.028 . . . . 0.0 113.085 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -103.0 -73.87 0.65 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.047 1.339 . . . . 0.0 112.998 -174.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.11 -37.22 84.28 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -169.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.526 ' NE2' HD21 ' A' ' 11' ' ' ASN . 1.6 tp60 -50.65 -37.89 43.33 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.734 2.014 . . . . 0.0 113.17 170.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 60.2 ttm -66.3 -46.14 77.96 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.09 -1.006 . . . . 0.0 111.183 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.51 -21.94 65.47 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 118.524 -0.751 . . . . 0.0 111.957 170.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -73.34 -53.1 11.6 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 120.402 1.455 . . . . 0.0 108.461 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.99 -50.23 62.67 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.24 0.924 . . . . 0.0 112.424 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.594 ' HB3' HG11 ' A' ' 123' ' ' VAL . 5.8 m-85 -66.55 -41.39 88.75 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.808 1.304 . . . . 0.0 113.078 176.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.38 -36.19 83.35 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.541 1.519 . . . . 0.0 110.091 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -64.3 -55.98 17.61 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.444 1.498 . . . . 0.0 109.916 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.7 p -70.59 -13.42 62.09 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 120.467 -1.395 . . . . 0.0 114.435 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.6 mt -96.82 -7.0 34.71 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.72 9.35 0.09 OUTLIER Glycine 0 N--CA 1.477 1.416 0 N-CA-C 119.028 2.371 . . . . 0.0 119.028 -172.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.53 -29.09 64.06 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.006 1.903 . . . . 0.0 114.464 -174.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.73 -9.33 86.92 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-O 119.247 -0.752 . . . . 0.0 114.891 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -101.75 -60.17 1.58 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.811 1.245 . . . . 0.0 111.968 -172.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.47 174.38 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 127.048 2.139 . . . . 0.0 110.483 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.26 129.23 42.46 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 121.384 -0.823 . . . . 0.0 110.926 176.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 m -101.68 148.42 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.014 0.926 . . . . 0.0 110.436 170.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.459 ' HB ' ' HE1' ' A' ' 5' ' ' MET . 3.3 m -146.94 157.35 43.61 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.011 0.924 . . . . 0.0 110.367 173.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -135.45 152.03 50.98 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 170.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 88.8 p -152.32 179.24 8.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.285 1.834 . . . . 0.0 111.886 -170.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.13 -178.78 48.51 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 115.639 1.015 . . . . 0.0 115.639 169.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.9 mt -64.81 -52.08 58.7 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.849 0.86 . . . . 0.0 112.069 -174.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -91.12 -38.14 12.95 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.561 1.544 . . . . 0.0 110.86 170.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.549 ' HA ' ' H ' ' A' ' 11' ' ' ASN . 0.6 OUTLIER 62.69 -46.46 0.19 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 127.727 2.411 . . . . 0.0 115.996 -177.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . 0.256 38.2 t 63.5 -123.86 0.56 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 127.247 2.219 . . . . 0.0 113.391 174.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -143.91 -178.23 5.82 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 126.447 1.899 . . . . 0.0 113.71 -171.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.5 m -64.79 111.18 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 120.853 -1.154 . . . . 0.0 109.793 169.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -77.97 137.69 61.54 Favored Pre-proline 0 N--CA 1.476 0.83 0 O-C-N 121.092 -1.005 . . . . 0.0 112.988 -169.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -57.59 -43.43 50.77 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.538 2.825 . . . . 0.0 113.768 -175.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.9 m -75.75 -31.6 59.62 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.763 -0.586 . . . . 0.0 110.795 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.46 -43.11 81.88 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.172 -0.955 . . . . 0.0 112.408 171.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.9 mt -55.47 -40.58 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 121.268 1.849 . . . . 0.0 109.913 175.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.17 -62.53 1.56 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 173.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.95 -11.96 61.27 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -174.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 96.3 mmm -91.86 -42.49 10.04 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.177 0.899 . . . . 0.0 110.325 171.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -60.73 -37.52 82.03 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.673 -1.267 . . . . 0.0 112.518 174.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -60.66 -25.66 66.51 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.25 7.8 p -105.19 15.67 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 125.525 1.53 . . . . 0.0 113.399 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.13 18.58 49.61 Favored Glycine 0 N--CA 1.477 1.37 0 O-C-N 120.796 -1.19 . . . . 0.0 115.555 173.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.7 mt -125.78 90.65 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.974 1.31 . . . . 0.0 110.853 -169.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -70.58 114.61 8.85 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.863 -1.148 . . . . 0.0 110.657 171.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.3 pt -101.37 0.29 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 123.73 0.812 . . . . 0.0 112.756 172.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.1 p -69.51 -17.63 63.61 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -169.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -101.89 8.98 56.48 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 125.344 1.45 . . . . 0.0 114.548 169.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -87.49 156.15 19.67 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.348 1.459 . . . . 0.0 112.295 -169.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.8 t -86.89 165.4 15.95 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -175.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.5 m -135.31 93.66 3.01 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.495 1.518 . . . . 0.0 109.103 169.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -88.97 133.37 35.61 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-O 118.469 -0.777 . . . . 0.0 111.806 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.09 153.94 22.14 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.655 2.237 . . . . 0.0 112.922 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.9 tp -55.96 -32.46 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -169.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -89.22 -13.83 37.33 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 120.786 -1.196 . . . . 0.0 113.267 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -90.1 -26.28 20.31 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.102 0.961 . . . . 0.0 112.832 175.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -52.81 46.72 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -169.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.1 m120 59.47 106.0 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.547 2.739 . . . . 0.0 114.561 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.05 13.85 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.97 1.708 . . . . 0.0 115.474 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -73.87 -29.28 62.01 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.069 0.948 . . . . 0.0 111.138 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -100.15 -5.67 27.42 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -124.89 94.46 4.19 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.27 1.428 . . . . 0.0 110.152 -172.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -73.12 -5.08 36.75 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -174.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.3 t -128.39 121.85 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 125.601 1.561 . . . . 0.0 109.451 173.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.2 t -132.31 119.35 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.052 0.541 . . . . 0.0 110.852 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 mp -110.24 134.35 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.001 0.92 . . . . 0.0 110.564 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.0 m -89.79 147.73 23.63 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.301 1.041 . . . . 0.0 108.253 168.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.9 mt -127.13 43.59 3.09 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.395 1.078 . . . . 0.0 110.728 -173.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 24.3 p . . . . . 0 N--CA 1.473 0.724 0 N-CA-C 117.59 2.441 . . . . 0.0 117.59 -169.172 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.7 mt . . . . . 0 CA--C 1.55 0.96 0 CA-C-O 119.447 -0.311 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.91 141.01 93.43 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.641 2.227 . . . . 0.0 111.522 172.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -63.07 -29.73 75.18 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.477 2.118 . . . . 0.0 112.666 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -62.79 -25.71 68.37 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 173.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -87.14 4.08 43.74 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 170.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.8 t -112.51 -36.63 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.949 1.7 . . . . 0.0 112.544 -175.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.9 p -79.28 10.09 4.01 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 -169.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -66.16 166.54 11.65 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.342 1.457 . . . . 0.0 112.056 169.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -56.78 -37.94 71.8 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -169.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 74.3 mt -127.07 119.8 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.52 1.128 . . . . 0.0 109.674 174.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -133.2 128.23 35.51 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.825 1.25 . . . . 0.0 110.57 169.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -146.81 161.19 41.18 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.809 1.644 . . . . 0.0 110.759 -174.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -127.47 117.02 21.32 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.384 -0.822 . . . . 0.0 112.93 173.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -88.36 94.17 9.76 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 169.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.405 ' H ' ' HG3' ' A' ' 100' ' ' GLN . 2.0 pp0? -51.79 59.82 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 128.823 2.849 . . . . 0.0 116.167 169.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 93.2 mt -84.24 153.35 23.65 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.735 2.414 . . . . 0.0 111.842 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -70.91 162.53 29.14 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.853 0.861 . . . . 0.0 111.408 169.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -88.28 107.79 18.44 Favored Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 120.76 -1.212 . . . . 0.0 108.136 169.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -79.05 -11.96 14.7 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 121.346 1.364 . . . . 0.0 114.643 -169.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -46.2 105.34 0.06 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.745 2.018 . . . . 0.0 113.792 -173.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.04 10.85 53.25 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.331 0.967 . . . . 0.0 115.507 174.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -74.87 -59.21 2.84 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.024 1.412 . . . . 0.0 111.141 -175.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.1 t -172.08 152.44 2.89 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.061 2.145 . . . . 0.0 108.542 170.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.4 mp -60.05 -30.95 69.53 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.75 -0.594 . . . . 0.0 111.117 172.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.0 -38.05 89.66 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.324 -0.86 . . . . 0.0 112.397 173.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.5 t -72.84 -39.85 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.568 0.747 . . . . 0.0 109.194 177.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -45.81 92.1 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.745 0.818 . . . . 0.0 111.406 176.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -69.09 -36.01 77.12 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.367 1.067 . . . . 0.0 112.273 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 62.3 m -59.6 -51.28 70.48 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 118.8 0.727 . . . . 0.0 111.286 174.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.0 m -70.39 -28.92 36.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 CA-C-O 117.206 -1.378 . . . . 0.0 112.553 177.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . 0.255 0.0 OUTLIER -67.06 -37.25 83.71 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 121.21 1.823 . . . . 0.0 112.46 172.249 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.55 -44.15 95.54 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.039 0.828 . . . . 0.0 112.446 173.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -61.65 -46.93 87.64 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 117.61 0.705 . . . . 0.0 112.129 171.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.7 t -58.63 -47.45 88.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 CA-C-O 117.042 -1.456 . . . . 0.0 110.593 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -51.53 -47.06 63.49 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 120.695 1.589 . . . . 0.0 112.79 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.21 -48.06 77.35 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.407 0.683 . . . . 0.0 112.265 177.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 63.8 mtt-85 -76.15 -32.24 59.0 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -176.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.594 HG11 ' HB3' ' A' ' 21' ' ' PHE . 4.0 p -73.93 -34.44 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.697 1.199 . . . . 0.0 111.427 175.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -60.97 -56.09 25.2 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.34 0.973 . . . . 0.0 108.621 168.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -50.25 -38.72 42.22 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.052 1.741 . . . . 0.0 112.487 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -78.16 -60.52 2.34 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.29 -0.882 . . . . 0.0 113.134 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.61 -34.54 51.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 123.981 0.913 . . . . 0.0 111.63 -175.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.91 -0.17 17.69 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.774 1.229 . . . . 0.0 114.239 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -98.27 -10.97 23.11 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.215 1.406 . . . . 0.0 113.312 169.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.7 pt -118.47 -0.25 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.66 1.584 . . . . 0.0 113.359 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 51.2 p . . . . . 0 C--O 1.256 1.429 0 C-N-CA 125.225 1.41 . . . . 0.0 113.69 169.824 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.3 ttm . . . . . 0 N--CA 1.503 2.214 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.795 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -83.96 92.53 7.85 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 119.273 0.942 . . . . 0.0 111.29 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -78.33 145.29 35.38 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.55 -0.719 . . . . 0.0 112.704 -173.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.2 t -113.63 142.65 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 125.117 1.367 . . . . 0.0 111.252 178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.444 ' HE3' ' CD1' ' A' ' 68' ' ' PHE . 62.8 tpp -131.02 122.35 26.65 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.015 0.926 . . . . 0.0 111.279 169.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -92.85 143.35 26.35 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.158 0.583 . . . . 0.0 109.611 168.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.0 t -135.42 130.69 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.905 1.282 . . . . 0.0 109.578 -173.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 p -144.33 174.2 11.12 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.19 0.996 . . . . 0.0 111.606 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -61.26 -56.62 18.49 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.904 -1.122 . . . . 0.0 109.663 173.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -94.5 123.69 38.08 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 106.503 -1.665 . . . . 0.0 106.503 168.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -63.29 -48.77 76.7 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 120.363 1.438 . . . . 0.0 108.89 169.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 94.1 p -47.53 -35.08 8.36 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.822 2.449 . . . . 0.0 115.273 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.6 p -91.03 -27.87 18.34 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.69 1.196 . . . . 0.0 114.139 -173.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 -136.97 -63.09 0.62 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -169.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 95.2 p -62.87 -30.34 71.44 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 120.757 1.617 . . . . 0.0 112.135 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -63.1 -41.84 99.45 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.86 1.264 . . . . 0.0 112.507 169.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.8 mtm -62.14 -45.54 92.98 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.827 -0.546 . . . . 0.0 111.08 174.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.39 -24.01 65.64 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.827 -1.083 . . . . 0.0 113.522 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -74.1 -48.66 28.15 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 121.656 2.025 . . . . 0.0 108.35 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.66 -43.15 99.41 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-O 119.024 -0.875 . . . . 0.0 112.829 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -64.47 -42.86 95.65 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.636 1.718 . . . . 0.0 112.267 173.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.31 -31.05 63.79 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.622 1.101 . . . . 0.0 111.135 -176.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -65.24 -53.9 37.4 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 125.354 1.462 . . . . 0.0 109.919 171.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.1 p -69.62 -11.07 60.55 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.6 mt -103.89 -1.68 27.35 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.551 1.141 . . . . 0.0 113.88 171.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.6 9.06 0.47 Allowed Glycine 0 N--CA 1.477 1.399 0 N-CA-C 117.288 1.675 . . . . 0.0 117.288 -169.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.98 133.8 55.82 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 119.249 1.525 . . . . 0.0 111.886 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.87 -6.83 54.02 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.473 1.035 . . . . 0.0 115.332 -175.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -87.59 -63.55 1.29 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.349 1.575 . . . . 0.0 110.6 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -142.98 173.94 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 127.222 2.209 . . . . 0.0 110.946 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.0 130.34 41.71 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.369 -0.832 . . . . 0.0 112.61 176.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -105.48 154.03 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.73 1.212 . . . . 0.0 112.974 171.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.5 147.0 25.7 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -172.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.7 p -108.75 139.76 43.11 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 127.107 2.163 . . . . 0.0 114.031 170.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.5 t -143.05 177.37 8.42 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.498 1.519 . . . . 0.0 110.463 169.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.69 173.26 39.76 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 120.122 -1.611 . . . . 0.0 115.06 173.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.1 mt -61.76 -35.52 78.35 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.457 0.703 . . . . 0.0 111.752 -174.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -125.19 111.56 15.42 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.836 2.455 . . . . 0.0 107.565 169.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.4 p -65.51 -33.79 76.75 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.179 -0.95 . . . . 0.0 112.064 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.5 t 48.72 -120.63 1.36 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.386 1.474 . . . . 0.0 111.814 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -144.28 -151.54 0.37 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.594 1.957 . . . . 0.0 111.008 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.2 m -91.18 116.26 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 168.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -68.66 133.77 90.58 Favored Pre-proline 0 N--CA 1.481 1.11 0 O-C-N 120.963 -1.086 . . . . 0.0 111.686 -169.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -59.82 -37.61 85.3 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.446 2.764 . . . . 0.0 113.736 -171.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.9 m -79.02 -35.68 42.35 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.912 -0.492 . . . . 0.0 110.364 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.13 93.8 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.903 -1.123 . . . . 0.0 112.422 174.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.3 mt -53.32 -44.84 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 120.944 1.702 . . . . 0.0 110.71 172.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.67 -56.23 17.31 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.972 0.731 . . . . 0.0 112.972 175.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 30.1 mmt -68.66 -19.21 64.4 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -174.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 87.0 mmm -91.86 -40.23 11.3 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.888 0.875 . . . . 0.0 110.659 176.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -60.49 -39.83 89.12 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.741 -1.224 . . . . 0.0 112.404 174.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -60.31 -26.86 66.87 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.173 -0.954 . . . . 0.0 113.533 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.7 p -100.34 12.83 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 124.894 1.277 . . . . 0.0 113.103 174.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.39 18.59 48.63 Favored Glycine 0 N--CA 1.475 1.286 0 C-N-CA 124.795 1.188 . . . . 0.0 115.263 172.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.4 mt -127.22 85.5 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.426 1.49 . . . . 0.0 110.048 -169.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -71.27 109.81 5.52 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.133 -1.604 . . . . 0.0 110.831 173.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.5 pt -87.5 -9.31 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 118.251 -0.88 . . . . 0.0 112.512 173.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.3 t -62.36 -34.55 76.9 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 120.552 1.524 . . . . 0.0 113.149 -169.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.86 3.99 85.81 Favored Glycine 0 CA--C 1.541 1.683 0 C-N-CA 124.782 1.182 . . . . 0.0 115.282 173.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -97.26 150.68 20.66 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.41 1.484 . . . . 0.0 111.895 -173.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.3 t -84.87 149.62 25.55 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.268 -0.895 . . . . 0.0 112.886 -175.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 71.1 m -121.8 111.45 17.15 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.04 0.936 . . . . 0.0 109.914 169.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -89.17 152.58 48.18 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.039 0.936 . . . . 0.0 112.825 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -91.83 150.84 3.35 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.268 3.312 . . . . 0.0 112.0 171.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 tt -63.18 -27.87 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -170.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -82.1 -11.41 58.78 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.0 -1.063 . . . . 0.0 113.246 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -96.81 -27.97 14.47 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.436 1.094 . . . . 0.0 113.323 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.444 ' CD1' ' HE3' ' A' ' 5' ' ' MET . 0.0 OUTLIER -62.54 -41.72 99.07 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -168.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.4 ' HA ' ' CH2' ' A' ' 90' ' ' TRP 0.341 0.0 OUTLIER 53.97 99.44 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.662 2.785 . . . . 0.0 115.043 -176.834 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 68' ' ' PHE . . . -67.66 5.31 0.85 Allowed 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -175.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -72.2 -27.13 62.36 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.023 1.329 . . . . 0.0 112.27 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -90.07 -2.47 58.11 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -119.79 140.2 51.12 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.982 1.313 . . . . 0.0 112.604 -169.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -88.74 -28.83 20.26 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.894 0.877 . . . . 0.0 111.83 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.6 t -130.08 120.42 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.516 1.127 . . . . 0.0 110.003 -170.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.6 t -126.42 129.34 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.573 0.749 . . . . 0.0 110.193 177.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.8 mm -121.73 126.94 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.086 0.954 . . . . 0.0 110.632 -171.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.6 t -89.45 121.7 31.94 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.863 0.465 . . . . 0.0 109.835 169.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.416 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 75.9 mt -98.6 13.42 32.07 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.496 1.518 . . . . 0.0 112.024 175.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.5 p . . . . . 0 CA--C 1.535 0.401 0 C-N-CA 126.799 2.039 . . . . 0.0 109.032 169.39 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.6 mt . . . . . 0 CA--C 1.549 0.94 0 CA-C-O 119.251 -0.404 . . . . 0.0 111.814 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -58.82 133.29 52.86 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.673 2.249 . . . . 0.0 111.081 173.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -61.18 -31.6 90.18 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.393 2.062 . . . . 0.0 113.184 -176.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -59.17 -32.86 70.28 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.059 -1.026 . . . . 0.0 112.959 171.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.4 ' CH2' ' HA ' ' A' ' 69' ' ' ASN . 0.4 OUTLIER -86.0 12.03 10.31 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.35 1.06 . . . . 0.0 113.821 174.633 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.9 t -116.48 -36.5 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.856 1.662 . . . . 0.0 111.74 178.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.8 p -79.59 25.31 0.34 Allowed 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 -169.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -76.17 167.02 22.62 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.858 1.663 . . . . 0.0 111.975 171.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -57.94 -37.09 73.48 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.932 0.893 . . . . 0.0 112.837 -171.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 67.4 mt -126.81 123.74 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.636 1.175 . . . . 0.0 109.215 169.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -131.52 134.25 45.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.208 1.003 . . . . 0.0 110.597 169.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -141.43 153.97 45.32 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.542 1.137 . . . . 0.0 112.155 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -120.92 117.67 27.92 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.74 1.216 . . . . 0.0 110.157 173.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.416 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 37.0 m0 -95.32 -0.79 52.43 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.669 1.188 . . . . 0.0 113.612 -177.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.308 1.3 pp0? 46.44 39.21 6.26 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 171.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.8 mt -79.4 159.64 26.99 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.8 0.84 . . . . 0.0 112.765 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -87.04 150.81 23.77 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.624 1.569 . . . . 0.0 111.958 173.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.44 116.26 59.32 Favored Pre-proline 0 CA--C 1.546 0.815 0 O-C-N 121.298 -0.877 . . . . 0.0 110.574 172.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -83.23 -14.82 8.13 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.496 2.131 . . . . 0.0 115.457 -169.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -46.59 108.08 0.13 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.759 1.624 . . . . 0.0 112.98 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.69 9.34 78.61 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-O 118.878 -0.957 . . . . 0.0 115.407 175.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -73.81 -68.17 0.54 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.04 1.42 . . . . 0.0 110.431 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.6 t -177.23 152.26 0.86 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 128.505 2.722 . . . . 0.0 108.106 173.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.8 mp -60.36 -29.94 69.23 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.822 0.737 . . . . 0.0 111.549 174.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -64.23 -38.65 91.81 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.091 -1.006 . . . . 0.0 112.423 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.2 t -73.61 -37.63 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.016 0.926 . . . . 0.0 109.476 176.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.8 -45.22 95.23 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.23 1.012 . . . . 0.0 111.177 175.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -67.79 -38.05 82.84 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.638 1.175 . . . . 0.0 112.491 173.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.4 m -58.86 -50.36 74.29 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 118.778 0.717 . . . . 0.0 110.886 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.6 m -71.25 -30.97 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 117.643 -1.17 . . . . 0.0 112.266 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -40.33 97.08 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 121.21 1.823 . . . . 0.0 111.966 171.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.49 -42.83 95.56 Favored Glycine 0 N--CA 1.474 1.183 0 C-N-CA 124.391 0.996 . . . . 0.0 112.579 176.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -60.75 -45.64 93.53 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.915 -0.756 . . . . 0.0 111.947 170.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 29.3 t -58.67 -48.73 84.94 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.807 177.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -51.56 -55.13 20.84 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.856 1.207 . . . . 0.0 111.487 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -59.69 -42.05 92.1 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.619 0.768 . . . . 0.0 112.572 -176.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -78.06 -35.01 50.08 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 39.1 t -61.19 -48.25 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.185 1.394 . . . . 0.0 111.19 172.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -51.88 -55.22 21.41 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.06 0.845 . . . . 0.0 109.606 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -56.93 -37.46 71.52 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.191 1.397 . . . . 0.0 112.276 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -74.25 -56.28 5.07 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.33 -0.856 . . . . 0.0 112.556 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.63 -34.44 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.775 1.23 . . . . 0.0 112.363 -175.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.14 -22.78 62.02 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 121.118 -0.989 . . . . 0.0 113.486 -174.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -70.2 -19.73 63.15 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.593 1.157 . . . . 0.0 113.849 173.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 28.7 pt -118.89 17.15 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 126.259 1.824 . . . . 0.0 112.652 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--O 1.256 1.401 0 C-N-CA 126.459 1.904 . . . . 0.0 111.313 172.158 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.6 tpp . . . . . 0 N--CA 1.502 2.139 0 CA-C-O 118.989 -0.529 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -82.7 85.42 7.04 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 119.873 1.215 . . . . 0.0 111.338 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -77.42 147.55 35.93 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -171.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.64 139.5 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.938 1.295 . . . . 0.0 111.074 176.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 49.4 tpp -127.36 115.36 18.85 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.499 0.72 . . . . 0.0 111.093 169.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -81.53 142.58 32.73 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.624 -0.673 . . . . 0.0 110.331 169.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.92 128.17 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 119.187 0.903 . . . . 0.0 111.66 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.5 p -144.76 178.02 8.3 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.462 1.105 . . . . 0.0 111.757 175.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -59.8 -61.46 2.6 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 120.083 1.31 . . . . 0.0 109.617 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.463 ' HB3' ' H ' ' A' ' 13' ' ' SER . 2.4 mpt_? -83.72 125.18 31.63 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 167.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -59.68 -43.25 94.08 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 120.029 1.286 . . . . 0.0 108.476 169.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.0 p -65.49 -48.58 72.13 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 115.848 1.795 . . . . 0.0 115.848 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.463 ' H ' ' HB3' ' A' ' 10' ' ' ARG . 4.3 m -71.8 -15.51 62.15 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -169.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.82 -55.05 0.82 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 120.325 1.421 . . . . 0.0 113.258 168.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.8 m -61.97 -38.2 87.64 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -171.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -62.71 -36.14 82.0 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.377 0.99 . . . . 0.0 113.214 169.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 82.5 mtp -59.83 -45.58 91.96 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.161 -0.962 . . . . 0.0 110.3 173.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.62 -31.38 69.47 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 117.954 -1.022 . . . . 0.0 113.555 174.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -68.61 -46.17 69.99 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 121.553 1.979 . . . . 0.0 109.033 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.49 -42.99 97.29 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 118.527 -1.152 . . . . 0.0 112.668 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.529 ' HB3' HG11 ' A' ' 123' ' ' VAL . 3.5 m-85 -66.13 -42.3 89.33 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.202 1.501 . . . . 0.0 112.144 171.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.501 ' HB1' HG11 ' A' ' 32' ' ' VAL . . . -63.93 -35.75 81.68 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.61 -1.306 . . . . 0.0 111.114 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -63.53 -55.78 21.18 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.135 1.774 . . . . 0.0 109.976 174.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.7 p -68.41 -14.47 63.02 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 178.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 50.8 mt -99.14 -6.68 27.83 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.384 1.074 . . . . 0.0 113.864 174.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -152.13 9.56 0.62 Allowed Glycine 0 N--CA 1.476 1.311 0 N-CA-C 117.185 1.634 . . . . 0.0 117.185 -169.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.36 132.21 50.37 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 119.514 1.657 . . . . 0.0 111.609 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.37 -6.22 57.92 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.803 1.192 . . . . 0.0 115.475 -176.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -86.46 -59.16 2.36 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 119.459 1.629 . . . . 0.0 110.813 175.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.6 pp -144.7 175.71 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 128.226 2.61 . . . . 0.0 110.118 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.35 132.5 41.79 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.22 -0.925 . . . . 0.0 112.788 174.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.501 HG11 ' HB1' ' A' ' 22' ' ' ALA . 30.7 m -104.02 145.93 12.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 124.667 1.187 . . . . 0.0 112.704 171.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.8 m -146.94 156.35 43.0 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.217 1.007 . . . . 0.0 111.707 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.9 p -126.02 139.83 53.1 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.885 2.074 . . . . 0.0 113.9 175.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.7 t -133.66 172.1 13.21 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 129.567 3.147 . . . . 0.0 109.322 -176.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.64 173.56 44.84 Favored Glycine 0 CA--C 1.523 0.587 0 O-C-N 120.551 -1.343 . . . . 0.0 115.094 169.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.1 mt -66.46 -28.43 68.58 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.291 0.636 . . . . 0.0 111.723 -178.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -121.26 127.91 51.86 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.48 1.912 . . . . 0.0 108.383 170.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.5 p -78.02 55.99 1.54 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.675 1.59 . . . . 0.0 110.381 171.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.5 p -68.13 149.2 49.89 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.29 1.436 . . . . 0.0 112.037 -169.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -58.24 155.3 11.7 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.395 0.678 . . . . 0.0 111.673 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.1 m -50.91 109.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 169.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -65.95 130.63 94.44 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 118.478 -0.772 . . . . 0.0 112.319 -168.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.03 -38.79 85.65 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.489 2.793 . . . . 0.0 113.391 -172.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.9 m -77.55 -34.02 53.95 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 119.224 -0.417 . . . . 0.0 110.684 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.82 -43.48 96.09 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.844 -1.16 . . . . 0.0 111.986 172.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.7 mt -54.72 -40.3 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 120.795 1.634 . . . . 0.0 110.328 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.62 -62.87 1.27 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 173.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 30.4 mmt -67.11 -21.69 65.84 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.951 0.9 . . . . 0.0 113.415 -172.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 86.4 mmm -85.36 -37.78 19.5 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.616 0.767 . . . . 0.0 110.524 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -63.75 -33.44 75.67 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.665 -1.272 . . . . 0.0 111.983 173.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -55.26 -28.49 53.75 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 170.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.1 m -107.11 19.48 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 125.328 1.451 . . . . 0.0 113.525 174.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.64 13.73 74.98 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.65 1.119 . . . . 0.0 115.37 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.3 mt -117.67 97.19 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.448 1.499 . . . . 0.0 109.855 -170.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -78.35 112.09 15.0 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.958 -1.089 . . . . 0.0 110.438 171.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.0 pt -93.09 -4.22 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 172.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.4 p -65.98 -26.33 67.51 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -169.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -100.58 9.29 58.77 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.362 1.458 . . . . 0.0 114.445 172.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -86.72 149.11 25.11 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.983 1.313 . . . . 0.0 112.266 -170.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.9 t -63.59 148.16 49.58 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.459 -0.776 . . . . 0.0 112.109 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.5 t -138.96 54.95 1.72 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.046 0.927 . . . . 0.0 111.689 174.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -68.88 147.45 97.84 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 125.192 1.397 . . . . 0.0 113.185 -170.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -82.75 151.81 14.77 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.635 2.224 . . . . 0.0 112.442 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.8 tt -60.48 -21.83 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -91.99 -9.42 43.02 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 177.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -97.58 -35.2 10.69 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.781 0.832 . . . . 0.0 111.913 171.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -68.43 160.41 29.73 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.18 0.592 . . . . 0.0 111.571 175.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.416 ' HA ' ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -136.63 119.38 16.16 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.666 0.786 . . . . 0.0 111.985 170.479 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.423 ' HB3' ' CE3' ' A' ' 90' ' ' TRP . . . -66.54 0.8 2.01 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -175.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -70.59 -29.26 65.63 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.906 0.882 . . . . 0.0 112.209 -175.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -88.78 -2.36 58.55 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.116 1.366 . . . . 0.0 113.322 177.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -124.67 95.15 4.41 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.706 1.602 . . . . 0.0 110.498 -171.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -55.13 -29.48 57.81 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.768 1.227 . . . . 0.0 112.83 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 t -121.55 118.3 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 125.111 1.364 . . . . 0.0 110.19 -172.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.8 t -130.17 134.38 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.818 0.847 . . . . 0.0 110.644 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.406 HG21 ' CE2' ' A' ' 99' ' ' TRP . 19.0 mm -128.71 132.64 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 121.434 -0.791 . . . . 0.0 111.399 -170.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.4 t -87.87 117.59 26.82 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.521 0.728 . . . . 0.0 111.116 169.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 mp -97.68 37.07 1.42 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.734 1.614 . . . . 0.0 109.177 173.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.2 t . . . . . 0 CA--C 1.54 0.562 0 C-N-CA 126.192 1.797 . . . . 0.0 111.647 -178.219 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.6 mt . . . . . 0 CA--C 1.545 0.787 0 CA-C-O 119.122 -0.466 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.96 153.73 47.46 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.47 2.114 . . . . 0.0 110.675 174.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -59.82 -34.0 95.87 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.859 2.372 . . . . 0.0 112.222 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -48.89 -46.25 42.38 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.499 1.52 . . . . 0.0 112.938 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.423 ' CE3' ' HB3' ' A' ' 70' ' ' ALA . 1.8 m95 -90.75 8.2 35.77 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.747 1.219 . . . . 0.0 112.961 -177.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.7 t -114.94 -38.53 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 127.03 2.132 . . . . 0.0 111.704 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.9 p -81.39 26.71 0.45 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -174.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -80.89 169.34 17.67 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.31 1.444 . . . . 0.0 111.896 174.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -53.58 -41.79 66.92 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 -169.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 59.9 mt -125.71 123.46 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.591 1.157 . . . . 0.0 109.373 170.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -133.49 135.06 44.23 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.007 0.923 . . . . 0.0 111.44 169.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -142.84 153.12 42.87 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.69 1.196 . . . . 0.0 112.42 -175.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -113.36 125.88 54.75 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.279 1.432 . . . . 0.0 111.133 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.406 ' CE2' HG21 ' A' ' 77' ' ' ILE . 44.3 m0 -100.91 -5.69 25.67 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 177.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.355 1.2 pp0? 50.3 31.89 5.71 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.3 mt -75.52 151.87 37.89 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -87.28 160.6 18.36 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.704 2.002 . . . . 0.0 112.511 178.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.61 115.02 60.75 Favored Pre-proline 0 CA--C 1.547 0.83 0 O-C-N 121.282 -0.886 . . . . 0.0 111.4 169.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.87 -13.74 9.14 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.471 2.114 . . . . 0.0 114.822 -170.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -44.05 113.7 0.56 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.506 1.922 . . . . 0.0 113.556 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.81 6.46 55.88 Favored Glycine 0 CA--C 1.534 1.234 0 N-CA-C 115.86 1.104 . . . . 0.0 115.86 173.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -78.04 -63.63 1.35 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.921 1.361 . . . . 0.0 110.881 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.6 t -174.24 152.47 1.82 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.391 2.277 . . . . 0.0 108.889 169.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.1 mp -59.96 -29.92 68.75 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.624 -0.672 . . . . 0.0 111.299 171.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -63.09 -39.75 95.63 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.056 -1.028 . . . . 0.0 112.483 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.3 t -71.43 -37.1 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.843 0.857 . . . . 0.0 109.733 175.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -41.9 92.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.914 0.885 . . . . 0.0 111.699 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -70.09 -36.8 75.17 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 121.22 -0.925 . . . . 0.0 111.987 171.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.3 m -58.06 -48.94 78.58 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.087 0.858 . . . . 0.0 111.639 174.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 23.8 m -68.25 -31.25 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 117.802 -1.094 . . . . 0.0 112.09 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.26 -42.22 98.27 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 120.867 1.667 . . . . 0.0 111.786 170.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.74 -43.82 93.44 Favored Glycine 0 N--CA 1.473 1.158 0 C-N-CA 124.256 0.932 . . . . 0.0 112.785 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -60.51 -45.21 94.65 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 122.166 -0.608 . . . . 0.0 112.032 170.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.9 t -59.67 -50.35 80.33 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 CA-C-O 117.518 -1.23 . . . . 0.0 109.434 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -50.81 -49.89 57.59 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.045 1.293 . . . . 0.0 112.068 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -60.48 -44.37 95.99 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.528 0.731 . . . . 0.0 112.948 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 46.4 mtp85 -81.92 -35.93 28.6 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.529 HG11 ' HB3' ' A' ' 21' ' ' PHE . 4.0 p -72.51 -34.07 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.17 1.388 . . . . 0.0 111.747 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -56.44 -56.98 14.48 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.249 0.931 . . . . 0.0 109.535 169.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -55.64 -35.68 66.18 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.885 1.274 . . . . 0.0 111.877 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -73.45 -57.16 4.19 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.631 -0.668 . . . . 0.0 112.385 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.96 -33.07 61.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.848 0.859 . . . . 0.0 112.211 -176.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.32 -23.25 60.23 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -173.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -68.57 -21.35 64.53 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.693 1.197 . . . . 0.0 113.811 173.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 29.0 pt -117.77 15.28 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 126.452 1.901 . . . . 0.0 112.634 -177.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--O 1.255 1.358 0 C-N-CA 126.501 1.92 . . . . 0.0 111.753 173.522 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.505 2.295 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -81.23 98.01 7.9 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.0 0.92 . . . . 0.0 110.147 175.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -80.47 146.46 31.37 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.647 -0.658 . . . . 0.0 112.324 -174.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.0 t -111.95 146.59 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.673 1.189 . . . . 0.0 110.743 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 45.3 tpp -130.83 112.81 13.36 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.226 1.011 . . . . 0.0 111.448 169.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -82.2 129.57 34.87 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.31 1.044 . . . . 0.0 110.362 169.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.3 t -127.22 136.23 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.069 1.348 . . . . 0.0 110.925 -176.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 t -149.78 -176.81 5.57 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 121.443 -0.786 . . . . 0.0 111.919 169.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -61.15 -45.0 96.43 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.412 -0.805 . . . . 0.0 110.617 170.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.56 129.59 56.68 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.435 1.494 . . . . 0.0 110.787 169.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -72.78 -55.79 6.21 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 169.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.0 p -27.35 -52.22 0.07 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 128.882 2.873 . . . . 0.0 116.758 173.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.4 p -100.96 -24.47 14.33 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.857 1.263 . . . . 0.0 113.898 -174.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -118.04 -71.46 0.74 Allowed 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 119.643 1.111 . . . . 0.0 111.98 -173.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.96 -30.38 70.88 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 121.256 -0.903 . . . . 0.0 112.924 -175.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -66.42 -34.25 77.52 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 126.405 1.882 . . . . 0.0 113.801 172.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 27.3 mmm -65.73 -36.4 83.5 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.656 -0.652 . . . . 0.0 110.27 172.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.41 -26.69 61.07 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.263 -0.898 . . . . 0.0 113.394 169.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -68.96 -53.25 21.8 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.395 1.452 . . . . 0.0 108.439 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.67 -49.07 77.0 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-O 118.935 -0.925 . . . . 0.0 112.488 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.575 ' HB3' HG11 ' A' ' 123' ' ' VAL . 8.4 m-85 -66.71 -38.34 86.51 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.586 1.193 . . . . 0.0 112.49 175.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.65 -38.07 80.16 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 120.024 1.283 . . . . 0.0 110.215 -178.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -57.74 -57.48 12.58 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 125.796 1.639 . . . . 0.0 110.889 171.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.9 p -71.35 -15.4 62.39 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -177.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.1 mt -95.14 -13.24 25.23 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -142.84 8.88 2.27 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 117.783 1.873 . . . . 0.0 117.783 -169.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.14 129.52 38.48 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.771 1.786 . . . . 0.0 111.784 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.33 -6.55 56.89 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 124.677 1.132 . . . . 0.0 115.571 -177.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -86.78 -57.37 3.01 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 119.471 1.636 . . . . 0.0 110.603 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.6 pp -142.17 177.13 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 127.504 2.322 . . . . 0.0 110.161 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.28 122.17 43.21 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.725 0.774 . . . . 0.0 111.591 173.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.9 m -87.74 149.92 3.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 123.781 0.833 . . . . 0.0 111.746 169.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.42 152.04 38.42 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.728 0.811 . . . . 0.0 110.93 176.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.0 p -133.44 145.65 50.45 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.941 1.696 . . . . 0.0 112.541 175.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.4 t -150.01 178.46 8.91 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.884 1.674 . . . . 0.0 110.573 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.26 -179.57 46.42 Favored Glycine 0 CA--C 1.527 0.794 0 O-C-N 120.92 -1.112 . . . . 0.0 114.185 170.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.1 mt -71.95 -44.39 63.65 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -169.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -90.73 -25.57 19.95 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.747 1.619 . . . . 0.0 112.473 173.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 60.3 p 58.84 -65.1 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 127.814 2.445 . . . . 0.0 113.128 -169.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 t 56.59 -174.58 0.06 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 130.22 3.408 . . . . 0.0 114.095 -177.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 54.6 ttt85 -79.83 147.51 31.75 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.873 1.669 . . . . 0.0 111.034 174.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.0 m -47.35 112.92 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.794 1.238 . . . . 0.0 109.739 169.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -63.12 137.56 97.1 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -167.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.4 -40.01 61.62 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.716 2.944 . . . . 0.0 113.518 -175.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.1 m -77.23 -33.04 56.19 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.978 -0.451 . . . . 0.0 110.513 176.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.3 -47.88 83.91 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.403 1.001 . . . . 0.0 111.706 171.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 68.7 mt -49.25 -44.56 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 120.388 1.449 . . . . 0.0 110.823 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.84 -59.44 5.14 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 174.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.2 mmt -67.11 -22.17 65.82 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -175.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.2 mtp -80.88 -45.16 17.24 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.993 1.317 . . . . 0.0 110.665 173.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -61.69 -33.45 74.02 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.804 -1.185 . . . . 0.0 112.532 176.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -55.53 -30.23 60.35 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.264 1.026 . . . . 0.0 113.455 172.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.0 m -105.87 14.98 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 125.146 1.379 . . . . 0.0 113.792 177.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.93 17.79 64.65 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.166 0.889 . . . . 0.0 115.124 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.6 mt -112.68 114.86 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.91 1.284 . . . . 0.0 110.944 -169.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -90.81 110.83 22.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.7 1.2 . . . . 0.0 111.783 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.3 pt -110.62 -5.89 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 169.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.8 p -67.32 -25.6 66.09 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 120.548 -1.345 . . . . 0.0 114.44 -169.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -106.99 14.12 40.84 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 125.683 1.611 . . . . 0.0 114.378 170.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -95.51 151.23 19.5 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.307 1.443 . . . . 0.0 112.128 -170.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.7 t -77.32 146.8 36.54 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 121.247 -0.908 . . . . 0.0 112.856 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.6 m -126.21 98.58 5.53 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.787 1.235 . . . . 0.0 109.069 169.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.79 155.99 75.3 Favored Pre-proline 0 CA--C 1.553 1.088 0 O-C-N 121.223 -0.923 . . . . 0.0 113.388 -174.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -97.63 152.45 0.92 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.866 3.711 . . . . 0.0 113.708 171.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.6 tp -60.81 -21.1 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 -169.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -103.15 -6.88 21.75 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -84.28 -37.91 21.11 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.97 0.804 . . . . 0.0 111.674 171.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.45 159.32 34.16 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.803 0.841 . . . . 0.0 111.574 173.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.449 ' HA ' ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -138.29 112.9 8.9 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.528 0.731 . . . . 0.0 111.728 171.428 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.7 -3.67 2.48 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -169.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.86 -27.62 67.67 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.004 -1.06 . . . . 0.0 112.214 -174.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -91.86 -0.87 57.53 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.087 1.355 . . . . 0.0 113.655 176.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -122.54 95.12 4.51 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.359 1.464 . . . . 0.0 110.597 -170.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -56.2 -31.3 63.33 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.878 1.271 . . . . 0.0 112.968 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.3 t -121.43 121.43 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 124.527 1.131 . . . . 0.0 110.494 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.7 t -127.1 133.59 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.079 0.952 . . . . 0.0 110.169 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.8 mm -122.84 136.7 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.909 0.883 . . . . 0.0 110.375 -175.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.7 t -96.96 127.23 42.73 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.042 0.937 . . . . 0.0 110.464 169.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -108.95 25.86 11.3 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.542 1.537 . . . . 0.0 110.173 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 31.3 p . . . . . 0 CA--C 1.541 0.613 0 C-N-CA 128.138 2.575 . . . . 0.0 111.837 177.081 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.2 mt . . . . . 0 CA--C 1.549 0.941 0 CA-C-O 119.37 -0.348 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -64.28 149.27 90.51 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.751 2.301 . . . . 0.0 113.954 -175.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -72.89 56.82 3.06 Favored 'Trans proline' 0 CA--C 1.549 1.261 1 C-N-CA 125.879 4.386 . . . . 0.0 111.183 171.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -157.03 -51.0 0.07 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.671 2.388 . . . . 0.0 109.431 -169.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.449 ' CH2' ' HA ' ' A' ' 69' ' ' ASN . 1.0 OUTLIER -85.39 -28.1 25.36 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.112 0.965 . . . . 0.0 111.899 177.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.4 m -84.16 -12.95 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 175.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.9 p -94.37 8.71 41.02 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.042 1.337 . . . . 0.0 114.202 -172.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -74.61 169.15 18.37 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.797 1.239 . . . . 0.0 112.98 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -52.07 -39.98 60.49 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -169.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.2 mt -126.3 122.98 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.553 1.141 . . . . 0.0 109.429 169.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -129.38 124.56 34.52 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.391 1.076 . . . . 0.0 110.143 169.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -141.79 167.61 21.74 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.334 1.454 . . . . 0.0 111.017 -174.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -135.27 146.84 48.94 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 172.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 36.7 m0 -109.38 7.68 25.13 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 64.46 -78.76 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.097 1.759 . . . . 0.0 112.983 -177.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 27.0 mt 49.94 -163.89 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 127.585 2.354 . . . . 0.0 113.852 -175.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -141.58 160.49 40.04 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.953 2.101 . . . . 0.0 108.105 171.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -81.1 110.53 18.3 Favored Pre-proline 0 N--CA 1.471 0.625 0 CA-C-N 119.764 1.166 . . . . 0.0 109.689 169.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -81.63 -10.77 11.83 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 121.249 1.3 . . . . 0.0 114.273 -169.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -45.47 109.26 0.16 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.666 1.586 . . . . 0.0 113.568 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.52 9.77 62.2 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 118.767 -1.018 . . . . 0.0 115.478 172.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -78.46 -64.8 1.09 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.877 1.338 . . . . 0.0 111.079 -176.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 21.4 t -173.74 151.62 1.88 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.372 2.269 . . . . 0.0 108.429 170.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.8 mp -60.81 -28.2 68.61 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.577 -0.702 . . . . 0.0 111.119 172.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.18 -39.6 95.1 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.027 -1.046 . . . . 0.0 112.334 173.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.5 t -71.68 -38.9 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.084 0.954 . . . . 0.0 109.654 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.34 -40.0 95.01 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.259 1.024 . . . . 0.0 111.608 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.8 mtt85 -73.23 -36.46 66.44 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 121.062 -1.024 . . . . 0.0 112.185 170.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 55.2 m -58.02 -47.73 82.17 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 119.147 0.885 . . . . 0.0 111.646 175.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.6 m -68.39 -30.24 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 119.589 1.086 . . . . 0.0 111.778 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.66 -43.52 98.59 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 120.236 1.38 . . . . 0.0 111.76 169.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.74 -44.33 94.99 Favored Glycine 0 N--CA 1.473 1.11 0 C-N-CA 124.47 1.033 . . . . 0.0 112.68 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -59.87 -46.41 89.4 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.242 0.617 . . . . 0.0 112.069 170.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.459 ' O ' HG12 ' A' ' 123' ' ' VAL . 3.9 t -59.42 -52.06 65.39 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.506 0 CA-C-O 117.136 -1.411 . . . . 0.0 110.3 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -49.52 -44.23 46.15 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.122 1.369 . . . . 0.0 113.215 -175.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -65.91 -45.59 81.4 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.416 0.686 . . . . 0.0 112.556 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 53.8 mtp85 -82.05 -34.46 29.46 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.752 0.821 . . . . 0.0 112.823 -173.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.575 HG11 ' HB3' ' A' ' 21' ' ' PHE . 9.4 p -68.64 -38.61 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.327 1.451 . . . . 0.0 111.785 173.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -57.54 -56.16 25.53 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.607 1.094 . . . . 0.0 109.631 169.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -55.23 -32.65 62.45 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.723 1.209 . . . . 0.0 112.342 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -77.04 -58.71 3.13 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.228 -0.92 . . . . 0.0 112.68 176.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.75 -32.64 58.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.88 1.272 . . . . 0.0 112.36 -174.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.93 -15.06 59.78 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -172.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -74.51 -26.54 60.06 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.529 1.131 . . . . 0.0 113.446 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 23.8 pt -110.23 -7.41 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.544 1.538 . . . . 0.0 113.589 -177.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.0 m . . . . . 0 C--O 1.252 1.207 0 C-N-CA 125.103 1.361 . . . . 0.0 113.117 173.83 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.9 ttm . . . . . 0 N--CA 1.502 2.138 0 CA-C-O 119.519 -0.277 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -93.92 91.11 6.75 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.658 1.183 . . . . 0.0 110.756 173.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.34 144.47 42.35 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 121.444 -0.785 . . . . 0.0 111.276 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 p -125.3 145.2 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.249 1.02 . . . . 0.0 112.199 -176.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 40.3 tpp -133.45 117.19 16.91 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.939 1.296 . . . . 0.0 112.071 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -84.19 141.08 31.3 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 119.198 -0.429 . . . . 0.0 111.138 169.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.7 t -134.23 124.73 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.297 1.439 . . . . 0.0 111.622 -176.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.9 p -145.8 -179.4 6.66 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.009 1.324 . . . . 0.0 111.608 175.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.79 -59.96 4.15 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 119.947 -1.721 . . . . 0.0 110.803 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -87.31 136.07 33.08 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 168.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -72.57 -55.92 6.17 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 169.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.479 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 24.9 p -50.8 -49.29 58.77 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.681 1.364 . . . . 0.0 114.681 -176.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 m -74.96 -10.88 59.9 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 -143.12 -68.25 0.35 Allowed 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 119.841 1.2 . . . . 0.0 113.571 177.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 44.5 m -65.43 -35.72 81.77 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.456 -1.402 . . . . 0.0 114.472 -172.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -68.97 -29.72 67.99 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 120.922 -1.111 . . . . 0.0 112.887 169.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.2 mtm -61.96 -46.97 86.94 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 169.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.31 -31.2 71.86 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 34' ' ' SER . 27.4 tt0 -69.58 -45.9 67.59 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 120.431 1.469 . . . . 0.0 109.531 176.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.404 ' CA ' HE22 ' A' ' 60' ' ' GLN . . . -63.05 -43.84 98.2 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 118.939 -0.923 . . . . 0.0 111.767 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -63.69 -42.97 97.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.47 1.135 . . . . 0.0 112.409 170.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.43 -31.7 72.07 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 120.515 -1.365 . . . . 0.0 111.056 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -67.86 -55.1 14.18 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 126.502 1.921 . . . . 0.0 109.296 174.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.8 p -68.69 -14.54 63.09 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 177.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 39.8 mt -101.05 1.51 39.55 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.66 1.184 . . . . 0.0 113.83 172.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.97 9.97 0.22 Allowed Glycine 0 CA--C 1.535 1.322 0 N-CA-C 117.402 1.721 . . . . 0.0 117.402 -169.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.96 131.35 50.79 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.763 1.782 . . . . 0.0 111.71 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.54 -3.39 59.66 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.491 1.043 . . . . 0.0 115.469 -175.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -87.11 -63.38 1.32 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 119.102 1.451 . . . . 0.0 110.329 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -142.09 173.9 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 127.44 2.296 . . . . 0.0 110.203 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.18 120.81 33.11 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 121.232 -0.917 . . . . 0.0 111.302 176.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 m -94.31 148.13 5.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.791 169.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.55 157.78 43.69 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.758 0.823 . . . . 0.0 110.741 -172.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.423 ' HB3' ' HB2' ' A' ' 19' ' ' GLU . 93.7 p -145.06 146.42 31.86 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 175.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 79.7 p -150.56 -179.04 6.91 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.676 1.591 . . . . 0.0 110.691 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.37 -174.3 43.63 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 116.46 1.344 . . . . 0.0 116.46 170.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.7 mt -71.49 -47.63 54.2 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.261 0.624 . . . . 0.0 111.822 -172.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -92.81 -32.8 14.52 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.26 1.824 . . . . 0.0 111.412 170.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . 0.282 26.0 p 61.22 -53.53 0.11 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 128.177 2.591 . . . . 0.0 114.813 -171.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.0 t 60.36 -178.82 0.1 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 127.579 2.352 . . . . 0.0 115.07 173.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -71.6 166.18 22.4 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 126.531 1.933 . . . . 0.0 112.375 172.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.1 m -62.54 117.83 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 169.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.479 ' H ' ' HB2' ' A' ' 12' ' ' SER . 56.0 t-80 -76.14 132.46 73.61 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 124.033 0.933 . . . . 0.0 113.141 -168.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -57.73 -41.93 65.07 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.484 2.789 . . . . 0.0 114.059 -170.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.6 m -77.68 -35.46 52.24 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.797 -0.564 . . . . 0.0 110.864 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.74 -43.14 94.33 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.327 -0.844 . . . . 0.0 111.942 173.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.7 mt -54.06 -46.54 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 120.34 1.427 . . . . 0.0 109.717 174.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.38 -60.01 4.38 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.4 mmt -66.71 -29.7 69.75 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.414 -0.804 . . . . 0.0 112.13 -172.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 75.4 mmm -80.43 -40.0 27.17 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.668 0.787 . . . . 0.0 110.364 178.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -58.33 -37.31 74.87 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.588 -1.32 . . . . 0.0 112.315 171.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -59.71 -23.8 63.46 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.3 m -105.19 16.0 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 124.715 1.206 . . . . 0.0 114.021 172.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.01 13.65 66.04 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.398 0.999 . . . . 0.0 115.029 177.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.9 mt -120.72 68.81 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.032 1.733 . . . . 0.0 109.601 -169.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -65.17 105.14 1.02 Allowed 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.231 -1.543 . . . . 0.0 110.668 174.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.1 pt -81.2 -0.42 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 O-C-N 121.528 -0.733 . . . . 0.0 112.815 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 85.1 p -71.67 -28.35 63.67 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.399 -1.438 . . . . 0.0 114.043 -172.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.28 2.93 71.88 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 125.332 1.444 . . . . 0.0 114.432 171.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.404 HE22 ' CA ' ' A' ' 20' ' ' GLY . 12.9 mt-30 -86.4 159.16 19.44 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.463 1.505 . . . . 0.0 112.202 -177.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.8 t -87.73 152.63 21.99 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -170.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.3 m -139.36 134.8 32.99 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.362 1.465 . . . . 0.0 110.398 169.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -142.26 142.69 24.81 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 123.979 0.912 . . . . 0.0 111.066 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -81.0 150.52 18.07 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.186 2.591 . . . . 0.0 112.714 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.3 tt -64.5 -18.25 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -172.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -95.86 -9.1 32.32 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -95.68 -36.32 11.25 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.095 0.958 . . . . 0.0 111.2 169.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -67.9 161.49 26.3 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.315 0.579 . . . . 0.0 111.609 174.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -135.78 122.23 20.66 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.338 1.055 . . . . 0.0 110.505 174.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.44 -0.35 10.16 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -171.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -70.49 -32.88 70.57 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.265 0.939 . . . . 0.0 113.421 -169.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -77.34 -21.01 54.02 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -105.27 90.9 3.57 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.003 1.321 . . . . 0.0 110.448 -169.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -58.08 -30.13 65.99 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.21 108.26 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.385 1.074 . . . . 0.0 109.874 -177.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.8 t -112.13 132.65 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.16 0.984 . . . . 0.0 109.81 177.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.6 mm -128.59 118.22 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 123.556 0.742 . . . . 0.0 110.374 -170.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 t -78.88 136.16 37.22 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.536 0.684 . . . . 0.0 109.346 168.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.6 mt -108.58 23.8 13.99 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.342 1.057 . . . . 0.0 109.848 169.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.8 p . . . . . 0 CA--C 1.544 0.727 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 -174.904 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 CA--C 1.547 0.851 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -59.57 137.34 76.98 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.902 2.401 . . . . 0.0 110.074 169.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -59.0 -33.86 98.94 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.241 1.961 . . . . 0.0 113.33 -174.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -65.41 -25.69 67.65 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.774 1.17 . . . . 0.0 113.974 176.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.72 -19.8 54.6 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.761 -1.212 . . . . 0.0 112.573 171.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.7 t -89.63 -37.28 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.834 1.654 . . . . 0.0 112.087 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.7 p -83.46 18.14 1.93 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -173.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -69.0 166.49 17.9 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.147 0.979 . . . . 0.0 111.519 169.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -53.16 -40.84 64.61 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -169.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 63.4 mt -129.4 126.65 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.664 1.186 . . . . 0.0 109.791 169.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -131.03 125.21 32.67 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.671 1.188 . . . . 0.0 109.929 169.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -140.96 166.16 25.56 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.906 1.282 . . . . 0.0 112.115 -175.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -129.81 134.38 47.52 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.087 1.355 . . . . 0.0 112.306 173.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 46.8 m0 -96.29 0.71 51.23 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 64.63 33.45 10.63 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.829 1.251 . . . . 0.0 114.275 170.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 26.7 mt -90.66 166.43 13.17 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -119.65 148.9 42.81 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.684 1.994 . . . . 0.0 111.178 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.74 119.13 76.12 Favored Pre-proline 0 CA--C 1.55 0.971 0 O-C-N 121.402 -0.812 . . . . 0.0 110.984 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -85.85 -10.19 7.29 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.234 1.956 . . . . 0.0 115.338 -173.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -47.74 113.81 0.78 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.927 1.291 . . . . 0.0 112.938 177.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.04 -3.65 84.57 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 123.978 0.799 . . . . 0.0 114.289 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -78.45 169.52 18.11 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.143 0.972 . . . . 0.0 110.044 169.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 97.2 p -64.13 156.82 27.22 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.383 -0.823 . . . . 0.0 111.903 173.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.9 -30.96 70.49 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.413 -0.804 . . . . 0.0 111.695 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -64.48 -36.34 83.87 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 120.957 -1.089 . . . . 0.0 113.388 173.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.5 t -73.7 -36.65 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 O-C-N 121.061 -1.024 . . . . 0.0 110.272 173.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.54 -40.03 95.95 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.805 0.842 . . . . 0.0 110.675 175.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -67.03 -42.49 84.77 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.046 1.738 . . . . 0.0 111.961 172.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.9 m -58.5 -50.72 72.74 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.402 1.081 . . . . 0.0 111.938 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 19.7 m -67.7 -31.81 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 119.389 0.995 . . . . 0.0 111.699 179.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.2 ptt-85 -70.44 -30.72 67.63 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 120.255 1.389 . . . . 0.0 112.954 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.58 -43.64 96.22 Favored Glycine 0 N--CA 1.477 1.429 0 C-N-CA 123.797 0.713 . . . . 0.0 111.998 169.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -62.61 -38.25 89.47 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.63 -0.923 . . . . 0.0 112.456 170.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.7 t -60.23 -50.41 80.34 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.595 173.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -53.13 -52.73 57.77 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 120.177 1.353 . . . . 0.0 111.79 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -48.31 -44.81 34.36 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.468 1.507 . . . . 0.0 112.352 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -90.91 -28.87 17.82 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.125 0.97 . . . . 0.0 112.022 -171.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.8 t -63.91 -50.07 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.916 1.286 . . . . 0.0 109.569 169.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -53.4 -55.27 26.44 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.663 0.665 . . . . 0.0 109.292 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -50.89 -36.69 39.45 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.107 1.763 . . . . 0.0 113.376 174.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -84.78 -61.53 1.76 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.609 1.095 . . . . 0.0 113.513 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -57.49 -33.33 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.751 1.62 . . . . 0.0 111.599 -177.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.5 -10.48 59.84 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 44.7 mttm -80.15 -20.12 45.66 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.596 1.158 . . . . 0.0 112.425 169.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.1 pt -122.23 28.27 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 127.309 2.243 . . . . 0.0 111.569 -176.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 24.3 t . . . . . 0 C--O 1.252 1.228 0 C-N-CA 127.633 2.373 . . . . 0.0 111.114 179.141 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.502 2.166 0 CA-C-O 119.378 -0.344 . . . . 0.0 111.87 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -84.51 99.66 10.86 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 118.995 0.816 . . . . 0.0 110.115 174.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -75.41 147.85 39.63 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.741 0.417 . . . . 0.0 111.855 -174.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.6 t -104.92 140.08 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.464 1.106 . . . . 0.0 110.635 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 49.3 tpp -127.15 113.97 17.08 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.586 0.755 . . . . 0.0 110.331 169.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -81.49 143.35 32.13 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.39 0.676 . . . . 0.0 110.315 169.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.4 t -134.86 123.95 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.443 1.497 . . . . 0.0 110.558 -178.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 p -136.32 170.9 15.28 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.472 1.109 . . . . 0.0 111.162 171.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -58.46 -53.94 52.66 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 120.342 1.428 . . . . 0.0 110.16 175.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -93.87 121.76 35.66 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 168.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.589 ' ND2' ' H ' ' A' ' 63' ' ' ASP . 23.0 t-20 -47.12 -41.36 17.29 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 121.406 1.912 . . . . 0.0 110.713 169.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.6 p -66.59 -35.89 81.31 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.888 1.675 . . . . 0.0 114.868 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 95.1 p -65.69 -37.07 85.45 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -169.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.27 -43.92 0.41 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.8 m -63.11 -42.68 99.62 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 119.731 1.15 . . . . 0.0 113.009 -169.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -57.63 -40.96 80.37 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.292 1.837 . . . . 0.0 112.456 169.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 94.7 mtp -64.87 -43.03 94.31 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.283 0.633 . . . . 0.0 110.488 175.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.14 -29.69 67.78 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 117.701 -1.142 . . . . 0.0 113.409 173.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -70.43 -48.3 56.67 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 121.45 1.932 . . . . 0.0 108.48 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.73 -46.24 94.37 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.607 -1.107 . . . . 0.0 113.676 176.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -66.96 -34.12 77.06 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.542 1.671 . . . . 0.0 112.378 175.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.447 ' HB1' HG11 ' A' ' 32' ' ' VAL . . . -75.05 -33.6 61.74 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.88 -1.137 . . . . 0.0 110.639 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -60.41 -56.21 24.24 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 125.621 1.569 . . . . 0.0 109.444 170.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.0 p -70.3 -11.01 60.61 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.6 mt -98.1 -5.47 33.66 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 171.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.59 17.4 0.08 OUTLIER Glycine 0 CA--C 1.536 1.368 0 N-CA-C 118.661 2.224 . . . . 0.0 118.661 -172.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.73 -33.25 64.08 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.848 1.824 . . . . 0.0 114.511 -173.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.36 -6.15 88.95 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 124.161 0.886 . . . . 0.0 115.043 177.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -101.1 -59.17 1.74 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.958 1.303 . . . . 0.0 112.003 -170.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.5 pp -143.84 171.91 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 127.345 2.258 . . . . 0.0 110.536 -174.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.53 131.99 42.58 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.409 -0.807 . . . . 0.0 112.9 175.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.447 HG11 ' HB1' ' A' ' 22' ' ' ALA . 28.9 m -104.28 149.37 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 C-N-CA 125.09 1.356 . . . . 0.0 113.259 171.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.53 144.87 27.6 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.413 0.685 . . . . 0.0 112.382 -173.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.0 t -114.24 129.44 56.63 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.976 2.111 . . . . 0.0 113.799 175.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 t -132.33 177.02 7.91 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.505 1.922 . . . . 0.0 110.764 171.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.55 175.08 46.11 Favored Glycine 0 CA--C 1.523 0.557 0 O-C-N 120.572 -1.33 . . . . 0.0 114.286 171.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.0 mt -67.39 -27.39 67.05 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 122.275 -0.544 . . . . 0.0 111.829 -176.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -123.48 115.56 21.76 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.157 2.183 . . . . 0.0 105.765 169.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 77.3 p -62.31 -20.37 64.25 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.314 -0.866 . . . . 0.0 113.076 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.6 t 54.83 -149.91 0.43 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.773 1.629 . . . . 0.0 113.905 168.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.68 165.11 28.39 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 128.244 2.618 . . . . 0.0 110.052 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 m -67.34 102.12 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 169.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -70.26 135.59 86.79 Favored Pre-proline 0 N--CA 1.476 0.841 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.936 -169.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -60.31 -36.79 86.2 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.911 2.407 . . . . 0.0 113.618 -171.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.2 m -77.56 -33.44 54.04 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.543 -0.723 . . . . 0.0 111.193 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.75 -44.32 81.79 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.053 0.842 . . . . 0.0 111.761 170.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 74.7 mt -50.97 -47.07 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 120.343 1.429 . . . . 0.0 110.337 173.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.54 -63.74 1.13 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 31.9 mmt -68.81 -24.43 64.39 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.45 -0.781 . . . . 0.0 112.942 -170.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 80.7 mmm -79.54 -35.74 39.43 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.732 0.696 . . . . 0.0 110.803 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -61.09 -30.88 70.62 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.631 -1.293 . . . . 0.0 112.693 171.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -54.35 -37.31 64.77 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.207 0.912 . . . . 0.0 112.755 172.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.2 m -98.16 15.2 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.58 1.152 . . . . 0.0 113.914 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.03 13.01 67.16 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.115 0.864 . . . . 0.0 115.029 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.6 mt -119.49 70.34 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.63 1.572 . . . . 0.0 109.709 -169.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -66.13 108.96 2.43 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 119.995 -1.691 . . . . 0.0 110.56 171.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.7 pt -84.52 -4.74 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.0 t -61.86 -32.68 73.05 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 120.382 1.446 . . . . 0.0 112.912 -170.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.32 4.51 80.49 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.03 1.3 . . . . 0.0 115.383 173.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -87.77 149.0 24.45 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.017 1.408 . . . . 0.0 112.36 -172.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.8 t -76.08 157.08 33.3 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.0 p -139.21 154.7 48.06 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.185 1.394 . . . . 0.0 109.847 169.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.589 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -146.88 149.98 37.7 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.387 1.075 . . . . 0.0 111.62 -175.099 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -88.79 152.61 6.07 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.637 2.891 . . . . 0.0 111.335 174.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.6 tp -60.23 -21.53 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.31 1.444 . . . . 0.0 114.863 -177.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -97.6 -9.1 27.53 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -92.08 -38.77 12.0 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 118.891 0.769 . . . . 0.0 111.609 172.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.0 158.24 36.0 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.388 0.613 . . . . 0.0 111.192 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -138.13 115.82 11.4 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.778 1.231 . . . . 0.0 109.476 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.5 0.18 5.65 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 -169.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -70.04 -29.12 66.08 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.715 1.143 . . . . 0.0 112.328 -172.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -87.43 -2.8 58.87 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.008 1.323 . . . . 0.0 113.062 175.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -124.88 83.29 2.14 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.106 1.762 . . . . 0.0 109.5 -171.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -57.76 -19.13 25.78 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.18 0.992 . . . . 0.0 113.404 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.3 t -121.03 113.9 41.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.46 1.504 . . . . 0.0 109.931 -177.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.6 t -127.42 133.79 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 121.501 -0.749 . . . . 0.0 110.199 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.454 HG21 ' CE2' ' A' ' 99' ' ' TRP . 24.2 mm -129.09 133.21 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 121.567 -0.708 . . . . 0.0 111.21 -169.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.7 t -92.7 119.4 32.06 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.798 1.639 . . . . 0.0 110.835 173.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.435 ' CD1' HG22 ' A' ' 77' ' ' ILE . 1.3 mp -103.33 27.96 6.82 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.21 1.804 . . . . 0.0 111.327 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.4 p . . . . . 0 CA--C 1.543 0.706 0 C-N-CA 126.465 1.906 . . . . 0.0 109.827 169.823 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.6 mt . . . . . 0 CA--C 1.549 0.905 0 CA-C-O 119.217 -0.42 . . . . 0.0 111.394 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.65 138.57 86.73 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.747 2.298 . . . . 0.0 111.51 172.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.1 -38.48 45.42 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.466 2.111 . . . . 0.0 112.595 -169.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.93 -23.96 65.13 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.121 -0.987 . . . . 0.0 113.586 176.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -78.69 -9.6 59.46 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.699 -1.251 . . . . 0.0 112.949 169.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.5 t -100.78 -41.66 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 126.513 1.925 . . . . 0.0 111.481 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.1 p -80.52 28.98 0.31 Allowed 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -172.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -79.29 170.47 16.58 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.955 1.302 . . . . 0.0 111.99 170.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -57.79 -36.6 72.4 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.125 0.97 . . . . 0.0 113.496 -170.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 61.9 mt -128.01 125.65 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.909 1.284 . . . . 0.0 109.59 170.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -135.71 138.96 43.28 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.041 0.937 . . . . 0.0 111.479 169.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -143.26 146.71 33.86 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.128 1.371 . . . . 0.0 112.03 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -109.35 116.84 32.6 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.175 1.39 . . . . 0.0 109.586 169.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.454 ' CE2' HG21 ' A' ' 77' ' ' ILE . 45.8 m0 -94.08 -6.95 43.92 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.331 1.2 pp0? 50.12 30.28 4.12 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 176.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.5 mt -73.04 150.05 42.69 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -86.07 158.9 19.71 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.872 1.669 . . . . 0.0 113.016 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -81.89 128.42 68.67 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.848 1.259 . . . . 0.0 112.866 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -88.24 -38.58 0.06 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.61 2.207 . . . . 0.0 113.595 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 19.43 51.35 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 131.622 3.969 . . . . 0.0 117.786 169.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.36 11.56 79.79 Favored Glycine 0 CA--C 1.539 1.588 0 O-C-N 120.797 -1.189 . . . . 0.0 115.046 176.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -63.37 -52.89 59.82 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.807 1.243 . . . . 0.0 111.076 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 34.1 t -168.48 153.56 6.38 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.742 2.017 . . . . 0.0 109.627 169.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.5 mp -56.85 -31.84 65.2 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.982 0.913 . . . . 0.0 110.999 172.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.56 -39.83 74.12 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.978 1.311 . . . . 0.0 112.568 173.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.6 t -73.16 -38.11 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 121.503 -0.748 . . . . 0.0 109.668 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -63.86 -44.58 92.67 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.265 0.484 . . . . 0.0 111.463 175.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -64.35 -39.12 93.27 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.514 1.126 . . . . 0.0 111.74 176.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.1 m -62.51 -52.84 61.88 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.012 0.925 . . . . 0.0 111.469 173.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.5 m -72.69 -29.71 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 117.047 -1.454 . . . . 0.0 112.78 -177.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.9 ptt85 -64.16 -37.12 86.33 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 121.805 2.093 . . . . 0.0 112.181 171.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.55 -48.99 77.65 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.886 0.755 . . . . 0.0 112.316 173.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -59.81 -45.58 91.89 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 117.586 0.693 . . . . 0.0 112.407 173.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.9 t -58.67 -46.88 90.2 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.495 0 CA-C-O 117.843 -1.075 . . . . 0.0 110.169 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -52.12 -53.57 41.08 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.044 1.293 . . . . 0.0 111.853 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -58.3 -45.66 87.59 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.098 0.475 . . . . 0.0 111.854 -178.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -75.11 -33.5 61.61 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 36.4 t -63.13 -47.91 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.97 1.308 . . . . 0.0 111.03 169.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -53.77 -55.71 23.95 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.523 1.056 . . . . 0.0 109.481 174.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -53.33 -26.2 17.99 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.059 1.344 . . . . 0.0 113.545 177.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -91.68 -62.27 1.46 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.277 1.431 . . . . 0.0 112.945 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.84 -31.03 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.581 1.552 . . . . 0.0 111.551 -176.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.52 -7.22 54.7 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -74.06 -27.79 61.09 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.6 1.16 . . . . 0.0 112.693 169.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.4 pt -117.26 -7.91 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.616 1.966 . . . . 0.0 113.555 -171.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 C--O 1.255 1.391 0 C-N-CA 125.261 1.424 . . . . 0.0 112.458 172.426 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 ttm . . . . . 0 N--CA 1.502 2.159 0 CA-C-O 119.653 -0.213 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -90.32 90.25 7.98 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.257 1.023 . . . . 0.0 110.487 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -80.94 149.24 29.47 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 121.573 -0.704 . . . . 0.0 112.232 -174.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.2 t -115.09 143.41 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.663 1.185 . . . . 0.0 111.124 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.1 tpp -130.62 122.68 27.88 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.248 1.019 . . . . 0.0 111.019 169.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -93.22 138.67 31.39 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.509 -0.744 . . . . 0.0 110.597 169.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.8 t -134.41 130.5 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.984 1.314 . . . . 0.0 110.384 -171.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 t -151.8 -165.67 2.29 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.439 0.696 . . . . 0.0 112.542 169.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -63.0 -70.54 0.2 Allowed 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 119.406 1.003 . . . . 0.0 111.045 170.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 56.6 mtt-85 -79.07 127.76 32.41 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 118.569 0.622 . . . . 0.0 109.955 169.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.598 ' ND2' ' H ' ' A' ' 63' ' ' ASP . 19.2 t-20 -61.06 -43.37 98.98 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 168.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 99.3 p -73.97 -48.26 31.69 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -169.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.0 p -83.29 -11.23 57.95 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.763 -1.211 . . . . 0.0 113.695 -173.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 -126.63 -67.42 0.86 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.788 1.235 . . . . 0.0 111.734 -176.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.3 m -64.21 -44.51 91.68 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.16 1.171 . . . . 0.0 114.16 -175.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -57.5 -30.68 65.31 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.832 1.253 . . . . 0.0 113.792 170.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.1 mtm -68.17 -49.36 61.44 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.072 0.851 . . . . 0.0 110.92 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.72 -29.93 70.04 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.622 -0.674 . . . . 0.0 112.686 172.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -71.23 -44.22 65.78 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 119.691 1.132 . . . . 0.0 109.269 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.96 -41.31 98.7 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 119.299 -0.723 . . . . 0.0 112.073 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -62.73 -44.24 96.73 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.885 1.342 . . . . 0.0 111.719 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.82 -32.79 69.97 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 120.574 -1.329 . . . . 0.0 111.224 -174.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -64.91 -56.3 14.14 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 126.432 1.893 . . . . 0.0 109.449 171.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.3 p -68.08 -14.93 63.35 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 52.7 mt -100.74 -8.16 23.04 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.454 1.102 . . . . 0.0 113.816 174.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.58 10.55 1.27 Allowed Glycine 0 CA--C 1.534 1.273 0 N-CA-C 117.181 1.632 . . . . 0.0 117.181 -169.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.98 131.01 46.19 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.16 1.48 . . . . 0.0 112.067 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.47 -6.44 57.66 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.528 1.061 . . . . 0.0 115.531 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -86.25 -61.32 1.77 Allowed 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 119.296 1.548 . . . . 0.0 110.339 175.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -142.75 173.01 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 127.667 2.387 . . . . 0.0 110.316 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.75 130.02 41.45 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.366 -0.834 . . . . 0.0 112.314 175.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.7 m -104.15 153.04 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.716 1.206 . . . . 0.0 112.478 170.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.19 145.7 27.27 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -171.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.1 t -110.33 133.49 53.2 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.835 2.054 . . . . 0.0 113.615 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.8 t -141.84 171.33 14.2 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.521 1.928 . . . . 0.0 110.949 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.59 -179.82 45.66 Favored Glycine 0 CA--C 1.526 0.778 0 O-C-N 120.883 -1.136 . . . . 0.0 114.567 169.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 38.0 mt -63.19 -26.7 68.93 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.23 1.012 . . . . 0.0 112.074 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -128.34 127.43 42.67 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.19 1.396 . . . . 0.0 109.09 170.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.6 p -77.48 58.04 1.65 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.262 1.425 . . . . 0.0 110.492 171.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.4 p -65.9 156.62 32.87 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 114.146 -1.388 . . . . 0.0 112.818 -169.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -64.74 144.64 57.1 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.251 1.02 . . . . 0.0 109.981 177.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.7 m -41.23 109.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.852 1.661 . . . . 0.0 109.082 170.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -68.03 132.31 92.06 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-O 118.383 -0.817 . . . . 0.0 112.82 -167.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.31 -39.15 80.17 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.372 2.715 . . . . 0.0 113.566 -170.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.0 m -78.05 -37.06 47.66 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 119.151 -0.452 . . . . 0.0 110.496 177.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.67 -40.78 96.02 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.626 1.103 . . . . 0.0 112.475 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.4 mt -52.38 -47.17 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 120.98 1.718 . . . . 0.0 109.927 172.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.82 -58.38 8.68 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 175.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.6 mmt -66.18 -22.0 66.34 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 88.5 mmm -90.93 -37.36 13.58 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.941 0.896 . . . . 0.0 110.592 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -60.89 -33.89 73.81 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.407 -1.433 . . . . 0.0 112.319 169.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -56.0 -30.06 61.26 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.036 0.934 . . . . 0.0 113.313 173.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.4 m -103.41 13.64 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.857 1.263 . . . . 0.0 114.155 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.13 17.2 63.32 Favored Glycine 0 CA--C 1.537 1.467 0 O-C-N 121.209 -0.932 . . . . 0.0 115.106 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.1 mt -122.54 79.68 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.977 1.711 . . . . 0.0 109.631 -169.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -70.28 106.59 3.4 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.053 -1.655 . . . . 0.0 111.185 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.1 pt -82.3 -10.14 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 118.166 -0.921 . . . . 0.0 112.576 175.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.5 t -61.85 -33.15 73.66 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 120.3 1.409 . . . . 0.0 113.029 -169.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -95.94 6.52 66.91 Favored Glycine 0 CA--C 1.541 1.674 0 C-N-CA 125.098 1.333 . . . . 0.0 115.294 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -93.32 151.27 19.89 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.028 1.414 . . . . 0.0 111.477 -171.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.6 t -68.25 149.98 48.83 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -170.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.8 t -135.81 133.24 37.67 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.36 1.464 . . . . 0.0 109.183 169.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.598 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 4.1 t70 -148.21 146.22 22.65 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.696 1.598 . . . . 0.0 110.836 -172.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -91.15 154.46 3.82 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.574 2.183 . . . . 0.0 112.65 -173.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.3 tt -60.66 -21.42 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -94.06 -9.58 36.24 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -94.51 -37.44 11.39 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.785 0.834 . . . . 0.0 111.816 170.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.58 163.18 27.5 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.26 0.552 . . . . 0.0 111.644 174.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -139.38 134.1 31.99 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.015 0.926 . . . . 0.0 110.633 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.62 6.87 6.41 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -174.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -74.31 -30.86 62.25 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.068 -1.02 . . . . 0.0 112.594 -173.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -88.86 -3.74 58.67 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.657 1.183 . . . . 0.0 113.6 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -123.72 94.01 4.11 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.739 1.616 . . . . 0.0 110.151 -171.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -62.75 -18.9 63.37 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.0 t -120.09 114.74 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.812 1.245 . . . . 0.0 110.472 -176.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.3 t -127.9 129.88 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.995 0.918 . . . . 0.0 110.814 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.5 mm -116.35 125.29 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.301 0.641 . . . . 0.0 111.56 -172.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.0 t -86.11 92.12 8.63 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.379 1.472 . . . . 0.0 109.155 169.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.9 mt -76.94 -11.04 59.75 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.884 0.873 . . . . 0.0 112.158 171.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 27.5 p . . . . . 0 CA--C 1.547 0.833 0 C-N-CA 123.586 0.755 . . . . 0.0 111.673 169.16 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.0 mt . . . . . 0 CA--C 1.547 0.845 0 CA-C-O 119.081 -0.485 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.86 136.68 75.26 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.326 2.018 . . . . 0.0 110.645 169.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -64.22 -29.55 64.43 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.485 2.123 . . . . 0.0 112.63 -176.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -61.37 -28.68 69.41 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 171.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.35 13.28 13.95 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.829 1.252 . . . . 0.0 114.163 171.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.6 t -114.1 -37.19 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.666 1.587 . . . . 0.0 111.416 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -81.04 27.09 0.41 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 115.297 1.592 . . . . 0.0 115.297 -169.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -77.11 165.7 24.25 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.822 1.649 . . . . 0.0 112.64 173.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -56.23 -38.23 70.8 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.776 1.23 . . . . 0.0 113.008 -172.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.0 mt -127.48 116.99 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.14 1.376 . . . . 0.0 108.704 169.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -128.14 128.44 44.82 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.191 0.997 . . . . 0.0 109.881 169.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -137.29 140.0 41.28 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.613 0.765 . . . . 0.0 113.007 -170.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -97.9 104.59 16.63 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.265 1.826 . . . . 0.0 112.173 176.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 16.2 m0 -95.2 92.14 6.63 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 169.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -60.92 54.43 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 128.277 2.631 . . . . 0.0 115.718 176.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 77.3 mt -76.43 167.71 21.37 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.036 2.134 . . . . 0.0 111.841 175.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -96.73 153.89 17.61 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.748 1.219 . . . . 0.0 110.628 169.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -77.31 120.24 80.75 Favored Pre-proline 0 CA--C 1.546 0.809 0 O-C-N 120.88 -1.138 . . . . 0.0 111.114 172.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -87.13 -19.29 2.54 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.466 1.444 . . . . 0.0 114.957 -170.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -53.42 107.41 0.24 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.635 1.174 . . . . 0.0 112.092 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.04 -0.94 69.78 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.288 0.947 . . . . 0.0 114.62 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -77.95 172.15 13.91 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 118.316 1.058 . . . . 0.0 110.18 169.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 90.4 p -66.35 156.68 33.8 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.045 -1.034 . . . . 0.0 111.557 169.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.92 -27.58 68.95 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.306 -0.871 . . . . 0.0 111.862 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.2 -40.73 86.69 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.128 -0.983 . . . . 0.0 112.354 170.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 78.7 t -74.04 -37.73 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.371 -0.831 . . . . 0.0 110.416 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.59 -41.56 99.03 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.515 0.726 . . . . 0.0 111.075 176.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -69.55 -37.54 77.1 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.715 1.206 . . . . 0.0 112.29 171.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 55.3 m -58.3 -49.09 78.38 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 119.157 0.89 . . . . 0.0 111.589 176.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 31.2 m -67.22 -30.68 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 119.934 1.243 . . . . 0.0 111.719 177.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.416 ' HA ' HG22 ' A' ' 119' ' ' VAL . 0.1 OUTLIER -60.37 -46.54 89.58 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 119.811 1.187 . . . . 0.0 111.318 169.592 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.53 -35.66 92.33 Favored Glycine 0 N--CA 1.472 1.054 0 C-N-CA 123.823 0.725 . . . . 0.0 112.153 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -68.46 -51.43 43.57 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 171.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.416 HG22 ' HA ' ' A' ' 116' ' ' ARG . 3.6 m -61.26 -39.68 83.43 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 CA-C-O 117.372 -1.299 . . . . 0.0 111.179 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -47.92 -57.5 5.63 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.331 1.423 . . . . 0.0 111.898 174.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -63.67 -41.78 98.15 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.274 0.629 . . . . 0.0 112.387 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 59.1 mtp85 -73.77 -34.74 64.82 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.87 -47.97 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.271 1.428 . . . . 0.0 111.465 171.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -52.63 -54.41 33.66 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.454 1.025 . . . . 0.0 109.563 177.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -55.56 -38.83 69.83 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.063 1.345 . . . . 0.0 112.668 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -73.1 -56.93 4.44 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.169 -0.957 . . . . 0.0 112.454 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -67.77 -34.22 66.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.014 1.326 . . . . 0.0 112.115 -176.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.21 -17.02 60.95 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -173.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -72.94 -22.07 60.78 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.39 1.076 . . . . 0.0 113.649 171.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.0 pt -118.37 11.29 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.3 1.84 . . . . 0.0 112.925 -175.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.19 1.796 . . . . 0.0 112.332 177.572 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.5 ttm . . . . . 0 N--CA 1.504 2.249 0 CA-C-O 119.246 -0.407 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -77.64 100.89 6.34 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 119.117 0.871 . . . . 0.0 110.74 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -86.6 136.06 33.19 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.111 1.764 . . . . 0.0 111.763 -172.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.4 t -114.64 143.06 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 124.176 0.991 . . . . 0.0 111.793 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.4 ' HG2' ' CZ ' ' A' ' 68' ' ' PHE . 48.2 tpp -131.05 125.06 32.23 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.277 1.031 . . . . 0.0 111.602 169.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -93.05 136.84 32.94 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.533 0.733 . . . . 0.0 110.48 169.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 t -130.61 130.15 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.38 1.472 . . . . 0.0 110.2 -174.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.8 p -149.14 176.42 10.5 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.989 0.916 . . . . 0.0 112.628 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -63.93 -46.79 83.21 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.904 -1.122 . . . . 0.0 111.251 171.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.406 ' HB3' ' H ' ' A' ' 13' ' ' SER . 1.0 OUTLIER -109.26 111.66 23.38 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.358 1.463 . . . . 0.0 109.791 169.326 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.515 ' ND2' ' H ' ' A' ' 63' ' ' ASP . 58.8 t-20 -57.56 -46.95 83.32 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 169.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.6 p -43.48 -46.59 6.91 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 174.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.406 ' H ' ' HB3' ' A' ' 10' ' ' ARG . 27.3 p -97.44 -16.12 20.32 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.05 1.129 . . . . 0.0 114.05 -172.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -130.94 -62.63 0.89 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 119.738 1.153 . . . . 0.0 113.979 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.8 m -61.34 -35.08 76.42 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 120.118 1.326 . . . . 0.0 112.953 -177.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -62.98 -38.19 90.15 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.722 1.209 . . . . 0.0 113.446 169.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 84.9 mtp -64.29 -48.79 74.35 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.445 1.021 . . . . 0.0 110.714 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.07 -28.45 68.85 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 175.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -75.27 -41.52 57.03 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 119.72 1.145 . . . . 0.0 109.067 -178.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.66 -45.0 96.7 Favored Glycine 0 CA--C 1.52 0.37 0 CA-C-O 119.345 -0.697 . . . . 0.0 112.425 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -64.55 -43.81 92.79 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.851 1.326 . . . . 0.0 112.065 172.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.56 -32.49 69.92 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.454 -1.404 . . . . 0.0 111.767 -175.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -64.89 -55.63 18.17 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 125.332 1.453 . . . . 0.0 109.425 170.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.1 p -73.12 -8.92 57.9 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.587 -1.32 . . . . 0.0 114.523 -176.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 51.7 mt -100.28 -5.75 27.0 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.48 1.112 . . . . 0.0 113.701 170.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.29 15.2 0.1 OUTLIER Glycine 0 CA--C 1.537 1.417 0 N-CA-C 118.609 2.204 . . . . 0.0 118.609 -171.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.22 -33.67 67.77 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.162 1.981 . . . . 0.0 114.308 -172.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.43 -5.5 89.93 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.257 0.932 . . . . 0.0 115.029 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -100.77 -63.01 1.17 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.862 1.265 . . . . 0.0 111.409 -172.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -141.87 173.34 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 126.128 1.771 . . . . 0.0 112.122 -175.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.93 123.22 36.04 Favored 'General case' 0 C--N 1.343 0.291 0 O-C-N 121.368 -0.832 . . . . 0.0 112.502 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.0 m -101.47 151.97 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.05 0.94 . . . . 0.0 111.67 169.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.65 152.38 37.76 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.15 0.58 . . . . 0.0 111.544 -173.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.5 p -120.69 141.47 50.38 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.661 1.585 . . . . 0.0 114.731 175.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.3 t -145.99 167.54 23.07 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 127.308 2.243 . . . . 0.0 110.005 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.87 171.46 38.32 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 120.73 -1.231 . . . . 0.0 114.803 169.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 35.0 mt -62.12 -40.28 95.38 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.738 0.815 . . . . 0.0 111.477 -173.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -120.55 116.6 25.7 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 127.879 2.472 . . . . 0.0 105.874 169.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.7 p -67.21 -49.19 65.5 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.128 -0.982 . . . . 0.0 110.41 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.4 t 53.64 -173.26 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 127.031 2.132 . . . . 0.0 113.838 -174.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -80.86 177.8 8.81 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 127.051 2.14 . . . . 0.0 113.005 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.4 m -66.44 116.69 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 120.596 -1.315 . . . . 0.0 107.639 168.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -66.36 128.09 93.65 Favored Pre-proline 0 N--CA 1.478 0.934 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -168.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.64 -39.23 55.53 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.265 2.644 . . . . 0.0 113.994 -169.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.4 ' HB ' ' CE2' ' A' ' 112' ' ' PHE . 28.4 m -80.48 -32.65 37.01 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 122.023 -0.423 . . . . 0.0 110.629 178.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.67 -38.07 86.06 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.011 -1.056 . . . . 0.0 112.375 174.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 65.1 mt -53.02 -42.18 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 120.634 1.561 . . . . 0.0 110.559 172.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.86 -61.23 2.3 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.355 0.662 . . . . 0.0 112.702 173.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.4 mmt -66.08 -24.18 66.66 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -172.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 79.3 mmm -87.78 -33.9 18.5 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.976 0.91 . . . . 0.0 110.95 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -60.84 -32.74 72.13 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.704 -1.247 . . . . 0.0 111.901 169.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -54.41 -31.58 55.41 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.326 -0.859 . . . . 0.0 113.232 173.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.1 m -104.0 14.27 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 175.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.52 13.35 65.51 Favored Glycine 0 CA--C 1.536 1.365 0 O-C-N 120.984 -1.072 . . . . 0.0 115.224 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.5 mt -118.36 71.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.803 1.641 . . . . 0.0 109.411 -169.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -64.07 110.69 2.24 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 120.34 -1.475 . . . . 0.0 110.218 172.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 pt -92.73 4.33 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.326 0.65 . . . . 0.0 112.627 178.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.3 p -68.4 -22.62 64.62 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.492 1.496 . . . . 0.0 113.855 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.5 8.24 62.03 Favored Glycine 0 CA--C 1.541 1.712 0 C-N-CA 125.548 1.547 . . . . 0.0 114.353 169.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -76.0 139.71 41.63 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.556 1.178 . . . . 0.0 111.274 -174.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.1 t -64.78 156.35 30.87 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.262 0.553 . . . . 0.0 111.588 169.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.0 t -143.57 127.99 17.89 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 169.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.515 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -124.64 142.23 40.07 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.593 1.157 . . . . 0.0 111.305 -174.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -87.58 152.87 7.63 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.611 2.874 . . . . 0.0 111.368 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.0 tt -60.91 -29.86 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -169.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -94.85 -6.92 41.67 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -80.91 -38.51 27.81 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.477 -0.764 . . . . 0.0 110.592 169.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.4 ' CZ ' ' HG2' ' A' ' 5' ' ' MET . 0.0 OUTLIER -77.22 160.09 29.18 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.375 1.07 . . . . 0.0 111.716 172.45 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.63 116.5 14.12 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.899 1.28 . . . . 0.0 109.612 174.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.97 -3.85 6.01 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 -169.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -67.44 -30.56 70.33 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.3 0.954 . . . . 0.0 113.431 -169.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -84.3 -8.78 58.91 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 176.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -104.72 100.4 10.05 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 120.898 -1.127 . . . . 0.0 110.12 -169.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -52.19 -33.74 42.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.279 1.431 . . . . 0.0 112.736 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.0 t -125.41 122.75 63.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 125.385 1.474 . . . . 0.0 110.003 -174.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.0 t -124.05 130.43 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.671 0.788 . . . . 0.0 109.86 175.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 50.1 mm -125.45 123.12 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 123.927 0.891 . . . . 0.0 110.687 -169.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.8 t -82.2 137.4 34.92 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 168.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.401 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 76.5 mt -110.03 28.25 8.79 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.871 1.268 . . . . 0.0 109.857 170.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.1 t . . . . . 0 CA--C 1.542 0.641 0 C-N-CA 125.322 1.449 . . . . 0.0 113.307 -169.73 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 CA--C 1.55 0.975 0 CA-C-O 119.233 -0.413 . . . . 0.0 111.721 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -58.77 163.69 10.8 Favored 'Trans proline' 0 CA--C 1.551 1.34 0 C-N-CA 123.716 2.944 . . . . 0.0 113.608 171.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.81 -52.74 1.16 Allowed 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.521 2.147 . . . . 0.0 113.784 -171.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -60.18 -36.61 78.01 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 120.664 -1.272 . . . . 0.0 111.897 177.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -63.89 7.01 0.13 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 127.928 2.491 . . . . 0.0 115.046 170.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.1 t -134.86 -42.7 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 127.109 2.164 . . . . 0.0 111.525 175.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.7 p -79.9 32.64 0.26 Allowed 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -169.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -85.47 168.8 14.22 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.374 1.069 . . . . 0.0 112.187 172.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -57.06 -36.1 70.13 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -169.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.4 mt -125.87 125.58 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.772 1.229 . . . . 0.0 108.813 169.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -133.33 131.14 39.78 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.172 0.989 . . . . 0.0 111.536 169.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -145.96 162.0 38.79 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.196 1.398 . . . . 0.0 111.757 -175.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -125.52 122.53 36.85 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.679 1.192 . . . . 0.0 111.422 170.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.401 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 44.1 m0 -82.54 -4.55 57.75 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 61.43 47.57 6.63 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.328 1.451 . . . . 0.0 113.62 169.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.0 mt -99.89 149.02 23.84 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -171.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -82.69 152.89 25.61 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.327 1.451 . . . . 0.0 111.336 170.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -80.85 120.67 79.56 Favored Pre-proline 0 CA--C 1.545 0.786 0 O-C-N 121.27 -0.894 . . . . 0.0 111.232 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -82.17 -10.6 11.25 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.231 1.954 . . . . 0.0 114.564 -176.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -53.23 107.63 0.25 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.754 1.161 . . . . 0.0 112.583 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.37 3.36 90.02 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 119.306 -0.719 . . . . 0.0 114.803 177.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -73.66 165.21 25.52 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.501 1.151 . . . . 0.0 110.437 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.2 m -60.66 147.84 40.59 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.42 -0.8 . . . . 0.0 111.171 170.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.83 -27.85 69.61 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.413 -0.805 . . . . 0.0 112.916 -172.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -59.04 -39.4 81.89 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.053 -1.029 . . . . 0.0 112.648 170.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.7 t -72.19 -37.03 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.907 0.883 . . . . 0.0 110.032 175.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.4 ' CE2' ' HB ' ' A' ' 45' ' ' THR . 0.3 OUTLIER -64.07 -40.93 97.35 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.435 0.694 . . . . 0.0 111.172 177.003 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -69.64 -37.2 76.67 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 120.778 -1.201 . . . . 0.0 112.521 171.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 55.1 m -59.15 -48.7 80.64 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.135 0.974 . . . . 0.0 111.558 175.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 19.7 m -66.51 -29.96 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 119.743 1.156 . . . . 0.0 111.947 175.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -45.94 89.61 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 120.086 1.312 . . . . 0.0 110.875 169.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.91 -41.33 97.73 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 118.955 0.798 . . . . 0.0 112.393 174.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -67.24 -43.04 82.93 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 175.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.3 m -67.15 -41.2 86.65 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.695 0 CA-C-N 119.807 1.185 . . . . 0.0 110.547 176.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -51.55 -54.13 30.7 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.689 1.586 . . . . 0.0 111.581 175.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -50.6 -49.64 55.99 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.779 1.631 . . . . 0.0 112.347 176.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -87.41 -27.95 22.44 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.661 0.784 . . . . 0.0 112.248 -170.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.4 t -63.53 -51.79 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.201 1.4 . . . . 0.0 109.187 169.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -54.01 -53.77 48.41 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.312 0.96 . . . . 0.0 109.613 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -52.01 -37.78 54.53 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.803 1.641 . . . . 0.0 112.49 176.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -79.07 -59.09 2.92 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.007 -1.058 . . . . 0.0 113.357 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.54 -33.89 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.789 1.636 . . . . 0.0 112.14 -174.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.53 -17.01 60.81 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.085 -1.009 . . . . 0.0 113.57 -174.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -74.03 -21.25 60.03 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.537 1.135 . . . . 0.0 113.786 171.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.5 pt -118.19 10.42 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.144 1.778 . . . . 0.0 113.006 -175.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.6 m . . . . . 0 C--O 1.253 1.283 0 C-N-CA 126.473 1.909 . . . . 0.0 112.024 177.721 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.8 ttm . . . . . 0 N--CA 1.503 2.207 0 CA-C-O 119.739 -0.172 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -88.01 83.2 7.06 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.3 1.04 . . . . 0.0 110.207 176.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -73.44 150.16 41.87 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 121.764 -0.585 . . . . 0.0 111.563 -175.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.6 t -109.7 146.86 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.346 1.058 . . . . 0.0 111.124 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.2 tpp -131.36 118.39 20.22 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.747 0.819 . . . . 0.0 110.643 168.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -88.41 131.32 34.9 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.302 1.041 . . . . 0.0 111.185 169.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.3 t -127.06 126.37 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.981 1.312 . . . . 0.0 110.643 -173.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.1 m -140.66 172.0 13.32 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.46 1.104 . . . . 0.0 111.303 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.95 -46.3 82.16 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 120.779 -1.201 . . . . 0.0 109.986 169.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -98.66 113.71 25.89 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.126 1.371 . . . . 0.0 109.821 169.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -62.28 -41.84 98.83 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 119.474 1.034 . . . . 0.0 109.43 169.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.2 p -46.35 -32.97 3.49 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.972 2.509 . . . . 0.0 116.894 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.4 p -98.99 -97.39 0.23 Allowed 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 123.832 0.853 . . . . 0.0 110.233 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -64.22 -44.1 92.95 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.859 1.264 . . . . 0.0 113.792 -169.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.9 m -63.11 -45.39 92.25 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.789 1.177 . . . . 0.0 111.889 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -63.81 -39.57 94.56 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 171.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 71.7 mtp -61.44 -44.76 96.55 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 120.769 -1.207 . . . . 0.0 110.994 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.52 -31.53 69.81 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 173.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -66.52 -50.44 63.19 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 119.478 1.036 . . . . 0.0 109.196 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.02 -45.48 95.85 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 118.868 -0.962 . . . . 0.0 112.634 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -64.17 -40.03 95.26 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.521 1.161 . . . . 0.0 112.416 173.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.44 -32.27 66.16 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.492 -1.38 . . . . 0.0 111.006 -176.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -62.42 -56.0 22.41 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 126.273 1.829 . . . . 0.0 110.159 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 67.9 p -70.46 -14.95 62.75 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.5 mt -100.98 -4.58 27.26 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.234 1.013 . . . . 0.0 113.62 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.58 5.37 1.15 Allowed Glycine 0 CA--C 1.534 1.256 0 N-CA-C 117.166 1.626 . . . . 0.0 117.166 -169.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.6 126.74 22.83 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.38 1.59 . . . . 0.0 112.539 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.9 -3.91 63.24 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 124.759 1.171 . . . . 0.0 115.877 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -87.61 -59.71 2.17 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 119.254 1.527 . . . . 0.0 110.613 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 pp -140.4 175.57 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 127.317 2.247 . . . . 0.0 109.538 170.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.78 125.98 42.89 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.998 0.904 . . . . 0.0 111.547 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.4 m -90.13 151.14 3.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 124.268 1.027 . . . . 0.0 112.295 169.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.72 152.81 39.43 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.439 1.095 . . . . 0.0 111.621 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.2 p -130.26 133.1 46.26 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.348 1.459 . . . . 0.0 114.925 174.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.3 p -134.47 173.3 11.8 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 127.618 2.367 . . . . 0.0 110.399 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.8 176.89 47.83 Favored Glycine 0 CA--C 1.525 0.68 0 O-C-N 120.248 -1.533 . . . . 0.0 114.7 169.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 27.9 mt -65.84 -34.09 77.35 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.035 0.534 . . . . 0.0 111.78 -175.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -117.39 116.3 26.91 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.981 2.112 . . . . 0.0 109.63 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.2 p -77.53 48.91 0.69 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.282 2.233 . . . . 0.0 111.917 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.7 t -70.72 165.72 22.41 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.038 -1.437 . . . . 0.0 112.67 -170.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -64.99 159.14 23.71 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 125.024 1.329 . . . . 0.0 112.495 -175.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.7 m -54.39 114.44 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.093 -1.004 . . . . 0.0 109.133 169.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -66.44 129.54 94.15 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -168.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -60.01 -39.64 68.76 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.475 2.784 . . . . 0.0 113.682 -171.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.4 m -79.33 -32.23 43.3 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.86 -0.525 . . . . 0.0 110.986 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.0 -40.91 87.43 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.832 -1.168 . . . . 0.0 112.568 173.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.9 mt -53.02 -39.82 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 120.613 1.551 . . . . 0.0 110.614 172.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.55 -64.31 0.89 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.432 0.693 . . . . 0.0 112.781 172.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.8 mmt -65.11 -23.68 67.22 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -171.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 89.7 mmm -85.59 -34.55 21.42 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.584 0.754 . . . . 0.0 110.732 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -62.06 -31.04 71.42 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.698 -1.251 . . . . 0.0 111.963 171.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -55.27 -30.57 60.37 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.75 0.82 . . . . 0.0 112.891 172.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.4 m -106.45 17.28 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 175.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.0 13.14 69.75 Favored Glycine 0 CA--C 1.536 1.388 0 O-C-N 121.085 -1.009 . . . . 0.0 115.225 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.4 mt -117.13 91.63 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.123 1.369 . . . . 0.0 110.061 -169.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -77.63 114.4 16.43 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.795 -1.19 . . . . 0.0 110.615 171.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.9 pt -91.31 -5.3 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 172.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 t -63.17 -27.65 69.52 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.352 1.433 . . . . 0.0 113.558 -169.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.62 9.82 60.68 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 124.977 1.275 . . . . 0.0 115.353 173.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -89.36 148.8 23.31 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 118.838 1.319 . . . . 0.0 113.2 -169.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.7 t -61.62 146.81 47.79 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.9 t -136.78 49.95 2.04 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 122.082 0.944 . . . . 0.0 112.403 175.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -64.66 145.05 98.81 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 125.241 1.416 . . . . 0.0 113.542 -172.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.28 154.39 32.17 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.804 2.336 . . . . 0.0 112.035 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.1 tt -62.93 -21.96 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -92.6 -10.83 36.08 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -91.4 -35.24 14.49 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.484 0.714 . . . . 0.0 111.962 171.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.36 164.48 25.67 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.562 0.745 . . . . 0.0 112.045 174.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -140.8 131.36 25.45 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.89 0.876 . . . . 0.0 110.921 169.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.4 6.13 4.93 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 115.551 1.685 . . . . 0.0 115.551 -174.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -71.58 -30.07 65.42 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.007 -1.058 . . . . 0.0 112.181 -174.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -93.48 -4.92 50.31 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.905 1.282 . . . . 0.0 113.511 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -125.24 79.47 1.8 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.542 1.537 . . . . 0.0 110.431 -171.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -69.06 0.78 4.17 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -171.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.0 t -129.03 94.64 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 125.868 1.667 . . . . 0.0 108.832 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.3 t -112.43 119.03 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 121.315 -0.866 . . . . 0.0 110.457 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 mp -110.2 134.38 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 124.281 1.032 . . . . 0.0 110.112 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.8 t -94.15 145.24 24.84 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.704 1.602 . . . . 0.0 109.854 169.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.5 mt -125.05 44.44 2.79 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.305 1.042 . . . . 0.0 111.39 -173.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 26.8 p -148.84 -9.13 0.35 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 -170.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.55 29.54 74.95 Favored Glycine 0 CA--C 1.537 1.431 0 O-C-N 121.137 -0.977 . . . . 0.0 111.027 -168.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.8 p -142.28 9.5 1.86 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.613 1.565 . . . . 0.0 114.188 -169.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -51.81 -26.87 18.82 Favored Glycine 0 CA--C 1.536 1.359 0 N-CA-C 116.994 1.558 . . . . 0.0 116.994 -169.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.7 m -64.76 -15.93 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 118.989 1.395 . . . . 0.0 114.108 173.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -81.96 -10.7 59.18 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.217 1.407 . . . . 0.0 113.433 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 80.5 mt -72.26 158.99 86.59 Favored Pre-proline 0 CA--C 1.55 0.949 0 O-C-N 121.292 -0.88 . . . . 0.0 111.277 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.54 132.12 48.57 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.657 2.238 . . . . 0.0 110.755 174.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -60.62 -30.63 90.91 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.542 2.162 . . . . 0.0 113.57 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -60.19 -31.74 70.43 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.949 -1.094 . . . . 0.0 112.867 171.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -87.98 13.2 11.49 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.747 1.219 . . . . 0.0 113.631 175.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.9 t -118.86 -34.75 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 126.565 1.946 . . . . 0.0 112.168 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.0 p -80.85 12.65 3.1 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 -169.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -66.91 161.97 22.86 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.348 1.459 . . . . 0.0 112.149 170.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -60.02 -36.75 77.92 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -169.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.7 mt -115.35 117.05 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.79 0.836 . . . . 0.0 109.307 169.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -134.51 126.56 29.63 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.362 1.065 . . . . 0.0 110.372 169.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -147.24 160.46 42.46 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.802 1.641 . . . . 0.0 110.85 -173.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -126.04 133.03 51.85 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.328 0.651 . . . . 0.0 111.679 169.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -90.04 -0.42 57.58 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 63.88 39.62 8.06 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 169.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.3 mt -93.01 157.6 16.22 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -172.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -102.58 144.48 30.94 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.552 1.941 . . . . 0.0 111.223 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -73.65 121.73 85.87 Favored Pre-proline 0 N--CA 1.475 0.791 0 CA-C-N 119.463 1.029 . . . . 0.0 111.866 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -83.89 -15.32 7.05 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.702 2.268 . . . . 0.0 114.856 -172.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -51.57 109.86 0.4 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.312 1.045 . . . . 0.0 112.442 175.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.85 -0.63 84.61 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 123.804 0.716 . . . . 0.0 114.446 176.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -76.01 171.36 14.59 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 118.437 1.119 . . . . 0.0 109.863 169.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 88.1 p -65.92 156.3 33.9 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.051 -1.031 . . . . 0.0 111.707 169.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.7 mp -64.51 -28.18 69.48 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.112 -0.993 . . . . 0.0 111.725 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -59.48 -41.06 88.95 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.048 -1.032 . . . . 0.0 112.389 170.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 79.4 t -73.79 -36.69 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 O-C-N 121.24 -0.913 . . . . 0.0 110.243 175.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.02 -40.3 97.35 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.277 0.631 . . . . 0.0 111.038 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -70.45 -36.49 73.97 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 120.772 -1.205 . . . . 0.0 112.545 170.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 55.0 m -58.98 -47.63 84.46 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.866 0.867 . . . . 0.0 111.662 175.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.6 m -67.46 -29.08 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 119.784 1.175 . . . . 0.0 111.673 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -45.36 94.11 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 119.968 1.258 . . . . 0.0 110.934 169.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.23 -40.85 97.88 Favored Glycine 0 N--CA 1.474 1.232 0 CA-C-N 118.856 0.753 . . . . 0.0 112.125 174.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -67.28 -43.41 81.85 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.0 m -66.91 -40.37 85.59 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.598 0 CA-C-N 120.071 1.305 . . . . 0.0 110.53 176.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -51.43 -55.0 21.1 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 120.587 1.539 . . . . 0.0 111.464 175.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -50.33 -47.48 55.83 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.301 1.44 . . . . 0.0 112.19 177.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -89.54 -27.75 20.06 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.451 0.701 . . . . 0.0 112.423 -170.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.22 -49.85 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.027 1.331 . . . . 0.0 109.308 169.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -54.09 -54.83 34.02 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.12 0.873 . . . . 0.0 109.551 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -51.58 -37.34 49.39 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.769 1.628 . . . . 0.0 112.676 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -79.22 -61.35 2.04 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.057 0.943 . . . . 0.0 112.92 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.72 -33.76 63.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.25 1.42 . . . . 0.0 112.063 -174.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.69 -17.89 61.08 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -174.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -77.56 -15.98 58.92 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.699 1.199 . . . . 0.0 113.816 171.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 20.6 pt -120.88 24.72 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 126.934 2.094 . . . . 0.0 111.778 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--O 1.255 1.344 0 C-N-CA 127.824 2.45 . . . . 0.0 111.469 178.099 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 tpp . . . . . 0 N--CA 1.501 2.092 0 CA-C-O 119.362 -0.352 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -83.22 87.92 6.93 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 119.408 1.004 . . . . 0.0 111.21 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -77.94 146.87 35.26 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -171.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.2 t -108.38 143.5 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.672 1.189 . . . . 0.0 110.473 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.1 tpp -129.44 114.4 16.1 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.964 0.906 . . . . 0.0 110.919 169.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -83.31 140.89 32.2 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.642 -0.661 . . . . 0.0 110.382 169.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.5 t -135.89 127.72 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 125.165 1.386 . . . . 0.0 110.507 -175.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.0 p -144.04 -179.2 6.35 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.673 1.189 . . . . 0.0 111.932 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -60.23 -70.98 0.14 Allowed 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 119.472 1.033 . . . . 0.0 109.744 169.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.3 mtt-85 -82.8 121.39 26.85 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 169.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -66.93 -45.26 78.42 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 119.137 0.881 . . . . 0.0 108.883 169.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.4 p -48.77 -31.41 6.95 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 127.975 2.51 . . . . 0.0 115.829 -175.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 86.9 p -91.66 -96.1 0.13 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.186 1.394 . . . . 0.0 110.908 169.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -56.27 -56.25 23.35 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -168.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.2 m -69.04 -33.28 73.35 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.709 1.14 . . . . 0.0 113.034 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -66.69 -39.05 87.93 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.358 1.463 . . . . 0.0 113.17 169.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 77.2 mtp -58.85 -45.47 90.01 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.633 0.773 . . . . 0.0 110.977 170.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.56 -28.59 67.09 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 117.7 -1.143 . . . . 0.0 113.609 173.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -72.23 -46.14 57.34 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 121.464 1.938 . . . . 0.0 108.836 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.11 -50.82 62.67 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-O 118.556 -1.136 . . . . 0.0 112.343 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -61.55 -41.24 97.08 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.126 1.463 . . . . 0.0 112.782 175.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.467 ' HB1' HG11 ' A' ' 32' ' ' VAL . . . -72.69 -29.72 63.64 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 120.812 -1.18 . . . . 0.0 111.216 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -65.31 -55.89 15.77 Favored 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 125.205 1.402 . . . . 0.0 109.977 170.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.5 p -71.09 -9.54 58.23 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 49.7 mt -101.83 -1.6 31.89 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 170.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -160.57 13.59 0.17 Allowed Glycine 0 CA--C 1.536 1.402 0 N-CA-C 118.262 2.065 . . . . 0.0 118.262 -171.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.82 -30.26 68.82 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 120.673 2.237 . . . . 0.0 114.331 -171.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.97 1.13 87.5 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 124.454 1.026 . . . . 0.0 114.949 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -112.28 -107.75 0.36 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.42 1.888 . . . . 0.0 110.407 -171.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -95.73 174.55 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 126.104 1.762 . . . . 0.0 111.492 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.6 129.13 39.97 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.22 -0.925 . . . . 0.0 112.264 175.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.467 HG11 ' HB1' ' A' ' 22' ' ' ALA . 30.1 m -99.19 148.25 6.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 124.367 1.067 . . . . 0.0 112.662 170.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.48 153.79 39.97 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.254 1.022 . . . . 0.0 111.115 -174.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.6 p -137.2 136.61 38.32 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.974 1.31 . . . . 0.0 114.163 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.5 t -140.38 -178.84 5.68 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.843 2.057 . . . . 0.0 110.746 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.88 177.97 41.86 Favored Glycine 0 CA--C 1.527 0.815 0 O-C-N 120.684 -1.26 . . . . 0.0 114.834 171.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.9 mt -62.5 -34.26 76.51 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.044 0.938 . . . . 0.0 111.725 -176.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -127.02 112.39 15.18 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.21 2.204 . . . . 0.0 107.754 169.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.5 p -61.51 -36.35 80.28 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.41 -0.806 . . . . 0.0 111.886 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.2 t 52.57 -135.22 1.54 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.943 1.297 . . . . 0.0 110.41 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.4 ptp85 -127.22 -139.59 0.26 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 126.735 2.014 . . . . 0.0 110.827 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.4 m -105.77 115.08 46.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 168.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -64.62 131.1 95.02 Favored Pre-proline 0 N--CA 1.48 1.045 0 O-C-N 121.176 -0.953 . . . . 0.0 112.378 -168.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -60.06 -37.66 82.95 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.432 2.755 . . . . 0.0 113.944 -169.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 33.5 m -77.78 -33.37 52.66 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.933 -0.479 . . . . 0.0 110.461 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.38 -38.79 92.27 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.073 -1.017 . . . . 0.0 112.56 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 70.4 mt -53.23 -44.46 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 120.657 1.571 . . . . 0.0 110.134 174.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.0 -58.95 4.77 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.0 mmt -65.15 -21.64 66.81 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -174.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 87.8 mmm -89.9 -38.89 13.39 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.015 0.926 . . . . 0.0 110.762 176.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -58.52 -36.61 74.09 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.577 -1.327 . . . . 0.0 112.205 169.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -54.43 -32.24 57.01 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.333 1.053 . . . . 0.0 113.672 173.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.2 m -101.6 13.98 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.694 1.198 . . . . 0.0 113.973 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.29 16.38 62.64 Favored Glycine 0 CA--C 1.535 1.337 0 O-C-N 121.184 -0.947 . . . . 0.0 114.917 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.4 mt -122.08 75.7 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.727 1.611 . . . . 0.0 109.952 -169.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -68.09 105.33 2.02 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 120.283 -1.511 . . . . 0.0 110.494 173.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.0 pt -84.35 -5.52 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.542 0.737 . . . . 0.0 112.833 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 92.4 p -64.92 -28.93 69.87 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -169.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.43 7.8 77.6 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.803 1.192 . . . . 0.0 114.58 172.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -98.87 149.83 22.52 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.196 1.398 . . . . 0.0 112.522 -169.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.8 t -85.64 145.58 27.25 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -173.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.3 m -124.49 111.65 15.96 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.352 1.061 . . . . 0.0 110.381 170.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.15 158.11 50.04 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 124.001 0.92 . . . . 0.0 113.009 177.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -95.7 150.79 1.46 Allowed 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 124.176 3.251 . . . . 0.0 111.879 169.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.38 -19.15 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 115.424 1.638 . . . . 0.0 115.424 -172.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -99.68 -7.79 25.19 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -87.92 -39.43 14.76 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.379 -0.826 . . . . 0.0 111.491 169.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.98 161.12 31.68 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.559 0.743 . . . . 0.0 111.759 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -136.56 117.21 13.93 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.388 1.075 . . . . 0.0 110.452 173.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.98 -1.76 4.48 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -171.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.91 -30.49 67.92 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.083 -1.011 . . . . 0.0 112.202 -173.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -86.14 -2.57 58.46 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.781 1.232 . . . . 0.0 113.293 177.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -124.35 90.56 3.28 Favored 'General case' 0 C--N 1.343 0.326 0 C-N-CA 125.711 1.604 . . . . 0.0 110.269 -171.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -55.18 -27.84 48.72 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.196 1.398 . . . . 0.0 113.37 -177.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.29 115.74 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 125.156 1.382 . . . . 0.0 110.541 -172.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.0 t -122.91 129.08 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.913 0.885 . . . . 0.0 110.746 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.7 mm -117.58 124.15 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.455 0.702 . . . . 0.0 111.109 -172.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.1 t -88.19 105.6 17.64 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 169.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.419 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 64.0 mt -82.91 31.89 0.43 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.805 1.642 . . . . 0.0 110.966 175.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.3 t -164.7 157.2 16.44 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.866 2.466 . . . . 0.0 109.162 -169.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -73.66 34.88 0.85 Allowed Glycine 0 CA--C 1.546 1.97 0 C-N-CA 124.185 0.898 . . . . 0.0 112.385 168.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 67.3 m -90.77 -1.81 57.83 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.764 2.425 . . . . 0.0 113.225 -169.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -49.95 -35.14 24.57 Favored Glycine 0 N--CA 1.477 1.422 0 N-CA-C 116.633 1.413 . . . . 0.0 116.633 -169.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.1 m -82.34 -16.78 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 176.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -92.84 -22.22 19.42 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.501 1.52 . . . . 0.0 112.637 175.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.6 mt -62.83 150.06 88.31 Favored Pre-proline 0 CA--C 1.549 0.923 0 O-C-N 121.384 -0.822 . . . . 0.0 111.507 171.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -59.22 132.11 44.96 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.708 2.272 . . . . 0.0 110.698 169.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -59.73 -33.23 96.46 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.468 2.112 . . . . 0.0 113.522 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -66.18 -26.64 67.5 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.72 1.145 . . . . 0.0 113.538 175.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.38 -15.96 59.11 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.772 -1.205 . . . . 0.0 112.629 171.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.8 t -90.63 -40.22 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.882 1.673 . . . . 0.0 111.725 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.1 p -81.99 27.9 0.45 Allowed 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -172.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -79.61 169.7 17.63 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.084 1.354 . . . . 0.0 112.14 170.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -55.35 -39.79 70.47 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.121 0.968 . . . . 0.0 113.431 -169.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 58.9 mt -128.31 125.06 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.594 1.157 . . . . 0.0 109.545 170.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -128.52 141.46 51.37 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.436 1.094 . . . . 0.0 110.339 169.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.37 154.54 43.11 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.215 1.006 . . . . 0.0 112.121 -171.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -129.16 113.22 14.81 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.49 1.516 . . . . 0.0 110.226 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.419 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 37.0 m0 -94.0 5.32 52.07 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -173.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 63.45 -89.12 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.497 1.519 . . . . 0.0 112.026 -173.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.7 mt 53.85 -177.96 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 127.789 2.435 . . . . 0.0 115.511 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -142.0 148.26 38.27 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.8 2.04 . . . . 0.0 108.887 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.26 119.48 77.64 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 119.654 1.115 . . . . 0.0 110.575 176.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -83.94 -6.85 10.42 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 121.912 1.742 . . . . 0.0 113.881 -171.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -45.25 112.4 0.44 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.184 1.394 . . . . 0.0 112.783 174.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.42 3.14 82.04 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 123.66 0.647 . . . . 0.0 114.375 173.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -79.88 173.18 12.85 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.103 0.961 . . . . 0.0 109.927 169.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 86.2 p -63.68 153.8 35.01 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.183 -0.948 . . . . 0.0 111.732 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.47 -29.49 70.57 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.53 -0.731 . . . . 0.0 111.497 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -67.15 -34.9 78.55 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.786 -1.196 . . . . 0.0 113.144 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 78.8 t -69.46 -37.48 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 O-C-N 121.163 -0.96 . . . . 0.0 109.611 170.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.52 -39.08 93.11 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.717 0.807 . . . . 0.0 111.109 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -71.69 -38.09 70.63 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.062 1.345 . . . . 0.0 112.376 171.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 51.7 m -57.84 -48.1 80.75 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.608 1.095 . . . . 0.0 111.525 177.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.4 m -69.3 -29.92 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.937 176.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.28 -42.86 99.35 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 120.155 1.343 . . . . 0.0 111.515 169.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.76 -42.13 95.37 Favored Glycine 0 N--CA 1.476 1.331 0 C-N-CA 124.253 0.93 . . . . 0.0 112.661 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -63.32 -48.18 79.09 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.127 -0.631 . . . . 0.0 112.218 171.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.0 t -58.52 -44.9 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.633 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -52.37 -54.55 30.36 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 120.046 1.293 . . . . 0.0 111.51 175.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -61.76 -43.38 98.97 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.13 0.572 . . . . 0.0 112.209 -176.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 49.3 mtp85 -76.16 -31.86 58.76 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 36.8 t -61.87 -49.01 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.532 1.133 . . . . 0.0 110.591 170.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -53.62 -54.75 33.17 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.018 0.827 . . . . 0.0 109.701 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -55.19 -31.59 61.53 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.374 1.47 . . . . 0.0 112.9 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -81.83 -59.97 2.4 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.035 -1.04 . . . . 0.0 112.704 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.24 -32.68 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.789 1.236 . . . . 0.0 111.691 -176.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.58 -0.39 33.39 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -90.88 -15.65 29.55 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.809 1.244 . . . . 0.0 113.51 170.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.5 pt -121.31 8.43 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 126.188 1.795 . . . . 0.0 113.041 -176.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.4 p . . . . . 0 C--O 1.254 1.323 0 C-N-CA 126.446 1.898 . . . . 0.0 113.815 171.92 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.9 ttm . . . . . 0 N--CA 1.501 2.084 0 CA-C-O 119.325 -0.369 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -86.35 107.1 17.84 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 169.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -82.11 144.87 30.47 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 118.077 0.398 . . . . 0.0 110.907 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.0 t -101.66 142.22 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.672 0.789 . . . . 0.0 109.804 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 42.3 tpp -127.97 118.27 23.26 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.692 0.797 . . . . 0.0 110.754 169.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -89.67 138.51 31.41 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.88 -0.512 . . . . 0.0 110.834 169.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 t -130.17 129.32 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.546 1.538 . . . . 0.0 109.631 -171.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.7 m -141.14 171.48 14.0 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.002 1.321 . . . . 0.0 110.503 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -66.0 -49.28 68.34 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 119.91 1.232 . . . . 0.0 108.934 169.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -103.67 114.08 28.07 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 167.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.535 ' ND2' ' H ' ' A' ' 63' ' ' ASP . 31.1 t-20 -51.92 -48.51 64.17 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 120.474 1.488 . . . . 0.0 109.673 172.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.0 p -53.17 -32.85 49.91 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.1 p -78.37 -33.58 48.85 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -174.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 -140.34 -55.79 0.53 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.903 0.881 . . . . 0.0 112.488 -170.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 m -55.71 -40.86 73.0 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 120.087 1.312 . . . . 0.0 113.333 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -66.91 -35.43 79.98 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.698 1.599 . . . . 0.0 113.46 173.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.5 mtm -64.92 -50.43 66.52 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.782 -0.574 . . . . 0.0 110.565 172.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.8 -26.19 67.58 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.415 -0.803 . . . . 0.0 113.011 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -71.4 -49.44 42.0 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 119.507 1.048 . . . . 0.0 108.45 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.458 ' CA ' HE22 ' A' ' 60' ' ' GLN . . . -63.32 -41.62 99.43 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 119.245 -0.753 . . . . 0.0 112.953 177.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -62.45 -43.32 99.1 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.287 1.544 . . . . 0.0 112.22 172.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.64 -35.96 67.89 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.683 -1.26 . . . . 0.0 110.863 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -57.73 -49.6 76.0 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.344 1.858 . . . . 0.0 110.833 171.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.4 p -78.67 -24.46 45.11 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.868 1.432 . . . . 0.0 114.868 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.8 mt -89.5 -28.19 19.82 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.157 0.89 . . . . 0.0 113.045 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.74 -68.74 1.15 Allowed Glycine 0 N--CA 1.473 1.118 0 C-N-CA 124.711 1.148 . . . . 0.0 112.065 175.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 54.32 90.83 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.176 2.59 . . . . 0.0 115.462 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.85 -7.25 78.15 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 116.299 1.28 . . . . 0.0 116.299 169.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -68.85 -47.19 66.56 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 118.898 1.349 . . . . 0.0 110.817 174.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.6 pp -140.35 -176.06 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 127.749 2.42 . . . . 0.0 110.479 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.13 128.52 55.08 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.52 0.676 . . . . 0.0 112.551 172.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.5 m -95.16 151.48 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 124.592 1.157 . . . . 0.0 112.907 170.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.14 156.45 42.6 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.672 0.789 . . . . 0.0 111.41 -172.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 97.5 p -126.77 142.37 51.56 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.169 1.388 . . . . 0.0 114.023 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.6 t -145.77 170.78 15.85 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 126.897 2.079 . . . . 0.0 109.874 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.24 171.11 34.6 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 120.883 -1.136 . . . . 0.0 114.358 170.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 38.3 mt -62.17 -35.18 78.01 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 117.4 0.6 . . . . 0.0 111.812 -174.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -125.08 122.05 36.08 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.559 2.744 . . . . 0.0 106.545 169.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 55.4 p -73.07 -41.88 63.64 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.842 -1.162 . . . . 0.0 111.024 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.5 t 55.49 -167.51 0.1 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 126.282 1.833 . . . . 0.0 113.877 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -94.0 168.79 10.73 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 126.936 2.094 . . . . 0.0 112.29 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.6 m -61.15 114.16 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 169.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -71.04 132.19 86.68 Favored Pre-proline 0 N--CA 1.476 0.864 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -168.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -57.77 -39.72 84.99 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.951 3.1 . . . . 0.0 114.305 -173.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.3 m -80.31 -37.59 32.34 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.776 -0.578 . . . . 0.0 110.626 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.28 96.54 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.267 0.939 . . . . 0.0 112.076 175.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.0 mt -48.95 -49.09 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 120.132 1.333 . . . . 0.0 110.376 171.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.03 -58.13 7.6 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.6 mmt -65.71 -22.46 66.61 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -172.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 76.6 mmm -90.28 -40.01 12.41 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.372 1.469 . . . . 0.0 110.998 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -57.78 -35.47 70.84 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.83 -1.169 . . . . 0.0 112.348 170.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -53.41 -32.44 49.64 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.469 1.107 . . . . 0.0 113.064 170.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -94.85 5.98 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.703 1.201 . . . . 0.0 113.521 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.97 15.55 64.91 Favored Glycine 0 CA--C 1.538 1.498 0 O-C-N 120.916 -1.115 . . . . 0.0 114.433 -173.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.4 mt -121.04 61.64 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.95 1.7 . . . . 0.0 109.651 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -62.24 110.46 1.63 Allowed 'General case' 0 CA--C 1.548 0.893 0 O-C-N 120.082 -1.636 . . . . 0.0 110.892 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.6 pt -85.89 -4.5 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 118.496 -0.764 . . . . 0.0 112.941 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.5 t -61.79 -33.86 74.86 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.159 1.345 . . . . 0.0 112.731 -171.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.49 10.08 66.92 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.133 1.349 . . . . 0.0 115.432 172.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.458 HE22 ' CA ' ' A' ' 20' ' ' GLY . 5.8 tt0 -101.74 163.03 12.47 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.911 1.284 . . . . 0.0 112.838 -170.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 p -72.94 158.75 34.87 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.022 1.729 . . . . 0.0 115.408 -170.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.8 t -151.31 148.14 27.8 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.153 2.181 . . . . 0.0 108.466 168.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.535 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 1.0 OUTLIER -149.36 147.91 24.79 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.672 1.189 . . . . 0.0 111.201 178.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -90.3 152.19 4.55 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.679 2.92 . . . . 0.0 111.854 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 tt -65.31 -18.78 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -171.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -98.22 -7.21 29.69 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -88.47 -38.98 14.56 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.585 0.629 . . . . 0.0 111.436 169.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.87 161.8 30.27 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.697 0.799 . . . . 0.0 112.241 173.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.94 123.51 17.23 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.271 1.028 . . . . 0.0 110.926 169.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.94 2.43 3.5 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -169.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -67.58 -28.6 67.91 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.341 -0.85 . . . . 0.0 112.437 -173.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -93.4 -2.31 54.82 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.157 1.383 . . . . 0.0 113.28 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -123.43 80.12 1.75 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.196 1.798 . . . . 0.0 109.878 -170.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -59.41 -21.29 59.74 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.707 1.203 . . . . 0.0 114.087 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.6 t -117.91 109.6 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.869 1.268 . . . . 0.0 110.015 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.8 t -121.21 129.37 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.819 0.848 . . . . 0.0 111.233 -176.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.1 mm -119.7 118.35 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 O-C-N 121.534 -0.729 . . . . 0.0 111.233 -171.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.3 t -82.85 105.8 14.16 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 168.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.428 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 85.4 mt -79.07 -32.38 44.74 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.622 -0.674 . . . . 0.0 111.135 177.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 31.7 p -71.58 158.29 36.46 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 122.993 0.517 . . . . 0.0 110.41 169.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.69 37.71 1.88 Allowed Glycine 0 CA--C 1.54 1.648 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 168.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 5.5 p -127.38 20.82 6.71 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.486 1.914 . . . . 0.0 114.124 -169.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -55.6 -36.3 64.31 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.699 1.143 . . . . 0.0 114.651 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.1 m -69.55 -13.51 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.03 -2.64 49.86 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.485 1.514 . . . . 0.0 112.568 176.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.5 mt -78.68 158.28 75.94 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.991 0.917 . . . . 0.0 111.371 173.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.32 133.43 54.97 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.852 2.368 . . . . 0.0 111.68 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -60.59 -31.03 91.76 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.795 2.33 . . . . 0.0 113.62 -174.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -65.48 -30.01 70.74 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.729 -1.232 . . . . 0.0 113.264 173.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.35 -19.94 49.01 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.855 -1.153 . . . . 0.0 112.688 173.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.6 t -87.73 -34.39 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.047 1.739 . . . . 0.0 112.41 176.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.6 p -88.59 25.83 1.62 Allowed 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -171.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -77.2 168.35 20.21 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.508 1.123 . . . . 0.0 112.263 169.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -55.72 -38.59 69.95 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -169.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 59.7 mt -126.03 123.51 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.717 1.207 . . . . 0.0 108.872 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -128.24 140.87 51.66 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.097 0.959 . . . . 0.0 110.702 169.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.84 154.95 44.67 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.671 1.188 . . . . 0.0 112.093 -171.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -130.13 115.45 17.07 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.9 1.28 . . . . 0.0 110.89 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.428 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 35.7 m0 -98.51 -1.63 40.72 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.457 1.103 . . . . 0.0 113.792 -175.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.32 1.2 pp0? 44.75 41.73 5.29 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 116.603 2.075 . . . . 0.0 116.603 172.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.8 mt -84.42 134.25 34.47 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.984 1.313 . . . . 0.0 112.977 -177.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -64.74 153.87 38.51 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.987 1.315 . . . . 0.0 111.977 172.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -81.72 116.74 64.98 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 121.192 -0.942 . . . . 0.0 112.832 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -84.52 -27.27 1.42 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.794 2.329 . . . . 0.0 115.103 -169.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -70.97 81.7 0.66 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.667 1.987 . . . . 0.0 111.949 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 141.17 -10.66 2.78 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 126.496 1.998 . . . . 0.0 113.785 -174.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -91.39 175.8 6.79 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.845 1.658 . . . . 0.0 111.624 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 96.9 p -70.86 159.77 34.0 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.628 -0.67 . . . . 0.0 111.581 169.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.9 -31.04 72.02 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.463 -0.773 . . . . 0.0 112.194 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.08 -40.89 95.41 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.05 -1.031 . . . . 0.0 112.283 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 94.0 t -72.93 -35.91 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.626 0.77 . . . . 0.0 110.47 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -60.15 -49.76 76.38 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.781 0.832 . . . . 0.0 110.638 173.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 66.4 mtt85 -63.14 -23.54 67.48 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.307 1.443 . . . . 0.0 113.453 173.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 57.4 m -75.63 -55.32 5.78 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.624 1.169 . . . . 0.0 111.412 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 19.2 m -65.54 -32.31 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 119.82 1.191 . . . . 0.0 110.762 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.47 -43.75 89.06 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 126.606 1.962 . . . . 0.0 112.939 169.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.43 -38.4 86.83 Favored Glycine 0 N--CA 1.476 1.323 0 C-N-CA 123.964 0.792 . . . . 0.0 113.392 174.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -61.94 -43.31 99.1 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.512 -0.993 . . . . 0.0 111.814 169.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 32.5 t -58.58 -47.65 87.91 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 CA-C-O 117.861 -1.066 . . . . 0.0 109.772 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -49.81 -55.36 14.43 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.866 1.212 . . . . 0.0 111.571 175.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -61.1 -43.75 98.41 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.5 mtp85 -76.12 -33.55 59.45 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.6 t -63.56 -46.09 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.122 0.969 . . . . 0.0 111.224 172.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -52.49 -54.97 25.46 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.246 0.93 . . . . 0.0 109.943 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -55.17 -37.75 67.42 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.783 1.233 . . . . 0.0 112.676 176.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -74.79 -57.28 4.01 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.18 -0.95 . . . . 0.0 112.752 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.56 -34.53 71.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.692 1.197 . . . . 0.0 112.168 -177.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.57 -15.8 60.83 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -173.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -73.43 -31.03 63.6 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.43 1.092 . . . . 0.0 113.382 170.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.9 pt -107.64 -7.15 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.323 1.449 . . . . 0.0 113.389 -174.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 73.9 m . . . . . 0 C--O 1.253 1.282 0 C-N-CA 125.779 1.632 . . . . 0.0 112.711 171.007 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 ttm . . . . . 0 N--CA 1.503 2.208 0 CA-C-O 119.77 -0.157 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -85.73 82.33 8.24 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.212 1.005 . . . . 0.0 110.777 173.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -72.18 139.23 48.14 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.208 1.003 . . . . 0.0 111.714 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.9 t -113.2 146.25 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.291 1.036 . . . . 0.0 111.657 -173.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.2 tpp -132.91 122.59 24.56 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.188 0.995 . . . . 0.0 111.573 169.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -95.88 134.86 38.36 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.267 1.027 . . . . 0.0 111.387 169.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.1 t -128.63 130.16 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.968 1.307 . . . . 0.0 111.436 -170.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.0 p -149.28 179.49 7.88 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.471 1.108 . . . . 0.0 111.953 173.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -66.33 -61.92 1.75 Allowed 'General case' 0 N--CA 1.483 1.208 0 O-C-N 120.79 -1.194 . . . . 0.0 111.102 173.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.32 110.98 19.01 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.223 1.009 . . . . 0.0 109.197 169.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -61.68 -34.96 76.67 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.156 0.889 . . . . 0.0 110.331 169.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.3 p -48.47 -37.89 18.53 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.828 2.451 . . . . 0.0 115.836 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.9 p -97.62 -92.39 0.24 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.329 1.052 . . . . 0.0 111.329 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.69 -54.24 49.13 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 120.924 -1.11 . . . . 0.0 113.764 -169.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.402 ' HB3' ' HB2' ' A' ' 34' ' ' SER . 18.5 m -63.6 -42.29 98.27 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.136 0.88 . . . . 0.0 111.868 -176.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -60.74 -39.82 90.11 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.447 1.499 . . . . 0.0 114.564 169.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 78.4 mtp -64.43 -45.97 85.21 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.167 0.894 . . . . 0.0 110.748 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.0 -25.78 64.68 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 172.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -67.27 -53.27 31.4 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.051 1.296 . . . . 0.0 108.168 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.56 -43.55 96.37 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 118.714 -1.048 . . . . 0.0 112.266 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -63.27 -43.41 98.04 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.852 1.826 . . . . 0.0 112.21 172.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.86 -35.56 64.78 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.198 1.363 . . . . 0.0 110.923 -173.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -60.44 -59.22 5.74 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 125.38 1.472 . . . . 0.0 109.378 169.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.0 p -66.5 -13.58 61.09 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.5 mt -97.87 -5.59 34.23 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 172.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.66 15.69 0.11 Allowed Glycine 0 CA--C 1.536 1.36 0 N-CA-C 118.304 2.081 . . . . 0.0 118.304 -171.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.69 -34.54 59.1 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 119.696 1.748 . . . . 0.0 114.643 -170.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.49 -5.58 86.76 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.38 0.99 . . . . 0.0 115.319 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -99.52 -60.87 1.45 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 118.632 1.216 . . . . 0.0 111.947 -170.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -139.85 170.64 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 126.846 2.059 . . . . 0.0 110.319 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.67 125.13 39.12 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 122.122 0.963 . . . . 0.0 111.275 175.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.2 m -92.79 153.61 3.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.901 169.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.73 149.94 34.39 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.435 0.694 . . . . 0.0 111.71 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' A' ' 15' ' ' SER . 34.4 p -119.92 139.34 52.57 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.994 2.118 . . . . 0.0 113.347 171.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.9 p -144.88 172.86 12.43 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.015 1.326 . . . . 0.0 110.777 169.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.68 -179.82 44.58 Favored Glycine 0 CA--C 1.52 0.367 0 O-C-N 120.383 -1.448 . . . . 0.0 114.569 171.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 34.7 mt -63.69 -30.07 71.22 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.78 0.432 . . . . 0.0 111.532 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -121.39 123.79 42.95 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.877 2.071 . . . . 0.0 108.948 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.3 p -77.8 43.23 0.41 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.92 1.688 . . . . 0.0 111.898 175.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.9 p -63.14 155.01 29.3 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.564 1.545 . . . . 0.0 113.337 -169.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -65.68 177.66 1.19 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.819 1.647 . . . . 0.0 114.471 -169.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 m -63.45 110.33 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 119.866 -1.771 . . . . 0.0 109.617 169.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -67.9 135.46 92.06 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-O 118.413 -0.803 . . . . 0.0 112.414 -169.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -58.79 -39.92 77.38 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.367 2.711 . . . . 0.0 113.795 -174.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.7 m -77.44 -37.87 50.67 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.869 0.468 . . . . 0.0 110.581 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.04 -41.83 97.26 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 118.143 -0.932 . . . . 0.0 112.448 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 66.8 mt -50.8 -47.01 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 120.482 1.492 . . . . 0.0 110.426 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.99 -59.76 3.8 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 175.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 31.0 mmt -67.29 -20.88 65.69 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -172.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 83.9 mmm -90.15 -37.52 14.14 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.721 0.809 . . . . 0.0 110.619 175.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -58.53 -36.46 73.88 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.58 -1.325 . . . . 0.0 112.129 169.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -54.25 -32.75 56.85 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.162 0.985 . . . . 0.0 113.59 172.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.6 m -100.67 13.18 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 124.818 1.247 . . . . 0.0 114.19 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.14 17.2 59.6 Favored Glycine 0 N--CA 1.476 1.329 0 O-C-N 121.047 -1.033 . . . . 0.0 114.896 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.0 mt -126.6 64.49 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.894 1.678 . . . . 0.0 109.965 -169.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -63.47 109.16 1.54 Allowed 'General case' 0 CA--C 1.545 0.759 0 O-C-N 119.985 -1.697 . . . . 0.0 110.905 173.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.1 pt -83.98 -4.89 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 118.36 -0.828 . . . . 0.0 113.04 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -60.13 -30.1 69.07 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 120.495 1.498 . . . . 0.0 113.502 -169.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.36 5.53 71.02 Favored Glycine 0 CA--C 1.541 1.667 0 C-N-CA 124.82 1.2 . . . . 0.0 115.534 173.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -98.82 140.37 33.11 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.11 1.455 . . . . 0.0 112.324 -171.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.8 t -71.21 155.83 40.27 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -173.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.1 m -128.37 143.2 50.97 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.738 1.615 . . . . 0.0 110.49 169.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -138.15 150.86 68.46 Favored Pre-proline 0 N--CA 1.485 1.295 0 CA-C-N 119.616 1.098 . . . . 0.0 113.36 -172.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -88.92 151.03 5.88 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.533 2.155 . . . . 0.0 112.165 177.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.5 tt -62.57 -17.83 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 125.125 1.37 . . . . 0.0 114.55 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.26 -8.05 27.98 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -87.68 -38.89 15.45 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.077 0.853 . . . . 0.0 111.258 170.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.11 157.52 38.04 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.392 0.677 . . . . 0.0 111.409 172.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.25 121.24 13.66 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.721 0.809 . . . . 0.0 111.156 170.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.16 1.79 1.89 Allowed 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -170.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -67.06 -28.1 67.92 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.147 -0.97 . . . . 0.0 111.979 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -93.8 -1.13 55.39 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.41 1.484 . . . . 0.0 113.418 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -130.24 91.62 3.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.615 1.566 . . . . 0.0 110.586 -171.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -59.62 -21.25 60.17 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.7 t -123.28 108.13 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.956 1.302 . . . . 0.0 110.41 -169.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.416 ' C ' HD12 ' A' ' 77' ' ' ILE . 22.6 t -125.58 127.6 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.674 0.79 . . . . 0.0 111.452 -176.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.416 HD12 ' C ' ' A' ' 76' ' ' VAL . 1.6 mp -118.86 130.93 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.39 1.076 . . . . 0.0 110.206 -170.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.7 t -90.32 124.88 35.28 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.912 1.285 . . . . 0.0 108.092 168.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.426 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 76.1 mt -104.24 23.44 13.09 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.824 1.649 . . . . 0.0 112.572 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 27.1 p -124.26 -176.92 3.63 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.705 2.002 . . . . 0.0 108.533 169.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.47 38.87 2.94 Favored Glycine 0 CA--C 1.538 1.531 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 168.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.0 p -136.55 16.72 3.13 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -168.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -54.14 -30.34 46.87 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 119.933 1.242 . . . . 0.0 115.872 -171.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.2 m -68.87 -15.52 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 175.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -83.19 -14.19 53.9 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.87 1.268 . . . . 0.0 112.99 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.8 mt -68.81 158.29 86.38 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 123.584 0.754 . . . . 0.0 111.432 174.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.67 132.77 53.82 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.703 2.269 . . . . 0.0 111.076 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -59.71 -33.95 96.29 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.426 2.084 . . . . 0.0 113.502 -171.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -64.62 -28.6 69.73 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.704 -1.247 . . . . 0.0 113.325 174.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.64 -4.52 52.02 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.797 -1.19 . . . . 0.0 112.859 172.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 72.3 t -104.78 -41.54 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.452 1.901 . . . . 0.0 111.391 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.3 p -82.04 49.12 1.33 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.637 1.175 . . . . 0.0 113.517 -173.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -104.64 170.31 7.96 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.282 1.833 . . . . 0.0 111.945 176.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -58.38 -37.25 74.87 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.736 0.815 . . . . 0.0 112.89 -170.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 56.2 mt -128.48 120.61 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.95 1.3 . . . . 0.0 108.512 169.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -130.37 138.11 50.23 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.03 0.932 . . . . 0.0 110.857 169.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -140.08 151.06 45.07 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.88 1.272 . . . . 0.0 112.05 -175.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -123.55 99.97 6.57 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.924 1.29 . . . . 0.0 109.886 175.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.426 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 39.5 m0 -79.37 -4.55 51.51 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -170.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.372 1.1 pp0? 50.4 37.55 15.83 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.034 1.734 . . . . 0.0 115.586 170.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 69.3 mt -75.5 157.82 33.45 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.834 1.254 . . . . 0.0 112.352 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -85.19 161.48 19.59 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.961 1.304 . . . . 0.0 111.438 170.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -89.52 122.03 68.67 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.511 1.124 . . . . 0.0 112.141 175.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -93.82 -18.69 0.5 Allowed 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 121.688 1.592 . . . . 0.0 114.872 -169.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -44.15 108.11 0.11 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.007 2.123 . . . . 0.0 113.355 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.22 8.58 62.27 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.544 1.069 . . . . 0.0 115.606 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -79.24 -65.75 0.96 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.004 1.402 . . . . 0.0 111.279 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.6 t -170.44 151.71 3.78 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.603 1.961 . . . . 0.0 109.247 171.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.2 mp -59.85 -29.09 68.06 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.204 0.602 . . . . 0.0 111.218 172.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.95 -39.88 95.98 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.95 -1.094 . . . . 0.0 112.332 173.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 86.4 t -71.61 -39.45 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.655 0.782 . . . . 0.0 109.254 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.35 -44.49 94.67 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.14 0.976 . . . . 0.0 111.739 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 -68.7 -37.39 79.49 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.201 -0.937 . . . . 0.0 112.092 172.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 64.0 m -58.58 -49.46 77.38 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 119.007 0.821 . . . . 0.0 111.674 175.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.8 m -69.97 -30.17 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 117.847 -1.073 . . . . 0.0 112.186 176.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -42.66 94.94 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 120.595 1.543 . . . . 0.0 111.595 169.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.68 -42.62 95.28 Favored Glycine 0 N--CA 1.474 1.175 0 C-N-CA 124.017 0.817 . . . . 0.0 112.758 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -62.32 -47.48 84.06 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 122.172 -0.605 . . . . 0.0 112.057 171.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 36.2 t -60.25 -45.32 96.37 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.059 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -52.47 -53.96 38.71 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 119.92 1.236 . . . . 0.0 111.843 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.21 -45.89 91.34 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.863 0.465 . . . . 0.0 112.08 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 66.9 mtt-85 -71.61 -33.29 68.87 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.1 t -65.2 -47.62 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.941 171.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -53.64 -54.32 39.34 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.604 1.093 . . . . 0.0 109.658 174.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -54.42 -37.33 64.97 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.206 1.003 . . . . 0.0 112.704 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -78.0 -57.56 3.73 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.213 0.915 . . . . 0.0 112.278 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.71 -32.69 59.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.666 1.187 . . . . 0.0 112.281 -176.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.77 -18.44 58.44 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -174.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -72.28 -21.89 61.29 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.551 1.141 . . . . 0.0 113.42 170.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.2 pt -114.76 20.48 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 126.504 1.921 . . . . 0.0 112.287 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.255 1.361 0 C-N-CA 127.759 2.424 . . . . 0.0 111.528 176.174 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.7 ttp . . . . . 0 N--CA 1.503 2.181 0 CA-C-O 119.889 -0.1 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -85.61 106.32 16.83 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.227 0.611 . . . . 0.0 109.972 171.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -77.84 149.61 34.33 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.144 0.578 . . . . 0.0 110.973 176.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 56.8 t -107.85 143.5 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.207 1.003 . . . . 0.0 110.226 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 58.4 tpp -130.55 116.22 17.85 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.483 0.713 . . . . 0.0 109.857 169.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -86.75 142.15 28.35 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 121.705 -0.622 . . . . 0.0 110.541 169.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.8 t -133.06 128.92 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.663 1.185 . . . . 0.0 111.562 -174.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.3 p -145.95 175.64 10.29 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.688 0.795 . . . . 0.0 111.564 169.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -61.21 -36.35 79.67 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 120.901 -1.125 . . . . 0.0 112.212 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -108.21 136.11 48.42 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.234 1.413 . . . . 0.0 111.113 169.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -98.29 -0.15 44.49 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.792 0.724 . . . . 0.0 110.971 168.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.4 p -74.51 -24.94 59.07 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.117 1.367 . . . . 0.0 112.936 169.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 t -133.49 -164.61 1.51 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.481 1.913 . . . . 0.0 109.73 174.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 41.03 -80.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 128.685 2.794 . . . . 0.0 116.159 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.0 p -56.37 -44.26 80.01 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.148 0.979 . . . . 0.0 112.347 173.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -63.64 -35.51 80.75 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 120.068 1.304 . . . . 0.0 113.408 168.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 87.8 mtp -61.45 -47.08 87.36 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.082 0.855 . . . . 0.0 110.177 176.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.76 -29.03 68.14 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 118.043 -0.98 . . . . 0.0 113.129 175.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -65.06 -54.28 32.55 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 120.277 1.398 . . . . 0.0 108.747 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.96 -45.66 96.15 Favored Glycine 0 CA--C 1.521 0.462 0 CA-C-O 118.882 -0.955 . . . . 0.0 112.814 -176.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.48 -33.85 73.19 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.155 0.977 . . . . 0.0 112.464 172.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.506 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -77.73 -37.52 49.13 Favored 'General case' 0 C--O 1.225 -0.189 0 O-C-N 121.256 -0.903 . . . . 0.0 111.607 -175.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -69.17 -40.78 77.93 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.77 1.168 . . . . 0.0 112.358 169.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.1 p -67.52 -6.35 19.37 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 121.489 1.95 . . . . 0.0 114.516 171.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.6 mt -111.62 0.01 16.24 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 171.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.7 16.52 0.22 Allowed Glycine 0 CA--C 1.536 1.37 0 N-CA-C 116.712 1.445 . . . . 0.0 116.712 -169.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.98 129.43 41.91 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.823 1.312 . . . . 0.0 111.634 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.49 -3.65 58.59 Favored Glycine 0 CA--C 1.539 1.531 0 CA-C-O 118.526 -1.152 . . . . 0.0 115.691 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -83.84 -58.47 2.78 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 119.675 1.738 . . . . 0.0 110.892 176.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -141.03 177.4 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.936 2.095 . . . . 0.0 110.898 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.93 109.32 21.7 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.131 -0.98 . . . . 0.0 111.672 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.506 HG11 ' HB3' ' A' ' 22' ' ' ALA . 40.0 t -85.74 135.75 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 125.757 1.623 . . . . 0.0 111.65 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.85 159.29 43.71 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.173 0.989 . . . . 0.0 112.984 -176.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 90.8 p -141.71 154.1 45.08 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.658 1.583 . . . . 0.0 114.564 172.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 83.4 p -151.54 -179.18 7.18 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 126.41 1.884 . . . . 0.0 111.184 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.32 178.97 48.28 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 120.309 -1.494 . . . . 0.0 115.417 176.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 35.0 mt -71.51 -44.31 64.88 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -170.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -116.94 87.59 2.73 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.818 2.447 . . . . 0.0 106.018 169.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.2 p -54.51 -46.46 73.49 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 121.656 -0.653 . . . . 0.0 111.74 -171.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.7 t 56.57 -166.18 0.13 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.478 1.911 . . . . 0.0 113.476 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -78.24 -153.4 0.06 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.978 2.111 . . . . 0.0 111.863 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.8 m -98.28 125.69 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.12 1.768 . . . . 0.0 106.848 168.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -71.53 131.53 86.28 Favored Pre-proline 0 N--CA 1.478 0.938 0 O-C-N 120.516 -1.365 . . . . 0.0 113.2 -168.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -59.35 -38.82 82.22 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.338 2.692 . . . . 0.0 113.84 -172.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.402 ' HB ' ' CE2' ' A' ' 112' ' ' PHE . 9.1 m -79.64 -36.22 38.17 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.838 -0.539 . . . . 0.0 110.608 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.54 -40.2 95.17 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.956 -1.09 . . . . 0.0 112.383 175.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 52.1 mt -52.7 -43.68 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-N 120.847 1.658 . . . . 0.0 110.652 173.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.42 -59.41 4.38 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 174.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.6 mmt -65.98 -21.81 66.43 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -173.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 82.7 mmm -89.79 -37.1 14.74 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.062 0.945 . . . . 0.0 111.238 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -60.8 -35.74 77.24 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.691 1.132 . . . . 0.0 111.572 170.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -55.37 -27.95 50.73 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 171.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.9 m -108.08 20.57 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 125.01 1.324 . . . . 0.0 113.934 175.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.09 11.92 75.06 Favored Glycine 0 CA--C 1.536 1.362 0 O-C-N 121.222 -0.924 . . . . 0.0 115.291 173.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.4 mt -122.84 87.67 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.513 1.525 . . . . 0.0 109.093 -169.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -70.66 111.33 6.06 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 120.315 -1.491 . . . . 0.0 110.419 170.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.7 pt -86.34 -6.28 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 O-C-N 121.496 -0.753 . . . . 0.0 112.608 175.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.3 t -63.78 -30.78 71.84 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 120.007 1.276 . . . . 0.0 112.736 -173.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.95 4.78 75.47 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 125.318 1.437 . . . . 0.0 115.508 171.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -78.06 147.77 34.59 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.108 1.454 . . . . 0.0 111.581 -175.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 10.8 t -62.76 147.47 49.69 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.588 -0.695 . . . . 0.0 112.084 174.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.5 t -127.94 131.98 49.28 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.839 0.856 . . . . 0.0 109.874 169.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -145.33 136.22 12.36 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.899 0.88 . . . . 0.0 113.087 -169.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -84.47 154.23 12.15 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.405 2.737 . . . . 0.0 113.11 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.0 tp -61.56 -18.67 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -103.98 -8.89 19.27 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -86.27 -35.18 20.1 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.297 0.953 . . . . 0.0 110.837 169.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.02 156.0 40.15 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 122.971 0.508 . . . . 0.0 110.702 170.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.1 121.05 15.56 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.557 0.743 . . . . 0.0 110.747 170.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.72 1.68 2.35 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -170.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -69.28 -27.08 65.1 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.343 -0.848 . . . . 0.0 111.918 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -93.33 -2.58 54.71 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.576 1.55 . . . . 0.0 113.225 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -127.1 84.37 2.26 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.998 1.719 . . . . 0.0 109.955 -172.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.69 -18.39 41.92 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.4 t -120.89 111.2 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 125.515 1.526 . . . . 0.0 109.762 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.4 t -126.34 121.39 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 121.611 -0.68 . . . . 0.0 110.476 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 mp -113.15 135.05 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.277 1.031 . . . . 0.0 109.958 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.0 m -95.8 148.4 22.63 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.604 1.162 . . . . 0.0 109.972 169.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.417 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 87.6 mt -129.09 44.21 3.01 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.065 0.946 . . . . 0.0 110.169 -171.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 22.5 p -151.85 -10.03 0.2 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 -169.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.9 31.06 77.07 Favored Glycine 0 CA--C 1.539 1.558 0 CA-C-N 119.553 1.069 . . . . 0.0 111.057 -168.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 2.4 p -139.74 2.09 1.95 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.234 1.814 . . . . 0.0 114.48 -169.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -54.08 -27.27 37.68 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 116.416 1.326 . . . . 0.0 116.416 -170.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.3 m -63.97 -15.34 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 118.673 1.236 . . . . 0.0 113.954 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -80.15 -11.01 59.79 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.042 1.337 . . . . 0.0 113.417 175.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.3 mt -73.58 160.41 82.31 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.91 0.884 . . . . 0.0 111.743 177.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -54.79 138.12 76.07 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.066 2.51 . . . . 0.0 111.827 173.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -59.02 -34.26 99.02 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.359 2.039 . . . . 0.0 113.628 -172.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -65.99 -26.77 67.71 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.817 -1.177 . . . . 0.0 113.692 174.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.38 -15.81 59.18 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.631 -1.293 . . . . 0.0 113.027 170.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.6 t -93.51 -37.75 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 126.548 1.939 . . . . 0.0 112.162 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.8 p -83.97 18.13 2.16 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -172.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -70.22 162.36 28.57 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.496 1.118 . . . . 0.0 112.359 169.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -55.47 -35.19 65.23 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.108 1.363 . . . . 0.0 113.781 -169.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.9 mt -127.9 118.79 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.812 1.245 . . . . 0.0 108.15 169.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -132.57 128.01 36.29 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.121 0.968 . . . . 0.0 111.298 170.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -147.51 161.96 40.04 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.805 1.642 . . . . 0.0 111.075 -174.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -129.94 129.96 44.5 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.557 0.743 . . . . 0.0 111.672 169.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.417 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 46.3 m0 -90.06 1.93 55.79 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -177.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 71.44 -72.35 0.12 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.44 1.896 . . . . 0.0 113.256 175.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 20.5 mt 50.14 -157.97 0.09 Allowed 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 126.143 1.777 . . . . 0.0 114.221 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -144.06 156.66 44.46 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.828 2.451 . . . . 0.0 108.045 172.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -80.13 120.04 78.43 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-N 120.683 1.583 . . . . 0.0 111.887 176.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -91.31 -21.69 0.63 Allowed 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 122.249 1.966 . . . . 0.0 115.746 -169.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -53.44 110.16 0.53 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.507 1.123 . . . . 0.0 112.403 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.73 1.43 87.32 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.068 0.842 . . . . 0.0 114.749 176.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -75.05 170.07 16.75 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.584 1.192 . . . . 0.0 110.822 169.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.2 t -63.31 148.27 48.76 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.531 -0.73 . . . . 0.0 110.361 169.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 mp -61.43 -27.86 68.85 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.604 -0.685 . . . . 0.0 112.485 -173.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.85 -34.76 78.02 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.998 -1.064 . . . . 0.0 113.444 171.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.2 t -71.12 -35.72 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 O-C-N 120.975 -1.078 . . . . 0.0 109.885 172.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.402 ' CE2' ' HB ' ' A' ' 45' ' ' THR . 0.3 OUTLIER -67.7 -38.52 83.77 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.322 0.649 . . . . 0.0 111.125 177.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -70.25 -37.38 74.93 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.994 1.318 . . . . 0.0 111.739 170.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.6 m -57.51 -45.88 84.43 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 119.118 0.872 . . . . 0.0 111.66 175.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.0 m -69.33 -29.91 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 119.723 1.147 . . . . 0.0 112.609 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -62.44 -41.75 98.95 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 120.542 1.519 . . . . 0.0 111.77 170.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.07 -45.41 87.51 Favored Glycine 0 N--CA 1.474 1.195 0 C-N-CA 124.039 0.828 . . . . 0.0 112.745 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -60.56 -40.53 91.96 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 122.197 -0.59 . . . . 0.0 112.375 171.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.2 t -64.99 -46.76 90.58 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.103 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -52.03 -53.15 45.45 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 120.141 1.337 . . . . 0.0 111.593 176.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -49.81 -45.1 49.65 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.301 1.44 . . . . 0.0 112.111 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -92.16 -27.05 17.95 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.058 0.943 . . . . 0.0 112.179 -171.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.9 t -62.19 -49.8 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.042 1.337 . . . . 0.0 109.799 169.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -54.06 -53.73 49.09 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.005 0.82 . . . . 0.0 109.583 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -53.03 -37.93 61.95 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.141 1.776 . . . . 0.0 112.364 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -78.83 -59.87 2.6 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.157 -0.964 . . . . 0.0 112.781 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.18 -33.55 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.887 1.275 . . . . 0.0 112.498 -174.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.97 -18.79 61.96 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -78.42 -25.13 45.93 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.648 1.179 . . . . 0.0 113.52 174.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.1 pt -106.25 -8.18 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.498 1.519 . . . . 0.0 113.678 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 C--O 1.254 1.315 0 C-N-CA 125.493 1.517 . . . . 0.0 113.088 173.653 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.2 ttp . . . . . 0 N--CA 1.503 2.203 0 CA-C-O 119.754 -0.165 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -88.35 97.85 11.27 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.079 0.952 . . . . 0.0 110.69 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -81.24 133.73 35.49 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 121.633 -0.667 . . . . 0.0 110.811 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.5 m -100.15 146.51 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.088 0.955 . . . . 0.0 110.998 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.8 tpp -126.41 112.11 15.26 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.907 0.883 . . . . 0.0 110.876 172.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -81.54 138.07 35.48 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.967 -0.458 . . . . 0.0 110.656 169.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.2 t -137.38 129.79 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.316 1.047 . . . . 0.0 111.234 -171.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 t -145.69 -175.6 4.8 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 119.166 0.894 . . . . 0.0 113.345 169.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -60.03 -37.66 80.45 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 121.752 -0.593 . . . . 0.0 110.323 169.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.434 ' HB3' ' H ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -113.95 127.74 56.09 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.985 0.914 . . . . 0.0 110.695 168.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -66.97 -33.65 76.04 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.552 168.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.8 p -67.97 -47.51 68.41 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.136 1.774 . . . . 0.0 115.584 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.434 ' H ' ' HB3' ' A' ' 10' ' ' ARG . 56.3 p -85.42 -24.96 27.26 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -171.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.27 -60.89 1.59 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 176.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.8 m -60.19 -41.06 92.15 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.147 0.885 . . . . 0.0 112.947 -169.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -60.44 -40.05 89.71 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.847 1.659 . . . . 0.0 113.088 169.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.7 mtm -61.94 -46.06 90.95 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.852 -1.155 . . . . 0.0 111.023 174.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.89 -28.52 66.76 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 173.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -71.24 -46.04 61.93 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.227 1.376 . . . . 0.0 108.96 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.61 -44.07 97.03 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-O 118.602 -1.11 . . . . 0.0 112.408 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -63.15 -41.31 99.25 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.974 1.387 . . . . 0.0 111.971 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.94 -34.58 71.63 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 120.719 -1.238 . . . . 0.0 110.572 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -59.45 -57.92 10.86 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.112 1.765 . . . . 0.0 109.94 170.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.6 p -69.09 -14.64 63.13 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.1 mt -99.87 -6.38 26.88 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.5 10.77 0.52 Allowed Glycine 0 N--CA 1.476 1.357 0 N-CA-C 117.192 1.637 . . . . 0.0 117.192 -169.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.02 131.06 39.88 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.076 1.438 . . . . 0.0 112.142 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.97 -8.68 49.71 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.387 -1.229 . . . . 0.0 115.777 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -84.76 -57.08 3.26 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 120.03 1.915 . . . . 0.0 110.461 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -139.02 179.43 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 126.57 1.948 . . . . 0.0 110.597 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.76 127.39 47.2 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.341 -0.849 . . . . 0.0 112.091 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.5 m -90.99 145.26 7.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 123.989 0.916 . . . . 0.0 113.212 169.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.8 157.4 43.66 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.998 0.919 . . . . 0.0 110.88 -174.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.9 p -141.89 141.85 33.04 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.394 1.478 . . . . 0.0 112.757 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.1 t -143.46 178.15 7.96 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.414 1.486 . . . . 0.0 111.208 169.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.03 170.21 37.11 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 119.905 -1.747 . . . . 0.0 114.494 172.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 52.5 mt -60.53 -45.0 95.46 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.453 0.701 . . . . 0.0 111.851 -170.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -109.45 111.63 23.27 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 127.239 2.216 . . . . 0.0 106.251 169.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.4 p -66.72 -43.17 84.96 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.446 -1.409 . . . . 0.0 110.975 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 t 52.62 -170.69 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.711 2.004 . . . . 0.0 114.081 -176.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -88.63 174.37 8.09 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.587 1.955 . . . . 0.0 111.787 173.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 m -60.77 113.4 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 169.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -64.45 130.37 94.64 Favored Pre-proline 0 N--CA 1.477 0.902 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -168.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -59.98 -39.2 72.93 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.475 2.783 . . . . 0.0 114.028 -171.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 m -78.3 -37.28 45.13 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.117 0.567 . . . . 0.0 110.507 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.05 -39.22 93.59 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.084 -0.96 . . . . 0.0 112.355 175.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.9 mt -52.07 -45.75 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 120.687 1.585 . . . . 0.0 110.083 173.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.2 -57.8 7.58 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.2 mmt -64.88 -23.07 67.12 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -174.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 87.7 mmm -89.97 -37.83 14.07 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.224 1.01 . . . . 0.0 110.851 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -58.75 -36.81 74.96 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 120.766 -1.209 . . . . 0.0 112.067 169.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -54.97 -30.57 59.44 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.353 1.061 . . . . 0.0 113.704 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.2 m -104.47 15.69 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 125.059 1.344 . . . . 0.0 114.113 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.86 15.43 63.16 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.131 0.872 . . . . 0.0 115.087 176.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.2 mt -124.56 74.2 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.832 1.653 . . . . 0.0 109.461 -169.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -66.39 108.06 2.24 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 119.938 -1.726 . . . . 0.0 110.498 172.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.8 pt -86.95 -0.47 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.0 p -67.71 -24.87 65.44 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.535 -1.353 . . . . 0.0 114.588 -169.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.61 6.0 64.86 Favored Glycine 0 CA--C 1.541 1.671 0 C-N-CA 125.389 1.471 . . . . 0.0 114.66 170.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -82.06 147.92 28.87 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.704 1.202 . . . . 0.0 112.029 -172.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.6 t -69.06 156.1 39.23 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 121.505 -0.747 . . . . 0.0 112.157 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.5 t -136.6 142.68 43.33 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.743 0.817 . . . . 0.0 111.243 170.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.31 140.6 21.08 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -171.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -89.96 156.48 4.91 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 124.123 3.215 . . . . 0.0 113.024 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.7 tp -61.52 -22.98 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -170.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -102.62 -5.34 23.97 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -87.87 -38.89 15.27 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.651 -0.656 . . . . 0.0 110.852 169.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.06 153.36 43.9 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.23 0.538 . . . . 0.0 111.436 171.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -136.98 120.63 17.26 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.529 1.132 . . . . 0.0 110.444 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.49 8.48 1.78 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -170.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -73.35 -29.87 62.95 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.47 -0.769 . . . . 0.0 112.305 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -93.39 -3.55 53.07 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.091 1.357 . . . . 0.0 113.642 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -125.06 89.36 3.04 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.869 1.668 . . . . 0.0 109.351 -172.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -59.7 -24.66 64.14 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -175.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.0 t -121.35 105.11 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.703 1.201 . . . . 0.0 110.106 -169.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.433 ' C ' HD12 ' A' ' 77' ' ' ILE . 37.8 t -116.05 130.49 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.584 1.154 . . . . 0.0 110.66 -174.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.433 HD12 ' C ' ' A' ' 76' ' ' VAL . 1.6 mp -119.38 124.97 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.714 0.806 . . . . 0.0 109.98 -174.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 t -85.7 124.68 32.49 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.419 1.088 . . . . 0.0 108.969 168.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.414 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 75.2 mt -111.54 37.68 2.83 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 126.673 1.989 . . . . 0.0 110.506 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 9.6 t -148.92 142.74 25.66 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.446 -0.783 . . . . 0.0 112.697 -175.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -62.92 -23.45 65.72 Favored Glycine 0 CA--C 1.547 2.069 0 O-C-N 121.617 -0.677 . . . . 0.0 111.469 168.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 16.9 p -73.44 3.99 5.34 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.267 2.227 . . . . 0.0 115.602 170.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -55.29 -26.22 43.03 Favored Glycine 0 CA--C 1.536 1.367 0 N-CA-C 116.727 1.451 . . . . 0.0 116.727 -169.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.9 m -62.84 -16.35 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 173.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -88.43 -0.29 57.04 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.025 1.33 . . . . 0.0 113.871 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.5 mt -67.94 152.8 96.11 Favored Pre-proline 0 CA--C 1.548 0.881 0 O-C-N 120.863 -1.148 . . . . 0.0 112.291 176.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.83 134.7 58.7 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.031 2.487 . . . . 0.0 111.798 176.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -61.62 -30.18 85.29 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.483 2.122 . . . . 0.0 113.557 -174.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -66.58 -30.89 71.29 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.544 -1.348 . . . . 0.0 113.183 173.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -78.61 -20.12 51.15 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.926 -1.108 . . . . 0.0 112.632 174.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.3 t -86.77 -38.65 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.801 1.64 . . . . 0.0 112.107 174.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.3 p -85.12 52.43 2.44 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 120.785 -1.197 . . . . 0.0 113.366 -172.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -110.65 171.51 7.42 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.339 1.856 . . . . 0.0 112.306 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -53.29 -42.48 66.66 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.401 1.08 . . . . 0.0 113.003 -169.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.3 mt -130.2 122.42 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.867 1.267 . . . . 0.0 108.756 169.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -122.36 132.45 54.39 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.706 0.802 . . . . 0.0 109.157 169.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.82 155.12 44.6 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.127 1.371 . . . . 0.0 111.156 -176.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -136.21 118.86 16.0 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.493 0.717 . . . . 0.0 111.92 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.414 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 31.8 m0 -97.94 3.06 49.66 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.725 1.21 . . . . 0.0 113.338 -175.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.329 1.2 pp0? 45.59 43.42 9.18 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.9 2.08 . . . . 0.0 115.905 171.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 83.9 mt -84.49 158.16 21.09 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.698 1.199 . . . . 0.0 113.917 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -79.85 164.07 23.88 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.331 1.852 . . . . 0.0 112.188 169.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -95.84 111.71 56.86 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 123.861 0.864 . . . . 0.0 108.975 169.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -85.44 -10.57 7.58 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.049 2.499 . . . . 0.0 116.067 -169.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -49.67 112.7 0.69 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.533 1.133 . . . . 0.0 112.816 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.6 -0.15 89.69 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 123.844 0.735 . . . . 0.0 114.836 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -75.79 170.68 15.75 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 118.295 1.047 . . . . 0.0 110.31 169.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.5 t -58.84 145.27 41.55 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.507 -0.746 . . . . 0.0 111.028 169.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.45 -28.32 68.22 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.15 0.58 . . . . 0.0 111.998 -176.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -65.82 -33.18 75.27 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 120.96 -1.087 . . . . 0.0 113.237 173.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.2 t -70.28 -36.47 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 O-C-N 121.037 -1.039 . . . . 0.0 109.823 171.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.87 -42.68 90.07 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.645 0.778 . . . . 0.0 110.736 176.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -67.12 -36.06 81.09 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.78 1.232 . . . . 0.0 112.367 171.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.5 m -59.53 -48.89 79.89 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 119.306 0.957 . . . . 0.0 111.427 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.3 m -68.21 -32.31 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 117.909 -1.043 . . . . 0.0 111.983 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.08 -43.4 91.8 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 120.825 1.648 . . . . 0.0 111.978 169.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.47 -41.89 89.91 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 124.388 0.994 . . . . 0.0 112.556 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -61.95 -46.14 90.59 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 122.214 -0.58 . . . . 0.0 111.897 169.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.42 -46.73 92.44 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.267 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -51.95 -54.92 23.92 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.654 1.182 . . . . 0.0 111.827 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -60.61 -41.42 94.74 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.351 0.661 . . . . 0.0 112.305 -176.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 50.7 mtp85 -79.2 -33.83 43.5 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.4 t -59.81 -47.58 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.182 0.993 . . . . 0.0 110.653 170.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -53.35 -55.3 26.0 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.11 0.868 . . . . 0.0 109.966 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -54.71 -40.63 69.4 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.881 1.273 . . . . 0.0 112.301 176.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.7 -58.81 3.07 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.183 -0.948 . . . . 0.0 112.52 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.36 -34.95 70.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.599 1.16 . . . . 0.0 111.624 -176.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.42 -15.95 61.33 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -173.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -71.17 -28.16 64.05 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.435 1.094 . . . . 0.0 113.42 170.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.7 pt -113.81 -6.95 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.189 1.796 . . . . 0.0 113.287 -173.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.7 m . . . . . 0 C--O 1.254 1.299 0 C-N-CA 125.735 1.614 . . . . 0.0 113.713 173.561 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.503 2.217 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -79.62 96.51 6.2 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.773 0.829 . . . . 0.0 110.079 171.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -77.12 144.96 38.09 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.759 -0.588 . . . . 0.0 111.191 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 p -122.43 141.72 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.524 1.13 . . . . 0.0 111.047 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 50.8 tpp -124.38 120.41 32.03 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.616 1.167 . . . . 0.0 111.774 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -88.89 130.06 35.49 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.313 0.645 . . . . 0.0 111.507 169.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.2 t -129.24 124.31 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.918 1.287 . . . . 0.0 110.188 -172.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.3 m -136.17 169.65 17.28 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.556 1.142 . . . . 0.0 111.467 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -64.92 -48.69 73.25 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 168.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -99.87 105.4 17.14 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.314 1.446 . . . . 0.0 108.366 168.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -53.58 -33.49 55.04 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 122.952 0.501 . . . . 0.0 110.884 169.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.9 p -65.37 -40.2 93.25 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.164 2.185 . . . . 0.0 115.793 176.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.4 p -97.09 -22.9 16.5 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -170.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.43 -51.14 1.75 Allowed 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 171.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.0 m -59.07 -44.57 91.89 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 121.284 1.857 . . . . 0.0 111.926 -175.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -58.23 -43.56 87.79 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.997 1.319 . . . . 0.0 113.474 169.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.415 ' HA ' ' CE ' ' A' ' 50' ' ' MET . 51.2 ttm -58.31 -50.81 72.31 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.325 1.05 . . . . 0.0 111.381 175.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.67 -27.22 66.66 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.254 1.022 . . . . 0.0 112.524 174.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -76.35 -43.55 40.51 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 120.424 1.466 . . . . 0.0 109.133 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -56.88 -52.99 47.65 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-O 119.152 -0.804 . . . . 0.0 111.248 174.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.513 ' HB3' HG11 ' A' ' 123' ' ' VAL . 17.3 m-85 -62.2 -41.61 98.53 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.286 1.043 . . . . 0.0 112.919 174.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.01 -40.83 97.23 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.211 1.369 . . . . 0.0 110.837 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -61.21 -50.06 74.65 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.326 1.85 . . . . 0.0 111.32 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.6 p -74.94 -22.73 58.42 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.1 mt -88.84 -23.26 22.85 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.264 0.938 . . . . 0.0 112.711 176.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -126.4 21.72 6.01 Favored Glycine 0 N--CA 1.473 1.124 0 C-N-CA 125.777 1.656 . . . . 0.0 115.431 -170.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.91 126.48 27.27 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.236 1.018 . . . . 0.0 112.531 -173.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.65 -2.6 47.22 Favored Glycine 0 CA--C 1.537 1.431 0 N-CA-C 116.024 1.17 . . . . 0.0 116.024 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -81.7 -54.77 5.11 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.587 1.694 . . . . 0.0 111.146 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.415 HD11 HD11 ' A' ' 127' ' ' ILE . 2.3 pp -143.04 -179.37 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 127.355 2.262 . . . . 0.0 110.989 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.23 121.49 42.34 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.482 0.658 . . . . 0.0 111.825 171.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.3 m -87.11 150.8 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 123.473 0.709 . . . . 0.0 111.981 169.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.68 159.77 43.05 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.265 1.026 . . . . 0.0 111.288 -174.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.5 t -144.7 127.7 16.49 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.144 1.378 . . . . 0.0 111.885 -169.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.0 p -144.09 -178.76 6.11 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.532 1.533 . . . . 0.0 111.299 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.06 172.11 35.47 Favored Glycine 0 CA--C 1.532 1.142 0 O-C-N 119.834 -1.791 . . . . 0.0 114.47 173.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 47.6 mt -61.68 -39.15 90.42 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 118.354 1.077 . . . . 0.0 112.176 -173.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -115.81 113.66 23.69 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.809 2.044 . . . . 0.0 107.843 169.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.3 p -65.88 -37.14 85.35 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.933 0.893 . . . . 0.0 112.046 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.4 t 44.09 -129.85 0.87 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 126.159 1.784 . . . . 0.0 112.786 -174.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -146.62 -175.77 4.92 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 127.139 2.176 . . . . 0.0 111.823 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.1 m -59.22 115.75 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 121.134 -0.979 . . . . 0.0 110.291 169.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.8 t-80 -73.85 131.7 81.33 Favored Pre-proline 0 N--CA 1.476 0.855 0 CA-C-O 118.501 -0.762 . . . . 0.0 113.035 -169.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -60.58 -39.74 62.2 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.488 2.792 . . . . 0.0 114.293 -171.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.1 m -80.95 -33.07 34.25 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.803 -0.56 . . . . 0.0 110.833 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.45 -42.46 87.55 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 118.087 -0.959 . . . . 0.0 112.166 174.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.0 mt -47.35 -48.22 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 119.997 1.271 . . . . 0.0 110.395 172.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.61 -61.54 2.14 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.8 mmt -66.31 -27.31 67.82 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.525 -0.735 . . . . 0.0 112.379 -171.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.415 ' CE ' ' HA ' ' A' ' 17' ' ' MET . 81.7 mtp -84.22 -38.18 20.88 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.595 0.758 . . . . 0.0 111.364 177.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -57.35 -38.05 73.54 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.715 1.143 . . . . 0.0 112.099 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -59.39 -23.39 62.55 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.0 m -108.28 15.07 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.39 16.54 58.7 Favored Glycine 0 N--CA 1.478 1.444 0 O-C-N 121.087 -1.008 . . . . 0.0 115.325 176.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.9 mt -125.43 53.31 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.892 1.677 . . . . 0.0 110.307 -169.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -60.4 113.2 2.28 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.26 -1.525 . . . . 0.0 111.435 176.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.8 pt -91.46 2.53 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.215 1.006 . . . . 0.0 113.648 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -62.19 -24.41 67.19 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 120.759 1.618 . . . . 0.0 113.262 -173.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.46 6.87 59.47 Favored Glycine 0 CA--C 1.543 1.84 0 C-N-CA 125.475 1.512 . . . . 0.0 115.77 170.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -83.24 152.21 25.29 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.089 1.445 . . . . 0.0 112.088 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.0 t -71.44 163.67 27.26 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 52.0 m -137.07 140.92 42.34 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.01 1.724 . . . . 0.0 109.49 169.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -145.96 141.89 17.17 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-N 119.548 1.067 . . . . 0.0 113.369 -175.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -86.45 148.27 8.78 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 123.221 2.614 . . . . 0.0 111.441 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.0 tt -66.48 -16.63 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 O-C-N 120.549 -1.344 . . . . 0.0 113.976 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -89.54 -10.52 45.86 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.112 -0.992 . . . . 0.0 113.485 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -88.5 -40.7 13.24 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.764 0.825 . . . . 0.0 111.453 170.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.71 153.03 43.19 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.816 0.847 . . . . 0.0 111.694 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.443 ' HA ' ' CH2' ' A' ' 90' ' ' TRP . 11.1 m120 -128.38 124.87 37.45 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.435 0.694 . . . . 0.0 110.329 169.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.405 ' HB3' ' CE3' ' A' ' 90' ' ' TRP . . . -70.29 5.71 1.62 Allowed 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -175.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -73.02 -29.02 62.7 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.983 0.913 . . . . 0.0 112.213 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -97.51 -3.79 39.17 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.81 1.244 . . . . 0.0 113.583 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -121.73 92.01 3.64 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.009 1.724 . . . . 0.0 109.353 -172.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -60.51 -28.17 68.18 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -174.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.5 t -113.67 116.74 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.383 1.073 . . . . 0.0 110.098 -177.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.1 t -126.4 132.51 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.909 0.884 . . . . 0.0 110.377 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.7 mm -123.07 127.78 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 121.771 -0.581 . . . . 0.0 111.466 -170.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.5 t -87.51 126.45 34.92 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.282 1.433 . . . . 0.0 109.964 169.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.5 mt -112.6 42.14 1.9 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.645 1.178 . . . . 0.0 113.015 -174.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 30.4 p -123.66 -162.28 1.04 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.126 2.17 . . . . 0.0 107.744 168.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -120.21 47.16 1.05 Allowed Glycine 0 CA--C 1.53 0.976 0 N-CA-C 107.729 -2.148 . . . . 0.0 107.729 168.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 16.2 p -138.42 -54.13 0.62 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -168.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.89 -43.37 0.2 Allowed Glycine 0 CA--C 1.543 1.837 0 C-N-CA 126.98 2.229 . . . . 0.0 116.04 -175.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 p -65.77 -20.69 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 126.933 2.093 . . . . 0.0 115.161 -169.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -79.24 -4.29 49.96 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.0 mt -91.65 146.98 34.18 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 125.355 1.462 . . . . 0.0 110.769 172.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -71.37 151.32 59.71 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.328 2.019 . . . . 0.0 110.863 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -58.62 -34.78 99.11 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.837 2.358 . . . . 0.0 112.613 -175.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -48.83 -46.25 41.73 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.602 1.561 . . . . 0.0 112.919 175.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.443 ' CH2' ' HA ' ' A' ' 69' ' ' ASN . 1.8 m95 -90.57 8.42 34.21 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.052 1.341 . . . . 0.0 113.072 -177.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.5 t -116.0 -39.32 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 126.868 2.067 . . . . 0.0 111.697 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.6 p -79.9 28.11 0.29 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -174.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -85.22 172.19 11.36 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.826 1.65 . . . . 0.0 111.961 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -53.69 -42.37 67.89 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -169.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.6 mt -129.4 125.67 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.463 1.105 . . . . 0.0 109.069 169.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -131.99 136.26 47.15 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.264 1.026 . . . . 0.0 111.533 169.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -143.06 154.94 44.47 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.111 1.364 . . . . 0.0 111.741 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -122.64 118.95 29.37 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.14 1.376 . . . . 0.0 109.976 171.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -84.86 3.98 35.38 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 117.788 2.514 . . . . 0.0 117.788 -169.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 58.44 51.16 8.43 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 120.252 1.387 . . . . 0.0 113.048 176.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 66.2 mt -107.73 165.93 11.07 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.336 1.855 . . . . 0.0 113.269 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -122.32 153.73 38.56 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.387 1.875 . . . . 0.0 110.32 173.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -74.34 118.32 68.84 Favored Pre-proline 0 CA--C 1.546 0.816 0 O-C-N 121.296 -0.878 . . . . 0.0 111.342 176.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.413 ' HB2' ' CD2' ' A' ' 112' ' ' PHE . 27.6 Cg_endo -85.27 -6.6 9.19 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.32 2.013 . . . . 0.0 114.013 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -48.67 116.03 1.46 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.231 1.013 . . . . 0.0 112.77 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.04 3.68 69.71 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.791 0.71 . . . . 0.0 114.338 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -80.94 171.58 14.82 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.463 1.105 . . . . 0.0 110.115 171.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.3 p -63.9 156.49 27.5 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.339 -0.85 . . . . 0.0 112.082 176.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.05 -29.06 70.03 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.578 -0.701 . . . . 0.0 111.43 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.27 -40.96 92.22 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.175 -0.953 . . . . 0.0 112.641 172.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.3 t -73.1 -39.85 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.753 0.821 . . . . 0.0 109.691 176.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.413 ' CD2' ' HB2' ' A' ' 104' ' ' PRO . 0.6 OUTLIER -63.52 -36.87 85.21 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.051 0.54 . . . . 0.0 111.189 177.553 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -70.95 -43.21 68.63 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.339 1.456 . . . . 0.0 112.199 172.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 53.2 m -57.69 -51.05 71.11 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.177 0.991 . . . . 0.0 111.838 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.4 m -68.1 -29.23 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 O-C-N 121.271 -0.893 . . . . 0.0 112.051 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.6 ptt-85 -70.6 -32.9 70.43 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 119.778 1.172 . . . . 0.0 113.051 173.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.11 -45.12 94.64 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 123.88 0.752 . . . . 0.0 112.262 170.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -61.97 -42.18 98.85 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.926 -0.749 . . . . 0.0 112.348 171.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.422 ' O ' HG12 ' A' ' 123' ' ' VAL . 8.3 t -60.22 -50.12 81.49 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.724 0 CA-C-O 117.139 -1.41 . . . . 0.0 110.182 174.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -51.19 -48.91 61.84 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.469 1.508 . . . . 0.0 112.158 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -55.27 -43.7 74.94 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.701 1.2 . . . . 0.0 112.492 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.0 mtt180 -91.59 -32.89 15.34 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.975 0.91 . . . . 0.0 112.75 -169.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.513 HG11 ' HB3' ' A' ' 21' ' ' PHE . 9.4 p -69.6 -36.66 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.574 1.55 . . . . 0.0 112.012 171.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -56.67 -58.76 6.7 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.81 1.186 . . . . 0.0 109.915 169.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -55.34 -27.65 48.58 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.504 1.122 . . . . 0.0 113.299 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -85.07 -59.33 2.37 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.336 0.971 . . . . 0.0 112.904 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.415 HD11 HD11 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -58.92 -33.34 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.553 1.141 . . . . 0.0 111.727 -178.063 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.83 -14.13 60.65 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -82.48 -28.38 31.22 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.501 1.121 . . . . 0.0 113.065 172.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.3 pt -98.92 -12.02 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.612 1.165 . . . . 0.0 113.817 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 74.2 m . . . . . 0 C--O 1.255 1.356 0 C-N-CA 124.766 1.226 . . . . 0.0 113.245 171.672 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 ttm . . . . . 0 N--CA 1.503 2.182 0 CA-C-O 119.712 -0.185 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -91.95 85.82 5.67 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.19 0.996 . . . . 0.0 110.277 177.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -77.45 150.74 34.94 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.535 -0.728 . . . . 0.0 111.351 -175.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.2 t -108.38 143.27 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.583 0.753 . . . . 0.0 111.45 -175.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 43.7 tpp -128.08 110.39 12.44 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.912 0.885 . . . . 0.0 110.156 169.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -81.83 138.51 35.09 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.635 169.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.6 t -135.62 128.39 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.083 0.953 . . . . 0.0 111.587 -174.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.7 p -147.17 -178.23 6.1 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.798 1.239 . . . . 0.0 111.813 175.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -62.35 -64.34 0.96 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 119.847 1.203 . . . . 0.0 110.124 172.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.27 107.42 16.56 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 168.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 39' ' ' SER . 13.7 t-20 -56.67 -41.73 77.78 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.748 0.704 . . . . 0.0 109.556 169.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.2 p -53.22 -29.57 33.08 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 127.446 2.299 . . . . 0.0 115.849 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.1 p -97.97 -97.47 0.21 Allowed 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 123.571 0.748 . . . . 0.0 109.82 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -53.19 -50.7 64.11 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.391 1.476 . . . . 0.0 113.38 -169.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.533 ' HB3' ' HB2' ' A' ' 34' ' ' SER . 69.9 m -71.36 -40.2 70.78 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -174.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -64.25 -37.2 86.63 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 168.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 77.0 mtp -58.38 -51.36 70.14 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.108 0.867 . . . . 0.0 109.592 172.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.24 -36.18 82.82 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -66.38 -40.22 89.57 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 119.524 1.056 . . . . 0.0 108.882 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.497 ' N ' HE22 ' A' ' 60' ' ' GLN . . . -68.16 -45.05 73.65 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-O 118.961 -0.911 . . . . 0.0 111.989 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -62.28 -38.88 91.04 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.305 1.052 . . . . 0.0 111.458 170.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.401 ' HB1' HG11 ' A' ' 32' ' ' VAL . . . -70.24 -33.46 71.68 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 120.587 -1.32 . . . . 0.0 111.368 -178.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -62.8 -55.5 25.87 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.443 1.897 . . . . 0.0 109.369 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.8 p -71.46 -15.51 62.33 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.6 mt -97.4 -11.12 24.3 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 173.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -143.99 9.2 2.01 Favored Glycine 0 N--CA 1.477 1.376 0 N-CA-C 117.227 1.651 . . . . 0.0 117.227 -169.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.5 128.98 27.58 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.155 1.478 . . . . 0.0 112.342 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.12 -6.89 55.28 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-O 118.319 -1.267 . . . . 0.0 115.888 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -85.68 -57.16 3.16 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.02 1.91 . . . . 0.0 110.286 175.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 pp -139.71 173.4 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 127.433 2.293 . . . . 0.0 109.141 171.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.37 131.2 44.27 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.522 -0.736 . . . . 0.0 111.833 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.401 HG11 ' HB1' ' A' ' 22' ' ' ALA . 32.7 m -100.11 143.8 13.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 123.709 0.804 . . . . 0.0 112.805 170.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 m -145.98 162.59 37.48 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.615 1.566 . . . . 0.0 109.467 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.533 ' HB2' ' HB3' ' A' ' 15' ' ' SER . 91.0 p -143.91 148.69 35.76 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.061 0.944 . . . . 0.0 113.097 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.5 p -138.39 -170.38 2.8 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.025 1.33 . . . . 0.0 110.914 171.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.93 173.44 37.36 Favored Glycine 0 CA--C 1.528 0.891 0 O-C-N 121.078 -1.013 . . . . 0.0 113.85 175.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.8 mt -64.78 -35.92 82.64 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.409 0.684 . . . . 0.0 112.253 -172.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -123.24 105.69 10.09 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 128.449 2.699 . . . . 0.0 107.09 172.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.408 ' HA ' ' HB3' ' A' ' 11' ' ' ASN . 11.2 p -60.9 -46.9 88.82 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.437 -0.79 . . . . 0.0 111.633 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.1 t 49.72 -171.83 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 127.898 2.479 . . . . 0.0 114.415 -174.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -77.98 166.74 22.47 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.65 1.58 . . . . 0.0 110.214 169.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.1 m -56.99 120.13 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 119.949 1.25 . . . . 0.0 108.098 169.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -65.15 127.56 92.96 Favored Pre-proline 0 N--CA 1.479 0.998 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -167.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -61.73 -39.48 52.75 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.256 2.637 . . . . 0.0 113.845 -169.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.1 m -77.85 -35.66 50.81 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.937 -0.477 . . . . 0.0 110.318 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.17 -38.1 87.24 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 117.956 -1.021 . . . . 0.0 112.407 174.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 56.0 mt -55.31 -41.64 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 121.455 1.934 . . . . 0.0 110.501 173.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.73 -59.77 4.15 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.0 mmt -63.69 -27.29 69.11 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.483 -0.761 . . . . 0.0 112.66 -174.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 88.0 mmm -85.01 -33.12 22.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.773 0.829 . . . . 0.0 110.561 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -61.86 -33.61 74.49 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.888 -1.133 . . . . 0.0 111.817 171.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -55.06 -33.6 62.87 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.088 0.955 . . . . 0.0 112.763 172.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.4 m -105.49 19.11 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.259 1.424 . . . . 0.0 113.859 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.34 17.01 74.89 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 115.528 0.971 . . . . 0.0 115.528 173.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.404 ' CG2' ' HA3' ' A' ' 20' ' ' GLY . 71.6 mt -115.36 125.93 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.206 1.402 . . . . 0.0 111.417 -169.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -100.43 73.41 1.65 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.558 1.943 . . . . 0.0 112.727 -172.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.33 -10.23 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 120.373 -1.454 . . . . 0.0 111.672 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.1 p -60.95 -32.03 71.56 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.888 2.475 . . . . 0.0 113.833 169.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.45 47.55 1.02 Allowed Glycine 0 N--CA 1.474 1.224 0 C-N-CA 126.418 1.961 . . . . 0.0 112.168 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.497 HE22 ' N ' ' A' ' 20' ' ' GLY . 11.0 mt-30 -135.87 171.94 13.73 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.668 1.587 . . . . 0.0 113.287 -169.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -76.56 137.26 39.44 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 121.37 -0.832 . . . . 0.0 112.944 -169.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.7 m -125.59 45.58 2.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.189 1.396 . . . . 0.0 111.004 -170.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.83 140.22 54.4 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -169.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -83.11 151.1 13.9 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.186 2.591 . . . . 0.0 111.008 169.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.9 tt -63.33 -21.57 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 -171.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -99.24 -4.71 31.32 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -88.51 -41.55 12.66 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.044 0.838 . . . . 0.0 112.117 171.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.35 164.33 24.73 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.229 0.538 . . . . 0.0 112.077 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -136.48 120.18 17.26 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.046 0.938 . . . . 0.0 111.069 171.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.96 2.86 1.79 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 -172.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -70.27 -31.78 69.31 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.406 1.003 . . . . 0.0 112.179 -174.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -90.27 -8.87 49.87 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.56 1.144 . . . . 0.0 113.364 176.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -120.79 72.23 0.96 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.921 1.689 . . . . 0.0 109.378 -173.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -65.37 -6.47 10.23 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -170.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.2 t -120.87 96.64 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 125.938 1.695 . . . . 0.0 109.055 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.4 t -109.63 135.15 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 121.376 -0.828 . . . . 0.0 110.211 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.462 HG21 ' CE2' ' A' ' 99' ' ' TRP . 12.5 mm -128.6 136.13 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 123.27 0.628 . . . . 0.0 110.297 -176.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.4 t -97.26 130.17 44.49 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.545 1.538 . . . . 0.0 110.736 172.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.8 mp -115.51 49.03 1.12 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.148 1.379 . . . . 0.0 110.295 -171.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.1 p -154.53 -9.17 0.14 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 117.27 2.322 . . . . 0.0 117.27 -170.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.01 30.9 76.61 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-N 119.685 1.13 . . . . 0.0 111.482 -169.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 3.9 p -139.68 10.24 2.44 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.879 1.671 . . . . 0.0 114.39 -169.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -55.1 -27.1 44.65 Favored Glycine 0 CA--C 1.533 1.157 0 N-CA-C 116.287 1.275 . . . . 0.0 116.287 -169.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 p -61.13 -21.73 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-N 118.505 1.152 . . . . 0.0 113.267 174.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -84.15 -6.77 59.45 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.038 1.335 . . . . 0.0 113.768 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.2 mt -76.66 160.94 75.9 Favored Pre-proline 0 CA--C 1.554 1.115 0 O-C-N 121.06 -1.025 . . . . 0.0 111.792 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -58.12 145.97 90.09 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.178 2.585 . . . . 0.0 114.394 -177.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -75.41 41.25 0.76 Allowed 'Trans proline' 0 CA--C 1.551 1.357 1 C-N-CA 126.062 4.508 . . . . 0.0 113.924 -175.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -156.7 -35.56 0.08 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.931 2.492 . . . . 0.0 111.023 -176.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.18 -22.66 61.25 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.49 -1.381 . . . . 0.0 111.346 169.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 m -89.69 -10.22 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 175.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.4 p -98.02 4.32 49.31 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -170.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -69.44 164.68 22.51 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.87 0.868 . . . . 0.0 111.86 175.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -57.32 -36.56 71.27 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -169.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.9 mt -116.61 118.19 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.684 0.793 . . . . 0.0 109.073 169.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -134.08 127.33 31.95 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.35 1.06 . . . . 0.0 110.521 169.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -147.03 157.47 43.62 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.054 1.342 . . . . 0.0 111.376 -172.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -122.62 131.27 53.74 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.413 0.685 . . . . 0.0 110.853 168.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.462 ' CE2' HG21 ' A' ' 77' ' ' ILE . 47.8 m0 -87.37 1.16 54.15 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.404 1.482 . . . . 0.0 114.999 -178.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 62.45 27.37 16.27 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.789 1.235 . . . . 0.0 113.98 170.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 75.5 mt -80.15 152.62 29.14 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -170.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -86.1 157.88 19.94 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.822 1.249 . . . . 0.0 111.131 170.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.68 137.21 77.13 Favored Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 120.658 -1.276 . . . . 0.0 113.1 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -99.91 -30.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.156 2.571 . . . . 0.0 113.842 171.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.97 100.25 0.06 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.942 1.697 . . . . 0.0 112.663 -176.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.48 -0.6 53.3 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.033 1.302 . . . . 0.0 114.689 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -87.68 171.76 10.2 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.06 1.344 . . . . 0.0 111.999 172.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 35.1 t -62.09 149.71 40.47 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.264 0.626 . . . . 0.0 111.753 171.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 mp -60.62 -28.83 68.83 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.943 0.897 . . . . 0.0 112.514 -174.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -67.56 -34.34 76.86 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.847 -1.158 . . . . 0.0 113.17 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.5 t -70.35 -37.04 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 O-C-N 121.209 -0.932 . . . . 0.0 109.524 171.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.35 -42.38 99.35 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.5 1.12 . . . . 0.0 111.384 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -71.73 -38.61 70.43 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.973 1.309 . . . . 0.0 112.291 173.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.0 m -55.38 -48.77 73.8 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.646 0.779 . . . . 0.0 111.263 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.3 m -73.11 -29.01 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 117.671 -1.157 . . . . 0.0 112.547 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . 0.252 0.0 OUTLIER -63.03 -36.8 84.78 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 121.21 1.823 . . . . 0.0 112.227 169.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.76 -45.75 91.79 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 124.556 1.074 . . . . 0.0 112.894 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -60.01 -42.46 94.36 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 117.767 0.783 . . . . 0.0 112.473 171.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.8 t -63.7 -47.44 91.08 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 C-N-CA 124.643 1.177 . . . . 0.0 110.155 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -49.6 -53.37 24.3 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 120.417 1.462 . . . . 0.0 111.648 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -58.48 -40.18 82.02 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.463 1.105 . . . . 0.0 112.602 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.6 mtt85 -82.55 -31.07 29.28 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.16 0.984 . . . . 0.0 112.931 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.78 -48.52 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.104 1.362 . . . . 0.0 109.947 169.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -54.35 -54.99 33.03 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.397 0.999 . . . . 0.0 109.497 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -50.63 -36.92 37.68 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.392 1.477 . . . . 0.0 112.67 176.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -81.06 -60.73 2.18 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.091 0.956 . . . . 0.0 112.976 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.17 -35.03 70.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 124.94 1.296 . . . . 0.0 111.856 -175.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.97 -20.73 61.69 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.112 -0.993 . . . . 0.0 113.443 -172.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -74.38 -20.46 60.06 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.822 1.249 . . . . 0.0 113.52 173.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.9 pt -118.07 1.48 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.086 1.754 . . . . 0.0 113.162 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 C--O 1.252 1.228 0 C-N-CA 125.932 1.693 . . . . 0.0 113.501 173.197 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.505 2.315 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -79.54 102.4 8.82 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.894 0.77 . . . . 0.0 109.557 169.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -77.25 144.13 38.43 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.677 0.791 . . . . 0.0 111.541 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 91.1 t -113.54 143.5 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.253 1.421 . . . . 0.0 110.107 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 45.1 ttm -130.72 130.76 44.22 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.18 0.592 . . . . 0.0 111.617 168.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -98.07 136.49 38.25 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.175 0.99 . . . . 0.0 110.612 169.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.1 t -129.73 126.03 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.974 1.31 . . . . 0.0 110.898 -169.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.3 m -143.34 176.6 9.03 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.217 1.007 . . . . 0.0 111.547 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -67.38 -65.21 0.71 Allowed 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 169.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.13 113.15 19.79 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 168.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.461 HD21 ' HA ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -70.37 -22.35 62.78 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 120.271 1.396 . . . . 0.0 110.294 169.464 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.4 p -57.63 -53.27 60.02 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 127.551 2.34 . . . . 0.0 116.17 173.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.4 p -93.19 -14.67 26.84 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.885 1.274 . . . . 0.0 113.376 -171.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -124.47 -68.88 0.83 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.406 1.082 . . . . 0.0 113.2 -176.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.1 m -57.24 -43.28 82.8 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 120.05 1.296 . . . . 0.0 113.044 -176.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -55.95 -34.77 65.98 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.757 1.623 . . . . 0.0 113.4 173.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 59.2 mtp -64.18 -48.27 76.61 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 119.399 1.0 . . . . 0.0 111.57 174.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.07 -23.48 63.08 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 118.656 -0.688 . . . . 0.0 112.551 173.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -73.23 -49.16 29.39 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 120.024 1.284 . . . . 0.0 108.598 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.06 -52.2 53.78 Favored Glycine 0 C--O 1.222 -0.628 0 CA-C-O 118.429 -1.206 . . . . 0.0 111.049 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.544 ' HB3' HG11 ' A' ' 123' ' ' VAL . 13.4 m-85 -62.36 -43.47 98.74 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.748 1.274 . . . . 0.0 112.948 176.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.13 -37.0 83.09 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.676 1.58 . . . . 0.0 111.165 -177.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -59.59 -62.48 1.84 Allowed 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 125.125 1.37 . . . . 0.0 109.925 169.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.9 p -67.71 -14.28 62.81 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -175.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.5 mt -92.59 -10.7 36.58 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 172.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.24 19.08 0.1 Allowed Glycine 0 CA--C 1.539 1.573 0 N-CA-C 118.715 2.246 . . . . 0.0 118.715 -172.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.83 -33.76 62.04 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.856 1.828 . . . . 0.0 114.803 -172.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.45 -8.95 87.05 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 124.069 0.842 . . . . 0.0 114.998 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -98.76 -55.33 2.76 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 118.625 1.212 . . . . 0.0 112.312 -171.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.5 pp -141.45 171.11 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 126.619 1.968 . . . . 0.0 111.053 -174.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.22 125.49 44.83 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 175.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.1 m -94.64 155.63 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.535 1.534 . . . . 0.0 112.896 169.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.34 123.0 11.82 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.1 t -89.18 123.5 33.49 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 120.74 -1.225 . . . . 0.0 113.074 173.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.5 t -148.72 169.61 20.02 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.764 0.711 . . . . 0.0 112.39 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.36 179.27 48.89 Favored Glycine 0 CA--C 1.521 0.457 0 O-C-N 120.577 -1.327 . . . . 0.0 114.27 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.2 mt -65.39 -30.42 71.24 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 122.86 0.464 . . . . 0.0 111.413 176.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -117.22 122.61 44.48 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.651 1.981 . . . . 0.0 108.958 169.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.8 p -78.24 44.69 0.51 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.998 1.719 . . . . 0.0 111.987 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.8 p -64.9 158.56 24.93 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.771 1.628 . . . . 0.0 114.149 -169.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 -64.2 174.16 1.7 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -169.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 m -65.98 109.08 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 120.295 -1.503 . . . . 0.0 107.552 168.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.7 t-80 -65.37 132.68 95.23 Favored Pre-proline 0 N--CA 1.476 0.874 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -169.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -59.55 -40.53 65.14 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.158 2.572 . . . . 0.0 113.334 -172.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.4 m -78.17 -30.62 49.18 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.053 -0.404 . . . . 0.0 110.911 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.5 -44.43 78.47 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.79 -1.194 . . . . 0.0 112.552 172.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.5 mt -52.85 -40.37 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 120.177 1.353 . . . . 0.0 110.463 173.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.58 -65.5 0.67 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 174.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.3 mmt -65.92 -24.92 66.93 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -170.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 85.3 mtp -84.91 -30.72 24.15 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 122.938 0.495 . . . . 0.0 111.484 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -61.14 -31.42 71.14 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.556 -1.34 . . . . 0.0 111.629 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -57.07 -31.95 65.74 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 121.085 -1.009 . . . . 0.0 112.819 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.28 7.61 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.413 1.485 . . . . 0.0 113.396 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.94 19.87 52.06 Favored Glycine 0 N--CA 1.479 1.501 0 O-C-N 120.286 -1.509 . . . . 0.0 115.038 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 25.1 mt -123.43 66.0 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.68 1.592 . . . . 0.0 110.313 -169.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -64.12 112.82 3.17 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 120.605 -1.309 . . . . 0.0 110.962 173.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 21.0 pt -90.34 -1.11 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 175.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 95.4 p -64.86 124.46 22.04 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 120.564 1.529 . . . . 0.0 110.36 -174.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.85 1.38 87.16 Favored Glycine 0 CA--C 1.546 2.023 0 N-CA-C 116.191 1.236 . . . . 0.0 116.191 -169.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -74.03 145.93 44.13 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.742 1.771 . . . . 0.0 111.916 177.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.9 t -61.21 145.35 51.52 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -175.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.461 ' HA ' HD21 ' A' ' 11' ' ' ASN . 2.0 m -137.42 117.64 13.55 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.623 1.569 . . . . 0.0 109.941 174.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -114.08 150.91 44.36 Favored Pre-proline 0 CA--C 1.557 1.214 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -169.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -91.84 126.51 0.92 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.618 2.879 . . . . 0.0 111.603 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.5 tt -77.11 -4.98 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -172.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -86.41 -13.1 47.27 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 120.654 -1.279 . . . . 0.0 113.149 170.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -91.86 -37.4 12.94 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.948 0.899 . . . . 0.0 112.569 174.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -71.08 169.38 15.12 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.37 1.068 . . . . 0.0 112.763 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.01 126.4 28.46 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.309 1.444 . . . . 0.0 109.785 169.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.48 3.34 3.93 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -175.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -66.44 -29.01 69.05 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.894 0.878 . . . . 0.0 112.887 -170.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -94.75 2.04 55.5 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.556 1.542 . . . . 0.0 113.671 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -122.91 93.13 3.87 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.353 1.461 . . . . 0.0 111.089 -169.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -61.58 -23.74 66.19 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.3 t -124.83 120.84 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.449 1.099 . . . . 0.0 110.697 -174.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.6 t -131.74 133.05 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.031 0.932 . . . . 0.0 109.956 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.0 mm -121.67 122.06 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 123.836 0.854 . . . . 0.0 110.716 -171.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.3 t -85.97 113.56 22.17 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 168.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.5 mt -83.77 45.11 1.04 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.238 1.015 . . . . 0.0 110.623 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.9 t -141.26 153.89 45.46 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.536 2.734 . . . . 0.0 109.42 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -73.67 -9.5 78.74 Favored Glycine 0 CA--C 1.541 1.701 0 O-C-N 121.477 -0.765 . . . . 0.0 112.885 169.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 24.5 p -80.79 -62.14 1.76 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.073 1.749 . . . . 0.0 113.985 -174.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.43 -56.03 0.66 Allowed Glycine 0 CA--C 1.54 1.61 0 C-N-CA 126.002 1.763 . . . . 0.0 115.031 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.3 p -59.53 -19.85 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 127.347 2.259 . . . . 0.0 114.928 -173.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -69.1 -19.83 64.06 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.233 1.013 . . . . 0.0 113.49 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.9 mt -79.51 159.95 71.01 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 124.363 1.065 . . . . 0.0 112.96 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -59.18 145.7 96.89 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.326 2.684 . . . . 0.0 113.913 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.11 44.04 1.11 Allowed 'Trans proline' 0 CA--C 1.548 1.213 1 C-N-CA 125.951 4.434 . . . . 0.0 113.324 -178.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -156.81 -36.66 0.08 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.601 2.36 . . . . 0.0 111.252 -174.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -75.93 -24.26 55.51 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.643 -1.285 . . . . 0.0 111.518 170.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.1 m -89.43 -11.29 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.395 1.478 . . . . 0.0 114.781 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.8 p -95.85 5.96 50.03 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -172.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -70.93 166.19 21.75 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.335 1.054 . . . . 0.0 112.285 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -52.08 -37.4 53.81 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -169.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 63.2 mt -125.15 122.3 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.656 1.182 . . . . 0.0 109.337 169.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -131.21 136.2 48.05 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.539 1.135 . . . . 0.0 111.091 169.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -140.25 146.86 39.17 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.175 0.99 . . . . 0.0 113.357 -173.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -103.18 95.72 6.3 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.189 2.196 . . . . 0.0 111.636 170.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 20.6 m0 -85.13 92.79 8.48 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 169.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.18 77.58 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 127.661 2.384 . . . . 0.0 113.688 169.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 58.5 mt -116.82 159.88 21.68 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.97 2.108 . . . . 0.0 112.067 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -95.53 148.92 21.99 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.256 1.422 . . . . 0.0 111.484 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -80.99 110.73 18.85 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.056 0.942 . . . . 0.0 109.908 169.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.415 ' HB2' ' CD2' ' A' ' 112' ' ' PHE . 15.1 Cg_endo -87.03 -5.03 7.84 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.519 2.146 . . . . 0.0 113.739 -169.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -48.26 105.59 0.08 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.66 1.584 . . . . 0.0 113.36 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.43 1.3 90.04 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 123.815 0.722 . . . . 0.0 114.758 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -77.79 168.79 19.38 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.17 0.985 . . . . 0.0 110.562 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 23.2 t -62.37 149.83 41.31 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.638 -0.664 . . . . 0.0 111.45 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.1 mp -60.04 -28.46 67.78 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.733 0.813 . . . . 0.0 111.787 -172.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -64.89 -35.8 82.3 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 173.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.6 t -66.32 -31.95 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.545 0.738 . . . . 0.0 109.452 170.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.415 ' CD2' ' HB2' ' A' ' 104' ' ' PRO . 0.4 OUTLIER -77.16 -39.54 48.68 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.732 0.813 . . . . 0.0 110.739 -177.16 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -68.42 -36.73 79.5 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.939 1.296 . . . . 0.0 112.457 170.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 50.6 m -59.86 -49.12 78.95 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.705 1.202 . . . . 0.0 111.259 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.6 m -67.02 -30.28 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 118.055 -0.974 . . . . 0.0 111.952 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.07 -47.83 84.23 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 120.189 1.359 . . . . 0.0 110.849 169.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.07 -41.57 99.78 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.552 1.072 . . . . 0.0 113.181 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -63.97 -48.76 75.19 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 122.148 -0.619 . . . . 0.0 112.223 171.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.422 ' O ' HG12 ' A' ' 123' ' ' VAL . 21.7 t -53.98 -51.86 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 116.939 -1.505 . . . . 0.0 111.086 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -46.14 -47.5 17.49 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 120.33 1.423 . . . . 0.0 113.286 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -66.07 -47.99 72.49 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.815 0.846 . . . . 0.0 112.029 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.8 mtp180 -71.09 -40.49 71.5 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.522 0.729 . . . . 0.0 112.642 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.544 HG11 ' HB3' ' A' ' 21' ' ' PHE . 8.0 p -72.23 -36.26 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.538 1.535 . . . . 0.0 112.021 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -58.51 -55.34 36.28 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.777 1.172 . . . . 0.0 109.406 169.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -55.16 -36.59 66.0 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.217 1.007 . . . . 0.0 112.03 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.42 -59.48 2.74 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.473 -0.767 . . . . 0.0 112.651 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.25 -34.53 67.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 123.968 0.907 . . . . 0.0 112.139 -175.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.48 -6.67 52.77 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -174.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -82.41 -20.41 37.13 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.664 1.186 . . . . 0.0 113.319 169.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.7 pt -119.18 -7.69 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.293 1.437 . . . . 0.0 113.837 -173.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.3 p . . . . . 0 C--O 1.254 1.298 0 C-N-CA 125.442 1.497 . . . . 0.0 113.249 170.783 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 tpp . . . . . 0 N--CA 1.5 2.059 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -76.72 105.84 8.03 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 119.621 1.1 . . . . 0.0 110.544 169.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -79.91 136.22 36.61 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 173.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.1 t -97.96 147.0 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.273 1.029 . . . . 0.0 109.95 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 42.6 tpp -130.26 112.29 13.2 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.869 0.868 . . . . 0.0 111.296 169.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -83.68 120.88 26.53 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.301 0.64 . . . . 0.0 111.04 169.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.7 t -118.84 135.52 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.492 1.517 . . . . 0.0 109.672 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.7 p -151.9 178.0 9.86 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 121.419 -0.8 . . . . 0.0 112.537 177.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -63.57 -42.96 98.29 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 121.512 -0.743 . . . . 0.0 111.067 169.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.484 ' HB3' ' H ' ' A' ' 13' ' ' SER . 1.1 mpt_? -117.69 103.6 10.18 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.953 1.301 . . . . 0.0 110.835 172.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -55.66 -33.62 64.25 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.287 -0.883 . . . . 0.0 110.223 169.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.4 p -57.01 -53.6 56.28 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.238 2.215 . . . . 0.0 115.303 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.484 ' H ' ' HB3' ' A' ' 10' ' ' ARG . 89.0 p -103.22 -1.67 28.52 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.09 1.356 . . . . 0.0 114.133 -176.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -126.68 -76.25 0.58 Allowed 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.076 -1.64 . . . . 0.0 111.283 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.424 ' HB3' ' HB2' ' A' ' 34' ' ' SER . 4.9 m -59.59 -39.04 82.82 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -172.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -56.13 -30.63 62.4 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.467 1.507 . . . . 0.0 114.499 171.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 93.2 mtp -69.73 -45.12 68.89 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.308 0.958 . . . . 0.0 110.358 174.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.35 -27.79 66.57 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 171.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -68.0 -49.01 64.15 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.99 1.268 . . . . 0.0 108.25 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.63 -52.3 51.86 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-O 118.814 -0.992 . . . . 0.0 111.854 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.491 ' HB3' HG11 ' A' ' 123' ' ' VAL . 12.7 m-85 -61.35 -42.64 99.02 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.507 1.153 . . . . 0.0 112.848 175.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.59 -37.17 85.88 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 120.082 -1.636 . . . . 0.0 111.104 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -62.51 -48.63 78.7 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.021 1.329 . . . . 0.0 111.489 174.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.5 p -80.27 -14.19 58.6 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 51.0 mt -97.83 -10.79 24.13 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.08 0.952 . . . . 0.0 113.393 174.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -148.66 25.3 1.34 Allowed Glycine 0 CA--C 1.534 1.22 0 N-CA-C 115.851 1.1 . . . . 0.0 115.851 -169.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.89 122.78 11.56 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.602 1.201 . . . . 0.0 112.792 -175.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.29 -2.47 36.69 Favored Glycine 0 CA--C 1.538 1.497 0 N-CA-C 116.138 1.215 . . . . 0.0 116.138 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -78.64 -46.58 18.88 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.429 1.615 . . . . 0.0 111.314 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -141.98 -177.78 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 128.265 2.626 . . . . 0.0 109.375 169.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.61 120.59 40.27 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.075 -1.016 . . . . 0.0 112.449 171.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.96 144.15 9.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 122.87 0.468 . . . . 0.0 111.796 169.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.47 163.64 35.05 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.943 1.297 . . . . 0.0 110.371 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.424 ' HB2' ' HB3' ' A' ' 15' ' ' SER . 88.2 p -148.68 150.19 32.78 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.467 1.107 . . . . 0.0 113.723 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 82.5 p -143.22 -175.36 4.5 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.39 1.876 . . . . 0.0 110.433 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.23 177.25 40.91 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-N 120.047 1.294 . . . . 0.0 115.23 172.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 35.6 mt -73.65 -43.78 58.59 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 118.515 1.157 . . . . 0.0 113.493 -169.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -130.42 70.65 1.45 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.387 2.275 . . . . 0.0 107.826 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.1 m -72.44 -20.33 61.42 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -169.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.2 m 37.54 -93.44 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 128.17 2.588 . . . . 0.0 117.316 172.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.1 ptp85 -154.73 -177.99 6.89 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 126.387 1.875 . . . . 0.0 112.228 -169.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.6 m -65.8 118.4 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.04 -1.038 . . . . 0.0 110.558 169.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -74.46 133.28 77.51 Favored Pre-proline 0 N--CA 1.478 0.968 0 O-C-N 121.058 -1.026 . . . . 0.0 113.0 -169.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -59.78 -40.9 59.66 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.543 2.829 . . . . 0.0 114.137 -171.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.1 m -78.29 -38.28 42.87 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 122.061 -0.399 . . . . 0.0 110.48 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.27 -40.35 97.14 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 118.123 -0.942 . . . . 0.0 112.467 176.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 66.7 mt -49.88 -47.69 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 120.197 1.362 . . . . 0.0 110.413 172.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.84 -58.79 4.8 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.5 mmt -66.25 -26.56 67.41 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.413 -0.805 . . . . 0.0 112.741 -173.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 72.2 mmm -84.2 -38.9 20.0 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.713 0.805 . . . . 0.0 110.563 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -59.59 -37.46 78.59 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.718 -1.239 . . . . 0.0 112.097 170.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -56.62 -22.32 33.24 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.538 1.135 . . . . 0.0 113.634 173.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.1 m -113.18 17.83 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 125.044 1.338 . . . . 0.0 114.576 175.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.2 13.63 61.62 Favored Glycine 0 N--CA 1.477 1.39 0 N-CA-C 115.597 0.999 . . . . 0.0 115.597 176.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 29.6 mt -126.67 62.78 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.62 1.568 . . . . 0.0 109.85 -169.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -60.67 110.69 1.37 Allowed 'General case' 0 CA--C 1.548 0.899 0 O-C-N 120.031 -1.668 . . . . 0.0 110.45 172.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.8 pt -89.58 4.2 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.7 p -67.36 -18.53 65.18 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.851 1.659 . . . . 0.0 114.648 -172.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -102.22 8.57 55.55 Favored Glycine 0 CA--C 1.542 1.728 0 C-N-CA 125.413 1.483 . . . . 0.0 114.634 169.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -79.57 143.04 35.14 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.379 1.472 . . . . 0.0 111.927 -171.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 10.8 t -66.05 153.68 41.59 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 121.53 -0.731 . . . . 0.0 112.734 172.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.4 p -147.06 133.7 19.9 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.316 1.446 . . . . 0.0 109.926 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -141.34 135.0 14.67 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 123.282 0.633 . . . . 0.0 112.049 -169.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -71.61 154.88 59.74 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.384 2.723 . . . . 0.0 112.903 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.1 tt -62.78 -18.96 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.022 1.329 . . . . 0.0 114.566 -176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -95.55 -9.11 33.25 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -80.39 -43.74 20.55 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.055 0.843 . . . . 0.0 109.236 169.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.31 159.71 32.96 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.889 1.276 . . . . 0.0 112.3 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -142.47 134.91 27.86 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.486 1.114 . . . . 0.0 110.36 169.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.2 9.33 4.65 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.632 1.716 . . . . 0.0 115.632 -172.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.35 -28.8 63.26 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.11 -0.993 . . . . 0.0 112.318 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -97.49 -3.65 39.51 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.065 1.346 . . . . 0.0 113.662 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -123.71 90.62 3.31 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.456 1.502 . . . . 0.0 110.039 -172.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -66.91 -12.34 59.14 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.5 t -123.99 116.49 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 126.005 1.722 . . . . 0.0 109.731 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.5 t -131.57 134.76 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.762 0.825 . . . . 0.0 111.016 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.509 HG21 ' CE2' ' A' ' 99' ' ' TRP . 10.5 mm -126.59 137.0 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.319 0.648 . . . . 0.0 111.333 -172.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.2 t -95.49 117.93 31.28 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.431 1.493 . . . . 0.0 108.989 169.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 mp -99.93 61.38 1.11 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.768 1.627 . . . . 0.0 107.816 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.8 t -155.39 -30.94 0.1 Allowed 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 -169.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.91 22.34 78.16 Favored Glycine 0 CA--C 1.54 1.628 0 O-C-N 120.798 -1.189 . . . . 0.0 111.223 -168.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 14.8 p -135.34 28.58 3.37 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.621 1.968 . . . . 0.0 112.411 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -55.74 -31.29 57.8 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 120.877 -1.139 . . . . 0.0 115.224 -169.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.6 m -67.98 -14.3 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 175.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -84.97 -11.02 56.42 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.858 1.263 . . . . 0.0 112.87 174.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.9 mt -72.03 157.47 89.39 Favored Pre-proline 0 CA--C 1.553 1.069 0 O-C-N 121.452 -0.78 . . . . 0.0 110.762 170.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -55.34 143.71 75.27 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.06 2.507 . . . . 0.0 113.174 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -75.62 41.36 0.79 Allowed 'Trans proline' 0 CA--C 1.549 1.256 1 C-N-CA 125.46 4.106 . . . . 0.0 113.624 -173.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -156.07 -30.84 0.09 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.995 2.518 . . . . 0.0 111.075 -175.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -82.21 14.82 2.68 Favored 'General case' 0 CA--C 1.553 1.073 0 O-C-N 120.918 -1.113 . . . . 0.0 113.415 169.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.5 m -131.48 -3.96 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 126.399 1.88 . . . . 0.0 113.387 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.6 p -95.68 -6.06 40.83 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.602 1.561 . . . . 0.0 113.667 -171.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -65.04 154.12 38.73 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.802 2.041 . . . . 0.0 111.932 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -53.74 -35.73 61.55 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.372 1.469 . . . . 0.0 114.304 -169.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 54.1 mt -119.02 107.38 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 169.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -121.44 131.69 54.3 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.29 1.036 . . . . 0.0 110.074 169.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -133.46 147.42 51.68 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.566 1.146 . . . . 0.0 111.647 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -115.42 95.41 5.15 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.444 1.116 . . . . 0.0 110.814 172.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.509 ' CE2' HG21 ' A' ' 77' ' ' ILE . 30.3 m0 -74.25 93.99 2.43 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 169.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.8 73.83 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.286 2.635 . . . . 0.0 113.403 169.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 71.1 mt -113.83 147.72 37.89 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.574 2.35 . . . . 0.0 111.616 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -84.47 158.88 20.88 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.369 1.068 . . . . 0.0 111.945 175.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -88.12 110.21 34.03 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 126.262 1.825 . . . . 0.0 111.765 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -84.95 -13.7 6.52 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 123.139 2.56 . . . . 0.0 116.21 -169.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -50.92 107.34 0.17 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.807 1.243 . . . . 0.0 112.527 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.18 11.54 85.45 Favored Glycine 0 CA--C 1.538 1.504 0 CA-C-O 118.837 -0.98 . . . . 0.0 115.487 177.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -74.42 -71.68 0.33 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.33 1.565 . . . . 0.0 110.625 176.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.5 t -173.89 150.1 1.61 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.891 2.476 . . . . 0.0 108.285 174.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.7 mp -60.4 -32.5 71.39 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 118.62 0.645 . . . . 0.0 111.799 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -70.59 -33.64 71.29 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.936 -1.103 . . . . 0.0 112.923 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 83.3 t -68.85 -37.38 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.398 -0.814 . . . . 0.0 109.527 170.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -45.09 92.06 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.58 1.152 . . . . 0.0 110.888 176.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -65.95 -23.88 66.69 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.868 1.667 . . . . 0.0 113.993 172.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.9 m -78.75 -51.74 9.36 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.672 1.589 . . . . 0.0 111.098 177.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.0 m -66.34 -26.52 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 121.104 -0.997 . . . . 0.0 111.628 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.78 -44.18 94.03 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.429 1.892 . . . . 0.0 111.203 169.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.84 -41.57 88.12 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 124.106 0.86 . . . . 0.0 112.771 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -60.87 -48.32 82.36 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 122.185 -0.597 . . . . 0.0 111.757 172.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.424 ' O ' HG12 ' A' ' 123' ' ' VAL . 38.2 t -57.65 -47.58 85.23 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-O 117.249 -1.358 . . . . 0.0 110.232 176.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -52.29 -48.61 65.24 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 120.423 1.465 . . . . 0.0 112.327 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -63.51 -48.01 79.36 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.935 0.494 . . . . 0.0 112.19 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -70.74 -36.79 73.31 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.491 HG11 ' HB3' ' A' ' 21' ' ' PHE . 6.0 p -74.54 -36.37 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.682 1.193 . . . . 0.0 111.831 177.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -56.53 -54.82 41.44 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.649 1.113 . . . . 0.0 108.334 168.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -59.81 -17.02 32.78 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -92.23 -60.46 1.84 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.381 1.446 . . . . 0.0 112.37 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -57.76 -33.79 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.17 0.988 . . . . 0.0 111.283 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.12 -6.97 53.65 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -176.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -74.37 -23.12 58.96 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.319 1.047 . . . . 0.0 112.165 169.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.5 pt -130.42 -0.87 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 125.717 1.607 . . . . 0.0 114.983 -168.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 60.9 p . . . . . 0 C--O 1.255 1.362 0 C-N-CA 125.052 1.341 . . . . 0.0 113.509 170.424 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttm . . . . . 0 N--CA 1.503 2.213 0 CA-C-O 119.429 -0.319 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -95.59 97.27 9.62 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.467 1.107 . . . . 0.0 110.519 174.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -86.61 149.26 25.05 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.594 -0.691 . . . . 0.0 112.693 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.3 t -117.97 143.39 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.652 1.181 . . . . 0.0 111.777 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 42.9 tpp -131.9 125.35 31.49 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.419 1.087 . . . . 0.0 110.865 169.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -94.59 142.35 27.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.221 0.608 . . . . 0.0 109.985 169.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.6 t -135.42 119.79 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.11 1.364 . . . . 0.0 111.093 -174.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 p -135.37 178.06 7.33 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.294 1.438 . . . . 0.0 111.823 175.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -58.53 -57.37 13.27 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 120.751 -1.218 . . . . 0.0 110.581 174.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -101.45 120.07 39.73 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 168.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -54.14 -50.54 66.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 120.41 1.459 . . . . 0.0 110.876 175.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.1 p -64.99 -16.61 63.6 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -174.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.5 p -77.48 -37.81 50.51 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.7 ptt-85 -152.19 -32.47 0.14 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 117.279 2.326 . . . . 0.0 117.279 -174.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.407 ' HA ' HD12 ' A' ' 79' ' ' LEU . 58.4 m -68.13 -38.11 81.85 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 121.503 1.956 . . . . 0.0 113.388 171.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -67.22 -31.81 72.43 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.187 0.995 . . . . 0.0 111.724 168.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.464 ' HA ' ' CE ' ' A' ' 50' ' ' MET . 45.6 ttm -62.27 -52.44 63.7 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.328 1.051 . . . . 0.0 111.532 173.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.43 -27.6 69.4 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 124.485 1.114 . . . . 0.0 112.327 172.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -73.0 -47.83 41.74 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.928 1.694 . . . . 0.0 109.465 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.89 -54.76 31.51 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-O 118.797 -1.002 . . . . 0.0 111.344 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.486 ' HB3' HG11 ' A' ' 123' ' ' VAL . 9.6 m-85 -57.58 -41.58 81.41 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.955 0.878 . . . . 0.0 112.379 174.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.73 ' HB1' HG11 ' A' ' 32' ' ' VAL . . . -65.68 -39.87 91.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.86 1.209 . . . . 0.0 112.187 -179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -71.31 -44.15 65.69 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.951 1.25 . . . . 0.0 112.325 173.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.6 p -65.93 -5.96 10.95 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 120.735 1.607 . . . . 0.0 114.632 173.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.8 mt -110.01 -5.43 15.43 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.847 1.259 . . . . 0.0 114.083 171.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.68 17.49 0.28 Allowed Glycine 0 N--CA 1.478 1.442 0 N-CA-C 116.841 1.496 . . . . 0.0 116.841 -170.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.11 135.22 56.99 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.923 1.362 . . . . 0.0 112.176 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.6 -6.33 46.72 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-O 118.62 -1.1 . . . . 0.0 115.588 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -85.52 -60.54 2.0 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.608 1.704 . . . . 0.0 110.672 175.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -141.37 172.53 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 127.359 2.264 . . . . 0.0 110.44 177.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.8 130.77 44.72 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.898 0.856 . . . . 0.0 112.831 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.73 HG11 ' HB1' ' A' ' 22' ' ' ALA . 15.9 m -105.34 151.76 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 124.744 1.218 . . . . 0.0 112.024 169.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.83 144.03 30.0 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.262 0.625 . . . . 0.0 111.369 -171.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.3 p -112.87 136.39 52.56 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.61 1.564 . . . . 0.0 113.46 176.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.0 t -152.61 177.26 10.85 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.866 1.266 . . . . 0.0 111.88 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.92 -175.72 47.05 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 120.671 -1.268 . . . . 0.0 114.294 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.2 mt -72.09 -33.57 67.98 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -175.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -134.44 73.32 1.49 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.535 2.334 . . . . 0.0 108.565 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.5 m -65.74 -22.7 66.62 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -172.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.9 t 43.96 -106.59 0.1 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.665 1.986 . . . . 0.0 114.607 169.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -149.34 171.55 16.35 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 127.002 2.121 . . . . 0.0 111.169 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.7 m -53.74 120.16 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.608 1.163 . . . . 0.0 110.758 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -82.52 136.03 45.98 Favored Pre-proline 0 N--CA 1.478 0.931 0 CA-C-O 118.053 -0.975 . . . . 0.0 112.237 -169.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -57.99 -44.65 38.01 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.455 2.77 . . . . 0.0 113.913 -173.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.9 m -76.98 -28.43 55.12 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.674 -0.641 . . . . 0.0 110.812 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.89 -47.09 66.71 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.223 -0.923 . . . . 0.0 111.973 169.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 57.6 mt -51.68 -48.3 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 120.27 1.396 . . . . 0.0 109.66 171.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.07 -65.13 0.65 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 177.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.44 -27.2 66.85 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -174.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.464 ' CE ' ' HA ' ' A' ' 17' ' ' MET . 87.4 mtp -80.62 -29.59 36.81 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.438 1.017 . . . . 0.0 111.669 178.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -63.93 -28.05 69.56 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.897 -1.127 . . . . 0.0 112.875 169.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -57.65 -34.71 69.64 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 119.307 0.958 . . . . 0.0 112.27 174.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.2 8.24 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.62 1.568 . . . . 0.0 113.232 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.14 23.7 43.7 Favored Glycine 0 N--CA 1.477 1.403 0 O-C-N 120.58 -1.325 . . . . 0.0 115.074 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.6 mt -123.83 60.66 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.678 1.591 . . . . 0.0 110.54 -169.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -62.34 109.82 1.46 Allowed 'General case' 0 CA--C 1.546 0.823 0 O-C-N 120.469 -1.394 . . . . 0.0 111.833 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 pt -85.87 -5.27 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 117.735 -1.126 . . . . 0.0 113.479 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.3 t -60.07 -28.54 67.89 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 120.917 1.69 . . . . 0.0 113.267 -170.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -101.34 8.52 57.08 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 125.405 1.479 . . . . 0.0 115.799 171.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -95.6 150.55 20.22 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.601 1.56 . . . . 0.0 112.034 -171.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.0 t -68.47 159.39 31.8 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -172.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.8 t -150.08 135.08 17.82 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.831 1.653 . . . . 0.0 109.625 169.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -144.02 138.78 15.31 Favored Pre-proline 0 N--CA 1.475 0.784 0 C-N-CA 123.659 0.784 . . . . 0.0 111.046 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -77.85 152.59 28.8 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.459 2.773 . . . . 0.0 113.382 -174.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.4 tt -59.21 -23.89 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -173.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -96.58 -8.2 32.42 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -94.27 -36.1 12.14 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.487 0.715 . . . . 0.0 111.439 170.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.28 161.26 30.7 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.146 0.498 . . . . 0.0 111.165 170.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.86 127.86 25.73 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.522 0.729 . . . . 0.0 111.431 169.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.23 2.61 4.46 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -173.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.8 -30.64 69.26 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.005 -1.059 . . . . 0.0 112.602 -170.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -89.37 -1.45 58.06 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.779 1.231 . . . . 0.0 113.422 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -120.66 97.06 5.38 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.224 1.41 . . . . 0.0 111.361 -169.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -55.35 -31.52 61.8 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.044 1.337 . . . . 0.0 112.85 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.6 120.23 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 124.544 1.138 . . . . 0.0 110.633 -172.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.6 t -124.92 132.83 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.14 0.976 . . . . 0.0 109.813 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.4 mm -123.51 123.51 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 123.581 0.752 . . . . 0.0 110.678 -172.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.4 t -82.55 123.55 29.31 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.968 0.907 . . . . 0.0 109.862 169.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 15' ' ' SER . 30.4 mt -114.34 34.55 4.65 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.853 1.661 . . . . 0.0 110.775 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 30.4 p -158.16 162.57 37.95 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.536 1.134 . . . . 0.0 113.194 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.39 -19.94 67.07 Favored Glycine 0 CA--C 1.544 1.854 0 O-C-N 121.388 -0.82 . . . . 0.0 111.532 168.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 11.6 p -64.49 0.07 1.18 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.977 2.111 . . . . 0.0 115.698 170.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -54.38 -33.68 53.52 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.671 1.129 . . . . 0.0 114.855 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.0 m -73.25 -13.8 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -101.75 -0.73 33.88 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.54 1.536 . . . . 0.0 113.124 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.3 mt -68.59 155.38 93.02 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 123.691 0.797 . . . . 0.0 111.703 176.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -58.99 145.07 98.83 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.031 2.488 . . . . 0.0 113.848 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.02 41.9 0.79 Allowed 'Trans proline' 0 CA--C 1.55 1.293 1 C-N-CA 125.979 4.453 . . . . 0.0 113.483 -177.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -156.75 -35.74 0.08 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.921 2.489 . . . . 0.0 111.084 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -73.06 -26.07 61.15 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.247 -1.533 . . . . 0.0 111.698 169.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.2 m -85.8 -11.25 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 79.6 p -98.36 5.57 48.08 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -172.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -69.6 164.79 22.54 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.367 1.067 . . . . 0.0 112.505 177.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -50.2 -39.98 45.8 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.752 1.221 . . . . 0.0 114.25 -169.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.8 mt -124.03 120.01 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.383 1.073 . . . . 0.0 109.011 169.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -129.35 125.39 36.55 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.126 0.97 . . . . 0.0 110.206 169.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -139.56 158.75 43.6 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.957 1.303 . . . . 0.0 111.647 -174.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -128.21 126.18 40.45 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.49 1.116 . . . . 0.0 112.121 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -100.48 7.04 44.4 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.127 1.528 . . . . 0.0 115.127 -174.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 62.06 22.73 13.31 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 169.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 68.3 mt -78.62 142.37 37.3 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -169.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -78.03 159.03 28.99 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.059 1.744 . . . . 0.0 111.866 173.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -85.31 113.29 49.72 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 124.214 1.006 . . . . 0.0 111.247 173.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -87.06 -17.26 3.11 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.203 2.602 . . . . 0.0 114.88 -170.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -61.6 120.33 10.37 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.888 -1.132 . . . . 0.0 111.366 178.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.57 -4.77 85.13 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 123.994 0.807 . . . . 0.0 113.967 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -80.89 171.19 15.32 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 118.083 0.941 . . . . 0.0 109.577 169.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 39.4 m -62.96 151.03 40.75 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.169 -0.957 . . . . 0.0 111.419 170.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.25 -29.22 68.64 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.241 -0.912 . . . . 0.0 112.439 -175.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -62.31 -33.56 74.9 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.988 0.915 . . . . 0.0 113.317 172.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 50.3 t -72.87 -35.27 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 121.048 -1.032 . . . . 0.0 110.219 172.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -66.43 -38.26 87.02 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.003 0.521 . . . . 0.0 111.093 175.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -68.69 -39.68 80.43 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.554 1.142 . . . . 0.0 112.249 169.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 42.8 m -58.48 -47.76 83.0 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.397 1.079 . . . . 0.0 111.951 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.0 m -66.39 -30.69 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 119.382 0.992 . . . . 0.0 111.816 176.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -41.06 95.26 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 120.111 1.323 . . . . 0.0 112.633 170.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.88 -44.73 97.0 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.174 0.892 . . . . 0.0 112.591 174.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -61.81 -47.3 85.75 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 122.171 -0.605 . . . . 0.0 111.931 172.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.4 t -57.06 -48.01 82.62 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.517 0 CA-C-O 117.495 -1.24 . . . . 0.0 110.442 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -53.55 -50.69 64.98 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 120.115 1.325 . . . . 0.0 112.221 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -59.25 -44.51 92.39 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.044 0.538 . . . . 0.0 112.397 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.8 mtp85 -79.57 -35.99 38.9 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -176.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.486 HG11 ' HB3' ' A' ' 21' ' ' PHE . 4.4 p -74.01 -33.89 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.212 1.405 . . . . 0.0 112.417 178.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -55.47 -55.33 33.03 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.162 0.892 . . . . 0.0 108.855 169.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.94 -32.11 52.62 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.586 1.554 . . . . 0.0 112.894 176.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -79.02 -56.57 4.29 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.949 0.795 . . . . 0.0 112.256 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -65.45 -35.35 75.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.553 0.741 . . . . 0.0 112.038 -177.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.18 -8.59 55.56 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -174.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -84.65 -15.46 45.32 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.145 1.378 . . . . 0.0 113.538 171.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 21.2 pt -127.34 -8.38 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.544 1.538 . . . . 0.0 113.923 -173.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.7 p . . . . . 0 C--O 1.255 1.371 0 C-N-CA 125.227 1.411 . . . . 0.0 113.358 169.866 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.8 ttm . . . . . 0 N--CA 1.503 2.198 0 CA-C-O 119.479 -0.296 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -84.93 91.29 8.01 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.064 0.946 . . . . 0.0 111.261 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -77.75 145.85 36.24 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 121.605 -0.684 . . . . 0.0 112.376 -173.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.0 t -110.09 143.48 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.707 1.203 . . . . 0.0 110.397 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 48.4 tpp -128.91 118.37 22.55 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.852 0.861 . . . . 0.0 111.024 170.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -89.16 135.55 33.5 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.943 0.497 . . . . 0.0 111.124 169.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.9 129.11 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.755 1.222 . . . . 0.0 110.467 -171.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 t -144.3 -177.09 5.29 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.281 0.632 . . . . 0.0 112.449 172.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -64.44 -47.51 78.81 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 121.468 -0.77 . . . . 0.0 110.152 169.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.66 116.75 32.49 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.903 1.281 . . . . 0.0 109.312 169.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.69 -37.04 85.37 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 168.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.8 p -56.41 -29.47 61.58 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 128.034 2.534 . . . . 0.0 115.067 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.2 p -102.33 -101.92 0.28 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.43 1.092 . . . . 0.0 111.98 176.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.14 -44.4 71.35 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 120.227 1.376 . . . . 0.0 113.947 -168.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 m -63.16 -51.63 65.65 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.169 0.895 . . . . 0.0 112.067 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -64.6 -33.76 76.67 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 96.4 mtp -60.08 -50.35 74.04 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.725 0.693 . . . . 0.0 110.478 171.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.86 -31.16 70.78 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.28 -45.73 72.29 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 120.119 1.327 . . . . 0.0 108.642 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.446 ' CA ' HE22 ' A' ' 60' ' ' GLN . . . -67.35 -39.67 91.73 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 118.631 -1.094 . . . . 0.0 112.7 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -65.02 -39.85 93.99 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.109 1.454 . . . . 0.0 111.783 170.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.72 -33.26 70.67 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.503 -1.373 . . . . 0.0 111.385 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -59.89 -56.95 15.43 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.32 1.848 . . . . 0.0 109.61 170.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.6 p -70.16 -15.69 62.98 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.0 mt -99.24 -1.95 37.86 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 173.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.32 4.34 0.59 Allowed Glycine 0 CA--C 1.536 1.387 0 N-CA-C 117.226 1.651 . . . . 0.0 117.226 -169.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.44 133.92 56.2 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.9 1.85 . . . . 0.0 111.869 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.87 -2.36 74.83 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 124.676 1.131 . . . . 0.0 115.386 -174.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -94.35 -76.48 0.48 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.881 1.341 . . . . 0.0 110.111 175.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -128.39 176.18 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 126.608 1.963 . . . . 0.0 111.349 173.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.1 125.56 40.71 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.3 -0.875 . . . . 0.0 112.129 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.8 m -92.93 147.97 5.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 123.787 0.835 . . . . 0.0 111.664 169.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.49 159.27 43.62 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.747 0.819 . . . . 0.0 110.591 -172.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.63 133.21 34.07 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.111 1.364 . . . . 0.0 113.153 -171.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.3 p -144.7 176.17 9.63 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.305 1.442 . . . . 0.0 111.465 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.85 175.85 43.59 Favored Glycine 0 CA--C 1.526 0.774 0 O-C-N 120.396 -1.44 . . . . 0.0 114.552 169.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.4 mt -63.69 -37.79 88.66 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.112 0.565 . . . . 0.0 111.263 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -121.39 113.35 19.75 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.964 2.105 . . . . 0.0 107.829 169.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.6 p -66.74 -35.3 79.78 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.799 0.84 . . . . 0.0 112.085 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.7 t 46.59 -127.29 1.5 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 126.324 1.849 . . . . 0.0 112.293 -177.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -141.41 -176.58 4.78 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 127.511 2.324 . . . . 0.0 111.26 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.8 m -66.42 113.51 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 120.162 -1.587 . . . . 0.0 108.886 169.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -68.56 133.61 90.8 Favored Pre-proline 0 N--CA 1.477 0.917 0 O-C-N 121.48 -0.762 . . . . 0.0 112.304 -169.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.39 -38.27 85.16 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.26 2.64 . . . . 0.0 113.543 -172.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.407 ' HB ' ' CE2' ' A' ' 112' ' ' PHE . 8.7 m -79.45 -35.39 40.44 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.996 0.519 . . . . 0.0 110.667 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.13 -42.25 99.46 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.268 0.94 . . . . 0.0 112.133 174.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.7 mt -52.88 -44.79 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 120.287 1.403 . . . . 0.0 110.436 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.72 -60.67 2.65 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 33.5 mmt -68.03 -19.57 64.92 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.767 0.827 . . . . 0.0 113.192 -172.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 84.1 mmm -89.47 -38.04 14.34 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.896 0.878 . . . . 0.0 110.553 173.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -59.39 -35.32 73.71 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.538 -1.351 . . . . 0.0 112.399 170.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -55.19 -31.76 61.67 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.123 0.969 . . . . 0.0 113.492 171.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.9 m -103.15 20.77 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.888 1.275 . . . . 0.0 113.978 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.56 12.13 78.62 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.329 0.966 . . . . 0.0 115.255 174.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.3 mt -120.38 78.25 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.21 1.804 . . . . 0.0 108.934 -170.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -69.06 106.88 2.94 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.044 -1.66 . . . . 0.0 110.276 171.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.7 pt -84.75 -0.89 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 121.578 -0.701 . . . . 0.0 112.832 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.9 t -64.23 -28.76 69.96 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 120.157 1.344 . . . . 0.0 112.827 -172.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.32 4.22 73.43 Favored Glycine 0 CA--C 1.541 1.7 0 C-N-CA 125.102 1.334 . . . . 0.0 115.368 172.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.446 HE22 ' CA ' ' A' ' 20' ' ' GLY . 9.8 mt-30 -92.31 160.07 15.3 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.268 1.427 . . . . 0.0 112.634 -176.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.0 t -95.59 156.91 16.13 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -170.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.8 m -137.15 140.72 42.02 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.925 1.69 . . . . 0.0 108.21 169.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -141.49 134.4 14.22 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.636 1.174 . . . . 0.0 111.393 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.15 145.91 50.4 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.305 2.003 . . . . 0.0 110.297 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.5 tt -56.07 -30.72 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -169.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -94.44 -9.18 36.39 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -82.4 -41.22 20.21 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.003 0.82 . . . . 0.0 109.958 169.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.75 159.17 34.23 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.244 0.545 . . . . 0.0 110.777 170.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -139.75 135.77 33.44 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.589 -0.694 . . . . 0.0 111.223 169.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.3 -0.73 8.61 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -169.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -68.02 -33.51 74.73 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.759 1.163 . . . . 0.0 113.006 -171.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -84.68 -3.03 58.34 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.224 1.01 . . . . 0.0 113.598 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -120.97 92.62 3.8 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.417 1.487 . . . . 0.0 110.163 -170.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -54.29 -27.47 35.52 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.115 1.366 . . . . 0.0 113.201 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.1 118.44 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 125.209 1.404 . . . . 0.0 110.126 -174.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.2 t -127.01 132.52 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.634 0.774 . . . . 0.0 110.268 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.3 mm -124.94 122.45 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 123.715 0.806 . . . . 0.0 111.61 -169.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.2 t -81.58 130.75 35.17 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.803 0.841 . . . . 0.0 109.962 169.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.0 mt -121.19 32.72 5.82 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.161 1.784 . . . . 0.0 111.282 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.3 p -158.54 162.24 37.4 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.575 1.15 . . . . 0.0 112.779 -176.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -64.96 -19.96 66.24 Favored Glycine 0 CA--C 1.545 1.931 0 O-C-N 121.215 -0.928 . . . . 0.0 111.307 168.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.6 p -63.92 -0.61 1.14 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.915 2.086 . . . . 0.0 115.547 170.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -54.22 -31.9 50.21 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 119.842 1.201 . . . . 0.0 114.748 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.7 m -75.18 -14.53 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 175.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -93.95 -9.08 38.21 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.434 1.494 . . . . 0.0 112.98 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.0 mt -61.02 139.9 94.11 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.091 0.956 . . . . 0.0 111.107 174.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -58.68 162.94 11.78 Favored 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 123.528 2.819 . . . . 0.0 113.728 174.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.05 -51.73 2.05 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.563 2.175 . . . . 0.0 113.663 -172.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -62.12 -35.42 78.69 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 120.653 -1.279 . . . . 0.0 112.28 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -64.89 5.64 0.31 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 127.298 2.239 . . . . 0.0 114.926 169.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.0 t -131.08 -43.01 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 127.26 2.224 . . . . 0.0 111.116 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.4 p -80.57 29.48 0.31 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -170.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -77.15 167.59 21.51 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.057 -1.027 . . . . 0.0 112.002 170.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -56.74 -36.12 69.38 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -169.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 57.7 mt -125.95 123.86 64.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.741 1.216 . . . . 0.0 108.88 169.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -131.76 138.56 48.65 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.758 0.823 . . . . 0.0 111.089 169.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -138.94 151.87 47.25 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.897 1.279 . . . . 0.0 110.517 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -122.41 114.3 20.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.482 0.713 . . . . 0.0 110.536 169.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 32.8 m0 -89.4 -2.36 58.38 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.205 1.002 . . . . 0.0 113.053 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.305 1.5 pp0? 47.35 37.64 6.26 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 171.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 81.7 mt -74.09 148.99 41.35 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.286 1.034 . . . . 0.0 112.686 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -75.0 153.46 38.5 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.537 1.135 . . . . 0.0 111.666 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -79.65 122.36 83.54 Favored Pre-proline 0 CA--C 1.542 0.673 0 O-C-N 121.126 -0.984 . . . . 0.0 111.858 173.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -93.86 -21.5 0.33 Allowed 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.091 1.861 . . . . 0.0 113.847 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.6 104.59 0.07 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.891 2.076 . . . . 0.0 112.636 -176.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.5 8.6 87.11 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.517 1.056 . . . . 0.0 114.96 175.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -84.27 -64.78 1.1 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.711 1.256 . . . . 0.0 111.343 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.7 t -169.3 152.37 4.91 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.174 1.789 . . . . 0.0 109.592 171.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.92 -30.89 68.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.322 0.649 . . . . 0.0 111.041 172.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -62.81 -39.94 95.83 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.173 -0.955 . . . . 0.0 112.565 174.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 79.0 t -71.1 -39.6 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.41 -0.806 . . . . 0.0 109.083 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.407 ' CE2' ' HB ' ' A' ' 45' ' ' THR . 0.2 OUTLIER -59.32 -49.88 76.11 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.398 1.079 . . . . 0.0 112.097 176.719 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -69.45 -34.46 74.43 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.667 -0.646 . . . . 0.0 111.979 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 65.2 m -59.06 -52.59 65.11 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.286 0.634 . . . . 0.0 111.199 172.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.1 m -73.5 -27.55 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 117.74 -1.124 . . . . 0.0 112.664 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.7 ptt180 -61.27 -38.71 87.74 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 121.227 1.83 . . . . 0.0 111.88 170.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.94 -43.08 96.48 Favored Glycine 0 N--CA 1.473 1.156 0 C-N-CA 123.847 0.737 . . . . 0.0 112.739 176.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -61.19 -46.75 89.19 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.406 0.682 . . . . 0.0 111.929 170.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 25.5 t -60.45 -45.05 97.42 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.302 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -52.86 -54.5 33.51 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.093 1.315 . . . . 0.0 111.69 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -62.6 -43.47 98.74 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.067 0.547 . . . . 0.0 112.36 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.9 mtt-85 -74.8 -31.85 61.84 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 39.6 t -64.37 -47.98 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.489 169.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -53.92 -55.18 29.31 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.3 0.955 . . . . 0.0 109.239 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -49.34 -38.95 29.79 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.81 1.644 . . . . 0.0 112.242 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -81.19 -62.08 1.76 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.5 -30.32 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.545 1.138 . . . . 0.0 111.588 -175.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -78.11 -2.86 39.49 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -79.2 -20.51 48.18 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.339 1.056 . . . . 0.0 112.568 169.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.3 pt -126.89 13.38 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 126.303 1.841 . . . . 0.0 113.408 -169.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 47.1 p . . . . . 0 C--O 1.256 1.425 0 C-N-CA 125.748 1.619 . . . . 0.0 113.966 172.561 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.6 ttm . . . . . 0 N--CA 1.501 2.111 0 CA-C-O 119.596 -0.24 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -88.19 92.05 9.01 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.887 0.875 . . . . 0.0 109.958 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -79.85 151.2 30.36 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.49 -0.756 . . . . 0.0 111.607 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.6 p -118.84 142.09 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.045 0.938 . . . . 0.0 112.209 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.459 ' HE1' ' HB ' ' A' ' 33' ' ' THR . 62.0 tpp -122.33 132.66 54.5 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.372 1.069 . . . . 0.0 110.881 171.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -105.09 138.8 40.73 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.78 0.718 . . . . 0.0 110.894 169.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.8 t -131.31 138.84 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.537 1.135 . . . . 0.0 112.272 -169.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 54.7 p -155.72 -169.81 3.22 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.282 1.033 . . . . 0.0 110.147 169.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -68.0 -40.74 82.98 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 120.354 -1.466 . . . . 0.0 110.102 168.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 51.7 mtp85 -124.0 101.76 7.4 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.925 1.69 . . . . 0.0 111.341 -176.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.549 ' H ' ' HA ' ' A' ' 39' ' ' SER . 19.7 t30 -52.53 -54.25 35.27 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 169.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.4 p -30.83 -57.25 0.22 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.018 2.127 . . . . 0.0 115.551 175.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.1 p -88.98 -41.95 12.07 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.27 1.028 . . . . 0.0 113.085 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -103.0 -73.87 0.65 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.047 1.339 . . . . 0.0 112.998 -174.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.11 -37.22 84.28 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -169.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.526 ' NE2' HD21 ' A' ' 11' ' ' ASN . 1.6 tp60 -50.65 -37.89 43.33 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.734 2.014 . . . . 0.0 113.17 170.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 60.2 ttm -66.3 -46.14 77.96 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.09 -1.006 . . . . 0.0 111.183 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.51 -21.94 65.47 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 118.524 -0.751 . . . . 0.0 111.957 170.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -73.34 -53.1 11.6 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 120.402 1.455 . . . . 0.0 108.461 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.99 -50.23 62.67 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.24 0.924 . . . . 0.0 112.424 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.594 ' HB3' HG11 ' A' ' 123' ' ' VAL . 5.8 m-85 -66.55 -41.39 88.75 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.808 1.304 . . . . 0.0 113.078 176.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.38 -36.19 83.35 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.541 1.519 . . . . 0.0 110.091 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -64.3 -55.98 17.61 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.444 1.498 . . . . 0.0 109.916 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.7 p -70.59 -13.42 62.09 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 120.467 -1.395 . . . . 0.0 114.435 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.6 mt -96.82 -7.0 34.71 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.72 9.35 0.09 OUTLIER Glycine 0 N--CA 1.477 1.416 0 N-CA-C 119.028 2.371 . . . . 0.0 119.028 -172.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.53 -29.09 64.06 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.006 1.903 . . . . 0.0 114.464 -174.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.73 -9.33 86.92 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-O 119.247 -0.752 . . . . 0.0 114.891 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -101.75 -60.17 1.58 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.811 1.245 . . . . 0.0 111.968 -172.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.47 174.38 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 127.048 2.139 . . . . 0.0 110.483 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.26 129.23 42.46 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 121.384 -0.823 . . . . 0.0 110.926 176.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 m -101.68 148.42 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.014 0.926 . . . . 0.0 110.436 170.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.459 ' HB ' ' HE1' ' A' ' 5' ' ' MET . 3.3 m -146.94 157.35 43.61 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.011 0.924 . . . . 0.0 110.367 173.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -135.45 152.03 50.98 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 170.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 88.8 p -152.32 179.24 8.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.285 1.834 . . . . 0.0 111.886 -170.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.13 -178.78 48.51 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 115.639 1.015 . . . . 0.0 115.639 169.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 55.9 mt -64.81 -52.08 58.7 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.849 0.86 . . . . 0.0 112.069 -174.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -91.12 -38.14 12.95 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.561 1.544 . . . . 0.0 110.86 170.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.549 ' HA ' ' H ' ' A' ' 11' ' ' ASN . 0.6 OUTLIER 62.69 -46.46 0.19 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 127.727 2.411 . . . . 0.0 115.996 -177.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . 0.256 38.2 t 63.5 -123.86 0.56 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 127.247 2.219 . . . . 0.0 113.391 174.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -143.91 -178.23 5.82 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 126.447 1.899 . . . . 0.0 113.71 -171.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.5 m -64.79 111.18 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 120.853 -1.154 . . . . 0.0 109.793 169.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -77.97 137.69 61.54 Favored Pre-proline 0 N--CA 1.476 0.83 0 O-C-N 121.092 -1.005 . . . . 0.0 112.988 -169.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -57.59 -43.43 50.77 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.538 2.825 . . . . 0.0 113.768 -175.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.9 m -75.75 -31.6 59.62 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.763 -0.586 . . . . 0.0 110.795 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.46 -43.11 81.88 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.172 -0.955 . . . . 0.0 112.408 171.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.9 mt -55.47 -40.58 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 121.268 1.849 . . . . 0.0 109.913 175.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.17 -62.53 1.56 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 173.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.95 -11.96 61.27 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -174.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 96.3 mmm -91.86 -42.49 10.04 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.177 0.899 . . . . 0.0 110.325 171.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -60.73 -37.52 82.03 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.673 -1.267 . . . . 0.0 112.518 174.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -60.66 -25.66 66.51 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . 0.25 7.8 p -105.19 15.67 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 125.525 1.53 . . . . 0.0 113.399 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.13 18.58 49.61 Favored Glycine 0 N--CA 1.477 1.37 0 O-C-N 120.796 -1.19 . . . . 0.0 115.555 173.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.7 mt -125.78 90.65 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.974 1.31 . . . . 0.0 110.853 -169.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -70.58 114.61 8.85 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.863 -1.148 . . . . 0.0 110.657 171.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.3 pt -101.37 0.29 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 123.73 0.812 . . . . 0.0 112.756 172.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.1 p -69.51 -17.63 63.61 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -169.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -101.89 8.98 56.48 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 125.344 1.45 . . . . 0.0 114.548 169.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -87.49 156.15 19.67 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.348 1.459 . . . . 0.0 112.295 -169.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.8 t -86.89 165.4 15.95 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -175.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.5 m -135.31 93.66 3.01 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.495 1.518 . . . . 0.0 109.103 169.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -88.97 133.37 35.61 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-O 118.469 -0.777 . . . . 0.0 111.806 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.09 153.94 22.14 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.655 2.237 . . . . 0.0 112.922 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.9 tp -55.96 -32.46 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -169.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -89.22 -13.83 37.33 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 120.786 -1.196 . . . . 0.0 113.267 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -90.1 -26.28 20.31 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.102 0.961 . . . . 0.0 112.832 175.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -52.81 46.72 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -169.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.1 m120 59.47 106.0 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.547 2.739 . . . . 0.0 114.561 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.05 13.85 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.97 1.708 . . . . 0.0 115.474 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -73.87 -29.28 62.01 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.069 0.948 . . . . 0.0 111.138 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -100.15 -5.67 27.42 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -124.89 94.46 4.19 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.27 1.428 . . . . 0.0 110.152 -172.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -73.12 -5.08 36.75 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -174.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.3 t -128.39 121.85 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 125.601 1.561 . . . . 0.0 109.451 173.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.2 t -132.31 119.35 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.052 0.541 . . . . 0.0 110.852 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 mp -110.24 134.35 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.001 0.92 . . . . 0.0 110.564 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.0 m -89.79 147.73 23.63 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.301 1.041 . . . . 0.0 108.253 168.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.9 mt -127.13 43.59 3.09 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.395 1.078 . . . . 0.0 110.728 -173.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 24.3 p -151.57 -16.56 0.2 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 117.59 2.441 . . . . 0.0 117.59 -169.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.08 34.42 70.31 Favored Glycine 0 CA--C 1.539 1.547 0 CA-C-N 119.898 1.226 . . . . 0.0 111.118 -168.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 4.0 p -141.97 -1.03 1.27 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.578 1.951 . . . . 0.0 114.756 -169.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -55.88 -21.47 30.42 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.064 1.792 . . . . 0.0 116.709 -169.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.09 -22.33 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 CA-C-N 118.692 1.246 . . . . 0.0 112.022 173.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -78.5 -10.19 59.62 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 176.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.7 mt -74.26 157.86 86.11 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-N 119.054 0.843 . . . . 0.0 111.707 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.91 141.01 93.43 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.641 2.227 . . . . 0.0 111.522 172.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -63.07 -29.73 75.18 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.477 2.118 . . . . 0.0 112.666 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -62.79 -25.71 68.37 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 173.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -87.14 4.08 43.74 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 170.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.8 t -112.51 -36.63 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.949 1.7 . . . . 0.0 112.544 -175.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.9 p -79.28 10.09 4.01 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 -169.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -66.16 166.54 11.65 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.342 1.457 . . . . 0.0 112.056 169.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -56.78 -37.94 71.8 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -169.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 74.3 mt -127.07 119.8 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.52 1.128 . . . . 0.0 109.674 174.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -133.2 128.23 35.51 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.825 1.25 . . . . 0.0 110.57 169.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -146.81 161.19 41.18 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.809 1.644 . . . . 0.0 110.759 -174.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -127.47 117.02 21.32 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.384 -0.822 . . . . 0.0 112.93 173.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -88.36 94.17 9.76 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 169.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.405 ' H ' ' HG3' ' A' ' 100' ' ' GLN . 2.0 pp0? -51.79 59.82 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 128.823 2.849 . . . . 0.0 116.167 169.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 93.2 mt -84.24 153.35 23.65 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.735 2.414 . . . . 0.0 111.842 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -70.91 162.53 29.14 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.853 0.861 . . . . 0.0 111.408 169.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -88.28 107.79 18.44 Favored Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 120.76 -1.212 . . . . 0.0 108.136 169.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -79.05 -11.96 14.7 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 121.346 1.364 . . . . 0.0 114.643 -169.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -46.2 105.34 0.06 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.745 2.018 . . . . 0.0 113.792 -173.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.04 10.85 53.25 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.331 0.967 . . . . 0.0 115.507 174.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -74.87 -59.21 2.84 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.024 1.412 . . . . 0.0 111.141 -175.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.1 t -172.08 152.44 2.89 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.061 2.145 . . . . 0.0 108.542 170.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.4 mp -60.05 -30.95 69.53 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.75 -0.594 . . . . 0.0 111.117 172.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.0 -38.05 89.66 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.324 -0.86 . . . . 0.0 112.397 173.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.5 t -72.84 -39.85 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.568 0.747 . . . . 0.0 109.194 177.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -45.81 92.1 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.745 0.818 . . . . 0.0 111.406 176.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -69.09 -36.01 77.12 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.367 1.067 . . . . 0.0 112.273 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 62.3 m -59.6 -51.28 70.48 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 118.8 0.727 . . . . 0.0 111.286 174.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.0 m -70.39 -28.92 36.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 CA-C-O 117.206 -1.378 . . . . 0.0 112.553 177.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . 0.255 0.0 OUTLIER -67.06 -37.25 83.71 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 121.21 1.823 . . . . 0.0 112.46 172.249 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.55 -44.15 95.54 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.039 0.828 . . . . 0.0 112.446 173.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -61.65 -46.93 87.64 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 117.61 0.705 . . . . 0.0 112.129 171.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.7 t -58.63 -47.45 88.67 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 CA-C-O 117.042 -1.456 . . . . 0.0 110.593 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -51.53 -47.06 63.49 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 120.695 1.589 . . . . 0.0 112.79 -178.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.21 -48.06 77.35 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.407 0.683 . . . . 0.0 112.265 177.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 63.8 mtt-85 -76.15 -32.24 59.0 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -176.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.594 HG11 ' HB3' ' A' ' 21' ' ' PHE . 4.0 p -73.93 -34.44 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.697 1.199 . . . . 0.0 111.427 175.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -60.97 -56.09 25.2 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.34 0.973 . . . . 0.0 108.621 168.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -50.25 -38.72 42.22 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.052 1.741 . . . . 0.0 112.487 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -78.16 -60.52 2.34 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.29 -0.882 . . . . 0.0 113.134 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.61 -34.54 51.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 123.981 0.913 . . . . 0.0 111.63 -175.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.91 -0.17 17.69 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.774 1.229 . . . . 0.0 114.239 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -98.27 -10.97 23.11 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.215 1.406 . . . . 0.0 113.312 169.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.7 pt -118.47 -0.25 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.66 1.584 . . . . 0.0 113.359 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 51.2 p . . . . . 0 C--O 1.256 1.429 0 C-N-CA 125.225 1.41 . . . . 0.0 113.69 169.824 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.3 ttm . . . . . 0 N--CA 1.503 2.214 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.795 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -83.96 92.53 7.85 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 119.273 0.942 . . . . 0.0 111.29 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -78.33 145.29 35.38 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.55 -0.719 . . . . 0.0 112.704 -173.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.2 t -113.63 142.65 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 125.117 1.367 . . . . 0.0 111.252 178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.444 ' HE3' ' CD1' ' A' ' 68' ' ' PHE . 62.8 tpp -131.02 122.35 26.65 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.015 0.926 . . . . 0.0 111.279 169.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -92.85 143.35 26.35 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.158 0.583 . . . . 0.0 109.611 168.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.0 t -135.42 130.69 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.905 1.282 . . . . 0.0 109.578 -173.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 p -144.33 174.2 11.12 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.19 0.996 . . . . 0.0 111.606 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -61.26 -56.62 18.49 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.904 -1.122 . . . . 0.0 109.663 173.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -94.5 123.69 38.08 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 106.503 -1.665 . . . . 0.0 106.503 168.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -63.29 -48.77 76.7 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 120.363 1.438 . . . . 0.0 108.89 169.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 94.1 p -47.53 -35.08 8.36 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.822 2.449 . . . . 0.0 115.273 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.6 p -91.03 -27.87 18.34 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.69 1.196 . . . . 0.0 114.139 -173.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 -136.97 -63.09 0.62 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -169.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 95.2 p -62.87 -30.34 71.44 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 120.757 1.617 . . . . 0.0 112.135 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -63.1 -41.84 99.45 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.86 1.264 . . . . 0.0 112.507 169.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.8 mtm -62.14 -45.54 92.98 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.827 -0.546 . . . . 0.0 111.08 174.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.39 -24.01 65.64 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.827 -1.083 . . . . 0.0 113.522 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -74.1 -48.66 28.15 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 121.656 2.025 . . . . 0.0 108.35 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.66 -43.15 99.41 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-O 119.024 -0.875 . . . . 0.0 112.829 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -64.47 -42.86 95.65 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.636 1.718 . . . . 0.0 112.267 173.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.31 -31.05 63.79 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.622 1.101 . . . . 0.0 111.135 -176.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -65.24 -53.9 37.4 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 125.354 1.462 . . . . 0.0 109.919 171.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.1 p -69.62 -11.07 60.55 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.6 mt -103.89 -1.68 27.35 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.551 1.141 . . . . 0.0 113.88 171.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -153.6 9.06 0.47 Allowed Glycine 0 N--CA 1.477 1.399 0 N-CA-C 117.288 1.675 . . . . 0.0 117.288 -169.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.98 133.8 55.82 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 119.249 1.525 . . . . 0.0 111.886 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.87 -6.83 54.02 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.473 1.035 . . . . 0.0 115.332 -175.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -87.59 -63.55 1.29 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.349 1.575 . . . . 0.0 110.6 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -142.98 173.94 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 127.222 2.209 . . . . 0.0 110.946 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.0 130.34 41.71 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.369 -0.832 . . . . 0.0 112.61 176.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.2 m -105.48 154.03 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.73 1.212 . . . . 0.0 112.974 171.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.5 147.0 25.7 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -172.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.7 p -108.75 139.76 43.11 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 127.107 2.163 . . . . 0.0 114.031 170.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.5 t -143.05 177.37 8.42 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.498 1.519 . . . . 0.0 110.463 169.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.69 173.26 39.76 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 120.122 -1.611 . . . . 0.0 115.06 173.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.1 mt -61.76 -35.52 78.35 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.457 0.703 . . . . 0.0 111.752 -174.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -125.19 111.56 15.42 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.836 2.455 . . . . 0.0 107.565 169.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.4 p -65.51 -33.79 76.75 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.179 -0.95 . . . . 0.0 112.064 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.5 t 48.72 -120.63 1.36 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.386 1.474 . . . . 0.0 111.814 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -144.28 -151.54 0.37 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.594 1.957 . . . . 0.0 111.008 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.2 m -91.18 116.26 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 168.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -68.66 133.77 90.58 Favored Pre-proline 0 N--CA 1.481 1.11 0 O-C-N 120.963 -1.086 . . . . 0.0 111.686 -169.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -59.82 -37.61 85.3 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.446 2.764 . . . . 0.0 113.736 -171.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.9 m -79.02 -35.68 42.35 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.912 -0.492 . . . . 0.0 110.364 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.13 93.8 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.903 -1.123 . . . . 0.0 112.422 174.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 64.3 mt -53.32 -44.84 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 120.944 1.702 . . . . 0.0 110.71 172.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.67 -56.23 17.31 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.972 0.731 . . . . 0.0 112.972 175.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 30.1 mmt -68.66 -19.21 64.4 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -174.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 87.0 mmm -91.86 -40.23 11.3 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.888 0.875 . . . . 0.0 110.659 176.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -60.49 -39.83 89.12 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 120.741 -1.224 . . . . 0.0 112.404 174.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -60.31 -26.86 66.87 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.173 -0.954 . . . . 0.0 113.533 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.7 p -100.34 12.83 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 124.894 1.277 . . . . 0.0 113.103 174.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.39 18.59 48.63 Favored Glycine 0 N--CA 1.475 1.286 0 C-N-CA 124.795 1.188 . . . . 0.0 115.263 172.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.4 mt -127.22 85.5 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.426 1.49 . . . . 0.0 110.048 -169.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -71.27 109.81 5.52 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.133 -1.604 . . . . 0.0 110.831 173.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.5 pt -87.5 -9.31 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 118.251 -0.88 . . . . 0.0 112.512 173.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.3 t -62.36 -34.55 76.9 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 120.552 1.524 . . . . 0.0 113.149 -169.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.86 3.99 85.81 Favored Glycine 0 CA--C 1.541 1.683 0 C-N-CA 124.782 1.182 . . . . 0.0 115.282 173.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -97.26 150.68 20.66 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.41 1.484 . . . . 0.0 111.895 -173.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.3 t -84.87 149.62 25.55 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.268 -0.895 . . . . 0.0 112.886 -175.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 71.1 m -121.8 111.45 17.15 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.04 0.936 . . . . 0.0 109.914 169.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -89.17 152.58 48.18 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.039 0.936 . . . . 0.0 112.825 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -91.83 150.84 3.35 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.268 3.312 . . . . 0.0 112.0 171.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 tt -63.18 -27.87 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -170.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -82.1 -11.41 58.78 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.0 -1.063 . . . . 0.0 113.246 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -96.81 -27.97 14.47 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.436 1.094 . . . . 0.0 113.323 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.444 ' CD1' ' HE3' ' A' ' 5' ' ' MET . 0.0 OUTLIER -62.54 -41.72 99.07 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -168.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.4 ' HA ' ' CH2' ' A' ' 90' ' ' TRP 0.341 0.0 OUTLIER 53.97 99.44 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.662 2.785 . . . . 0.0 115.043 -176.834 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 68' ' ' PHE . . . -67.66 5.31 0.85 Allowed 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -175.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -72.2 -27.13 62.36 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.023 1.329 . . . . 0.0 112.27 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -90.07 -2.47 58.11 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -119.79 140.2 51.12 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.982 1.313 . . . . 0.0 112.604 -169.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -88.74 -28.83 20.26 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.894 0.877 . . . . 0.0 111.83 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.6 t -130.08 120.42 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.516 1.127 . . . . 0.0 110.003 -170.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.6 t -126.42 129.34 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.573 0.749 . . . . 0.0 110.193 177.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.8 mm -121.73 126.94 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.086 0.954 . . . . 0.0 110.632 -171.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.6 t -89.45 121.7 31.94 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.863 0.465 . . . . 0.0 109.835 169.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.416 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 75.9 mt -98.6 13.42 32.07 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.496 1.518 . . . . 0.0 112.024 175.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.5 p -133.22 157.99 44.0 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.799 2.039 . . . . 0.0 109.032 169.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.71 72.84 0.36 Allowed Glycine 0 N--CA 1.476 1.364 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 171.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 82.3 m -129.93 5.27 4.97 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.403 1.881 . . . . 0.0 114.872 -168.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -54.84 -28.09 46.23 Favored Glycine 0 CA--C 1.538 1.507 0 CA-C-N 120.321 1.419 . . . . 0.0 116.098 -173.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.2 m -99.05 -8.71 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 174.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -95.36 -28.56 14.89 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.093 1.357 . . . . 0.0 112.452 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.6 mt -63.22 150.07 89.84 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.585 1.154 . . . . 0.0 111.814 174.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -58.82 133.29 52.86 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.673 2.249 . . . . 0.0 111.081 173.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -61.18 -31.6 90.18 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.393 2.062 . . . . 0.0 113.184 -176.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -59.17 -32.86 70.28 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.059 -1.026 . . . . 0.0 112.959 171.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.4 ' CH2' ' HA ' ' A' ' 69' ' ' ASN . 0.4 OUTLIER -86.0 12.03 10.31 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.35 1.06 . . . . 0.0 113.821 174.633 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.9 t -116.48 -36.5 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.856 1.662 . . . . 0.0 111.74 178.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.8 p -79.59 25.31 0.34 Allowed 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 -169.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -76.17 167.02 22.62 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.858 1.663 . . . . 0.0 111.975 171.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -57.94 -37.09 73.48 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.932 0.893 . . . . 0.0 112.837 -171.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 67.4 mt -126.81 123.74 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.636 1.175 . . . . 0.0 109.215 169.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -131.52 134.25 45.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.208 1.003 . . . . 0.0 110.597 169.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -141.43 153.97 45.32 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.542 1.137 . . . . 0.0 112.155 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -120.92 117.67 27.92 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.74 1.216 . . . . 0.0 110.157 173.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.416 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 37.0 m0 -95.32 -0.79 52.43 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.669 1.188 . . . . 0.0 113.612 -177.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.308 1.3 pp0? 46.44 39.21 6.26 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 171.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.8 mt -79.4 159.64 26.99 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.8 0.84 . . . . 0.0 112.765 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -87.04 150.81 23.77 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.624 1.569 . . . . 0.0 111.958 173.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.44 116.26 59.32 Favored Pre-proline 0 CA--C 1.546 0.815 0 O-C-N 121.298 -0.877 . . . . 0.0 110.574 172.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -83.23 -14.82 8.13 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.496 2.131 . . . . 0.0 115.457 -169.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -46.59 108.08 0.13 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.759 1.624 . . . . 0.0 112.98 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.69 9.34 78.61 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-O 118.878 -0.957 . . . . 0.0 115.407 175.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -73.81 -68.17 0.54 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.04 1.42 . . . . 0.0 110.431 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.6 t -177.23 152.26 0.86 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 128.505 2.722 . . . . 0.0 108.106 173.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.8 mp -60.36 -29.94 69.23 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.822 0.737 . . . . 0.0 111.549 174.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -64.23 -38.65 91.81 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.091 -1.006 . . . . 0.0 112.423 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.2 t -73.61 -37.63 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.016 0.926 . . . . 0.0 109.476 176.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.8 -45.22 95.23 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.23 1.012 . . . . 0.0 111.177 175.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -67.79 -38.05 82.84 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.638 1.175 . . . . 0.0 112.491 173.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.4 m -58.86 -50.36 74.29 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 118.778 0.717 . . . . 0.0 110.886 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.6 m -71.25 -30.97 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 117.643 -1.17 . . . . 0.0 112.266 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -40.33 97.08 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 121.21 1.823 . . . . 0.0 111.966 171.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.49 -42.83 95.56 Favored Glycine 0 N--CA 1.474 1.183 0 C-N-CA 124.391 0.996 . . . . 0.0 112.579 176.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -60.75 -45.64 93.53 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.915 -0.756 . . . . 0.0 111.947 170.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 29.3 t -58.67 -48.73 84.94 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.807 177.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -51.56 -55.13 20.84 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.856 1.207 . . . . 0.0 111.487 176.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -59.69 -42.05 92.1 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.619 0.768 . . . . 0.0 112.572 -176.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -78.06 -35.01 50.08 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 39.1 t -61.19 -48.25 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.185 1.394 . . . . 0.0 111.19 172.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -51.88 -55.22 21.41 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.06 0.845 . . . . 0.0 109.606 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -56.93 -37.46 71.52 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.191 1.397 . . . . 0.0 112.276 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -74.25 -56.28 5.07 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.33 -0.856 . . . . 0.0 112.556 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.63 -34.44 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.775 1.23 . . . . 0.0 112.363 -175.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.14 -22.78 62.02 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 121.118 -0.989 . . . . 0.0 113.486 -174.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -70.2 -19.73 63.15 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.593 1.157 . . . . 0.0 113.849 173.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 28.7 pt -118.89 17.15 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 126.259 1.824 . . . . 0.0 112.652 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--O 1.256 1.401 0 C-N-CA 126.459 1.904 . . . . 0.0 111.313 172.158 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.6 tpp . . . . . 0 N--CA 1.502 2.139 0 CA-C-O 118.989 -0.529 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -82.7 85.42 7.04 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 119.873 1.215 . . . . 0.0 111.338 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -77.42 147.55 35.93 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -171.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.64 139.5 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.938 1.295 . . . . 0.0 111.074 176.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 49.4 tpp -127.36 115.36 18.85 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.499 0.72 . . . . 0.0 111.093 169.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -81.53 142.58 32.73 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.624 -0.673 . . . . 0.0 110.331 169.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.92 128.17 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 119.187 0.903 . . . . 0.0 111.66 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.5 p -144.76 178.02 8.3 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.462 1.105 . . . . 0.0 111.757 175.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -59.8 -61.46 2.6 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 120.083 1.31 . . . . 0.0 109.617 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.463 ' HB3' ' H ' ' A' ' 13' ' ' SER . 2.4 mpt_? -83.72 125.18 31.63 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 167.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -59.68 -43.25 94.08 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 120.029 1.286 . . . . 0.0 108.476 169.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.0 p -65.49 -48.58 72.13 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 115.848 1.795 . . . . 0.0 115.848 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.463 ' H ' ' HB3' ' A' ' 10' ' ' ARG . 4.3 m -71.8 -15.51 62.15 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -169.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.82 -55.05 0.82 Allowed 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 120.325 1.421 . . . . 0.0 113.258 168.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.8 m -61.97 -38.2 87.64 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -171.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -62.71 -36.14 82.0 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.377 0.99 . . . . 0.0 113.214 169.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 82.5 mtp -59.83 -45.58 91.96 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.161 -0.962 . . . . 0.0 110.3 173.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.62 -31.38 69.47 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 117.954 -1.022 . . . . 0.0 113.555 174.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -68.61 -46.17 69.99 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 121.553 1.979 . . . . 0.0 109.033 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.49 -42.99 97.29 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 118.527 -1.152 . . . . 0.0 112.668 -179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.529 ' HB3' HG11 ' A' ' 123' ' ' VAL . 3.5 m-85 -66.13 -42.3 89.33 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.202 1.501 . . . . 0.0 112.144 171.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.501 ' HB1' HG11 ' A' ' 32' ' ' VAL . . . -63.93 -35.75 81.68 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.61 -1.306 . . . . 0.0 111.114 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -63.53 -55.78 21.18 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.135 1.774 . . . . 0.0 109.976 174.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.7 p -68.41 -14.47 63.02 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 178.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 50.8 mt -99.14 -6.68 27.83 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.384 1.074 . . . . 0.0 113.864 174.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -152.13 9.56 0.62 Allowed Glycine 0 N--CA 1.476 1.311 0 N-CA-C 117.185 1.634 . . . . 0.0 117.185 -169.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.36 132.21 50.37 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 119.514 1.657 . . . . 0.0 111.609 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.37 -6.22 57.92 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.803 1.192 . . . . 0.0 115.475 -176.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -86.46 -59.16 2.36 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 119.459 1.629 . . . . 0.0 110.813 175.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.6 pp -144.7 175.71 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 128.226 2.61 . . . . 0.0 110.118 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.35 132.5 41.79 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.22 -0.925 . . . . 0.0 112.788 174.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.501 HG11 ' HB1' ' A' ' 22' ' ' ALA . 30.7 m -104.02 145.93 12.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 124.667 1.187 . . . . 0.0 112.704 171.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.8 m -146.94 156.35 43.0 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.217 1.007 . . . . 0.0 111.707 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.9 p -126.02 139.83 53.1 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.885 2.074 . . . . 0.0 113.9 175.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.7 t -133.66 172.1 13.21 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 129.567 3.147 . . . . 0.0 109.322 -176.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.64 173.56 44.84 Favored Glycine 0 CA--C 1.523 0.587 0 O-C-N 120.551 -1.343 . . . . 0.0 115.094 169.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.1 mt -66.46 -28.43 68.58 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.291 0.636 . . . . 0.0 111.723 -178.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -121.26 127.91 51.86 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.48 1.912 . . . . 0.0 108.383 170.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.5 p -78.02 55.99 1.54 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.675 1.59 . . . . 0.0 110.381 171.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.5 p -68.13 149.2 49.89 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.29 1.436 . . . . 0.0 112.037 -169.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -58.24 155.3 11.7 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.395 0.678 . . . . 0.0 111.673 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.1 m -50.91 109.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 169.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -65.95 130.63 94.44 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 118.478 -0.772 . . . . 0.0 112.319 -168.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.03 -38.79 85.65 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.489 2.793 . . . . 0.0 113.391 -172.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.9 m -77.55 -34.02 53.95 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 119.224 -0.417 . . . . 0.0 110.684 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.82 -43.48 96.09 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.844 -1.16 . . . . 0.0 111.986 172.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.7 mt -54.72 -40.3 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 120.795 1.634 . . . . 0.0 110.328 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.62 -62.87 1.27 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 173.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 30.4 mmt -67.11 -21.69 65.84 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.951 0.9 . . . . 0.0 113.415 -172.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 86.4 mmm -85.36 -37.78 19.5 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.616 0.767 . . . . 0.0 110.524 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -63.75 -33.44 75.67 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.665 -1.272 . . . . 0.0 111.983 173.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -55.26 -28.49 53.75 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 170.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.1 m -107.11 19.48 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 125.328 1.451 . . . . 0.0 113.525 174.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.64 13.73 74.98 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.65 1.119 . . . . 0.0 115.37 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.3 mt -117.67 97.19 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.448 1.499 . . . . 0.0 109.855 -170.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -78.35 112.09 15.0 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.958 -1.089 . . . . 0.0 110.438 171.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.0 pt -93.09 -4.22 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 172.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.4 p -65.98 -26.33 67.51 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -169.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -100.58 9.29 58.77 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.362 1.458 . . . . 0.0 114.445 172.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -86.72 149.11 25.11 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.983 1.313 . . . . 0.0 112.266 -170.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.9 t -63.59 148.16 49.58 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.459 -0.776 . . . . 0.0 112.109 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.5 t -138.96 54.95 1.72 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.046 0.927 . . . . 0.0 111.689 174.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -68.88 147.45 97.84 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 125.192 1.397 . . . . 0.0 113.185 -170.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -82.75 151.81 14.77 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.635 2.224 . . . . 0.0 112.442 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.8 tt -60.48 -21.83 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -91.99 -9.42 43.02 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 177.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -97.58 -35.2 10.69 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.781 0.832 . . . . 0.0 111.913 171.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -68.43 160.41 29.73 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.18 0.592 . . . . 0.0 111.571 175.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.416 ' HA ' ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -136.63 119.38 16.16 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.666 0.786 . . . . 0.0 111.985 170.479 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.423 ' HB3' ' CE3' ' A' ' 90' ' ' TRP . . . -66.54 0.8 2.01 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -175.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -70.59 -29.26 65.63 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.906 0.882 . . . . 0.0 112.209 -175.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -88.78 -2.36 58.55 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.116 1.366 . . . . 0.0 113.322 177.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -124.67 95.15 4.41 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.706 1.602 . . . . 0.0 110.498 -171.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -55.13 -29.48 57.81 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.768 1.227 . . . . 0.0 112.83 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 t -121.55 118.3 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 125.111 1.364 . . . . 0.0 110.19 -172.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.8 t -130.17 134.38 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.818 0.847 . . . . 0.0 110.644 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.406 HG21 ' CE2' ' A' ' 99' ' ' TRP . 19.0 mm -128.71 132.64 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 121.434 -0.791 . . . . 0.0 111.399 -170.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.4 t -87.87 117.59 26.82 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.521 0.728 . . . . 0.0 111.116 169.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 mp -97.68 37.07 1.42 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.734 1.614 . . . . 0.0 109.177 173.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.2 t -135.63 146.2 47.63 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.192 1.797 . . . . 0.0 111.647 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.16 -16.58 80.59 Favored Glycine 0 CA--C 1.542 1.723 0 O-C-N 121.946 -0.471 . . . . 0.0 112.798 169.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 24.5 p -63.35 -56.46 16.16 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.652 1.581 . . . . 0.0 114.173 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.27 -60.7 0.82 Allowed Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.69 1.614 . . . . 0.0 114.908 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.9 m -59.74 -21.62 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 126.23 1.812 . . . . 0.0 115.468 -170.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -76.79 -11.11 59.78 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.6 mt -80.82 135.97 51.61 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.615 0.766 . . . . 0.0 110.685 170.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.96 153.73 47.46 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.47 2.114 . . . . 0.0 110.675 174.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -59.82 -34.0 95.87 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.859 2.372 . . . . 0.0 112.222 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -48.89 -46.25 42.38 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.499 1.52 . . . . 0.0 112.938 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.423 ' CE3' ' HB3' ' A' ' 70' ' ' ALA . 1.8 m95 -90.75 8.2 35.77 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.747 1.219 . . . . 0.0 112.961 -177.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.7 t -114.94 -38.53 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 127.03 2.132 . . . . 0.0 111.704 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.9 p -81.39 26.71 0.45 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -174.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -80.89 169.34 17.67 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.31 1.444 . . . . 0.0 111.896 174.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -53.58 -41.79 66.92 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 -169.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 59.9 mt -125.71 123.46 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.591 1.157 . . . . 0.0 109.373 170.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -133.49 135.06 44.23 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.007 0.923 . . . . 0.0 111.44 169.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -142.84 153.12 42.87 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.69 1.196 . . . . 0.0 112.42 -175.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -113.36 125.88 54.75 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.279 1.432 . . . . 0.0 111.133 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.406 ' CE2' HG21 ' A' ' 77' ' ' ILE . 44.3 m0 -100.91 -5.69 25.67 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 177.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.355 1.2 pp0? 50.3 31.89 5.71 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.3 mt -75.52 151.87 37.89 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -87.28 160.6 18.36 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.704 2.002 . . . . 0.0 112.511 178.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.61 115.02 60.75 Favored Pre-proline 0 CA--C 1.547 0.83 0 O-C-N 121.282 -0.886 . . . . 0.0 111.4 169.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.87 -13.74 9.14 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.471 2.114 . . . . 0.0 114.822 -170.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -44.05 113.7 0.56 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.506 1.922 . . . . 0.0 113.556 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.81 6.46 55.88 Favored Glycine 0 CA--C 1.534 1.234 0 N-CA-C 115.86 1.104 . . . . 0.0 115.86 173.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -78.04 -63.63 1.35 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.921 1.361 . . . . 0.0 110.881 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.6 t -174.24 152.47 1.82 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.391 2.277 . . . . 0.0 108.889 169.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.1 mp -59.96 -29.92 68.75 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.624 -0.672 . . . . 0.0 111.299 171.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -63.09 -39.75 95.63 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.056 -1.028 . . . . 0.0 112.483 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.3 t -71.43 -37.1 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.843 0.857 . . . . 0.0 109.733 175.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.55 -41.9 92.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.914 0.885 . . . . 0.0 111.699 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -70.09 -36.8 75.17 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 121.22 -0.925 . . . . 0.0 111.987 171.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.3 m -58.06 -48.94 78.58 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.087 0.858 . . . . 0.0 111.639 174.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 23.8 m -68.25 -31.25 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 117.802 -1.094 . . . . 0.0 112.09 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.26 -42.22 98.27 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 120.867 1.667 . . . . 0.0 111.786 170.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.74 -43.82 93.44 Favored Glycine 0 N--CA 1.473 1.158 0 C-N-CA 124.256 0.932 . . . . 0.0 112.785 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -60.51 -45.21 94.65 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 122.166 -0.608 . . . . 0.0 112.032 170.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.9 t -59.67 -50.35 80.33 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 CA-C-O 117.518 -1.23 . . . . 0.0 109.434 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -50.81 -49.89 57.59 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 120.045 1.293 . . . . 0.0 112.068 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -60.48 -44.37 95.99 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.528 0.731 . . . . 0.0 112.948 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 46.4 mtp85 -81.92 -35.93 28.6 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.529 HG11 ' HB3' ' A' ' 21' ' ' PHE . 4.0 p -72.51 -34.07 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.17 1.388 . . . . 0.0 111.747 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -56.44 -56.98 14.48 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.249 0.931 . . . . 0.0 109.535 169.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -55.64 -35.68 66.18 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.885 1.274 . . . . 0.0 111.877 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -73.45 -57.16 4.19 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.631 -0.668 . . . . 0.0 112.385 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.96 -33.07 61.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 123.848 0.859 . . . . 0.0 112.211 -176.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.32 -23.25 60.23 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -173.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -68.57 -21.35 64.53 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.693 1.197 . . . . 0.0 113.811 173.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 29.0 pt -117.77 15.28 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 126.452 1.901 . . . . 0.0 112.634 -177.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--O 1.255 1.358 0 C-N-CA 126.501 1.92 . . . . 0.0 111.753 173.522 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.505 2.295 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -81.23 98.01 7.9 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.0 0.92 . . . . 0.0 110.147 175.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -80.47 146.46 31.37 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.647 -0.658 . . . . 0.0 112.324 -174.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.0 t -111.95 146.59 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.673 1.189 . . . . 0.0 110.743 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 45.3 tpp -130.83 112.81 13.36 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.226 1.011 . . . . 0.0 111.448 169.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -82.2 129.57 34.87 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.31 1.044 . . . . 0.0 110.362 169.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.3 t -127.22 136.23 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.069 1.348 . . . . 0.0 110.925 -176.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 t -149.78 -176.81 5.57 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 121.443 -0.786 . . . . 0.0 111.919 169.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -61.15 -45.0 96.43 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.412 -0.805 . . . . 0.0 110.617 170.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.56 129.59 56.68 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.435 1.494 . . . . 0.0 110.787 169.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -72.78 -55.79 6.21 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 169.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.0 p -27.35 -52.22 0.07 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 128.882 2.873 . . . . 0.0 116.758 173.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 94.4 p -100.96 -24.47 14.33 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.857 1.263 . . . . 0.0 113.898 -174.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -118.04 -71.46 0.74 Allowed 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 119.643 1.111 . . . . 0.0 111.98 -173.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.96 -30.38 70.88 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 121.256 -0.903 . . . . 0.0 112.924 -175.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -66.42 -34.25 77.52 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 126.405 1.882 . . . . 0.0 113.801 172.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 27.3 mmm -65.73 -36.4 83.5 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.656 -0.652 . . . . 0.0 110.27 172.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.41 -26.69 61.07 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.263 -0.898 . . . . 0.0 113.394 169.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -68.96 -53.25 21.8 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.395 1.452 . . . . 0.0 108.439 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.67 -49.07 77.0 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-O 118.935 -0.925 . . . . 0.0 112.488 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.575 ' HB3' HG11 ' A' ' 123' ' ' VAL . 8.4 m-85 -66.71 -38.34 86.51 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.586 1.193 . . . . 0.0 112.49 175.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.65 -38.07 80.16 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 120.024 1.283 . . . . 0.0 110.215 -178.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -57.74 -57.48 12.58 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 125.796 1.639 . . . . 0.0 110.889 171.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.9 p -71.35 -15.4 62.39 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -177.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.1 mt -95.14 -13.24 25.23 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -142.84 8.88 2.27 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 117.783 1.873 . . . . 0.0 117.783 -169.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.14 129.52 38.48 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.771 1.786 . . . . 0.0 111.784 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.33 -6.55 56.89 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 124.677 1.132 . . . . 0.0 115.571 -177.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -86.78 -57.37 3.01 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 119.471 1.636 . . . . 0.0 110.603 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.6 pp -142.17 177.13 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 127.504 2.322 . . . . 0.0 110.161 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.28 122.17 43.21 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.725 0.774 . . . . 0.0 111.591 173.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.9 m -87.74 149.92 3.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 123.781 0.833 . . . . 0.0 111.746 169.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.42 152.04 38.42 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.728 0.811 . . . . 0.0 110.93 176.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.0 p -133.44 145.65 50.45 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.941 1.696 . . . . 0.0 112.541 175.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.4 t -150.01 178.46 8.91 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.884 1.674 . . . . 0.0 110.573 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.26 -179.57 46.42 Favored Glycine 0 CA--C 1.527 0.794 0 O-C-N 120.92 -1.112 . . . . 0.0 114.185 170.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.1 mt -71.95 -44.39 63.65 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -169.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -90.73 -25.57 19.95 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.747 1.619 . . . . 0.0 112.473 173.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 60.3 p 58.84 -65.1 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 127.814 2.445 . . . . 0.0 113.128 -169.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 t 56.59 -174.58 0.06 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 130.22 3.408 . . . . 0.0 114.095 -177.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 54.6 ttt85 -79.83 147.51 31.75 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.873 1.669 . . . . 0.0 111.034 174.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.0 m -47.35 112.92 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.794 1.238 . . . . 0.0 109.739 169.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -63.12 137.56 97.1 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -167.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -60.4 -40.01 61.62 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.716 2.944 . . . . 0.0 113.518 -175.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.1 m -77.23 -33.04 56.19 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.978 -0.451 . . . . 0.0 110.513 176.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.3 -47.88 83.91 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.403 1.001 . . . . 0.0 111.706 171.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 68.7 mt -49.25 -44.56 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 120.388 1.449 . . . . 0.0 110.823 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.84 -59.44 5.14 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 174.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.2 mmt -67.11 -22.17 65.82 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -175.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.2 mtp -80.88 -45.16 17.24 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.993 1.317 . . . . 0.0 110.665 173.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -61.69 -33.45 74.02 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.804 -1.185 . . . . 0.0 112.532 176.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -55.53 -30.23 60.35 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.264 1.026 . . . . 0.0 113.455 172.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.0 m -105.87 14.98 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 125.146 1.379 . . . . 0.0 113.792 177.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.93 17.79 64.65 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.166 0.889 . . . . 0.0 115.124 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 65.6 mt -112.68 114.86 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.91 1.284 . . . . 0.0 110.944 -169.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -90.81 110.83 22.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.7 1.2 . . . . 0.0 111.783 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.3 pt -110.62 -5.89 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 169.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.8 p -67.32 -25.6 66.09 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 120.548 -1.345 . . . . 0.0 114.44 -169.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -106.99 14.12 40.84 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 125.683 1.611 . . . . 0.0 114.378 170.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -95.51 151.23 19.5 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.307 1.443 . . . . 0.0 112.128 -170.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.7 t -77.32 146.8 36.54 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 121.247 -0.908 . . . . 0.0 112.856 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.6 m -126.21 98.58 5.53 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.787 1.235 . . . . 0.0 109.069 169.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.79 155.99 75.3 Favored Pre-proline 0 CA--C 1.553 1.088 0 O-C-N 121.223 -0.923 . . . . 0.0 113.388 -174.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -97.63 152.45 0.92 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.866 3.711 . . . . 0.0 113.708 171.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.6 tp -60.81 -21.1 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 -169.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -103.15 -6.88 21.75 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -84.28 -37.91 21.11 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.97 0.804 . . . . 0.0 111.674 171.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.45 159.32 34.16 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.803 0.841 . . . . 0.0 111.574 173.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.449 ' HA ' ' CH2' ' A' ' 90' ' ' TRP . 0.4 OUTLIER -138.29 112.9 8.9 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.528 0.731 . . . . 0.0 111.728 171.428 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.7 -3.67 2.48 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -169.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.86 -27.62 67.67 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.004 -1.06 . . . . 0.0 112.214 -174.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -91.86 -0.87 57.53 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.087 1.355 . . . . 0.0 113.655 176.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -122.54 95.12 4.51 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.359 1.464 . . . . 0.0 110.597 -170.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -56.2 -31.3 63.33 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.878 1.271 . . . . 0.0 112.968 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.3 t -121.43 121.43 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 124.527 1.131 . . . . 0.0 110.494 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.7 t -127.1 133.59 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.079 0.952 . . . . 0.0 110.169 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.8 mm -122.84 136.7 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 123.909 0.883 . . . . 0.0 110.375 -175.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.7 t -96.96 127.23 42.73 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.042 0.937 . . . . 0.0 110.464 169.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -108.95 25.86 11.3 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.542 1.537 . . . . 0.0 110.173 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 31.3 p -150.56 165.28 33.76 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.138 2.575 . . . . 0.0 111.837 177.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.31 -19.25 75.8 Favored Glycine 0 CA--C 1.541 1.672 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 168.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 11.0 p -61.99 -6.39 2.84 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 127.235 2.214 . . . . 0.0 115.431 174.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.1 -31.96 59.4 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.613 1.102 . . . . 0.0 114.633 177.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.2 m -67.81 -16.09 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 176.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -97.61 2.25 49.69 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.256 1.422 . . . . 0.0 113.195 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.2 mt -71.92 155.3 92.15 Favored Pre-proline 0 CA--C 1.549 0.941 0 O-C-N 121.148 -0.97 . . . . 0.0 111.538 173.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -64.28 149.27 90.51 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.751 2.301 . . . . 0.0 113.954 -175.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -72.89 56.82 3.06 Favored 'Trans proline' 0 CA--C 1.549 1.261 1 C-N-CA 125.879 4.386 . . . . 0.0 111.183 171.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -157.03 -51.0 0.07 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.671 2.388 . . . . 0.0 109.431 -169.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.449 ' CH2' ' HA ' ' A' ' 69' ' ' ASN . 1.0 OUTLIER -85.39 -28.1 25.36 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.112 0.965 . . . . 0.0 111.899 177.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.4 m -84.16 -12.95 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 175.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.9 p -94.37 8.71 41.02 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.042 1.337 . . . . 0.0 114.202 -172.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -74.61 169.15 18.37 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.797 1.239 . . . . 0.0 112.98 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -52.07 -39.98 60.49 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -169.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.2 mt -126.3 122.98 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.553 1.141 . . . . 0.0 109.429 169.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -129.38 124.56 34.52 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.391 1.076 . . . . 0.0 110.143 169.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -141.79 167.61 21.74 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.334 1.454 . . . . 0.0 111.017 -174.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -135.27 146.84 48.94 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 172.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 36.7 m0 -109.38 7.68 25.13 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 64.46 -78.76 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.097 1.759 . . . . 0.0 112.983 -177.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 27.0 mt 49.94 -163.89 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 127.585 2.354 . . . . 0.0 113.852 -175.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -141.58 160.49 40.04 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.953 2.101 . . . . 0.0 108.105 171.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -81.1 110.53 18.3 Favored Pre-proline 0 N--CA 1.471 0.625 0 CA-C-N 119.764 1.166 . . . . 0.0 109.689 169.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -81.63 -10.77 11.83 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 121.249 1.3 . . . . 0.0 114.273 -169.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -45.47 109.26 0.16 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.666 1.586 . . . . 0.0 113.568 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.52 9.77 62.2 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 118.767 -1.018 . . . . 0.0 115.478 172.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -78.46 -64.8 1.09 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.877 1.338 . . . . 0.0 111.079 -176.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 21.4 t -173.74 151.62 1.88 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.372 2.269 . . . . 0.0 108.429 170.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.8 mp -60.81 -28.2 68.61 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.577 -0.702 . . . . 0.0 111.119 172.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.18 -39.6 95.1 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.027 -1.046 . . . . 0.0 112.334 173.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.5 t -71.68 -38.9 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.084 0.954 . . . . 0.0 109.654 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.34 -40.0 95.01 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.259 1.024 . . . . 0.0 111.608 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.8 mtt85 -73.23 -36.46 66.44 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 121.062 -1.024 . . . . 0.0 112.185 170.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 55.2 m -58.02 -47.73 82.17 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 119.147 0.885 . . . . 0.0 111.646 175.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.6 m -68.39 -30.24 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 119.589 1.086 . . . . 0.0 111.778 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.66 -43.52 98.59 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 120.236 1.38 . . . . 0.0 111.76 169.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.74 -44.33 94.99 Favored Glycine 0 N--CA 1.473 1.11 0 C-N-CA 124.47 1.033 . . . . 0.0 112.68 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -59.87 -46.41 89.4 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.242 0.617 . . . . 0.0 112.069 170.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.459 ' O ' HG12 ' A' ' 123' ' ' VAL . 3.9 t -59.42 -52.06 65.39 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.506 0 CA-C-O 117.136 -1.411 . . . . 0.0 110.3 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -49.52 -44.23 46.15 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.122 1.369 . . . . 0.0 113.215 -175.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -65.91 -45.59 81.4 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.416 0.686 . . . . 0.0 112.556 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 53.8 mtp85 -82.05 -34.46 29.46 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.752 0.821 . . . . 0.0 112.823 -173.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.575 HG11 ' HB3' ' A' ' 21' ' ' PHE . 9.4 p -68.64 -38.61 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.327 1.451 . . . . 0.0 111.785 173.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -57.54 -56.16 25.53 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.607 1.094 . . . . 0.0 109.631 169.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -55.23 -32.65 62.45 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.723 1.209 . . . . 0.0 112.342 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -77.04 -58.71 3.13 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.228 -0.92 . . . . 0.0 112.68 176.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.75 -32.64 58.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.88 1.272 . . . . 0.0 112.36 -174.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.93 -15.06 59.78 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -172.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -74.51 -26.54 60.06 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.529 1.131 . . . . 0.0 113.446 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 23.8 pt -110.23 -7.41 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.544 1.538 . . . . 0.0 113.589 -177.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.0 m . . . . . 0 C--O 1.252 1.207 0 C-N-CA 125.103 1.361 . . . . 0.0 113.117 173.83 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.9 ttm . . . . . 0 N--CA 1.502 2.138 0 CA-C-O 119.519 -0.277 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -93.92 91.11 6.75 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.658 1.183 . . . . 0.0 110.756 173.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.34 144.47 42.35 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 121.444 -0.785 . . . . 0.0 111.276 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 p -125.3 145.2 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.249 1.02 . . . . 0.0 112.199 -176.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 40.3 tpp -133.45 117.19 16.91 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.939 1.296 . . . . 0.0 112.071 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -84.19 141.08 31.3 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 119.198 -0.429 . . . . 0.0 111.138 169.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.7 t -134.23 124.73 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.297 1.439 . . . . 0.0 111.622 -176.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.9 p -145.8 -179.4 6.66 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.009 1.324 . . . . 0.0 111.608 175.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.79 -59.96 4.15 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 119.947 -1.721 . . . . 0.0 110.803 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -87.31 136.07 33.08 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 168.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -72.57 -55.92 6.17 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 169.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.479 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 24.9 p -50.8 -49.29 58.77 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.681 1.364 . . . . 0.0 114.681 -176.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.6 m -74.96 -10.88 59.9 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 -143.12 -68.25 0.35 Allowed 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 119.841 1.2 . . . . 0.0 113.571 177.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 44.5 m -65.43 -35.72 81.77 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.456 -1.402 . . . . 0.0 114.472 -172.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -68.97 -29.72 67.99 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 120.922 -1.111 . . . . 0.0 112.887 169.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.2 mtm -61.96 -46.97 86.94 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 169.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.31 -31.2 71.86 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 34' ' ' SER . 27.4 tt0 -69.58 -45.9 67.59 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 120.431 1.469 . . . . 0.0 109.531 176.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.404 ' CA ' HE22 ' A' ' 60' ' ' GLN . . . -63.05 -43.84 98.2 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 118.939 -0.923 . . . . 0.0 111.767 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -63.69 -42.97 97.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.47 1.135 . . . . 0.0 112.409 170.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.43 -31.7 72.07 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 120.515 -1.365 . . . . 0.0 111.056 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -67.86 -55.1 14.18 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 126.502 1.921 . . . . 0.0 109.296 174.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.8 p -68.69 -14.54 63.09 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 177.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 39.8 mt -101.05 1.51 39.55 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.66 1.184 . . . . 0.0 113.83 172.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -157.97 9.97 0.22 Allowed Glycine 0 CA--C 1.535 1.322 0 N-CA-C 117.402 1.721 . . . . 0.0 117.402 -169.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.96 131.35 50.79 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.763 1.782 . . . . 0.0 111.71 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.54 -3.39 59.66 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.491 1.043 . . . . 0.0 115.469 -175.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -87.11 -63.38 1.32 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 119.102 1.451 . . . . 0.0 110.329 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -142.09 173.9 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 127.44 2.296 . . . . 0.0 110.203 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.18 120.81 33.11 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 121.232 -0.917 . . . . 0.0 111.302 176.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 m -94.31 148.13 5.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.791 169.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.55 157.78 43.69 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.758 0.823 . . . . 0.0 110.741 -172.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.423 ' HB3' ' HB2' ' A' ' 19' ' ' GLU . 93.7 p -145.06 146.42 31.86 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 175.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 79.7 p -150.56 -179.04 6.91 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.676 1.591 . . . . 0.0 110.691 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.37 -174.3 43.63 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 116.46 1.344 . . . . 0.0 116.46 170.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.7 mt -71.49 -47.63 54.2 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.261 0.624 . . . . 0.0 111.822 -172.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -92.81 -32.8 14.52 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.26 1.824 . . . . 0.0 111.412 170.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . 0.282 26.0 p 61.22 -53.53 0.11 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 128.177 2.591 . . . . 0.0 114.813 -171.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.0 t 60.36 -178.82 0.1 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 127.579 2.352 . . . . 0.0 115.07 173.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -71.6 166.18 22.4 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 126.531 1.933 . . . . 0.0 112.375 172.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.1 m -62.54 117.83 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 169.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.479 ' H ' ' HB2' ' A' ' 12' ' ' SER . 56.0 t-80 -76.14 132.46 73.61 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 124.033 0.933 . . . . 0.0 113.141 -168.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -57.73 -41.93 65.07 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.484 2.789 . . . . 0.0 114.059 -170.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.6 m -77.68 -35.46 52.24 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.797 -0.564 . . . . 0.0 110.864 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.74 -43.14 94.33 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.327 -0.844 . . . . 0.0 111.942 173.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.7 mt -54.06 -46.54 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 120.34 1.427 . . . . 0.0 109.717 174.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.38 -60.01 4.38 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.4 mmt -66.71 -29.7 69.75 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.414 -0.804 . . . . 0.0 112.13 -172.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 75.4 mmm -80.43 -40.0 27.17 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.668 0.787 . . . . 0.0 110.364 178.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -58.33 -37.31 74.87 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.588 -1.32 . . . . 0.0 112.315 171.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -59.71 -23.8 63.46 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.3 m -105.19 16.0 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 124.715 1.206 . . . . 0.0 114.021 172.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.01 13.65 66.04 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.398 0.999 . . . . 0.0 115.029 177.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.9 mt -120.72 68.81 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.032 1.733 . . . . 0.0 109.601 -169.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -65.17 105.14 1.02 Allowed 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.231 -1.543 . . . . 0.0 110.668 174.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.1 pt -81.2 -0.42 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 O-C-N 121.528 -0.733 . . . . 0.0 112.815 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 85.1 p -71.67 -28.35 63.67 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.399 -1.438 . . . . 0.0 114.043 -172.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.28 2.93 71.88 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 125.332 1.444 . . . . 0.0 114.432 171.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.404 HE22 ' CA ' ' A' ' 20' ' ' GLY . 12.9 mt-30 -86.4 159.16 19.44 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.463 1.505 . . . . 0.0 112.202 -177.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.8 t -87.73 152.63 21.99 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -170.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.3 m -139.36 134.8 32.99 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.362 1.465 . . . . 0.0 110.398 169.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -142.26 142.69 24.81 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 123.979 0.912 . . . . 0.0 111.066 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -81.0 150.52 18.07 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.186 2.591 . . . . 0.0 112.714 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.3 tt -64.5 -18.25 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -172.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -95.86 -9.1 32.32 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -95.68 -36.32 11.25 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.095 0.958 . . . . 0.0 111.2 169.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -67.9 161.49 26.3 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.315 0.579 . . . . 0.0 111.609 174.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -135.78 122.23 20.66 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.338 1.055 . . . . 0.0 110.505 174.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.44 -0.35 10.16 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -171.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -70.49 -32.88 70.57 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.265 0.939 . . . . 0.0 113.421 -169.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -77.34 -21.01 54.02 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -105.27 90.9 3.57 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.003 1.321 . . . . 0.0 110.448 -169.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -58.08 -30.13 65.99 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.21 108.26 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.385 1.074 . . . . 0.0 109.874 -177.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.8 t -112.13 132.65 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.16 0.984 . . . . 0.0 109.81 177.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.6 mm -128.59 118.22 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 123.556 0.742 . . . . 0.0 110.374 -170.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 t -78.88 136.16 37.22 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.536 0.684 . . . . 0.0 109.346 168.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.6 mt -108.58 23.8 13.99 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.342 1.057 . . . . 0.0 109.848 169.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.8 p -151.05 2.36 0.43 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 -174.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.81 26.93 69.29 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-N 119.642 1.11 . . . . 0.0 113.57 -171.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 74.0 m -80.48 -2.04 44.24 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -169.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.88 -22.15 46.96 Favored Glycine 0 CA--C 1.538 1.489 0 O-C-N 120.291 -1.506 . . . . 0.0 115.162 -171.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.8 m -72.71 -13.8 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 172.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -113.57 -17.15 12.24 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.44 1.496 . . . . 0.0 112.135 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.8 mp -67.03 153.72 93.98 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 124.403 1.081 . . . . 0.0 113.039 176.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -59.57 137.34 76.98 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.902 2.401 . . . . 0.0 110.074 169.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -59.0 -33.86 98.94 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.241 1.961 . . . . 0.0 113.33 -174.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -65.41 -25.69 67.65 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.774 1.17 . . . . 0.0 113.974 176.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.72 -19.8 54.6 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.761 -1.212 . . . . 0.0 112.573 171.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.7 t -89.63 -37.28 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.834 1.654 . . . . 0.0 112.087 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.7 p -83.46 18.14 1.93 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -173.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -69.0 166.49 17.9 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.147 0.979 . . . . 0.0 111.519 169.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -53.16 -40.84 64.61 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -169.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 63.4 mt -129.4 126.65 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.664 1.186 . . . . 0.0 109.791 169.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -131.03 125.21 32.67 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.671 1.188 . . . . 0.0 109.929 169.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -140.96 166.16 25.56 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.906 1.282 . . . . 0.0 112.115 -175.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -129.81 134.38 47.52 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.087 1.355 . . . . 0.0 112.306 173.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 46.8 m0 -96.29 0.71 51.23 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 64.63 33.45 10.63 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.829 1.251 . . . . 0.0 114.275 170.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 26.7 mt -90.66 166.43 13.17 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -119.65 148.9 42.81 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.684 1.994 . . . . 0.0 111.178 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.74 119.13 76.12 Favored Pre-proline 0 CA--C 1.55 0.971 0 O-C-N 121.402 -0.812 . . . . 0.0 110.984 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -85.85 -10.19 7.29 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.234 1.956 . . . . 0.0 115.338 -173.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -47.74 113.81 0.78 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.927 1.291 . . . . 0.0 112.938 177.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.04 -3.65 84.57 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 123.978 0.799 . . . . 0.0 114.289 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -78.45 169.52 18.11 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.143 0.972 . . . . 0.0 110.044 169.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 97.2 p -64.13 156.82 27.22 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.383 -0.823 . . . . 0.0 111.903 173.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.9 -30.96 70.49 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.413 -0.804 . . . . 0.0 111.695 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -64.48 -36.34 83.87 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 120.957 -1.089 . . . . 0.0 113.388 173.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.5 t -73.7 -36.65 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 O-C-N 121.061 -1.024 . . . . 0.0 110.272 173.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.54 -40.03 95.95 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.805 0.842 . . . . 0.0 110.675 175.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -67.03 -42.49 84.77 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.046 1.738 . . . . 0.0 111.961 172.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.9 m -58.5 -50.72 72.74 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.402 1.081 . . . . 0.0 111.938 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 19.7 m -67.7 -31.81 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 119.389 0.995 . . . . 0.0 111.699 179.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.2 ptt-85 -70.44 -30.72 67.63 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 120.255 1.389 . . . . 0.0 112.954 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.58 -43.64 96.22 Favored Glycine 0 N--CA 1.477 1.429 0 C-N-CA 123.797 0.713 . . . . 0.0 111.998 169.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -62.61 -38.25 89.47 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 121.63 -0.923 . . . . 0.0 112.456 170.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.7 t -60.23 -50.41 80.34 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.595 173.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -53.13 -52.73 57.77 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 120.177 1.353 . . . . 0.0 111.79 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -48.31 -44.81 34.36 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.468 1.507 . . . . 0.0 112.352 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -90.91 -28.87 17.82 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.125 0.97 . . . . 0.0 112.022 -171.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.8 t -63.91 -50.07 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.916 1.286 . . . . 0.0 109.569 169.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -53.4 -55.27 26.44 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.663 0.665 . . . . 0.0 109.292 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -50.89 -36.69 39.45 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.107 1.763 . . . . 0.0 113.376 174.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -84.78 -61.53 1.76 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.609 1.095 . . . . 0.0 113.513 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -57.49 -33.33 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.751 1.62 . . . . 0.0 111.599 -177.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.5 -10.48 59.84 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 44.7 mttm -80.15 -20.12 45.66 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.596 1.158 . . . . 0.0 112.425 169.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.1 pt -122.23 28.27 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 127.309 2.243 . . . . 0.0 111.569 -176.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 24.3 t . . . . . 0 C--O 1.252 1.228 0 C-N-CA 127.633 2.373 . . . . 0.0 111.114 179.141 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.502 2.166 0 CA-C-O 119.378 -0.344 . . . . 0.0 111.87 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -84.51 99.66 10.86 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 118.995 0.816 . . . . 0.0 110.115 174.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -75.41 147.85 39.63 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.741 0.417 . . . . 0.0 111.855 -174.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.6 t -104.92 140.08 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.464 1.106 . . . . 0.0 110.635 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 49.3 tpp -127.15 113.97 17.08 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.586 0.755 . . . . 0.0 110.331 169.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -81.49 143.35 32.13 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.39 0.676 . . . . 0.0 110.315 169.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.4 t -134.86 123.95 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.443 1.497 . . . . 0.0 110.558 -178.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 p -136.32 170.9 15.28 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.472 1.109 . . . . 0.0 111.162 171.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -58.46 -53.94 52.66 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 120.342 1.428 . . . . 0.0 110.16 175.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -93.87 121.76 35.66 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 168.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.589 ' ND2' ' H ' ' A' ' 63' ' ' ASP . 23.0 t-20 -47.12 -41.36 17.29 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 121.406 1.912 . . . . 0.0 110.713 169.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.6 p -66.59 -35.89 81.31 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.888 1.675 . . . . 0.0 114.868 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 95.1 p -65.69 -37.07 85.45 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -169.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.27 -43.92 0.41 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.8 m -63.11 -42.68 99.62 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 119.731 1.15 . . . . 0.0 113.009 -169.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -57.63 -40.96 80.37 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.292 1.837 . . . . 0.0 112.456 169.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 94.7 mtp -64.87 -43.03 94.31 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.283 0.633 . . . . 0.0 110.488 175.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.14 -29.69 67.78 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 117.701 -1.142 . . . . 0.0 113.409 173.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -70.43 -48.3 56.67 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 121.45 1.932 . . . . 0.0 108.48 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.73 -46.24 94.37 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.607 -1.107 . . . . 0.0 113.676 176.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -66.96 -34.12 77.06 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.542 1.671 . . . . 0.0 112.378 175.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.447 ' HB1' HG11 ' A' ' 32' ' ' VAL . . . -75.05 -33.6 61.74 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.88 -1.137 . . . . 0.0 110.639 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -60.41 -56.21 24.24 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 125.621 1.569 . . . . 0.0 109.444 170.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.0 p -70.3 -11.01 60.61 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.6 mt -98.1 -5.47 33.66 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 171.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.59 17.4 0.08 OUTLIER Glycine 0 CA--C 1.536 1.368 0 N-CA-C 118.661 2.224 . . . . 0.0 118.661 -172.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.73 -33.25 64.08 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.848 1.824 . . . . 0.0 114.511 -173.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.36 -6.15 88.95 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 124.161 0.886 . . . . 0.0 115.043 177.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -101.1 -59.17 1.74 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.958 1.303 . . . . 0.0 112.003 -170.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.5 pp -143.84 171.91 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 127.345 2.258 . . . . 0.0 110.536 -174.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.53 131.99 42.58 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.409 -0.807 . . . . 0.0 112.9 175.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.447 HG11 ' HB1' ' A' ' 22' ' ' ALA . 28.9 m -104.28 149.37 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 C-N-CA 125.09 1.356 . . . . 0.0 113.259 171.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.53 144.87 27.6 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.413 0.685 . . . . 0.0 112.382 -173.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.0 t -114.24 129.44 56.63 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.976 2.111 . . . . 0.0 113.799 175.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.1 t -132.33 177.02 7.91 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.505 1.922 . . . . 0.0 110.764 171.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.55 175.08 46.11 Favored Glycine 0 CA--C 1.523 0.557 0 O-C-N 120.572 -1.33 . . . . 0.0 114.286 171.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.0 mt -67.39 -27.39 67.05 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 122.275 -0.544 . . . . 0.0 111.829 -176.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -123.48 115.56 21.76 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.157 2.183 . . . . 0.0 105.765 169.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 77.3 p -62.31 -20.37 64.25 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.314 -0.866 . . . . 0.0 113.076 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.6 t 54.83 -149.91 0.43 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.773 1.629 . . . . 0.0 113.905 168.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.68 165.11 28.39 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 128.244 2.618 . . . . 0.0 110.052 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 m -67.34 102.12 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 169.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -70.26 135.59 86.79 Favored Pre-proline 0 N--CA 1.476 0.841 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.936 -169.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -60.31 -36.79 86.2 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.911 2.407 . . . . 0.0 113.618 -171.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.2 m -77.56 -33.44 54.04 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.543 -0.723 . . . . 0.0 111.193 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.75 -44.32 81.79 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.053 0.842 . . . . 0.0 111.761 170.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 74.7 mt -50.97 -47.07 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 120.343 1.429 . . . . 0.0 110.337 173.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.54 -63.74 1.13 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 31.9 mmt -68.81 -24.43 64.39 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.45 -0.781 . . . . 0.0 112.942 -170.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 80.7 mmm -79.54 -35.74 39.43 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.732 0.696 . . . . 0.0 110.803 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -61.09 -30.88 70.62 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.631 -1.293 . . . . 0.0 112.693 171.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -54.35 -37.31 64.77 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.207 0.912 . . . . 0.0 112.755 172.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.2 m -98.16 15.2 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.58 1.152 . . . . 0.0 113.914 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.03 13.01 67.16 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.115 0.864 . . . . 0.0 115.029 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 47.6 mt -119.49 70.34 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.63 1.572 . . . . 0.0 109.709 -169.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -66.13 108.96 2.43 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 119.995 -1.691 . . . . 0.0 110.56 171.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.7 pt -84.52 -4.74 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.0 t -61.86 -32.68 73.05 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 120.382 1.446 . . . . 0.0 112.912 -170.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.32 4.51 80.49 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.03 1.3 . . . . 0.0 115.383 173.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -87.77 149.0 24.45 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.017 1.408 . . . . 0.0 112.36 -172.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.8 t -76.08 157.08 33.3 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.0 p -139.21 154.7 48.06 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.185 1.394 . . . . 0.0 109.847 169.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.589 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -146.88 149.98 37.7 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.387 1.075 . . . . 0.0 111.62 -175.099 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -88.79 152.61 6.07 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.637 2.891 . . . . 0.0 111.335 174.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.6 tp -60.23 -21.53 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.31 1.444 . . . . 0.0 114.863 -177.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -97.6 -9.1 27.53 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -92.08 -38.77 12.0 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 118.891 0.769 . . . . 0.0 111.609 172.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.0 158.24 36.0 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.388 0.613 . . . . 0.0 111.192 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -138.13 115.82 11.4 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.778 1.231 . . . . 0.0 109.476 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.5 0.18 5.65 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 -169.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -70.04 -29.12 66.08 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.715 1.143 . . . . 0.0 112.328 -172.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -87.43 -2.8 58.87 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.008 1.323 . . . . 0.0 113.062 175.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -124.88 83.29 2.14 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.106 1.762 . . . . 0.0 109.5 -171.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -57.76 -19.13 25.78 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.18 0.992 . . . . 0.0 113.404 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.3 t -121.03 113.9 41.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.46 1.504 . . . . 0.0 109.931 -177.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.6 t -127.42 133.79 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 121.501 -0.749 . . . . 0.0 110.199 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.454 HG21 ' CE2' ' A' ' 99' ' ' TRP . 24.2 mm -129.09 133.21 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 121.567 -0.708 . . . . 0.0 111.21 -169.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.7 t -92.7 119.4 32.06 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.798 1.639 . . . . 0.0 110.835 173.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.435 ' CD1' HG22 ' A' ' 77' ' ' ILE . 1.3 mp -103.33 27.96 6.82 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.21 1.804 . . . . 0.0 111.327 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.4 p -146.23 173.37 12.29 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.465 1.906 . . . . 0.0 109.827 169.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.82 58.47 4.24 Favored Glycine 0 N--CA 1.478 1.493 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 168.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 27.4 p -133.32 -3.93 3.04 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -167.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -57.14 -36.86 76.84 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 120.463 1.483 . . . . 0.0 114.997 -170.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.9 m -68.69 -14.59 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 176.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -99.11 -4.23 32.77 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.2 1.4 . . . . 0.0 113.177 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.6 mt -74.67 158.92 84.34 Favored Pre-proline 0 CA--C 1.549 0.905 0 O-C-N 121.239 -0.913 . . . . 0.0 111.394 173.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.65 138.57 86.73 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.747 2.298 . . . . 0.0 111.51 172.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.1 -38.48 45.42 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.466 2.111 . . . . 0.0 112.595 -169.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.93 -23.96 65.13 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.121 -0.987 . . . . 0.0 113.586 176.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -78.69 -9.6 59.46 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.699 -1.251 . . . . 0.0 112.949 169.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.5 t -100.78 -41.66 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 126.513 1.925 . . . . 0.0 111.481 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.1 p -80.52 28.98 0.31 Allowed 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -172.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -79.29 170.47 16.58 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.955 1.302 . . . . 0.0 111.99 170.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -57.79 -36.6 72.4 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.125 0.97 . . . . 0.0 113.496 -170.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 61.9 mt -128.01 125.65 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.909 1.284 . . . . 0.0 109.59 170.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -135.71 138.96 43.28 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.041 0.937 . . . . 0.0 111.479 169.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -143.26 146.71 33.86 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.128 1.371 . . . . 0.0 112.03 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -109.35 116.84 32.6 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.175 1.39 . . . . 0.0 109.586 169.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.454 ' CE2' HG21 ' A' ' 77' ' ' ILE . 45.8 m0 -94.08 -6.95 43.92 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.331 1.2 pp0? 50.12 30.28 4.12 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 176.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.5 mt -73.04 150.05 42.69 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -86.07 158.9 19.71 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.872 1.669 . . . . 0.0 113.016 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -81.89 128.42 68.67 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.848 1.259 . . . . 0.0 112.866 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -88.24 -38.58 0.06 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.61 2.207 . . . . 0.0 113.595 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 19.43 51.35 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 131.622 3.969 . . . . 0.0 117.786 169.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.36 11.56 79.79 Favored Glycine 0 CA--C 1.539 1.588 0 O-C-N 120.797 -1.189 . . . . 0.0 115.046 176.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -63.37 -52.89 59.82 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.807 1.243 . . . . 0.0 111.076 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 34.1 t -168.48 153.56 6.38 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.742 2.017 . . . . 0.0 109.627 169.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.5 mp -56.85 -31.84 65.2 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.982 0.913 . . . . 0.0 110.999 172.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.56 -39.83 74.12 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.978 1.311 . . . . 0.0 112.568 173.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.6 t -73.16 -38.11 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 121.503 -0.748 . . . . 0.0 109.668 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -63.86 -44.58 92.67 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.265 0.484 . . . . 0.0 111.463 175.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -64.35 -39.12 93.27 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.514 1.126 . . . . 0.0 111.74 176.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.1 m -62.51 -52.84 61.88 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.012 0.925 . . . . 0.0 111.469 173.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.5 m -72.69 -29.71 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 117.047 -1.454 . . . . 0.0 112.78 -177.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.9 ptt85 -64.16 -37.12 86.33 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 121.805 2.093 . . . . 0.0 112.181 171.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.55 -48.99 77.65 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.886 0.755 . . . . 0.0 112.316 173.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -59.81 -45.58 91.89 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 117.586 0.693 . . . . 0.0 112.407 173.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.9 t -58.67 -46.88 90.2 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.495 0 CA-C-O 117.843 -1.075 . . . . 0.0 110.169 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -52.12 -53.57 41.08 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.044 1.293 . . . . 0.0 111.853 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -58.3 -45.66 87.59 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.098 0.475 . . . . 0.0 111.854 -178.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -75.11 -33.5 61.61 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 36.4 t -63.13 -47.91 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.97 1.308 . . . . 0.0 111.03 169.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -53.77 -55.71 23.95 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.523 1.056 . . . . 0.0 109.481 174.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -53.33 -26.2 17.99 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.059 1.344 . . . . 0.0 113.545 177.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -91.68 -62.27 1.46 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.277 1.431 . . . . 0.0 112.945 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.84 -31.03 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.581 1.552 . . . . 0.0 111.551 -176.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.52 -7.22 54.7 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -74.06 -27.79 61.09 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.6 1.16 . . . . 0.0 112.693 169.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.4 pt -117.26 -7.91 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.616 1.966 . . . . 0.0 113.555 -171.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 C--O 1.255 1.391 0 C-N-CA 125.261 1.424 . . . . 0.0 112.458 172.426 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.3 ttm . . . . . 0 N--CA 1.502 2.159 0 CA-C-O 119.653 -0.213 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -90.32 90.25 7.98 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.257 1.023 . . . . 0.0 110.487 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -80.94 149.24 29.47 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 121.573 -0.704 . . . . 0.0 112.232 -174.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.2 t -115.09 143.41 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.663 1.185 . . . . 0.0 111.124 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.1 tpp -130.62 122.68 27.88 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.248 1.019 . . . . 0.0 111.019 169.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -93.22 138.67 31.39 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.509 -0.744 . . . . 0.0 110.597 169.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.8 t -134.41 130.5 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.984 1.314 . . . . 0.0 110.384 -171.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 t -151.8 -165.67 2.29 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.439 0.696 . . . . 0.0 112.542 169.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -63.0 -70.54 0.2 Allowed 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 119.406 1.003 . . . . 0.0 111.045 170.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 56.6 mtt-85 -79.07 127.76 32.41 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 118.569 0.622 . . . . 0.0 109.955 169.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.598 ' ND2' ' H ' ' A' ' 63' ' ' ASP . 19.2 t-20 -61.06 -43.37 98.98 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 168.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 99.3 p -73.97 -48.26 31.69 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 -169.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.0 p -83.29 -11.23 57.95 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.763 -1.211 . . . . 0.0 113.695 -173.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 -126.63 -67.42 0.86 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.788 1.235 . . . . 0.0 111.734 -176.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.3 m -64.21 -44.51 91.68 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.16 1.171 . . . . 0.0 114.16 -175.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -57.5 -30.68 65.31 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.832 1.253 . . . . 0.0 113.792 170.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.1 mtm -68.17 -49.36 61.44 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.072 0.851 . . . . 0.0 110.92 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.72 -29.93 70.04 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.622 -0.674 . . . . 0.0 112.686 172.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -71.23 -44.22 65.78 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 119.691 1.132 . . . . 0.0 109.269 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.96 -41.31 98.7 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 119.299 -0.723 . . . . 0.0 112.073 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -62.73 -44.24 96.73 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.885 1.342 . . . . 0.0 111.719 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.82 -32.79 69.97 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 120.574 -1.329 . . . . 0.0 111.224 -174.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -64.91 -56.3 14.14 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 126.432 1.893 . . . . 0.0 109.449 171.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.3 p -68.08 -14.93 63.35 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 52.7 mt -100.74 -8.16 23.04 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.454 1.102 . . . . 0.0 113.816 174.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.58 10.55 1.27 Allowed Glycine 0 CA--C 1.534 1.273 0 N-CA-C 117.181 1.632 . . . . 0.0 117.181 -169.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.98 131.01 46.19 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.16 1.48 . . . . 0.0 112.067 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.47 -6.44 57.66 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.528 1.061 . . . . 0.0 115.531 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -86.25 -61.32 1.77 Allowed 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 119.296 1.548 . . . . 0.0 110.339 175.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 pp -142.75 173.01 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 127.667 2.387 . . . . 0.0 110.316 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.75 130.02 41.45 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 121.366 -0.834 . . . . 0.0 112.314 175.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.7 m -104.15 153.04 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.716 1.206 . . . . 0.0 112.478 170.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.19 145.7 27.27 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -171.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.1 t -110.33 133.49 53.2 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.835 2.054 . . . . 0.0 113.615 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.8 t -141.84 171.33 14.2 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.521 1.928 . . . . 0.0 110.949 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.59 -179.82 45.66 Favored Glycine 0 CA--C 1.526 0.778 0 O-C-N 120.883 -1.136 . . . . 0.0 114.567 169.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 38.0 mt -63.19 -26.7 68.93 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.23 1.012 . . . . 0.0 112.074 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -128.34 127.43 42.67 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.19 1.396 . . . . 0.0 109.09 170.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.6 p -77.48 58.04 1.65 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.262 1.425 . . . . 0.0 110.492 171.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.4 p -65.9 156.62 32.87 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 114.146 -1.388 . . . . 0.0 112.818 -169.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -64.74 144.64 57.1 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.251 1.02 . . . . 0.0 109.981 177.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.7 m -41.23 109.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.852 1.661 . . . . 0.0 109.082 170.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -68.03 132.31 92.06 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-O 118.383 -0.817 . . . . 0.0 112.82 -167.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.31 -39.15 80.17 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.372 2.715 . . . . 0.0 113.566 -170.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.0 m -78.05 -37.06 47.66 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 119.151 -0.452 . . . . 0.0 110.496 177.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.67 -40.78 96.02 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.626 1.103 . . . . 0.0 112.475 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 60.4 mt -52.38 -47.17 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 120.98 1.718 . . . . 0.0 109.927 172.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.82 -58.38 8.68 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 175.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.6 mmt -66.18 -22.0 66.34 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -175.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 88.5 mmm -90.93 -37.36 13.58 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.941 0.896 . . . . 0.0 110.592 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -60.89 -33.89 73.81 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.407 -1.433 . . . . 0.0 112.319 169.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -56.0 -30.06 61.26 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.036 0.934 . . . . 0.0 113.313 173.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.4 m -103.41 13.64 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.857 1.263 . . . . 0.0 114.155 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.13 17.2 63.32 Favored Glycine 0 CA--C 1.537 1.467 0 O-C-N 121.209 -0.932 . . . . 0.0 115.106 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.1 mt -122.54 79.68 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.977 1.711 . . . . 0.0 109.631 -169.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -70.28 106.59 3.4 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.053 -1.655 . . . . 0.0 111.185 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.1 pt -82.3 -10.14 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 118.166 -0.921 . . . . 0.0 112.576 175.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.5 t -61.85 -33.15 73.66 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 120.3 1.409 . . . . 0.0 113.029 -169.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -95.94 6.52 66.91 Favored Glycine 0 CA--C 1.541 1.674 0 C-N-CA 125.098 1.333 . . . . 0.0 115.294 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -93.32 151.27 19.89 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.028 1.414 . . . . 0.0 111.477 -171.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.6 t -68.25 149.98 48.83 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -170.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.8 t -135.81 133.24 37.67 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.36 1.464 . . . . 0.0 109.183 169.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.598 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 4.1 t70 -148.21 146.22 22.65 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.696 1.598 . . . . 0.0 110.836 -172.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -91.15 154.46 3.82 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.574 2.183 . . . . 0.0 112.65 -173.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.3 tt -60.66 -21.42 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -94.06 -9.58 36.24 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -94.51 -37.44 11.39 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.785 0.834 . . . . 0.0 111.816 170.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.58 163.18 27.5 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.26 0.552 . . . . 0.0 111.644 174.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -139.38 134.1 31.99 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.015 0.926 . . . . 0.0 110.633 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.62 6.87 6.41 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -174.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -74.31 -30.86 62.25 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.068 -1.02 . . . . 0.0 112.594 -173.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -88.86 -3.74 58.67 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.657 1.183 . . . . 0.0 113.6 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -123.72 94.01 4.11 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.739 1.616 . . . . 0.0 110.151 -171.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -62.75 -18.9 63.37 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.0 t -120.09 114.74 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.812 1.245 . . . . 0.0 110.472 -176.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.3 t -127.9 129.88 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.995 0.918 . . . . 0.0 110.814 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.5 mm -116.35 125.29 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.301 0.641 . . . . 0.0 111.56 -172.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.0 t -86.11 92.12 8.63 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.379 1.472 . . . . 0.0 109.155 169.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.9 mt -76.94 -11.04 59.75 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.884 0.873 . . . . 0.0 112.158 171.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 27.5 p -75.71 -22.88 56.19 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.586 0.755 . . . . 0.0 111.673 169.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.88 21.86 65.91 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 123.587 0.613 . . . . 0.0 112.503 -169.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 31.3 p -98.06 -54.28 3.13 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.163 1.385 . . . . 0.0 113.028 -169.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.29 -65.02 1.0 Allowed Glycine 0 N--CA 1.476 1.344 0 C-N-CA 124.791 1.186 . . . . 0.0 114.002 177.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.5 m -64.24 -22.09 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.444 1.498 . . . . 0.0 114.175 -176.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -87.98 -0.96 57.67 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.177 0.991 . . . . 0.0 112.998 175.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.0 mt -94.43 151.31 39.26 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 124.958 1.303 . . . . 0.0 109.867 170.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.86 136.68 75.26 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.326 2.018 . . . . 0.0 110.645 169.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -64.22 -29.55 64.43 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.485 2.123 . . . . 0.0 112.63 -176.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -61.37 -28.68 69.41 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 171.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.35 13.28 13.95 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.829 1.252 . . . . 0.0 114.163 171.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.6 t -114.1 -37.19 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.666 1.587 . . . . 0.0 111.416 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -81.04 27.09 0.41 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 115.297 1.592 . . . . 0.0 115.297 -169.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -77.11 165.7 24.25 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.822 1.649 . . . . 0.0 112.64 173.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -56.23 -38.23 70.8 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.776 1.23 . . . . 0.0 113.008 -172.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.0 mt -127.48 116.99 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.14 1.376 . . . . 0.0 108.704 169.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -128.14 128.44 44.82 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.191 0.997 . . . . 0.0 109.881 169.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -137.29 140.0 41.28 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.613 0.765 . . . . 0.0 113.007 -170.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -97.9 104.59 16.63 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.265 1.826 . . . . 0.0 112.173 176.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 16.2 m0 -95.2 92.14 6.63 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 169.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -60.92 54.43 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 128.277 2.631 . . . . 0.0 115.718 176.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 77.3 mt -76.43 167.71 21.37 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.036 2.134 . . . . 0.0 111.841 175.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -96.73 153.89 17.61 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.748 1.219 . . . . 0.0 110.628 169.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -77.31 120.24 80.75 Favored Pre-proline 0 CA--C 1.546 0.809 0 O-C-N 120.88 -1.138 . . . . 0.0 111.114 172.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -87.13 -19.29 2.54 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.466 1.444 . . . . 0.0 114.957 -170.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -53.42 107.41 0.24 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.635 1.174 . . . . 0.0 112.092 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.04 -0.94 69.78 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.288 0.947 . . . . 0.0 114.62 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -77.95 172.15 13.91 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 118.316 1.058 . . . . 0.0 110.18 169.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 90.4 p -66.35 156.68 33.8 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.045 -1.034 . . . . 0.0 111.557 169.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.92 -27.58 68.95 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.306 -0.871 . . . . 0.0 111.862 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.2 -40.73 86.69 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.128 -0.983 . . . . 0.0 112.354 170.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 78.7 t -74.04 -37.73 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.371 -0.831 . . . . 0.0 110.416 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.59 -41.56 99.03 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.515 0.726 . . . . 0.0 111.075 176.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -69.55 -37.54 77.1 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.715 1.206 . . . . 0.0 112.29 171.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 55.3 m -58.3 -49.09 78.38 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 119.157 0.89 . . . . 0.0 111.589 176.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 31.2 m -67.22 -30.68 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 119.934 1.243 . . . . 0.0 111.719 177.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.416 ' HA ' HG22 ' A' ' 119' ' ' VAL . 0.1 OUTLIER -60.37 -46.54 89.58 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 119.811 1.187 . . . . 0.0 111.318 169.592 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.53 -35.66 92.33 Favored Glycine 0 N--CA 1.472 1.054 0 C-N-CA 123.823 0.725 . . . . 0.0 112.153 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -68.46 -51.43 43.57 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 171.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.416 HG22 ' HA ' ' A' ' 116' ' ' ARG . 3.6 m -61.26 -39.68 83.43 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 CA-C-O 117.372 -1.299 . . . . 0.0 111.179 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -47.92 -57.5 5.63 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.331 1.423 . . . . 0.0 111.898 174.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -63.67 -41.78 98.15 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.274 0.629 . . . . 0.0 112.387 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 59.1 mtp85 -73.77 -34.74 64.82 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.87 -47.97 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.271 1.428 . . . . 0.0 111.465 171.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -52.63 -54.41 33.66 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.454 1.025 . . . . 0.0 109.563 177.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -55.56 -38.83 69.83 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.063 1.345 . . . . 0.0 112.668 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -73.1 -56.93 4.44 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.169 -0.957 . . . . 0.0 112.454 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -67.77 -34.22 66.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.014 1.326 . . . . 0.0 112.115 -176.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.21 -17.02 60.95 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -173.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -72.94 -22.07 60.78 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.39 1.076 . . . . 0.0 113.649 171.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.0 pt -118.37 11.29 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.3 1.84 . . . . 0.0 112.925 -175.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.19 1.796 . . . . 0.0 112.332 177.572 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.5 ttm . . . . . 0 N--CA 1.504 2.249 0 CA-C-O 119.246 -0.407 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -77.64 100.89 6.34 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 119.117 0.871 . . . . 0.0 110.74 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -86.6 136.06 33.19 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.111 1.764 . . . . 0.0 111.763 -172.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.4 t -114.64 143.06 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 124.176 0.991 . . . . 0.0 111.793 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.4 ' HG2' ' CZ ' ' A' ' 68' ' ' PHE . 48.2 tpp -131.05 125.06 32.23 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.277 1.031 . . . . 0.0 111.602 169.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -93.05 136.84 32.94 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.533 0.733 . . . . 0.0 110.48 169.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 t -130.61 130.15 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.38 1.472 . . . . 0.0 110.2 -174.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.8 p -149.14 176.42 10.5 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.989 0.916 . . . . 0.0 112.628 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -63.93 -46.79 83.21 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.904 -1.122 . . . . 0.0 111.251 171.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.406 ' HB3' ' H ' ' A' ' 13' ' ' SER . 1.0 OUTLIER -109.26 111.66 23.38 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.358 1.463 . . . . 0.0 109.791 169.326 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.515 ' ND2' ' H ' ' A' ' 63' ' ' ASP . 58.8 t-20 -57.56 -46.95 83.32 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 169.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.6 p -43.48 -46.59 6.91 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 174.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.406 ' H ' ' HB3' ' A' ' 10' ' ' ARG . 27.3 p -97.44 -16.12 20.32 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.05 1.129 . . . . 0.0 114.05 -172.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -130.94 -62.63 0.89 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 119.738 1.153 . . . . 0.0 113.979 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.8 m -61.34 -35.08 76.42 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 120.118 1.326 . . . . 0.0 112.953 -177.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -62.98 -38.19 90.15 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.722 1.209 . . . . 0.0 113.446 169.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 84.9 mtp -64.29 -48.79 74.35 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.445 1.021 . . . . 0.0 110.714 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.07 -28.45 68.85 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 175.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -75.27 -41.52 57.03 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 119.72 1.145 . . . . 0.0 109.067 -178.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.66 -45.0 96.7 Favored Glycine 0 CA--C 1.52 0.37 0 CA-C-O 119.345 -0.697 . . . . 0.0 112.425 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -64.55 -43.81 92.79 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.851 1.326 . . . . 0.0 112.065 172.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.56 -32.49 69.92 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.454 -1.404 . . . . 0.0 111.767 -175.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -64.89 -55.63 18.17 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 125.332 1.453 . . . . 0.0 109.425 170.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.1 p -73.12 -8.92 57.9 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.587 -1.32 . . . . 0.0 114.523 -176.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 51.7 mt -100.28 -5.75 27.0 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.48 1.112 . . . . 0.0 113.701 170.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.29 15.2 0.1 OUTLIER Glycine 0 CA--C 1.537 1.417 0 N-CA-C 118.609 2.204 . . . . 0.0 118.609 -171.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.22 -33.67 67.77 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.162 1.981 . . . . 0.0 114.308 -172.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.43 -5.5 89.93 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.257 0.932 . . . . 0.0 115.029 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -100.77 -63.01 1.17 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.862 1.265 . . . . 0.0 111.409 -172.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -141.87 173.34 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 126.128 1.771 . . . . 0.0 112.122 -175.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.93 123.22 36.04 Favored 'General case' 0 C--N 1.343 0.291 0 O-C-N 121.368 -0.832 . . . . 0.0 112.502 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.0 m -101.47 151.97 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.05 0.94 . . . . 0.0 111.67 169.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.65 152.38 37.76 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.15 0.58 . . . . 0.0 111.544 -173.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.5 p -120.69 141.47 50.38 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.661 1.585 . . . . 0.0 114.731 175.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.3 t -145.99 167.54 23.07 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 127.308 2.243 . . . . 0.0 110.005 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 173.87 171.46 38.32 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 120.73 -1.231 . . . . 0.0 114.803 169.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 35.0 mt -62.12 -40.28 95.38 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.738 0.815 . . . . 0.0 111.477 -173.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -120.55 116.6 25.7 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 127.879 2.472 . . . . 0.0 105.874 169.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.7 p -67.21 -49.19 65.5 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.128 -0.982 . . . . 0.0 110.41 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.4 t 53.64 -173.26 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 127.031 2.132 . . . . 0.0 113.838 -174.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -80.86 177.8 8.81 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 127.051 2.14 . . . . 0.0 113.005 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.4 m -66.44 116.69 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 120.596 -1.315 . . . . 0.0 107.639 168.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -66.36 128.09 93.65 Favored Pre-proline 0 N--CA 1.478 0.934 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -168.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.64 -39.23 55.53 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.265 2.644 . . . . 0.0 113.994 -169.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.4 ' HB ' ' CE2' ' A' ' 112' ' ' PHE . 28.4 m -80.48 -32.65 37.01 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 122.023 -0.423 . . . . 0.0 110.629 178.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.67 -38.07 86.06 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.011 -1.056 . . . . 0.0 112.375 174.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 65.1 mt -53.02 -42.18 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 120.634 1.561 . . . . 0.0 110.559 172.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.86 -61.23 2.3 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.355 0.662 . . . . 0.0 112.702 173.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.4 mmt -66.08 -24.18 66.66 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -172.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 79.3 mmm -87.78 -33.9 18.5 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.976 0.91 . . . . 0.0 110.95 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -60.84 -32.74 72.13 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.704 -1.247 . . . . 0.0 111.901 169.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -54.41 -31.58 55.41 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.326 -0.859 . . . . 0.0 113.232 173.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.1 m -104.0 14.27 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 175.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.52 13.35 65.51 Favored Glycine 0 CA--C 1.536 1.365 0 O-C-N 120.984 -1.072 . . . . 0.0 115.224 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.5 mt -118.36 71.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.803 1.641 . . . . 0.0 109.411 -169.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -64.07 110.69 2.24 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 120.34 -1.475 . . . . 0.0 110.218 172.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 pt -92.73 4.33 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.326 0.65 . . . . 0.0 112.627 178.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.3 p -68.4 -22.62 64.62 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.492 1.496 . . . . 0.0 113.855 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.5 8.24 62.03 Favored Glycine 0 CA--C 1.541 1.712 0 C-N-CA 125.548 1.547 . . . . 0.0 114.353 169.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -76.0 139.71 41.63 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.556 1.178 . . . . 0.0 111.274 -174.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.1 t -64.78 156.35 30.87 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.262 0.553 . . . . 0.0 111.588 169.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.0 t -143.57 127.99 17.89 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 169.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.515 ' H ' ' ND2' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -124.64 142.23 40.07 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.593 1.157 . . . . 0.0 111.305 -174.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -87.58 152.87 7.63 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.611 2.874 . . . . 0.0 111.368 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.0 tt -60.91 -29.86 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -169.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -94.85 -6.92 41.67 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -80.91 -38.51 27.81 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.477 -0.764 . . . . 0.0 110.592 169.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.4 ' CZ ' ' HG2' ' A' ' 5' ' ' MET . 0.0 OUTLIER -77.22 160.09 29.18 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.375 1.07 . . . . 0.0 111.716 172.45 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.63 116.5 14.12 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.899 1.28 . . . . 0.0 109.612 174.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.97 -3.85 6.01 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 -169.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -67.44 -30.56 70.33 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.3 0.954 . . . . 0.0 113.431 -169.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -84.3 -8.78 58.91 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 176.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -104.72 100.4 10.05 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 120.898 -1.127 . . . . 0.0 110.12 -169.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -52.19 -33.74 42.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.279 1.431 . . . . 0.0 112.736 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.0 t -125.41 122.75 63.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 125.385 1.474 . . . . 0.0 110.003 -174.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.0 t -124.05 130.43 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.671 0.788 . . . . 0.0 109.86 175.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 50.1 mm -125.45 123.12 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 123.927 0.891 . . . . 0.0 110.687 -169.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.8 t -82.2 137.4 34.92 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 168.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.401 ' CD2' ' CE3' ' A' ' 99' ' ' TRP . 76.5 mt -110.03 28.25 8.79 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.871 1.268 . . . . 0.0 109.857 170.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 28.1 t -155.11 140.02 17.27 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.322 1.449 . . . . 0.0 113.307 -169.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.05 -21.57 59.37 Favored Glycine 0 CA--C 1.541 1.667 0 O-C-N 121.418 -0.801 . . . . 0.0 112.921 169.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.1 p -66.41 -0.19 2.54 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.154 1.782 . . . . 0.0 114.915 169.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.0 -23.93 40.76 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.843 1.211 . . . . 0.0 114.878 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.3 m -64.05 -17.09 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 O-C-N 121.272 -1.134 . . . . 0.0 113.969 172.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.16 5.09 51.85 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.215 1.406 . . . . 0.0 113.073 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.3 mt -70.0 145.64 94.29 Favored Pre-proline 0 CA--C 1.55 0.975 0 O-C-N 120.828 -1.17 . . . . 0.0 111.721 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -58.77 163.69 10.8 Favored 'Trans proline' 0 CA--C 1.551 1.34 0 C-N-CA 123.716 2.944 . . . . 0.0 113.608 171.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.81 -52.74 1.16 Allowed 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.521 2.147 . . . . 0.0 113.784 -171.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -60.18 -36.61 78.01 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 120.664 -1.272 . . . . 0.0 111.897 177.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -63.89 7.01 0.13 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 127.928 2.491 . . . . 0.0 115.046 170.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.1 t -134.86 -42.7 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 127.109 2.164 . . . . 0.0 111.525 175.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.7 p -79.9 32.64 0.26 Allowed 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -169.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -85.47 168.8 14.22 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.374 1.069 . . . . 0.0 112.187 172.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -57.06 -36.1 70.13 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -169.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 60.4 mt -125.87 125.58 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.772 1.229 . . . . 0.0 108.813 169.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -133.33 131.14 39.78 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.172 0.989 . . . . 0.0 111.536 169.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -145.96 162.0 38.79 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.196 1.398 . . . . 0.0 111.757 -175.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -125.52 122.53 36.85 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.679 1.192 . . . . 0.0 111.422 170.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.401 ' CE3' ' CD2' ' A' ' 79' ' ' LEU . 44.1 m0 -82.54 -4.55 57.75 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 61.43 47.57 6.63 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.328 1.451 . . . . 0.0 113.62 169.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.0 mt -99.89 149.02 23.84 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -171.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -82.69 152.89 25.61 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.327 1.451 . . . . 0.0 111.336 170.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -80.85 120.67 79.56 Favored Pre-proline 0 CA--C 1.545 0.786 0 O-C-N 121.27 -0.894 . . . . 0.0 111.232 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -82.17 -10.6 11.25 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.231 1.954 . . . . 0.0 114.564 -176.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -53.23 107.63 0.25 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.754 1.161 . . . . 0.0 112.583 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.37 3.36 90.02 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 119.306 -0.719 . . . . 0.0 114.803 177.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -73.66 165.21 25.52 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.501 1.151 . . . . 0.0 110.437 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.2 m -60.66 147.84 40.59 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.42 -0.8 . . . . 0.0 111.171 170.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.83 -27.85 69.61 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.413 -0.805 . . . . 0.0 112.916 -172.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -59.04 -39.4 81.89 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.053 -1.029 . . . . 0.0 112.648 170.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.7 t -72.19 -37.03 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.907 0.883 . . . . 0.0 110.032 175.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.4 ' CE2' ' HB ' ' A' ' 45' ' ' THR . 0.3 OUTLIER -64.07 -40.93 97.35 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.435 0.694 . . . . 0.0 111.172 177.003 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -69.64 -37.2 76.67 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 120.778 -1.201 . . . . 0.0 112.521 171.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 55.1 m -59.15 -48.7 80.64 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.135 0.974 . . . . 0.0 111.558 175.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 19.7 m -66.51 -29.96 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 119.743 1.156 . . . . 0.0 111.947 175.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -45.94 89.61 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 120.086 1.312 . . . . 0.0 110.875 169.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.91 -41.33 97.73 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 118.955 0.798 . . . . 0.0 112.393 174.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -67.24 -43.04 82.93 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 175.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.3 m -67.15 -41.2 86.65 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.695 0 CA-C-N 119.807 1.185 . . . . 0.0 110.547 176.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -51.55 -54.13 30.7 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.689 1.586 . . . . 0.0 111.581 175.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -50.6 -49.64 55.99 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.779 1.631 . . . . 0.0 112.347 176.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -87.41 -27.95 22.44 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.661 0.784 . . . . 0.0 112.248 -170.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.4 t -63.53 -51.79 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.201 1.4 . . . . 0.0 109.187 169.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -54.01 -53.77 48.41 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.312 0.96 . . . . 0.0 109.613 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -52.01 -37.78 54.53 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.803 1.641 . . . . 0.0 112.49 176.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -79.07 -59.09 2.92 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.007 -1.058 . . . . 0.0 113.357 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.54 -33.89 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.789 1.636 . . . . 0.0 112.14 -174.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.53 -17.01 60.81 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.085 -1.009 . . . . 0.0 113.57 -174.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -74.03 -21.25 60.03 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.537 1.135 . . . . 0.0 113.786 171.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.5 pt -118.19 10.42 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.144 1.778 . . . . 0.0 113.006 -175.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.6 m . . . . . 0 C--O 1.253 1.283 0 C-N-CA 126.473 1.909 . . . . 0.0 112.024 177.721 . . . . . . . . 0 0 . 1 stop_ save_